Secretory	O
immunoglobulin	O
A	O
(	O
SIgA	O
)	O
antibodies	O
reactive	O
with	O
the	O
pioneer	O
oral	O
streptococci	B-bacteria
Streptococcus	B-bacteria
mitis	I-bacteria
biovar	I-bacteria
1	I-bacteria
and	O
Streptococcus	B-bacteria
oralis	I-bacteria
,	O
the	O
late	O
oral	O
colonizer	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
and	O
the	O
pioneer	O
enteric	O
bacterium	O
Enterococcus	B-bacteria
faecalis	I-bacteria
in	O
saliva	O
samples	O
from	O
10	O
human	O
infants	O
from	O
birth	O
to	O
age	O
2	O
years	O
were	O
analyzed	O
.	O

Low	O
levels	O
of	O
salivary	O
SIgA1	O
and	O
SIgA2	O
antibodies	O
reactive	O
with	O
whole	O
cells	O
of	O
all	O
four	O
species	O
were	O
detected	O
within	O
the	O
first	O
month	O
after	O
birth	O
,	O
even	O
though	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
were	O
not	O
recovered	O
from	O
the	O
mouths	O
of	O
the	O
infants	O
during	O
the	O
study	O
period	O
.	O

Although	O
there	O
was	O
a	O
fivefold	O
increase	O
in	O
the	O
concentration	O
of	O
SIgA	O
between	O
birth	O
and	O
age	O
2	O
years	O
,	O
there	O
were	O
no	O
differences	O
between	O
the	O
concentrations	O
of	O
SIgA1	O
and	O
SIgA2	O
antibodies	O
reactive	O
with	O
the	O
four	O
species	O
over	O
this	O
time	O
period	O
.	O

When	O
the	O
concentrations	O
of	O
SIgA1	O
and	O
SIgA2	O
antibodies	O
reactive	O
with	O
all	O
four	O
species	O
were	O
normalized	O
to	O
the	O
concentrations	O
of	O
SIgA1	O
and	O
SIgA2	O
in	O
saliva	O
,	O
SIgA1	O
and	O
SIgA2	O
antibodies	O
reactive	O
with	O
these	O
bacteria	O
showed	O
a	O
significant	O
decrease	O
from	O
birth	O
to	O
2	O
years	O
of	O
age	O
.	O

Adsorption	O
of	O
each	O
infant	O
'	O
s	O
saliva	O
with	O
cells	O
of	O
one	O
species	O
produced	O
a	O
dramatic	O
reduction	O
of	O
antibodies	O
recognizing	O
the	O
other	O
three	O
species	O
.	O

Sequential	O
adsorption	O
of	O
saliva	O
samples	O
removed	O
all	O
SIgA	O
antibody	O
to	O
the	O
bacteria	O
,	O
indicating	O
that	O
the	O
SIgA	O
antibodies	O
were	O
directed	O
to	O
antigens	O
shared	O
by	O
all	O
four	O
species	O
.	O

The	O
induction	O
by	O
the	O
host	O
of	O
a	O
limited	O
immune	O
response	O
to	O
common	O
antigens	O
that	O
are	O
likely	O
not	O
involved	O
in	O
adherence	O
may	O
be	O
among	O
the	O
mechanisms	O
that	O
commensal	O
streptococci	B-bacteria
employ	O
to	O
persist	O
in	O
the	O
oral	O
cavity	O
.	O

Human	O
salivary	O
mucin	O
MG2	O
was	O
purified	O
from	O
submandibular	O
/	O
sublingual	O
gland	O
secretion	O
by	O
ultrafiltration	O
and	O
sequential	O
gel	O
filtration	O
chromatography	O
on	O
Sephadex	O
G	O
-	O
200	O
,	O
Superose	O
6	O
(	O
prepgrade	O
)	O
,	O
and	O
Superose	O
6	O
.	O

This	O
method	O
differs	O
from	O
earlier	O
procedures	O
in	O
that	O
all	O
steps	O
are	O
performed	O
in	O
the	O
presence	O
of	O
4	O
M	O
guanidine	O
hydrochloride	O
and	O
do	O
not	O
involve	O
covalent	O
modification	O
of	O
the	O
mucin	O
molecule	O
.	O

Electrophoretic	O
analyses	O
and	O
Western	O
blotting	O
showed	O
that	O
purified	O
MG2	O
did	O
not	O
contain	O
detectable	O
levels	O
of	O
other	O
salivary	O
proteins	O
.	O

Amino	O
acid	O
analysis	O
showed	O
that	O
the	O
composition	O
of	O
purified	O
MG2	O
was	O
in	O
excellent	O
agreement	O
with	O
the	O
deduced	O
sequence	O
of	O
MG2	O
apomucin	O
encoded	O
in	O
the	O
MUC7	O
gene	O
.	O

The	O
yield	O
of	O
purified	O
MG2	O
was	O
10	O
-	O
15	O
mg	O
from	O
750	O
ml	O
of	O
salivary	O
secretion	O
.	O

Binding	O
of	O
purified	O
MG2	O
to	O
Streptococcus	B-bacteria
mutans	I-bacteria
in	O
vitro	O
was	O
not	O
significantly	O
affected	O
by	O
reductive	O
methylation	O
,	O
but	O
was	O
nearly	O
abolished	O
by	O
reduction	O
and	O
alkylation	O
.	O

These	O
data	O
identified	O
a	O
functional	O
determinant	O
for	O
mucin	O
-	O
bacterial	O
interactions	O
in	O
the	O
N	O
-	O
terminal	O
region	O
where	O
the	O
only	O
two	O
cysteines	O
(	O
Cys45	O
and	O
Cys50	O
)	O
in	O
the	O
MG2	O
apomucin	O
occur	O
.	O

Additionally	O
,	O
purified	O
MG2	O
bound	O
to	O
four	O
strains	O
of	O
oral	O
Streptococci	B-bacteria
,	O
indicating	O
that	O
the	O
binding	O
is	O
not	O
dependent	O
on	O
complexing	O
with	O
other	O
salivary	O
proteins	O
,	O
such	O
as	O
secretory	O
immunoglobulin	O
A	O
.	O

The	O
purification	O
procedure	O
described	O
in	O
this	O
work	O
will	O
facilitate	O
investigation	O
of	O
the	O
role	O
of	O
MG2	O
in	O
the	O
oral	O
environment	O
.	O

The	O
effects	O
of	O
a	O
magnesium	O
monoperoxyphthalate	O
(	O
MMPP	O
)	O
mouth	O
-	O
rinse	O
,	O
with	O
or	O
without	O
sodium	O
lauryl	O
sulphate	O
(	O
SLS	O
)	O
,	O
and	O
an	O
MMPP	O
dentifrice	O

,	O
on	O
salivary	O
counts	O
of	O
bacterial	O
flora	O
and	O
yeasts	O
,	O
and	O
on	O
supragingival	O
plaque	O
scores	O
were	O
investigated	O
in	O
131	O
healthy	O
oral	O
candida	O
carriers	O
over	O
a	O
9	O
week	O
double	O
blind	O
study	O
.	O

There	O
were	O
no	O
changes	O
in	O
the	O
salivary	O
counts	O
of	O
bacteria	O
studied	O
(	O
anaerobes	O
,	O
streptococci	B-bacteria
,	O
fusobacteria	B-bacteria
,	O
Actinomyces	B-bacteria
,	O
Viellonella	B-bacteria
)	O
in	O
the	O
test	O
or	O
placebo	O
groups	O
.	O

A	O
significant	O
increase	O
in	O
salivary	O
candida	O
counts	O
was	O
seen	O
in	O
subjects	O
using	O
an	O
MMPP	O
rinse	O
and	O
dentifrice	O
compared	O
with	O
placebo	O
subjects	O
and	O
this	O
phenomenon	O
was	O
not	O
influenced	O
by	O
the	O
presence	O
of	O
SLS	O
.	O

A	O
significant	O
reduction	O
in	O
plaque	O
was	O
seen	O
in	O
subjects	O
using	O
an	O
MMPP	O
rinse	O
and	O
dentifrice	O
compared	O
with	O
placebo	O
subjects	O
.	O

Frank	O
candidosis	O
was	O
observed	O
in	O
only	O
2	O
subjects	O
(	O
1	O
in	O
the	O
placebo	O
rinse	O
group	O
and	O
1	O
in	O
the	O
MMPP	O
dentifrice	O
group	O
)	O
but	O
erythematous	O
lesions	O
,	O
with	O
subjective	O
reports	O
of	O
soreness	O
,	O
dryness	O
or	O
burning	O
sensation	O
,	O
were	O
recorded	O
and	O
observed	O
more	O
frequently	O
in	O
the	O
experimental	O
groups	O
than	O
in	O
the	O
placebos	O
,	O
especially	O
in	O
those	O
also	O
using	O
SLS	O
.	O

The	O
substantial	O
plaque	O
reduction	O
achieved	O
with	O
MMPP	O
in	O
the	O
absence	O
of	O
tooth	O
staining	O
but	O
with	O
the	O
increase	O
in	O
salivary	O
Candida	O
counts	O
suggests	O
that	O
further	O
studies	O
of	O
MMPP	O
are	O
warranted	O
.	O

Bacteroides	B-bacteria
forsythus	I-bacteria
strains	I-bacteria
recovered	O
from	O
cat	O
and	O
dog	O
bite	O
wound	O
infections	O
in	O
humans	O
(	O
n	O
=	O
3	O
)	O
,	O
monkey	O
oral	O
strains	O
(	O
n	O
=	O
3	O
)	O
,	O
and	O
the	O
human	O
oral	O
ATCC	B-bacteria
43037	I-bacteria
type	I-bacteria
strain	I-bacteria
were	O
characterized	O
by	O
using	O
phenotypic	O
characteristics	O
,	O
enzymatic	O
tests	O
,	O
whole	O
cell	O
fatty	O
acid	O
analysis	O
,	O
sodium	O
dodecyl	O
sulfate	O
-	O
polyacrylamide	O
gel	O
electrophoresis	O
(	O
SDS	O
-	O
PAGE	O
)	O
analysis	O
,	O
PCR	O
fingerprinting	O
,	O
and	O
16S	O
rDNA	O
(	O
genes	O
coding	O
for	O
rRNA	O
)	O
sequencing	O
.	O

All	O
three	O
bite	O
wound	O
isolates	O
grew	O
on	O
brucella	O
agar	O
supplemented	O
with	O
5	O
%	O
sheep	O
blood	O
,	O
vitamin	O
K1	O
,	O
and	O
hemin	O
.	O

These	O
strains	O
,	O
unlike	O
the	O
ATCC	B-bacteria
strain	I-bacteria
and	O
previously	O
described	O
monkey	O
oral	O
and	O
human	O
clinical	O
strains	O
,	O
did	O
not	O
require	O
N	O
-	O
acetylmuramic	O
acid	O
supplementation	O
for	O
growth	O
as	O
pure	O
cultures	O
.	O

However	O
,	O
their	O
phenotypic	O
characteristics	O
,	O
except	O
for	O
catalase	O
production	O
,	O
were	O
similar	O
to	O
those	O
of	O
previously	O
identified	O
strains	O
.	O

PCR	O
fingerprinting	O
analysis	O
showed	O
differences	O
in	O
band	O
patterns	O
from	O
the	O
ATCC	B-bacteria
strain	I-bacteria
.	O

Also	O
,	O
SDS	O
-	O
PAGE	O
and	O
whole	O
cell	O
fatty	O
acid	O
analysis	O
indicated	O
that	O
the	O
dog	O
and	O
cat	O
bite	O
wound	O
strains	O
were	O
similar	O
but	O
not	O
identical	O
to	O
the	O
human	O
B	B-bacteria
.	I-bacteria
forsythus	I-bacteria
ATCC	I-bacteria
43037	I-bacteria
type	I-bacteria
strain	I-bacteria
and	O
the	O
monkey	O
oral	O
strains	O
.	O

The	O
rDNA	O
sequence	O
analysis	O
indicated	O
that	O
the	O
three	O
bite	O
wound	O
isolates	O
had	O
99	O
.	O
93	O
%	O
homology	O
with	O
each	O
other	O
and	O
98	O
.	O
9	O
and	O
99	O
.	O
22	O
%	O
homology	O
with	O
the	O
human	O
ATCC	B-bacteria
43037	I-bacteria
and	O
monkey	O
oral	O
strains	O
,	O
respectively	O
.	O

These	O
results	O
suggest	O
that	O
there	O
are	O
host	O
-	O
specific	O
variations	O
within	O
each	O
group	O
.	O

Information	O
about	O
the	O
total	O
amount	O
of	O
bacteria	O
in	O
oral	O
samples	O
contributes	O
to	O
assessment	O
of	O
an	O
individual	O
'	O
s	O
risk	O
of	O
contracting	O
dental	O
caries	O
or	O
developing	O
periodontitis	O
and	O
the	O
prediction	O
of	O
that	O
individual	O
'	O
s	O
clinical	O
course	O
.	O

Since	O
existing	O
techniques	O
are	O
often	O
time	O
-	O
consuming	O
and	O
expensive	O
,	O
it	O
seemed	O
attractive	O
to	O
look	O
for	O
alternative	O
methods	O
for	O
the	O
quantification	O
of	O
eubacteria	O
.	O

With	O
their	O
high	O
specificity	O
and	O
sensitivity	O
,	O
polymerase	O
chain	O
-	O
reaction	O
(	O
PCR	O
)	O
techniques	O
have	O
the	O
potential	O
of	O
supplying	O
fast	O
and	O
reliable	O
results	O
.	O

We	O
developed	O
a	O
method	O
of	O
competitive	O
PCR	O
for	O
the	O
quantification	O
of	O
eubacteria	O
.	O

We	O
designed	O
forward	O
and	O
reverse	O
PCR	O
primers	O
which	O
bind	O
to	O
highly	O
conserved	O
sequences	O
of	O
the	O
bacterial	O
16S	O
rRNA	O
gene	O
.	O

A	O
homologous	O
competitor	O
was	O
synthesized	O
with	O
Escherichia	B-bacteria
coli	I-bacteria
16S	O
rDNA	O
as	O
a	O
template	O
,	O
with	O
the	O
reverse	O
primer	O
and	O
a	O
hybrid	O
primer	O
which	O
binds	O
67	O
bases	O
downstream	O
to	O
the	O
forward	O
primer	O
and	O
carries	O
the	O
forward	O
primer	O
sequence	O
at	O
its	O
5	O
'	O
end	O
.	O

Specificity	O
controls	O
with	O
30	O
different	O
bacterial	O
species	O
,	O
5	O
Archaea	O
,	O
3	O
fungi	O
,	O
human	O
astrocytoma	O
cells	O
,	O
and	O
rat	O
hepatoblastoma	O
cells	O
were	O
carried	O
out	O
.	O

Results	O
were	O
positive	O
for	O
all	O
eubacteria	O
and	O
negative	O
for	O
all	O
other	O
cells	O
tested	O
.	O

Calibration	O
curves	O
were	O
obtained	O
by	O
co	O
-	O
amplification	O
of	O
known	O
amounts	O
of	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
cells	O
in	O
the	O
presence	O
of	O
the	O
homologous	O
competitor	O
.	O

The	O
developed	O
method	O
was	O
successfully	O
applied	O
to	O
assessment	O
of	O
the	O
accumulation	O
of	O
bacteria	O
during	O
an	O
oral	O
hygiene	O
cessation	O
experiment	O
.	O

The	O
competitive	O
PCR	O
method	O
proved	O
to	O
be	O
a	O
reliable	O
and	O
fast	O
method	O
for	O
the	O
quantification	O
of	O
bacterial	O
DNA	O
and	O
cultured	O
eubacteria	O
,	O
as	O
well	O
as	O
of	O
bacteria	O
in	O
biological	O
samples	O
.	O

It	O
may	O
find	O
further	O
applications	O
not	O
only	O
in	O
periodontology	O
and	O
cariology	O
but	O
also	O
in	O
other	O
fields	O
of	O
medical	O
microbiology	O
.	O

Several	O
publications	O
have	O
reported	O
an	O
increased	O
susceptibility	O
for	O
root	O
caries	O
after	O
periodontal	O
therapy	O
.	O

It	O
has	O
been	O
suggested	O
that	O
newly	O
exposed	O
roots	O
were	O
less	O
resistant	O
to	O
cariogenic	O
species	O
.	O

This	O
study	O
examined	O
the	O
hypothesis	O
that	O
the	O
increased	O
susceptibility	O
could	O
also	O
be	O
related	O
to	O
an	O
intra	O
-	O
oral	O
microbial	O
shift	O
during	O
the	O
initial	O
phase	O
of	O
the	O
periodontal	O
therapy	O
from	O
a	O
perio	O
-	O
pathogenic	O
to	O
a	O
more	O
cariogenic	O
flora	O
.	O

10	O
patients	O
with	O
severe	O
periodontitis	O
were	O
followed	O
for	O
8	O
months	O
after	O
thorough	O
scaling	O
and	O
root	O
planing	O
in	O
combination	O
with	O
optimal	O
plaque	O
control	O
.	O

At	O
baseline	O
and	O
after	O
4	O
and	O
8	O
months	O
,	O
samples	O
were	O
taken	O
from	O
the	O
saliva	O
,	O
the	O
tongue	O
dorsum	O
and	O
the	O
supragingival	O
interdental	O
spaces	O
.	O

These	O
samples	O
were	O
cultured	O
both	O
aerobically	O
and	O
anaerobically	O
in	O
order	O
to	O
determine	O
the	O
total	O
number	O
of	O
colony	O
forming	O
units	O
(	O
CFU	O
)	O
per	O
sample	O
as	O
well	O
as	O
the	O
number	O
of	O
CFU	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
and	O
Lactobacillus	B-bacteria
species	I-bacteria
.	O

Oral	O
hygiene	O
parameters	O
were	O
recorded	O
at	O
the	O
same	O
visits	O
.	O

Finally	O
,	O
at	O
baseline	O
and	O
at	O
the	O
8	O
months	O
follow	O
-	O
up	O
,	O
changes	O
in	O
caries	O
activity	O
and	O
periodontal	O
health	O
were	O
registered	O
.	O

Although	O
the	O
total	O
number	O
of	O
aerobic	O
and	O
anaerobic	O
CFU	O
in	O
samples	O
from	O
the	O
tongue	O
and	O
the	O
saliva	O
remained	O
nearly	O
constant	O
over	O
the	O
entire	O
observation	O
period	O
(	O
variations	O
within	O
0	O
.	O
5	O
log	O
)	O
,	O
significant	O
(	O
p	O
<	O
or	O
=	O
0	O
.	O
05	O
)	O
increases	O
in	O
the	O
number	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
could	O
be	O
detected	O
,	O
especially	O
at	O
month	O
8	O
.	O

The	O
significant	O
decrease	O
in	O
the	O
total	O
number	O
of	O
anaerobic	O
CFU	O
in	O
samples	O
from	O
the	O
teeth	O
was	O
not	O
associated	O
with	O
a	O
reduction	O
in	O
the	O
number	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
so	O
that	O
also	O
for	O
this	O
niche	O
the	O
relative	O
proportion	O
of	O
the	O
latter	O
increased	O
.	O

The	O
number	O
of	O
lactobacilli	B-bacteria
species	I-bacteria
for	O
the	O
different	O
niches	O
showed	O
only	O
negligible	O
changes	O
(	O
within	O
0	O
.	O
5	O
log	O
values	O
)	O
,	O
except	O
for	O
samples	O
from	O
the	O
teeth	O
for	O
which	O
a	O
small	O
(	O
1	O
log	O
)	O
,	O
but	O
statistically	O
significant	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
,	O
reduction	O
could	O
be	O
detected	O
.	O

The	O
periodontal	O
conditions	O
improved	O
for	O
all	O
patients	O
,	O
but	O
the	O
caries	O
activity	O
could	O
not	O
be	O
arrested	O
.	O

These	O
findings	O
seem	O
to	O
indicate	O
that	O
the	O
increased	O
caries	O
susceptibility	O
after	O
periodontal	O
therapy	O
might	O
partially	O
be	O
explained	O
by	O
a	O
significant	O
increase	O
in	O
the	O
number	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
due	O
to	O
ecological	O
changes	O
within	O
the	O
oral	O
cavity	O
.	O

The	O
clinical	O
consequence	O
of	O
this	O
observation	O
would	O
be	O
to	O
advocate	O
a	O
more	O
strict	O
caries	O
preventive	O
program	O
during	O
initial	O
periodontal	O
therapy	O
.	O

The	O
many	O
viruses	O
associated	O
with	O
Pagetic	O
osteoclasts	O
could	O
be	O
opportunistic	O
rather	O
than	O
causative	O
.	O

Some	O
mouth	O
bacteria	O
can	O
lyse	O
bone	O
.	O

One	O
(	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
)	O
can	O
grow	O
and	O
even	O
multiply	O
inside	O
human	O
cell	O
lines	O
in	O
culture	O
,	O
producing	O
osteolytic	O
materials	O
-	O
-	O
one	O
62	O
kDa	O
protein	O
having	O
a	O
potency	O
in	O
the	O
picomolar	O
range	O
.	O

A	O
small	O
focus	O
of	O
this	O
,	O
or	O
of	O
one	O
of	O
the	O
other	O
periodontitis	O
-	O
causing	O
bacteria	O
,	O
in	O
a	O
bone	O
might	O
gradually	O
spread	O
its	O
influence	O
to	O
activate	O
osteoclasts	O
-	O
-	O
the	O
first	O
stage	O
in	O
Paget	O
'	O
s	O
disease	O
.	O

The	O
focus	O
in	O
each	O
bone	O
might	O
be	O
small	O
and	O
easily	O
overlooked	O
,	O
as	O
other	O
intracellular	O
bacteria	O
have	O
been	O
in	O
the	O
past	O
.	O

The	O
reduced	O
susceptibility	O
to	O
phagocytosis	O
found	O
among	O
some	O
periodontopathogenic	O
anaerobes	O
may	O
account	O
for	O
the	O
differences	O
between	O
invasive	O
and	O
non	O
-	O
invasive	O
strains	O
.	O

We	O
applied	O
flow	O
cytometry	O
as	O
a	O
powerful	O
tool	O
to	O
analyze	O
and	O
quantify	O
phagocytosis	O
using	O
standardized	O
cultures	O
of	O
oral	O
anaerobes	O
(	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
nigrescens	I-bacteria
,	O
Capnocytophaga	B-bacteria
gingivalis	I-bacteria
,	O
C	B-bacteria
.	I-bacteria
ochracea	I-bacteria
,	O
C	B-bacteria
.	I-bacteria
sputigena	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
and	O
Peptostreptococcus	B-bacteria
micros	I-bacteria
)	O
and	O
heparinized	O
whole	O
blood	O
.	O

Bacteria	O
were	O
labeled	O
by	O
a	O
fluorescein	O
-	O
methylester	O
and	O
their	O
esterase	O
activity	O
,	O
resulting	O
in	O
green	O
fluorescence	O
.	O

Ingested	O
bacteria	O
could	O
be	O
detected	O
easily	O
and	O
quantified	O
by	O
a	O
shift	O
towards	O
green	O
fluorescence	O
in	O
the	O
PMNL	O
population	O
involved	O
and	O
a	O
concomitant	O
decrease	O
in	O
the	O
bacterial	O
population	O
.	O

Furthermore	O
,	O
the	O
oxidative	O
burst	O
of	O
PMNLs	O
was	O
detected	O
in	O
parallel	O
assays	O
using	O
the	O
dye	O
DHR123	O
which	O
becomes	O
fluorescent	O
upon	O
oxidation	O
during	O
the	O
oxidative	O
burst	O
process	O
.	O

We	O
found	O
a	O
great	O
diversity	O
in	O
phagocytosis	O
susceptibility	O
determined	O
by	O
estimating	O
the	O
portion	O
of	O
phagocytosing	O
PMNLs	O
,	O
ranging	O
from	O
10	O
.	O
6	O
%	O
(	O
strain	O
W83	B-bacteria
)	O
to	O
>	O
99	O
.	O
4	O
%	O
(	O
e	O
.	O
g	O
.	O
ATCC	B-bacteria
33277T	I-bacteria
)	O
in	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
and	O
from	O
15	O
.	O
9	O
%	O
(	O
strain	O
MH5	B-bacteria
)	O
to	O
>	O
95	O
%	O
(	O
ATCC	B-bacteria
33563T	I-bacteria
)	O
in	O
P	B-bacteria
.	I-bacteria
nigrescens	I-bacteria
.	O

In	O
contrast	O
,	O
almost	O
all	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
strains	I-bacteria
as	O
well	O
as	O
the	O
representatives	O
of	O
the	O
other	O
anaerobic	O
,	O
putative	O
periodontopathic	O
species	O
tested	O
showed	O
no	O
or	O
only	O
moderate	O
resistance	O
in	O
the	O
phagocytosis	O
assay	O
.	O

Comparison	O
of	O
clinical	O
data	O
of	O
patients	O
and	O
the	O
extent	O
of	O
phagocytosis	O
resistance	O
of	O
the	O
corresponding	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
strains	I-bacteria
suggests	O
that	O
this	O
virulence	O
factor	O
may	O
contribute	O
to	O
the	O
clinical	O
outcome	O
.	O

Recent	O
studies	O
showed	O
the	O
clinical	O
benefits	O
of	O
a	O
one	O
stage	O
full	O
-	O
mouth	O
disinfection	O
,	O
when	O
compared	O
to	O
the	O
worldwide	O
standard	O
treatmen	O
strategy	O
of	O
consecutive	O
root	O
planings	O
per	O
quadrant	O
without	O
proper	O
disinfection	O
of	O
the	O
remaining	O
intraoral	O
niches	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
microbiological	O
benefits	O
of	O
such	O
a	O
one	O
stage	O
full	O
-	O
mouth	O
disinfectio	O
with	O
special	O
attention	O
to	O
all	O
intraoral	O
niches	O
for	O
periodontopathogens	O
and	O
to	O
evaluate	O
the	O
perception	O
by	O
the	O
patients	O
of	O
the	O
new	O
treatment	O
strategy	O
.	O

Sixteen	O
patients	O
with	O
early	O
-	O
onset	O
periodontitis	O
and	O
24	O
patients	O
with	O
severe	O
adult	O
periodontitis	O
were	O
randomly	O
assigned	O
to	O
test	O
and	O
control	O
groups	O
.	O

The	O
control	O
group	O
was	O
scaled	O
and	O
root	O
planed	O
,	O
per	O
quadrant	O
,	O
at	O
2	O
-	O
week	O
intervals	O
and	O
given	O
oral	O
hygiene	O
instructions	O
.	O

The	O
test	O
group	O
received	O
the	O
one	O
stage	O
full	O
-	O
mouth	O
disinfection	O
treatment	O
.	O

At	O
baseline	O
and	O
after	O
1	O
,	O
2	O
,	O
4	O
,	O
and	O
8	O
months	O
,	O
microbiological	O
samples	O
were	O
taken	O
from	O
all	O
niches	O
(	O
tongue	O
,	O
mucosa	O
,	O
saliva	O
,	O
and	O
pooled	O
samples	O
from	O
single	O
-	O
and	O
multi	O
-	O
rooted	O
teeth	O
)	O
.	O

The	O
samples	O
were	O
cultured	O
on	O
selective	O
and	O
non	O
-	O
selective	O
media	O
.	O

Patient	O
perception	O
of	O
the	O
treatment	O
was	O
evaluated	O
using	O
a	O
questionnaire	O
.	O

In	O
comparison	O
to	O
the	O
standard	O
therapy	O
,	O
the	O
one	O
stage	O
full	O
-	O
mouth	O
disinfection	O
resulted	O
in	O
significant	O
additional	O
microbial	O
improvements	O
.	O

The	O
test	O
group	O
showed	O
larger	O
reductions	O
in	O
the	O
proportions	O
of	O
spirochetes	B-bacteria
and	O
motile	O
organisms	O
in	O
the	O
subgingival	O
flora	O
,	O
and	O
more	O
significant	O
reductions	O
in	O
the	O
density	O
of	O
key	O
pathogens	O
,	O
with	O
even	O
the	O
eradication	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
.	O

The	O
beneficial	O
effects	O
in	O
the	O
other	O
niches	O
were	O
primarily	O
restricted	O
to	O
the	O
number	O
of	O
colony	O
-	O
forming	O
units	O
/	O
ml	O
of	O
black	O
-	O
pigmented	O
bacteria	O
,	O
especially	O
on	O
the	O
mucosa	O
and	O
in	O
the	O
saliva	O
and	O
to	O
a	O
lesser	O
extent	O
on	O
the	O
tongue	O
.	O

Both	O
treatments	O
were	O
well	O
tolerated	O
by	O
the	O
patients	O
and	O
the	O
overall	O
severity	O
rating	O
for	O
both	O
therapies	O
was	O
comparable	O
,	O
although	O
4	O
quadrants	O
were	O
treated	O
within	O
24	O
hours	O
in	O
the	O
test	O
group	O
versus	O
only	O
1	O
in	O
the	O
control	O
group	O
.	O

The	O
full	O
-	O
mouth	O
disinfection	O
approach	O
resulted	O
more	O
frequently	O
in	O
a	O
slight	O
increase	O
of	O
body	O
temperature	O
,	O
especially	O
after	O
the	O
second	O
day	O
.	O

These	O
findings	O
support	O
the	O
benefit	O
of	O
a	O
one	O
stage	O
full	O
-	O
mouth	O
disinfection	O
in	O
the	O
treatment	O
of	O
patients	O
with	O
either	O
chronic	O
adult	O
or	O
early	O
-	O
onset	O
periodontitis	O
.	O

Ninety	O
-	O
one	O
isolates	O
of	O
nutritionally	B-bacteria
variant	I-bacteria
streptococci	I-bacteria
(	O
NVS	B-bacteria
)	O
that	O
were	O
previously	O
isolated	O
from	O
the	O
human	O
mouth	O
were	O
regarded	O
as	O
consisting	O
of	O
7	O
Streptococcus	B-bacteria
defectivus	I-bacteria
isolates	I-bacteria
,	O
78	O
Streptococcus	B-bacteria
adjacens	I-bacteria
isolates	I-bacteria
,	O
and	O
6	O
Gemella	B-bacteria
morbillorum	I-bacteria
isolates	I-bacteria
.	O

However	O
,	O
recent	O
references	O
to	O
the	O
taxonomic	O
reclassification	O
of	O
NVS	B-bacteria
,	O
from	O
S	B-bacteria
.	I-bacteria
defectivus	I-bacteria
to	O
Abiotrophia	B-bacteria
defectiva	I-bacteria
and	O
from	O
S	B-bacteria
.	I-bacteria
adjacens	I-bacteria
to	O
Abiotrophia	B-bacteria
adiacens	I-bacteria
,	O
and	O
the	O
newly	O
introduced	O
species	O
Abiotrophia	B-bacteria
elegans	I-bacteria
as	O
a	O
third	O
Abiotrophia	B-bacteria
species	I-bacteria
,	O
emphasize	O
the	O
need	O
for	O
genetic	O
analyses	O
for	O
identification	O
of	O
NVS	B-bacteria
.	O

When	O
PCR	O
-	O
restriction	O
fragment	O
length	O
polymorphism	O
(	O
RFLP	O
)	O
and	O
phylogenetic	O
distances	O
were	O
examined	O
based	O
on	O
16S	O
rRNA	O
gene	O
sequences	O
,	O
the	O
results	O
indicated	O
that	O
7	O
of	O
the	O
91	O
NVS	B-bacteria
isolates	I-bacteria
were	O
closely	O
related	O
to	O
A	B-bacteria
.	I-bacteria
elegans	I-bacteria
.	O

These	O
seven	O
isolates	O
consisted	O
of	O
four	O
isolates	O
previously	O
identified	O
as	O
G	B-bacteria
.	I-bacteria
morbillorum	I-bacteria
and	O
three	O
isolates	O
previously	O
identified	O
as	O
S	B-bacteria
.	I-bacteria
adjacens	I-bacteria
.	O

Two	O
isolates	O
previously	O
identified	O
as	O
G	B-bacteria
.	I-bacteria
morbillorum	I-bacteria
were	O
related	O
to	O
A	B-bacteria
.	I-bacteria
adiacens	I-bacteria
.	O

In	O
biochemical	O
tests	O
,	O
A	B-bacteria
.	I-bacteria
elegans	I-bacteria
and	O
the	O
seven	O
isolates	O
related	O
to	O
it	O
possessed	O
arginine	O
dihydrolase	O
(	O
ADH	O
)	O
activity	O
but	O
the	O
other	O
Abiotrophia	B-bacteria
species	I-bacteria
did	O
not	O
.	O

As	O
a	O
result	O
,	O
A	B-bacteria
.	I-bacteria
elegans	I-bacteria
strains	I-bacteria
comprised	O
8	O
%	O
of	O
the	O
91	O
NVS	B-bacteria
isolates	I-bacteria
.	O

Our	O
findings	O
suggest	O
that	O
A	B-bacteria
.	I-bacteria
elegans	I-bacteria
,	O
A	B-bacteria
.	I-bacteria
adiacens	I-bacteria
,	O
and	O
A	B-bacteria
.	I-bacteria
defectiva	I-bacteria
exist	O
in	O
the	O
human	O
mouth	O
in	O
proportions	O
of	O
about	O
1	O
:	O
11	O
:	O
1	O
and	O
that	O
A	B-bacteria
.	I-bacteria
elegans	I-bacteria
can	O
be	O
genetically	O
distinguished	O
from	O
the	O
other	O
two	O
Abiotrophia	B-bacteria
species	I-bacteria
by	O
PCR	O
-	O
RFLP	O
analysis	O
of	O
16S	O
rRNA	O
gene	O
sequences	O
and	O
can	O
be	O
biochemically	O
distinguished	O
by	O
ADH	O
activity	O
.	O

It	O
is	O
generally	O
assumed	O
that	O
a	O
decreased	O
salivary	O
secretion	O
rate	O
will	O
promote	O
plaque	O
accumulation	O
and	O
increase	O
the	O
risk	O
for	O
caries	O
,	O
gingival	O
inflammation	O
,	O
and	O
mucosal	O
infections	O
.	O

In	O
this	O
study	O
,	O
the	O
effect	O
of	O
hyposalivation	O
on	O
the	O
oral	O
microflora	O
was	O
examined	O
.	O

The	O
following	O
micro	O
-	O
organisms	O
were	O
analyzed	O
in	O
rinsing	O
samples	O
from	O
14	O
subjects	O
with	O
hyposalivation	O
:	O
the	O
total	O
number	O
of	O
anaerobically	O
growing	O
micro	O
-	O
organisms	O
,	O
alpha	B-bacteria
-	I-bacteria
hemolytic	I-bacteria
streptococci	I-bacteria
,	O
mutans	B-bacteria
streptococci	I-bacteria
,	O
lactobacilli	B-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
/	O
Prevotella	B-bacteria
nigrescens	I-bacteria
,	O
Staphylococcus	B-bacteria
aureus	I-bacteria
,	O
Candida	O
albicans	O
,	O
and	O
enterics	O
.	O

The	O
study	O
group	O
,	O
age	O
53	O
+	O
/	O
-	O
7	O
years	O
,	O
had	O
no	O
history	O
of	O
radiation	O
therapy	O
and	O
showed	O
no	O
signs	O
of	O
inflammation	O
in	O
their	O
salivary	O
glands	O
on	O
biopsy	O
.	O

All	O
were	O
dentate	O
with	O
a	O
mean	O
of	O
24	O
+	O
/	O
-	O
3	O
teeth	O
.	O

Their	O
salivary	O
secretion	O
rates	O
were	O
0	O
.	O
03	O
+	O
/	O
-	O
0	O
.	O
02	O
mL	O
/	O
min	O
(	O
unstimulated	O
)	O
and	O
0	O
.	O
84	O
+	O
/	O
-	O
0	O
.	O
65	O
mL	O
/	O
min	O
(	O
stimulated	O
)	O
.	O

The	O
control	O
group	O
was	O
matched	O
to	O
the	O
hyposalivation	O
group	O
according	O
to	O
age	O
,	O
sex	O
,	O
and	O
number	O
of	O
teeth	O
.	O

There	O
was	O
a	O
significantly	O
increased	O
number	O
of	O
lactobacilli	B-bacteria
,	O
and	O
a	O
tendency	O
,	O
not	O
statistically	O
significant	O
and	O
with	O
large	O
variations	O
within	O
the	O
groups	O
,	O
toward	O
a	O
higher	O
proportion	O
of	O
mutans	B-bacteria
streptococci	I-bacteria
and	O
a	O
lower	O
proportion	O
of	O
alpha	B-bacteria
-	I-bacteria
hemolytic	I-bacteria
streptococci	I-bacteria
in	O
the	O
hyposalivation	O
group	O
.	O

The	O
presence	O
of	O
micro	O
-	O
organisms	O
associated	O
with	O
gingival	O
inflammation	O
and	O
mucosal	O
infections	O
was	O
comparable	O
with	O
that	O
in	O
the	O
healthy	O
controls	O
.	O

The	O
results	O
indicated	O
that	O
a	O
low	O
salivary	O
secretion	O
rate	O
mainly	O
promotes	O
a	O
flora	O
associated	O
with	O
the	O
development	O
of	O
caries	O
.	O

An	O
association	O
between	O
oral	O
conditions	O
such	O
as	O
periodontal	O
disease	O
and	O
several	O
respiratory	O
conditions	O
has	O
been	O
noted	O
.	O

For	O
example	O
,	O
recent	O
evidence	O
has	O
suggested	O
a	O
central	O
role	O
for	O
the	O
oral	O
cavity	O
in	O
the	O
process	O
of	O
respiratory	O
infection	O
.	O

Oral	O
periodontopathic	O
bacteria	O
can	O
be	O
aspirated	O
into	O
the	O
lung	O
to	O
cause	O
aspiration	O
pneumonia	O
.	O

The	O
teeth	O
may	O
also	O
serve	O
as	O
a	O
reservoir	O
for	O
respiratory	O
pathogen	O
colonization	O
and	O
subsequent	O
nosocomial	O
pneumonia	O
.	O

Typical	O
respiratory	O
pathogens	O
have	O
been	O
shown	O
to	O
colonize	O
the	O
dental	O
plaque	O
of	O
hospitalized	O
intensive	O
care	O
and	O
nursing	O
home	O
patients	O
.	O

Once	O
established	O
in	O
the	O
mouth	O
,	O
these	O
pathogens	O
may	O
be	O
aspirated	O
into	O
the	O
lung	O
to	O
cause	O
infection	O
.	O

Other	O
epidemiologic	O
studies	O
have	O
noted	O
a	O
relationship	O
between	O
poor	O
oral	O
hygiene	O
or	O
periodontal	O
bone	O
loss	O
and	O
chronic	O
obstructive	O
pulmonary	O
disease	O
.	O

Several	O
mechanisms	O
are	O
proposed	O
to	O
explain	O
the	O
potential	O
role	O
of	O
oral	O
bacteria	O
in	O
the	O
pathogenesis	O
of	O
respiratory	O
infection	O
:	O
1	O
.	O
aspiration	O
of	O
oral	O
pathogens	O
(	O
such	O
as	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
etc	O
.	O
)	O
into	O
the	O
lung	O
to	O
cause	O
infection	O
;	O
2	O
.	O
periodontal	O
disease	O
-	O
associated	O
enzymes	O
in	O
saliva	O
may	O
modify	O
mucosal	O
surfaces	O
to	O
promote	O
adhesion	O
and	O
colonization	O
by	O
respiratory	O
pathogens	O
,	O
which	O
are	O
then	O
aspirated	O
into	O
the	O
lung	O
;	O
3	O
.	O
periodontal	O
disease	O
-	O
associated	O
enzymes	O
may	O
destroy	O
salivary	O
pellicles	O
on	O
pathogenic	O
bacteria	O
to	O
hinder	O
their	O
clearance	O
from	O
the	O
mucosal	O
surface	O
;	O
and	O
4	O
.	O
cytokines	O
originating	O
from	O
periodontal	O
tissues	O
may	O
alter	O
respiratory	O
epithelium	O
to	O
promote	O
infection	O
by	O
respiratory	O
pathogens	O
.	O

The	O
majority	O
of	O
cases	O
of	O
oral	O
malodour	O
are	O
thought	O
to	O
be	O
due	O
to	O
bacterial	O
activities	O
in	O
the	O
mouth	O
,	O
but	O
many	O
of	O
the	O
bacterial	O
species	O
responsible	O
have	O
not	O
been	O
identified	O
.	O

Volatile	O
sulphide	O
compounds	O
have	O
been	O
proposed	O
as	O
constituents	O
of	O
oral	O
malodour	O
.	O

Therefore	O
,	O
the	O
relation	O
between	O
intensity	O
of	O
odour	O
and	O
numbers	O
of	O
bacteria	O
in	O
the	O
mouth	O
that	O
are	O
sulphide	O
-	O
producing	O
from	O
sulphate	O
was	O
investigated	O
.	O

Numbers	O
of	O
such	O
dissimilatory	O
sulphate	B-bacteria
-	I-bacteria
reducing	I-bacteria
bacteria	I-bacteria
(	O
SRB	B-bacteria
)	O
and	O
sulphide	O
reduction	O
rates	O
were	O
evaluated	O
in	O
samples	O
from	O
different	O
oral	O
sites	O
in	O
relation	O
to	O
measures	O
of	O
oral	O
malodour	O
.	O

Results	O
showed	O
that	O
sulphate	B-bacteria
-	I-bacteria
reducing	I-bacteria
bacterial	I-bacteria
numbers	O
and	O
activities	O
were	O
negatively	O
correlated	O
with	O
malodour	O
,	O
as	O
determined	O
by	O
organoleptic	O
assessment	O
and	O
measurement	O
with	O
a	O
sulphide	O
-	O
monitoring	O
instrument	O
,	O
the	O
Halimeter	O
.	O

The	O
data	O
indicate	O
that	O
sulphide	O
produced	O
by	O
oral	O
SRB	B-bacteria
may	O
not	O
be	O
an	O
important	O
contributor	O
to	O
oral	O
malodour	O
.	O

A	O
rather	O
poor	O
correlation	O
was	O
observed	O
between	O
Halimetric	O
and	O
organoleptic	O
values	O
,	O
indicating	O
that	O
these	O
methods	O
may	O
measure	O
different	O
aspects	O
of	O
oral	O
malodour	O
intensity	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
monitor	O
the	O
presence	O
of	O
sulfate	B-bacteria
-	I-bacteria
reducing	I-bacteria
bacteria	I-bacteria
(	O
SRB	B-bacteria
)	O
at	O
different	O
sites	O
in	O
the	O
mouths	O
of	O
both	O
healthy	O
individuals	O
and	O
periodontitis	O
patients	O
.	O

In	O
20	O
healthy	O
subjects	O
and	O
21	O
periodontitis	O
patients	O
,	O
samples	O
were	O
taken	O
from	O
the	O
palate	O
,	O
vestibulum	O
,	O
dorsum	O
of	O
the	O
tongue	O
,	O
supragingival	O
plaque	O
,	O
and	O
periodontal	O
pockets	O
.	O

In	O
order	O
to	O
demonstrate	O
growth	O
of	O
SRB	B-bacteria
,	O
samples	O
were	O
incubated	O
in	O
an	O
anoxic	O
chamber	O
in	O
a	O
reduced	O
growth	O
-	O
medium	O
for	O
SRB	B-bacteria
,	O
with	O
an	O
iron	O
-	O
indicator	O
for	O
sulfide	O
production	O
.	O

The	O
SRB	B-bacteria
were	O
detected	O
throughout	O
the	O
oral	O
cavity	O
.	O

They	O
were	O
found	O
on	O
the	O
mucosa	O
in	O
10	O
%	O
of	O
both	O
healthy	O
subjects	O
and	O
periodontitis	O
patients	O
.	O

On	O
the	O
tongue	O
and	O
in	O
supragingival	O
plaque	O
,	O
the	O
frequency	O
of	O
detection	O
was	O
slightly	O
higher	O
(	O
22	O
%	O
of	O
the	O
subjects	O
)	O
.	O

In	O
contrast	O
,	O
86	O
%	O
of	O
the	O
periodontitis	O
patients	O
harbored	O
SRB	B-bacteria
in	O
one	O
or	O
more	O
pockets	O
.	O

In	O
1	O
/	O
3	O
of	O
the	O
patients	O
,	O
SRB	B-bacteria
were	O
present	O
in	O
all	O
3	O
pockets	O
that	O
were	O
sampled	O
.	O

The	O
data	O
indicated	O
that	O
SRB	B-bacteria
belong	O
to	O
the	O
normal	O
oral	O
microbiota	O
,	O
and	O
have	O
a	O
preference	O
for	O
periodontal	O
pockets	O
.	O

This	O
study	O
examined	O
and	O
compared	O
levels	O
of	O
salivary	O
bacteria	O
which	O
produced	O
volatile	O
sulfur	O
compounds	O
(	O
VSC	O
)	O
in	O
young	O
children	O
with	O
and	O
without	O
oral	O
malodor	O
.	O

Clinic	O
populations	O
of	O
children	O
aged	O
two	O
to	O
seven	O
years	O
,	O
whose	O
parents	O
presented	O
with	O
an	O
unsolicited	O
major	O
complaint	O
of	O
oral	O
malodor	O
in	O
their	O
child	O
(	O
OM	O
+	O
)	O
,	O
or	O
aged	O
-	O
matched	O
controls	O
in	O
whom	O
oral	O
malodor	O
was	O
not	O
detected	O
by	O
parents	O
(	O
OM	O
-	O
)	O
,	O
were	O
investigated	O
.	O

Saliva	O
specimens	O
were	O
cultured	O
anaerobically	O
on	O
media	O
that	O
differentiated	O
VSC	O
+	O
bacteria	O
.	O

These	O
were	O
quantified	O
and	O
identified	O
.	O

Levels	O
in	O
OM	O
+	O
and	O
OM	O
-	O
children	O
were	O
compared	O
and	O
statistically	O
analyzed	O
.	O

OM	O
+	O
children	O
harbored	O
significantly	O
higher	O
levels	O
of	O
VSC	O
+	O
isolates	O
in	O
saliva	O
than	O
OM	O
-	O
children	O
(	O
OM	O
+	O
=	O
44	O
%	O
of	O
total	O
viable	O
counts	O
,	O
TVC	O
;	O
OM	O
-	O
=	O
24	O
%	O
of	O
TVC	O
;	O
P	O
=	O
0	O
.	O
0083	O
)	O
.	O

Types	O
of	O
recovered	O
bacterial	O
species	O
did	O
not	O
differ	O
in	O
the	O
two	O
groups	O
,	O
but	O
levels	O
of	O
Prevotella	B-bacteria
oralis	I-bacteria
were	O
significantly	O
higher	O
in	O
OM	O
+	O
children	O
(	O
P	O
=	O
0	O
.	O
0001	O
)	O
.	O

Veillonella	B-bacteria
species	I-bacteria
followed	O
by	O
P	B-bacteria
.	I-bacteria
oralis	I-bacteria
were	O
the	O
predominant	O
VSC	O
+	O
isolates	O
recovered	O
in	O
both	O
populations	O
.	O

VSC	O
+	O
salivary	O
bacteria	O
may	O
differ	O
both	O
in	O
type	O
and	O
quantity	O
in	O
young	O
children	O
with	O
and	O
without	O
parent	O
-	O
perceived	O
oral	O
malodor	O
.	O

Peptides	O
derived	O
from	O
the	O
N	O
-	O
terminal	O
domain	O
that	O
comprises	O
an	O
amphipathic	O
alpha	O
-	O
helix	O
in	O
human	O
lactoferrin	O
(	O
LFh	O
18	O
-	O
31	O
and	O
LFh	O
20	O
-	O
38	O
)	O
and	O
bovine	O
lactoferrin	O
(	O
LFb	O
17	O
-	O
30	O
and	O
LFb	O
19	O
-	O
37	O
)	O
were	O
chemically	O
synthesised	O
.	O

Since	O
many	O
positively	O
charged	O
amphipathic	O
alpha	O
-	O
helices	O
contain	O
antimicrobial	O
activity	O
,	O
the	O
peptides	O
were	O
tested	O
for	O
their	O
antimicrobial	O
activity	O
against	O
various	O
oral	O
pathogens	O
.	O

Both	O
peptides	O
from	O
bovine	O
lactoferrin	O
had	O
more	O
potent	O
antimicrobial	O
activities	O
than	O
the	O
human	O
equivalent	O
.	O

Peptide	O
LFb	O
17	O
-	O
30	O
,	O
containing	O
the	O
largest	O
number	O
of	O
positively	O
charged	O
amino	O
acids	O
,	O
showed	O
the	O
highest	O
antimicrobial	O
activity	O
to	O
both	O
Gram	O
-	O
positive	O
and	O
Gram	O
-	O
negative	O
bacteria	O
.	O

Since	O
native	O
lactoferrin	O
molecules	O
had	O
no	O
killing	O
activity	O
,	O
release	O
of	O
these	O
peptides	O
from	O
the	O
native	O
protein	O
should	O
be	O
investigated	O
to	O
explore	O
the	O
use	O
in	O
oral	O
care	O
products	O
.	O

Thirty	O
patients	O
with	O
oral	O
mucosal	O
cancer	O
were	O
studied	O
in	O
relation	O
to	O
oral	O
mucosal	O
damage	O
and	O
bacterial	O
translocation	O
to	O
the	O
regional	O
lymph	O
nodes	O
in	O
the	O
neck	O
.	O

All	O
30	O
patients	O
(	O
gingiva	O
11	O
,	O
tongue	O
13	O
,	O
cheek	O
mucosa	O
four	O
,	O
oral	O
floor	O
two	O
)	O
underwent	O
extensive	O
,	O
clean	O
-	O
contaminated	O
,	O
head	O
-	O
and	O
-	O
neck	O
surgery	O
(	O
including	O
neck	O
dissection	O
)	O
with	O
free	O
flap	O
reconstruction	O
.	O

A	O
total	O
of	O
153	O
lymph	O
nodes	O
was	O
harvested	O
for	O
microbial	O
and	O
histological	O
examination	O
.	O

Viable	O
bacteria	O
were	O
isolated	O
from	O
70	O
lymph	O
nodes	O
(	O
45	O
.	O
8	O
%	O
)	O
from	O
25	O
patients	O
(	O
83	O
.	O
3	O
%	O
)	O
.	O

Bacterial	O
cells	O
in	O
the	O
nodes	O
were	O
detected	O
by	O
scanning	O
electron	O
microscopy	O
.	O

Bacterial	O
translocation	O
was	O
found	O
more	O
often	O
in	O
metastatic	O
nodes	O
(	O
75	O
.	O
0	O
%	O
)	O
than	O
in	O
uninvolved	O
nodes	O
(	O
40	O
.	O
3	O
%	O
)	O
(	O
p	O
=	O
0	O
.	O
015	O
;	O
chi2	O
test	O
)	O
.	O

Gingival	O
carcinoma	O
yielded	O
56	O
.	O
4	O
%	O
of	O
bacterial	O
growth	O
in	O
the	O
regional	O
lymph	O
nodes	O
compared	O
to	O
tongue	O
(	O
40	O
.	O
3	O
%	O
)	O
,	O
oral	O
floor	O
(	O
40	O
.	O
0	O
%	O
)	O
and	O
cheek	O
mucosa	O
(	O
37	O
.	O
5	O
%	O
)	O
.	O

As	O
the	O
gingival	O
carcinoma	O
group	O
includes	O
more	O
T4	O
cases	O
(	O
11	O
/	O
11	O
;	O
100	O
%	O
)	O
than	O
the	O
other	O
three	O
groups	O
(	O
7	O
/	O
19	O
;	O
36	O
.	O
8	O
%	O
)	O
,	O
bacterial	O
translocation	O
in	O
uninvolved	O
nodes	O
could	O
be	O
caused	O
by	O
the	O
size	O
and	O
invasion	O
of	O
the	O
primary	O
oral	O
tumor	O
.	O

Oral	O
streptococci	B-bacteria
(	O
Streptococcus	B-bacteria
intermedius	I-bacteria
,	O
Strep	B-bacteria
.	I-bacteria
constellatus	I-bacteria
,	O
Strep	B-bacteria
.	I-bacteria
oralis	I-bacteria
,	O
Strep	B-bacteria
.	I-bacteria
mitis	I-bacteria
,	O
Strep	B-bacteria
.	I-bacteria
sanguis	I-bacteria
,	O
Strep	B-bacteria
.	I-bacteria
salivarius	I-bacteria
)	O
were	O
the	O
most	O
common	O
isolates	O
.	O

Aerobic	O
enteric	O
bacteria	O
(	O
Enterococcus	B-bacteria
,	O
Escherichia	B-bacteria
,	O
Klebsiella	B-bacteria
etc	O
.	O
)	O
were	O
also	O
found	O
in	O
the	O
lymph	O
nodes	O
.	O

Among	O
the	O
anaerobic	O
bacteria	O
,	O
Peptostreptococcus	B-bacteria
spp	I-bacteria
.	I-bacteria
were	O
isolated	O
from	O
12	O
patients	O
.	O

Damaged	O
oral	O
mucosa	O
in	O
patients	O
with	O
oral	O
cancer	O
might	O
allow	O
the	O
new	O
bacterial	O
colonization	O
on	O
the	O
surface	O
and	O
subsequently	O
drain	O
the	O
bacteria	O
into	O
the	O
regional	O
lymph	O
nodes	O
as	O
well	O
as	O
the	O
general	O
circulation	O
.	O

Anaerobes	O
constitute	O
a	O
significant	O
part	O
of	O
bacterial	O
communities	O
in	O
human	O
mouths	O
.	O

Their	O
ability	O
to	O
colonize	O
and	O
survive	O
in	O
the	O
environment	O
,	O
where	O
remarkable	O
changes	O
occur	O
during	O
early	O
childhood	O
,	O
is	O
fundamental	O
for	O
oral	O
homeostasis	O
.	O

However	O
,	O
relatively	O
little	O
is	O
known	O
of	O
the	O
time	O
of	O
colonization	O
and	O
succession	O
of	O
anaerobic	O
species	O
in	O
the	O
oral	O
cavity	O
.	O

This	O
article	O
presents	O
an	O
up	O
-	O
to	O
-	O
date	O
review	O
on	O
the	O
development	O
of	O
the	O
oral	O
anaerobic	O
microflora	O
in	O
respect	O
to	O
age	O
,	O
and	O
in	O
addition	O
,	O
considers	O
some	O
aspects	O
of	O
the	O
role	O
of	O
oral	O
anaerobes	O
in	O
health	O
and	O
disease	O
.	O

Behcet	O
'	O
s	O
disease	O
is	O
a	O
multisystem	O
disorder	O
of	O
unknown	O
etiology	O
,	O
affecting	O
predominantly	O
the	O
oral	O
mucosa	O
,	O
skin	O
,	O
and	O
eyes	O
.	O

Recurrent	O
and	O
painful	O
episodes	O
of	O
oral	O
ulcerations	O
interfere	O
with	O
regular	O
oral	O
hygiene	O
leading	O
to	O
rapid	O
bacterial	O
plaque	O
accumulation	O
.	O

The	O
aims	O
of	O
this	O
study	O
were	O
to	O
evaluate	O
the	O
periodontal	O
status	O
of	O
patients	O
with	O
Behcet	O
'	O
s	O
disease	O
and	O
determine	O
serum	O
antibody	O
responses	O
to	O
selected	O
oral	O
microorganisms	O
,	O
including	O
major	O
periodontopathogens	O
in	O
these	O
patients	O
.	O

Thirty	O
-	O
three	O
patients	O
with	O
Behcet	O
'	O
s	O
disease	O
and	O
15	O
healthy	O
subjects	O
were	O
included	O
in	O
the	O
study	O
.	O

Plaque	O
,	O
sulcular	O
bleeding	O
,	O
periodontal	O
index	O
scores	O
,	O
probing	O
depths	O
,	O
and	O
total	O
number	O
of	O
teeth	O
were	O
recorded	O
.	O

Serum	O
IgG	O
antibody	O
levels	O
to	O
a	O
panel	O
of	O
13	O
oral	O
microorganisms	O
were	O
determined	O
.	O

Significantly	O
higher	O
values	O
for	O
each	O
of	O
the	O
clinical	O
measures	O
were	O
observed	O
in	O
patients	O
with	O
Behcet	O
'	O
s	O
disease	O
compared	O
to	O
healthy	O
subjects	O
(	O
P	O
<	O
0	O
.	O
0001	O
)	O
.	O

Antibody	O
levels	O
to	O
selected	O
members	O
of	O
plaque	O
,	O
including	O
Actinomyces	B-bacteria
viscosus	I-bacteria
,	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Streptococcus	B-bacteria
sanguis	I-bacteria
,	O
Streptococcus	B-bacteria
oralis	I-bacteria
,	O
Eikenella	B-bacteria
corrodens	I-bacteria
,	O
Campylobacter	B-bacteria
rectus	I-bacteria
,	O
and	O
Prevotella	B-bacteria
intermedia	I-bacteria
were	O
significantly	O
lower	O
in	O
patients	O
with	O
Behcet	O
'	O
s	O
disease	O
than	O
in	O
controls	O
(	O
P	O
<	O
0	O
.	O
001	O
-	O
0	O
.	O
05	O
)	O
.	O

In	O
contrast	O
,	O
these	O
patients	O
exhibited	O
significantly	O
elevated	O
antibody	O
levels	O
to	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
Y4	I-bacteria
compared	O
to	O
controls	O
(	O
P	O
<	O
0	O
.	O
01	O
)	O
.	O

Our	O
data	O
indicate	O
that	O
the	O
patients	O
with	O
Behcet	O
'	O
s	O
disease	O
generally	O
exhibit	O
clinical	O
findings	O
of	O
established	O
periodontal	O
disease	O
.	O

Decreased	O
antibody	O
responses	O
to	O
early	O
colonizers	O
of	O
both	O
supra	O
-	O
and	O
subgingival	O
plaque	O
were	O
observed	O
along	O
with	O
the	O
elevation	O
in	O
antibody	O
levels	O
to	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
.	O

These	O
results	O
suggest	O
that	O
the	O
bacterial	O
plaque	O
ecology	O
and	O
/	O
or	O
immune	O
responses	O
to	O
these	O
microorganisms	O
may	O
be	O
affected	O
in	O
Behcet	O
'	O
s	O
disease	O
which	O
could	O
lead	O
to	O
changes	O
in	O
the	O
expression	O
of	O
periodontal	O
disease	O
.	O

MG2	O
(	O
the	O
MUC7	O
gene	O
product	O
)	O
is	O
a	O
low	O
-	O
molecular	O
-	O
mass	O
mucin	O
found	O
in	O
human	O
submandibular	O
/	O
sublingual	O
secretions	O
.	O

This	O
mucin	O
is	O
believed	O
to	O
agglutinate	O
a	O
variety	O
of	O
microbes	O
and	O
thus	O
is	O
considered	O
an	O
important	O
component	O
of	O
the	O
non	O
-	O
immune	O
host	O
defence	O
system	O
in	O
the	O
oral	O
cavity	O
.	O

We	O
have	O
shown	O
that	O
MUC7	O
can	O
bind	O
to	O
cariogenic	O
strains	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
and	O
that	O
this	O
binding	O
requires	O
a	O
structural	O
determinant	O
in	O
the	O
N	O
-	O
terminal	O
region	O
.	O

In	O
the	O
present	O
study	O
an	O
expression	O
construct	O
,	O
pNMuc7	O
,	O
encoding	O
the	O
N	O
-	O
terminal	O
144	O
amino	O
acids	O
of	O
MUC7	O
was	O
generated	O
,	O
and	O
the	O
recombinant	O
protein	O
rNMUC7	O
was	O
expressed	O
in	O
Escherichia	B-bacteria
coli	I-bacteria
.	O

Purified	O
rNMUC7	O
was	O
characterized	O
and	O
the	O
binding	O
of	O
this	O
protein	O
to	O
oral	O
bacteria	O
was	O
investigated	O
in	O
an	O
established	O
assay	O
.	O

The	O
results	O
showed	O
that	O
the	O
recombinant	O
protein	O
bound	O
to	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
ATCC	I-bacteria
25175	I-bacteria
and	O
ATCC	B-bacteria
33402	I-bacteria
,	O
and	O
that	O
alkylation	O
of	O
the	O
two	O
cysteine	O
residues	O
(	O
Cys	O
(	O
45	O
)	O
and	O
Cys	O
(	O
50	O
)	O
)	O
resulted	O
in	O
the	O
complete	O
loss	O
of	O
bacterial	O
binding	O
.	O

This	O
suggests	O
that	O
binding	O
of	O
MUC7	O
to	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
occurs	O
between	O
the	O
N	O
-	O
terminal	O
region	O
of	O
the	O
mucin	O
molecule	O
and	O
the	O
bacterial	O
surface	O
,	O
and	O
that	O
this	O
interaction	O
is	O
dependent	O
on	O
a	O
cysteine	O
-	O
containing	O
domain	O
within	O
this	O
region	O
of	O
MUC7	O
.	O

In	O
addition	O
,	O
the	O
killing	O
activity	O
of	O
rNMUC7	O
was	O
compared	O
with	O
that	O
of	O
the	O
candidacidal	O
salivary	O
protein	O
histatin	O
5	O
in	O
an	O
established	O
Candida	O
albicans	O
(	O
ATCC	O
44505	O
)	O
blastoconidia	O
killing	O
assay	O
.	O

It	O
was	O
found	O
that	O
the	O
LD	O
(	O
50	O
)	O
values	O
of	O
rNMUC7	O
and	O
histatin	O
5	O
were	O
comparable	O
,	O
and	O
that	O
the	O
recombinant	O
protein	O
displayed	O
significant	O
killing	O
activity	O
at	O
the	O
physiological	O
concentration	O
range	O
of	O
MUC7	O
in	O
whole	O
saliva	O
.	O

This	O
study	O
is	O
the	O
first	O
to	O
show	O
that	O
the	O
N	O
-	O
terminal	O
region	O
of	O
MUC7	O
contains	O
a	O
structural	O
determinant	O
for	O
bacterial	O
binding	O
and	O
that	O
this	O
region	O
exhibits	O
candidacidal	O
activity	O
.	O

The	O
aim	O
was	O
to	O
establish	O
defined	O
-	O
species	O
consortium	O
plaque	O
biofilms	O
to	O
investigate	O
enamel	O
and	O
root	O
caries	O
in	O
an	O
artificial	O
mouth	O
.	O

Strains	O
of	O
the	O
putative	O
enamel	O
and	O
root	O
caries	O
pathogens	O
,	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Strep	B-bacteria
.	I-bacteria
sobrinus	I-bacteria
,	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
and	O
Lactobacillus	B-bacteria
rhamnosus	I-bacteria
,	O
were	O
screened	O
in	O
batch	O
culture	O
for	O
potential	O
cariogenic	O
properties	O
:	O
a	O
low	O
terminal	O
pH	O
,	O
ability	O
to	O
aggregate	O
,	O
and	O
catabolic	O
diversity	O
.	O

The	O
strains	O
selected	O
were	O
grown	O
as	O
monoculture	O
biofilms	O
and	O
as	O
consortium	O
plaque	O
biofilms	O
in	O
a	O
multiplaque	O
artificial	O
mouth	O
.	O

The	O
biofilms	O
were	O
supplied	O
with	O
a	O
constant	O
flow	O
of	O
a	O
simulated	O
oral	O
fluid	O
and	O
were	O
given	O
periodic	O
sucrose	O
(	O
and	O
in	O
some	O
instances	O
glucose	O
)	O
to	O
simulate	O
meals	O
.	O

All	O
the	O
bacteria	O
except	O
L	B-bacteria
.	I-bacteria
rhamnosus	I-bacteria
formed	O
large	O
,	O
monospecies	O
biofilms	O
with	O
resting	O
pH	O
in	O
the	O
range	O
5	O
.	O
3	O
-	O
5	O
.	O
8	O
.	O

The	O
consortia	O
biofilms	O
were	O
larger	O
and	O
had	O
a	O
resting	O
pH	O
of	O
4	O
.	O
9	O
-	O
5	O
.	O
3	O
.	O

The	O
consortia	O
biofilms	O
supplied	O
with	O
8	O
-	O
hourly	O
carbohydrate	O
comprised	O
mainly	O
'	B-bacteria
mutans	I-bacteria
'	I-bacteria
streptococci	I-bacteria
(	O
58	O
,	O
SD	O
5	O
.	O
5	O
%	O
)	O
and	O
L	B-bacteria
.	I-bacteria
rhamnosus	I-bacteria
(	O
42	O
,	O
SD	O
5	O
.	O
7	O
%	O
)	O
.	O

A	B-bacteria
.	I-bacteria
naeslundii	I-bacteria
characteristically	O
was	O
absent	O
or	O
present	O
in	O
a	O
low	O
percentage	O
(	O
up	O
to	O
4	O
%	O
colony	O
-	O
forming	O
units	O
)	O
.	O

All	O
biofilms	O
demineralized	O
polished	O
bovine	O
enamel	O
and	O
dentine	O
blocks	O
,	O
as	O
assessed	O
by	O
microradiography	O
and	O
enamel	O
-	O
surface	O
microhardness	O
measurement	O
.	O

The	O
consortia	O
also	O
demineralized	O
intact	O
enamel	O
and	O
tooth	O
roots	O
;	O
they	O
were	O
more	O
cariogenic	O
to	O
enamel	O
than	O
any	O
of	O
the	O
monoculture	O
biofilms	O
,	O
as	O
measured	O
by	O
enamel	O
-	O
surface	O
softening	O
,	O
but	O
variation	O
in	O
lesion	O
depth	O
was	O
proportional	O
to	O
biofilm	O
wet	O
weight	O
irrespective	O
of	O
acidogen	O
composition	O
(	O
r	O
=	O
0	O
.	O
93	O
,	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

Enamel	O
lesions	O
had	O
a	O
well	O
-	O
mineralized	O
intact	O
surface	O
and	O
a	O
zone	O
of	O
subsurface	O
demineralization	O
,	O
typical	O
of	O
early	O
natural	O
lesions	O
.	O

Dentine	O
and	O
root	O
lesions	O
showed	O
extensive	O
demineralization	O
but	O
lacked	O
a	O
pronounced	O
surface	O
mineralized	O
zone	O
.	O

Substitution	O
of	O
glucose	O
for	O
sucrose	O
had	O
no	O
effect	O
on	O
the	O
cariogenicity	O
of	O
the	O
consortium	O
to	O
bovine	O
enamel	O
or	O
human	O
roots	O
and	O
had	O
no	O
major	O
effect	O
on	O
the	O
plaque	O
composition	O
.	O

Continuously	O
supplied	O
fluoride	O
(	O
19	O
parts	O
/	O
10	O
(	O
6	O
)	O
)	O
resulted	O
in	O
a	O
substantially	O
reduced	O
enamel	O
surface	O
softening	O
and	O
subsurface	O
demineralization	O
of	O
intact	O
roots	O
.	O

It	O
was	O
concluded	O
that	O
consortia	O
biofilms	O
of	O
selected	O
caries	O
pathogens	O
generate	O
realistic	O
caries	O
lesions	O
in	O
all	O
tooth	O
hard	O
tissues	O
under	O
controlled	O
growth	O
conditions	O
in	O
the	O
artificial	O
mouth	O
.	O

This	O
in	O
vitro	O
caries	O
experimental	O
model	O
may	O
prove	O
useful	O
for	O
the	O
study	O
of	O
interrelations	O
between	O
the	O
plaque	O
biofilm	O
,	O
tooth	O
tissues	O
and	O
the	O
oral	O
environment	O
,	O
and	O
for	O
the	O
development	O
of	O
procedures	O
to	O
modify	O
the	O
course	O
of	O
caries	O
development	O
.	O

intimate	O
relationship	O
with	O
bacteria	O
is	O
a	O
fundamental	O
factor	O
in	O
the	O
health	O
status	O
of	O
an	O
individual	O
.	O

After	O
birth	O
infants	O
are	O
exposed	O
to	O
continuous	O
person	O
-	O
to	O
-	O
person	O
and	O
environmental	O
contacts	O
with	O
microbes	O
,	O
and	O
the	O
development	O
of	O
the	O
indigenous	O
microflora	O
begins	O
on	O
the	O
surfaces	O
of	O
the	O
human	O
body	O
.	O

In	O
a	O
developing	O
ecosystem	O
microbial	O
colonization	O
may	O
easily	O
occur	O
because	O
of	O
the	O
still	O
inadequate	O
host	O
response	O
.	O

Adhesion	O
is	O
the	O
initial	O
event	O
in	O
the	O
colonization	O
of	O
bacteria	O
.	O

In	O
the	O
mouth	O
,	O
only	O
mucosal	O
surfaces	O
are	O
available	O
during	O
the	O
first	O
months	O
of	O
life	O
.	O

After	O
teeth	O
emerge	O
,	O
the	O
number	O
of	O
attachment	O
sites	O
and	O
potential	O
niches	O
increases	O
significantly	O
.	O

Bacteria	O
adhere	O
not	O
only	O
to	O
oral	O
surfaces	O
but	O
also	O
to	O
each	O
other	O
,	O
forming	O
multigeneric	O
communities	O
where	O
specific	O
partner	O
relationships	O
influence	O
their	O
composition	O
and	O
stability	O
.	O

Viridans	B-bacteria
streptococci	I-bacteria
and	O
a	O
strictly	O
anaerobic	O
species	O
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
are	O
of	O
interest	O
in	O
this	O
context	O
.	O

The	O
oral	O
colonization	O
pattern	O
differs	O
between	O
individuals	O
already	O
in	O
infancy	O
;	O
variable	O
bacterial	O
load	O
in	O
saliva	O
of	O
attendants	O
and	O
other	O
close	O
contacts	O
and	O
the	O
frequency	O
of	O
this	O
bacterial	O
exposure	O
may	O
partly	O
account	O
for	O
individual	O
differences	O
.	O

In	O
addition	O
,	O
the	O
exposure	O
of	O
an	O
infant	O
to	O
antibiotics	O
affects	O
the	O
quality	O
of	O
colonizing	O
bacteria	O
.	O

This	O
article	O
presents	O
an	O
overview	O
of	O
the	O
age	O
-	O
related	O
acquisition	O
of	O
oral	O
bacterial	O
and	O
the	O
role	O
of	O
the	O
indigenous	O
oral	O
microflora	O
in	O
health	O
and	O
disease	O
.	O

Bacteria	O
are	O
causative	O
agents	O
of	O
periodontal	O
diseases	O
.	O

Interactions	O
between	O
oral	O
bacteria	O
and	O
gingival	O
epithelial	O
cells	O
are	O
essential	O
aspects	O
of	O
periodontal	O
infections	O
.	O

Using	O
an	O
in	O
vitro	O
tissue	O
culture	O
model	O
,	O
a	O
selected	O
group	O
of	O
gram	O
-	O
negative	O
anaerobic	O
bacteria	O
frequently	O
associated	O
with	O
periodontal	O
diseases	O
,	O
including	O
Bacteroides	B-bacteria
forsythus	I-bacteria
,	O
Campylobacter	B-bacteria
curvus	I-bacteria
,	O
Eikenella	B-bacteria
corrodens	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
and	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
were	O
examined	O
for	O
their	O
ability	O
to	O
adhere	O
to	O
and	O
invade	O
primary	O
cultures	O
of	O
human	O
gingival	O
epithelial	O
cells	O
(	O
HGEC	O
)	O
.	O

The	O
effects	O
of	O
these	O
bacteria	O
on	O
the	O
production	O
of	O
interleukin	O
-	O
8	O
(	O
IL	O
-	O
8	O
)	O
,	O
a	O
proinflammatory	O
chemokine	O
,	O
were	O
also	O
measured	O
.	O

These	O
studies	O
provided	O
an	O
initial	O
demonstration	O
that	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
adhered	O
to	O
and	O
invaded	O
HGEC	O
and	O
that	O
this	O
was	O
accompanied	O
by	O
high	O
levels	O
of	O
IL	O
-	O
8	O
secretion	O
from	O
the	O
epithelial	O
cells	O
.	O

The	O
attachment	O
and	O
invasion	O
characteristics	O
of	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
were	O
also	O
tested	O
using	O
KB	O
cells	O
,	O
an	O
oral	O
epithelial	O
cell	O
line	O
.	O

The	O
invasion	O
was	O
verified	O
by	O
transmission	O
electron	O
microscopy	O
and	O
with	O
metabolic	O
inhibitors	O
.	O

Invasion	O
appeared	O
to	O
occur	O
via	O
a	O
`	O
`	O
zipping	O
'	O
'	O
mechanism	O
and	O
required	O
the	O
involvement	O
of	O
actins	O
,	O
microtubules	O
,	O
signal	O
transduction	O
,	O
protein	O
synthesis	O
,	O
and	O
energy	O
metabolism	O
of	O
the	O
epithelial	O
cell	O
,	O
as	O
well	O
as	O
protein	O
synthesis	O
by	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
.	O

A	O
spontaneous	O
mutant	O
,	O
lam	O
,	O
of	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
,	O
isolated	O
as	O
defective	O
in	O
autoagglutination	O
,	O
was	O
unable	O
to	O
attach	O
to	O
or	O
invade	O
HGEC	O
or	O
KB	O
cells	O
,	O
further	O
indicating	O
the	O
requirement	O
of	O
bacterial	O
components	O
in	O
these	O
processes	O
.	O

Sugar	O
inhibition	O
assays	O
indicated	O
that	O
lectin	O
-	O
like	O
interactions	O
were	O
involved	O
in	O
the	O
attachment	O
of	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
to	O
KB	O
cells	O
.	O

Investigation	O
of	O
these	O
new	O
virulence	O
phenotypes	O
should	O
improve	O
our	O
understanding	O
of	O
the	O
role	O
of	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
in	O
periodontal	O
infections	O
.	O

The	O
heterogeneous	O
group	O
of	O
oral	O
bacteria	O
within	O
the	O
sanguinis	B-bacteria
(	I-bacteria
sanguis	I-bacteria
)	I-bacteria
streptococci	I-bacteria
comprise	O
members	O
of	O
the	O
indigenous	O
biota	O
of	O
the	O
human	O
oral	O
cavity	O
.	O

While	O
the	O
association	O
of	O
Streptococcus	B-bacteria
sanguinis	I-bacteria
with	O
bacterial	O
endocarditis	O
is	O
well	O
described	O
in	O
the	O
literature	O
,	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
is	O
thought	O
to	O
play	O
a	O
benign	O
,	O
if	O
not	O
a	O
beneficial	O
,	O
role	O
in	O
the	O
oral	O
cavity	O
.	O

Little	O
is	O
known	O
,	O
however	O
,	O
about	O
the	O
natural	O
history	O
of	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
and	O
its	O
specific	O
relationship	O
with	O
other	O
oral	O
bacteria	O
.	O

As	O
part	O
of	O
a	O
longitudinal	O
study	O
concerning	O
the	O
transmission	O
and	O
acquisition	O
of	O
oral	O
bacteria	O
within	O
mother	O
-	O
infant	O
pairs	O
,	O
we	O
examined	O
the	O
initial	O
acquisition	O
of	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
and	O
described	O
its	O
colonization	O
relative	O
to	O
tooth	O
emergence	O
and	O
its	O
proportions	O
in	O
plaque	O
and	O
saliva	O
as	O
a	O
function	O
of	O
other	O
biological	O
events	O
,	O
including	O
subsequent	O
colonization	O
with	O
mutans	B-bacteria
streptococci	I-bacteria
.	O

A	O
second	O
cohort	O
of	O
infants	O
was	O
recruited	O
to	O
define	O
the	O
taxonomic	O
affiliation	O
of	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
.	O

We	O
found	O
that	O
the	O
colonization	O
of	O
the	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
occurs	O
during	O
a	O
discrete	O
`	O
`	O
window	O
of	O
infectivity	O
'	O
'	O
at	O
a	O
median	O
age	O
of	O
9	O
months	O
in	O
the	O
infants	O
.	O

Its	O
colonization	O
is	O
tooth	O
dependent	O
and	O
correlated	O
to	O
the	O
time	O
of	O
tooth	O
emergence	O
;	O
its	O
proportions	O
in	O
saliva	O
increase	O
as	O
new	O
teeth	O
emerge	O
.	O

In	O
addition	O
,	O
early	O
colonization	O
of	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
and	O
its	O
elevated	O
levels	O
in	O
the	O
oral	O
cavity	O
were	O
correlated	O
to	O
a	O
significant	O
delay	O
in	O
the	O
colonization	O
of	O
mutans	B-bacteria
streptococci	I-bacteria
.	O

Underpinning	O
this	O
apparent	O
antagonism	O
between	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
and	O
mutans	B-bacteria
streptococci	I-bacteria
is	O
the	O
observation	O
that	O
after	O
mutans	B-bacteria
streptococci	I-bacteria
colonize	O
the	O
infant	O
,	O
the	O
levels	O
of	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
decrease	O
.	O

Children	O
who	O
do	O
not	O
harbor	O
detectable	O
levels	O
of	O
mutans	B-bacteria
streptococci	I-bacteria
have	O
significantly	O
higher	O
levels	O
of	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
in	O
their	O
saliva	O
than	O
do	O
children	O
colonized	O
with	O
mutans	B-bacteria
streptococci	I-bacteria
.	O

Collectively	O
,	O
these	O
findings	O
suggest	O
that	O
the	O
colonization	O
of	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
may	O
influence	O
the	O
subsequent	O
colonization	O
of	O
mutans	B-bacteria
streptococci	I-bacteria
,	O
and	O
this	O
in	O
turn	O
may	O
suggest	O
several	O
ecological	O
approaches	O
toward	O
controlling	O
dental	O
caries	O
.	O

A	O
novel	O
group	O
of	O
oral	O
spirochaetes	B-bacteria
that	O
were	O
specifically	O
labeled	O
by	O
H9	O
-	O
2	O
,	O
a	O
monoclonal	O
antibody	O
against	O
the	O
37	O
-	O
kDa	O
endoflagellar	O
sheath	O
protein	O
of	O
Treponema	B-bacteria
pallidum	I-bacteria
,	O
have	O
earlier	O
been	O
demonstrated	O
in	O
periodontitis	O
-	O
associated	O
plaque	O
samples	O
;	O
two	O
cultivable	O
oral	O
spirochaetes	B-bacteria
T	B-bacteria
.	I-bacteria
vincentii	I-bacteria
and	O
T	B-bacteria
.	I-bacteria
medium	I-bacteria
displayed	O
cross	O
-	O
reactivity	O
with	O
that	O
monoclonal	O
,	O
but	O
the	O
molecular	O
basis	O
for	O
this	O
cross	O
-	O
reactivity	O
is	O
not	O
yet	O
defined	O
.	O

Here	O
,	O
the	O
flaA	O
-	O
1	O
genes	O
which	O
encode	O
the	O
37	O
-	O
kDa	O
sheath	O
protein	O
from	O
T	B-bacteria
.	I-bacteria
vincentii	I-bacteria
and	O
the	O
oral	O
spirochaetes	B-bacteria
present	O
in	O
samples	O
from	O
advanced	O
periodontitis	O
were	O
examined	O
.	O

A	O
856	O
bp	O
fragment	O
of	O
the	O
flaA	O
-	O
1	O
gene	O
was	O
amplified	O
in	O
T	B-bacteria
.	I-bacteria
pallidum	I-bacteria
and	O
T	B-bacteria
.	I-bacteria
vincentii	I-bacteria
.	O

The	O
same	O
-	O
size	O
polymerase	O
chain	O
reaction	O
fragments	O
were	O
also	O
amplified	O
in	O
two	O
clinical	O
samples	O
from	O
patients	O
with	O
advanced	O
periodontitis	O
but	O
not	O
from	O
samples	O
of	O
healthy	O
plaque	O
.	O

The	O
sequences	O
of	O
the	O
flaA	O
-	O
1	O
genes	O
of	O
the	O
oral	O
spirochaetes	B-bacteria
detected	O
in	O
human	O
periodontal	O
plaque	O
were	O
closely	O
similar	O
to	O
those	O
of	O
T	B-bacteria
.	I-bacteria
pallidum	I-bacteria
and	O
T	B-bacteria
.	I-bacteria
vincentii	I-bacteria
,	O
but	O
neither	O
of	O
these	O
two	O
organisms	O
could	O
be	O
detected	O
in	O
these	O
samples	O
using	O
rRNA	O
-	O
specific	O
primers	O
.	O

The	O
identity	O
of	O
the	O
flaA	O
-	O
1	O
positive	O
spirochaetes	B-bacteria
associated	O
with	O
periodontitis	O
remains	O
to	O
be	O
determined	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
antibacterial	O
effect	O
of	O
Coptidis	O
Rhizoma	O
(	O
CR	O
)	O
,	O
a	O
traditional	O
medicinal	O
plant	O
,	O
on	O
oral	O
bacteria	O
.	O

CR	O
extract	O
was	O
prepared	O
by	O
boiling	O
CR	O
in	O
water	O
for	O
2	O
h	O
.	O

Alkaloids	O
contained	O
in	O
CR	O
extract	O
were	O
assayed	O
by	O
high	O
performance	O
liquid	O
chromatography	O
(	O
HPLC	O
)	O
.	O

Antibacterial	O
activity	O
of	O
CR	O
extract	O
was	O
estimated	O
from	O
the	O
lowest	O
concentration	O
that	O
did	O
not	O
permit	O
bacterial	O
growth	O
(	O
minimum	O
inhibitory	O
concentration	O
,	O
MIC	O
)	O
and	O
the	O
concentrations	O
that	O
inhibited	O
50	O
%	O
of	O
bacterial	O
proteolytic	O
activity	O
(	O
IC50	O
)	O
.	O

CR	O
extract	O
inhibited	O
the	O
growth	O
of	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Prevotella	B-bacteria
nigrescens	I-bacteria
and	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
at	O
MIC	O
of	O
0	O
.	O
031	O
-	O
0	O
.	O
25	O
mg	O
ml	O
(	O
-	O
1	O
)	O
,	O
whereas	O
it	O
had	O
less	O
inhibitory	O
effect	O
(	O
MIC	O
:	O
0	O
.	O
5	O
-	O
2	O
mg	O
ml	O
(	O
-	O
1	O
)	O
)	O
on	O
the	O
growth	O
of	O
Streptococcus	B-bacteria
and	O
Lactobacillus	B-bacteria
.	O

The	O
major	O
active	O
component	O
of	O
CR	O
extract	O
was	O
berberine	O
(	O
Ber	O
)	O
,	O
an	O
alkaloid	O
,	O
and	O
its	O
inhibiting	O
specificity	O
to	O
bacterial	O
growth	O
was	O
similar	O
to	O
that	O
of	O
CR	O
extract	O
.	O

CR	O
extract	O
and	O
Ber	O
were	O
bacteriostatic	O
at	O
the	O
MICs	O
against	O
most	O
of	O
the	O
bacteria	O
,	O
and	O
bacteriocidal	O
at	O
the	O
concentrations	O
higher	O
than	O
the	O
MICs	O
.	O

Ber	O
inhibited	O
the	O
activities	O
of	O
collagenase	O
from	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
and	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
.	O

CR	O
extract	O
and	O
Ber	O
had	O
an	O
inhibitory	O
effect	O
on	O
periodontopathogenic	O
bacteria	O
.	O

These	O
results	O
suggest	O
the	O
possibility	O
of	O
their	O
clinical	O
application	O
for	O
the	O
treatment	O
of	O
periodontal	O
diseases	O
.	O

Lymphocytes	O
cultures	O
were	O
used	O
as	O
an	O
in	O
vitro	O
experimental	O
model	O
to	O
get	O
a	O
deeper	O
insight	O
into	O
immune	O
response	O
to	O
oral	O
bacteria	O
in	O
periapical	O
granulomas	O
.	O

Lymphocytes	O
isolated	O
from	O
leucocyte	O
concentrate	O
were	O
in	O
lymphocyte	O
cultures	O
stimulated	O
by	O
antigen	O
preparations	O
of	O
oral	O
bacteria	O
.	O

Lymphocyte	O
subsets	O
that	O
have	O
developed	O
in	O
lymphocyte	O
cultures	O
after	O
a	O
week	O
of	O
stimulation	O
were	O
analysed	O
by	O
flow	O
cytometry	O
.	O

A	O
significant	O
increase	O
in	O
expression	O
of	O
INF	O
-	O
gamma	O
molecules	O
in	O
CD3	O
+	O
cells	O
stimulated	O
by	O
antigen	O
preparations	O
of	O
oral	O
streptococci	B-bacteria
was	O
found	O
,	O
compared	O
with	O
negative	O
control	O
.	O

On	O
the	O
other	O
hand	O
we	O
observed	O
a	O
significant	O
increase	O
in	O
expression	O
of	O
IL	O
-	O
4	O
in	O
CD3	O
+	O
cells	O
stimulated	O
by	O
antigens	O
of	O
anaerobic	O
bacteria	O
,	O
compared	O
with	O
negative	O
control	O
.	O

Our	O
results	O
show	O
that	O
antigens	O
of	O
oral	O
streptococci	B-bacteria
in	O
in	O
vitro	O
lymphocyte	O
cultures	O
induce	O
the	O
differentiation	O
of	O
T	O
helper	O
cells	O
into	O
Th2	O
cells	O
and	O
that	O
antigen	O
preparations	O
of	O
anaerobic	O
bacteria	O
induce	O
the	O
differentiation	O
of	O
T	O
helper	O
cells	O
into	O
Th1	O
cells	O
.	O

Furthermore	O
,	O
an	O
increased	O
expression	O
of	O
HLA	O
-	O
DR	O
molecules	O
on	O
CD8	O
+	O
T	O
cells	O
stimulated	O
by	O
antigens	O
of	O
oral	O
streptococci	B-bacteria
was	O
found	O
,	O
compared	O
with	O
negative	O
control	O
.	O

Many	O
epidemiological	O
studies	O
have	O
identified	O
chronic	O
alcohol	O
consumption	O
as	O
a	O
significant	O
risk	O
factor	O
for	O
cancer	O
of	O
the	O
upper	O
aerodigestive	O
tract	O
(	O
UAT	O
)	O
in	O
human	O
.	O

Although	O
acetaldehyde	O
,	O
the	O
first	O
metabolite	O
from	O
ethanol	O
by	O
alcohol	O
dehydrogenase	O
(	O
ADH	O
)	O
,	O
is	O
regarded	O
as	O
a	O
carcinogen	O
,	O
how	O
systemic	O
production	O
of	O
acetaldehyde	O
particularly	O
affects	O
the	O
UAT	O
remains	O
unclear	O
.	O

In	O
our	O
study	O
,	O
we	O
searched	O
for	O
the	O
regional	O
source	O
of	O
acetaldehyde	O
in	O
UAT	O
,	O
especially	O
the	O
involvement	O
of	O
bacteria	O
in	O
the	O
human	O
normal	O
oral	O
microflora	O
.	O

Here	O
we	O
demonstrate	O
that	O
,	O
among	O
the	O
bacterial	O
species	O
identified	O
from	O
the	O
human	O
oral	O
cavity	O
,	O
genus	O
Neisseria	B-bacteria
had	O
extremely	O
high	O
ADH	O
activity	O
and	O
produced	O
significant	O
amounts	O
of	O
acetaldehyde	O
when	O
cultured	O
with	O
medium	O
containing	O
ethanol	O
in	O
vitro	O
.	O

The	O
ability	O
to	O
produce	O
acetaldehyde	O
was	O
more	O
than	O
100	O
-	O
fold	O
higher	O
than	O
that	O
produced	O
by	O
any	O
other	O
genera	O
we	O
studied	O
.	O

Furthermore	O
,	O
alcohol	O
ingestion	O
influences	O
the	O
bacterial	O
composition	O
of	O
the	O
oral	O
microflora	O
,	O
resulting	O
in	O
an	O
increased	O
proportion	O
of	O
Neisseria	B-bacteria
.	O

Although	O
Neisseria	B-bacteria
present	O
in	O
normal	O
oral	O
microflora	O
is	O
generally	O
non	O
-	O
pathogenic	O
,	O
these	O
findings	O
suggest	O
that	O
this	O
microbe	O
can	O
be	O
a	O
regional	O
source	O
of	O
carcinogenic	O
acetaldehyde	O
and	O
thus	O
potentially	O
play	O
an	O
important	O
role	O
in	O
alcohol	O
-	O
related	O
carcinogenesis	O
in	O
human	O
UAT	O
.	O

The	O
aims	O
of	O
the	O
present	O
study	O
were	O
to	O
screen	O
and	O
characterize	O
the	O
antimicrobial	O
lactic	B-bacteria
acid	I-bacteria
bacteria	I-bacteria
which	O
were	O
isolated	O
from	O
healthy	O
oral	O
cavities	O
of	O
Thai	O
volunteers	O
,	O
and	O
to	O
characterize	O
their	O
inhibiting	O
substances	O
.	O

Among	O
3790	O
isolates	O
(	O
suspected	O
to	O
be	O
lactic	B-bacteria
acid	I-bacteria
bacteria	I-bacteria
)	O
from	O
130	O
volunteers	O
,	O
five	O
showed	O
an	O
appreciable	O
effect	O
against	O
Sarcina	B-bacteria
lutea	I-bacteria
ATCC	I-bacteria
9341	I-bacteria
,	O
Bacillus	B-bacteria
cereus	I-bacteria
ATCC	I-bacteria
11778	I-bacteria
,	O
Escherichia	B-bacteria
coli	I-bacteria
ATCC	I-bacteria
25922	I-bacteria
,	O
Staphylococcus	B-bacteria
aureus	I-bacteria
ATCC	I-bacteria
6538	I-bacteria
,	O
Streptococcus	B-bacteria
mutans	I-bacteria
DTMU	I-bacteria
1	I-bacteria
,	O
Strep	B-bacteria
.	I-bacteria
salivarius	I-bacteria
DTMU	I-bacteria
1	I-bacteria
,	O
Strep	B-bacteria
.	I-bacteria
sanguis	I-bacteria
DTMU	I-bacteria
1	I-bacteria
,	O
Candida	O
albicans	O
ATCC	O
13803	O
and	O
C	O
.	O
albicans	O
DTMU	O
2	O
,	O
as	O
well	O
as	O
the	O
oral	O
pathogens	O
.	O

These	O
antimicrobial	O
isolates	O
included	O
L17	B-bacteria
and	O
N14	B-bacteria
which	O
showed	O
the	O
antibacterial	O
activity	O
,	O
D14	B-bacteria
which	O
showed	O
the	O
anticandidal	O
activity	O
,	O
and	O
D6	B-bacteria
and	O
N8	B-bacteria
which	O
showed	O
both	O
the	O
antibacterial	O
and	O
anticandidal	O
activities	O
.	O

The	O
isolates	O
were	O
later	O
found	O
to	O
be	O
facultative	O
anaerobic	O
,	O
Gram	O
-	O
positive	O
,	O
non	O
-	O
spore	O
-	O
forming	O
,	O
non	O
-	O
capsule	O
-	O
forming	O
and	O
catalase	O
-	O
negative	O
bacilli	O
.	O

They	O
could	O
utilize	O
casein	O
but	O
could	O
not	O
hydrolyse	O
starch	O
,	O
and	O
they	O
produced	O
hydrogen	O
peroxide	O
and	O
bacteriocins	O
.	O

Their	O
antimicrobial	O
potentials	O
were	O
found	O
to	O
be	O
affected	O
by	O
pH	O
,	O
catalase	O
,	O
proteolytic	O
enzymes	O
and	O
temperature	O
.	O

The	O
activity	O
was	O
partially	O
inactivated	O
after	O
catalase	O
treatment	O
,	O
significantly	O
declined	O
at	O
pH	O
>	O
or	O
=	O
9	O
.	O
0	O
or	O
after	O
trypsin	O
and	O
pepsin	O
treatments	O
,	O
and	O
also	O
reduced	O
after	O
heating	O
at	O
>	O
or	O
=	O
100	O
degrees	O
C	O
.	O

However	O
,	O
the	O
antimicrobial	O
activity	O
of	O
these	O
five	O
isolates	O
was	O
somewhat	O
resistant	O
to	O
heat	O
.	O

When	O
the	O
isolates	O
were	O
tested	O
for	O
their	O
antimicrobial	O
sensitivity	O
,	O
they	O
were	O
shown	O
to	O
be	O
sensitive	O
to	O
a	O
number	O
of	O
antimicrobial	O
agents	O
.	O

The	O
final	O
identification	O
revealed	O
that	O
D6	B-bacteria
,	O
D14	B-bacteria
and	O
N14	B-bacteria
were	O
Lactobacillus	B-bacteria
paracasei	I-bacteria
subsp	I-bacteria
.	I-bacteria
paracasei	I-bacteria
,	O
and	O
L17	B-bacteria
and	O
N8	B-bacteria
were	O
Lact	B-bacteria
.	I-bacteria
rhamnosus	I-bacteria
.	O

Beta	O
-	O
galactosyllactose	O
is	O
a	O
trisaccharide	O
containing	O
the	O
beta	O
-	O
galactosidic	O
linkage	O
at	O
the	O
nonreducing	O
end	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
determine	O
whether	O
certain	O
oral	O
streptococci	B-bacteria
could	O
utilize	O
four	O
kinds	O
of	O
beta	O
-	O
galactosyllactoses	O
.	O

Three	O
of	O
four	O
beta	O
-	O
galactosyllactoses	O
were	O
unable	O
to	O
support	O
growth	O
of	O
the	O
oral	O
streptococci	B-bacteria
and	O
to	O
be	O
a	O
substrate	O
for	O
producing	O
acid	O
from	O
the	O
cell	O
suspensions	O
and	O
dental	O
plaque	O
.	O

4	O
'	O
-	O
beta	O
-	O
Galactosyllactose	O
supported	O
growth	O
of	O
Streptococcus	B-bacteria
sanguis	I-bacteria
ATCC	I-bacteria
35105	I-bacteria
,	O
ATCC	B-bacteria
49298	I-bacteria
,	O
Streptococcus	B-bacteria
mitis	I-bacteria
ATCC	I-bacteria
15914	I-bacteria
,	O
Streptococcus	B-bacteria
oralis	I-bacteria
ATCC	I-bacteria
35037	I-bacteria
,	O
ATCC	B-bacteria
10557	I-bacteria
and	O
Streptococcus	B-bacteria
milleri	I-bacteria
10707	I-bacteria
and	O
produced	O
acid	O
from	O
dental	O
plaque	O
.	O

Although	O
beta	O
-	O
galactosidase	O
activities	O
were	O
observed	O
in	O
all	O
the	O
strains	O
,	O
4	O
'	O
-	O
beta	O
-	O
galactosyllactose	O
could	O
not	O
be	O
used	O
as	O
a	O
carbon	O
source	O
for	O
the	O
growth	O
of	O
mutans	B-bacteria
streptococci	I-bacteria
.	O

Enzymes	O
metabolizing	O
4	O
'	O
-	O
beta	O
-	O
galactosyllactose	O
were	O
induced	O
when	O
S	B-bacteria
.	I-bacteria
oralis	I-bacteria
ATCC	I-bacteria
10557	I-bacteria
was	O
cultured	O
in	O
medium	O
containing	O
galactose	O
.	O

These	O
results	O
suggested	O
that	O
4	O
'	O
-	O
beta	O
-	O
galactosyllactose	O
could	O
be	O
as	O
cariogenic	O
as	O
lactose	O
if	O
it	O
is	O
consumed	O
frequently	O
and	O
retained	O
for	O
a	O
long	O
period	O
in	O
the	O
mouth	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
adsorption	O
of	O
[	O
3H	O
]	O
-	O
thymidine	O
labeled	O
oral	O
microorganisms	O
to	O
porous	O
type	O
calcium	O
carbonate	O
(	O
PCC	O
)	O
beads	O
in	O
a	O
buffer	O
containing	O
human	O
parotid	O
saliva	O
and	O
to	O
PCC	O
combined	O
chewing	O
gum	O
sheets	O
.	O

Adsorption	O
rates	O
of	O
Streptococcus	B-bacteria
sobrinus	I-bacteria
B13	I-bacteria
and	I-bacteria
6715	I-bacteria
,	O
Streptococcus	B-bacteria
mutans	I-bacteria
MT8148R	I-bacteria
and	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
T14V	I-bacteria
with	O
PCC	O
were	O
significantly	O
higher	O
than	O
those	O
with	O
calcium	O
carbonate	O
(	O
CC	O
)	O
beads	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O

Adsorption	O
rates	O
of	O
S	B-bacteria
.	I-bacteria
sobrinus	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
A	B-bacteria
.	I-bacteria
naeslundii	I-bacteria
with	O
PCC	O
combined	O
chewing	O
gum	O
were	O
significantly	O
higher	O
than	O
those	O
with	O
CC	O
combined	O
chewing	O
gum	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O

The	O
present	O
results	O
suggested	O
that	O
the	O
chewing	O
gum	O
containing	O
PCC	O
may	O
be	O
able	O
to	O
exclude	O
oral	O
bacteria	O
,	O
including	O
cariogenic	O
and	O
periodontopathic	O
bacteria	O
,	O
for	O
prevention	O
of	O
dental	O
caries	O
and	O
periodontal	O
disease	O
.	O

One	O
promising	O
way	O
of	O
reducing	O
caries	O
is	O
by	O
using	O
sucrose	O
substitutes	O
in	O
food	O
,	O
e	O
.	O
g	O
.	O
,	O
palatinose	O
or	O
leucrose	O
.	O

Previous	O
experiments	O
addressing	O
cariogenic	O
potential	O
of	O
sucrose	O
substitutes	O
have	O
focused	O
mainly	O
on	O
Streptococcus	B-bacteria
mutans	I-bacteria
.	O

However	O
,	O
given	O
the	O
many	O
other	O
micro	O
-	O
organisms	O
in	O
the	O
oral	O
cavity	O
,	O
this	O
study	O
compared	O
the	O
acid	O
production	O
of	O
100	O
bacterial	O
strains	O
representing	O
44	O
different	O
species	O
,	O
by	O
batch	O
fermentation	O
in	O
a	O
test	O
tube	O
containing	O
,	O
as	O
a	O
sole	O
carbohydrate	O
source	O
,	O
glucose	O
,	O
sucrose	O
,	O
palatinose	O
,	O
or	O
leucrose	O
.	O

Selected	O
strains	O
were	O
further	O
analyzed	O
in	O
a	O
fermenter	O
.	O

Additionally	O
,	O
30	O
yeast	O
strains	O
were	O
tested	O
by	O
an	O
auxanographic	O
sugar	O
assimilation	O
test	O
.	O

Only	O
Lactobacillus	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
Stomatococcus	B-bacteria
mucilaginosus	I-bacteria
,	O
Leuconostoc	B-bacteria
mesenteroides	I-bacteria
,	O
and	O
Weissella	B-bacteria
paramesenteroides	I-bacteria
,	O
and	O
some	O
of	O
the	O
yeasts	O
studied	O
-	O
i	O
.	O
e	O
.	O
,	O
Candida	O
albicans	O
,	O
C	O
.	O
tropicalis	O
,	O
C	O
.	O
parapsilosis	O
,	O
and	O
Saccharomyces	O
cerevisiae	O
-	O
utilized	O
leucrose	O
and	O
/	O
or	O
palatinose	O
well	O
.	O

Strikingly	O
,	O
Stomatococcus	B-bacteria
mucilaginosus	I-bacteria
produced	O
water	O
-	O
insoluble	O
polysaccharides	O
by	O
fermentation	O
of	O
leucrose	O
and	O
palatinose	O
.	O

In	O
the	O
fermenter	O
,	O
the	O
respective	O
sucrose	O
substitutes	O
were	O
not	O
only	O
cleaved	O
but	O
also	O
utilized	O
.	O

Thus	O
,	O
extracellular	O
cleavage	O
by	O
autochthonous	O
micro	O
-	O
organisms	O
may	O
produce	O
cariogenic	O
cleavage	O
products	O
(	O
glucose	O
,	O
fructose	O
)	O
that	O
can	O
be	O
used	O
by	O
other	O
well	O
-	O
characterized	O
cariogenic	O
bacteria	O
found	O
in	O
the	O
oral	O
flora	O
.	O

Therefore	O
,	O
the	O
anticariogenic	O
potential	O
of	O
sucrose	O
substitutes	O
in	O
food	O
might	O
be	O
limited	O
.	O

The	O
susceptibility	O
(	O
MIC	O
)	O
of	O
44	O
strains	O
of	O
anaerobic	O
bacteria	O
isolated	O
from	O
the	O
oral	O
cavity	O
and	O
3	O
standard	O
strains	O
to	O
statherin	O
and	O
its	O
C	O
-	O
terminal	O
fragments	O
with	O
sequences	O
QYQQYTF	O
,	O
YQQYTF	O
,	O
QQYTF	O
,	O
QYTF	O
and	O
YTF	O
was	O
determined	O
by	O
means	O
of	O
plate	O
dilution	O
technique	O
in	O
Brucella	B-bacteria
agar	O
with	O
5	O
%	O
content	O
of	O
defibrinated	O
sheep	O
'	O
s	O
blood	O
,	O
menadione	O
and	O
hemin	O
.	O

The	O
culture	O
was	O
anaerobic	O
.	O

As	O
shown	O
,	O
at	O
concentrations	O
from	O
12	O
.	O
5	O
to	O
100	O
microg	O
/	O
ml	O
statherin	O
and	O
its	O
C	O
-	O
terminal	O
fragments	O
inhibited	O
the	O
growth	O
of	O
anaerobic	O
bacteria	O
isolated	O
from	O
the	O
oral	O
cavity	O
.	O

Peptostreptococcus	B-bacteria
strains	I-bacteria
were	O
the	O
most	O
susceptible	O
to	O
statherin	O
and	O
YTF	O
(	O
MIC	O
<	O
or	O
=	O
12	O
.	O
5	O
mg	O
/	O
ml	O
)	O
,	O
whereas	O
the	O
most	O
susceptible	O
to	O
the	O
peptides	O
investigated	O
were	O
Fusobacterium	B-bacteria
necrogenes	I-bacteria
and	O
Fusobacterium	B-bacteria
necrophorum	I-bacteria
strains	I-bacteria
:	O
QYQQYTF	O
,	O
YQQYTF	O
,	O
QQYTF	O
,	O
QYTF	O
(	O
MIC	O
<	O
or	O
=	O
12	O
.	O
5	O
microg	O
/	O
ml	O
)	O
.	O

Prevotella	B-bacteria
oralis	I-bacteria
,	O
Bacteroides	B-bacteria
forsythus	I-bacteria
,	O
and	O
Bacteroides	B-bacteria
ureolyticus	I-bacteria
,	O
strains	O
exhibited	O
the	O
lowest	O
susceptibility	O
(	O
MIC	O
>	O
100	O
microg	O
/	O
ml	O
)	O
.	O

When	O
analysing	O
the	O
bacteriostatic	O
activity	O
of	O
statherin	O
it	O
should	O
be	O
pointed	O
out	O
that	O
the	O
concentrations	O
of	O
this	O
peptide	O
used	O
in	O
microbiological	O
investigations	O
are	O
within	O
the	O
range	O
of	O
physiological	O
concentrations	O
determined	O
for	O
whole	O
saliva	O
when	O
at	O
rest	O
and	O
stimulated	O
in	O
healthy	O
donors	O
of	O
19	O
-	O
25	O
years	O
of	O
age	O
.	O

Since	O
the	O
anaerobes	O
investigated	O
may	O
be	O
involved	O
in	O
the	O
diseases	O
of	O
periodontum	O
,	O
the	O
results	O
presented	O
seem	O
to	O
have	O
also	O
a	O
practical	O
aspect	O
,	O
i	O
.	O
e	O
.	O
a	O
possibility	O
to	O
apply	O
the	O
C	O
-	O
terminal	O
fragments	O
of	O
statherin	O
as	O
a	O
novel	O
therapeutic	O
agent	O
,	O
affecting	O
favourably	O
the	O
oral	O
cavity	O
.	O

Escherichia	B-bacteria
coli	I-bacteria
is	O
a	O
common	O
gut	O
inhabitant	O
,	O
but	O
it	O
is	O
usually	O
out	O
numbered	O
by	O
strictly	O
anaerobic	O
bacteria	O
.	O

When	O
fecal	O
material	O
is	O
exposed	O
to	O
oxygen	O
,	O
fermentation	O
acids	O
can	O
be	O
respired	O
,	O
and	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
numbers	O
increase	O
.	O

E	B-bacteria
.	I-bacteria
coli	I-bacteria
can	O
survive	O
for	O
long	O
periods	O
of	O
time	O
in	O
feces	O
,	O
but	O
subsequent	O
proliferation	O
is	O
dependent	O
on	O
its	O
ability	O
to	O
re	O
-	O
enter	O
the	O
gastrointestinal	O
tract	O
via	O
contaminated	O
water	O
and	O
food	O
.	O

The	O
oral	O
-	O
fecal	O
lifestyle	O
of	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
is	O
facilitated	O
by	O
its	O
ability	O
to	O
survive	O
the	O
low	O
pH	O
of	O
the	O
human	O
gastric	O
stomach	O
.	O

Most	O
strains	O
of	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
do	O
not	O
cause	O
human	O
disease	O
,	O
but	O
some	O
strains	O
produce	O
toxins	O
and	O
other	O
virulence	O
factors	O
.	O

Mature	O
cattle	O
carry	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
O157	I-bacteria
:	I-bacteria
H7	I-bacteria
without	O
showing	O
signs	O
of	O
infection	O
,	O
and	O
beef	O
can	O
be	O
contaminated	O
with	O
cattle	O
feces	O
at	O
slaughter	O
.	O

Cattle	O
manure	O
is	O
often	O
used	O
as	O
a	O
fertilizer	O
by	O
the	O
vegetable	O
industry	O
,	O
and	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
from	O
manure	O
can	O
migrate	O
through	O
the	O
soil	O
into	O
water	O
supplies	O
.	O

Sanitation	O
,	O
cooking	O
and	O
chlorination	O
have	O
been	O
used	O
to	O
combat	O
fecal	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
,	O
but	O
these	O
methods	O
are	O
not	O
always	O
effective	O
.	O

Recent	O
work	O
indicates	O
that	O
cattle	O
diets	O
can	O
be	O
modified	O
overcome	O
the	O
extreme	O
acid	O
resistance	O
of	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
.	O

When	O
cattle	O
were	O
fed	O
have	O
for	O
only	O
a	O
few	O
days	O
,	O
colonic	O
volatile	O
fatty	O
acid	O
concentrations	O
declined	O
,	O
pH	O
increased	O
,	O
and	O
the	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
were	O
no	O
longer	O
able	O
to	O
survive	O
a	O
pH	O
shock	O
that	O
mimicked	O
the	O
human	O
gastric	O
stomach	O
.	O

E	B-bacteria
.	I-bacteria
coli	I-bacteria
in	O
stored	O
cattle	O
manure	O
eventually	O
become	O
highly	O
acid	O
resistant	O
even	O
if	O
the	O
cattle	O
were	O
fed	O
hay	O
,	O
but	O
these	O
bacteria	O
could	O
be	O
killed	O
by	O
sodium	O
carbonate	O
(	O
150	O
mM	O
,	O
pH	O
8	O
.	O
5	O
)	O
.	O

Because	O
the	O
diet	O
manipulations	O
and	O
carbonate	O
treatments	O
affected	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
in	O
general	O
rather	O
than	O
specific	O
serotypes	O
,	O
there	O
is	O
an	O
increased	O
likelihood	O
of	O
successful	O
field	O
application	O
.	O

Recent	O
studies	O
reported	O
significant	O
,	O
additional	O
clinical	O
and	O
microbiological	O
improvements	O
when	O
severe	O
adult	O
periodontitis	O
was	O
treated	O
via	O
the	O
one	O
-	O
stage	O
full	O
-	O
mouth	O
(	O
OSFM	O
)	O
disinfection	O
approach	O
,	O
instead	O
of	O
a	O
standard	O
treatment	O
scheme	O
with	O
staged	O
instrumentation	O
per	O
quadrant	O
.	O

The	O
OSFM	O
disinfection	O
involves	O
dealing	O
with	O
the	O
remaining	O
oropharyngeal	O
niches	O
such	O
as	O
tonsils	O
,	O
saliva	O
,	O
tongue	O
,	O
and	O
mucosa	O
.	O

The	O
OSFM	O
disinfection	O
procedure	O
involves	O
scaling	O
and	O
root	O
planing	O
of	O
all	O
pockets	O
within	O
24	O
hours	O
in	O
combination	O
with	O
chlorhexidine	O
application	O
to	O
all	O
oropharyngeal	O
niches	O
(	O
chairside	O
and	O
at	O
home	O
for	O
2	O
months	O
)	O
.	O

This	O
study	O
aimed	O
to	O
compare	O
the	O
microbiological	O
shifts	O
with	O
the	O
OSFM	O
approach	O
versus	O
standard	O
therapy	O
.	O

Nineteen	O
patients	O
with	O
advanced	O
chronic	O
periodontitis	O
(	O
AP	O
)	O
and	O
12	O
patients	O
with	O
early	O
-	O
onset	O
periodontitis	O
(	O
EOP	O
)	O
were	O
randomly	O
assigned	O
to	O
the	O
test	O
and	O
control	O
groups	O
.	O

The	O
control	O
group	O
(	O
9	O
AP	O
patients	O
,	O
6	O
EOP	O
patients	O
)	O
was	O
scaled	O
and	O
root	O
planed	O
,	O
per	O
quadrant	O
,	O
with	O
2	O
-	O
week	O
intervals	O
.	O

The	O
test	O
group	O
(	O
10	O
AP	O
patients	O
and	O
6	O
EOP	O
patients	O
)	O
underwent	O
OSFM	O
disinfection	O
treatment	O
.	O

At	O
baseline	O
and	O
after	O
2	O
,	O
4	O
,	O
and	O
8	O
months	O
,	O
pooled	O
subgingival	O
plaque	O
samples	O
were	O
taken	O
from	O
single	O
-	O
and	O
multi	O
-	O
rooted	O
teeth	O
.	O

The	O
presence	O
and	O
levels	O
of	O
30	O
subgingival	O
taxa	O
were	O
determined	O
using	O
whole	O
genomic	O
DNA	O
probes	O
and	O
checkerboard	O
DNA	O
-	O
DNA	O
hybridization	O
.	O

Both	O
treatments	O
resulted	O
in	O
important	O
reductions	O
of	O
the	O
pathogenic	O
species	O
up	O
to	O
8	O
months	O
after	O
therapy	O
,	O
both	O
for	O
their	O
detection	O
level	O
and	O
frequency	O
.	O

The	O
OSFM	O
disinfection	O
resulted	O
in	O
an	O
additional	O
improvement	O
,	O
especially	O
in	O
the	O
AP	O
group	O
.	O

P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
and	O
B	B-bacteria
.	I-bacteria
forsythus	I-bacteria
were	O
reduced	O
below	O
detection	O
level	O
.	O

The	O
number	O
of	O
beneficial	O
species	O
remained	O
nearly	O
unchanged	O
.	O

The	O
OSFM	O
disinfection	O
results	O
in	O
supplementary	O
reductions	O
of	O
periodontal	O
pathogens	O
even	O
after	O
8	O
months	O
in	O
the	O
treatment	O
of	O
patients	O
with	O
advanced	O
or	O
early	O
-	O
onset	O
periodontitis	O
.	O

The	O
frequency	O
of	O
carriage	O
of	O
antibiotic	O
-	O
resistant	O
bacteria	O
in	O
healthy	O
7	O
-	O
and	O
8	O
-	O
year	O
-	O
old	O
children	O
in	O
Bristol	O
was	O
studied	O
.	O

Children	O
born	O
in	O
Avon	O
between	O
1	O
April	O
1991	O
and	O
31	O
December	O
1992	O
,	O
attending	O
the	O
Avon	O
Longitudinal	O
Study	O
of	O
Pregnancy	O
and	O
Childhood	O
(	O
ALSPAC	O
)	O
7	O
year	O
follow	O
-	O
up	O
clinic	O
,	O
formed	O
the	O
study	O
population	O
.	O

Carriage	O
was	O
estimated	O
using	O
mouth	O
and	O
stool	O
samples	O
.	O

None	O
of	O
105	O
children	O
on	O
whom	O
information	O
was	O
available	O
had	O
received	O
tetracycline	O
,	O
chloramphenicol	O
,	O
ciprofloxacin	O
or	O
an	O
extended	O
-	O
spectrum	O
cephalosporin	O
in	O
the	O
previous	O
year	O
.	O

Staphylococcus	B-bacteria
aureus	I-bacteria
was	O
isolated	O
from	O
mouthwashes	O
from	O
200	O
(	O
37	O
.	O
1	O
%	O
)	O
of	O
539	O
children	O
sampled	O
.	O

Six	O
(	O
3	O
%	O
)	O
of	O
the	O
isolates	O
were	O
resistant	O
to	O
chloramphenicol	O
or	O
tetracycline	O
and	O
four	O
(	O
2	O
%	O
)	O
were	O
methicillin	O
resistant	O
.	O

Haemophilus	B-bacteria
spp	I-bacteria
.	I-bacteria
were	O
isolated	O
from	O
369	O
(	O
72	O
%	O
)	O
of	O
513	O
samples	O
and	O
63	O
(	O
17	O
%	O
)	O
were	O
ampicillin	O
resistant	O
,	O
49	O
(	O
13	O
.	O
3	O
%	O
)	O
were	O
erythromycin	O
resistant	O
and	O
seven	O
(	O
1	O
.	O
9	O
%	O
)	O
were	O
tetracycline	O
resistant	O
.	O

Branhamella	B-bacteria
catarrhalis	I-bacteria
was	O
isolated	O
from	O
333	O
(	O
74	O
%	O
)	O
of	O
450	O
samples	O
.	O

Twenty	O
-	O
eight	O
(	O
8	O
.	O
4	O
%	O
)	O
were	O
erythromycin	O
resistant	O
and	O
14	O
(	O
4	O
.	O
2	O
%	O
)	O
strains	O
were	O
tetracycline	O
resistant	O
.	O

Group	O
A	O
beta	B-bacteria
-	I-bacteria
haemolytic	I-bacteria
streptococci	I-bacteria
were	O
isolated	O
from	O
17	O
of	O
507	O
children	O
sampled	O
.	O

One	O
(	O
5	O
.	O
9	O
%	O
)	O
was	O
tetracycline	O
resistant	O
.	O

Stool	O
samples	O
were	O
returned	O
from	O
335	O
(	O
62	O
%	O
)	O
of	O
539	O
children	O
from	O
whom	O
they	O
were	O
requested	O
.	O

Eleven	O
per	O
cent	O
of	O
samples	O
yielded	O
Gram	O
-	O
negative	O
bacilli	O
with	O
high	O
-	O
level	O
resistance	O
to	O
chloramphenicol	O
,	O
which	O
was	O
frequently	O
linked	O
to	O
resistance	O
to	O
ampicillin	O
,	O
spectinomycin	O
and	O
streptomycin	O
.	O

Isolates	O
demonstrating	O
resistance	O
to	O
the	O
third	O
-	O
generation	O
cephalosporin	O
ceftazidime	O
were	O
recovered	O
from	O
17	O
subjects	O
(	O
3	O
.	O
2	O
%	O
)	O
.	O

Six	O
(	O
35	O
%	O
)	O
of	O
17	O
isolates	O
possessed	O
extended	O
-	O
spectrum	O
beta	O
-	O
lactamases	O
.	O

Healthy	O
children	O
carry	O
bacteria	O
resistant	O
to	O
antibiotics	O
to	O
which	O
children	O
are	O
not	O
usually	O
exposed	O
.	O

Resistance	O
to	O
ceftazidime	O
,	O
chloramphenicol	O
and	O
tetracycline	O
may	O
be	O
co	O
-	O
selected	O
by	O
exposure	O
to	O
other	O
antibiotics	O
used	O
in	O
children	O
or	O
may	O
be	O
acquired	O
from	O
family	O
members	O
,	O
pets	O
,	O
other	O
children	O
or	O
food	O
.	O

These	O
results	O
suggest	O
that	O
antibiotic	O
-	O
resistant	O
bacteria	O
are	O
widely	O
disseminated	O
and	O
may	O
be	O
acquired	O
by	O
children	O
before	O
exposure	O
to	O
specific	O
selection	O
pressure	O
.	O

A	O
total	O
of	O
eight	O
bacterial	O
isolates	O
belonging	O
to	O
six	O
species	O
,	O
and	O
a	O
select	O
group	O
of	O
12	O
oral	O
Candida	O
albicans	O
isolates	O
,	O
were	O
used	O
to	O
study	O
the	O
effect	O
of	O
bacteria	O
on	O
germ	O
-	O
tube	O
formation	O
.	O

Briefly	O
,	O
each	O
bacterial	O
suspension	O
(	O
10	O
(	O
5	O
-	O
6	O
)	O
cells	O
/	O
ml	O
)	O
was	O
mixed	O
with	O
a	O
C	O
.	O
albicans	O
suspension	O
(	O
10	O
(	O
7	O
)	O
cells	O
/	O
ml	O
)	O
and	O
incubated	O
at	O
37	O
degrees	O
C	O
for	O
90	O
min	O
with	O
bovine	O
serum	O
,	O
and	O
the	O
percentage	O
germ	O
-	O
tube	O
-	O
positive	O
Candida	O
cells	O
was	O
quantified	O
using	O
a	O
haemocytometer	O
,	O
under	O
light	O
microscopy	O
.	O

In	O
general	O
,	O
out	O
of	O
eight	O
bacteria	O
,	O
Streptococcus	B-bacteria
sanguis	I-bacteria
SK21A	I-bacteria
,	O
Streptococcus	B-bacteria
salivarius	I-bacteria
SK56	I-bacteria
,	O
Escherichia	B-bacteria
coli	I-bacteria
ATCC	I-bacteria
25922	I-bacteria
,	O
and	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
OBU3	I-bacteria
suppressed	O
germ	O
-	O
tube	O
formation	O
to	O
varying	O
degrees	O
,	O
with	O
different	O
C	O
albicans	O
isolates	O
.	O

Porphyromonas	B-bacteria
gingivalis	I-bacteria
Pg	I-bacteria
50	I-bacteria
,	O
Lactobacillus	B-bacteria
casei	I-bacteria
ATCC	I-bacteria
7469	I-bacteria
and	O
Prevotella	B-bacteria
intermedia	I-bacteria
OBU4	I-bacteria
elicited	O
significant	O
enhancement	O
of	O
germ	O
-	O
tube	O
formation	O
,	O
whereas	O
S	B-bacteria
.	I-bacteria
sanguis	I-bacteria
OBU	I-bacteria
2	I-bacteria
had	O
no	O
effect	O
.	O

E	B-bacteria
.	I-bacteria
coli	I-bacteria
ATCC	I-bacteria
25922	I-bacteria
was	O
the	O
only	O
organism	O
to	O
show	O
statistically	O
significant	O
suppression	O
of	O
germ	O
-	O
tube	O
formation	O
(	O
p	O
=	O
0	O
.	O
0312	O
)	O
.	O

A	O
significant	O
increase	O
in	O
the	O
germ	O
tube	O
production	O
of	O
C	O
.	O
albicans	O
isolated	O
from	O
HIV	O
-	O
infected	O
compared	O
with	O
HIV	O
-	O
free	O
individuals	O
was	O
also	O
noted	O
.	O

The	O
current	O
results	O
tend	O
to	O
suggest	O
that	O
commensal	O
and	O
transient	O
oral	O
bacterial	O
populations	O
may	O
selectively	O
influence	O
the	O
differential	O
expression	O
of	O
germ	O
-	O
tube	O
-	O
forming	O
ability	O
of	O
C	O
.	O
albicans	O
isolates	O
.	O

The	O
species	O
of	O
sulfate	B-bacteria
-	I-bacteria
reducing	I-bacteria
bacteria	I-bacteria
that	O
prevail	O
in	O
sites	O
affected	O
by	O
periodontal	O
disease	O
may	O
be	O
different	O
from	O
those	O
commonly	O
occurring	O
in	O
the	O
digestive	O
tracts	O
of	O
healthy	O
individuals	O
.	O

Ten	O
strains	O
of	O
mesophilic	O
sulfate	B-bacteria
-	I-bacteria
reducing	I-bacteria
bacteria	I-bacteria
(	O
SRB	B-bacteria
)	O
were	O
isolated	O
from	O
subgingival	O
plaque	O
in	O
periodontal	O
lesions	O
of	O
ten	O
patients	O
with	O
periodontitis	O
.	O

Characterization	O
on	O
the	O
basis	O
of	O
morphological	O
,	O
physiological	O
and	O
phylogenetic	O
properties	O
demonstrated	O
two	O
distinct	O
types	O
of	O
oral	O
SRB	B-bacteria
.	O

One	O
strain	O
was	O
a	O
curved	O
rod	O
with	O
high	O
motility	O
.	O

For	O
dissimilatory	O
sulfate	O
reduction	O
,	O
lactate	O
or	O
pyruvate	O
was	O
oxidized	O
incompletely	O
to	O
equimolar	O
amounts	O
of	O
acetate	O
.	O

Desulfoviridin	O
and	O
cytochrome	O
c3	O
were	O
present	O
in	O
this	O
mesophilic	O
vibrio	B-bacteria
and	O
the	O
cellular	O
lipid	O
profile	O
was	O
similar	O
to	O
that	O
from	O
members	O
of	O
the	O
genus	O
Desulfovibrio	B-bacteria
.	O

The	O
16S	O
rDNA	O
sequence	O
was	O
similar	O
to	O
that	O
of	O
the	O
proposed	O
'	O
Desulfovibrio	B-bacteria
fairfieldensis	I-bacteria
'	O
.	O

Cells	O
of	O
the	O
nine	O
other	O
strains	O
were	O
straight	O
,	O
rod	O
-	O
shaped	O
,	O
exhibited	O
a	O
low	O
growth	O
rate	O
and	O
oxidized	O
substrates	O
incompletely	O
to	O
acetate	O
.	O

These	O
SRB	B-bacteria
,	O
like	O
members	O
of	O
the	O
genus	O
Desulfomicrobium	B-bacteria
,	O
lacked	O
desulfoviridin	O
.	O

Analysis	O
of	O
the	O
16S	O
rDNA	O
sequences	O
of	O
seven	O
of	O
the	O
nine	O
isolates	O
showed	O
a	O
high	O
degree	O
of	O
similarity	O
among	O
these	O
oral	O
strains	O
,	O
forming	O
a	O
distinct	O
lineage	O
within	O
the	O
genus	O
Desulfomicrobium	B-bacteria
.	O

The	O
cellular	O
lipid	O
profile	O
of	O
a	O
representative	O
oral	O
strain	O
,	O
NY678T	B-bacteria
,	O
was	O
in	O
accordance	O
with	O
that	O
of	O
other	O
Desulfomicrobium	B-bacteria
species	I-bacteria
,	O
but	O
also	O
showed	O
dissimilar	O
features	O
.	O

The	O
phenotypic	O
and	O
phylogenetic	O
analyses	O
indicate	O
that	O
these	O
rod	O
-	O
shaped	O
SRB	B-bacteria
from	O
the	O
oral	O
cavity	O
could	O
be	O
regarded	O
as	O
a	O
new	O
species	O
,	O
for	O
which	O
the	O
designation	O
Desulfomicrobium	B-bacteria
orale	I-bacteria
sp	I-bacteria
.	I-bacteria
nov	I-bacteria
.	I-bacteria
is	O
proposed	O
.	O

Transformation	O
of	O
Streptococcus	B-bacteria
gordonii	I-bacteria
DL1	I-bacteria
by	O
free	O
DNA	O
was	O
studied	O
in	O
human	O
saliva	O
.	O

Competent	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
could	O
be	O
transformed	O
in	O
vitro	O
with	O
plasmid	O
DNA	O
that	O
had	O
been	O
taken	O
into	O
the	O
human	O
mouth	O
.	O

Transformation	O
also	O
occurred	O
with	O
a	O
plasmid	O
that	O
can	O
not	O
replicate	O
in	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
,	O
but	O
that	O
has	O
a	O
region	O
of	O
chromosomal	O
homology	O
,	O
by	O
integration	O
into	O
the	O
bacterial	O
chromosome	O
,	O
although	O
linearised	O
plasmid	O
DNA	O
gave	O
no	O
transformants	O
.	O

Linear	O
chromosomal	O
DNA	O
fragments	O
did	O
however	O
transform	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
/	I-bacteria
Tn916	I-bacteria
efficiently	O
in	O
saliva	O
when	O
regions	O
of	O
homology	O
with	O
the	O
recipient	O
chromosome	O
flanked	O
the	O
marker	O
gene	O
.	O

These	O
findings	O
are	O
discussed	O
in	O
relation	O
to	O
the	O
potential	O
for	O
acquisition	O
of	O
DNA	O
sequences	O
,	O
including	O
genetically	O
modified	O
DNA	O
,	O
by	O
gut	O
and	O
oral	O
bacteria	O
.	O

To	O
develop	O
a	O
simple	O
and	O
flexible	O
novel	O
in	O
vitro	O
model	O
system	O
to	O
grow	O
films	O
of	O
oral	O
bacteria	O
that	O
could	O
be	O
used	O
to	O
study	O
aspects	O
of	O
dental	O
caries	O
.	O

Standardized	O
suspensions	O
of	O
bacteria	O
were	O
inoculated	O
into	O
Ultrafree	O
-	O
CL	O
(	O
Millipore	O
)	O
ultrafiltration	O
units	O
at	O
various	O
densities	O
.	O

These	O
were	O
incubated	O
for	O
varying	O
time	O
intervals	O
with	O
a	O
range	O
of	O
carbon	O
sources	O
.	O

The	O
bacterial	O
films	O
reproducibly	O
achieved	O
between	O
107	O
and	O
108	O
cfu	O
cm	O
-	O
2	O
,	O
irrespective	O
of	O
the	O
number	O
inoculated	O
and	O
with	O
no	O
significant	O
changes	O
for	O
14	O
d	O
.	O
However	O
,	O
Streptococcus	B-bacteria
mutans	I-bacteria
grew	O
through	O
membranes	O
with	O
pores	O
of	O
diameter	O
greater	O
than	O
0	O
.	O
1	O
microm	O
after	O
6	O
d	O
.	O
Culture	O
of	O
films	O
in	O
sucrose	O
or	O
water	O
for	O
6	O
d	O
led	O
to	O
a	O
decreased	O
number	O
of	O
colony	O
-	O
forming	O
units	O
,	O
but	O
returning	O
them	O
to	O
broth	O
reversed	O
this	O
.	O

Reproducible	O
films	O
of	O
oral	O
bacteria	O
can	O
be	O
cultured	O
in	O
Ultrafree	O
-	O
CL	O
units	O
.	O

This	O
study	O
has	O
shown	O
that	O
Ultrafree	O
-	O
CL	O
units	O
can	O
be	O
used	O
as	O
a	O
simple	O
model	O
system	O
to	O
grow	O
biofilms	O
that	O
could	O
be	O
used	O
for	O
dental	O
caries	O
research	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
compare	O
the	O
resistance	O
of	O
the	O
corrosion	O
of	O
dental	O
alloys	O
in	O
a	O
solution	O
containing	O
oral	O
bacteria	O
named	O
Actinomyces	B-bacteria
viscosus	I-bacteria
(	O
ATCC19246	B-bacteria
)	O
.	O

In	O
this	O
paper	O
,	O
we	O
explain	O
the	O
choice	O
of	O
this	O
precise	O
species	O
of	O
bacteria	O
,	O
then	O
specify	O
its	O
culture	O
in	O
artificial	O
saliva	O
and	O
the	O
experimental	O
precautions	O
needed	O
to	O
avoid	O
the	O
pollution	O
by	O
other	O
bacteria	O
.	O

The	O
electrochemical	O
behaviour	O
of	O
two	O
dental	O
alloys	O
(	O
Ni	O
-	O
Cr	O
alloy	O
and	O
gold	O
-	O
based	O
alloy	O
)	O
was	O
investigated	O
by	O
electrochemical	O
means	O
in	O
sterile	O
Fusayama	O
artificial	O
saliva	O
(	O
AS	O
)	O
,	O
AS	O
enriched	O
with	O
sterile	O
yeast	O
extract	O
(	O
YE	O
)	O
and	O
YE	O
modified	O
by	O
introducing	O
bacteria	O
(	O
AV	O
)	O
.	O

Open	O
-	O
circuit	O
potentials	O
,	O
potentiodynamic	O
curves	O
,	O
polarization	O
resistance	O
and	O
impedance	O
spectroscopy	O
are	O
the	O
electrochemical	O
procedures	O
selected	O
for	O
this	O
work	O
.	O

It	O
has	O
thus	O
been	O
shown	O
that	O
the	O
open	O
-	O
circuit	O
potential	O
of	O
the	O
non	O
-	O
precious	O
alloy	O
is	O
always	O
lower	O
than	O
that	O
of	O
the	O
gold	O
precious	O
alloy	O
,	O
and	O
the	O
colonization	O
of	O
metal	O
surface	O
by	O
bacteria	O
caused	O
a	O
drop	O
in	O
open	O
circuit	O
potential	O
.	O

The	O
electrochemical	O
impedance	O
spectroscopy	O
results	O
have	O
shown	O
that	O
the	O
electrolyte	O
resistance	O
decreased	O
between	O
the	O
AS	O
,	O
YE	O
and	O
AV	O
milieu	O
,	O
in	O
the	O
presence	O
of	O
bacteria	O
a	O
slight	O
decrease	O
in	O
polarization	O
resistance	O
was	O
observed	O
with	O
the	O
precious	O
alloy	O
and	O
an	O
increase	O
with	O
the	O
non	O
-	O
precious	O
alloy	O
.	O

The	O
drop	O
in	O
the	O
electrolyte	O
resistance	O
can	O
not	O
explain	O
the	O
change	O
in	O
polarization	O
resistance	O
.	O

The	O
influence	O
of	O
Actinomyces	B-bacteria
viscosus	I-bacteria
might	O
be	O
essentially	O
due	O
to	O
the	O
consumption	O
of	O
oxygen	O
at	O
the	O
metal	O
/	O
electrolyte	O
interface	O
of	O
the	O
specimen	O
.	O

For	O
the	O
non	O
-	O
precious	O
alloy	O
,	O
the	O
absence	O
of	O
oxygen	O
(	O
instigator	O
of	O
corrosion	O
)	O
led	O
to	O
an	O
increase	O
in	O
polarization	O
resistance	O
whereas	O
the	O
slight	O
decrease	O
for	O
the	O
precious	O
alloys	O
might	O
be	O
justified	O
by	O
the	O
organic	O
and	O
inorganic	O
metabolites	O
released	O
by	O
bacteria	O
in	O
to	O
the	O
electrolyte	O
.	O

The	O
scanning	O
electron	O
micrography	O
after	O
electrochemical	O
analysis	O
,	O
confirmed	O
the	O
absence	O
of	O
contaminants	O
.	O

These	O
preliminary	O
results	O
demonstrate	O
the	O
unquestionable	O
influence	O
of	O
this	O
bacteria	O
on	O
the	O
corrosion	O
behaviour	O
of	O
the	O
alloys	O
studied	O
,	O
however	O
,	O
further	O
studies	O
are	O
necessary	O
.	O

Dental	O
caries	O
and	O
periodontitis	O
,	O
although	O
generally	O
not	O
life	O
threatening	O
,	O
are	O
nevertheless	O
of	O
significant	O
importance	O
.	O

An	O
understanding	O
of	O
the	O
molecular	O
nature	O
of	O
these	O
diseases	O
could	O
aid	O
the	O
development	O
of	O
novel	O
methods	O
of	O
prevention	O
and	O
control	O
,	O
and	O
increase	O
our	O
knowledge	O
of	O
their	O
etiology	O
.	O

The	O
identification	O
of	O
virulence	O
factors	O
in	O
oral	O
bacteria	O
could	O
lead	O
to	O
the	O
development	O
of	O
vaccines	O
directed	O
against	O
these	O
organisms	O
,	O
the	O
design	O
of	O
inhibitors	O
of	O
biofilm	O
formation	O
,	O
and	O
the	O
development	O
of	O
replacement	O
therapy	O
strategies	O
.	O

The	O
oral	O
streptococci	B-bacteria
are	O
normally	O
non	O
-	O
pathogenic	O
residents	O
of	O
the	O
human	O
microflora	O
.	O

There	O
is	O
substantial	O
evidence	O
that	O
these	O
bacteria	O
can	O
,	O
however	O
,	O
act	O
as	O
`	O
`	O
genetic	O
reservoirs	O
'	O
'	O
and	O
transfer	O
genetic	O
information	O
to	O
transient	O
bacteria	O
as	O
they	O
make	O
their	O
way	O
through	O
the	O
mouth	O
,	O
the	O
principal	O
entry	O
point	O
for	O
a	O
wide	O
variety	O
of	O
bacteria	O
.	O

Examples	O
that	O
are	O
of	O
particular	O
concern	O
include	O
the	O
transfer	O
of	O
antibiotic	O
resistance	O
from	O
oral	O
streptococci	B-bacteria
to	O
Streptococcus	B-bacteria
pneumoniae	I-bacteria
.	O

The	O
mechanisms	O
that	O
are	O
used	O
by	O
oral	O
streptococci	B-bacteria
to	O
exchange	O
genetic	O
information	O
are	O
not	O
well	O
-	O
understood	O
,	O
although	O
several	O
species	O
are	O
known	O
to	O
enter	O
a	O
physiological	O
state	O
of	O
genetic	O
competence	O
.	O

This	O
state	O
permits	O
them	O
to	O
become	O
capable	O
of	O
natural	O
genetic	O
transformation	O
,	O
facilitating	O
the	O
acquisition	O
of	O
foreign	O
DNA	O
from	O
the	O
external	O
environment	O
.	O

The	O
oral	O
streptococci	B-bacteria
share	O
many	O
similarities	O
with	O
two	O
closely	O
related	O
Gram	O
-	O
positive	O
bacteria	O
,	O
S	B-bacteria
.	I-bacteria
pneumoniae	I-bacteria
and	O
Bacillus	B-bacteria
subtilis	I-bacteria
.	O

In	O
these	O
bacteria	O
,	O
the	O
mechanisms	O
of	O
quorum	O
-	O
sensing	O
,	O
the	O
development	O
of	O
competence	O
,	O
and	O
DNA	O
uptake	O
and	O
integration	O
are	O
well	O
-	O
characterized	O
.	O

Using	O
this	O
knowledge	O
and	O
the	O
data	O
available	O
in	O
genome	O
databases	O
allowed	O
us	O
to	O
identify	O
putative	O
genes	O
involved	O
in	O
these	O
processes	O
in	O
the	O
oral	O
organism	O
Streptococcus	B-bacteria
mutans	I-bacteria
.	O

Models	O
of	O
competence	O
development	O
and	O
genetic	O
transformation	O
in	O
the	O
oral	O
streptococci	B-bacteria
and	O
strategies	O
to	O
confirm	O
these	O
models	O
are	O
discussed	O
.	O

Future	O
studies	O
of	O
competence	O
in	O
oral	O
biofilms	O
,	O
the	O
natural	O
environment	O
of	O
oral	O
streptococci	B-bacteria
,	O
will	O
be	O
discussed	O
.	O

Nested	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
was	O
performed	O
to	O
detect	O
the	O
presence	O
of	O
Helicobacter	B-bacteria
pylori	I-bacteria
in	O
tongue	O
mucosa	O
in	O
268	O
patients	O
divided	O
into	O
four	O
groups	O
according	O
to	O
their	O
diagnosis	O
:	O
87	O
with	O
atrophic	O
glossitis	O
,	O
37	O
with	O
benign	O
migratory	O
glossitis	O
and	O
144	O
with	O
burning	O
mouth	O
syndrome	O
(	O
BMS	O
)	O
.	O

The	O
latter	O
group	O
was	O
subdivided	O
according	O
to	O
anatomic	O
site	O
of	O
burning	O
sensation	O
:	O
subgroup	O
A	O
(	O
54	O
patients	O
)	O
with	O
complaints	O
limited	O
to	O
tongue	O
and	O
subgroup	O
B	O
(	O
90	O
patients	O
)	O
with	O
burning	O
sensations	O
in	O
other	O
parts	O
of	O
oral	O
mucosa	O
.	O

H	B-bacteria
.	I-bacteria
pylori	I-bacteria
was	O
found	O
in	O
43	O
samples	O
(	O
16	O
%	O
)	O
.	O

Bacteria	O
were	O
significantly	O
less	O
present	O
in	O
tongue	O
mucosa	O
affected	O
with	O
benign	O
migratory	O
glossitis	O
compared	O
with	O
atrophic	O
glossitis	O
and	O
BMS	O
(	O
P	O
=	O
0	O
.	O
025	O
)	O
.	O

This	O
difference	O
was	O
more	O
obvious	O
when	O
compared	O
with	O
atrophic	O
glossitis	O
only	O
(	O
P	O
=	O
0	O
.	O
006	O
)	O
.	O

Mucosal	O
changes	O
in	O
these	O
conditions	O
might	O
make	O
the	O
oral	O
environment	O
more	O
acceptable	O
for	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
colonization	O
compared	O
with	O
normal	O
mucosa	O
,	O
and	O
this	O
mechanism	O
may	O
play	O
a	O
role	O
in	O
its	O
oro	O
-	O
oral	O
transmission	O
.	O

A	O
growing	O
body	O
of	O
information	O
has	O
provided	O
insights	O
into	O
the	O
mechanisms	O
by	O
which	O
the	O
oral	O
streptococci	B-bacteria
maintain	O
their	O
niches	O
in	O
the	O
human	O
mouth	O
.	O

In	O
at	O
least	O
one	O
case	O
,	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
the	O
organism	O
apparently	O
uses	O
a	O
panel	O
of	O
proteins	O
to	O
survive	O
in	O
acidic	O
conditions	O
while	O
it	O
promotes	O
the	O
formation	O
of	O
dental	O
caries	O
.	O

Oral	O
streptococci	B-bacteria
,	O
which	O
are	O
not	O
as	O
inherently	O
resistant	O
to	O
acidification	O
,	O
use	O
protective	O
schemes	O
to	O
ameliorate	O
acidic	O
plaque	O
pH	O
values	O
.	O

Existing	O
information	O
clearly	O
shows	O
that	O
while	O
the	O
streptococci	B-bacteria
are	O
highly	O
related	O
,	O
very	O
different	O
strategies	O
have	O
evolved	O
for	O
them	O
to	O
take	O
advantage	O
of	O
their	O
particular	O
location	O
in	O
the	O
oral	O
cavity	O
.	O

The	O
picture	O
that	O
emerges	O
is	O
that	O
the	O
acid	O
-	O
adaptive	O
regulatory	O
mechanisms	O
of	O
the	O
oral	O
streptococci	B-bacteria
differ	O
markedly	O
from	O
those	O
used	O
by	O
Gram	O
-	O
negative	O
bacteria	O
.	O

What	O
future	O
research	O
must	O
determine	O
is	O
the	O
extent	O
and	O
complexity	O
of	O
the	O
acid	O
-	O
adaptive	O
systems	O
in	O
these	O
organisms	O
and	O
how	O
they	O
permit	O
the	O
organisms	O
to	O
maintain	O
themselves	O
in	O
the	O
face	O
of	O
a	O
low	O
-	O
pH	O
environment	O
and	O
the	O
microbial	O
competition	O
present	O
in	O
their	O
respective	O
niches	O
.	O

Whilst	O
the	O
diversity	O
of	O
organisms	O
present	O
in	O
the	O
oral	O
cavity	O
is	O
well	O
accepted	O
,	O
there	O
remains	O
considerable	O
controversy	O
as	O
to	O
whether	O
Staphylococcus	B-bacteria
spp	I-bacteria
.	I-bacteria
play	O
a	O
role	O
in	O
the	O
ecology	O
of	O
the	O
normal	O
oral	O
flora	O
.	O

Surprisingly	O
little	O
detailed	O
work	O
has	O
been	O
performed	O
on	O
the	O
quantitative	O
and	O
qualitative	O
aspects	O
of	O
colonisation	O
or	O
infection	O
either	O
by	O
coagulase	B-bacteria
-	I-bacteria
negative	I-bacteria
staphylococci	I-bacteria
(	O
CNS	B-bacteria
)	O
or	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
.	O

The	O
latter	O
is	O
especially	O
interesting	O
in	O
the	O
light	O
of	O
present	O
difficulties	O
in	O
eradicating	O
carriage	O
of	O
methicillin	B-bacteria
-	I-bacteria
resistant	I-bacteria
S	I-bacteria
.	I-bacteria
aureus	I-bacteria
(	O
MRSA	B-bacteria
)	O
from	O
the	O
oropharynx	O
in	O
affected	O
individuals	O
.	O

This	O
paper	O
reviews	O
the	O
current	O
knowledge	O
of	O
staphylococcal	B-bacteria
colonisation	O
and	O
infection	O
of	O
the	O
oral	O
cavity	O
in	O
health	O
and	O
disease	O
.	O

S	B-bacteria
.	I-bacteria
aureus	I-bacteria
has	O
been	O
isolated	O
from	O
a	O
wide	O
range	O
of	O
infective	O
oral	O
conditions	O
,	O
such	O
as	O
angular	O
cheilitis	O
and	O
parotitis	O
.	O

More	O
recently	O
,	O
a	O
clinical	O
condition	O
classified	O
as	O
staphylococcal	B-bacteria
mucositis	O
has	O
emerged	O
as	O
a	O
clinical	O
problem	O
in	O
many	O
debilitated	O
elderly	O
patients	O
and	O
those	O
with	O
oral	O
Crohn	O
'	O
s	O
disease	O
.	O

Higher	O
carriage	O
rates	O
of	O
both	O
CNS	B-bacteria
or	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
,	O
or	O
both	O
,	O
in	O
patients	O
prone	O
to	O
joint	O
infections	O
raises	O
the	O
interesting	O
possibility	O
of	O
the	O
oral	O
cavity	O
serving	O
as	O
a	O
potential	O
source	O
for	O
bacteraemic	O
spread	O
to	O
compromised	O
joint	O
spaces	O
.	O

In	O
conclusion	O
,	O
there	O
is	O
a	O
surprising	O
paucity	O
of	O
knowledge	O
regarding	O
the	O
role	O
of	O
oral	O
staphylococci	B-bacteria
in	O
both	O
health	O
and	O
disease	O
.	O

Further	O
work	O
in	O
this	O
area	O
may	O
lead	O
to	O
benefits	O
,	O
such	O
as	O
improved	O
decolonisation	O
regimens	O
for	O
eradication	O
of	O
MRSA	B-bacteria
and	O
acknowledgement	O
of	O
the	O
mouth	O
as	O
a	O
source	O
of	O
bacteraemic	O
staphylococci	B-bacteria
.	O

To	O
study	O
the	O
effect	O
of	O
a	O
new	O
Triclosan	O
-	O
containing	O
mouthrinse	O
-	O
-	O
LIBO	O
Anti	O
-	O
plaque	O
mouth	O
rinse	O
on	O
oral	O
infection	O
.	O

1	O
.	O
Before	O
and	O
after	O
the	O
use	O
of	O
triclosan	O
mouthrinse	O
:	O
the	O
gingival	O
data	O
were	O
checked	O
and	O
secorded	O
;	O
plaque	O
sausples	O
were	O
collected	O
,	O
cultured	O
in	O
selective	O
and	O
non	O
-	O
selective	O
media	O
,	O
bacteria	O
were	O
isolated	O
,	O
sounted	O
,	O
and	O
compased	O
.	O

2	O
.	O
With	O
Streptococcus	B-bacteria
mutans	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
Gingivalis	I-bacteria
as	O
experimental	O
bacteria	O
,	O
triclosan	O
and	O
chlorhexidine	O
(	O
CHX	O
)	O
mouthrinses	O
anti	O
-	O
bacterium	O
substance	O
,	O
the	O
minimum	O
inhibitory	O
concentrations	O
(	O
MICs	O
)	O
of	O
the	O
two	O
rinses	O
were	O
compared	O
.	O

3	O
.	O
Smooth	O
plates	O
with	O
the	O
film	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
C	I-bacteria
were	O
set	O
in	O
different	O
mouthrinses	O
and	O
water	O
.	O

Observing	O
the	O
exfoliation	O
of	O
bacteria	O
film	O
from	O
the	O
plates	O
in	O
three	O
agents	O
.	O

1	O
.	O
Triclosan	O
mouthrinse	O
was	O
effective	O
to	O
decrease	O
the	O
plaque	O
index	O
(	O
PLI	O
)	O
and	O
supragingival	O
bleeding	O
index	O
(	O
SBI	O
)	O
.	O

2	O
.	O
The	O
bacteria	O
count	O
obtained	O
after	O
use	O
of	O
triclosan	O
mouthrinse	O
was	O
lower	O
than	O
that	O
before	O
using	O
it	O
.	O

3	O
.	O
The	O
minimum	O
inhibitory	O
concentrations	O
of	O
triclosan	O
mouthrinse	O
against	O
Streptococcus	B-bacteria
mutans	I-bacteria
C	I-bacteria
was	O
much	O
lower	O
than	O
that	O
of	O
chlorhexidine	O
mouthrinse	O
.	O

4	O
.	O
In	O
triclosan	O
mouthrinse	O
,	O
the	O
bacterial	O
films	O
were	O
most	O
easily	O
exfoliated	O
from	O
the	O
plate	O
.	O

Triclosan	O
mouthrinse	O
has	O
strongest	O
anti	O
-	O
adhesion	O
effect	O
among	O
the	O
three	O
tested	O
agents	O
.	O

Triclosan	O
mouthrinse	O
has	O
continuous	O
disinfecting	O
effect	O
and	O
help	O
control	O
the	O
formation	O
and	O
adhesion	O
of	O
dental	O
plaque	O
.	O

Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
is	O
capable	O
of	O
colonizing	O
mucosa	O
and	O
dental	O
plaque	O
and	O
plays	O
an	O
important	O
role	O
in	O
periodontal	O
disease	O
in	O
young	O
peoples	O
and	O
adult	O
.	O

Adherence	O
mechanisms	O
on	O
epithelial	O
cells	O
,	O
tooth	O
or	O
oral	O
bacteria	O
and	O
gingival	O
invasion	O
probably	O
are	O
the	O
initial	O
steps	O
in	O
the	O
pathogenesis	O
of	O
gingivitis	O
or	O
periodontitis	O
.	O

In	O
this	O
study	O
,	O
the	O
adherence	O
of	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
on	O
oral	O
epithelial	O
cells	O
following	O
subculturing	O
were	O
examined	O
.	O

The	O
adherence	O
on	O
oral	O
epithelial	O
cells	O
showed	O
high	O
in	O
all	O
the	O
isolates	O
values	O
but	O
with	O
differences	O
among	O
them	O
and	O
at	O
each	O
time	O
of	O
subculturing	O
.	O

The	O
adherence	O
of	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
FDC	I-bacteria
Y4	I-bacteria
was	O
stable	O
in	O
each	O
of	O
the	O
subcultures	O
.	O

However	O
,	O
adhesion	O
values	O
of	O
all	O
the	O
tested	O
isolates	O
were	O
different	O
except	O
for	O
strains	O
#	O
1	O
,	O
#	O
38	O
and	O
Y4	B-bacteria
,	O
suggesting	O
a	O
heterogenicity	O
within	O
this	O
microbial	O
group	O
.	O

Morphologic	O
variations	O
were	O
observed	O
in	O
extracellular	O
structures	O
of	O
the	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
tested	O
.	O

The	O
adhesion	O
process	O
on	O
oral	O
epithelial	O
cells	O
of	O
this	O
organism	O
can	O
be	O
influenced	O
by	O
subcultures	O
,	O
but	O
additional	O
studies	O
are	O
necessary	O
to	O
verify	O
the	O
influence	O
of	O
subculturing	O
on	O
adherence	O
or	O
other	O
virulence	O
factors	O
.	O

AIMS	O
AND	O
Currently	O
,	O
as	O
a	O
preventive	O
measure	O
against	O
air	O
contamination	O
caused	O
by	O
dental	O
procedures	O
,	O
dust	O
-	O
collecting	O
aspirators	O
such	O
as	O
an	O
extra	O
-	O
oral	O
vacuum	O
aspirator	O
(	O
EOVA	O
)	O
are	O
coming	O
into	O
general	O
use	O
.	O

In	O
this	O
study	O
,	O
we	O
tested	O
the	O
ability	O
of	O
a	O
modified	O
EOVA	O
that	O
uses	O
a	O
household	O
vacuum	O
machine	O
.	O

The	O
study	O
was	O
conducted	O
in	O
two	O
parts	O
.	O

First	O
,	O
the	O
modified	O
EOVA	O
was	O
tested	O
for	O
its	O
ability	O
to	O
eliminate	O
an	O
Escherichia	B-bacteria
coli	I-bacteria
aerosol	O
generated	O
in	O
a	O
manikin	O
.	O

Second	O
,	O
the	O
device	O
was	O
tested	O
for	O
its	O
ability	O
to	O
remove	O
the	O
aerosol	O
generated	O
by	O
dental	O
treatment	O
procedures	O
,	O
scaling	O
and	O
drilling	O
a	O
tooth	O
,	O
on	O
human	O
subjects	O
.	O

There	O
was	O
a	O
statistically	O
significant	O
reduction	O
in	O
both	O
the	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
aerosol	O
and	O
the	O
oral	O
bacterial	O
aerosol	O
during	O
dental	O
treatment	O
procedures	O
.	O

The	O
modified	O
EOVA	O
machine	O
is	O
highly	O
effective	O
in	O
preventing	O
air	O
contamination	O
by	O
dental	O
procedures	O
.	O

Its	O
main	O
advantages	O
are	O
that	O
it	O
can	O
easily	O
be	O
modified	O
for	O
use	O
with	O
any	O
dental	O
unit	O
and	O
it	O
is	O
relatively	O
inexpensive	O
.	O

Black	O
-	O
pigmented	O
anaerobic	O
bacteria	O
,	O
such	O
as	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
and	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
are	O
amongst	O
the	O
predominant	O
bacteria	O
in	O
periodontal	O
pockets	O
and	O
have	O
been	O
implicated	O
in	O
periodontal	O
diseases	O
.	O

To	O
elucidate	O
the	O
roles	O
of	O
gingival	O
keratinocytes	O
,	O
which	O
are	O
the	O
first	O
cells	O
encountered	O
by	O
oral	O
bacteria	O
in	O
periodontal	O
diseases	O
,	O
human	O
gingival	O
keratinocytes	O
in	O
primary	O
culture	O
were	O
stimulated	O
with	O
cell	O
-	O
surface	O
components	O
of	O
P	B-bacteria
gingivalis	I-bacteria
and	O
Pr	B-bacteria
.	I-bacteria
intermedia	I-bacteria
.	O

A	O
glycoprotein	O
fraction	O
from	O
Pr	B-bacteria
.	I-bacteria
intermedia	I-bacteria
(	O
PGP	O
)	O
clearly	O
augmented	O
the	O
release	O
of	O
interleukin	O
-	O
8	O
,	O
granulocyte	O
colony	O
-	O
stimulating	O
factor	O
and	O
granulocyte	O
-	O
macrophage	O
colony	O
-	O
stimulating	O
factor	O
,	O
as	O
determined	O
by	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
.	O

This	O
PGP	O
also	O
induced	O
expression	O
of	O
intercellular	O
adhesion	O
molecule	O
-	O
1	O
(	O
ICAM	O
-	O
1	O
)	O
,	O
as	O
determined	O
by	O
flow	O
cytometry	O
.	O

The	O
augmentation	O
of	O
mRNA	O
expression	O
for	O
these	O
molecules	O
was	O
also	O
confirmed	O
by	O
reverse	O
transcription	O
PCR	O
.	O

In	O
contrast	O
,	O
lipopolysaccharide	O
(	O
LPS	O
)	O
from	O
Pr	B-bacteria
.	I-bacteria
intermedia	I-bacteria
and	O
Escherichia	B-bacteria
coli	I-bacteria
was	O
completely	O
inactive	O
in	O
these	O
assays	O
.	O

LPS	O
fraction	O
and	O
purified	O
fimbriae	O
from	O
P	B-bacteria
gingivalis	I-bacteria
exhibited	O
weak	O
activities	O
.	O

Cytokine	O
production	O
and	O
ICAM	O
-	O
1	O
expression	O
by	O
gingival	O
keratinocytes	O
might	O
cause	O
accumulation	O
and	O
activation	O
of	O
neutrophils	O
in	O
the	O
epithelium	O
and	O
,	O
therefore	O
,	O
may	O
be	O
involved	O
in	O
the	O
initiation	O
and	O
development	O
of	O
inflammation	O
in	O
periodontal	O
tissues	O
.	O

Novel	O
isolates	O
,	O
strains	O
HM	B-bacteria
-	I-bacteria
7	I-bacteria
,	O
HM	B-bacteria
-	I-bacteria
6	I-bacteria
,	O
HH	B-bacteria
-	I-bacteria
31	I-bacteria
,	O
P9a	B-bacteria
-	I-bacteria
hT	I-bacteria
and	O
UJB13	B-bacteria
-	I-bacteria
d	I-bacteria
,	O
which	O
were	O
isolated	O
from	O
tongue	O
plaque	O
and	O
necrotic	O
dental	O
pulp	O
,	O
were	O
studied	O
taxonomically	O
and	O
phylogenetically	O
.	O

These	O
organisms	O
were	O
anaerobic	O
,	O
non	O
-	O
spore	O
-	O
forming	O
,	O
gram	O
-	O
positive	O
,	O
rod	O
-	O
shaped	O
bacteria	O
that	O
were	O
inert	O
in	O
most	O
of	O
the	O
conventional	O
biochemical	O
tests	O
and	O
phenotypically	O
resemble	O
Mogibacterium	B-bacteria
species	I-bacteria
or	O
asaccharolytic	O
Eubacterium	B-bacteria
species	I-bacteria
.	O

The	O
G	O
+	O
C	O
contents	O
of	O
the	O
DNAs	O
from	O
the	O
novel	O
isolates	O
ranged	O
from	O
41	O
to	O
42	O
mol	O
%	O
.	O

DNA	O
-	O
DNA	O
hybridization	O
studies	O
demonstrated	O
that	O
these	O
strains	O
might	O
be	O
assigned	O
to	O
the	O
genus	O
Mogibacterium	B-bacteria
but	O
not	O
to	O
the	O
previously	O
described	O
species	O
.	O

It	O
was	O
also	O
apparent	O
that	O
strain	O
HM	B-bacteria
-	I-bacteria
7	I-bacteria
belonged	O
to	O
the	O
same	O
species	O
as	O
strains	O
HM	B-bacteria
-	I-bacteria
6	I-bacteria
and	O
HH	B-bacteria
-	I-bacteria
31	I-bacteria
,	O
and	O
that	O
strains	O
P9a	B-bacteria
-	I-bacteria
hT	I-bacteria
and	O
UJB13	B-bacteria
-	I-bacteria
d	I-bacteria
belonged	O
to	O
a	O
second	O
species	O
.	O

The	O
levels	O
of	O
DNA	O
-	O
DNA	O
relatedness	O
to	O
asaccharolytic	O
Eubacterium	B-bacteria
species	I-bacteria
,	O
including	O
Eubacterium	B-bacteria
brachy	I-bacteria
,	O
Eubacterium	B-bacteria
nodatum	I-bacteria
,	O
Eubacterium	B-bacteria
saphenum	I-bacteria
and	O
the	O
more	O
recently	O
proposed	O
Eubacterium	B-bacteria
minutum	I-bacteria
and	O
Eubacterium	B-bacteria
exiguum	I-bacteria
(	O
reclassified	O
as	O
Slackia	B-bacteria
exigua	I-bacteria
)	O
,	O
are	O
less	O
than	O
2	O
%	O
.	O

The	O
results	O
of	O
16S	O
rDNA	O
sequence	O
comparisons	O
revealed	O
that	O
these	O
organisms	O
represent	O
novel	O
lineages	O
distinct	O
from	O
all	O
previously	O
described	O
species	O
of	O
gram	O
-	O
positive	O
,	O
rod	O
-	O
shaped	O
bacteria	O
.	O

On	O
the	O
basis	O
of	O
phenotypic	O
characteristics	O
,	O
DNA	O
-	O
DNA	O
hybridization	O
data	O
and	O
phylogenetic	O
analysis	O
with	O
16S	O
rRNA	O
gene	O
sequence	O
data	O
,	O
new	O
species	O
are	O
proposed	O
,	O
namely	O
Mogibacterium	B-bacteria
diversum	I-bacteria
(	O
for	O
strains	O
HM	B-bacteria
-	I-bacteria
7	I-bacteria
,	O
HM	B-bacteria
-	I-bacteria
6	I-bacteria
and	O
HH	B-bacteria
-	I-bacteria
31	I-bacteria
)	O
and	O
Mogibacterium	B-bacteria
neglectum	I-bacteria
(	O
for	O
strains	O
P9a	B-bacteria
-	I-bacteria
hT	I-bacteria
and	O
UJB13	B-bacteria
-	I-bacteria
d	I-bacteria
)	O
.	O

HM	B-bacteria
-	I-bacteria
7T	I-bacteria
(	O
=	O
ATCC	B-bacteria
700923T	I-bacteria
=	O
JCM	B-bacteria
11205T	I-bacteria
)	O
is	O
the	O
type	O
strain	O
of	O
the	O
former	O
and	O
P9a	B-bacteria
-	I-bacteria
hT	I-bacteria
(	O
=	O
ATCC	B-bacteria
700924T	I-bacteria
=	O
JCM	B-bacteria
11204T	I-bacteria
)	O
is	O
the	O
type	O
strain	O
for	O
the	O
latter	O
.	O

The	O
ability	O
of	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
to	O
produce	O
bacteriocin	O
has	O
rarely	O
been	O
reported	O
.	O

antagonistic	O
substance	O
production	O
may	O
confer	O
an	O
important	O
ecological	O
advantage	O
for	O
the	O
producer	O
microorganisms	O
,	O
especially	O
in	O
a	O
competitive	O
ecosystem	O
such	O
as	O
the	O
oral	O
cavity	O
.	O

In	O
the	O
present	O
study	O
,	O
75	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
strains	I-bacteria
isolated	O
from	O
the	O
oral	O
cavity	O
of	O
human	O
patients	O
with	O
periodontal	O
disease	O
,	O
periodontally	O
healthy	O
subjects	O
and	O
marmosets	O
,	O
as	O
well	O
as	O
two	O
reference	O
strains	O
(	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
ATCC	I-bacteria
29523	I-bacteria
and	O
FDC	B-bacteria
Y4	I-bacteria
)	O
were	O
evaluated	O
for	O
auto	O
-	O
,	O
iso	O
-	O
,	O
and	O
heteroantagonistic	O
activity	O
.	O

Fifty	O
-	O
one	O
(	O
68	O
.	O
00	O
%	O
)	O
strains	O
exhibited	O
antagonistic	O
activity	O
;	O
heteroantagonism	O
was	O
observed	O
more	O
often	O
than	O
isoantagonism	O
.	O

Isolated	O
strains	O
antagonized	O
17	O
different	O
species	O
of	O
gram	O
-	O
positive	O
and	O
gram	O
-	O
negative	O
bacteria	O
from	O
the	O
oral	O
and	O
nonoral	O
microbiota	O
.	O

Sensitivity	O
to	O
heat	O
and	O
to	O
proteolytic	O
enzymes	O
constituted	O
strong	O
evidence	O
that	O
the	O
antagonistic	O
substance	O
has	O
a	O
proteic	O
nature	O
.	O

Taken	O
together	O
,	O
our	O
data	O
enabled	O
us	O
to	O
confirm	O
that	O
the	O
antagonistic	O
substance	O
detected	O
was	O
a	O
bacteriocin	O
.	O

The	O
wide	O
spectrum	O
of	O
activity	O
indicates	O
the	O
possibility	O
that	O
more	O
than	O
one	O
antagonistic	O
substance	O
is	O
produced	O
and	O
that	O
these	O
substances	O
play	O
an	O
important	O
role	O
in	O
the	O
ecological	O
balance	O
of	O
the	O
oral	O
ecosystem	O
.	O

For	O
more	O
than	O
100	O
years	O
,	O
investigators	O
have	O
tried	O
to	O
identify	O
the	O
bacteria	O
responsible	O
for	O
dental	O
caries	O
formation	O
and	O
to	O
determine	O
whether	O
their	O
role	O
is	O
one	O
of	O
specificity	O
.	O

Frequent	O
association	O
of	O
Lactobacillus	B-bacteria
acidophilus	I-bacteria
and	O
Streptococcus	B-bacteria
mutans	I-bacteria
with	O
caries	O
activity	O
gave	O
credence	O
to	O
their	O
being	O
specific	O
cariogens	O
.	O

However	O
,	O
dental	O
caries	O
occurrence	O
in	O
their	O
absence	O
,	O
and	O
the	O
presence	O
of	O
other	O
bacteria	O
able	O
to	O
produce	O
substantial	O
amounts	O
of	O
acid	O
from	O
fermentable	O
carbohydrate	O
,	O
provided	O
arguments	O
for	O
non	O
-	O
specificity	O
.	O

In	O
the	O
1940s	O
,	O
Stephan	O
found	O
that	O
the	O
mixed	O
bacteria	O
in	O
dental	O
plaque	O
produced	O
a	O
rapid	O
drop	O
in	O
pH	O
following	O
a	O
sugar	O
rinse	O
and	O
a	O
slow	O
pH	O
return	O
toward	O
baseline	O
.	O

This	O
response	O
became	O
a	O
cornerstone	O
of	O
plaque	O
and	O
mixed	O
-	O
bacterial	O
involvement	O
in	O
dental	O
caries	O
causation	O
when	O
Stephan	O
showed	O
that	O
the	O
pH	O
decrease	O
was	O
inversely	O
and	O
clearly	O
related	O
to	O
caries	O
activity	O
.	O

Detailed	O
examination	O
of	O
the	O
pH	O
(	O
acid	O
-	O
base	O
)	O
metabolisms	O
of	O
oral	O
pure	O
cultures	O
,	O
dental	O
plaque	O
,	O
and	O
salivary	O
sediment	O
identified	O
the	O
main	O
bacteria	O
and	O
metabolic	O
processes	O
responsible	O
for	O
the	O
pH	O
metabolism	O
of	O
dental	O
plaque	O
.	O

It	O
was	O
discovered	O
that	O
this	O
metabolism	O
in	O
different	O
individuals	O
,	O
in	O
plaque	O
in	O
different	O
dentition	O
locations	O
within	O
individuals	O
,	O
and	O
in	O
individuals	O
of	O
different	O
levels	O
of	O
caries	O
activity	O
could	O
be	O
described	O
in	O
terms	O
of	O
a	O
relatively	O
small	O
number	O
of	O
acid	O
-	O
base	O
metabolic	O
processes	O
.	O

This	O
led	O
to	O
an	O
overall	O
bacterial	O
metabolic	O
vector	O
concept	O
for	O
dental	O
plaque	O
,	O
and	O
helped	O
unravel	O
the	O
bacterial	O
involvement	O
in	O
the	O
degradation	O
of	O
the	O
carbohydrate	O
and	O
nitrogenous	O
substrates	O
that	O
produce	O
the	O
acids	O
and	O
alkali	O
that	O
affect	O
the	O
pH	O
and	O
favor	O
and	O
inhibit	O
dental	O
caries	O
production	O
,	O
respectively	O
.	O

A	O
central	O
role	O
of	O
oral	O
arginolytic	O
and	O
non	O
-	O
arginolytic	O
acidogens	O
in	O
the	O
production	O
of	O
the	O
Stephan	O
pH	O
curve	O
was	O
discovered	O
.	O

The	O
non	O
-	O
arginolytics	O
could	O
produce	O
only	O
the	O
pH	O
fall	O
part	O
of	O
this	O
curve	O
,	O
whereas	O
the	O
arginolytics	O
could	O
produce	O
both	O
the	O
fall	O
and	O
the	O
rise	O
.	O

The	O
net	O
result	O
of	O
the	O
latter	O
was	O
a	O
less	O
acidic	O
Stephan	O
pH	O
curve	O
.	O

Both	O
kinds	O
of	O
bacteria	O
are	O
numerous	O
in	O
dental	O
plaque	O
.	O

By	O
varying	O
their	O
ratios	O
,	O
we	O
were	O
easily	O
able	O
to	O
produce	O
Stephan	O
pH	O
curves	O
indicative	O
of	O
different	O
levels	O
of	O
caries	O
activity	O
.	O

This	O
and	O
substantial	O
related	O
metabolic	O
and	O
microbial	O
data	O
indicated	O
that	O
it	O
is	O
the	O
proportions	O
and	O
numbers	O
of	O
acid	O
-	O
base	O
-	O
producing	O
bacteria	O
that	O
are	O
at	O
the	O
core	O
of	O
dental	O
caries	O
activity	O
.	O

The	O
elimination	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
as	O
with	O
a	O
vaccine	O
,	O
was	O
considered	O
to	O
have	O
little	O
chance	O
of	O
success	O
in	O
preventing	O
dental	O
caries	O
in	O
humans	O
,	O
since	O
,	O
in	O
most	O
cases	O
,	O
this	O
would	O
simply	O
make	O
more	O
room	O
for	O
one	O
or	O
more	O
of	O
the	O
many	O
acidogens	O
remaining	O
.	O

An	O
understanding	O
of	O
mixed	O
-	O
bacterial	O
metabolism	O
,	O
knowledge	O
of	O
how	O
to	O
manipulate	O
and	O
work	O
with	O
mixed	O
bacteria	O
,	O
and	O
the	O
use	O
of	O
a	O
bacterial	O
metabolic	O
vector	O
approach	O
as	O
described	O
in	O
this	O
article	O
have	O
led	O
to	O
(	O
1	O
)	O
a	O
more	O
ecological	O
focus	O
for	O
dealing	O
with	O
dental	O
caries	O
,	O
and	O
(	O
2	O
)	O
new	O
means	O
of	O
developing	O
and	O
evaluating	O
anti	O
-	O
caries	O
agents	O
directed	O
toward	O
microbial	O
mixtures	O
that	O
counter	O
excess	O
acid	O
accumulation	O
and	O
tooth	O
demineralization	O
.	O

Bacterial	O
invasion	O
of	O
dentinal	O
tubules	O
commonly	O
occurs	O
when	O
dentin	O
is	O
exposed	O
following	O
a	O
breach	O
in	O
the	O
integrity	O
of	O
the	O
overlying	O
enamel	O
or	O
cementum	O
.	O

Bacterial	O
products	O
diffuse	O
through	O
the	O
dentinal	O
tubule	O
toward	O
the	O
pulp	O
and	O
evoke	O
inflammatory	O
changes	O
in	O
the	O
pulpo	O
-	O
dentin	O
complex	O
.	O

These	O
may	O
eliminate	O
the	O
bacterial	O
insult	O
and	O
block	O
the	O
route	O
of	O
infection	O
.	O

Unchecked	O
,	O
invasion	O
results	O
in	O
pulpitis	O
and	O
pulp	O
necrosis	O
,	O
infection	O
of	O
the	O
root	O
canal	O
system	O
,	O
and	O
periapical	O
disease	O
.	O

While	O
several	O
hundred	O
bacterial	O
species	O
are	O
known	O
to	O
inhabit	O
the	O
oral	O
cavity	O
,	O
a	O
relatively	O
small	O
and	O
select	O
group	O
of	O
bacteria	O
is	O
involved	O
in	O
the	O
invasion	O
of	O
dentinal	O
tubules	O
and	O
subsequent	O
infection	O
of	O
the	O
root	O
canal	O
space	O
.	O

Gram	O
-	O
positive	O
organisms	O
dominate	O
the	O
tubule	O
microflora	O
in	O
both	O
carious	O
and	O
non	O
-	O
carious	O
dentin	O
.	O

The	O
relatively	O
high	O
numbers	O
of	O
obligate	O
anaerobes	O
present	O
-	O
such	O
as	O
Eubacterium	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
Propionibacterium	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
Bifidobacterium	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
Peptostreptococcus	B-bacteria
micros	I-bacteria
,	O
and	O
Veillonella	B-bacteria
spp	I-bacteria
.	I-bacteria
-	O
suggest	O
that	O
the	O
environment	O
favors	O
growth	O
of	O
these	O
bacteria	O
.	O

Gram	O
-	O
negative	O
obligate	O
anaerobic	O
rods	O
,	O
e	O
.	O
g	O
.	O
,	O
Porphyromonas	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
are	O
less	O
frequently	O
recovered	O
.	O

Streptococci	B-bacteria
are	O
among	O
the	O
most	O
commonly	O
identified	O
bacteria	O
that	O
invade	O
dentin	O
.	O

Recent	O
evidence	O
suggests	O
that	O
streptococci	B-bacteria
may	O
recognize	O
components	O
present	O
within	O
dentinal	O
tubules	O
,	O
such	O
as	O
collagen	O
type	O
I	O
,	O
which	O
stimulate	O
bacterial	O
adhesion	O
and	O
intra	O
-	O
tubular	O
growth	O
.	O

Specific	O
interactions	O
of	O
other	O
oral	O
bacteria	O
with	O
invading	O
streptococci	B-bacteria
may	O
then	O
facilitate	O
the	O
invasion	O
of	O
dentin	O
by	O
select	O
bacterial	O
groupings	O
.	O

An	O
understanding	O
the	O
mechanisms	O
involved	O
in	O
dentinal	O
tubule	O
invasion	O
by	O
bacteria	O
should	O
allow	O
for	O
the	O
development	O
of	O
new	O
control	O
strategies	O
,	O
such	O
as	O
inhibitory	O
compounds	O
incorporated	O
into	O
oral	O
health	O
care	O
products	O
or	O
dental	O
materials	O
,	O
which	O
would	O
assist	O
in	O
the	O
practice	O
of	O
endodontics	O
.	O

To	O
analyse	O
the	O
relationship	O
between	O
oral	O
bacteria	O
and	O
the	O
health	O
and	O
functional	O
status	O
of	O
the	O
elderly	O
.	O

The	O
bacteria	O
species	O
in	O
the	O
oral	O
cavity	O
of	O
the	O
elderly	O
were	O
examined	O
.	O

It	O
was	O
found	O
that	O
the	O
bedridden	O
subjects	O
staying	O
at	O
two	O
hospitals	O
for	O
long	O
-	O
term	O
(	O
HOBR	O
)	O
showed	O
significantly	O
lower	O
detection	O
rates	O
of	O
commensal	O
bacteria	O
species	O
and	O
significantly	O
higher	O
detection	O
rates	O
of	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
,	O
of	O
methicillin	B-bacteria
-	I-bacteria
resistant	I-bacteria
Staphylococcus	I-bacteria
aureus	I-bacteria
(	O
MRSA	B-bacteria
)	O
and	O
of	O
coagulase	B-bacteria
(	I-bacteria
-	I-bacteria
)	I-bacteria
Staph		I-bacteria
.	I-bacteria
aureus	I-bacteria
than	O
those	O
living	O
independently	O
(	O
the	O
independent	O
)	O
.	O

In	O
addition	O
,	O
the	O
detection	O
rate	O
of	O
Haemophilus	B-bacteria
parainfluenzae	I-bacteria
in	O
NUBR	O
was	O
discovered	O
to	O
be	O
higher	O
than	O
that	O
found	O
in	O
the	O
independent	O
.	O

In	O
HOBR	O
,	O
the	O
detection	O
rate	O
of	O
Ps	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
was	O
significantly	O
higher	O
among	O
in	O
-	O
patients	O
who	O
required	O
continual	O
care	O
than	O
those	O
in	O
need	O
of	O
partial	O
care	O
,	O
while	O
the	O
detection	O
rate	O
of	O
MRSA	B-bacteria
was	O
significantly	O
higher	O
among	O
in	O
-	O
patients	O
with	O
low	O
serum	O
albumin	O
than	O
those	O
with	O
normal	O
serum	O
albumin	O
.	O

Oral	O
bacteria	O
examination	O
analysis	O
proved	O
that	O
the	O
risks	O
of	O
infection	O
of	O
some	O
pathogenic	O
bacteria	O
species	O
were	O
correlated	O
with	O
functional	O
status	O
,	O
physical	O
function	O
and	O
nutritional	O
state	O
.	O

Our	O
study	O
suggests	O
that	O
the	O
oral	O
bacteria	O
,	O
especially	O
pathogenic	O
bacteria	O
were	O
influenced	O
by	O
the	O
functional	O
status	O
of	O
the	O
elderly	O
and	O
the	O
type	O
and	O
quality	O
of	O
the	O
facilities	O
for	O
the	O
bedridden	O
,	O
physical	O
function	O
and	O
nutritional	O
state	O
.	O

The	O
aim	O
of	O
the	O
study	O
was	O
to	O
assess	O
the	O
prevalence	O
of	O
different	O
bacteria	O
in	O
the	O
oral	O
cavity	O
.	O

The	O
bacteria	O
were	O
present	O
in	O
the	O
oral	O
cavities	O
of	O
73	O
(	O
48	O
.	O
7	O
%	O
)	O
of	O
150	O
individuals	O
.	O

Nesterenkonia	B-bacteria
halobia	I-bacteria
,	O
the	O
most	O
frequently	O
isolated	O
species	O
,	O
was	O
found	O
in	O
20	O
(	O
27	O
%	O
)	O
individuals	O
,	O
Micrococcus	B-bacteria
luteus	I-bacteria
in	O
16	O
(	O
22	O
%	O
)	O
,	O
Kocuria	B-bacteria
kristinae	I-bacteria
in	O
12	O
(	O
16	O
%	O
)	O
,	O
Kocuria	B-bacteria
varians	I-bacteria
in	O
10	O
(	O
14	O
%	O
)	O
,	O
Dermacoccus	B-bacteria
sedentarius	I-bacteria
in	O
9	O
(	O
12	O
%	O
)	O
,	O
Micrococcus	B-bacteria
lylae	I-bacteria
in	O
8	O
(	O
11	O
%	O
)	O
,	O
and	O
Kytococcus	B-bacteria
nishinomiyaensis	I-bacteria
in	O
3	O
(	O
4	O
%	O
)	O
.	O

Mean	O
counts	O
of	O
these	O
microorganisms	O
were	O
relatively	O
low	O
and	O
amounted	O
in	O
log10	O
CFU	O
/	O
ml	O
saliva	O
for	O
M	B-bacteria
.	I-bacteria
luteus	I-bacteria
1	O
.	O
87	O
+	O
/	O
-	O
0	O
.	O
52	O
,	O
for	O
M	B-bacteria
.	I-bacteria
lylae	I-bacteria
2	O
.	O
03	O
+	O
/	O
-	O
0	O
.	O
39	O
,	O
for	O
N	B-bacteria
.	I-bacteria
halobia	I-bacteria
2	O
.	O
14	O
+	O
/	O
-	O
0	O
.	O
56	O
,	O
for	O
K	B-bacteria
.	I-bacteria
kristinae	I-bacteria
2	O
.	O
20	O
+	O
/	O
-	O
0	O
.	O
69	O
,	O
for	O
K	B-bacteria
.	I-bacteria
varians	I-bacteria
2	O
.	O
19	O
+	O
/	O
-	O
0	O
.	O
67	O
,	O
for	O
K	B-bacteria
.	I-bacteria
nishinomiyaensis	I-bacteria
1	O
.	O
72	O
+	O
/	O
-	O
0	O
.	O
39	O
,	O
and	O
for	O
D	B-bacteria
.	I-bacteria
sedentarius	I-bacteria
2	O
.	O
27	O
+	O
/	O
-	O
0	O
.	O
55	O
.	O

The	O
factor	O
limiting	O
the	O
population	O
sizes	O
of	O
these	O
microorganisms	O
was	O
most	O
probably	O
the	O
antagonistic	O
activity	O
of	O
the	O
bacteria	O
living	O
in	O
oral	O
cavity	O
.	O

The	O
increasing	O
prevalence	O
of	O
antibiotic	O
-	O
resistant	O
bacteria	O
emphasises	O
the	O
need	O
for	O
new	O
treatments	O
that	O
can	O
replace	O
traditional	O
antibiotics	O
.	O

Oral	O
immunotherapy	O
with	O
yolk	O
antibodies	O
from	O
hyperimmunised	O
hens	O
is	O
a	O
new	O
promising	O
treatment	O
strategy	O
,	O
primarily	O
for	O
infections	O
in	O
the	O
mouth	O
and	O
gastrointestinal	O
tract	O
.	O

Several	O
studies	O
show	O
that	O
bacterial	O
and	O
viral	O
infections	O
can	O
be	O
prevented	O
with	O
egg	O
c	O
c	O
(	O
IgY	O
)	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
.	O

Oral	O
treatment	O
could	O
potentially	O
be	O
used	O
against	O
many	O
frequently	O
encountered	O
diseases	O
(	O
e	O
.	O
g	O
.	O
common	O
cold	O
,	O
tonsillitis	O
and	O
caries	O
)	O
.	O

Healthy	O
volunteers	O
.	O

We	O
studied	O
the	O
presence	O
of	O
yolk	O
anti	O
-	O
Pseudomonas	O
aeruginosa	O
antibodies	O
in	O
saliva	O
from	O
healthy	O
volunteers	O
over	O
time	O
after	O
1	O
or	O
2	O
minutes	O
'	O
mouth	O
rinse	O
,	O
performed	O
in	O
the	O
evening	O
,	O
with	O
an	O
aqueous	O
IgY	O
antibody	O
preparation	O
.	O

The	O
test	O
persons	O
rinsed	O
the	O
mouth	O
with	O
8	O
.	O
0ml	O
phosphate	O
buffered	O
saline	O
before	O
gargling	O
with	O
the	O
antibody	O
preparation	O
8	O
and	O
24	O
hours	O
later	O
.	O

Statistical	O
analysis	O
was	O
performed	O
with	O
the	O
Mann	O
-	O
Whitney	O
U	O
test	O
.	O

The	O
antibody	O
titres	O
in	O
the	O
mouth	O
rinses	O
were	O
tested	O
for	O
their	O
specific	O
activity	O
against	O
P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
by	O
ELISA	O
.	O

The	O
next	O
morning	O
there	O
were	O
still	O
active	O
antibodies	O
detected	O
in	O
the	O
saliva	O
from	O
18	O
of	O
19	O
subjects	O
.	O

After	O
24	O
hours	O
,	O
active	O
antibodies	O
could	O
be	O
detected	O
in	O
saliva	O
from	O
only	O
a	O
few	O
of	O
the	O
subjects	O
.	O

A	O
2	O
-	O
minute	O
mouth	O
rinse	O
resulted	O
in	O
higher	O
mean	O
ELISA	O
absorbance	O
values	O
than	O
a	O
1	O
-	O
minute	O
rinse	O
.	O

A	O
strain	O
,	O
No	O
.	O
90	O
-	O
1	O
,	O
is	O
isolated	O
from	O
the	O
oral	O
cavity	O
of	O
a	O
patient	O
with	O
periodontophthy	O
.	O

This	O
strain	O
is	O
a	O
Gram	O
-	O
positive	O
,	O
non	O
-	O
endospore	O
-	O
forming	O
,	O
facultative	O
anaerobe	O
with	O
spherical	O
cells	O
,	O
0	O
.	O
9	O
-	O
1	O
.	O
5	O
microns	O
in	O
diameter	O
,	O
occuring	O
in	O
pairs	O
and	O
seldom	O
in	O
short	O
chains	O
of	O
four	O
cells	O
,	O
and	O
motile	O
by	O
one	O
flagellum	O
per	O
cell	O
.	O

The	O
optimum	O
growing	O
temperature	O
is	O
35	O
-	O
37	O
degrees	O
C	O
;	O
appreciable	O
growth	O
is	O
not	O
found	O
below	O
10	O
degrees	O
C	O
,	O
but	O
growth	O
at	O
53	O
degrees	O
and	O
tolerance	O
to	O
60	O
degrees	O
C	O
for	O
30	O
min	O
.	O

This	O
strain	O
is	O
microhalophilous	O
and	O
grows	O
best	O
,	O
well	O
and	O
poorly	O
in	O
the	O
medium	O
containing	O
2	O
%	O
,	O
10	O
%	O
-	O
15	O
%	O
and	O
25	O
%	O
NaCl	O
respectively	O
.	O

Catalase	O
and	O
urease	O
are	O
positive	O
and	O
nitrate	O
is	O
reduced	O
.	O

Acid	O
is	O
produced	O
from	O
many	O
carbohydrates	O
,	O
but	O
no	O
gas	O
.	O

Gelatin	O
can	O
be	O
hydrolyzed	O
,	O
but	O
starch	O
,	O
cellulose	O
and	O
dextrin	O
do	O
not	O
.	O

G	O
+	O
C	O
content	O
in	O
DNA	O
is	O
41	O
.	O
34	O
mol	O
%	O
(	O
Tm	O
)	O
.	O

The	O
strain	O
(	O
90	O
-	O
1	O
)	O
is	O
considered	O
to	O
be	O
a	O
new	O
species	O
belonging	O
to	O
a	O
new	O
genus	O
because	O
its	O
some	O
characteristics	O
are	O
different	O
from	O
those	O
of	O
the	O
known	O
coccus	B-bacteria
genuera	I-bacteria
and	O
designated	O
as	O
Stomatostreptococcus	B-bacteria
microhalophilus	I-bacteria
Ping	I-bacteria
,	I-bacteria
Zhou	I-bacteria
,	I-bacteria
Sun	I-bacteria
et	I-bacteria
Fan	I-bacteria
gen	I-bacteria
.	I-bacteria
nov	I-bacteria
.	I-bacteria
sp	I-bacteria
.	I-bacteria
nov	I-bacteria
.	I-bacteria
according	O
to	O
its	O
source	O
and	O
microhalophilic	O
trait	O
.	O

Aerobic	O
oral	O
bacteria	O
only	O
rarely	O
colonize	O
the	O
cleft	O
nasal	O
floor	O
in	O
patients	O
with	O
patent	O
oronasal	O
fistula	O
.	O

There	O
are	O
no	O
studies	O
that	O
have	O
investigated	O
whether	O
anaerobic	O
oral	O
flora	O
colonize	O
this	O
site	O
and	O
whether	O
attempting	O
to	O
culture	O
them	O
is	O
useful	O
for	O
assessing	O
the	O
patency	O
of	O
oronasal	O
fistulae	O
in	O
the	O
clinic	O
.	O

A	O
prospective	O
study	O
of	O
13	O
patients	O
with	O
cleft	O
with	O
patent	O
unilateral	O
oronasal	O
fistulae	O
.	O

Microbiological	O
culture	O
swabs	O
were	O
taken	O
from	O
the	O
oral	O
cavity	O
and	O
both	O
nasal	O
floors	O
,	O
with	O
the	O
unaffected	O
side	O
being	O
used	O
as	O
a	O
control	O
.	O

Following	O
aerobic	O
and	O
anaerobic	O
culture	O
,	O
bacterial	O
isolates	O
were	O
identified	O
and	O
compared	O
.	O

A	O
significant	O
growth	O
of	O
anaerobic	O
oral	O
bacteria	O
from	O
the	O
cleft	O
nasal	O
floor	O
when	O
compared	O
with	O
the	O
unaffected	O
side	O
.	O

Aerobic	O
oral	O
flora	O
was	O
cultured	O
from	O
the	O
oral	O
cavity	O
in	O
all	O
13	O
patients	O
.	O

A	O
light	O
growth	O
of	O
aerobic	O
oral	O
flora	O
was	O
found	O
in	O
the	O
cleft	O
nasal	O
floor	O
in	O
two	O
patients	O
,	O
and	O
anaerobic	O
oral	O
flora	O
was	O
cultured	O
from	O
the	O
cleft	O
nasal	O
floor	O
in	O
the	O
same	O
two	O
patients	O
.	O

No	O
statistical	O
correlation	O
was	O
found	O
between	O
growth	O
of	O
anaerobic	O
flora	O
and	O
the	O
cleft	O
nasal	O
floor	O
(	O
p	O
=	O
.	O
48	O
)	O
.	O

Like	O
aerobic	O
oral	O
flora	O
,	O
anaerobic	O
oral	O
bacteria	O
would	O
appear	O
to	O
only	O
rarely	O
colonize	O
the	O
cleft	O
nasal	O
floor	O
in	O
patients	O
with	O
oronasal	O
fistulae	O
.	O

This	O
additional	O
investigation	O
does	O
not	O
appear	O
to	O
be	O
helpful	O
in	O
the	O
assessment	O
of	O
oronasal	O
fistulae	O
in	O
the	O
clinic	O
.	O

Five	O
streptococcal	B-bacteria
strains	I-bacteria
were	O
isolated	O
from	O
dental	O
plaque	O
and	O
saliva	O
of	O
caries	O
-	O
free	O
humans	O
.	O

The	O
cells	O
were	O
gram	O
-	O
positive	O
,	O
non	O
-	O
spore	O
-	O
forming	O
,	O
non	O
-	O
motile	O
cocci	O
that	O
were	O
arranged	O
in	O
short	O
chains	O
.	O

The	O
strains	O
were	O
catalase	O
-	O
negative	O
,	O
facultatively	O
anaerobic	O
and	O
produced	O
lactic	O
acid	O
exclusively	O
from	O
glucose	O
fermentation	O
.	O

Biochemical	O
analysis	O
that	O
used	O
both	O
conventional	O
methods	O
and	O
the	O
commercial	O
API	O
20	O
Strep	O
system	O
showed	O
that	O
the	O
five	O
strains	O
fermented	O
only	O
a	O
few	O
kinds	O
of	O
sugar	O
.	O

The	O
mean	O
DNA	O
G	O
+	O
C	O
content	O
of	O
the	O
five	O
novel	O
strains	O
was	O
39	O
.	O
5	O
+	O
/	O
-	O
0	O
.	O
8	O
mol	O
%	O
.	O

Phylogenetic	O
analysis	O
based	O
on	O
16S	O
rDNA	O
sequence	O
homology	O
indicated	O
that	O
the	O
new	O
isolates	O
represented	O
a	O
novel	O
member	O
of	O
the	O
mitis	O
group	O
of	O
the	O
genus	O
Streptococcus	B-bacteria
,	O
related	O
most	O
closely	O
to	O
the	O
recently	O
described	O
species	O
Streptococcus	B-bacteria
sinensis	I-bacteria
.	O

DNA	O
-	O
DNA	O
relatedness	O
between	O
novel	O
strain	O
LMG	B-bacteria
21535T	I-bacteria
and	O
type	O
strains	O
of	O
phylogenetically	O
related	O
species	O
of	O
oral	O
streptococci	B-bacteria
was	O
7	O
.	O
1	O
-	O
16	O
.	O
4	O
%	O
.	O

Therefore	O
a	O
novel	O
Streptococcus	B-bacteria
species	I-bacteria
,	O
Streptococcus	B-bacteria
oligofermentans	I-bacteria
sp	I-bacteria
.	I-bacteria
nov	I-bacteria
.	I-bacteria
,	O
is	O
proposed	O
.	O

The	O
type	O
strain	O
is	O
LMG	B-bacteria
21535T	I-bacteria
=	O
AS	B-bacteria
1	I-bacteria
.	I-bacteria
3089T	I-bacteria
.	O

Previous	O
work	O
has	O
shown	O
that	O
the	O
indigenous	O
gut	O
microflora	O
in	O
mice	O
plays	O
a	O
protective	O
role	O
against	O
Escherichia	B-bacteria
coli	I-bacteria
heat	O
-	O
labile	O
enterotoxin	O
(	O
LT	O
)	O
-	O
mediated	O
abrogation	O
of	O
oral	O
tolerance	O
to	O
an	O
unrelated	O
co	O
-	O
ingested	O
protein	O
.	O

To	O
assess	O
potential	O
protection	O
by	O
human	O
gut	O
microflora	O
,	O
we	O
studied	O
the	O
effect	O
of	O
human	O
gut	O
microflora	O
in	O
a	O
murine	O
model	O
.	O

Oral	O
tolerance	O
was	O
studied	O
in	O
adult	O
gnotobiotic	O
mice	O
(	O
i	O
.	O
e	O
.	O
ex	O
-	O
germ	O
-	O
free	O
mice	O
)	O
colonized	O
with	O
the	O
entire	O
human	O
fecal	O
microflora	O
and	O
orally	O
administered	O
once	O
with	O
LT	O
and	O
ovalbumin	O
.	O

Systemic	O
suppression	O
of	O
IgG	O
,	O
IgG1	O
,	O
IgG2a	O
,	O
and	O
IgE	O
antibody	O
responses	O
was	O
assessed	O
by	O
ELISA	O
.	O

Both	O
specific	O
IgG	O
subclasses	O
and	O
IgE	O
hyporesponsiveness	O
was	O
induced	O
in	O
LT	O
+	O
ovalbumin	O
-	O
fed	O
gnotobiotic	O
mice	O
,	O
indicating	O
that	O
the	O
human	O
gut	O
microflora	O
can	O
protect	O
against	O
the	O
LT	O
-	O
mediated	O
abrogation	O
of	O
oral	O
tolerance	O
.	O

However	O
,	O
as	O
confirmed	O
with	O
mouse	O
gut	O
microflora	O
,	O
this	O
protective	O
effect	O
only	O
occurs	O
when	O
the	O
gut	O
microflora	O
is	O
associated	O
from	O
birth	O
on	O
.	O

Colonization	O
of	O
germ	O
-	O
free	O
mice	O
with	O
a	O
single	O
bacterial	O
strain	O
,	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
,	O
predominant	O
in	O
the	O
human	O
and	O
mouse	O
gut	O
microflora	O
in	O
the	O
neonatal	O
period	O
,	O
showed	O
that	O
this	O
strain	O
alone	O
did	O
not	O
induce	O
protection	O
.	O

These	O
results	O
supported	O
the	O
hypothesis	O
that	O
the	O
natural	O
establishment	O
of	O
the	O
gut	O
microflora	O
in	O
neonates	O
crucially	O
influenced	O
resistance	O
to	O
LT	O
-	O
mediated	O
abrogation	O
of	O
oral	O
tolerance	O
by	O
reinforcing	O
suppression	O
of	O
both	O
T	O
helper	O
type	O
1	O
-	O
and	O
T	O
helper	O
type	O
2	O
-	O
controlled	O
responses	O
,	O
and	O
suggested	O
that	O
sequential	O
bacterial	O
colonization	O
of	O
the	O
gut	O
rather	O
than	O
a	O
single	O
bacterial	O
species	O
may	O
be	O
involved	O
in	O
this	O
phenomenon	O
.	O

Our	O
long	O
-	O
term	O
oral	O
administration	O
of	O
dimethylarsinic	O
acid	O
(	O
DMAV	O
)	O
in	O
rats	O
revealed	O
that	O
three	O
unidentified	O
metabolites	O
,	O
M	O
-	O
1	O
,	O
M	O
-	O
2	O
,	O
and	O
M	O
-	O
3	O
,	O
were	O
detected	O
in	O
urine	O
and	O
feces	O
.	O

DMAV	O
and	O
trimethylarsine	O
oxide	O
(	O
TMAO	O
)	O
were	O
converted	O
to	O
M	O
-	O
2	O
and	O
M	O
-	O
3	O
and	O
M	O
-	O
1	O
by	O
Escherichia	B-bacteria
coli	I-bacteria
strain	I-bacteria
A3	I-bacteria
-	I-bacteria
6	I-bacteria
isolated	O
from	O
the	O
ceca	O
of	O
DMAV	O
-	O
administered	O
rats	O
,	O
respectively	O
.	O

In	O
this	O
study	O
,	O
we	O
report	O
on	O
the	O
mechanism	O
of	O
production	O
and	O
the	O
chemical	O
properties	O
of	O
these	O
unknown	O
metabolites	O
.	O

To	O
investigate	O
the	O
pattern	O
of	O
conversion	O
of	O
DMAV	O
or	O
TMAO	O
by	O
A3	B-bacteria
-	I-bacteria
6	I-bacteria
in	O
the	O
presence	O
of	O
cysteine	O
(	O
Cys	O
)	O
,	O
arsenic	O
metabolites	O
of	O
DMAV	O
or	O
TMAO	O
in	O
medium	O
after	O
incubation	O
with	O
A3	B-bacteria
-	I-bacteria
6	I-bacteria
and	O
Cys	O
were	O
analyzed	O
by	O
liquid	O
chromatography	O
with	O
inductively	O
coupled	O
plasma	O
mass	O
spectrometry	O
(	O
LC	O
-	O
ICP	O
-	O
MS	O
)	O
.	O

DMAV	O
was	O
reduced	O
to	O
dimethylarsinous	O
acid	O
(	O
DMAIII	O
)	O
to	O
form	O
M	O
-	O
2	O
in	O
the	O
presence	O
of	O
Cys	O
and	O
A3	B-bacteria
-	I-bacteria
6	I-bacteria
,	O
and	O
M	O
-	O
2	O
was	O
further	O
converted	O
to	O
M	O
-	O
3	O
.	O

TMAO	O
was	O
rapidly	O
converted	O
to	O
M	O
-	O
1	O
by	O
A3	B-bacteria
-	I-bacteria
6	I-bacteria
.	O

The	O
cytotoxicity	O
of	O
the	O
unidentified	O
metabolites	O
was	O
investigated	O
.	O

M	O
-	O
2	O
was	O
more	O
cytotoxic	O
than	O
DMAV	O
,	O
M	O
-	O
1	O
,	O
and	O
M	O
-	O
3	O
in	O
V79	O
cells	O
.	O

The	O
cytotoxicity	O
of	O
M	O
-	O
2	O
in	O
HL	O
-	O
60	O
cells	O
was	O
decreased	O
by	O
the	O
addition	O
of	O
superoxide	O
dismutase	O
,	O
suggesting	O
that	O
the	O
cytotoxicity	O
of	O
M	O
-	O
2	O
might	O
be	O
due	O
to	O
the	O
production	O
of	O
reactive	O
oxygen	O
species	O
.	O

In	O
addition	O
,	O
we	O
examined	O
the	O
chemical	O
properties	O
of	O
M	O
-	O
2	O
by	O
LC	O
-	O
ICP	O
-	O
MS	O
and	O
LC	O
-	O
MS	O
.	O
M	O
-	O
2	O
was	O
oxidized	O
to	O
DMAV	O
by	O
hydrogen	O
peroxide	O
,	O
suggesting	O
that	O
M	O
-	O
2	O
may	O
be	O
a	O
reduced	O
form	O
of	O
DMAV	O
.	O

M	O
-	O
2	O
was	O
consistent	O
with	O
the	O
reactant	O
of	O
DMAV	O
with	O
metabisulfite	O
-	O
thiosulfate	O
reagent	O
but	O
not	O
DMAIII	O
by	O
analyses	O
of	O
LC	O
-	O
ICP	O
-	O
MS	O
and	O
LC	O
-	O
MS	O
.	O

The	O
molecular	O
weight	O
of	O
M	O
-	O
2	O
was	O
154	O
,	O
and	O
M	O
-	O
2	O
was	O
a	O
sulfur	O
-	O
containing	O
metabolite	O
.	O

This	O
study	O
compared	O
removal	O
of	O
pairs	O
of	O
co	O
-	O
adhering	O
and	O
non	O
-	O
co	O
-	O
adhering	O
oral	O
actinomyces	B-bacteria
and	O
streptococci	B-bacteria
from	O
salivary	O
pellicles	O
by	O
manual	O
,	O
rotating	O
/	O
oscillating	O
electric	O
and	O
sonic	O
toothbrushes	O
,	O
applying	O
weights	O
up	O
to	O
240	O
g	O
.	O
First	O
,	O
actinomyces	B-bacteria
were	O
allowed	O
to	O
adhere	O
to	O
a	O
pellicle	O
in	O
a	O
parallel	O
plate	O
flow	O
chamber	O
,	O
after	O
which	O
streptococci	B-bacteria
suspended	O
in	O
saliva	O
were	O
perfused	O
through	O
the	O
chamber	O
at	O
33	O
degrees	O
C	O
.	O
On	O
average	O
,	O
34	O
-	O
39	O
%	O
of	O
the	O
adhering	O
bacteria	O
were	O
adhering	O
as	O
single	O
organisms	O
.	O

For	O
co	O
-	O
adhering	O
and	O
non	O
-	O
co	O
-	O
adhering	O
pairs	O
,	O
33	O
and	O
10	O
%	O
of	O
the	O
adhering	O
bacteria	O
were	O
involved	O
,	O
respectively	O
,	O
in	O
aggregates	O
comprising	O
more	O
than	O
10	O
organisms	O
.	O

Brushing	O
by	O
hand	O
removed	O
82	O
%	O
at	O
low	O
weight	O
(	O
40	O
g	O
)	O
,	O
which	O
was	O
less	O
than	O
by	O
electric	O
(	O
93	O
%	O
)	O
or	O
sonic	O
(	O
92	O
%	O
)	O
brushing	O
,	O
while	O
for	O
all	O
modes	O
of	O
brushing	O
bacterial	O
removal	O
increased	O
with	O
increasing	O
weight	O
to	O
95	O
-	O
99	O
%	O
.	O

For	O
a	O
non	O
-	O
co	O
-	O
adhering	O
pair	O
,	O
subsequent	O
exposure	O
of	O
brushed	O
pellicles	O
to	O
a	O
streptococcal	B-bacteria
suspension	O
yielded	O
only	O
2	O
-	O
16	O
%	O
of	O
bacteria	O
involved	O
in	O
large	O
aggregates	O
,	O
regardless	O
of	O
the	O
mode	O
of	O
brushing	O
.	O

For	O
the	O
co	O
-	O
adhering	O
pair	O
,	O
however	O
,	O
de	B-bacteria
novo	I-bacteria
streptococcal	I-bacteria
adhesion	O
to	O
hand	O
-	O
brushed	O
pellicles	O
yielded	O
34	O
-	O
57	O
%	O
of	O
bacteria	O
involved	O
in	O
large	O
aggregates	O
,	O
while	O
electric	O
and	O
sonic	O
brushing	O
left	O
22	O
-	O
35	O
%	O
of	O
the	O
bacteria	O
involved	O
in	O
large	O
aggregates	O
.	O

De	B-bacteria
novo	I-bacteria
streptococcal	I-bacteria
adhesion	O
for	O
the	O
co	O
-	O
adhering	O
pair	O
increased	O
with	O
increasing	O
weight	O
for	O
the	O
electric	O
and	O
sonic	O
brush	O
in	O
contrast	O
to	O
the	O
manual	O
brush	O
.	O

Since	O
a	O
strong	O
influence	O
of	O
co	O
-	O
adhesion	O
is	O
evident	O
in	O
de	B-bacteria
novo	I-bacteria
streptococcal	I-bacteria
adhesion	O
,	O
despite	O
nearly	O
complete	O
removal	O
of	O
all	O
actinomyces	B-bacteria
,	O
these	O
observations	O
suggest	O
that	O
the	O
three	O
modes	O
of	O
brushing	O
leave	O
footprints	O
to	O
which	O
streptococci	B-bacteria
preferentially	O
adhere	O
.	O

To	O
examine	O
the	O
occurrence	O
of	O
specific	O
periodontal	O
bacteria	O
in	O
children	O
and	O
adolescents	O
.	O

Ten	O
putative	O
periodontal	O
bacteria	O
were	O
longitudinally	O
examined	O
in	O
plaque	O
and	O
saliva	O
samples	O
from	O
119	O
periodontally	O
healthy	O
children	O
(	O
2	O
-	O
15	O
years	O
old	O
)	O
using	O
a	O
polymerase	O
chain	O
reaction	O
method	O
.	O

Capnocytophaga	B-bacteria
ochracea	I-bacteria
,	O
C	B-bacteria
.	I-bacteria
sputigena	I-bacteria
,	O
and	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
were	O
frequently	O
found	O
in	O
saliva	O
,	O
and	O
tended	O
to	O
persist	O
in	O
saliva	O
for	O
the	O
remainder	O
of	O
the	O
study	O
,	O
whereas	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Treponema	B-bacteria
denticola	I-bacteria
,	O
and	O
Prevotella	B-bacteria
intermedia	I-bacteria
were	O
rarely	O
detected	O
.	O

P	B-bacteria
.	I-bacteria
nigrescens	I-bacteria
was	O
more	O
frequently	O
detected	O
in	O
plaque	O
and	O
its	O
prevalence	O
increased	O
with	O
age	O
.	O

Eikenella	B-bacteria
corrodens	I-bacteria
and	O
Campylobacter	B-bacteria
rectus	I-bacteria
were	O
sometimes	O
detected	O
in	O
both	O
plaque	O
and	O
saliva	O
,	O
while	O
Tannerella	B-bacteria
forsythensis	I-bacteria
was	O
occasionally	O
detected	O
in	O
saliva	O
.	O

A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
,	O
C	B-bacteria
.	I-bacteria
ochracea	I-bacteria
,	O
C	B-bacteria
.	I-bacteria
sputigena	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
nigrescens	I-bacteria
,	O
C	B-bacteria
.	I-bacteria
rectus	I-bacteria
,	O
and	O
E	B-bacteria
.	I-bacteria
corrodens	I-bacteria
are	O
common	O
members	O
of	O
the	O
oral	O
microbial	O
flora	O
of	O
healthy	O
children	O
,	O
whereas	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
,	O
and	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
appear	O
to	O
be	O
transient	O
organisms	O
.	O

A	O
selectivity	O
factor	O
was	O
specified	O
to	O
the	O
previously	O
developed	O
nutrient	O
medium	O
meant	O
for	O
the	O
cultivation	O
of	O
Haemophilus	B-bacteria
bacteria	I-bacteria
-	O
-	O
CAE	O
,	O
which	O
is	O
based	O
on	O
the	O
acid	O
hydrolysate	O
of	O
casein	O
,	O
enzyme	O
hydrolysate	O
of	O
animal	O
blood	O
(	O
aminopeptide	O
)	O
and	O
an	O
extract	O
of	O
nutrient	O
yeast	O
.	O

The	O
above	O
nutrient	O
medium	O
containing	O
additionally	O
growth	O
factors	O
V	O
and	O
X	O
,	O
glucose	O
and	O
bacitracin	O
was	O
shown	O
to	O
fit	O
well	O
for	O
the	O
primary	O
sowing	O
of	O
Haemophilus	B-bacteria
bacteria	I-bacteria
and	O
it	O
can	O
be	O
used	O
in	O
diagnostic	O
examinations	O
.	O

Active	O
immunization	O
with	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
whole	O
-	O
cell	O
preparations	O
has	O
been	O
shown	O
to	O
prevent	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
infection	O
and	O
oral	O
bone	O
loss	O
.	O

Employing	O
passive	O
antibody	O
transfer	O
and	O
opsonization	O
,	O
we	O
demonstrate	O
with	O
this	O
study	O
that	O
immunization	O
-	O
elicited	O
P	O
.	O
gingivalis	O
-	O
specific	O
immunoglobulin	O
G	O
facilitates	O
clearance	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
in	O
a	O
subcutaneous	O
chamber	O
model	O
and	O
prevents	O
P	O
.	O
gingivalis	O
-	O
elicited	O
oral	O
bone	O
loss	O
.	O

Oral	O
malodor	O
is	O
considered	O
to	O
originate	O
primarily	O
from	O
tongue	O
microbiota	O
populations	O
.	O

However	O
,	O
the	O
relationship	O
between	O
oral	O
malodor	O
and	O
tongue	O
microbiota	O
remains	O
unclear	O
.	O

In	O
this	O
study	O
,	O
tongue	O
periodontal	O
pathogens	O
were	O
analyzed	O
via	O
real	O
-	O
time	O
PCR	O
,	O
and	O
the	O
association	O
between	O
oral	O
malodor	O
and	O
tongue	O
periodontal	O
pathogens	O
,	O
including	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Prevotella	B-bacteria
nigrescens	I-bacteria
and	O
Treponema	B-bacteria
denticola	I-bacteria
,	O
was	O
examined	O
.	O

The	O
subject	O
population	O
consisted	O
of	O
29	O
individuals	O
with	O
and	O
10	O
healthy	O
persons	O
without	O
oral	O
malodor	O
.	O

Oral	O
malodor	O
was	O
assessed	O
by	O
organoleptic	O
test	O
and	O
volatile	O
sulfur	O
compound	O
(	O
VSC	O
)	O
levels	O
as	O
measured	O
by	O
gas	O
chromatography	O
.	O

Real	O
-	O
time	O
PCR	O
was	O
conducted	O
for	O
anaerobes	O
in	O
tongue	O
biofilm	O
samples	O
employing	O
a	O
LightCycler	O
system	O
;	O
furthermore	O
,	O
bacterial	O
proportion	O
served	O
as	O
a	O
quantitative	O
parameter	O
.	O

Among	O
the	O
five	O
anaerobes	O
,	O
only	O
T	B-bacteria
.	I-bacteria
forsythia	I-bacteria
displayed	O
higher	O
proportions	O
in	O
malodor	O
subjects	O
than	O
corresponding	O
values	O
in	O
healthy	O
controls	O
.	O

Proportions	O
of	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
nigrescens	I-bacteria
correlated	O
strongly	O
with	O
hydrogen	O
sulfide	O
concentration	O
.	O

Proportions	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
nigrescens	I-bacteria
also	O
exhibited	O
strong	O
correlation	O
with	O
methyl	O
mercaptan	O
concentration	O
.	O

The	O
correlation	O
coefficient	O
between	O
the	O
proportion	O
of	O
the	O
total	O
of	O
the	O
five	O
anaerobes	O
and	O
total	O
VSC	O
level	O
(	O
r	O
=	O
0	O
.	O
88	O
)	O
was	O
greater	O
than	O
that	O
between	O
bacterial	O
proportion	O
and	O
organoleptic	O
score	O
(	O
r	O
=	O
0	O
.	O
29	O
)	O
.	O

When	O
a	O
linear	O
regression	O
analysis	O
was	O
performed	O
utilizing	O
the	O
proportion	O
of	O
each	O
of	O
the	O
five	O
periodontal	O
pathogens	O
as	O
an	O
independent	O
variable	O
,	O
the	O
explanatory	O
power	O
of	O
these	O
independent	O
variables	O
revealed	O
81	O
%	O
for	O
total	O
VSC	O
level	O
and	O
16	O
%	O
for	O
organoleptic	O
score	O
.	O

These	O
results	O
suggest	O
that	O
these	O
five	O
periodontal	O
pathogens	O
on	O
tongue	O
dorsa	O
may	O
contribute	O
greatly	O
to	O
VSC	O
production	O
.	O

Fifty	O
-	O
three	O
beta	O
-	O
lactamase	O
-	O
producing	O
strains	O
of	O
oral	O
bacteria	O
isolated	O
from	O
patients	O
with	O
refractory	O
periodontitis	O
in	O
Norway	O
and	O
USA	O
were	O
screened	O
for	O
the	O
presence	O
of	O
the	O
bla	O
(	O
TEM	O
)	O
,	O
bla	O
(	O
SHV	O
)	O
,	O
bla	O
(	O
OXA	O
)	O
,	O
bla	O
(	O
ampC	O
)	O
,	O
bla	O
(	O
cfxA	O
)	O
,	O
and	O
bla	O
(	O
cepA	O
/	O
cblA	O
)	O
genes	O
by	O
the	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
.	O

The	O
PCR	O
products	O
were	O
characterized	O
by	O
direct	O
sequencing	O
of	O
the	O
amplified	O
DNA	O
.	O

Thirty	O
-	O
four	O
of	O
the	O
53	O
enzyme	O
-	O
producing	O
strains	O
(	O
64	O
%	O
)	O
were	O
positive	O
in	O
one	O
of	O
the	O
PCR	O
assays	O
.	O

All	O
beta	O
-	O
lactamase	O
-	O
producing	O
Prevotella	B-bacteria
and	O
Capnocytophaga	B-bacteria
spp	I-bacteria
.	I-bacteria
were	O
CfxA	O
positive	O
.	O

TEM	O
-	O
type	O
beta	O
-	O
lactamases	O
were	O
identified	O
in	O
one	O
strain	O
each	O
of	O
Escherichia	B-bacteria
coli	I-bacteria
and	O
Neisseria	B-bacteria
sp	I-bacteria
.	I-bacteria
,	O
and	O
one	O
strain	O
of	O
Citrobacter	B-bacteria
freundii	I-bacteria
possessed	O
an	O
AmpC	O
-	O
type	O
beta	O
-	O
lactamase	O
.	O

Screening	O
for	O
gene	O
cassettes	O
and	O
genes	O
known	O
to	O
be	O
associated	O
with	O
integrons	O
did	O
not	O
reveal	O
the	O
presence	O
of	O
integrons	O
in	O
these	O
oral	O
bacteria	O
.	O

Sequence	O
analyses	O
showed	O
that	O
most	O
CfxA	O
positive	O
Prevotella	B-bacteria
and	O
Capnocytophaga	B-bacteria
isolates	I-bacteria
from	O
patients	O
with	O
refractory	O
periodontitis	O
harboured	O
variants	O
of	O
the	O
CfxA2	O
and	O
CfxA3	O
enzyme	O
.	O

The	O
present	O
study	O
also	O
showed	O
that	O
many	O
different	O
genetic	O
determinants	O
of	O
beta	O
-	O
lactamase	O
production	O
are	O
found	O
in	O
bacteria	O
isolated	O
from	O
refractory	O
periodontitis	O
,	O
many	O
of	O
which	O
remain	O
to	O
be	O
characterized	O
.	O

The	O
oral	O
mucosa	O
is	O
exposed	O
to	O
a	O
high	O
density	O
and	O
diversity	O
of	O
gram	O
-	O
positive	O
and	O
gram	O
-	O
negative	O
bacteria	O
,	O
but	O
very	O
little	O
is	O
known	O
about	O
how	O
immune	O
homeostasis	O
is	O
maintained	O
in	O
this	O
environment	O
,	O
particularly	O
in	O
the	O
inflammatory	O
disease	O
chronic	O
periodontitis	O
(	O
CP	O
)	O
.	O

The	O
cells	O
of	O
the	O
innate	O
immune	O
response	O
recognize	O
bacterial	O
structures	O
via	O
the	O
Toll	O
-	O
like	O
receptors	O
(	O
TLR	O
)	O
.	O

This	O
activates	O
intracellular	O
signaling	O
and	O
transcription	O
of	O
proteins	O
essential	O
for	O
the	O
induction	O
of	O
an	O
adaptive	O
immune	O
response	O
;	O
however	O
,	O
if	O
unregulated	O
,	O
it	O
can	O
lead	O
to	O
destructive	O
inflammatory	O
responses	O
.	O

Using	O
single	O
-	O
immunoenzyme	O
labeling	O
,	O
we	O
show	O
that	O
the	O
human	O
oral	O
mucosa	O
(	O
gingiva	O
)	O
is	O
infiltrated	O
by	O
large	O
numbers	O
of	O
TLR2	O
(	O
+	O
)	O
and	O
TLR4	O
(	O
+	O
)	O
cells	O
and	O
that	O
their	O
numbers	O
increase	O
significantly	O
in	O
CP	O
,	O
relative	O
to	O
health	O
(	O
P	O
<	O
0	O
.	O
05	O
,	O
Student	O
'	O
s	O
t	O
test	O
)	O
.	O

We	O
also	O
show	O
that	O
the	O
numbers	O
of	O
TLR2	O
(	O
+	O
)	O
but	O
not	O
TLR4	O
(	O
+	O
)	O
cells	O
increase	O
linearly	O
with	O
inflammation	O
(	O
r	O
(	O
2	O
)	O
=	O
0	O
.	O
33	O
,	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

Double	O
-	O
immunofluorescence	O
analysis	O
confirms	O
that	O
TLR2	O
is	O
coexpressed	O
by	O
monocytes	O
(	O
MC	O
)	O
/	O
macrophages	O
(	O
mphi	O
)	O
in	O
situ	O
.	O

Further	O
analysis	O
of	O
gingival	O
tissues	O
by	O
quantitative	O
real	O
-	O
time	O
PCR	O
,	O
however	O
,	O
indicates	O
that	O
despite	O
a	O
threefold	O
increase	O
in	O
the	O
expression	O
of	O
interleukin	O
-	O
1beta	O
(	O
IL	O
-	O
1beta	O
)	O
mRNA	O
during	O
CP	O
,	O
there	O
is	O
significant	O
(	O
30	O
-	O
fold	O
)	O
downregulation	O
of	O
TLR2	O
mRNA	O
(	O
P	O
<	O
0	O
.	O
05	O
,	O
Student	O
'	O
s	O
t	O
test	O
)	O
.	O

Also	O
showing	O
similar	O
trends	O
are	O
the	O
levels	O
of	O
TLR4	O
(	O
ninefold	O
reduction	O
)	O
,	O
TLR5	O
(	O
twofold	O
reduction	O
)	O
,	O
and	O
MD	O
-	O
2	O
(	O
sevenfold	O
reduction	O
)	O
mRNA	O
in	O
CP	O
patients	O
compared	O
to	O
healthy	O
persons	O
,	O
while	O
the	O
level	O
of	O
CD14	O
was	O
unchanged	O
.	O

In	O
vitro	O
studies	O
with	O
human	O
MC	O
indicate	O
that	O
MC	O
respond	O
to	O
an	O
initial	O
stimulus	O
of	O
lipopolysaccharide	O
(	O
LPS	O
)	O
from	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
(	O
PgLPS	O
)	O
or	O
Escherichia	B-bacteria
coli	I-bacteria
(	O
EcLPS	O
)	O
by	O
upregulation	O
of	O
TLR2	O
and	O
TLR4	O
mRNA	O
and	O
protein	O
;	O
moreover	O
,	O
IL	O
-	O
1beta	O
mRNA	O
is	O
induced	O
and	O
tumor	O
necrosis	O
factor	O
alpha	O
(	O
TNF	O
-	O
alpha	O
)	O
,	O
IL	O
-	O
10	O
,	O
IL	O
-	O
6	O
,	O
and	O
IL	O
-	O
8	O
proteins	O
are	O
secreted	O
.	O

However	O
,	O
restimulation	O
of	O
MC	O
with	O
either	O
PgLPS	O
or	O
EcLPS	O
downregulates	O
TLR2	O
and	O
TLR4	O
mRNA	O
and	O
protein	O
and	O
IL	O
-	O
1beta	O
mRNA	O
and	O
induces	O
a	O
ca	O
.	O

10	O
-	O
fold	O
reduction	O
in	O
TNF	O
-	O
alpha	O
secretion	O
,	O
suggesting	O
the	O
induction	O
of	O
endotoxin	O
tolerance	O
by	O
either	O
LPS	O
.	O

Less	O
susceptible	O
to	O
tolerance	O
than	O
TNF	O
-	O
alpha	O
were	O
IL	O
-	O
6	O
,	O
IL	O
-	O
10	O
,	O
and	O
IL	O
-	O
8	O
.	O

These	O
studies	O
suggest	O
that	O
certain	O
components	O
of	O
the	O
innate	O
oral	O
mucosal	O
immune	O
response	O
,	O
most	O
notably	O
TLRs	O
and	O
inflammatory	O
cytokines	O
,	O
may	O
become	O
tolerized	O
during	O
sustained	O
exposure	O
to	O
bacterial	O
structures	O
such	O
as	O
LPS	O
and	O
that	O
this	O
may	O
be	O
one	O
mechanism	O
used	O
in	O
the	O
oral	O
mucosa	O
to	O
attempt	O
to	O
regulate	O
local	O
immune	O
responses	O
.	O

Clinical	O
research	O
assessing	O
different	O
therapeutic	O
protocols	O
aimed	O
at	O
treating	O
oral	O
halitosis	O
is	O
scarce	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
effects	O
of	O
a	O
combined	O
mechanical	O
and	O
pharmacological	O
approach	O
to	O
treat	O
oral	O
halitosis	O
on	O
clinical	O
and	O
microbiological	O
outcomes	O
on	O
patients	O
followed	O
for	O
3	O
months	O
.	O

Nineteen	O
subjects	O
with	O
oral	O
malodor	O
participated	O
.	O

At	O
baseline	O
,	O
all	O
subjects	O
completed	O
a	O
questionnaire	O
and	O
carried	O
out	O
an	O
examination	O
including	O
full	O
-	O
mouth	O
organoleptic	O
and	O
volatile	O
sulfur	O
compound	O
(	O
VSC	O
)	O
levels	O
and	O
the	O
Winkel	O
tongue	O
coating	O
index	O
.	O

Standard	O
periodontal	O
outcome	O
variables	O
were	O
assessed	O
at	O
six	O
teeth	O
.	O

Standardized	O
microbiological	O
samples	O
of	O
subgingival	O
plaque	O
,	O
unstimulated	O
saliva	O
,	O
and	O
tongue	O
coating	O
were	O
obtained	O
for	O
culture	O
analysis	O
.	O

The	O
treatment	O
protocol	O
included	O
supragingival	O
prophylaxis	O
;	O
instructions	O
in	O
oral	O
hygiene	O
(	O
toothbrushing	O
,	O
interproximal	O
cleaning	O
,	O
and	O
tongue	O
scraping	O
)	O
;	O
and	O
gargling	O
with	O
a	O
mouthrinse	O
containing	O
chlorhexidine	O
,	O
cetylpiridinium	O
chloride	O
,	O
and	O
zinc	O
lactate	O
.	O

The	O
same	O
outcome	O
variables	O
were	O
registered	O
1	O
and	O
3	O
months	O
after	O
baseline	O
.	O

Statistically	O
significant	O
reductions	O
in	O
organoleptic	O
scores	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
,	O
VSC	O
levels	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
,	O
and	O
tongue	O
coating	O
index	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
were	O
observed	O
after	O
1	O
and	O
3	O
months	O
.	O

Mean	O
probing	O
depth	O
and	O
plaque	O
levels	O
also	O
demonstrated	O
significant	O
reductions	O
after	O
3	O
months	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

Total	O
anaerobic	O
counts	O
were	O
significantly	O
reduced	O
at	O
all	O
three	O
locations	O
after	O
1	O
month	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
,	O
and	O
in	O
samples	O
from	O
tongue	O
coating	O
and	O
subgingival	O
plaque	O
at	O
3	O
months	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

Aerobic	O
counts	O
were	O
significantly	O
reduced	O
in	O
saliva	O
at	O
1	O
month	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
,	O
and	O
the	O
anaerobic	O
/	O
aerobic	O
ratio	O
significantly	O
increased	O
in	O
the	O
tongue	O
samples	O
.	O

Among	O
the	O
selected	O
pathogens	O
evaluated	O
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
was	O
the	O
most	O
affected	O
of	O
the	O
three	O
microflora	O
evaluated	O
.	O

The	O
evaluated	O
therapeutic	O
approach	O
demonstrated	O
its	O
efficacy	O
in	O
the	O
management	O
of	O
oral	O
halitosis	O
,	O
demonstrating	O
statistically	O
significant	O
improvements	O
in	O
both	O
organoleptic	O
and	O
VSC	O
values	O
at	O
1	O
and	O
3	O
months	O
.	O

The	O
proposed	O
clinical	O
protocol	O
significantly	O
affected	O
the	O
microbial	O
composition	O
in	O
tongue	O
coating	O
,	O
saliva	O
,	O
and	O
subgingival	O
microflora	O
.	O

This	O
study	O
evaluated	O
the	O
in	O
vivo	O
effects	O
of	O
bleaching	O
agents	O
containing	O
10	O
%	O
carbamide	O
peroxide	O
(	O
Platinum	O
/	O
Colgate	O
)	O
or	O
7	O
.	O
5	O
%	O
hydrogen	O
peroxide	O
(	O
Day	O
White	O
2Z	O
/	O
Discus	O
Dental	O
)	O
on	O
mutans	B-bacteria
Streptococcus	I-bacteria
during	O
dental	O
bleaching	O
.	O

The	O
products	O
were	O
applied	O
on	O
30	O
volunteers	O
who	O
needed	O
dental	O
bleaching	O
.	O

In	O
each	O
volunteer	O
,	O
one	O
of	O
the	O
two	O
bleaching	O
agents	O
was	O
used	O
on	O
both	O
dental	O
arches	O
one	O
hour	O
a	O
day	O
for	O
three	O
weeks	O
.	O

Analysis	O
of	O
the	O
bacterial	O
counts	O
was	O
made	O
by	O
collecting	O
saliva	O
before	O
(	O
baseline	O
values	O
)	O
,	O
during	O
(	O
7	O
and	O
21	O
days	O
)	O
bleaching	O
treatments	O
and	O
14	O
days	O
posttreatment	O
.	O

The	O
Friedman	O
non	O
-	O
parametric	O
analysis	O
(	O
alpha	O
=	O
0	O
.	O
05	O
)	O
found	O
no	O
differences	O
in	O
microorganism	O
counts	O
at	O
different	O
times	O
for	O
each	O
group	O
for	O
both	O
agents	O
(	O
p	O
>	O
0	O
.	O
05	O
)	O
.	O

The	O
Mann	O
Whitney	O
nonparametric	O
test	O
(	O
alpha	O
=	O
0	O
.	O
05	O
)	O
showed	O
no	O
differences	O
in	O
micro	O
-	O
organism	O
counts	O
for	O
both	O
agents	O
(	O
p	O
>	O
0	O
.	O
05	O
)	O
.	O

Different	O
bleaching	O
agents	O
did	O
not	O
change	O
the	O
oral	O
cavity	O
mutans	B-bacteria
Streptococcus	I-bacteria
counts	O
.	O

Listeria	B-bacteria
monocytogenes	I-bacteria
is	O
a	O
food	O
-	O
borne	O
pathogen	O
that	O
causes	O
serious	O
listeriosis	O
in	O
humans	O
.	O

Antimicrobial	O
effects	O
of	O
human	O
lactoferrin	O
(	O
hLF	O
)	O
against	O
L	B-bacteria
.	I-bacteria
monocytogenes	I-bacteria
have	O
been	O
clearly	O
demonstrated	O
in	O
in	O
vitro	O
studies	O
.	O

However	O
,	O
in	O
vivo	O
studies	O
have	O
not	O
been	O
reported	O
yet	O
.	O

This	O
study	O
investigated	O
whether	O
the	O
oral	O
administration	O
of	O
hLF	O
could	O
inhibit	O
oral	O
infection	O
of	O
listeria	B-bacteria
in	O
BALB	O
/	O
c	O
mice	O
.	O

The	O
MICs	O
for	O
several	O
strains	O
of	O
L	B-bacteria
.	I-bacteria
monocytogenes	I-bacteria
were	O
determined	O
,	O
and	O
the	O
most	O
sensitive	O
strain	O
was	O
used	O
for	O
the	O
animal	O
work	O
.	O

hLF	O
was	O
administered	O
to	O
BALB	O
/	O
c	O
mice	O
for	O
7	O
days	O
,	O
commencing	O
4	O
days	O
before	O
oral	O
infection	O
.	O

The	O
effect	O
of	O
hLF	O
was	O
determined	O
by	O
bacterial	O
enumeration	O
and	O
histopathological	O
analysis	O
of	O
the	O
liver	O
and	O
spleen	O
,	O
which	O
are	O
well	O
-	O
known	O
as	O
the	O
major	O
targets	O
of	O
oral	O
listeria	B-bacteria
infection	O
in	O
mice	O
.	O

In	O
bacterial	O
enumeration	O
,	O
hLF	O
decreased	O
the	O
number	O
of	O
L	B-bacteria
.	I-bacteria
monocytogenes	I-bacteria
cells	O
in	O
the	O
liver	O
.	O

Histopathologically	O
,	O
the	O
size	O
and	O
frequency	O
of	O
necrotic	O
foci	O
in	O
the	O
liver	O
samples	O
decreased	O
with	O
hLF	O
administration	O
.	O

However	O
,	O
these	O
changes	O
were	O
not	O
observed	O
in	O
the	O
spleen	O
samples	O
.	O

The	O
mRNA	O
levels	O
of	O
inflammatory	O
cytokines	O
,	O
such	O
as	O
interleukin	O
(	O
IL	O
)	O
-	O
1beta	O
,	O
tumour	O
necrosis	O
factor	O
(	O
TNF	O
)	O
-	O
alpha	O
and	O
interferon	O
(	O
IFN	O
)	O
-	O
gamma	O
,	O
decreased	O
in	O
the	O
liver	O
of	O
mice	O
receiving	O
hLF	O
.	O

This	O
study	O
has	O
shown	O
that	O
hLF	O
decreases	O
the	O
hepatic	O
colonization	O
of	O
L	B-bacteria
.	I-bacteria
monocytogenes	I-bacteria
,	O
hepatic	O
necrosis	O
and	O
expression	O
of	O
inflammatory	O
cytokines	O
.	O

It	O
revealed	O
that	O
perorally	O
given	O
hLF	O
could	O
mediate	O
antimicrobial	O
and	O
anti	O
-	O
inflammatory	O
activities	O
remote	O
from	O
the	O
gut	O
(	O
i	O
.	O
e	O
.	O

in	O
the	O
liver	O
)	O
of	O
mice	O
challenged	O
with	O
L	B-bacteria
.	I-bacteria
monocytogenes	I-bacteria
.	O

Oral	O
administration	O
of	O
microcapsules	O
containing	O
live	O
bacterial	O
cells	O
has	O
potential	O
as	O
an	O
alternative	O
therapy	O
for	O
several	O
diseases	O
.	O

This	O
article	O
evaluates	O
the	O
suitability	O
of	O
the	O
alginate	O
-	O
poly	O
-	O
L	O
-	O
lysine	O
-	O
alginate	O
(	O
APA	O
)	O
microcapsules	O
for	O
oral	O
delivery	O
of	O
live	O
bacterial	O
cells	O
,	O
in	O
-	O
vitro	O
,	O
using	O
a	O
dynamic	O
simulated	O
human	O
gastro	O
-	O
intestinal	O
(	O
GI	O
)	O
model	O
.	O

Results	O
showed	O
that	O
the	O
APA	O
microcapsules	O
were	O
morphologically	O
stable	O
in	O
the	O
simulated	O
stomach	O
conditions	O
,	O
but	O
did	O
not	O
retain	O
their	O
structural	O
integrity	O
after	O
a	O
3	O
-	O
day	O
exposure	O
in	O
simulated	O
human	O
GI	O
media	O
.	O

The	O
microbial	O
populations	O
of	O
the	O
tested	O
bacterial	O
cells	O
and	O
the	O
activities	O
of	O
the	O
tested	O
enzymes	O
in	O
the	O
simulated	O
human	O
GI	O
suspension	O
were	O
not	O
substantially	O
altered	O
by	O
the	O
presence	O
of	O
the	O
APA	O
microcapsules	O
,	O
suggesting	O
that	O
there	O
were	O
no	O
significant	O
adverse	O
effects	O
of	O
oral	O
administration	O
of	O
the	O
APA	O
microcapsules	O
on	O
the	O
flora	O
of	O
the	O
human	O
gastrointestinal	O
tract	O
.	O

When	O
the	O
APA	O
microcapsules	O
containing	O
Lactobacillus	B-bacteria
plantarum	I-bacteria
80	I-bacteria
(	O
LP80	B-bacteria
)	O
were	O
challenged	O
in	O
the	O
simulated	O
gastric	O
medium	O
(	O
pH	O
=	O
2	O
.	O
0	O
)	O
,	O
80	O
.	O
0	O
%	O
of	O
the	O
encapsulated	O
cells	O
remained	O
viable	O
after	O
a	O
5	O
-	O
min	O
incubation	O
;	O
however	O
,	O
the	O
viability	O
decreased	O
considerably	O
(	O
8	O
.	O
3	O
%	O
)	O
after	O
15	O
min	O
and	O
dropped	O
to	O
2	O
.	O
6	O
%	O
after	O
30	O
min	O
and	O
lower	O
than	O
0	O
.	O
2	O
%	O
after	O
60	O
min	O
,	O
indicating	O
the	O
limitations	O
of	O
the	O
currently	O
obtainable	O
APA	O
membrane	O
for	O
oral	O
delivery	O
of	O
live	O
bacteria	O
.	O

Further	O
in	O
-	O
vivo	O
studies	O
are	O
required	O
before	O
conclusions	O
can	O
be	O
made	O
concerning	O
the	O
inadequacy	O
of	O
APA	O
microcapsules	O
for	O
oral	O
delivery	O
of	O
live	O
bacterial	O
cells	O
.	O

The	O
microbiota	O
of	O
the	O
human	O
stomach	O
and	O
the	O
influence	O
of	O
Helicobacter	B-bacteria
pylori	I-bacteria
colonization	O
on	O
its	O
composition	O
remain	O
largely	O
unknown	O
.	O

We	O
characterized	O
bacterial	O
diversity	O
within	O
the	O
human	O
gastric	O
mucosa	O
by	O
using	O
a	O
small	O
subunit	O
16S	O
rDNA	O
clone	O
library	O
approach	O
and	O
analyzed	O
1	O
,	O
833	O
sequences	O
generated	O
by	O
broad	O
-	O
range	O
bacterial	O
PCR	O
from	O
23	O
gastric	O
endoscopic	O
biopsy	O
samples	O
.	O

A	O
diverse	O
community	O
of	O
128	O
phylotypes	O
was	O
identified	O
,	O
featuring	O
diversity	O
at	O
this	O
site	O
greater	O
than	O
previously	O
described	O
.	O

The	O
majority	O
of	O
sequences	O
were	O
assigned	O
to	O
the	O
Proteobacteria	B-bacteria
,	O
Firmicutes	B-bacteria
,	O
Actinobacteria	B-bacteria
,	O
Bacteroidetes	B-bacteria
,	O
and	O
Fusobacteria	B-bacteria
phyla	I-bacteria
.	O

Ten	O
percent	O
of	O
the	O
phylotypes	O
were	O
previously	O
uncharacterized	O
,	O
including	O
a	O
Deinococcus	O
-	O
related	O
organism	O
,	O
relatives	O
of	O
which	O
have	O
been	O
found	O
in	O
extreme	O
environments	O
but	O
not	O
reported	O
before	O
in	O
humans	O
.	O

The	O
gastric	O
clone	O
libraries	O
from	O
19	O
subjects	O
contained	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
rDNA	O
;	O
however	O
,	O
only	O
12	O
of	O
these	O
subjects	O
tested	O
positive	O
for	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
by	O
conventional	O
laboratory	O
methods	O
.	O

Statistical	O
analysis	O
revealed	O
a	O
large	O
degree	O
of	O
intersubject	O
variability	O
of	O
the	O
gastric	O
ecosystem	O
.	O

The	O
presence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
did	O
not	O
affect	O
the	O
composition	O
of	O
the	O
gastric	O
community	O
.	O

This	O
gastric	O
bacterial	O
rDNA	O
data	O
set	O
was	O
significantly	O
different	O
from	O
sequence	O
collections	O
of	O
the	O
human	O
mouth	O
and	O
esophagus	O
described	O
in	O
other	O
studies	O
,	O
indicating	O
that	O
the	O
human	O
stomach	O
may	O
be	O
home	O
to	O
a	O
distinct	O
microbial	O
eco	O
-	O
system	O
.	O

The	O
gastric	O
microbiota	O
may	O
play	O
important	O
,	O
as	O
-	O
yet	O
-	O
undiscovered	O
roles	O
in	O
human	O
health	O
and	O
disease	O
.	O

The	O
aim	O
of	O
this	O
work	O
was	O
to	O
study	O
clinical	O
changes	O
and	O
microorganisms	O
in	O
mouths	O
of	O
three	O
patient	O
groups	O
:	O
with	O
congenital	O
disorders	O
(	O
Cd	O
)	O
,	O
dialyzed	O
(	O
D	O
)	O
and	O
control	O
(	O
C	O
)	O
.	O

Fifty	O
five	O
patients	O
,	O
20	O
to	O
62	O
years	O
old	O
were	O
assessed	O
.	O

Swabs	O
and	O
samples	O
of	O
periodontal	O
tissue	O
were	O
used	O
for	O
microscopical	O
study	O
to	O
detect	O
of	O
protozoans	O
and	O
for	O
bacterial	O
and	O
fungal	O
cultures	O
.	O

E	O
.	O
gingivalis	O
and	O
T	O
.	O
tenax	O
were	O
found	O
in	O
all	O
groups	O
.	O

Three	O
out	O
of	O
Cd	O
patients	O
were	O
infected	O
with	O
Acanthamoeba	O
sp	O
.	O
.	O

Fecal	O
bacteria	O
were	O
more	O
often	O
found	O
in	O
D	O
than	O
Cd	O
.	O

In	O
all	O
30	O
-	O
40	O
years	O
old	O
D	O
patients	O
,	O
fecal	O
bacteria	O
and	O
various	O
strains	O
of	O
C	O
.	O
albicans	O
occurred	O
.	O

We	O
found	O
that	O
systemic	O
diseases	O
favour	O
instabilities	O
in	O
mouths	O
changing	O
interrelations	O
between	O
protozoa	O
,	O
bacteria	O
and	O
fungi	O
.	O

It	O
may	O
increase	O
risk	O
of	O
clinical	O
complications	O
.	O

Artemisia	O
princeps	O
Pampanini	O
,	O
which	O
is	O
called	O
Ssajuarissuk	O
in	O
Korean	O
(	O
SS	O
-	O
1	O
)	O
,	O
was	O
fermented	O
with	O
lactic	B-bacteria
acid	I-bacteria
bacteria	I-bacteria
(	O
LAB	B-bacteria
)	O
and	O
their	O
passive	O
cutaneous	O
anaphylaxis	O
reaction	O
-	O
inhibitory	O
activity	O
was	O
investigated	O
.	O

Of	O
these	O
fermented	O
agents	O
,	O
SS	O
-	O
1	O
extract	O
fermented	O
with	O
Bifidobacterium	B-bacteria
infantis	I-bacteria
K	I-bacteria
-	I-bacteria
525		I-bacteria
(	O
F	O
-	O
SS	O
-	O
1	O
)	O
most	O
effectively	O
inhibited	O
the	O
release	O
of	O
P	O
-	O
hexosamindase	O
from	O
RBL	O
-	O
2H3	O
cells	O
induced	O
IgE	O
.	O

In	O
IgE	O
-	O
induced	O
RBL	O
-	O
2H3	O
cells	O
,	O
F	O
-	O
SS	O
-	O
1	O
inhibited	O
proinflammatory	O
cytokines	O
IL	O
-	O
6	O
and	O
TNF	O
-	O
alpha	O
mRNA	O
expression	O
.	O

Oral	O
administration	O
of	O
SS	O
-	O
1	O
and	O
F	O
-	O
SS	O
-	O
1	O
to	O
mice	O
inhibited	O
passive	O
cutaneous	O
anaphylaxis	O
(	O
PCA	O
)	O
reaction	O
induced	O
by	O
IgE	O
and	O
scratching	O
behaviors	O
induced	O
by	O
compound	O
48	O
/	O
80	O
.	O

The	O
inhibitory	O
activity	O
of	O
F	O
-	O
SS	O
-	O
1	O
against	O
scratching	O
behaviors	O
was	O
more	O
effective	O
than	O
that	O
of	O
SS	O
-	O
1	O
.	O

These	O
findings	O
suggest	O
that	O
the	O
fermentation	O
of	O
SS	O
-	O
1	O
with	O
LAB	B-bacteria
can	O
increase	O
its	O
antiallergic	O
activity	O
.	O

Squamous	O
cell	O
carcinomas	O
of	O
the	O
upper	O
aerodigestive	O
tract	O
are	O
a	O
global	O
health	O
-	O
political	O
challenge	O
.	O

Accordingly	O
,	O
current	O
research	O
efforts	O
are	O
aimed	O
towards	O
the	O
opportunities	O
for	O
early	O
recognition	O
of	O
risk	O
patients	O
,	O
and	O
at	O
the	O
recognition	O
of	O
risk	O
factors	O
related	O
to	O
carcinogenesis	O
.	O

We	O
determined	O
the	O
revertant	O
number	O
of	O
the	O
variety	O
Salmonella	B-bacteria
typhimurium	I-bacteria
TA	I-bacteria
98	I-bacteria
and	O
TA	B-bacteria
100	I-bacteria
after	O
incubation	O
,	O
with	O
saliva	O
samples	O
from	O
100	O
probands	O
as	O
a	O
measure	O
of	O
a	O
genotoxic	O
environment	O
within	O
the	O
oral	O
cavity	O
,	O
depending	O
on	O
the	O
dental	O
status	O
as	O
measure	O
of	O
oral	O
health	O
.	O

Beside	O
chronic	O
alcohol	O
(	O
p	O
=	O
0	O
.	O
032	O
)	O
and	O
tobacco	O
consumption	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
the	O
dental	O
status	O
displayed	O
in	O
partial	O
aspects	O
(	O
high	O
plaque	O
index	O
,	O
high	O
number	O
of	O
decayed	O
teeth	O
,	O
prosthetically	O
not	O
rehabilitated	O
status	O
,	O
p	O
<	O
or	O
=	O
0	O
.	O
050	O
)	O
a	O
significant	O
connection	O
with	O
the	O
genotoxic	O
salivary	O
activity	O
.	O

The	O
periodontal	O
status	O
and	O
the	O
type	O
of	O
restorative	O
filling	O
material	O
,	O
as	O
well	O
as	O
dental	O
prostheses	O
,	O
however	O
,	O
had	O
no	O
important	O
influence	O
on	O
the	O
revertant	O
number	O
(	O
p	O
>	O
or	O
=	O
0	O
.	O
104	O
)	O
.	O

Therefore	O
,	O
it	O
can	O
be	O
concluded	O
that	O
the	O
polymicrobial	O
supragingival	O
plaque	O
,	O
as	O
a	O
possible	O
independent	O
factor	O
,	O
possesses	O
a	O
relevant	O
mutagenic	O
interaction	O
with	O
saliva	O
,	O
and	O
that	O
individual	O
oral	O
health	O
is	O
a	O
co	O
-	O
factor	O
in	O
the	O
development	O
of	O
carcinomas	O
in	O
the	O
oral	O
cavity	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
microbiota	O
of	O
noncaries	O
associated	O
supra	O
-	O
gingival	O
plaque	O
(	O
SGP	O
)	O
microbiology	O
in	O
Sjogren	O
'	O
s	O
syndrome	O
(	O
SS	O
)	O
.	O

Stimulated	O
whole	O
saliva	O
(	O
SWS	O
)	O
and	O
full	O
-	O
mouth	O
SGP	O
on	O
intact	O
tooth	O
surfaces	O
were	O
collected	O
from	O
26	O
primary	O
(	O
p	O
)	O
SS	O
,	O
27	O
secondary	O
(	O
s	O
)	O
SS	O
,	O
and	O
29	O
control	O
subjects	O
for	O
selective	O
culture	O
of	O
lactobacilli	B-bacteria
,	O
mutans	B-bacteria
streptococci	I-bacteria
,	O
and	O
aerobic	O
and	O
facultatively	O
anaerobic	O
gram	O
-	O
negative	O
rods	O
(	O
AGNR	O
)	O
.	O

Predominant	O
cultivable	O
anaerobes	O
from	O
SGP	O
of	O
11	O
randomly	O
selected	O
subjects	O
from	O
each	O
group	O
were	O
investigated	O
.	O

Clinical	O
and	O
sialometric	O
data	O
were	O
also	O
collected	O
.	O

SS	O
sufferers	O
had	O
significantly	O
lower	O
SWS	O
flow	O
rate	O
and	O
higher	O
mean	O
DMFT	O
(	O
decayed	O
,	O
missing	O
,	O
filled	O
teeth	O
)	O
,	O
while	O
pSS	O
subjects	O
also	O
had	O
lower	O
SWS	O
pH	O
and	O
fewer	O
standing	O
teeth	O
.	O

Lactobacillus	B-bacteria
acidophilus	I-bacteria
levels	O
in	O
SWS	O
(	O
P	O
=	O
0	O
.	O
012	O
)	O
and	O
SGP	O
(	O
P	O
<	O
0	O
.	O
0001	O
)	O
were	O
significantly	O
elevated	O
in	O
pSS	O
sufferers	O
compared	O
with	O
sSS	O
individuals	O
and	O
controls	O
.	O

AGNR	O
isolation	O
was	O
uncommon	O
.	O

SS	O
sufferers	O
had	O
significantly	O
lower	O
proportion	O
of	O
gram	O
-	O
negative	O
species	O
(	O
P	O
=	O
0	O
.	O
047	O
)	O
.	O

Non	O
-	O
oral	O
species	O
were	O
isolated	O
in	O
greater	O
proportions	O
from	O
pSS	O
SGP	O
(	O
P	O
=	O
0	O
.	O
007	O
)	O
.	O

Subjects	O
with	O
pSS	O
harbored	O
increased	O
levels	O
of	O
L	B-bacteria
.	I-bacteria
acidophilus	I-bacteria
and	O
non	O
-	O
oral	O
species	O
,	O
while	O
SS	O
sufferers	O
generally	O
had	O
lower	O
proportions	O
of	O
gram	O
-	O
negative	O
species	O
.	O

The	O
microbial	O
composition	O
of	O
noncaries	O
associated	O
SGP	O
indicates	O
a	O
potential	O
source	O
of	O
increased	O
caries	O
risk	O
in	O
SS	O
.	O

New	O
molecules	O
were	O
designed	O
for	O
efficient	O
intra	O
-	O
oral	O
delivery	O
of	O
antimicrobials	O
to	O
prevent	O
and	O
treat	O
oral	O
infection	O
.	O

The	O
salivary	O
statherin	O
fragment	O
,	O
which	O
has	O
high	O
affinity	O
for	O
the	O
tooth	O
enamel	O
,	O
was	O
used	O
as	O
a	O
carrier	O
peptide	O
.	O

This	O
was	O
linked	O
through	O
the	O
side	O
chain	O
of	O
the	O
N	O
-	O
terminal	O
residue	O
to	O
the	O
C	O
-	O
terminus	O
of	O
a	O
defensin	O
-	O
like	O
12	O
-	O
residue	O
peptide	O
to	O
generate	O
two	O
bifunctional	O
hybrid	O
molecules	O
,	O
one	O
with	O
an	O
ester	O
linkage	O
and	O
the	O
other	O
with	O
an	O
anhydride	O
bond	O
between	O
the	O
carrier	O
and	O
the	O
antimicrobial	O
components	O
.	O

They	O
were	O
examined	O
for	O
their	O
affinity	O
to	O
a	O
HAP	O
(	O
hydroxyapatite	O
)	O
surface	O
.	O

The	O
extent	O
of	O
the	O
antimicrobial	O
release	O
in	O
human	O
whole	O
saliva	O
was	O
determined	O
using	O
13C	O
-	O
NMR	O
spectroscopy	O
.	O

The	O
candidacidal	O
activity	O
of	O
the	O
molecules	O
was	O
determined	O
as	O
a	O
function	O
of	O
the	O
antimicrobial	O
release	O
from	O
the	O
carrier	O
peptide	O
in	O
human	O
saliva	O
.	O

The	O
hybrid	O
-	O
adsorbed	O
HAP	O
surface	O
was	O
examined	O
against	O
Candida	O
albicans	O
and	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
using	O
the	O
fluorescence	O
technique	O
.	O

The	O
bifunctional	O
molecules	O
were	O
tested	O
on	O
human	O
erythrocytes	O
,	O
GECs	O
(	O
gingival	O
epithelial	O
cells	O
)	O
and	O
GFCs	O
(	O
gingival	O
fibroblast	O
cells	O
)	O
for	O
cytotoxicity	O
.	O

They	O
were	O
found	O
to	O
possess	O
high	O
affinity	O
for	O
the	O
HAP	O
mineral	O
.	O

In	O
human	O
whole	O
saliva	O
,	O
a	O
sustained	O
antimicrobial	O
release	O
over	O
a	O
period	O
of	O
more	O
than	O
40	O
-	O
60	O
h	O
,	O
and	O
candidacidal	O
activity	O
consistent	O
with	O
the	O
extent	O
of	O
hybrid	O
dissociation	O
were	O
observed	O
.	O

Moreover	O
,	O
the	O
bifunctional	O
peptide	O
-	O
bound	O
HAP	O
surface	O
was	O
found	O
to	O
exhibit	O
antimicrobial	O
activity	O
when	O
suspended	O
in	O
clarified	O
human	O
saliva	O
.	O

The	O
hybrid	O
peptides	O
did	O
not	O
show	O
any	O
toxic	O
influence	O
on	O
human	O
erythrocytes	O
,	O
GECs	O
and	O
GFCs	O
.	O

These	O
novel	O
hybrids	O
could	O
be	O
safely	O
used	O
to	O
deliver	O
therapeutic	O
agents	O
intra	O
-	O
orally	O
for	O
the	O
treatment	O
and	O
prevention	O
of	O
oral	O
infectious	O
diseases	O
.	O

Human	O
papillomavirus	O
type	O
16	O
L1	O
(	O
HPV16	O
L1	O
)	O
has	O
shown	O
considerable	O
promise	O
as	O
a	O
parenteral	O
vaccine	O
for	O
prevention	O
of	O
cervical	O
cancers	O
.	O

Here	O
,	O
we	O
report	O
the	O
possibility	O
of	O
oral	O
vaccination	O
for	O
HPV16	O
L1	O
using	O
Lactococcus	B-bacteria
lactis	I-bacteria
(	O
L	B-bacteria
.	I-bacteria
lactis	I-bacteria
)	O
as	O
a	O
live	O
vector	O
.	O

L	B-bacteria
.	I-bacteria
lactis	I-bacteria
MG1363	I-bacteria
was	O
transformed	O
with	O
two	O
types	O
of	O
HPV16	O
L1	O
-	O
encoding	O
plasmids	O
for	O
intracellular	O
expression	O
or	O
secretion	O
.	O

L	B-bacteria
.	I-bacteria
lactis	I-bacteria
transformed	O
with	O
HPV16	O
L1	O
-	O
encoding	O
plasmids	O
retained	O
biochemical	O
lactic	O
acid	O
production	O
capability	O
.	O

The	O
mucosal	O
and	O
systemic	O
immune	O
responses	O
were	O
affected	O
by	O
the	O
cellular	O
location	O
of	O
expressed	O
HPV16	O
L1	O
proteins	O
in	O
L	B-bacteria
.	I-bacteria
lactis	I-bacteria
.	O

Serum	O
IgG	O
responses	O
were	O
induced	O
after	O
oral	O
immunizations	O
of	O
L	B-bacteria
.	I-bacteria
lactis	I-bacteria
secreting	O
HPV16	O
L1	O
.	O

Vaginal	O
IgA	O
immune	O
responses	O
were	O
observed	O
following	O
oral	O
immunization	O
with	O
L	B-bacteria
.	I-bacteria
lactis	I-bacteria
expressing	O
HPV16	O
L1	O
in	O
an	O
intracellular	O
form	O
,	O
but	O
not	O
with	O
L	B-bacteria
.	I-bacteria
lactis	I-bacteria
secreting	O
HPV16	O
L1	O
.	O

Furthermore	O
,	O
induction	O
of	O
HPV16	O
L1	O
-	O
specific	O
mucosal	O
immune	O
responses	O
was	O
affected	O
by	O
immunization	O
frequency	O
.	O

Six	O
immunizations	O
over	O
5	O
weeks	O
were	O
required	O
to	O
induce	O
vaginal	O
immune	O
responses	O
.	O

The	O
levels	O
of	O
HPV16	O
L1	O
-	O
specific	O
vaginal	O
IgA	O
were	O
maintained	O
until	O
12	O
weeks	O
after	O
the	O
first	O
vaccination	O
.	O

These	O
results	O
suggest	O
the	O
feasibility	O
of	O
L	B-bacteria
.	I-bacteria
lactis	I-bacteria
as	O
an	O
oral	O
vaccine	O
vehicle	O
of	O
HPV16	O
L1	O
and	O
demonstrate	O
the	O
importance	O
of	O
cellular	O
loci	O
of	O
expressed	O
antigen	O
for	O
induction	O
of	O
vaginal	O
and	O
systemic	O
immune	O
responses	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
examine	O
the	O
presence	O
of	O
bacteria	O
in	O
synovial	O
fluids	O
from	O
patients	O
with	O
temporomandibular	O
joint	O
disorder	O
(	O
TMD	O
)	O
by	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
targeting	O
the	O
16S	O
ribosomal	O
RNA	O
(	O
rRNA	O
)	O
gene	O
,	O
followed	O
by	O
cloning	O
and	O
sequencing	O
.	O

Universal	O
bacterial	O
primers	O
were	O
used	O
to	O
amplify	O
16S	O
rRNA	O
genes	O
in	O
28	O
synovial	O
fluid	O
samples	O
from	O
27	O
patients	O
with	O
TMD	O
(	O
TMD	O
group	O
)	O
as	O
well	O
as	O
control	O
subjects	O
:	O
5	O
patients	O
with	O
dislocation	O
of	O
TMJ	O
(	O
non	O
-	O
TMD	O
group	O
)	O
.	O

Subsequently	O
,	O
PCR	O
amplicons	O
were	O
purified	O
and	O
cloned	O
.	O

Partial	O
16S	O
rRNA	O
sequences	O
of	O
the	O
cloned	O
insert	O
were	O
used	O
to	O
determine	O
the	O
species	O
identities	O
or	O
closest	O
relative	O
by	O
comparison	O
with	O
known	O
sequences	O
using	O
GeneBank	O
.	O

Nineteen	O
(	O
67	O
.	O
86	O
%	O
)	O
of	O
28	O
samples	O
from	O
patients	O
in	O
the	O
TMD	O
group	O
were	O
identified	O
with	O
the	O
presence	O
of	O
bacterial	O
DNA	O
by	O
PCR	O
.	O

The	O
5	O
control	O
samples	O
from	O
the	O
nonTMD	O
group	O
were	O
all	O
negative	O
in	O
this	O
study	O
.	O

After	O
cloning	O
and	O
sequencing	O
,	O
a	O
total	O
of	O
11	O
bacterial	O
species	O
was	O
detected	O
,	O
including	O
Granulicatella	B-bacteria
adiacen	I-bacteria
(	O
6	O
samples	O
)	O
,	O
Pseudomonas	B-bacteria
sp	I-bacteria
.	I-bacteria
(	O
6	O
samples	O
)	O
,	O
Methylobacterium	B-bacteria
sp	I-bacteria
.	I-bacteria
(	O
5	O
samples	O
)	O
,	O
and	O
Beta	B-bacteria
proteobacterium	I-bacteria
(	O
4	O
samples	O
)	O
.	O

Other	O
species	O
,	O
such	O
as	O
Acidovorax	B-bacteria
sp	I-bacteria
.	I-bacteria
,	O
Bradyrhizobium	B-bacteria
sp	I-bacteria
.	I-bacteria
,	O
Sphingomonas	B-bacteria
,	O
Streptococcus	B-bacteria
,	O
Leptothrix	B-bacteria
sp	I-bacteria
.	I-bacteria
oral	I-bacteria
clone	I-bacteria
,	O
Thiobacillus	B-bacteria
denitrificans	I-bacteria
,	O
and	O
Comamonadaceae	B-bacteria
bacterium	I-bacteria
,	O
were	O
also	O
identified	O
.	O

Eight	O
patients	O
were	O
found	O
with	O
mixed	O
bacteria	O
,	O
with	O
2	O
-	O
4	O
bacteria	O
per	O
sample	O
.	O

The	O
patients	O
with	O
fastidious	O
bacteria	O
such	O
as	O
Granulicatella	B-bacteria
adiacen	I-bacteria
and	O
mixed	O
bacteria	O
were	O
more	O
likely	O
to	O
be	O
older	O
than	O
45	O
years	O
(	O
P	O
<	O
.	O
05	O
)	O
.	O

A	O
wide	O
variety	O
of	O
bacteria	O
,	O
including	O
some	O
not	O
previously	O
reported	O
associated	O
with	O
TMD	O
,	O
were	O
identified	O
in	O
the	O
synovial	O
fluids	O
from	O
patients	O
with	O
TMD	O
.	O

Actinomyces	B-bacteria
are	O
members	O
of	O
the	O
indigenous	O
oral	O
microbiota	O
which	O
have	O
been	O
implicated	O
in	O
root	O
caries	O
,	O
but	O
their	O
role	O
in	O
childhood	O
caries	O
initiation	O
and	O
progression	O
is	O
not	O
well	O
-	O
understood	O
.	O

The	O
distribution	O
of	O
Actinomyces	B-bacteria
in	O
supragingival	O
plaque	O
on	O
the	O
primary	O
teeth	O
and	O
the	O
relationship	O
between	O
oral	O
Actinomyces	B-bacteria
spp	I-bacteria
.	I-bacteria
and	O
childhood	O
caries	O
primarily	O
were	O
investigated	O
.	O

Forty	O
children	O
aged	O
from	O
three	O
to	O
five	O
years	O
old	O
were	O
divided	O
into	O
two	O
groups	O
.	O

Twenty	O
children	O
were	O
caries	O
-	O
free	O
and	O
twenty	O
were	O
caries	O
-	O
susceptible	O
.	O

Dental	O
plaque	O
samples	O
from	O
different	O
places	O
of	O
the	O
teeth	O
were	O
collected	O
with	O
sterile	O
toothpick	O
and	O
polymerase	O
chain	O
reaction	O
was	O
performed	O
with	O
specific	O
primers	O
which	O
were	O
designed	O
for	O
this	O
research	O
.	O

Actinomyces	B-bacteria
spp	I-bacteria
.	I-bacteria
were	O
detected	O
100	O
%	O
in	O
the	O
caries	O
-	O
free	O
group	O
,	O
while	O
95	O
%	O
in	O
the	O
caries	O
-	O
susceptible	O
group	O
.	O

There	O
was	O
no	O
significant	O
differences	O
between	O
the	O
two	O
groups	O
(	O
P	O
>	O
0	O
.	O
05	O
)	O
.	O

Actinomyces	B-bacteria
naeslundii	I-bacteria
,	O
Actinomyces	B-bacteria
odontolyticus	I-bacteria
,	O
Actinomyces	B-bacteria
gerencseriae	I-bacteria
,	O
Actinomyces	B-bacteria
israelii	I-bacteria
and	O
Actinomyces	B-bacteria
viscosus	I-bacteria
all	O
could	O
be	O
detected	O
in	O
both	O
groups	O
.	O

The	O
prevalence	O
of	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
,	O
Actinomyces	B-bacteria
gerencseriae	I-bacteria
and	O
Actinomyces	B-bacteria
odontolyticus	I-bacteria
were	O
higher	O
in	O
caries	O
-	O
free	O
group	O
than	O
those	O
in	O
caries	O
-	O
susceptible	O
group	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
,	O
while	O
the	O
prevalence	O
of	O
Actinomyces	B-bacteria
israelii	I-bacteria
and	O
Actinomyces	B-bacteria
viscosus	I-bacteria
had	O
no	O
significant	O
difference	O
between	O
the	O
two	O
groups	O
(	O
P	O
>	O
0	O
.	O
05	O
)	O
.	O

Actinomyces	B-bacteria
is	O
the	O
main	O
colonized	O
bacteria	O
in	O
the	O
supragingival	O
plaque	O
of	O
children	O
.	O

The	O
prevalence	O
of	O
the	O
Actinomyces	B-bacteria
spp	I-bacteria
.	I-bacteria
may	O
have	O
a	O
negative	O
relationship	O
with	O
the	O
childhood	O
caries	O
,	O
and	O
has	O
nothing	O
to	O
do	O
with	O
different	O
places	O
of	O
the	O
teeth	O
.	O

The	O
use	O
of	O
vaccines	O
against	O
infectious	O
microbes	O
has	O
been	O
critical	O
to	O
the	O
advancement	O
of	O
medicine	O
.	O

Vaccine	O
strategies	O
combined	O
with	O
,	O
or	O
without	O
,	O
adjuvants	O
have	O
been	O
established	O
to	O
eradicate	O
various	O
bacterial	O
and	O
viral	O
pathogens	O
.	O

A	O
new	O
generation	O
of	O
vaccines	O
is	O
being	O
developed	O
using	O
specific	O
strains	O
of	O
Gram	O
-	O
positive	O
,	O
lactic	B-bacteria
acid	I-bacteria
bacteria	I-bacteria
and	O
,	O
notably	O
,	O
some	O
probiotic	O
lactobacilli	B-bacteria
.	O

These	O
bacteria	O
have	O
been	O
safely	O
consumed	O
by	O
humans	O
for	O
centuries	O
in	O
fermented	O
foods	O
.	O

Thus	O
,	O
they	O
can	O
be	O
orally	O
administered	O
,	O
are	O
well	O
tolerated	O
by	O
recipients	O
and	O
could	O
be	O
easily	O
and	O
economically	O
provided	O
to	O
large	O
populations	O
.	O

In	O
this	O
overview	O
,	O
we	O
focus	O
on	O
mucosal	O
immunity	O
and	O
how	O
its	O
cellular	O
component	O
(	O
s	O
)	O
,	O
particularly	O
dendritic	O
cells	O
,	O
can	O
be	O
specifically	O
targeted	O
to	O
deliver	O
immunogenic	O
subunits	O
,	O
such	O
as	O
the	O
protective	O
antigen	O
from	O
Bacillus	B-bacteria
anthracis	I-bacteria
(	O
the	O
causative	O
agent	O
of	O
anthrax	O
)	O
.	O

An	O
antigen	O
-	O
specific	O
immune	O
response	O
can	O
be	O
elicited	O
using	O
specific	O
strains	O
of	O
Lactobacillus	B-bacteria
acidophilus	I-bacteria
expressing	O
the	O
protective	O
antigen	O
.	O

A	O
mucosal	O
,	O
dendritic	O
cell	O
-	O
targeted	O
approach	O
increases	O
the	O
bioavailability	O
of	O
an	O
immunogen	O
of	O
interest	O
when	O
delivered	O
orally	O
by	O
L	B-bacteria
.	I-bacteria
acidophilus	I-bacteria
.	O

This	O
provides	O
an	O
efficiently	O
elegant	O
natural	O
strategy	O
and	O
serves	O
a	O
dual	O
function	O
as	O
an	O
immune	O
-	O
stimulating	O
adjuvant	O
in	O
vivo	O
.	O

To	O
analyze	O
the	O
localization	O
of	O
attenuated	O
Salmonella	B-bacteria
typhimurium	I-bacteria
after	O
oral	O
immunization	O
.	O

Prokaryotic	O
expression	O
plasmid	O
pYA33	O
-	O
DsRed	O
,	O
carrying	O
the	O
RFP	O
gene	O
,	O
was	O
constructed	O
and	O
electro	O
-	O
transformed	O
into	O
an	O
attenuated	O
strain	O
X4550	B-bacteria
of	O
Salmonella	B-bacteria
typhimurium	I-bacteria
,	O
the	O
recombinant	O
bacteria	O
were	O
named	O
as	O
X4550	B-bacteria
(	O
33	O
-	O
DsRed	O
)	O
.	O

The	O
macrophage	O
cell	O
line	O
RAW264	O
.	O
7	O
and	O
bone	O
marrow	O
dendritic	O
cell	O
(	O
BMDC	O
)	O
were	O
invaded	O
by	O
X4550	B-bacteria
(	O
33	O
-	O
DsRed	O
)	O
in	O
vitro	O
.	O

Furthermore	O
,	O
BALB	O
/	O
c	O
mice	O
were	O
immunized	O
with	O
recombinant	O
bacteria	O
orally	O
.	O

RFP	O
positive	O
cells	O
(	O
RFP	O
+	O
cells	O
)	O
were	O
detected	O
by	O
Flow	O
Cytometry	O
(	O
FCM	O
)	O
from	O
spleen	O
,	O
liver	O
,	O
Mesenteric	O
lymp	O
node	O
(	O
MLN	O
)	O
,	O
Peyer	O
'	O
s	O
patch	O
(	O
PP	O
)	O
,	O
Inguinal	O
lymph	O
node	O
(	O
ILN	O
)	O
.	O

The	O
invasion	O
rate	O
increased	O
when	O
the	O
multiplicity	O
of	O
infection	O
(	O
MOI	O
)	O
were	O
improved	O
in	O
this	O
two	O
kinds	O
of	O
cells	O
respectively	O
.	O

After	O
oral	O
immunization	O
with	O
X4550	B-bacteria
(	O
33	O
-	O
DsRed	O
)	O
,	O
RFP	O
+	O
cells	O
were	O
detected	O
by	O
FCM	O
on	O
1d	O
,	O
2d	O
,	O
3d	O
,	O
5d	O
,	O
7d	O
in	O
spleen	O
,	O
liver	O
,	O
MLN	O
,	O
PP	O
,	O
ILN	O
cells	O
.	O

The	O
first	O
day	O
,	O
RFP	O
+	O
cells	O
were	O
detected	O
in	O
MLN	O
and	O
PP	O
,	O
and	O
in	O
PP	O
at	O
a	O
higher	O
rate	O
of	O
1	O
.	O
4	O
%	O
than	O
that	O
of	O
MLN	O
.	O

0	O
.	O
4	O
%	O
RFP	O
+	O
cells	O
were	O
detected	O
the	O
next	O
day	O
in	O
ILN	O
.	O

On	O
3th	O
day	O
,	O
the	O
rates	O
of	O
RFP	O
+	O
cells	O
were	O
increased	O
in	O
all	O
of	O
above	O
tissues	O
or	O
organs	O
and	O
decreased	O
on	O
the	O
5th	O
day	O
.	O

At	O
the	O
7th	O
day	O
,	O
RFP	O
+	O
cells	O
could	O
n	O
'	O
t	O
be	O
detected	O
in	O
all	O
tissues	O
or	O
organs	O
tested	O
.	O

It	O
is	O
suggested	O
that	O
the	O
invasion	O
ability	O
and	O
the	O
transfer	O
through	O
mucosal	O
pathway	O
and	O
targeting	O
to	O
recognize	O
immune	O
tissue	O
or	O
organs	O
are	O
favor	O
of	O
the	O
research	O
in	O
mucosal	O
vaccine	O
and	O
the	O
vaccine	O
efficiency	O
.	O

We	O
evaluated	O
the	O
possibility	O
of	O
using	O
Yersinia	B-bacteria
pseudotuberculosis	I-bacteria
as	O
a	O
live	O
vaccine	O
against	O
plague	O
because	O
it	O
shares	O
high	O
genetic	O
identity	O
with	O
Y	B-bacteria
.	I-bacteria
pestis	I-bacteria
while	O
being	O
much	O
less	O
virulent	O
,	O
genetically	O
much	O
more	O
stable	O
,	O
and	O
deliverable	O
orally	O
.	O

A	O
total	O
of	O
41	O
Y	B-bacteria
.	I-bacteria
pseudotuberculosis	I-bacteria
strains	I-bacteria
were	O
screened	O
by	O
PCR	O
for	O
the	O
absence	O
of	O
the	O
high	O
pathogenicity	O
island	O
,	O
the	O
superantigens	O
YPM	O
,	O
and	O
the	O
type	O
IV	O
pilus	O
and	O
the	O
presence	O
of	O
the	O
pYV	O
virulence	O
plasmid	O
.	O

One	O
strain	O
(	O
IP32680	O
)	O
fulfilled	O
these	O
criteria	O
.	O

This	O
strain	O
was	O
avirulent	O
in	O
mice	O
upon	O
intragastric	O
or	O
subcutaneous	O
inoculation	O
and	O
persisted	O
for	O
2	O
months	O
in	O
the	O
mouse	O
intestine	O
without	O
clinical	O
signs	O
of	O
disease	O
.	O

IP32680	O
reached	O
the	O
mesenteric	O
lymph	O
nodes	O
,	O
spleen	O
,	O
and	O
liver	O
without	O
causing	O
major	O
histological	O
lesions	O
and	O
was	O
cleared	O
after	O
13	O
days	O
.	O

The	O
antibodies	O
produced	O
in	O
vaccinated	O
animals	O
recognized	O
both	O
Y	B-bacteria
.	I-bacteria
pseudotuberculosis	I-bacteria
and	O
Y	B-bacteria
.	I-bacteria
pestis	I-bacteria
antigens	O
efficiently	O
.	O

After	O
a	O
subcutaneous	O
challenge	O
with	O
Y	B-bacteria
.	I-bacteria
pestis	I-bacteria
CO92	I-bacteria
,	O
bacteria	O
were	O
found	O
in	O
low	O
amounts	O
in	O
the	O
organs	O
and	O
rarely	O
in	O
the	O
blood	O
of	O
vaccinated	O
animals	O
.	O

One	O
oral	O
IP32680	O
inoculation	O
protected	O
75	O
%	O
of	O
the	O
mice	O
,	O
and	O
two	O
inoculations	O
induced	O
much	O
higher	O
antibody	O
titers	O
and	O
protected	O
88	O
%	O
of	O
the	O
mice	O
.	O

Our	O
results	O
thus	O
validate	O
the	O
concept	O
that	O
an	O
attenuated	O
Y	B-bacteria
.	I-bacteria
pseudotuberculosis	I-bacteria
strain	I-bacteria
can	O
be	O
an	O
efficient	O
,	O
inexpensive	O
,	O
safe	O
,	O
and	O
easy	O
-	O
to	O
-	O
produce	O
live	O
vaccine	O
for	O
oral	O
immunization	O
against	O
bubonic	O
plague	O
.	O

In	O
order	O
to	O
assess	O
the	O
prevalence	O
of	O
beta	O
-	O
lactamase	O
producing	O
oral	O
bacteria	O
in	O
childhood	O
,	O
the	O
influence	O
of	O
different	O
parameters	O
on	O
the	O
oral	O
carriage	O
of	O
Capnocytophaga	B-bacteria
was	O
studied	O
in	O
a	O
specific	O
population	O
of	O
children	O
with	O
cancer	O
.	O

The	O
examined	O
parameters	O
included	O
clinical	O
observation	O
of	O
oropharyngeal	O
mucosa	O
,	O
type	O
of	O
malignant	O
disease	O
and	O
intake	O
of	O
chemotherapy	O
and	O
antimicrobial	O
treatment	O
.	O

The	O
gingival	O
and	O
mucosal	O
status	O
of	O
the	O
patients	O
was	O
recorded	O
before	O
each	O
sampling	O
procedure	O
.	O

Samples	O
were	O
collected	O
by	O
oropharyngeal	O
swabbing	O
in	O
children	O
with	O
leukaemia	O
or	O
other	O
oncological	O
diseases	O
for	O
isolation	O
of	O
Capnocytophaga	B-bacteria
strains	I-bacteria
.	O

Capnocytophaga	B-bacteria
strains	I-bacteria
were	O
more	O
often	O
isolated	O
in	O
samples	O
from	O
children	O
with	O
oncological	O
diseases	O
(	O
71	O
%	O
)	O
other	O
than	O
leukaemia	O
(	O
57	O
%	O
)	O
.	O

Concomitant	O
chemotherapy	O
had	O
no	O
influence	O
on	O
oral	O
Capnocytophaga	B-bacteria
carriage	O
.	O

A	O
significant	O
decrease	O
of	O
the	O
prevalence	O
of	O
Capnocytophaga	B-bacteria
strains	I-bacteria
isolated	O
was	O
observed	O
in	O
children	O
who	O
received	O
antimicrobial	O
treatment	O
within	O
8	O
days	O
before	O
the	O
sampling	O
procedure	O
(	O
15	O
.	O
5	O
%	O
vs	O
.	O
28	O
%	O
)	O
.	O

But	O
,	O
the	O
incidence	O
of	O
beta	O
-	O
lactamase	O
-	O
producing	O
strains	O
was	O
not	O
linked	O
to	O
previous	O
antimicrobial	O
treatments	O
.	O

Oral	O
carriage	O
of	O
Capnocytophaga	B-bacteria
strains	I-bacteria
can	O
be	O
linked	O
to	O
haematological	O
disease	O
and	O
previous	O
antibiotherapy	O
,	O
but	O
results	O
did	O
not	O
confirm	O
that	O
beta	O
-	O
lactamase	O
treatments	O
exert	O
a	O
selective	O
pressure	O
.	O

Other	O
factors	O
might	O
be	O
involved	O
in	O
emerging	O
for	O
oral	O
beta	O
-	O
lactamase	O
-	O
producing	O
Capnocytophaga	B-bacteria
strains	I-bacteria
.	O

During	O
periodontitis	O
,	O
an	O
innate	O
immune	O
response	O
to	O
bacterial	O
challenge	O
is	O
primarily	O
mediated	O
by	O
neutrophils	O
.	O

We	O
compared	O
neutrophilic	O
content	O
and	O
the	O
level	O
of	O
neutrophil	O
-	O
derived	O
antimicrobial	O
peptides	O
in	O
gingival	O
crevicular	O
fluid	O
(	O
GCF	O
)	O
in	O
two	O
clinical	O
forms	O
of	O
severe	O
periodontitis	O
.	O

GCF	O
was	O
collected	O
from	O
14	O
patients	O
with	O
aggressive	O
periodontitis	O
,	O
17	O
patients	O
with	O
chronic	O
periodontitis	O
,	O
and	O
nine	O
healthy	O
subjects	O
.	O

Samples	O
were	O
analyzed	O
for	O
periodontopathogen	O
load	O
using	O
real	O
-	O
time	O
polymerase	O
chain	O
reactions	O
.	O

The	O
amounts	O
of	O
myeloperoxidase	O
and	O
alpha	O
-	O
defensins	O
(	O
HNP1	O
-	O
3	O
)	O
were	O
determined	O
by	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
,	O
and	O
the	O
level	O
of	O
cathelicidin	O
(	O
hCAP18	O
/	O
LL	O
-	O
37	O
)	O
was	O
assayed	O
by	O
Western	O
blot	O
.	O

Myeloperoxidase	O
concentration	O
was	O
not	O
correlated	O
with	O
levels	O
of	O
LL	O
-	O
37	O
and	O
HNP1	O
-	O
3	O
in	O
samples	O
from	O
patients	O
,	O
compared	O
to	O
controls	O
.	O

The	O
amount	O
of	O
HNP1	O
-	O
3	O
was	O
twofold	O
and	O
fourfold	O
higher	O
in	O
patients	O
with	O
aggressive	O
and	O
chronic	O
periodontitis	O
,	O
respectively	O
.	O

Those	O
with	O
chronic	O
disease	O
had	O
significantly	O
elevated	O
amounts	O
of	O
mature	O
LL	O
-	O
37	O
.	O

The	O
increased	O
concentration	O
of	O
both	O
peptides	O
in	O
chronic	O
periodontitis	O
correlated	O
with	O
the	O
load	O
of	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
,	O
and	O
Treponema	B-bacteria
denticola	I-bacteria
.	O

The	O
lack	O
of	O
a	O
correlation	O
between	O
LL	O
-	O
37	O
,	O
HNP1	O
-	O
3	O
,	O
and	O
myeloperoxidase	O
content	O
suggests	O
that	O
neutrophils	O
are	O
not	O
the	O
sole	O
source	O
of	O
these	O
bactericidal	O
peptides	O
in	O
the	O
GCF	O
of	O
patients	O
with	O
periodontitis	O
;	O
and	O
that	O
other	O
cells	O
contribute	O
to	O
their	O
local	O
production	O
.	O

The	O
bacterial	O
proteases	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
T	B-bacteria
.	I-bacteria
forsythia	I-bacteria
,	O
and	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
might	O
degrade	O
hCAP18	O
/	O
LL	O
-	O
37	O
,	O
because	O
the	O
11	O
-	O
kDa	O
cathelicidin	O
-	O
derived	O
fragment	O
was	O
present	O
in	O
GCF	O
collected	O
from	O
pockets	O
infected	O
with	O
these	O
bacteria	O
.	O

Collectively	O
,	O
it	O
appears	O
that	O
a	O
local	O
deficiency	O
in	O
LL	O
-	O
37	O
can	O
be	O
considered	O
as	O
a	O
supporting	O
factor	O
in	O
the	O
pathogenesis	O
of	O
severe	O
cases	O
of	O
periodontitis	O
.	O

Lipoteichoic	O
acid	O
(	O
LTA	O
)	O
is	O
a	O
major	O
immunostimulating	O
component	O
in	O
the	O
cell	O
wall	O
of	O
Gram	O
-	O
positive	O
bacteria	O
as	O
lipopolysaccharide	O
of	O
Gram	O
-	O
negative	O
bacteria	O
.	O

However	O
,	O
LTA	O
is	O
expressed	O
on	O
not	O
only	O
pathogenic	O
but	O
also	O
nonpathogenic	O
Gram	O
-	O
positive	O
bacteria	O
.	O

In	O
order	O
to	O
examine	O
whether	O
the	O
immunostimulating	O
potentials	O
of	O
Gram	O
-	O
positive	O
bacteria	O
are	O
correlated	O
with	O
their	O
LTAs	O
,	O
we	O
prepared	O
highly	O
pure	O
LTAs	O
from	O
Staphylococcus	B-bacteria
aureus	I-bacteria
(	O
pathogenic	O
)	O
,	O
Bacillus	B-bacteria
subtilis	I-bacteria
(	O
non	O
-	O
pathogenic	O
)	O
,	O
or	O
Lactobacillus	B-bacteria
plantarum	I-bacteria
(	O
beneficial	O
)	O
.	O

When	O
a	O
murine	O
macrophage	O
cell	O
-	O
line	O
,	O
RAW	O
264	O
.	O
7	O
,	O
was	O
stimulated	O
with	O
heat	O
-	O
killed	O
bacteria	O
,	O
both	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
and	O
B	B-bacteria
.	I-bacteria
subtilis	I-bacteria
induced	O
nitric	O
oxide	O
(	O
NO	O
)	O
production	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
while	O
L	B-bacteria
.	I-bacteria
plantarum	I-bacteria
showed	O
a	O
minimal	O
induction	O
.	O

Interestingly	O
,	O
purified	O
LTAs	O
from	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
and	O
B	B-bacteria
.	I-bacteria
subtilis	I-bacteria
,	O
but	O
not	O
from	O
L	B-bacteria
.	I-bacteria
plantarum	I-bacteria
,	O
were	O
able	O
to	O
induce	O
the	O
production	O
of	O
NO	O
.	O

The	O
differential	O
inflammatory	O
potentials	O
of	O
LTAs	O
coincided	O
with	O
their	O
abilities	O
to	O
activate	O
Toll	O
-	O
like	O
receptor	O
2	O
(	O
TLR2	O
)	O
,	O
which	O
is	O
known	O
to	O
recognize	O
Gram	O
-	O
positive	O
bacteria	O
and	O
LTA	O
,	O
and	O
transcription	O
factors	O
NF	O
-	O
kappaB	O
and	O
AP	O
-	O
1	O
.	O

Similar	O
results	O
were	O
obtained	O
with	O
the	O
expression	O
of	O
cytokines	O
related	O
to	O
inflammation	O
by	O
RAW	O
264	O
.	O
7	O
and	O
human	O
peripheral	O
blood	O
mononuclear	O
cells	O
as	O
well	O
.	O

The	O
ability	O
of	O
LTA	O
to	O
induce	O
TNF	O
-	O
alpha	O
and	O
NO	O
production	O
was	O
abolished	O
when	O
the	O
LTAs	O
were	O
treated	O
with	O
0	O
.	O
2	O
N	O
NaOH	O
.	O

Collectively	O
,	O
we	O
suggest	O
that	O
the	O
immunostimulating	O
potentials	O
of	O
Gram	O
-	O
positive	O
bacteria	O
differ	O
due	O
to	O
their	O
LTAs	O
with	O
differential	O
potencies	O
in	O
the	O
stimulation	O
of	O
TLR2	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
test	O
the	O
hypothesis	O
that	O
periodontal	O
pathogens	O
associated	O
with	O
aggressive	O
periodontitis	O
persist	O
in	O
extracrevicular	O
locations	O
following	O
scaling	O
and	O
root	O
planing	O
,	O
systemic	O
antibiotics	O
,	O
and	O
antimicrobial	O
rinses	O
.	O

Eighteen	O
patients	O
with	O
aggressive	O
periodontitis	O
received	O
a	O
clinical	O
examination	O
during	O
which	O
samples	O
of	O
subgingival	O
plaque	O
and	O
buccal	O
epithelial	O
cells	O
were	O
obtained	O
.	O

Treatment	O
consisted	O
of	O
full	O
-	O
mouth	O
root	O
planing	O
,	O
systemic	O
antibiotics	O
,	O
and	O
chlorhexidine	O
rinses	O
.	O

Clinical	O
measurements	O
and	O
sampling	O
were	O
repeated	O
at	O
3	O
and	O
6	O
months	O
.	O

Quantitative	O
polymerase	O
chain	O
reaction	O
determined	O
the	O
number	O
of	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
(	O
previously	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
)	O
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
(	O
previously	O
T	B-bacteria
.	I-bacteria
forsythensis	I-bacteria
)	O
,	O
and	O
Treponema	B-bacteria
denticola	I-bacteria
in	O
the	O
plaque	O
.	O

Fluorescence	O
in	O
situ	O
hybridization	O
and	O
confocal	O
microscopy	O
determined	O
the	O
extent	O
of	O
intracellular	O
invasion	O
in	O
epithelial	O
cells	O
.	O

Clinical	O
measurements	O
improved	O
significantly	O
following	O
treatment	O
.	O

All	O
bacterial	O
species	O
except	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
were	O
significantly	O
reduced	O
in	O
plaque	O
between	O
baseline	O
and	O
3	O
months	O
.	O

However	O
,	O
all	O
species	O
showed	O
a	O
trend	O
to	O
repopulate	O
between	O
3	O
and	O
6	O
months	O
.	O

This	O
increase	O
was	O
statistically	O
significant	O
for	O
log	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
counts	O
.	O

All	O
species	O
were	O
detected	O
intracellularly	O
.	O

The	O
percentage	O
of	O
cells	O
infected	O
intracellularly	O
was	O
not	O
affected	O
by	O
therapy	O
.	O

The	O
6	O
-	O
month	O
increasing	O
trend	O
in	O
the	O
levels	O
of	O
plaque	O
bacteria	O
suggests	O
that	O
subgingival	O
recolonization	O
was	O
occurring	O
.	O

Because	O
the	O
presence	O
of	O
these	O
species	O
within	O
epithelial	O
cells	O
was	O
not	O
altered	O
after	O
treatment	O
,	O
it	O
is	O
plausible	O
that	O
recolonization	O
may	O
occur	O
from	O
the	O
oral	O
mucosa	O
.	O

Systemic	O
antibiotics	O
and	O
topical	O
chlorhexidine	O
did	O
not	O
reduce	O
the	O
percentage	O
of	O
invaded	O
epithelial	O
cells	O
.	O

These	O
data	O
support	O
the	O
hypothesis	O
that	O
extracrevicular	O
reservoirs	O
of	O
bacteria	O
exist	O
,	O
which	O
might	O
contribute	O
to	O
recurrent	O
or	O
refractory	O
disease	O
in	O
some	O
patients	O
.	O

The	O
oral	O
pathogen	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
has	O
been	O
shown	O
to	O
modulate	O
apoptosis	O
in	O
different	O
cell	O
types	O
,	O
but	O
its	O
effect	O
on	O
epithelial	O
cells	O
remains	O
unclear	O
.	O

We	O
demonstrate	O
that	O
primary	O
human	O
gingival	O
epithelial	O
cells	O
(	O
HGECs	O
)	O
challenged	O
with	O
live	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
for	O
24	O
hours	O
exhibit	O
apoptosis	O
,	O
and	O
we	O
characterize	O
this	O
by	O
M30	O
epitope	O
detection	O
,	O
caspase	O
-	O
3	O
activity	O
,	O
DNA	O
fragmentation	O
and	O
Annexin	O
-	O
V	O
staining	O
.	O

Live	O
bacteria	O
strongly	O
upregulated	O
intrinsic	O
and	O
extrinsic	O
apoptotic	O
pathways	O
.	O

Pro	O
-	O
apoptotic	O
molecules	O
such	O
as	O
caspase	O
-	O
3	O
,	O
-	O
8	O
,	O
-	O
9	O
,	O
Bid	O
and	O
Bax	O
were	O
upregulated	O
after	O
24	O
hours	O
.	O

The	O
anti	O
-	O
apoptotic	O
Bcl	O
-	O
2	O
was	O
also	O
upregulated	O
,	O
but	O
this	O
was	O
not	O
sufficient	O
to	O
ensure	O
cell	O
survival	O
.	O

The	O
main	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
proteases	O
arginine	O
and	O
lysine	O
gingipains	O
are	O
necessary	O
and	O
sufficient	O
to	O
induce	O
host	O
cell	O
apoptosis	O
.	O

Thus	O
,	O
live	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
can	O
invoke	O
gingival	O
epithelial	O
cell	O
apoptosis	O
in	O
a	O
time	O
and	O
dose	O
dependent	O
manner	O
with	O
significant	O
apoptosis	O
occurring	O
between	O
12	O
and	O
24	O
hours	O
of	O
challenge	O
via	O
a	O
gingipain	O
-	O
dependent	O
mechanism	O
.	O

The	O
present	O
study	O
provides	O
evidence	O
that	O
live	O
,	O
but	O
not	O
heat	O
-	O
killed	O
,	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
can	O
induce	O
apoptosis	O
after	O
24	O
hours	O
of	O
challenge	O
in	O
primary	O
human	O
gingival	O
epithelial	O
cells	O
.	O

Either	O
arginine	O
or	O
lysine	O
gingipains	O
are	O
necessary	O
and	O
sufficient	O
factors	O
in	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
elicited	O
apoptosis	O
.	O

This	O
study	O
covers	O
phase	O
IV	O
of	O
a	O
prospective	O
clinical	O
long	O
-	O
term	O
study	O
.	O

Objective	O
of	O
this	O
clinical	O
investigation	O
was	O
to	O
analyze	O
the	O
effects	O
of	O
a	O
long	O
-	O
term	O
prevention	O
program	O
on	O
dental	O
and	O
oral	O
health	O
of	O
teenagers	O
at	O
the	O
age	O
of	O
13	O
to	O
14	O
years	O
.	O

The	O
entire	O
study	O
was	O
subdivided	O
into	O
four	O
phases	O
.	O

Phase	O
I	O
comprised	O
an	O
individual	O
preventive	O
care	O
during	O
pregnancy	O
(	O
`	O
`	O
primary	O
-	O
primary	O
prevention	O
'	O
'	O
)	O
;	O
phase	O
II	O
assessed	O
mothers	O
and	O
their	O
young	O
children	O
until	O
the	O
age	O
of	O
3	O
years	O
(	O
`	O
`	O
primary	O
prevention	O
'	O
'	O
)	O
;	O
and	O
in	O
phase	O
III	O
,	O
mothers	O
and	O
children	O
at	O
the	O
age	O
of	O
6	O
years	O
were	O
investigated	O
.	O

In	O
phase	O
IV	O
of	O
the	O
study	O
,	O
the	O
oral	O
health	O
of	O
13	O
-	O
to	O
14	O
-	O
year	O
-	O
old	O
teenagers	O
was	O
examined	O
(	O
13	O
.	O
4	O
+	O
/	O
-	O
0	O
.	O
5	O
years	O
;	O
n	O
=	O
29	O
)	O
.	O

All	O
phases	O
consisted	O
of	O
an	O
examination	O
,	O
education	O
about	O
oral	O
health	O
care	O
,	O
and	O
treatment	O
based	O
on	O
the	O
concept	O
of	O
an	O
early	O
oral	O
health	O
care	O
promotion	O
.	O

The	O
control	O
group	O
consisted	O
of	O
randomly	O
selected	O
adolescents	O
at	O
the	O
same	O
age	O
(	O
n	O
=	O
30	O
)	O
.	O

The	O
following	O
clinical	O
parameters	O
were	O
assessed	O
:	O
decayed	O
/	O
missing	O
/	O
filled	O
teeth	O
(	O
DMF	O
-	O
T	O
)	O
/	O
decayed	O
,	O
missing	O
,	O
and	O
filled	O
surface	O
teeth	O
index	O
,	O
hygiene	O
index	O
,	O
papilla	O
bleeding	O
index	O
,	O
Periodontal	O
Screening	O
Index	O
,	O
and	O
Streptococcus	B-bacteria
mutans	I-bacteria
/	O
Lactobacillus	B-bacteria
concentration	O
in	O
saliva	O
.	O

The	O
teenagers	O
of	O
the	O
`	O
`	O
prevention	O
'	O
'	O
group	O
of	O
phase	O
IV	O
of	O
our	O
prospective	O
study	O
revealed	O
a	O
share	O
of	O
89	O
.	O
7	O
%	O
caries	O
-	O
free	O
dentitions	O
(	O
65	O
.	O
5	O
%	O
sound	O
;	O
24	O
.	O
2	O
%	O
caries	O
-	O
free	O
with	O
fillings	O
)	O
.	O

Mean	O
DMF	O
-	O
T	O
was	O
0	O
.	O
55	O
+	O
/	O
-	O
1	O
.	O
0	O
.	O

The	O
control	O
group	O
showed	O
a	O
significantly	O
higher	O
mean	O
DMF	O
-	O
T	O
of	O
1	O
.	O
5	O
+	O
/	O
-	O
1	O
.	O
5	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
and	O
revealed	O
56	O
.	O
7	O
%	O
of	O
caries	O
-	O
free	O
dentitions	O
(	O
30	O
%	O
sound	O
,	O
26	O
.	O
7	O
%	O
caries	O
-	O
free	O
with	O
restorations	O
)	O
.	O

Our	O
data	O
clearly	O
document	O
that	O
an	O
early	O
oral	O
health	O
care	O
promotion	O
starting	O
during	O
pregnancy	O
may	O
cause	O
a	O
sustained	O
and	O
long	O
-	O
term	O
improvement	O
of	O
the	O
oral	O
health	O
of	O
children	O
.	O

The	O
arginine	O
deiminase	O
system	O
(	O
ADS	O
)	O
of	O
oral	O
bacteria	O
is	O
a	O
major	O
generator	O
of	O
alkali	O
(	O
ammonia	O
)	O
in	O
dental	O
plaque	O
and	O
is	O
considered	O
to	O
have	O
anticaries	O
effects	O
.	O

However	O
,	O
many	O
of	O
the	O
antimicrobial	O
agents	O
used	O
in	O
oral	O
care	O
products	O
may	O
reduce	O
alkali	O
production	O
by	O
the	O
ADS	O
.	O

The	O
objective	O
of	O
our	O
work	O
was	O
to	O
assess	O
the	O
sensitivity	O
of	O
the	O
ADS	O
of	O
oral	O
streptococci	B-bacteria
to	O
commonly	O
used	O
antimicrobials	O
,	O
fluoride	O
,	O
triclosan	O
and	O
organic	O
weak	O
acids	O
.	O

Streptococcus	B-bacteria
sanguinis	I-bacteria
NCTC	I-bacteria
10904	I-bacteria
and	O
Streptococcus	B-bacteria
ratti	I-bacteria
FA	I-bacteria
-	I-bacteria
1	I-bacteria
were	O
grown	O
in	O
suspension	O
cultures	O
and	O
mono	O
-	O
organism	O
biofilms	O
.	O

ADS	O
activity	O
at	O
pH	O
values	O
of	O
4	O
,	O
5	O
and	O
6	O
was	O
assessed	O
,	O
and	O
the	O
actions	O
of	O
the	O
agents	O
was	O
determined	O
in	O
terms	O
of	O
reduced	O
production	O
of	O
alkali	O
from	O
arginine	O
,	O
inhibition	O
of	O
ADS	O
enzymes	O
and	O
changes	O
in	O
uptake	O
of	O
arginine	O
.	O

ADS	O
activity	O
was	O
not	O
greatly	O
affected	O
by	O
pH	O
changes	O
between	O
4	O
and	O
6	O
and	O
was	O
greater	O
per	O
unit	O
of	O
biomass	O
for	O
cell	O
suspensions	O
than	O
for	O
biofilms	O
.	O

NaF	O
was	O
a	O
poor	O
inhibitor	O
,	O
while	O
triclosan	O
was	O
highly	O
effective	O
with	O
a	O
50	O
%	O
inhibitory	O
dose	O
for	O
the	O
two	O
organisms	O
between	O
0	O
.	O
03	O
and	O
0	O
.	O
05	O
and	O
between	O
0	O
.	O
10	O
and	O
0	O
.	O
15	O
mm	O
-	O
h	O
for	O
suspension	O
cells	O
and	O
biofilms	O
,	O
respectively	O
.	O

The	O
weak	O
acid	O
indomethacin	O
was	O
nearly	O
as	O
potent	O
at	O
pH	O
4	O
.	O
0	O
as	O
triclosan	O
,	O
while	O
capric	O
and	O
lauric	O
acids	O
were	O
less	O
potent	O
,	O
especially	O
for	O
biofilms	O
.	O

The	O
methyl	O
ester	O
of	O
lauric	O
acid	O
was	O
slightly	O
stimulatory	O
.	O

The	O
major	O
targets	O
for	O
the	O
inhibitors	O
appeared	O
to	O
be	O
transport	O
systems	O
for	O
arginine	O
uptake	O
,	O
although	O
carbamate	O
kinase	O
was	O
a	O
secondary	O
target	O
.	O

Triclosan	O
,	O
indomethacin	O
,	O
caprate	O
and	O
laurate	O
can	O
reduce	O
ADS	O
activity	O
in	O
dental	O
plaque	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
prevalence	O
of	O
select	O
microorganisms	O
in	O
oral	O
biofilms	O
and	O
to	O
investigate	O
relationships	O
between	O
oral	O
and	O
respiratory	O
status	O
in	O
persons	O
with	O
mental	O
retardation	O
/	O
intellectual	O
and	O
developmental	O
disabilities	O
(	O
IDD	O
)	O
.	O

We	O
conducted	O
a	O
6	O
-	O
month	O
-	O
long	O
observational	O
cohort	O
study	O
with	O
63	O
persons	O
with	O
IDD	O
.	O

Oral	O
examinations	O
,	O
oral	O
sampling	O
,	O
and	O
medical	O
record	O
reviews	O
were	O
performed	O
at	O
baseline	O
and	O
then	O
monthly	O
.	O

Polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
was	O
used	O
to	O
analyze	O
all	O
baseline	O
oral	O
samples	O
for	O
the	O
presence	O
of	O
Streptococcus	B-bacteria
pneumoniae	I-bacteria
,	O
Methicillin	B-bacteria
-	I-bacteria
resistant	I-bacteria
Staphylococcus	I-bacteria
aureus	I-bacteria
(	O
MRSA	B-bacteria
)	O
,	O
Prevotella	B-bacteria
melaninogenica	I-bacteria
,	O
and	O
Candida	O
albicans	O
.	O

PCR	O
analyses	O
were	O
also	O
performed	O
on	O
participants	O
'	O
samples	O
collected	O
in	O
the	O
month	O
before	O
being	O
diagnosed	O
with	O
a	O
respiratory	O
infection	O
.	O

All	O
subjects	O
had	O
P	B-bacteria
.	I-bacteria
melaninogenica	I-bacteria
detected	O
by	O
PCR	O
in	O
their	O
oral	O
samples	O
.	O

Fifty	O
-	O
five	O
percent	O
(	O
35	O
of	O
63	O
)	O
of	O
participants	O
had	O
S	B-bacteria
.	I-bacteria
pneumoniae	I-bacteria
,	O
MRSA	B-bacteria
,	O
and	O
C	O
.	O
albicans	O
in	O
their	O
oral	O
samples	O
at	O
baseline	O
.	O

No	O
dental	O
decay	O
was	O
detected	O
clinically	O
,	O
oral	O
hygiene	O
was	O
fair	O
,	O
and	O
dysphagia	O
was	O
common	O
.	O

During	O
the	O
6	O
months	O
of	O
the	O
study	O
,	O
there	O
were	O
22	O
respiratory	O
infections	O
(	O
35	O
%	O
of	O
participants	O
)	O
-	O
12	O
pneumonias	O
,	O
7	O
sinusitis	O
,	O
1	O
bronchitis	O
,	O
and	O
1	O
upper	O
respiratory	O
tract	O
infection	O
.	O

Participants	O
with	O
microorganisms	O
in	O
their	O
baseline	O
samples	O
were	O
significantly	O
more	O
likely	O
to	O
develop	O
any	O
respiratory	O
infection	O
and	O
those	O
who	O
had	O
poor	O
oral	O
status	O
were	O
significantly	O
more	O
likely	O
to	O
develop	O
pneumonia	O
.	O

Almost	O
60	O
%	O
of	O
participants	O
who	O
developed	O
respiratory	O
infections	O
had	O
the	O
same	O
microorganism	O
detected	O
in	O
the	O
sample	O
collected	O
in	O
the	O
month	O
before	O
infection	O
as	O
had	O
been	O
detected	O
in	O
their	O
baseline	O
sample	O
.	O

Potentially	O
pathogenic	O
microorganisms	O
in	O
the	O
oral	O
cavity	O
and	O
poor	O
oral	O
status	O
significantly	O
increased	O
the	O
risk	O
of	O
developing	O
respiratory	O
infections	O
,	O
including	O
pneumonia	O
,	O
in	O
persons	O
with	O
IDD	O
.	O

The	O
results	O
suggest	O
that	O
colonization	O
with	O
these	O
microorganisms	O
may	O
persist	O
despite	O
routine	O
tooth	O
brushing	O
.	O

Meticulous	O
comprehensive	O
oral	O
hygiene	O
of	O
the	O
oral	O
cavity	O
may	O
be	O
needed	O
to	O
reduce	O
oropharyngeal	O
microbial	O
load	O
.	O

The	O
aim	O
was	O
to	O
study	O
the	O
oral	O
carriage	O
of	O
Enterococcus	B-bacteria
and	O
Escherichia	B-bacteria
coli	I-bacteria
isolates	I-bacteria
and	O
their	O
content	O
in	O
antimicrobial	O
-	O
resistance	O
and	O
virulence	O
genes	O
in	O
patients	O
with	O
fixed	O
appliances	O
and	O
in	O
healthy	O
volunteers	O
.	O

STUDY	O
Samples	O
from	O
supragingival	O
plaques	O
/	O
tooth	O
surfaces	O
/	O
fixed	O
orthodontic	O
appliances	O
were	O
taken	O
in	O
patients	O
with	O
fixed	O
appliances	O
(	O
n	O
=	O
46	O
)	O
and	O
in	O
healthy	O
volunteers	O
(	O
n	O
=	O
55	O
)	O
.	O

Samples	O
were	O
seeded	O
on	O
specific	O
media	O
for	O
enterococcal	B-bacteria
and	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
recovery	O
,	O
and	O
1	O
isolate	O
of	O
each	O
type	O
per	O
sample	O
was	O
selected	O
.	O

Antimicrobial	O
susceptibility	O
and	O
the	O
presence	O
of	O
genes	O
encoding	O
antimicrobial	O
resistance	O
,	O
bacteriocins	O
,	O
and	O
virulence	O
factors	O
were	O
checked	O
by	O
polymerase	O
chain	O
reaction	O
.	O

Enterococci	B-bacteria
or	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
were	O
not	O
recovered	O
from	O
healthy	O
volunteers	O
.	O

Nevertheless	O
,	O
10	O
isolates	O
(	O
5	O
E	B-bacteria
.	I-bacteria
faecium	I-bacteria
,	O
3	O
E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
,	O
and	O
2	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
)	O
were	O
obtained	O
from	O
19	O
.	O
5	O
%	O
of	O
patients	O
with	O
fixed	O
appliances	O
,	O
and	O
poor	O
oral	O
hygiene	O
was	O
evidenced	O
in	O
all	O
of	O
the	O
these	O
patients	O
.	O

Percentages	O
of	O
antimicrobial	O
resistance	O
and	O
the	O
resistance	O
genes	O
detected	O
among	O
the	O
enterococci	B-bacteria
were	O
:	O
erythromycin	O
:	O
100	O
%	O
,	O
erm	O
(	O
B	O
)	O
;	O
kanamycin	O
:	O
75	O
%	O
,	O
aph	O
(	O
3	O
'	O
)	O
-	O
IIIa	O
;	O
tetracycline	O
:	O
50	O
%	O
,	O
tet	O
(	O
L	O
)	O
with	O
/	O
without	O
tet	O
(	O
M	O
)	O
;	O
streptomycin	O
:	O
37	O
%	O
,	O
ant	O
(	O
6	O
)	O
-	O
Ia	O
;	O
chloramphenicol	O
:	O
12	O
%	O
,	O
catA	O
.	O

One	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
isolate	I-bacteria
showed	O
a	O
phenotype	O
of	O
multiresistance	O
containing	O
5	O
resistance	O
genes	O
and	O
class	O
1	O
and	O
2	O
integrons	O
.	O

All	O
enterococci	B-bacteria
produced	O
gelatinase	O
,	O
and	O
4	O
isolates	O
contained	O
genes	O
encoding	O
enterocins	O
L50A	O
/	O
B	O
and	O
P	O
.	O
The	O
esp	O
virulence	O
gene	O
was	O
found	O
in	O
1	O
multiresistant	O
E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
isolate	I-bacteria
.	O

Poor	O
or	O
improper	O
oral	O
hygiene	O
in	O
individuals	O
with	O
fixed	O
appliances	O
favors	O
the	O
oral	O
carriage	O
of	O
antimicrobial	B-bacteria
-	I-bacteria
resistant	I-bacteria
E	I-bacteria
.	I-bacteria
coli	I-bacteria
and	O
enterococci	B-bacteria
.	O

Additional	O
investigations	O
are	O
needed	O
to	O
assess	O
its	O
implication	O
in	O
human	O
health	O
.	O

Vaccination	O
against	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
is	O
a	O
desirable	O
,	O
yet	O
challenging	O
strategy	O
for	O
prevention	O
of	O
airway	O
infection	O
in	O
patients	O
with	O
cystic	O
fibrosis	O
.	O

We	O
compared	O
the	O
formation	O
of	O
antibodies	O
in	O
lower	O
airways	O
induced	O
by	O
systemic	O
and	O
mucosal	O
vaccination	O
strategies	O
.	O

We	O
immunised	O
48	O
volunteers	O
in	O
six	O
vaccination	O
groups	O
with	O
either	O
a	O
systemic	O
,	O
a	O
nasal	O
,	O
or	O
four	O
newly	O
constructed	O
oral	O
live	O
vaccines	O
based	O
on	O
attenuated	O
live	O
Salmonella	B-bacteria
(	O
strains	O
CVD908	B-bacteria
and	O
Ty21a	B-bacteria
)	O
,	O
followed	O
by	O
a	O
systemic	O
booster	O
vaccination	O
.	O

All	O
vaccines	O
were	O
based	O
on	O
a	O
recombinant	O
fusion	O
protein	O
of	O
the	O
highly	O
conserved	O
P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
outer	O
membrane	O
proteins	O
OprF	O
and	O
OprI	O
as	O
antigen	O
.	O

While	O
systemic	O
and	O
mucosal	O
vaccines	O
induced	O
a	O
comparable	O
rise	O
of	O
serum	O
antibody	O
titers	O
,	O
a	O
significant	O
rise	O
of	O
IgA	O
and	O
IgG	O
antibodies	O
in	O
the	O
lower	O
airways	O
was	O
noted	O
only	O
after	O
nasal	O
and	O
oral	O
vaccinations	O
.	O

We	O
conclude	O
that	O
nasal	O
and	O
oral	O
OprF	O
-	O
OprI	O
vaccines	O
are	O
promising	O
candidates	O
for	O
development	O
of	O
antipseudomonal	O
immunisation	O
through	O
inducing	O
a	O
specific	O
antibody	O
response	O
in	O
the	O
lung	O
.	O

Periodontal	O
diseases	O
(	O
PDs	O
)	O
are	O
infectious	O
diseases	O
in	O
which	O
periodontopathogens	O
trigger	O
chronic	O
inflammatory	O
and	O
immune	O
responses	O
that	O
lead	O
to	O
tissue	O
destruction	O
.	O

Recently	O
,	O
viruses	O
have	O
been	O
implicated	O
in	O
the	O
pathogenesis	O
of	O
PDs	O
.	O

Individuals	O
infected	O
with	O
human	O
T	O
lymphotropic	O
virus	O
1	O
(	O
HTLV	O
-	O
1	O
)	O
present	O
with	O
abnormal	O
oral	O
health	O
and	O
a	O
marked	O
increased	O
prevalence	O
of	O
periodontal	O
disease	O
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
patterns	O
of	O
periodontopathogen	O
infection	O
and	O
local	O
inflammatory	O
immune	O
markers	O
in	O
HTLV	O
-	O
1	O
-	O
seropositive	O
individuals	O
with	O
chronic	O
periodontitis	O
(	O
CP	O
/	O
HTLV	O
-	O
1	O
group	O
)	O
compared	O
with	O
HTLV	O
-	O
1	O
-	O
seronegative	O
individuals	O
with	O
chronic	O
periodontitis	O
(	O
CP	O
group	O
)	O
and	O
periodontally	O
healthy	O
,	O
HTLV	O
-	O
1	O
-	O
seronegative	O
individuals	O
(	O
control	O
group	O
)	O
.	O

Patients	O
in	O
the	O
CP	O
/	O
HTLV	O
-	O
1	O
group	O
had	O
significantly	O
higher	O
values	O
of	O
bleeding	O
on	O
probing	O
,	O
mean	O
probing	O
depth	O
,	O
and	O
attachment	O
loss	O
than	O
patients	O
in	O
the	O
CP	O
group	O
.	O

The	O
expression	O
of	O
tumor	O
necrosis	O
factor	O
alpha	O
and	O
interleukin	O
(	O
IL	O
)	O
4	O
was	O
found	O
to	O
be	O
similar	O
in	O
the	O
CP	O
and	O
CP	O
/	O
HTLV	O
-	O
1	O
groups	O
,	O
whereas	O
IL	O
-	O
12	O
and	O
IL	O
-	O
17	O
levels	O
trended	O
toward	O
a	O
higher	O
expression	O
in	O
the	O
CP	O
/	O
HTLV	O
-	O
1	O
group	O
.	O

A	O
significant	O
increase	O
was	O
seen	O
in	O
the	O
levels	O
of	O
IL	O
-	O
1beta	O
and	O
interferon	O
gamma	O
in	O
the	O
CP	O
/	O
HTLV	O
-	O
1	O
group	O
compared	O
with	O
the	O
CP	O
group	O
,	O
whereas	O
expression	O
of	O
the	O
regulatory	O
T	O
cell	O
marker	O
FOXp3	O
and	O
IL	O
-	O
10	O
was	O
significantly	O
decreased	O
in	O
the	O
lesions	O
from	O
the	O
CP	O
/	O
HTLV	O
-	O
1	O
group	O
.	O

Interestingly	O
,	O
similar	O
frequency	O
and	O
/	O
or	O
load	O
of	O
periodontopathogens	O
(	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
,	O
Treponema	B-bacteria
denticola	I-bacteria
,	O
and	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
)	O
and	O
frequency	O
of	O
viruses	O
(	O
herpes	O
simplex	O
virus	O
1	O
,	O
human	O
cytomegalovirus	O
,	O
and	O
Epstein	O
-	O
Barr	O
virus	O
)	O
characteristically	O
associated	O
with	O
PDs	O
were	O
found	O
in	O
the	O
CP	O
/	O
HTLV	O
and	O
CP	O
groups	O
.	O

HTLV	O
-	O
1	O
may	O
play	O
a	O
critical	O
role	O
in	O
the	O
pathogenesis	O
of	O
periodontal	O
disease	O
through	O
the	O
deregulation	O
of	O
the	O
local	O
cytokine	O
network	O
,	O
resulting	O
in	O
an	O
exacerbated	O
response	O
against	O
a	O
standard	O
periodontopathogen	O
infection	O
.	O

It	O
is	O
well	O
established	O
that	O
severe	O
periodontitis	O
clusters	O
in	O
families	O
,	O
but	O
there	O
are	O
no	O
data	O
about	O
the	O
relationship	O
between	O
mothers	O
with	O
chronic	O
periodontitis	O
and	O
their	O
children	O
'	O
s	O
periodontal	O
status	O
.	O

To	O
evaluate	O
a	O
risk	O
for	O
periodontal	O
diseases	O
in	O
children	O
of	O
periodontally	O
diseased	O
and	O
healthy	O
mothers	O
.	O

Four	O
study	O
groups	O
were	O
included	O
:	O
(	O
I	O
)	O
20	O
female	O
patients	O
with	O
untreated	O
generalized	O
severe	O
chronic	O
periodontitis	O
,	O
(	O
II	O
)	O
their	O
children	O
(	O
34	O
)	O
,	O
(	O
III	O
)	O
13	O
periodontally	O
healthy	O
mothers	O
and	O
(	O
IV	O
)	O
their	O
children	O
(	O
13	O
)	O
.	O

Material	O
was	O
collected	O
from	O
years	O
2004	O
-	O
2006	O
.	O

The	O
clinical	O
examination	O
included	O
registration	O
of	O
visible	O
plaque	O
index	O
,	O
modified	O
gingival	O
index	O
and	O
,	O
bleeding	O
sites	O
on	O
probing	O
.	O

Periodontal	O
microbiological	O
samples	O
were	O
obtained	O
from	O
all	O
study	O
subjects	O
and	O
the	O
isolates	O
were	O
identified	O
according	O
to	O
morphology	O
and	O
biochemical	O
profiles	O
;	O
similar	O
interfamilial	O
pathogens	O
were	O
compared	O
by	O
PCR	O
-	O
technique	O
.	O

The	O
children	O
of	O
diseased	O
mothers	O
more	O
frequently	O
had	O
periodontal	O
diseases	O
,	O
especially	O
gingivitis	O
.	O

In	O
addition	O
,	O
clinical	O
parameters	O
of	O
gingival	O
inflammation	O
were	O
more	O
expressed	O
and	O
oral	O
hygiene	O
was	O
worse	O
in	O
this	O
group	O
of	O
children	O
.	O

VPI	O
and	O
VPI	O
%	O
of	O
the	O
diseased	O
and	O
healthy	O
mothers	O
differed	O
significantly	O
.	O

The	O
most	O
common	O
oral	O
pathogens	O
were	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
/	I-bacteria
nigrescens	I-bacteria
and	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
.	O

The	O
children	O
of	O
healthy	O
mothers	O
harboured	O
pathogens	O
less	O
frequently	O
than	O
the	O
children	O
of	O
diseased	O
mothers	O
.	O

The	O
sharing	O
of	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
/	I-bacteria
nigrescens	I-bacteria
was	O
more	O
frequent	O
(	O
5	O
families	O
)	O
than	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
(	O
2	O
families	O
)	O
.	O

Maternal	O
indicators	O
,	O
such	O
as	O
periodontitis	O
,	O
hygiene	O
habits	O
,	O
and	O
periodontal	O
microflora	O
are	O
risk	O
factors	O
for	O
childhood	O
periodontal	O
diseases	O
,	O
and	O
might	O
be	O
predictive	O
of	O
future	O
childhood	O
and	O
adolescent	O
periodontitis	O
.	O

A	O
-	O
type	O
cranberry	O
proanthocyanidins	O
(	O
AC	O
-	O
PACs	O
)	O
have	O
recently	O
been	O
reported	O
to	O
be	O
beneficial	O
for	O
human	O
health	O
,	O
especially	O
urinary	O
tract	O
health	O
.	O

The	O
effect	O
of	O
these	O
proanthocyanidins	O
on	O
periodontitis	O
,	O
a	O
destructive	O
disease	O
of	O
tooth	O
-	O
supporting	O
tissues	O
,	O
needs	O
to	O
be	O
investigated	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
effects	O
of	O
AC	O
-	O
PACs	O
on	O
various	O
virulence	O
determinants	O
of	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
as	O
well	O
as	O
on	O
the	O
inflammatory	O
response	O
of	O
oral	O
epithelial	O
cells	O
stimulated	O
by	O
this	O
periodontopathogen	O
.	O

We	O
examined	O
the	O
effects	O
of	O
AC	O
-	O
PACs	O
on	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
growth	O
and	O
biofilm	O
formation	O
,	O
adherence	O
to	O
human	O
oral	O
epithelial	O
cells	O
and	O
protein	O
-	O
coated	O
surfaces	O
,	O
collagenase	O
activity	O
,	O
and	O
invasiveness	O
.	O

We	O
also	O
tested	O
the	O
ability	O
of	O
AC	O
-	O
PACs	O
to	O
modulate	O
the	O
P	O
.	O
gingivalis	O
-	O
induced	O
inflammatory	O
response	O
by	O
human	O
oral	O
epithelial	O
cells	O
.	O

Our	O
results	O
showed	O
that	O
while	O
AC	O
-	O
PACs	O
neutralized	O
all	O
the	O
virulence	O
properties	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
in	O
a	O
dose	O
-	O
dependent	O
fashion	O
,	O
they	O
did	O
not	O
interfere	O
with	O
growth	O
.	O

They	O
also	O
inhibited	O
the	O
secretion	O
of	O
interleukin	O
-	O
8	O
(	O
IL	O
-	O
8	O
)	O
and	O
chemokine	O
(	O
C	O
-	O
C	O
motif	O
)	O
ligand	O
5	O
(	O
CCL5	O
)	O
but	O
did	O
not	O
affect	O
the	O
secretion	O
of	O
IL	O
-	O
6	O
by	O
epithelial	O
cells	O
stimulated	O
with	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
.	O

This	O
anti	O
-	O
inflammatory	O
effect	O
was	O
associated	O
with	O
reduced	O
activation	O
of	O
the	O
nuclear	O
factor	O
-	O
kappaB	O
(	O
NF	O
-	O
kappaB	O
)	O
p65	O
pathway	O
.	O

AC	O
-	O
PACs	O
may	O
be	O
potentially	O
valuable	O
bioactive	O
molecules	O
for	O
the	O
development	O
of	O
new	O
strategies	O
to	O
treat	O
and	O
prevent	O
P	O
.	O
gingivalis	O
-	O
associated	O
periodontal	O
diseases	O
.	O

The	O
subgingival	O
microbiome	O
is	O
largely	O
uncultivated	O
,	O
and	O
therefore	O
,	O
cultivation	O
-	O
based	O
and	O
targeted	O
molecular	O
approaches	O
have	O
limited	O
value	O
in	O
examining	O
the	O
effect	O
of	O
smoking	O
on	O
this	O
community	O
.	O

We	O
tested	O
the	O
hypothesis	O
that	O
the	O
subgingival	O
biofilm	O
is	O
compositionally	O
different	O
in	O
current	O
and	O
never	O
-	O
smokers	O
by	O
using	O
an	O
open	O
-	O
ended	O
molecular	O
approach	O
for	O
bacterial	O
identification	O
.	O

Subgingival	O
plaque	O
from	O
deep	O
sites	O
of	O
current	O
and	O
never	O
-	O
smokers	O
matched	O
for	O
disease	O
was	O
analyzed	O
by	O
16S	O
sequencing	O
.	O

Smokers	O
demonstrated	O
greater	O
abundance	O
of	O
Parvimonas	B-bacteria
,	O
Fusobacterium	B-bacteria
,	O
Campylobacter	B-bacteria
,	O
Bacteroides	B-bacteria
,	O
and	O
Treponema	B-bacteria
and	O
lower	O
levels	O
of	O
Veillonella	B-bacteria
,	O
Neisseria	B-bacteria
,	O
and	O
Streptococcus	B-bacteria
.	O

Several	O
uncultivated	O
Peptostreptococci	B-bacteria
,	O
Parvimonas	B-bacteria
micra	I-bacteria
,	O
Campylobacter	B-bacteria
gracilis	I-bacteria
,	O
Treponema	B-bacteria
socranskii	I-bacteria
,	O
Dialister	B-bacteria
pneumosintes	I-bacteria
,	O
and	O
Tannerella	B-bacteria
forsythia	I-bacteria
were	O
elevated	O
in	O
this	O
group	O
,	O
while	O
Veillonella	B-bacteria
sp	I-bacteria
.	I-bacteria
oral	I-bacteria
clone	I-bacteria
B2	I-bacteria
,	O
Neisseria	B-bacteria
sp	I-bacteria
.	I-bacteria
oral	I-bacteria
clone	I-bacteria
2	I-bacteria
.	I-bacteria
24	I-bacteria
,	O
Streptococcus	B-bacteria
sanguinis	I-bacteria
,	O
and	O
Capnocytophaga	B-bacteria
sp	I-bacteria
.	I-bacteria
clone	I-bacteria
AH015	I-bacteria
were	O
at	O
lower	O
levels	O
.	O

The	O
microbial	O
profile	O
of	O
smoking	O
-	O
associated	O
periodontitis	O
is	O
distinct	O
from	O
that	O
of	O
non	O
-	O
smokers	O
,	O
with	O
significant	O
differences	O
in	O
the	O
prevalence	O
and	O
abundance	O
of	O
disease	O
-	O
associated	O
and	O
health	O
-	O
compatible	O
organisms	O
.	O

Feline	O
chronic	O
gingivostomatitis	O
(	O
FCGS	O
)	O
is	O
a	O
chronic	O
inflammatory	O
disease	O
of	O
the	O
oral	O
cavity	O
that	O
causes	O
severe	O
pain	O
and	O
distress	O
.	O

There	O
are	O
currently	O
no	O
specific	O
treatment	O
methods	O
available	O
and	O
little	O
is	O
known	O
regarding	O
its	O
aetiology	O
,	O
although	O
bacteria	O
are	O
thought	O
to	O
play	O
a	O
major	O
role	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
identify	O
the	O
oral	O
bacterial	O
flora	O
in	O
normal	O
and	O
diseased	O
cats	O
.	O

Oral	O
swabs	O
were	O
obtained	O
from	O
the	O
palatoglossal	O
folds	O
of	O
eight	O
cats	O
(	O
three	O
normal	O
and	O
five	O
FCGS	O
)	O
and	O
were	O
subjected	O
to	O
microbiological	O
culture	O
.	O

Pasteurella	B-bacteria
pneumotropica	I-bacteria
and	O
Pasteurella	B-bacteria
multocida	I-bacteria
subsp	I-bacteria
.	I-bacteria
multocida	I-bacteria
were	O
the	O
most	O
prevalent	O
species	O
identified	O
by	O
culture	O
methods	O
in	O
the	O
normal	O
and	O
FCGS	O
samples	O
,	O
respectively	O
.	O

Bacteria	O
were	O
also	O
identified	O
using	O
culture	O
-	O
independent	O
methods	O
(	O
bacterial	O
16S	O
rRNA	O
gene	O
sequencing	O
)	O
.	O

For	O
the	O
normal	O
samples	O
,	O
158	O
clones	O
were	O
analysed	O
and	O
85	O
clones	O
were	O
sequenced	O
.	O

Capnocytophaga	B-bacteria
canimorsus	I-bacteria
(	O
10	O
.	O
8	O
%	O
of	O
clones	O
analysed	O
)	O
was	O
the	O
predominant	O
species	O
.	O

Uncultured	O
species	O
accounted	O
for	O
8	O
.	O
2	O
%	O
of	O
clones	O
analysed	O
,	O
and	O
43	O
.	O
7	O
%	O
of	O
clones	O
analysed	O
represented	O
potentially	O
novel	O
species	O
.	O

For	O
the	O
FCGS	O
samples	O
,	O
253	O
clones	O
were	O
analysed	O
and	O
91	O
clones	O
were	O
sequenced	O
.	O

The	O
predominant	O
species	O
was	O
P	B-bacteria
.	I-bacteria
multocida	I-bacteria
subsp	I-bacteria
.	I-bacteria
multocida	I-bacteria
(	O
51	O
.	O
8	O
%	O
of	O
clones	O
analysed	O
)	O
.	O

Uncultured	O
species	O
accounted	O
for	O
8	O
.	O
7	O
%	O
of	O
clones	O
analysed	O
,	O
and	O
4	O
.	O
7	O
%	O
of	O
clones	O
analysed	O
represented	O
potentially	O
novel	O
species	O
.	O

It	O
is	O
concluded	O
that	O
the	O
oral	O
flora	O
in	O
cats	O
with	O
FCGS	O
appears	O
to	O
be	O
less	O
diverse	O
than	O
that	O
found	O
in	O
normal	O
cats	O
.	O

However	O
,	O
P	B-bacteria
.	I-bacteria
multocida	I-bacteria
subsp	I-bacteria
.	I-bacteria
multocida	I-bacteria
is	O
found	O
to	O
be	O
significantly	O
more	O
prevalent	O
in	O
FCGS	O
than	O
in	O
normal	O
cats	O
and	O
consequently	O
may	O
be	O
of	O
aetiological	O
significance	O
in	O
this	O
disease	O
.	O

The	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
compare	O
dental	O
caries	O
and	O
periodontal	O
disease	O
status	O
associated	O
with	O
oral	O
microflora	O
among	O
smokeless	O
tobacco	O
chewers	O
and	O
non	O
-	O
chewers	O
.	O

Forty	O
-	O
two	O
smokeless	O
tobacco	O
chewers	O
and	O
42	O
non	O
-	O
chewers	O
(	O
age	O
20	O
to	O
60	O
years	O
)	O
were	O
assessed	O
for	O
dental	O
caries	O
and	O
periodontal	O
disease	O
status	O
using	O
the	O
Decayed	O
Missing	O
Filled	O
Surface	O
(	O
DMFS	O
)	O
Index	O
,	O
Community	O
Periodontal	O
Index	O
(	O
CPI	O
)	O
and	O
Loss	O
of	O
Attachment	O
(	O
LA	O
)	O
Index	O
.	O

Stimulated	O
saliva	O
and	O
subgingival	O
plaque	O
samples	O
were	O
collected	O
from	O
each	O
subject	O
for	O
performing	O
a	O
culture	O
-	O
based	O
analysis	O
of	O
20	O
types	O
of	O
oral	O
microorganisms	O
.	O

Qualitative	O
and	O
semi	O
-	O
quantitative	O
culture	O
-	O
based	O
analysis	O
using	O
MacConkey	O
agar	O
,	O
and	O
aerobic	O
and	O
anaerobic	O
blood	O
agar	O
was	O
carried	O
out	O
to	O
determine	O
the	O
total	O
cultivable	O
microflora	O
.	O

Mutans	O
-	O
Sanguis	O
agar	O
,	O
Pfizer	O
selective	O
Enterococcus	B-bacteria
agar	O
and	O
Rogosa	O
SL	O
agar	O
were	O
used	O
for	O
the	O
culture	O
of	O
microorganisms	O
associated	O
with	O
dental	O
caries	O
.	O

Mann	O
-	O
Whitney	O
U	O
test	O
and	O
Student	O
t	O
test	O
were	O
employed	O
to	O
compare	O
colony	O
-	O
forming	O
units	O
(	O
CFUs	O
)	O
and	O
caries	O
experience	O
between	O
smokeless	O
tobacco	O
chewers	O
and	O
nonchewers	O
.	O

Z	O
proportionality	O
test	O
was	O
used	O
to	O
compare	O
the	O
periodontal	O
disease	O
status	O
.	O

Caries	O
experience	O
among	O
chewers	O
(	O
26	O
of	O
42	O
)	O
,	O
that	O
is	O
those	O
subjects	O
who	O
were	O
affected	O
by	O
caries	O
,	O
was	O
significantly	O
less	O
at	O
61	O
.	O
9	O
%	O
(	O
mean	O
DMFS	O
=	O
3	O
.	O
5	O
)	O
compared	O
to	O
non	O
-	O
chewers	O
(	O
38	O
of	O
42	O
,	O
90	O
.	O
5	O
%	O
)	O
(	O
mean	O
DMFS	O
=	O
5	O
.	O
5	O
)	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

Deep	O
pockets	O
measuring	O
>	O
5	O
.	O
5	O
mm	O
on	O
a	O
CPI	O
probe	O
were	O
found	O
among	O
26	O
.	O
2	O
%	O
of	O
chewers	O
and	O
19	O
.	O
1	O
%	O
of	O
nonchewers	O
,	O
with	O
no	O
statistically	O
significant	O
differences	O
(	O
P	O
>	O
0	O
.	O
05	O
)	O
.	O

Counts	O
of	O
Lactobacillus	B-bacteria
species	I-bacteria
were	O
significantly	O
lower	O
among	O
chewers	O
(	O
median	O
CFU	O
=	O
0	O
.	O
788	O
x	O
10	O
(	O
5	O
)	O
)	O
than	O
among	O
non	O
-	O
chewers	O
(	O
median	O
CFU	O
=	O
1	O
.	O
52	O
x	O
10	O
(	O
5	O
)	O
)	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

Prevotella	B-bacteria
and	O
Porphyromonas	B-bacteria
species	I-bacteria
had	O
a	O
median	O
CFU	O
of	O
0	O
.	O
04	O
x	O
105	O
in	O
chewers	O
and	O
0	O
.	O
15	O
x	O
10	O
(	O
5	O
)	O
in	O
non	O
-	O
chewers	O
,	O
whereas	O
Fusobacterium	B-bacteria
species	I-bacteria
had	O
a	O
median	O
CFU	O
of	O
0	O
.	O
02	O
x	O
10	O
(	O
5	O
)	O
in	O
chewers	O
and	O
0	O
.	O
1	O
x	O
10	O
(	O
5	O
)	O
in	O
non	O
-	O
chewers	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

A	O
higher	O
percentage	O
of	O
caries	O
among	O
non	O
-	O
chewers	O
can	O
be	O
explained	O
by	O
greater	O
numbers	O
of	O
Lactobacillus	B-bacteria
species	I-bacteria
in	O
this	O
population	O
.	O

Chewers	O
experienced	O
a	O
slightly	O
higher	O
incidence	O
of	O
periodontal	O
disease	O
than	O
non	O
-	O
chewers	O
,	O
but	O
the	O
difference	O
was	O
not	O
significant	O
.	O

These	O
clinical	O
observations	O
suggest	O
a	O
lower	O
ability	O
of	O
Gram	O
-	O
negative	O
bacteria	O
to	O
mediate	O
more	O
periodontal	O
disease	O
in	O
this	O
population	O
.	O

The	O
escalating	O
global	O
incidence	O
of	O
bacterial	O
infection	O
,	O
particularly	O
in	O
chronic	O
wounds	O
,	O
is	O
a	O
problem	O
that	O
requires	O
significant	O
improvements	O
to	O
existing	O
therapies	O
.	O

We	O
have	O
developed	O
hyperbranched	O
poly	O
(	O
NIPAM	O
)	O
polymers	O
functionalized	O
with	O
the	O
antibiotics	O
Vancomycin	O
and	O
Polymyxin	O
-	O
B	O
that	O
are	O
sensitive	O
to	O
the	O
presence	O
of	O
bacteria	O
in	O
solution	O
.	O

Binding	O
of	O
bacteria	O
to	O
the	O
polymers	O
causes	O
a	O
conformational	O
change	O
,	O
resulting	O
in	O
collapse	O
of	O
the	O
polymers	O
and	O
the	O
formation	O
of	O
insoluble	O
polymer	O
/	O
bacteria	O
complexes	O
.	O

We	O
have	O
applied	O
these	O
novel	O
polymers	O
to	O
our	O
tissue	O
engineered	O
human	O
skin	O
model	O
of	O
a	O
burn	O
wound	O
infected	O
with	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
and	O
Staphylococcus	B-bacteria
aureus	I-bacteria
.	O

When	O
the	O
polymers	O
were	O
removed	O
from	O
the	O
infected	O
skin	O
,	O
either	O
in	O
a	O
polymer	O
gel	O
solution	O
or	O
in	O
the	O
form	O
of	O
hydrogel	O
membranes	O
,	O
they	O
removed	O
bound	O
bacteria	O
,	O
thus	O
reducing	O
the	O
bacterial	O
load	O
in	O
the	O
infected	O
skin	O
model	O
.	O

These	O
bacteria	O
-	O
binding	O
polymers	O
have	O
many	O
potential	O
uses	O
,	O
including	O
coatings	O
for	O
wound	O
dressings	O
.	O

Following	O
an	O
outbreak	O
of	O
carbapenem	B-bacteria
resistant	I-bacteria
Klebsiella	I-bacteria
pneumoniae	I-bacteria
(	O
CRKP	B-bacteria
)	O
bacteremia	O
among	O
inpatients	O
in	O
the	O
Hemato	O
-	O
oncology	O
and	O
BMT	O
unit	O
,	O
we	O
studied	O
the	O
course	O
of	O
this	O
infection	O
in	O
patients	O
undergoing	O
intensive	O
chemotherapy	O
and	O
SCT	O
.	O

In	O
addition	O
,	O
we	O
conducted	O
a	O
pilot	O
study	O
aimed	O
to	O
eradicate	O
CRKP	B-bacteria
colonization	O
in	O
the	O
gastrointestinal	O
tract	O
,	O
using	O
oral	O
gentamicin	O
.	O

Adult	O
patients	O
admitted	O
to	O
the	O
BMT	O
unit	O
,	O
identified	O
as	O
CRKP	B-bacteria
carriers	O
on	O
surveillance	O
rectal	O
cultures	O
,	O
were	O
included	O
in	O
the	O
study	O
.	O

Oral	O
gentamicin	O
at	O
a	O
dose	O
of	O
80	O
mg	O
q	O
.	O
i	O
.	O
d	O
.	O
was	O
administered	O
to	O
all	O
identified	O
carriers	O
until	O
eradication	O
.	O

Among	O
15	O
colonized	O
patients	O
included	O
in	O
the	O
study	O
,	O
the	O
eradication	O
rate	O
achieved	O
was	O
66	O
%	O
(	O
10	O
/	O
15	O
)	O
;	O
discontinuation	O
of	O
persistent	O
bacteremia	O
occurred	O
in	O
62	O
.	O
5	O
%	O
(	O
5	O
/	O
8	O
)	O
and	O
nosocomial	O
spread	O
of	O
CRKP	B-bacteria
carrier	O
state	O
ceased	O
.	O

Administration	O
of	O
intensive	O
chemotherapy	O
and	O
SCT	O
is	O
feasible	O
,	O
although	O
associated	O
with	O
increased	O
risk	O
.	O

Hematological	O
patients	O
in	O
need	O
of	O
intensive	O
chemotherapy	O
/	O
SCT	O
should	O
not	O
be	O
denied	O
the	O
required	O
treatment	O
on	O
the	O
basis	O
of	O
being	O
CRKP	B-bacteria
carriers	O
.	O

Oral	O
gentamicin	O
treatment	O
for	O
eradication	O
of	O
CRKP	B-bacteria
from	O
the	O
gastrointestinal	O
reservoir	O
could	O
serve	O
as	O
additional	O
tool	O
in	O
the	O
combat	O
against	O
the	O
nosocomial	O
spread	O
and	O
severe	O
infections	O
caused	O
by	O
this	O
difficult	O
-	O
to	O
-	O
treat	O
organism	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
electrochemical	O
behavior	O
of	O
nickel	O
titanium	O
(	O
NiTi	O
)	O
orthodontic	O
wires	O
in	O
a	O
solution	O
containing	O
Streptococcus	B-bacteria
mutans	I-bacteria
oral	O
bacteria	O
.	O

In	O
this	O
article	O
,	O
we	O
explain	O
our	O
choice	O
of	O
bacterial	O
species	O
before	O
describing	O
the	O
culture	O
process	O
in	O
artificial	O
saliva	O
and	O
the	O
precautions	O
needed	O
to	O
prevent	O
contamination	O
by	O
other	O
bacteria	O
.	O

The	O
electrochemical	O
behavior	O
of	O
the	O
alloy	O
(	O
NiTi	O
)	O
was	O
analyzed	O
electrochemically	O
in	O
Ringer	O
sterile	O
artificial	O
saliva	O
and	O
in	O
artificial	O
saliva	O
enriched	O
with	O
a	O
sterile	O
broth	O
and	O
modified	O
by	O
addition	O
of	O
bacteria	O
.	O

The	O
electrochemical	O
procedures	O
chosen	O
for	O
this	O
study	O
were	O
:	O
free	O
corrosion	O
potential	O
,	O
potentiodynamic	O
curves	O
and	O
impedance	O
spectroscopy	O
.	O

In	O
this	O
way	O
,	O
we	O
were	O
able	O
to	O
show	O
that	O
the	O
free	O
corrosion	O
potential	O
of	O
the	O
NiTi	O
in	O
the	O
Ringer	O
solution	O
increases	O
with	O
time	O
and	O
then	O
stabilizes	O
,	O
thus	O
passivating	O
the	O
alloy	O
.	O

We	O
also	O
demonstrated	O
that	O
colonization	O
of	O
the	O
metal	O
surface	O
by	O
bacteria	O
triggered	O
a	O
drop	O
in	O
the	O
free	O
corrosion	O
potential	O
.	O

The	O
electrochemical	O
impedance	O
findings	O
revealed	O
no	O
significant	O
difference	O
in	O
NiTi	O
behavior	O
between	O
the	O
two	O
media	O
.	O

Finally	O
,	O
we	O
observed	O
a	O
slight	O
difference	O
between	O
the	O
two	O
corrosion	O
currents	O
in	O
favor	O
of	O
the	O
bacteria	O
-	O
enriched	O
solution	O
,	O
in	O
which	O
the	O
NiTi	O
underwent	O
greater	O
corrosion	O
.	O

These	O
findings	O
demonstrate	O
the	O
impact	O
of	O
acidogenic	O
bacteria	O
on	O
corrosion	O
behavior	O
of	O
the	O
NiTi	O
wires	O
investigated	O
.	O

However	O
,	O
further	O
research	O
is	O
required	O
,	O
notably	O
incorporating	O
longer	O
immersion	O
times	O
in	O
the	O
two	O
media	O
.	O

As	O
in	O
other	O
fields	O
of	O
healthcare	O
,	O
probiotics	O
have	O
been	O
introduced	O
for	O
prevention	O
and	O
treatment	O
of	O
periodontal	O
diseases	O
.	O

This	O
review	O
was	O
initiated	O
to	O
explore	O
whether	O
the	O
use	O
of	O
probiotics	O
can	O
influence	O
the	O
periodontal	O
microbiota	O
and	O
periodontal	O
health	O
.	O

Literature	O
on	O
the	O
mode	O
of	O
action	O
of	O
oral	O
probiotics	O
was	O
reviewed	O
and	O
a	O
systematic	O
review	O
was	O
performed	O
on	O
the	O
microbiological	O
and	O
clinical	O
effects	O
of	O
oral	O
probiotics	O
on	O
periodontal	O
health	O
.	O

Three	O
animal	O
and	O
11	O
in	O
vivo	O
human	O
studies	O
were	O
retrieved	O
.	O

Six	O
studies	O
reported	O
on	O
microbiological	O
effects	O
whereas	O
eight	O
studies	O
report	O
on	O
clinical	O
effects	O
.	O

Seven	O
studies	O
were	O
performed	O
on	O
healthy	O
or	O
gingivitis	O
patients	O
and	O
four	O
studies	O
on	O
periodontitis	O
patients	O
.	O

Many	O
of	O
the	O
retrieved	O
studies	O
are	O
pilot	O
in	O
nature	O
and	O
with	O
low	O
quality	O
.	O

The	O
high	O
degree	O
of	O
heterogeneity	O
between	O
studies	O
hampered	O
analysis	O
.	O

Taking	O
into	O
consideration	O
all	O
limitations	O
,	O
the	O
currently	O
available	O
data	O
indicate	O
an	O
effect	O
of	O
probiotics	O
on	O
the	O
oral	O
microbiota	O
and	O
a	O
more	O
limited	O
effect	O
on	O
clinical	O
periodontal	O
outcome	O
measures	O
.	O

However	O
,	O
there	O
is	O
an	O
urgent	O
need	O
for	O
properly	O
conducted	O
clinical	O
trials	O
where	O
probiotics	O
are	O
used	O
as	O
adjuncts	O
to	O
standard	O
periodontal	O
care	O
,	O
similar	O
to	O
antibiotics	O
,	O
using	O
probiotic	O
strains	O
with	O
,	O
at	O
least	O
at	O
an	O
in	O
vitro	O
level	O
,	O
proven	O
periodontal	O
probiotic	O
effects	O
.	O

Atopic	O
dermatitis	O
(	O
AD	O
)	O
is	O
marked	O
by	O
elevated	O
levels	O
of	O
immunoglobulin	O
E	O
and	O
skin	O
lesions	O
such	O
as	O
oedema	O
and	O
haemorrhage	O
.	O

Kimchi	O
is	O
a	O
Korean	O
fermented	O
food	O
that	O
contains	O
beneficial	O
bacteria	O
for	O
human	O
health	O
.	O

In	O
this	O
study	O
,	O
Lactobacillus	B-bacteria
plantarum	I-bacteria
CJLP55	I-bacteria
,	O
CJLP56	B-bacteria
,	O
CJLP133	B-bacteria
and	O
CJLP136	B-bacteria
isolated	O
from	O
Kimchi	O
were	O
investigated	O
for	O
their	O
capacity	O
to	O
inhibit	O
AD	O
.	O

The	O
three	O
strains	O
,	O
CJLP55	B-bacteria
,	O
CJLP133	B-bacteria
and	O
CJLP136	B-bacteria
,	O
suppressed	O
AD	O
-	O
like	O
skin	O
lesions	O
,	O
high	O
serum	O
IgE	O
levels	O
and	O
epidermal	O
thickening	O
.	O

The	O
three	O
strains	O
diminished	O
the	O
accumulation	O
of	O
eosinophils	O
and	O
mast	O
cells	O
into	O
topical	O
inflammatory	O
sites	O
and	O
the	O
enlargement	O
of	O
axillary	O
lymph	O
nodes	O
,	O
which	O
are	O
responsible	O
for	O
the	O
dorsal	O
dermatitis	O
.	O

CJLP55	B-bacteria
,	O
CJLP133	B-bacteria
and	O
CJLP136	B-bacteria
decreased	O
production	O
of	O
type	O
2	O
cytokines	O
such	O
as	O
IL	O
-	O
4	O
and	O
IL	O
-	O
5	O
in	O
lymph	O
node	O
cell	O
culture	O
.	O

CJLP133	B-bacteria
and	O
CJLP136	B-bacteria
increased	O
IFN	O
-	O
gamma	O
secretion	O
,	O
while	O
CJLP55	B-bacteria
enhanced	O
IL	O
-	O
10	O
production	O
.	O

The	O
three	O
strains	O
isolated	O
from	O
Kimchi	O
suppress	O
house	O
-	O
dust	O
mite	O
-	O
induced	O
dermatitis	O
in	O
NC	O
/	O
Nga	O
mouse	O
,	O
a	O
representative	O
animal	O
model	O
of	O
human	O
AD	O
.	O

These	O
findings	O
suggest	O
that	O
lactobacilli	B-bacteria
isolated	O
from	O
Kimchi	O
inhibit	O
AD	O
,	O
probably	O
by	O
altering	O
the	O
balance	O
of	O
Th1	O
/	O
Th2	O
ratio	O
or	O
inducing	O
IL	O
-	O
10	O
production	O
.	O

The	O
areca	O
nut	O
is	O
the	O
most	O
widely	O
consumed	O
psychoactive	O
substance	O
in	O
Taiwan	O
,	O
India	O
,	O
and	O
Southeast	O
Asia	O
.	O

It	O
is	O
considered	O
to	O
be	O
an	O
environmental	O
risk	O
factor	O
for	O
the	O
development	O
of	O
oral	O
submucous	O
fibrosis	O
and	O
cancer	O
.	O

Arecoline	O
,	O
the	O
major	O
alkaloid	O
of	O
areca	O
nut	O
,	O
has	O
been	O
known	O
to	O
cause	O
cytotoxicity	O
and	O
genotoxicity	O
in	O
various	O
systems	O
.	O

However	O
,	O
the	O
active	O
compound	O
accounting	O
for	O
arecoline	O
-	O
induced	O
damage	O
in	O
normal	O
human	O
oral	O
cells	O
is	O
still	O
uncharacterized	O
.	O

The	O
present	O
study	O
was	O
undertaken	O
to	O
identify	O
the	O
active	O
metabolite	O
of	O
arecoline	O
that	O
might	O
induce	O
damage	O
in	O
human	O
oral	O
tissues	O
and	O
cause	O
mutagenicity	O
in	O
Salmonella	B-bacteria
typhimurium	I-bacteria
tester	O
strains	O
TA	B-bacteria
100	I-bacteria
and	O
TA	B-bacteria
98	I-bacteria
.	O

It	O
is	O
interesting	O
to	O
find	O
that	O
the	O
major	O
metabolite	O
of	O
arecoline	O
,	O
arecoline	O
N	O
-	O
oxide	O
,	O
is	O
moderately	O
mutagenic	O
to	O
these	O
Salmonella	B-bacteria
tester	I-bacteria
strains	I-bacteria
.	O

This	O
mutagenicity	O
was	O
potently	O
inhibited	O
by	O
sulfhydryl	O
compounds	O
,	O
namely	O
,	O
glutathione	O
,	O
N	O
-	O
acetylcysteine	O
,	O
and	O
cysteine	O
,	O
whereas	O
methionine	O
is	O
inactive	O
in	O
this	O
inhibition	O
.	O

The	O
mutagenicity	O
of	O
arecoline	O
N	O
-	O
oxide	O
was	O
strongly	O
inhibited	O
by	O
the	O
N	O
-	O
oxide	O
reducing	O
agent	O
titanium	O
trichloride	O
.	O

The	O
possible	O
role	O
of	O
arecoline	O
N	O
-	O
oxide	O
in	O
the	O
induction	O
of	O
oral	O
carcinogenesis	O
by	O
areca	O
nut	O
chewing	O
is	O
discussed	O
.	O

Periodontal	O
disease	O
is	O
one	O
of	O
the	O
most	O
common	O
diseases	O
of	O
adult	O
dogs	O
,	O
with	O
up	O
to	O
80	O
%	O
of	O
animals	O
affected	O
.	O

The	O
aetiology	O
of	O
the	O
disease	O
is	O
poorly	O
studied	O
,	O
although	O
bacteria	O
are	O
known	O
to	O
play	O
a	O
major	O
role	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
identify	O
the	O
bacteria	O
associated	O
with	O
canine	O
gingivitis	O
and	O
periodontitis	O
and	O
to	O
compare	O
this	O
with	O
the	O
normal	O
oral	O
flora	O
.	O

Swabs	O
were	O
obtained	O
from	O
the	O
gingival	O
margin	O
of	O
three	O
dogs	O
with	O
gingivitis	O
and	O
three	O
orally	O
healthy	O
controls	O
,	O
and	O
subgingival	O
plaque	O
was	O
collected	O
from	O
three	O
dogs	O
with	O
periodontitis	O
.	O

Samples	O
were	O
subjected	O
to	O
routine	O
bacterial	O
culture	O
.	O

The	O
prevalent	O
species	O
identified	O
in	O
the	O
normal	O
,	O
gingivitis	O
and	O
periodontitis	O
groups	O
were	O
uncultured	O
bacterium	O
(	O
12	O
.	O
5	O
%	O
of	O
isolates	O
)	O
,	O
Bacteroides	B-bacteria
heparinolyticus	I-bacteria
/	O
Pasteurella	B-bacteria
dagmatis	I-bacteria
(	O
10	O
.	O
0	O
%	O
)	O
and	O
Actinomyces	B-bacteria
canis	I-bacteria
(	O
19	O
.	O
4	O
%	O
)	O
,	O
respectively	O
.	O

Bacteria	O
were	O
also	O
identified	O
using	O
culture	O
-	O
independent	O
methods	O
(	O
16S	O
rRNA	O
gene	O
sequencing	O
)	O
and	O
the	O
predominant	O
species	O
identified	O
were	O
Pseudomonas	B-bacteria
sp	I-bacteria
.	I-bacteria
(	O
30	O
.	O
9	O
%	O
of	O
clones	O
analysed	O
)	O
,	O
Porphyromonas	B-bacteria
cangingivalis	I-bacteria
(	O
16	O
.	O
1	O
%	O
)	O
and	O
Desulfomicrobium	B-bacteria
orale	I-bacteria
(	O
12	O
.	O
0	O
%	O
)	O
in	O
the	O
normal	O
,	O
gingivitis	O
and	O
periodontitis	O
groups	O
,	O
respectively	O
.	O

Uncultured	O
species	O
accounted	O
for	O
13	O
.	O
2	O
%	O
,	O
2	O
.	O
0	O
%	O
and	O
10	O
.	O
5	O
%	O
,	O
and	O
potentially	O
novel	O
species	O
for	O
38	O
.	O
2	O
%	O
,	O
38	O
.	O
3	O
%	O
and	O
35	O
.	O
3	O
%	O
,	O
of	O
clones	O
in	O
the	O
normal	O
,	O
gingivitis	O
and	O
periodontitis	O
groups	O
,	O
respectively	O
.	O

This	O
is	O
the	O
first	O
study	O
to	O
use	O
utilise	O
culture	O
-	O
independent	O
methods	O
for	O
the	O
identification	O
of	O
bacteria	O
associated	O
with	O
this	O
disease	O
.	O

It	O
is	O
concluded	O
that	O
the	O
canine	O
oral	O
flora	O
in	O
health	O
and	O
disease	O
is	O
highly	O
diverse	O
and	O
also	O
contains	O
a	O
high	O
proportion	O
of	O
uncultured	O
and	O
,	O
in	O
particular	O
,	O
potentially	O
novel	O
species	O
.	O

Advances	O
in	O
isolation	O
and	O
culturing	O
techniques	O
have	O
brought	O
the	O
role	O
of	O
anaerobic	O
bacteria	O
-	O
causing	O
maxillofacial	O
infections	O
to	O
the	O
fore	O
.	O

Recent	O
literature	O
also	O
favors	O
the	O
role	O
of	O
anaerobes	O
in	O
maxillofacial	O
infections	O
.	O

A	O
prospective	O
clinical	O
and	O
microbiological	O
study	O
was	O
designed	O
to	O
check	O
the	O
validity	O
of	O
such	O
claims	O
.	O

This	O
study	O
included	O
88	O
patients	O
who	O
fulfilled	O
the	O
inclusion	O
criteria	O
.	O

Pus	O
was	O
obtained	O
by	O
aspirating	O
the	O
involved	O
spaces	O
and	O
culture	O
and	O
sensitivity	O
tests	O
were	O
performed	O
to	O
determine	O
the	O
microbes	O
involved	O
and	O
their	O
sensitivity	O
to	O
various	O
antibiotics	O
.	O

Upon	O
isolating	O
the	O
various	O
organisms	O
causing	O
infection	O
,	O
it	O
was	O
found	O
that	O
68	O
.	O
2	O
%	O
were	O
aerobes	O
,	O
13	O
.	O
6	O
%	O
were	O
mixed	O
infections	O
,	O
and	O
9	O
.	O
1	O
%	O
were	O
anaerobes	O
.	O

Streptococcus	B-bacteria
and	O
Peptostreptococcus	B-bacteria
species	I-bacteria
were	O
the	O
most	O
common	O
among	O
aerobes	O
and	O
anaerobes	O
,	O
respectively	O
.	O

On	O
determining	O
sensitivity	O
to	O
penicillin	O
,	O
81	O
.	O
3	O
%	O
were	O
sensitive	O
and	O
18	O
.	O
8	O
%	O
were	O
resistant	O
.	O

Coagulase	B-bacteria
-	I-bacteria
negative	I-bacteria
Staphylococcus	B-bacteria
and	O
Staphylococcus	B-bacteria
aureus	I-bacteria
were	O
predominantly	O
resistant	O
to	O
penicillin	O
.	O

Analysis	O
of	O
the	O
results	O
indicated	O
no	O
change	O
in	O
microflora	O
-	O
causing	O
infections	O
in	O
the	O
maxillofacial	O
region	O
and	O
penicillin	O
remains	O
the	O
drug	O
of	O
choice	O
in	O
treating	O
these	O
infections	O
.	O

To	O
clarify	O
the	O
regulatory	O
mechanism	O
by	O
bactericidal	O
peptides	O
secretion	O
,	O
the	O
secretion	O
of	O
bactericidal	O
peptides	O
was	O
immunohistochemically	O
and	O
histoplanimetrically	O
compared	O
with	O
the	O
degree	O
of	O
Gram	O
-	O
positive	O
/	O
negative	O
bacterial	O
colonization	O
throughout	O
the	O
rat	O
alimentary	O
tract	O
.	O

In	O
the	O
associated	O
exocrine	O
glands	O
from	O
the	O
oral	O
cavity	O
to	O
the	O
stomach	O
,	O
no	O
comparable	O
differences	O
were	O
observed	O
under	O
the	O
changes	O
of	O
development	O
of	O
indigenous	O
bacterial	O
colonies	O
.	O

In	O
the	O
small	O
intestine	O
,	O
immunopositive	O
granules	O
for	O
lysozyme	O
and	O
secretory	O
phospholipase	O
A2	O
(	O
sPLA2	O
)	O
were	O
markedly	O
decreased	O
,	O
whereas	O
immunopositive	O
vacuoles	O
in	O
the	O
Paneth	O
cells	O
were	O
more	O
increased	O
at	O
sites	O
with	O
hyper	O
-	O
development	O
of	O
indigenous	O
bacterial	O
colonies	O
in	O
the	O
intervillous	O
spaces	O
than	O
at	O
sites	O
with	O
no	O
or	O
less	O
development	O
.	O

No	O
changes	O
in	O
exocrine	O
glands	O
were	O
observed	O
in	O
the	O
large	O
intestine	O
because	O
of	O
the	O
constant	O
existence	O
of	O
large	O
quantities	O
of	O
bacteria	O
.	O

Gram	O
-	O
positive	O
bacterial	O
colonies	O
on	O
the	O
mucosal	O
surfaces	O
were	O
dominant	O
from	O
the	O
oral	O
cavity	O
to	O
the	O
stomach	O
.	O

Gram	O
-	O
negative	O
bacteria	O
were	O
dominant	O
in	O
the	O
large	O
intestine	O
,	O
and	O
the	O
distributions	O
of	O
both	O
Gram	O
-	O
positive	O
and	O
negative	O
bacteria	O
were	O
intermediate	O
in	O
the	O
small	O
intestine	O
.	O

These	O
findings	O
suggest	O
that	O
lysozyme	O
and	O
sPLA2	O
secreted	O
from	O
the	O
Paneth	O
cells	O
contribute	O
to	O
the	O
regulation	O
of	O
the	O
proliferation	O
of	O
indigenous	O
bacteria	O
in	O
the	O
intervillous	O
spaces	O
of	O
the	O
small	O
intestine	O
,	O
and	O
that	O
the	O
inversion	O
of	O
distributions	O
of	O
Gram	O
-	O
positive	O
and	O
-	O
negative	O
bacteria	O
in	O
the	O
alimentary	O
tract	O
might	O
be	O
caused	O
by	O
the	O
secretion	O
of	O
lysozyme	O
and	O
sPLA2	O
in	O
the	O
small	O
intestine	O
.	O

The	O
goal	O
of	O
this	O
project	O
was	O
to	O
develop	O
an	O
alternative	O
foot	O
and	O
mouth	O
disease	O
(	O
FMD	O
)	O
vaccine	O
candidate	O
based	O
on	O
a	O
recombinant	O
protein	O
consisting	O
of	O
efficient	O
viral	O
epitopes	O
.	O

A	O
recombinant	O
gene	O
was	O
designed	O
that	O
encodes	O
B	O
-	O
cell	O
epitopes	O
of	O
proteins	O
VP1	O
and	O
VP4	O
and	O
T	O
-	O
cell	O
epitopes	O
of	O
proteins	O
2C	O
and	O
3D	O
.	O

The	O
polyepitope	O
protein	O
(	O
H	O
-	O
PE	O
)	O
was	O
produced	O
in	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
bacteria	I-bacteria
or	O
in	O
N	O
.	O
benthamiana	O
plants	O
using	O
a	O
phytovirus	O
expression	O
system	O
.	O

The	O
methods	O
of	O
extraction	O
and	O
purification	O
of	O
H	O
-	O
PE	O
proteins	O
from	O
bacteria	O
and	O
plants	O
were	O
developed	O
.	O

Immunization	O
of	O
guinea	O
pigs	O
with	O
the	O
purified	O
H	O
-	O
PE	O
proteins	O
induced	O
an	O
efficient	O
immune	O
response	O
against	O
foot	O
and	O
mouth	O
disease	O
virus	O
(	O
FMDV	O
)	O
serotype	O
O	O
/	O
Taiwan	O
/	O
99	O
and	O
protection	O
against	O
the	O
disease	O
.	O

The	O
polyepitope	O
protein	O
H	O
-	O
PE	O
can	O
be	O
used	O
as	O
a	O
basis	O
for	O
developing	O
a	O
new	O
recombinant	O
vaccine	O
against	O
FMD	O
.	O

Although	O
Candida	O
albicans	O
has	O
been	O
isolated	O
from	O
periodontal	O
pockets	O
,	O
its	O
relationship	O
to	O
periodontitis	O
is	O
unclear	O
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
effect	O
of	O
C	O
.	O
albicans	O
on	O
the	O
adhesion	O
and	O
invasion	O
of	O
Ca9	O
-	O
22	O
,	O
a	O
human	O
gingival	O
epithelial	O
cell	O
line	O
,	O
and	O
human	O
gingival	O
fibroblasts	O
by	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
.	O

Heat	O
-	O
killed	O
C	O
.	O
albicans	O
and	O
water	O
-	O
soluble	O
mannoprotein	O
-	O
beta	O
-	O
glucan	O
complex	O
from	O
C	O
.	O
albicans	O
(	O
CAWS	O
)	O
did	O
not	O
enhance	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
adhesion	O
or	O
upregulate	O
the	O
expression	O
of	O
beta1	O
integrin	O
and	O
ICAM	O
-	O
1	O
,	O
which	O
are	O
required	O
for	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
invasion	O
;	O
both	O
the	O
epithelial	O
cells	O
and	O
fibroblasts	O
expressed	O
dectin	O
-	O
1	O
,	O
which	O
recognizes	O
components	O
of	O
the	O
C	O
.	O
albicans	O
cell	O
wall	O
.	O

However	O
,	O
pretreatment	O
of	O
Ca9	O
-	O
22	O
cells	O
and	O
human	O
gingival	O
fibroblasts	O
with	O
heat	O
-	O
killed	O
C	O
.	O
albicans	O
or	O
CAWS	O
significantly	O
enhanced	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
invasion	O
.	O

These	O
results	O
suggest	O
that	O
C	O
.	O
albicans	O
may	O
exacerbate	O
infectious	O
disease	O
by	O
enhancing	O
the	O
invasion	O
of	O
host	O
cells	O
by	O
anaerobic	O
bacteria	O
.	O

Retrospective	O
and	O
prospective	O
studies	O
were	O
used	O
to	O
assess	O
the	O
numbers	O
,	O
types	O
and	O
persistence	O
of	O
microbes	O
that	O
contaminate	O
wind	O
instruments	O
.	O

All	O
previously	O
played	O
instruments	O
(	O
n	O
=	O
20	O
)	O
harbored	O
viable	O
bacteria	O
as	O
well	O
as	O
mold	O
and	O
/	O
or	O
yeast	O
.	O

Reedinstruments	O
consistently	O
carried	O
higher	O
microbial	O
loads	O
than	O
did	O
flutes	O
or	O
trumpets	O
.	O

Instruments	O
played	O
within	O
the	O
previous	O
three	O
days	O
bore	O
typical	O
mouth	O
flora	O
,	O
while	O
bacteria	O
recovered	O
after	O
72	O
h	O
following	O
play	O
consisted	O
of	O
normal	O
environmental	O
flora	O
.	O

Prospective	O
studies	O
tested	O
survival	O
of	O
potentially	O
pathogenic	O
bacteria	O
(	O
Staphylococcus	B-bacteria
,	O
Streptococcus	B-bacteria
,	O
Moraxella	B-bacteria
,	O
Escherichia	B-bacteria
coli	I-bacteria
and	O
attenuated	O
Mycobacterium	B-bacteria
tuberculosis	I-bacteria
)	O
when	O
applied	O
to	O
reeds	O
or	O
following	O
simulated	O
'	O
play	O
'	O
of	O
a	O
clarinet	O
.	O

All	O
species	O
survived	O
for	O
a	O
maximum	O
of	O
24	O
-	O
48	O
h	O
on	O
reeds	O
,	O
except	O
Mycobacterium	B-bacteria
,	O
which	O
persisted	O
through	O
13	O
days	O
.	O

In	O
simulated	O
play	O
experiments	O
,	O
test	O
bacteria	O
could	O
persist	O
for	O
up	O
to	O
five	O
days	O
.	O

These	O
findings	O
support	O
the	O
establishment	O
of	O
guidelines	O
for	O
decontamination	O
of	O
wind	O
instruments	O
and	O
for	O
sharing	O
or	O
transfer	O
of	O
these	O
instruments	O
among	O
players	O
.	O

Patients	O
with	O
xerostomia	O
,	O
or	O
dry	O
mouth	O
,	O
resulting	O
from	O
various	O
causes	O
,	O
are	O
at	O
higher	O
risk	O
for	O
developing	O
caries	O
because	O
of	O
a	O
loss	O
of	O
saliva	O
and	O
its	O
benefits	O
.	O

A	O
loss	O
of	O
saliva	O
increases	O
the	O
acidity	O
of	O
the	O
mouth	O
,	O
which	O
affects	O
many	O
factors	O
that	O
contribute	O
to	O
the	O
development	O
of	O
caries	O
,	O
such	O
as	O
proliferation	O
of	O
acid	O
-	O
producing	O
bacteria	O
,	O
inability	O
to	O
buffer	O
the	O
acid	O
produced	O
by	O
bacteria	O
or	O
from	O
ingested	O
foods	O
,	O
loss	O
of	O
minerals	O
from	O
tooth	O
surfaces	O
and	O
inability	O
to	O
replenish	O
the	O
lost	O
minerals	O
,	O
and	O
loss	O
of	O
lubrication	O
.	O

Currently	O
,	O
a	O
number	O
of	O
new	O
products	O
that	O
can	O
substitute	O
for	O
these	O
functions	O
of	O
saliva	O
or	O
induce	O
production	O
of	O
saliva	O
are	O
available	O
in	O
Canada	O
.	O

Some	O
of	O
these	O
products	O
are	O
reviewed	O
and	O
a	O
protocol	O
for	O
caries	O
prevention	O
in	O
this	O
high	O
-	O
risk	O
population	O
is	O
proposed	O
.	O

Trying	O
to	O
find	O
out	O
the	O
mechanism	O
of	O
microstructure	O
influencing	O
bacterial	O
adhesion	O
,	O
we	O
prepared	O
different	O
microstructures	O
to	O
compare	O
the	O
adsorptive	O
behavior	O
of	O
graphite	O
powder	O
and	O
adhesive	O
behavior	O
of	O
oral	O
microbe	O
.	O

We	O
used	O
polydimethylsiloxane	O
(	O
PDMS	O
)	O
to	O
copy	O
23	O
microstructures	O
of	O
hydroxyapatite	O
(	O
HA	O
)	O
chip	O
,	O
and	O
cultured	O
them	O
with	O
different	O
sizes	O
graphite	O
powder	O
and	O
oral	O
microbes	O
respectively	O
,	O
to	O
observe	O
and	O
compare	O
their	O
behavior	O
on	O
microstructures	O
.	O

The	O
adsorption	O
of	O
30	O
-	O
50	O
microm	O
powder	O
on	O
different	O
microstructures	O
was	O
insignificant	O
,	O
while	O
10	O
-	O
20	O
microm	O
powder	O
had	O
maximum	O
adsorption	O
on	O
10	O
microm	O
and	O
20	O
microm	O
microstructures	O
.	O

Saccharomyces	O
albicans	O
was	O
most	O
likely	O
to	O
adhere	O
to	O
5	O
microm	O
microstructures	O
which	O
was	O
equivalent	O
to	O
its	O
own	O
size	O
.	O

However	O
,	O
microstructures	O
had	O
little	O
effect	O
on	O
adhesion	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
which	O
grew	O
in	O
a	O
chain	O
.	O

The	O
size	O
of	O
microstructure	O
was	O
the	O
most	O
effective	O
factor	O
that	O
affects	O
the	O
adsorption	O
of	O
non	O
-	O
living	O
powder	O
,	O
and	O
it	O
also	O
had	O
the	O
same	O
effect	O
on	O
the	O
microbial	O
adhesion	O
;	O
but	O
some	O
special	O
bacteria	O
,	O
such	O
as	O
Streptococcus	B-bacteria
mutans	I-bacteria
which	O
grew	O
in	O
a	O
chain	O
,	O
was	O
not	O
affected	O
by	O
the	O
sizes	O
or	O
shapes	O
of	O
microstructures	O
.	O

Helicobacter	B-bacteria
pylori	I-bacteria
,	O
the	O
causative	O
agent	O
of	O
gastritis	O
and	O
gastric	O
ulcer	O
,	O
plays	O
a	O
crucial	O
role	O
in	O
development	O
of	O
gastric	O
carcinomas	O
.	O

Antibiotic	O
therapy	O
fails	O
in	O
almost	O
20	O
%	O
of	O
cases	O
due	O
to	O
development	O
of	O
antibiotic	O
resistance	O
.	O

Development	O
of	O
antibodies	O
against	O
specific	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
targets	O
could	O
have	O
significant	O
therapeutic	O
effect	O
.	O

In	O
the	O
present	O
research	O
attempts	O
have	O
been	O
made	O
to	O
study	O
the	O
effect	O
of	O
IgY	O
purified	O
from	O
egg	O
yolk	O
of	O
hens	O
immunized	O
with	O
recombinant	O
UreC	O
in	O
treatment	O
of	O
mice	O
infected	O
with	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
.	O

Purified	O
IgY	O
-	O
HpUc	O
was	O
used	O
in	O
two	O
forms	O
:	O
powdered	O
and	O
PBS	O
dissolved	O
.	O

10	O
(	O
9	O
)	O
bacteria	O
in	O
BHI	O
were	O
orally	O
administered	O
to	O
C57BL6	O
/	O
j	O
mice	O
three	O
times	O
on	O
alternate	O
day	O
intervals	O
.	O

Eight	O
weeks	O
after	O
the	O
last	O
inoculation	O
,	O
the	O
serum	O
was	O
assayed	O
for	O
infection	O
rate	O
by	O
ELISA	O
.	O

The	O
severity	O
of	O
gastritis	O
was	O
analyzed	O
histopathologically	O
.	O

Infected	O
mice	O
were	O
randomly	O
divided	O
into	O
three	O
groups	O
.	O

Groups	O
one	O
and	O
two	O
were	O
treated	O
with	O
dietary	O
IgY	O
-	O
HpUc	O
and	O
IgY	O
-	O
HpUc	O
dissolved	O
in	O
PBS	O
respectively	O
for	O
28	O
days	O
.	O

The	O
untreated	O
group	O
served	O
as	O
control	O
.	O

Serology	O
and	O
histopathology	O
confirmed	O
the	O
establishment	O
of	O
the	O
infection	O
.	O

Indirect	O
ELISA	O
results	O
in	O
the	O
treated	O
animals	O
showed	O
considerable	O
reduction	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
specific	O
antibodies	O
in	O
their	O
sera	O
.	O

Pathological	O
examination	O
of	O
gastric	O
mucosa	O
of	O
infected	O
mice	O
treated	O
with	O
IgY	O
-	O
HpUc	O
showed	O
considerable	O
reduction	O
of	O
inflammation	O
in	O
the	O
stomach	O
tissues	O
.	O

The	O
bacterial	O
presence	O
on	O
mucosal	O
layer	O
of	O
the	O
stomach	O
was	O
considerably	O
reduced	O
.	O

UreC	O
-	O
induced	O
IgY	O
is	O
specifically	O
successful	O
in	O
inhibition	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
infection	O
and	O
could	O
be	O
an	O
alternative	O
to	O
antibiotic	O
treatment	O
.	O

The	O
vaginal	O
microbiome	O
,	O
which	O
harbors	O
beneficial	O
Lactobacillus	B-bacteria
strains	I-bacteria
,	O
is	O
believed	O
to	O
be	O
a	O
major	O
host	O
defense	O
mechanism	O
for	O
preventing	O
infections	O
of	O
the	O
urogenital	O
tract	O
.	O

It	O
has	O
been	O
suggested	O
that	O
the	O
gastrointestinal	O
tract	O
serves	O
as	O
a	O
reservoir	O
for	O
lactobacilli	B-bacteria
that	O
colonize	O
the	O
vagina	O
.	O

Using	O
rhesus	O
macaques	O
,	O
we	O
examined	O
whether	O
oral	O
delivery	O
of	O
human	O
vaginal	O
Lactobacillus	B-bacteria
jensenii	I-bacteria
1153	I-bacteria
-	I-bacteria
1646	I-bacteria
,	O
a	O
GusA	O
-	O
producing	O
strain	O
,	O
would	O
result	O
in	O
colonization	O
of	O
the	O
rectum	O
and	O
the	O
vagina	O
.	O

Lactobacilli	B-bacteria
were	O
identified	O
from	O
the	O
vagina	O
tracts	O
of	O
three	O
macaques	O
on	O
the	O
basis	O
of	O
beta	O
-	O
glucuronidase	O
enzyme	O
production	O
,	O
16S	O
rRNA	O
gene	O
sequence	O
and	O
DNA	O
homology	O
using	O
a	O
repetitive	O
sequence	O
-	O
based	O
polymerase	O
chain	O
reaction	O
.	O

No	O
consensus	O
has	O
yet	O
been	O
reached	O
to	O
associate	O
oral	O
bacteria	O
conclusively	O
with	O
the	O
etio	O
-	O
pathogenesis	O
of	O
bisphosphonate	O
-	O
induced	O
osteonecrosis	O
of	O
the	O
jaw	O
(	O
BONJ	O
)	O
.	O

Therefore	O
,	O
the	O
present	O
study	O
examined	O
the	O
effects	O
of	O
oral	O
bacteria	O
on	O
the	O
development	O
of	O
BONJ	O
-	O
like	O
lesions	O
in	O
a	O
mouse	O
model	O
.	O

In	O
the	O
pamidronate	O
(	O
Pam	O
)	O
-	O
treated	O
mice	O
,	O
but	O
not	O
control	O
non	O
-	O
drug	O
-	O
treated	O
mice	O
,	O
tooth	O
extraction	O
followed	O
by	O
oral	O
infection	O
with	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
caused	O
BONJ	O
-	O
like	O
lesions	O
and	O
delayed	O
epithelial	O
healing	O
,	O
both	O
of	O
which	O
were	O
completely	O
suppressed	O
by	O
a	O
broad	O
-	O
spectrum	O
antibiotic	O
cocktail	O
.	O

Furthermore	O
,	O
in	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
experiments	O
,	O
the	O
combination	O
of	O
Pam	O
and	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
caused	O
the	O
death	O
of	O
gingival	O
fibroblasts	O
(	O
GFs	O
)	O
and	O
down	O
-	O
regulated	O
their	O
production	O
of	O
keratinocyte	O
growth	O
factor	O
(	O
KGF	O
)	O
,	O
which	O
induces	O
epithelial	O
cell	O
growth	O
and	O
migration	O
.	O

Therefore	O
,	O
in	O
periodontal	O
tissues	O
pre	O
-	O
exposed	O
to	O
bisphosphonate	O
,	O
bacterial	O
infection	O
at	O
tooth	O
extraction	O
sites	O
caused	O
diminished	O
KGF	O
expression	O
in	O
GFs	O
,	O
leading	O
to	O
a	O
delay	O
in	O
the	O
epithelial	O
wound	O
-	O
healing	O
process	O
that	O
was	O
mitigated	O
by	O
antibiotics	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
prevalence	O
of	O
dental	O
enamel	O
defects	O
,	O
recurrent	O
aphthous	O
stomatitis	O
(	O
RAS	O
)	O
and	O
caries	O
experience	O
and	O
to	O
measure	O
salivary	O
flow	O
rate	O
,	O
buffer	O
capacity	O
,	O
saliva	O
and	O
plaque	O
pH	O
and	O
salivary	O
cariogenic	O
microflora	O
in	O
patients	O
with	O
celiac	O
disease	O
(	O
CD	O
)	O
compared	O
to	O
healthy	O
subjects	O
.	O
Thirty	O
-	O
five	O
patients	O
,	O
aged	O
6	O
-	O
19	O
years	O
,	O
with	O
a	O
diagnosis	O
of	O
CD	O
and	O
35	O
healthy	O
children	O
of	O
the	O
same	O
age	O
participated	O
in	O
the	O
study	O
.	O

Enamel	O
defects	O
were	O
diagnosed	O
and	O
classified	O
using	O
Aine	O
'	O
s	O
classification	O
.	O

The	O
patients	O
with	O
RAS	O
and	O
dental	O
caries	O
were	O
recorded	O
using	O
WHO	O
criteria	O
.	O

The	O
parents	O
were	O
interviewed	O
about	O
various	O
oral	O
health	O
-	O
related	O
factors	O
.	O

Saliva	O
samples	O
were	O
collected	O
to	O
measure	O
the	O
stimulated	O
salivary	O
flow	O
rate	O
,	O
buffer	O
capacity	O
and	O
pH	O
values	O
of	O
saliva	O
and	O
plaque	O
.	O

Salivary	O
mutans	B-bacteria
streptococci	I-bacteria
and	O
lactobacilli	B-bacteria
were	O
counted	O
.	O

The	O
enamel	O
defects	O
and	O
RAS	O
prevalence	O
were	O
statistically	O
higher	O
(	O
40	O
and	O
37	O
.	O
1	O
%	O
,	O
respectively	O
)	O
in	O
the	O
CD	O
group	O
,	O
and	O
the	O
prevalence	O
of	O
salivary	O
mutans	B-bacteria
streptococci	I-bacteria
(	O
48	O
and	O
14	O
%	O
)	O
and	O
lactobacilli	B-bacteria
(	O
51	O
and	O
34	O
%	O
)	O
colonization	O
was	O
statistically	O
lower	O
(	O
p	O
=	O
0	O
.	O
012	O
,	O
p	O
=	O
0	O
.	O
010	O
)	O
in	O
the	O
CD	O
group	O
;	O
the	O
DMFS	O
and	O
dfs	O
values	O
were	O
similar	O
in	O
both	O
groups	O
.	O

CD	O
appeared	O
to	O
be	O
associated	O
with	O
a	O
significantly	O
higher	O
prevalence	O
of	O
developing	O
enamel	O
defects	O
and	O
RAS	O
,	O
but	O
a	O
lower	O
prevalence	O
of	O
salivary	O
mutans	B-bacteria
streptococci	I-bacteria
and	O
lactobacilli	B-bacteria
colonization	O
,	O
and	O
the	O
diagnosis	O
of	O
these	O
oral	O
manifestations	O
might	O
be	O
helpful	O
for	O
an	O
early	O
diagnosis	O
of	O
CD	O
.	O

Previously	O
,	O
we	O
reported	O
that	O
epithelial	O
cells	O
respond	O
to	O
exogenous	O
interleukin	O
(	O
IL	O
)	O
-	O
1alpha	O
by	O
increasing	O
expression	O
of	O
several	O
genes	O
involved	O
in	O
the	O
host	O
response	O
to	O
microbes	O
,	O
including	O
the	O
antimicrobial	O
protein	O
complex	O
calprotectin	O
(	O
S100A8	O
/	O
A9	O
)	O
.	O

Given	O
that	O
S100A8	O
/	O
A9	O
protects	O
epithelial	O
cells	O
against	O
invading	O
bacteria	O
,	O
we	O
studied	O
whether	O
IL	O
-	O
1alpha	O
augments	O
S100A8	O
/	O
A9	O
-	O
dependent	O
resistance	O
to	O
bacterial	O
invasion	O
of	O
oral	O
keratinocytes	O
.	O

When	O
inoculated	O
with	O
Listeria	B-bacteria
monocytogenes	I-bacteria
,	O
human	O
buccal	O
epithelial	O
(	O
TR146	O
)	O
cells	O
expressed	O
and	O
released	O
IL	O
-	O
1alpha	O
.	O

Subsequently	O
,	O
IL	O
-	O
1alpha	O
-	O
containing	O
media	O
from	O
Listeria	O
-	O
infected	O
cells	O
increased	O
S100A8	O
/	O
A9	O
gene	O
expression	O
in	O
naive	O
TR146	O
cells	O
an	O
IL	O
-	O
1	O
receptor	O
(	O
IL	O
-	O
1R	O
)	O
-	O
dependent	O
manner	O
.	O

Incubation	O
with	O
exogenous	O
IL	O
-	O
1alpha	O
decreased	O
Listeria	B-bacteria
invasion	O
into	O
TR146	O
cells	O
,	O
whereas	O
invasion	O
increased	O
with	O
IL	O
-	O
1R	O
antagonist	O
.	O

Conversely	O
,	O
when	O
S100A8	O
/	O
A9	O
genes	O
were	O
knocked	O
down	O
using	O
short	O
hairpin	O
RNA	O
(	O
shRNA	O
)	O
,	O
TR146	O
cells	O
responded	O
to	O
exogenous	O
IL	O
-	O
1alpha	O
with	O
increased	O
intracellular	O
bacteria	O
.	O

These	O
data	O
strongly	O
suggest	O
that	O
infected	O
epithelial	O
cells	O
release	O
IL	O
-	O
1alpha	O
to	O
signal	O
neighboring	O
keratinocytes	O
in	O
a	O
paracrine	O
manner	O
,	O
promoting	O
S100A8	O
/	O
A9	O
-	O
dependent	O
resistance	O
to	O
invasive	O
L	B-bacteria
.	I-bacteria
monocytogenes	I-bacteria
.	O

Modifications	O
of	O
titanium	O
(	O
Ti	O
)	O
implant	O
surfaces	O
have	O
a	O
significant	O
effect	O
on	O
early	O
biofilm	O
formation	O
and	O
the	O
outcome	O
of	O
implant	O
procedures	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
examine	O
the	O
role	O
of	O
plasma	O
proteins	O
and	O
electrostatic	O
forces	O
in	O
the	O
adhesion	O
mechanism	O
of	O
oral	O
bacteria	O
to	O
modified	O
Ti	O
surfaces	O
.	O

Ti	O
discs	O
with	O
three	O
different	O
types	O
of	O
surface	O
modifications	O
,	O
machined	O
,	O
acid	O
-	O
etched	O
,	O
and	O
acid	O
-	O
etched	O
and	O
blasted	O
,	O
were	O
examined	O
for	O
adhesion	O
of	O
oral	O
bacteria	O
:	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
and	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
.	O

Following	O
pretreatment	O
of	O
the	O
Ti	O
with	O
ion	O
rich	O
solutions	O
or	O
coating	O
by	O
human	O
serum	O
albumin	O
or	O
fibronectin	O
,	O
bacterial	O
adhesion	O
was	O
examined	O
by	O
scanning	O
electron	O
microscopy	O
and	O
assessed	O
quantitatively	O
by	O
DNA	O
analysis	O
.	O

Ti	O
coating	O
by	O
proteins	O
as	O
well	O
as	O
bacterial	O
adhesion	O
and	O
their	O
interrelationships	O
were	O
further	O
investigated	O
through	O
confocal	O
scanning	O
laser	O
microscopy	O
.	O

Acid	O
-	O
etched	O
and	O
blasted	O
Ti	O
surfaces	O
exhibited	O
significantly	O
higher	O
amounts	O
of	O
bacteria	O
adhesion	O
than	O
the	O
other	O
two	O
surfaces	O
.	O

Calcium	O
was	O
found	O
to	O
serve	O
as	O
a	O
bridging	O
agent	O
in	O
the	O
adhesion	O
process	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
to	O
Ti	O
surfaces	O
.	O

Although	O
albumin	O
coating	O
of	O
the	O
Ti	O
reduced	O
the	O
adhesion	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
to	O
all	O
surfaces	O
,	O
it	O
had	O
no	O
influence	O
on	O
the	O
adhesion	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
or	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
.	O

Coating	O
the	O
Ti	O
with	O
fibronectin	O
enhanced	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
and	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
adhesion	O
.	O

Bacterial	O
adhesion	O
to	O
Ti	O
surfaces	O
is	O
roughness	O
-	O
dependent	O
,	O
and	O
the	O
adhesion	O
mechanism	O
is	O
influenced	O
by	O
ions	O
and	O
proteins	O
of	O
the	O
initial	O
coating	O
derived	O
from	O
the	O
blood	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
profiles	O
of	O
periodontopathogenic	O
bacteria	O
in	O
a	O
Chinese	O
population	O
using	O
quantitative	O
real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
(	O
qRT	O
-	O
PCR	O
)	O
.	O

Twenty	O
-	O
four	O
periodontally	O
healthy	O
Chinese	O
subjects	O
and	O
60	O
patients	O
with	O
chronic	O
periodontitis	O
(	O
CP	O
)	O
were	O
enrolled	O
in	O
this	O
cross	O
-	O
sectional	O
study	O
.	O

qRT	O
-	O
PCR	O
was	O
used	O
to	O
quantify	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
and	O
Prevotella	B-bacteria
intermedia	I-bacteria
as	O
well	O
as	O
total	O
bacterial	O
counts	O
from	O
252	O
samples	O
collected	O
from	O
the	O
saliva	O
,	O
supragingival	O
plaque	O
,	O
and	O
subgingival	O
plaque	O
of	O
all	O
84	O
subjects	O
.	O

The	O
detection	O
frequency	O
of	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
was	O
less	O
than	O
50	O
%	O
.	O

F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
was	O
detected	O
in	O
all	O
subjects	O
and	O
CP	O
patients	O
had	O
higher	O
bacterial	O
loads	O
than	O
healthy	O
subjects	O
.	O

The	O
median	O
proportion	O
of	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
was	O
significantly	O
higher	O
in	O
subgingival	O
plaque	O
than	O
in	O
supragingival	O
plaque	O
and	O
saliva	O
.	O

P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
had	O
higher	O
detection	O
frequencies	O
and	O
bacterial	O
loads	O
in	O
CP	O
patients	O
than	O
in	O
healthy	O
subjects	O
.	O

The	O
median	O
proportion	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
was	O
significantly	O
different	O
among	O
the	O
three	O
intraoral	O
locations	O
in	O
the	O
CP	O
group	O
and	O
its	O
proportion	O
in	O
subgingival	O
plaque	O
was	O
9	O
.	O
01	O
%	O
.	O

Moreover	O
,	O
strong	O
positive	O
Spearman	O
'	O
s	O
correlations	O
were	O
found	O
in	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
and	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
counts	O
across	O
the	O
three	O
intraoral	O
locations	O
.	O

The	O
presence	O
and	O
bacteria	O
loads	O
of	O
these	O
four	O
bacteria	O
in	O
this	O
Chinese	O
population	O
are	O
similar	O
to	O
those	O
from	O
other	O
populations	O
.	O

Examination	O
of	O
bacterial	O
detection	O
frequency	O
and	O
loads	O
in	O
Chinese	O
adults	O
may	O
assist	O
microbial	O
studies	O
of	O
periodontal	O
disease	O
and	O
will	O
shed	O
light	O
on	O
periodontal	O
disease	O
diagnosis	O
and	O
treatment	O
using	O
antibiotics	O
in	O
the	O
Chinese	O
population	O
.	O

Recently	O
,	O
plasma	O
sterilization	O
has	O
attracted	O
increasing	O
attention	O
in	O
dental	O
community	O
for	O
the	O
atmospheric	O
pressure	O
non	O
-	O
equilibrium	O
plasma	O
jet	O
(	O
APNPs	O
)	O
,	O
which	O
is	O
driven	O
by	O
a	O
kilohertz	O
pulsed	O
DC	O
power	O
,	O
may	O
be	O
applied	O
to	O
the	O
dental	O
and	O
oral	O
diseases	O
.	O

However	O
,	O
it	O
is	O
still	O
in	O
doubt	O
whether	O
APNPs	O
can	O
effectively	O
kill	O
pathogenic	O
bacteria	O
in	O
the	O
oral	O
cavity	O
and	O
produce	O
no	O
harmful	O
effects	O
on	O
normal	O
oral	O
tissues	O
,	O
especially	O
on	O
normal	O
mucosa	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
bacterial	O
-	O
killing	O
effect	O
of	O
APNPs	O
in	O
the	O
biofilms	O
containing	O
a	O
single	O
breed	O
of	O
bacteria	O
(	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
g	I-bacteria
.	I-bacteria
)	O
,	O
and	O
the	O
pathological	O
changes	O
of	O
the	O
oral	O
mucosa	O
after	O
treatment	O
by	O
APNPs	O
.	O

P	B-bacteria
.	I-bacteria
g	I-bacteria
.	I-bacteria
was	O
incubated	O
to	O
form	O
the	O
biofilms	O
in	O
vitro	O
,	O
and	O
the	O
samples	O
were	O
divided	O
into	O
three	O
groups	O
randomly	O
:	O
group	O
A	O
(	O
blank	O
control	O
)	O
;	O
group	O
B	O
in	O
which	O
the	O
biofilms	O
were	O
treated	O
by	O
APNPs	O
(	O
the	O
setting	O
of	O
the	O
equipment	O
:	O
10	O
kHz	O
,	O
1600	O
ns	O
and	O
8	O
kV	O
)	O
;	O
group	O
C	O
in	O
which	O
the	O
biofilms	O
were	O
exposed	O
only	O
to	O
a	O
gas	O
jet	O
without	O
ignition	O
of	O
the	O
plasma	O
.	O

Each	O
group	O
had	O
three	O
samples	O
and	O
each	O
sample	O
was	O
processed	O
for	O
up	O
to	O
5	O
min	O
.	O

The	O
biofilms	O
were	O
then	O
fluorescently	O
stained	O
,	O
observed	O
and	O
photographed	O
under	O
a	O
laser	O
scanning	O
confocal	O
microscope	O
.	O

In	O
the	O
animal	O
experiment	O
,	O
six	O
male	O
Japanese	O
white	O
rabbits	O
were	O
divided	O
into	O
two	O
groups	O
randomly	O
(	O
n	O
=	O
3	O
in	O
each	O
group	O
)	O
in	O
terms	O
of	O
the	O
different	O
post	O
-	O
treatment	O
time	O
(	O
1	O
-	O
day	O
group	O
and	O
5	O
-	O
day	O
group	O
)	O
.	O

The	O
buccal	O
mucosa	O
of	O
the	O
left	O
side	O
and	O
the	O
mucosa	O
of	O
the	O
ventral	O
surface	O
of	O
the	O
tongue	O
were	O
treated	O
by	O
APNPs	O
for	O
10	O
min	O
in	O
the	O
same	O
way	O
as	O
the	O
bacterial	O
biofilm	O
experiment	O
in	O
each	O
rabbit	O
,	O
and	O
the	O
corresponding	O
mucosa	O
of	O
the	O
other	O
sides	O
served	O
as	O
normal	O
control	O
.	O

The	O
clinical	O
manifestations	O
of	O
the	O
oral	O
mucosa	O
were	O
observed	O
and	O
recorded	O
every	O
day	O
.	O

The	O
rabbits	O
were	O
sacrificed	O
one	O
or	O
five	O
day	O
(	O
s	O
)	O
after	O
APNPs	O
treatment	O
.	O

The	O
oral	O
mucosa	O
were	O
harvested	O
and	O
prepared	O
to	O
haematoxylin	O
and	O
eosin	O
-	O
stained	O
sections	O
.	O

Clinical	O
observation	O
and	O
histopathological	O
scores	O
were	O
used	O
to	O
assess	O
mucosal	O
changes	O
.	O

The	O
results	O
showed	O
the	O
obvious	O
P	B-bacteria
.	I-bacteria
g	I-bacteria
.	I-bacteria
biofilms	O
were	O
formed	O
at	O
10	O
days	O
,	O
and	O
most	O
of	O
the	O
bacteria	O
in	O
groups	O
A	O
and	O
C	O
were	O
alive	O
under	O
a	O
laser	O
scanning	O
confocal	O
microscope	O
,	O
but	O
the	O
bacteria	O
in	O
the	O
group	O
B	O
were	O
almost	O
all	O
dead	O
.	O

In	O
animal	O
experiment	O
,	O
no	O
ulcers	O
,	O
anabrosis	O
and	O
oral	O
mucositis	O
were	O
found	O
in	O
both	O
the	O
1	O
-	O
day	O
and	O
5	O
-	O
day	O
groups	O
.	O

The	O
average	O
mucous	O
membrane	O
irritation	O
index	O
was	O
-	O
0	O
.	O
83	O
and	O
-	O
0	O
.	O
67	O
in	O
the	O
1	O
-	O
day	O
and	O
5	O
-	O
day	O
groups	O
,	O
respectively	O
,	O
suggesting	O
that	O
no	O
intense	O
mucosal	O
membrane	O
irritation	O
responses	O
occurred	O
.	O

It	O
was	O
concluded	O
that	O
APNPs	O
could	O
effectively	O
kill	O
P	B-bacteria
.	I-bacteria
g	I-bacteria
.	I-bacteria
in	O
the	O
biofilms	O
and	O
did	O
not	O
cause	O
any	O
pathological	O
changes	O
in	O
the	O
normal	O
mucosa	O
,	O
suggesting	O
that	O
the	O
plasma	O
jet	O
(	O
APNPs	O
)	O
may	O
be	O
applied	O
to	O
oral	O
diseases	O
as	O
a	O
novel	O
sterilization	O
device	O
in	O
the	O
future	O
.	O

This	O
study	O
sought	O
to	O
determine	O
whether	O
the	O
mechanical	O
properties	O
of	O
titanium	O
dental	O
implants	O
changed	O
after	O
exposure	O
to	O
bacteria	O
.	O

Two	O
strains	O
of	O
bacteria	O
(	O
Streptococcus	B-bacteria
sanguinis	I-bacteria
and	O
Lactobacillus	B-bacteria
salivarius	I-bacteria
)	O
were	O
used	O
in	O
the	O
study	O
.	O

The	O
adhesive	O
properties	O
of	O
the	O
two	O
strains	O
were	O
investigated	O
as	O
follows	O
.	O

Titanium	O
implants	O
were	O
placed	O
in	O
bacteria	O
broth	O
,	O
seeded	O
with	O
the	O
two	O
bacteria	O
strains	O
,	O
and	O
left	O
in	O
the	O
broth	O
for	O
1	O
or	O
3	O
months	O
.	O

Another	O
group	O
of	O
titanium	O
implants	O
was	O
immersed	O
in	O
artificial	O
saliva	O
at	O
37	O
degrees	O
C	O
for	O
3	O
months	O
.	O

Ten	O
implants	O
in	O
each	O
group	O
were	O
tested	O
in	O
37	O
degrees	O
C	O
artificial	O
saliva	O
to	O
evaluate	O
their	O
mechanical	O
flexural	O
strength	O
and	O
fatigue	O
life	O
.	O

The	O
bacterial	O
cultures	O
grew	O
quickly	O
on	O
titanium	O
surfaces	O
.	O

After	O
1	O
month	O
of	O
bacteria	O
culture	O
in	O
vitro	O
,	O
the	O
bacteria	O
had	O
produced	O
corrosion	O
pits	O
on	O
the	O
titanium	O
surfaces	O
.	O

After	O
3	O
months	O
of	O
bacterial	O
culture	O
,	O
a	O
7	O
%	O
decrease	O
in	O
the	O
flexural	O
strength	O
of	O
the	O
implant	O
samples	O
and	O
a	O
decrease	O
of	O
15	O
%	O
in	O
the	O
number	O
of	O
cycles	O
to	O
failure	O
by	O
fatigue	O
were	O
seen	O
versus	O
implants	O
not	O
exposed	O
to	O
bacteria	O
.	O

These	O
results	O
demonstrate	O
that	O
,	O
in	O
physiologic	O
conditions	O
in	O
vitro	O
,	O
bacteria	O
have	O
the	O
capacity	O
to	O
produce	O
a	O
pitting	O
corrosion	O
phenomenon	O
on	O
exposed	O
titanium	O
surfaces	O
,	O
leading	O
to	O
a	O
significant	O
deterioration	O
in	O
the	O
mechanical	O
properties	O
of	O
the	O
implant	O
.	O

It	O
is	O
therefore	O
logical	O
to	O
conclude	O
that	O
bacteria	O
may	O
produce	O
corrosion	O
that	O
reduces	O
the	O
useful	O
life	O
of	O
dental	O
implants	O
.	O

Treponema	B-bacteria
denticola	I-bacteria
is	O
found	O
ubiquitously	O
in	O
the	O
human	O
oral	O
cavity	O
and	O
is	O
mainly	O
associated	O
with	O
bacterial	O
communities	O
implicated	O
in	O
the	O
establishment	O
and	O
development	O
of	O
periodontal	O
disease	O
.	O

The	O
ability	O
to	O
become	O
integrated	O
within	O
biofilm	O
communities	O
is	O
crucial	O
to	O
the	O
growth	O
and	O
survival	O
of	O
oral	O
bacteria	O
,	O
and	O
involves	O
inter	O
-	O
bacterial	O
coaggregation	O
,	O
metabolic	O
cooperation	O
,	O
and	O
synergy	O
against	O
host	O
defences	O
.	O

In	O
this	O
article	O
we	O
show	O
that	O
the	O
chymotrypsin	O
-	O
like	O
proteinase	O
(	O
CTLP	O
)	O
,	O
found	O
within	O
a	O
high	O
-	O
molecular	O
-	O
mass	O
complex	O
on	O
the	O
cell	O
surface	O
,	O
mediates	O
adherence	O
of	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
to	O
other	O
potential	O
periodontal	O
pathogens	O
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
and	O
Parvimonas	B-bacteria
micra	I-bacteria
.	O

Proteolytic	O
activity	O
per	O
se	O
did	O
not	O
appear	O
to	O
be	O
required	O
for	O
the	O
interactions	O
,	O
and	O
expression	O
of	O
the	O
major	O
outer	O
-	O
sheath	O
protein	O
(	O
Msp	O
)	O
was	O
not	O
necessary	O
,	O
except	O
for	O
binding	O
Parv	B-bacteria
.	I-bacteria
micra	I-bacteria
.	O

Biofilms	O
of	O
densely	O
packed	O
cells	O
and	O
matrix	O
,	O
up	O
to	O
40	O
microm	O
in	O
depth	O
,	O
were	O
formed	O
between	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
on	O
salivary	O
pellicle	O
,	O
with	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
cells	O
enriched	O
in	O
the	O
upper	O
layers	O
.	O

Expression	O
of	O
CTLP	O
,	O
but	O
not	O
Msp	O
,	O
was	O
critical	O
for	O
dual	O
-	O
species	O
biofilm	O
formation	O
with	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
.	O

T	B-bacteria
.	I-bacteria
denticola	I-bacteria
did	O
not	O
form	O
dual	O
-	O
species	O
biofilms	O
with	O
any	O
of	O
the	O
other	O
three	O
periodontal	O
bacterial	O
species	O
under	O
various	O
conditions	O
.	O

Synergy	O
between	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
was	O
also	O
shown	O
by	O
increased	O
inhibition	O
of	O
blood	O
clotting	O
,	O
which	O
was	O
CTLP	O
-	O
dependent	O
.	O

The	O
results	O
demonstrate	O
the	O
critical	O
role	O
of	O
CTLP	O
in	O
interactions	O
of	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
with	O
other	O
oral	O
micro	O
-	O
organisms	O
,	O
leading	O
to	O
synergy	O
in	O
microbial	O
community	O
development	O
and	O
host	O
tissue	O
pathogenesis	O
.	O

Periodontitis	O
is	O
an	O
inflammatory	O
disease	O
caused	O
by	O
pathogenic	O
microorganisms	O
,	O
such	O
as	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
and	O
characterized	O
by	O
the	O
destruction	O
of	O
the	O
periodontium	O
.	O

Obese	O
individuals	O
have	O
an	O
increased	O
risk	O
for	O
periodontitis	O
and	O
show	O
decreased	O
serum	O
levels	O
of	O
adiponectin	O
.	O

This	O
in	O
-	O
vitro	O
study	O
was	O
established	O
to	O
examine	O
whether	O
adiponectin	O
modulates	O
critical	O
effects	O
of	O
lipopolysaccharide	O
(	O
LPS	O
)	O
from	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
on	O
oral	O
epithelial	O
cells	O
(	O
OECs	O
)	O
.	O

The	O
presence	O
of	O
adiponectin	O
and	O
its	O
receptors	O
in	O
human	O
gingival	O
tissue	O
samples	O
and	O
OECs	O
was	O
analyzed	O
by	O
immunohistochemistry	O
and	O
PCR	O
.	O

Furthermore	O
,	O
OECs	O
were	O
treated	O
with	O
LPS	O
and	O
/	O
or	O
adiponectin	O
for	O
up	O
to	O
72	O
h	O
,	O
and	O
the	O
gene	O
expression	O
and	O
protein	O
synthesis	O
of	O
pro	O
-	O
and	O
anti	O
-	O
inflammatory	O
mediators	O
,	O
matrix	O
metalloproteinases	O
(	O
MMPs	O
)	O
and	O
growth	O
factors	O
were	O
analyzed	O
by	O
real	O
-	O
time	O
PCR	O
and	O
ELISA	O
.	O

Additionally	O
,	O
cell	O
proliferation	O
,	O
differentiation	O
and	O
in	O
-	O
vitro	O
wound	O
healing	O
were	O
studied	O
.	O

The	O
nuclear	O
translocation	O
of	O
NFkappaB	O
was	O
investigated	O
by	O
immunofluorescence	O
.	O

Gingival	O
tissue	O
sections	O
showed	O
a	O
strong	O
synthesis	O
of	O
adiponectin	O
and	O
its	O
receptors	O
in	O
the	O
epithelial	O
layer	O
.	O

In	O
cell	O
cultures	O
,	O
LPS	O
induced	O
a	O
significant	O
up	O
-	O
regulation	O
of	O
interleukin	O
(	O
IL	O
)	O
1beta	O
,	O
IL6	O
,	O
IL8	O
,	O
MMP1	O
and	O
MMP3	O
.	O

Adiponectin	O
abrogated	O
significantly	O
the	O
stimulatory	O
effects	O
of	O
LPS	O
on	O
these	O
molecules	O
.	O

Similarly	O
,	O
adiponectin	O
inhibited	O
significantly	O
the	O
LPS	O
-	O
induced	O
decrease	O
in	O
cell	O
viability	O
and	O
increase	O
in	O
cell	O
proliferation	O
and	O
differentiation	O
.	O

Adiponectin	O
led	O
to	O
a	O
time	O
-	O
dependent	O
induction	O
of	O
the	O
anti	O
-	O
inflammatory	O
mediators	O
IL10	O
and	O
heme	O
oxygenase	O
1	O
,	O
and	O
blocked	O
the	O
LPS	O
-	O
stimulated	O
NFkappaB	O
nuclear	O
translocation	O
.	O

Adiponectin	O
may	O
counteract	O
critical	O
actions	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
on	O
oral	O
epithelial	O
cells	O
.	O

Low	O
levels	O
of	O
adiponectin	O
,	O
as	O
observed	O
in	O
obese	O
individuals	O
,	O
may	O
increase	O
the	O
risk	O
for	O
periodontal	O
inflammation	O
and	O
destruction	O

.	O

Latently	O
infected	O
cells	O
harbor	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV	O
-	O
1	O
)	O
proviral	O
DNA	O
copies	O
integrated	O
in	O
heterochromatin	O
,	O
allowing	O
persistence	O
of	O
transcriptionally	O
silent	O
proviruses	O
.	O

It	O
is	O
widely	O
accepted	O
that	O
hypoacetylation	O
of	O
histone	O
proteins	O
by	O
histone	O
deacetylases	O
(	O
HDACs	O
)	O
is	O
involved	O
in	O
maintaining	O
the	O
HIV	O
-	O
1	O
latency	O
by	O
repressing	O
viral	O
transcription	O
.	O

HIV	O
-	O
1	O
replication	O
can	O
be	O
induced	O
from	O
latently	O
infected	O
cells	O
by	O
environmental	O
factors	O
,	O
such	O
as	O
inflammation	O
and	O
co	O
-	O
infection	O
with	O
other	O
microbes	O
.	O

It	O
is	O
known	O
that	O
a	O
bacterial	O
metabolite	O
butyric	O
acid	O
inhibits	O
catalytic	O
action	O
of	O
HDAC	O
and	O
induces	O
transcription	O
of	O
silenced	O
genes	O
including	O
HIV	O
-	O
1	O
provirus	O
.	O

There	O
are	O
a	O
number	O
of	O
such	O
bacteria	O
in	O
gut	O
,	O
vaginal	O
,	O
and	O
oral	O
cavities	O
that	O
produce	O
butyric	O
acid	O
during	O
their	O
anaerobic	O
glycolysis	O
.	O

Since	O
these	O
organs	O
are	O
known	O
to	O
be	O
the	O
major	O
site	O
of	O
HIV	O
-	O
1	O
transmission	O
and	O
its	O
replication	O
,	O
we	O
explored	O
a	O
possibility	O
that	O
explosive	O
viral	O
replication	O
in	O
these	O
organs	O
could	O
be	O
ascribable	O
to	O
butyric	O
acid	O
produced	O
from	O
anaerobic	O
resident	O
bacteria	O
.	O

In	O
this	O
study	O
,	O
we	O
demonstrate	O
that	O
the	O
culture	O
supernatant	O
of	O
various	O
bacteria	O
producing	O
butyric	O
acid	O
could	O
greatly	O
reactivate	O
the	O
latently	O
-	O
infected	O
HIV	O
-	O
1	O
.	O

These	O
bacteria	O
include	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
(	O
commonly	O
present	O
in	O
oral	O
cavity	O
,	O
and	O
gut	O
)	O
,	O
Clostridium	B-bacteria
cochlearium	I-bacteria
,	O
Eubacterium	B-bacteria
multiforme	I-bacteria
(	O
gut	O
)	O
,	O
and	O
Anaerococcus	B-bacteria
tetradius	I-bacteria
(	O
vagina	O
)	O
.	O

We	O
also	O
clarified	O
that	O
butyric	O
acid	O
in	O
these	O
culture	O
supernatants	O
could	O
induce	O
histone	O
acetylation	O
and	O
HIV	O
-	O
1	O
replication	O
by	O
inhibiting	O
HDAC	O
.	O

Our	O
observations	O
indicate	O
that	O
butyric	O
acid	O
-	O
producing	O
bacteria	O
could	O
be	O
involved	O
in	O
AIDS	O
progression	O
by	O
reactivating	O
the	O
latent	O
HIV	O
provirus	O
and	O
,	O
subsequently	O
,	O
by	O
eliminating	O
such	O
bacterial	O
infection	O
may	O
contribute	O
to	O
the	O
prevention	O
of	O
the	O
AIDS	O
development	O
and	O
transmission	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
examine	O
the	O
relationship	O
between	O
turbidity	O
of	O
mouth	O
rinsed	O
water	O
and	O
oral	O
health	O
status	O
such	O
as	O
dental	O
and	O
periodontal	O
conditions	O
,	O
oral	O
hygiene	O
status	O
,	O
flow	O
rate	O
of	O
saliva	O
and	O
oral	O
bacteria	O
.	O

Subjects	O
were	O
165	O
patients	O
who	O
visited	O
the	O
Dental	O
Hospital	O
,	O
Tokyo	O
Medical	O
and	O
Dental	O
University	O
.	O

Oral	O
health	O
status	O
,	O
including	O
dental	O
and	O
periodontal	O
conditions	O
,	O
oral	O
hygiene	O
status	O
and	O
flow	O
rate	O
of	O
saliva	O
,	O
was	O
clinically	O
examined	O
.	O

The	O
turbidity	O
was	O
measured	O
with	O
a	O
turbidimeter	O
.	O

Quantification	O
of	O
Fusobacterium	B-bacteria
spp	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
,	O
Treponema	B-bacteria
denticola	I-bacteria
and	O
total	O
bacteria	O
levels	O
was	O
performed	O
using	O
real	O
-	O
time	O
PCR	O
.	O

The	O
Pearson	O
correlation	O
and	O
multiple	O
regression	O
analysis	O
were	O
used	O
to	O
explore	O
the	O
associations	O
between	O
the	O
turbidity	O
and	O
oral	O
health	O
parameters	O
.	O

The	O
turbidity	O
showed	O
significant	O
correlations	O
with	O
the	O
number	O
of	O
decayed	O
teeth	O
and	O
deep	O
pockets	O
,	O
the	O
plaque	O
index	O
,	O
extent	O
of	O
tongue	O
coating	O
and	O
Fusobacterium	B-bacteria
spp	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
T	B-bacteria
.	I-bacteria
forsythia	I-bacteria
,	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
and	O
total	O
bacteria	O
levels	O
.	O

In	O
a	O
multiple	O
regression	O
model	O
,	O
the	O
turbidity	O
was	O
negatively	O
associated	O
with	O
the	O
flow	O
rate	O
of	O
saliva	O
and	O
positively	O
associated	O
with	O
the	O
total	O
number	O
of	O
bacteria	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

Current	O
findings	O
suggested	O
that	O
turbidity	O
of	O
mouth	O
rinsed	O
water	O
could	O
be	O
used	O
as	O
an	O
indicator	O
to	O
evaluate	O
oral	O
health	O
condition	O
and	O
the	O
amount	O
of	O
bacteria	O
in	O
the	O
oral	O
cavity	O
.	O

In	O
addition	O
,	O
the	O
turbiditimeter	O
appeared	O
as	O
a	O
simple	O
and	O
objective	O
device	O
for	O
screening	O
abnormality	O
of	O
oral	O
health	O
condition	O
at	O
chair	O
side	O
as	O
well	O
as	O
community	O
-	O
based	O
research	O
.	O

The	O
objective	O
of	O
this	O
paper	O
is	O
to	O
evaluate	O
the	O
effects	O
of	O
oil	O
drops	O
containing	O
Lactobacillus	B-bacteria
salivarius	I-bacteria
WB21	I-bacteria
on	O
periodontal	O
health	O
and	O
oral	O
microbiota	O
producing	O
volatile	O
sulfur	O
compounds	O
(	O
VSCs	O
)	O
.	O

For	O
this	O
study	O
,	O
42	O
subjects	O
were	O
randomly	O
assigned	O
to	O
receive	O
oil	O
samples	O
containing	O
L	B-bacteria
.	I-bacteria
salivarius	I-bacteria
WB21	I-bacteria
or	O
a	O
placebo	O
for	O
two	O
weeks	O
.	O

Oral	O
assessment	O
and	O
saliva	O
collection	O
were	O
performed	O
on	O
days	O
1	O
and	O
15	O
.	O

Bacterial	O
analysis	O
was	O
performed	O
using	O
the	O
real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
and	O
terminal	O
restriction	O
fragment	O
length	O
polymorphism	O
(	O
T	O
-	O
RFLP	O
)	O
.	O

In	O
both	O
the	O
experimental	O
and	O
placebo	O
groups	O
,	O
the	O
average	O
probing	O
depth	O
,	O
number	O
of	O
periodontal	O
pockets	O
,	O
and	O
the	O
percentage	O
of	O
bleeding	O
on	O
probing	O
(	O
BOP	O
)	O
decreased	O
while	O
stimulated	O
salivary	O
flow	O
increased	O
on	O
day	O
15	O
.	O

BOP	O
was	O
reduced	O
in	O
the	O
experimental	O
group	O
compared	O
with	O
the	O
placebo	O
group	O
(	O
P	O
=	O
0	O
.	O
010	O
)	O
.	O

In	O
the	O
experimental	O
group	O
,	O
total	O
bacterial	O
numbers	O
decreased	O
,	O
and	O
the	O
number	O
of	O
L	B-bacteria
.	I-bacteria
salivarius	I-bacteria
increased	O
.	O

The	O
number	O
of	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
which	O
is	O
correlated	O
with	O
hydrogen	O
sulfide	O
concentration	O
in	O
mouth	O
air	O
,	O
increased	O
in	O
the	O
placebo	O
group	O
and	O
did	O
not	O
change	O
in	O
the	O
experimental	O
group	O
.	O

T	O
-	O
RFLP	O
analysis	O
found	O
that	O
the	O
peak	O
area	O
proportions	O
representing	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
,	O
Tannerella	B-bacteria
forsythensis	I-bacteria
,	O
and	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
decreased	O
in	O
the	O
experimental	O
group	O
,	O
although	O
there	O
was	O
no	O
significant	O
change	O
in	O
the	O
bacterial	O
composition	O
.	O

Thus	O
we	O
observed	O
oil	O
drops	O
containing	O
L	B-bacteria
.	I-bacteria
salivarius	I-bacteria
WB21	I-bacteria
improved	O
BOP	O
and	O
inhibited	O
the	O
reproduction	O
of	O
total	O
and	O
VSC	O
-	O
producing	O
periodontopathic	O
bacteria	O
compared	O
with	O
the	O
placebo	O
group	O
,	O
but	O
also	O
showed	O
the	O
limit	O
of	O
its	O
efficacy	O
in	O
controlling	O
VSCs	O
producing	O
and	O
periodontal	O
pathogens	O
.	O

This	O
reference	O
study	O
aims	O
to	O
survey	O
the	O
bacterial	O
flora	O
of	O
the	O
healthy	O
lower	O
human	O
esophagus	O
and	O
to	O
compare	O
it	O
with	O
that	O
of	O
the	O
upper	O
esophagus	O
and	O
oral	O
mucosa	O
.	O

The	O
use	O
of	O
biopsies	O
,	O
in	O
addition	O
to	O
brush	O
samples	O
,	O
allows	O
inclusion	O
of	O
not	O
only	O
transient	O
bacteria	O
present	O
on	O
the	O
surface	O
but	O
also	O
bacteria	O
residing	O
in	O
the	O
epithelia	O
,	O
and	O
the	O
yield	O
of	O
the	O
two	O
methods	O
can	O
be	O
compared	O
.	O

Forty	O
patients	O
scheduled	O
for	O
surgery	O
for	O
reasons	O
with	O
no	O
known	O
influence	O
on	O
esophageal	O
flora	O
and	O
with	O
no	O
symptoms	O
or	O
endoscopic	O
signs	O
of	O
esophageal	O
disease	O
were	O
included	O
.	O

Samples	O
were	O
collected	O
from	O
the	O
oral	O
,	O
upper	O
esophageal	O
,	O
and	O
lower	O
esophageal	O
mucosa	O
using	O
sealed	O
brushes	O
and	O
biopsy	O
forceps	O
.	O

Colonies	O
cultivated	O
on	O
agar	O
plates	O
were	O
classified	O
and	O
semiquantified	O
.	O

Twenty	O
-	O
three	O
different	O
bacterial	O
species	O
were	O
identified	O
,	O
with	O
similar	O
strains	O
present	O
at	O
the	O
three	O
sites	O
.	O

The	O
most	O
common	O
group	O
of	O
bacteria	O
was	O
viridans	B-bacteria
streptococci	I-bacteria
,	O
with	O
an	O
occurrence	O
rate	O
in	O
brush	O
samples	O
and	O
biopsies	O
of	O
98	O
%	O
and	O
95	O
%	O
,	O
respectively	O
.	O

The	O
median	O
number	O
of	O
species	O
occurring	O
in	O
the	O
oral	O
cavity	O
,	O
upper	O
esophagus	O
,	O
and	O
lower	O
esophagus	O
was	O
between	O
3	O
and	O
4	O
(	O
range	O
0	O
-	O
7	O
)	O
.	O

The	O
total	O
number	O
of	O
species	O
in	O
the	O
oral	O
cavity	O
was	O
significantly	O
higher	O
when	O
compared	O
with	O
either	O
level	O
in	O
the	O
esophagus	O
,	O
while	O
the	O
yields	O
obtained	O
by	O
brush	O
and	O
biopsy	O
sampling	O
were	O
highly	O
correlated	O
.	O

Hence	O
,	O
the	O
normal	O
human	O
esophagus	O
is	O
colonized	O
with	O
a	O
resident	O
bacterial	O
flora	O
of	O
its	O
own	O
,	O
which	O
has	O
similarities	O
to	O
that	O
of	O
the	O
oral	O
mucosa	O
.	O

There	O
are	O
diverse	O
species	O
that	O
make	O
up	O
this	O
flora	O
,	O
although	O
in	O
relatively	O
low	O
amounts	O
.	O

The	O
most	O
frequent	O
inhabitants	O
of	O
the	O
esophagus	O
are	O
streptococci	B-bacteria
,	O
with	O
an	O
occurrence	O
rate	O
in	O
brush	O
samples	O
and	O
biopsies	O
of	O
95	O
-	O
98	O
%	O
.	O

Comparative	O
studies	O
of	O
patients	O
with	O
eosinophilic	O
esophagitis	O
and	O
gastroesophageal	O
reflux	O
disease	O
are	O
warranted	O
.	O

To	O
investigate	O
the	O
antimicrobial	O
activity	O
of	O
the	O
bacteriocin	O
-	O
producing	O
strain	O
Streptococcus	B-bacteria
salivarius	I-bacteria
K12	I-bacteria
against	O
several	O
bacteria	O
involved	O
in	O
halitosis	O
.	O

The	O
inhibitory	O
activity	O
of	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
K12	I-bacteria
against	O
Solobacterium	B-bacteria
moorei	I-bacteria
CCUG39336	I-bacteria
,	O
four	O
clinical	O
S	B-bacteria
.	I-bacteria
moorei	I-bacteria
isolates	I-bacteria
,	O
Atopobium	B-bacteria
parvulum	I-bacteria
ATCC33793	I-bacteria
and	O
Eubacterium	B-bacteria
sulci	I-bacteria
ATCC35585	I-bacteria
was	O
examined	O
by	O
a	O
deferred	O
antagonism	O
test	O
.	O

Eubacterium	B-bacteria
saburreum	I-bacteria
ATCC33271	I-bacteria
and	O
Parvimonas	B-bacteria
micra	I-bacteria
ATCC33270	I-bacteria
,	O
which	O
have	O
been	O
tested	O
in	O
previous	O
studies	O
,	O
served	O
as	O
positive	O
controls	O
,	O
and	O
the	O
Gram	O
-	O
negative	O
strain	O
Bacteroides	B-bacteria
fragilis	I-bacteria
ZIB2800	I-bacteria
served	O
as	O
a	O
negative	O
control	O
.	O

Additionally	O
,	O
the	O
occurrence	O
of	O
resistance	O
in	O
S	B-bacteria
.	I-bacteria
moorei	I-bacteria
CCUG39336	I-bacteria
to	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
K12	I-bacteria
was	O
analysed	O
by	O
either	O
direct	O
plating	O
or	O
by	O
passage	O
of	O
S	B-bacteria
.	I-bacteria
moorei	I-bacteria
CCUG39336	I-bacteria
on	O
chloroform	O
-	O
inactived	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
K12	I-bacteria
-	O
containing	O
agar	O
plates	O
.	O

S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
K12	I-bacteria
suppressed	O
the	O
growth	O
of	O
all	O
Gram	O
-	O
positive	O
bacteria	O
tested	O
,	O
but	O
the	O
extent	O
to	O
which	O
the	O
bacteria	O
were	O
inhibited	O
varied	O
.	O

E	B-bacteria
.	I-bacteria
sulci	I-bacteria
ATCC35585	I-bacteria
was	O
the	O
most	O
sensitive	O
strain	O
,	O
while	O
all	O
five	O
S	B-bacteria
.	I-bacteria
moorei	I-bacteria
isolates	I-bacteria
were	O
inhibited	O
to	O
a	O
lesser	O
extent	O
.	O

Natural	O
resistance	O
seems	O
to	O
be	O
very	O
low	O
in	O
S	B-bacteria
.	I-bacteria
moorei	I-bacteria
CCUG39336	I-bacteria
,	O
and	O
there	O
was	O
only	O
a	O
slight	O
decrease	O
in	O
sensitivity	O
after	O
exposure	O
to	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
K12	I-bacteria
over	O
10	O
passages	O
.	O

Our	O
studies	O
demonstrate	O
that	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
K12	I-bacteria
has	O
antimicrobial	O
activity	O
against	O
bacteria	O
involved	O
in	O
halitosis	O
.	O

This	O
strain	O
might	O
be	O
an	O
interesting	O
and	O
valuable	O
candidate	O
for	O
the	O
development	O
of	O
an	O
antimicrobial	O
therapy	O
for	O
halitosis	O
.	O

Bacterial	O
cultures	O
and	O
chemical	O
analyses	O
were	O
performed	O
from	O
cloacal	O
and	O
oral	O
swabs	O
taken	O
from	O
43	O
American	O
crocodiles	O
Crocodylus	O
acutus	O
and	O
28	O
Morelet	O
'	O
s	O
crocodiles	O
C	O
.	O
moreletii	O
captured	O
in	O
Quintana	O
Roo	O
State	O
,	O
Mexico	O
.	O

We	O
recovered	O
47	O
bacterial	O
species	O
(	O
28	O
genera	O
and	O
14	O
families	O
)	O
from	O
all	O
samples	O
with	O
51	O
.	O
1	O
%	O
of	O
these	O
belonging	O
to	O
the	O
family	O
Enterobacteriaceae	B-bacteria
.	O

Fourteen	O
species	O
(	O
29	O
.	O
8	O
%	O
)	O
were	O
detected	O
in	O
both	O
crocodile	O
species	O
and	O
18	O
(	O
38	O
.	O
3	O
%	O
)	O
and	O
15	O
(	O
31	O
.	O
9	O
%	O
)	O
species	O
were	O
only	O
detected	O
in	O
American	O
and	O
Morelet	O
'	O
s	O
crocodiles	O
,	O
respectively	O
.	O

We	O
recovered	O
35	O
bacterial	O
species	O
from	O
all	O
oral	O
samples	O
,	O
of	O
which	O
9	O
(	O
25	O
.	O
8	O
%	O
)	O
were	O
detected	O
in	O
both	O
crocodile	O
species	O
.	O

From	O
all	O
cloacal	O
samples	O
,	O
we	O
recovered	O
21	O
bacterial	O
species	O
,	O
of	O
which	O
8	O
(	O
38	O
.	O
1	O
%	O
)	O
were	O
detected	O
in	O
both	O
crocodile	O
species	O
.	O

The	O
most	O
commonly	O
isolated	O
bacteria	O
in	O
cloacal	O
samples	O
were	O
Aeromonas	B-bacteria
hydrophila	I-bacteria
and	O
Escherichia	B-bacteria
coli	I-bacteria
,	O
whereas	O
in	O
oral	O
samples	O
the	O
most	O
common	O
bacteria	O
were	O
A	B-bacteria
.	I-bacteria
hydrophila	I-bacteria
and	O
Arcanobacterium	B-bacteria
pyogenes	I-bacteria
.	O

The	O
bacteria	O
isolated	O
represent	O
a	O
potential	O
threat	O
to	O
crocodile	O
health	O
during	O
conditions	O
of	O
stress	O
and	O
a	O
threat	O
to	O
human	O
health	O
through	O
crocodile	O
bites	O
,	O
crocodile	O
meat	O
consumption	O
or	O
carrying	O
out	O
activities	O
in	O
crocodile	O
habitat	O
.	O

We	O
especially	O
warn	O
about	O
the	O
presence	O
of	O
Salmonella	B-bacteria
arizonae	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
typhi	I-bacteria
,	O
which	O
cause	O
enteritis	O
and	O
septicemia	O
in	O
crocodiles	O
and	O
salmonellosis	O
and	O
typhoid	O
fever	O
in	O
humans	O
.	O

The	O
risk	O
of	O
bacterial	O
contamination	O
from	O
crocodiles	O
to	O
humans	O
could	O
increase	O
in	O
the	O
future	O
because	O
of	O
the	O
accelerated	O
destruction	O
of	O
crocodile	O
habitat	O
,	O
which	O
could	O
lead	O
to	O
an	O
augmentation	O
of	O
human	O
-	O
crocodile	O
interactions	O
.	O

Information	O
on	O
bacterial	O
diversity	O
reported	O
here	O
could	O
help	O
in	O
the	O
choice	O
of	O
antibacterial	O
products	O
in	O
case	O
of	O
infections	O
that	O
are	O
of	O
crocodile	O
origin	O
.	O

Infection	O
has	O
been	O
hypothesized	O
as	O
a	O
contributing	O
factor	O
to	O
bisphosphonate	O
(	O
BP	O
)	O
-	O
related	O
osteonecrosis	O
of	O
the	O
jaw	O
(	O
BRONJ	O
)	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
bacterial	O
colonization	O
of	O
jawbone	O
and	O
identify	O
the	O
bacterial	O
phylotypes	O
associated	O
with	O
BRONJ	O
.	O
Culture	O
-	O
independent	O
16S	O
rRNA	O
gene	O
-	O
based	O
molecular	O
techniques	O
were	O
used	O
to	O
determine	O
and	O
compare	O
the	O
total	O
bacterial	O
diversity	O
in	O
bone	O
samples	O
collected	O
from	O
12	O
patients	O
with	O
cancer	O
(	O
six	O
,	O
BRONJ	O
with	O
history	O
of	O
BP	O
;	O
six	O
,	O
controls	O
without	O
BRONJ	O
,	O
no	O
history	O
of	O
BP	O
but	O
have	O
infection	O
)	O
.	O

Denaturing	O
gradient	O
gel	O
electrophoresis	O
profile	O
and	O
Dice	O
coefficient	O
displayed	O
a	O
statistically	O
significant	O
clustering	O
of	O
profiles	O
,	O
indicating	O
different	O
bacterial	O
population	O
in	O
BRONJ	O
subjects	O
and	O
control	O
.	O

The	O
top	O
three	O
genera	O
ranked	O
among	O
the	O
BRONJ	O
group	O
were	O
Streptococcus	B-bacteria
(	O
29	O
%	O
)	O
,	O
Eubacterium	B-bacteria
(	O
9	O
%	O
)	O
,	O
and	O
Pseudoramibacter	B-bacteria
(	O
8	O
%	O
)	O
,	O
while	O
in	O
the	O
control	O
group	O
were	O
Parvimonas	B-bacteria
(	O
17	O
%	O
)	O
,	O
Streptococcus	B-bacteria
(	O
15	O
%	O
)	O
,	O
and	O
Fusobacterium	B-bacteria
(	O
15	O
%	O
)	O
.	O

H	O
&	O
E	O
sections	O
of	O
BRONJ	O
bone	O
revealed	O
layers	O
of	O
bacteria	O
along	O
the	O
surfaces	O
and	O
often	O
are	O
packed	O
into	O
the	O
scalloped	O
edges	O
of	O
the	O
bone	O
.	O

This	O
study	O
using	O
limited	O
sample	O
size	O
indicated	O
that	O
the	O
jawbone	O
associated	O
with	O
BRONJ	O
was	O
heavily	O
colonized	O
by	O
specific	O
oral	O
bacteria	O
and	O
there	O
were	O
apparent	O
differences	O
between	O
the	O
microbiota	O
of	O
BRONJ	O
and	O
controls	O
.	O

Bacterial	O
vaginosis	O
(	O
BV	O
)	O
represents	O
shifts	O
in	O
microbiota	O
from	O
Lactobacillus	B-bacteria
spp	I-bacteria
.	I-bacteria
to	O
diverse	O
anaerobes	O
.	O

Although	O
antibiotics	O
relieve	O
symptoms	O
and	O
temporarily	O
eradicate	O
BV	B-bacteria
-	I-bacteria
associated	I-bacteria
bacteria	I-bacteria
(	O
BVAB	B-bacteria
)	O
,	O
BV	O
usually	O
recurs	O
.	O

We	O
investigated	O
the	O
role	O
of	O
extravaginal	O
BVAB	B-bacteria
reservoirs	O
in	O
recurrence	O
.	O

Risks	O
for	O
BV	O
acquisition	O
over	O
the	O
course	O
of	O
1	O
year	O
were	O
defined	O
.	O

DNA	O
in	O
vaginal	O
,	O
anal	O
,	O
and	O
oral	O
swab	O
samples	O
from	O
enrollment	O
was	O
subjected	O
to	O
quantitative	O
polymerase	O
chain	O
reaction	O
assays	O
targeting	O
16S	O
ribosomal	O
RNA	O
genes	O
of	O
Gardnerella	B-bacteria
vaginalis	I-bacteria
,	O
Lactobacillus	B-bacteria
crispatus	I-bacteria
,	O
BVAB1	B-bacteria
,	O
BVAB2	B-bacteria
,	O
BVAB3	B-bacteria
,	O
Megasphaera	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
Lactobacillus	B-bacteria
jensenii	I-bacteria
,	O
and	O
Leptotrichia	B-bacteria
/	I-bacteria
Sneathia	I-bacteria
spp	I-bacteria
.	O

A	O
case	O
-	O
control	O
approach	O
analyzed	O
BVAB	B-bacteria
detection	O
at	O
enrollment	O
for	O
case	O
patients	O
(	O
BV	O
acquisition	O
)	O
versus	O
controls	O
(	O
none	O
)	O
.	O

Of	O
239	O
women	O
enrolled	O
without	O
BV	O
,	O
199	O
were	O
seen	O
in	O
follow	O
-	O
up	O
,	O
and	O
40	O
experienced	O
BV	O
;	O
15	O
had	O
all	O
samples	O
for	O
analysis	O
.	O

Detection	O
of	O
G	B-bacteria
.	I-bacteria
vaginalis	I-bacteria
in	O
oral	O
cavity	O
or	O
anal	O
samples	O
and	O
Leptotrichia	B-bacteria
/	I-bacteria
Sneathia	I-bacteria
spp	I-bacteria
.	I-bacteria
in	O
anal	O
samples	O
was	O
more	O
common	O
at	O
enrollment	O
among	O
case	O
patients	O
,	O
who	O
also	O
had	O
higher	O
concentrations	O
of	O
these	O
bacteria	O
and	O
Megasphaera	B-bacteria
relative	O
to	O
30	O
controls	O
at	O
each	O
site	O
.	O

In	O
contrast	O
,	O
L	B-bacteria
.	I-bacteria
crispatus	I-bacteria
was	O
detected	O
more	O
frequently	O
in	O
anal	O
samples	O
among	O
controls	O
.	O

Women	O
who	O
acquire	O
BV	O
are	O
more	O
likely	O
have	O
previous	O
colonization	O
of	O
extravaginal	O
reservoirs	O
with	O
some	O
BVAB	B-bacteria
,	O
and	O
less	O
likely	O
to	O
have	O
L	B-bacteria
.	I-bacteria
crispatus	I-bacteria
,	O
suggesting	O
that	O
BVAB	B-bacteria
may	O
be	O
acquired	O
vaginally	O
from	O
extravaginal	O
reservoirs	O
.	O

Treating	O
patients	O
with	O
systemic	O
lupus	O
erythematosus	O
(	O
SLE	O
)	O
with	O
steroids	O
and	O
immunosuppressive	O
drugs	O
may	O
interfere	O
in	O
the	O
presence	O
of	O
potentially	O
opportunistic	O
microorganisms	O
in	O
the	O
oral	O
cavity	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
presence	O
of	O
Candida	O
spp	O
.	O
,	O
Staphylococcus	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
Enterobacteria	B-bacteria
and	O
Pseudomonas	B-bacteria
spp	I-bacteria
.	I-bacteria
in	O
the	O
oral	O
cavity	O
of	O
SLE	O
patients	O
,	O
compared	O
with	O
healthy	O
controls	O
.	O

A	O
group	O
of	O
40	O
patients	O
who	O
had	O
received	O
therapy	O
for	O
at	O
least	O
60	O
days	O
was	O
selected	O
(	O
19	O
-	O
53	O
years	O
)	O
.	O

For	O
the	O
control	O
group	O
,	O
40	O
healthy	O
individuals	O
matched	O
for	O
age	O
,	O
gender	O
and	O
use	O
of	O
partial	O
prosthesis	O
were	O
selected	O
.	O

Oral	O
rinse	O
samples	O
were	O
collected	O
and	O
plated	O
on	O
specific	O
culture	O
media	O
.	O

After	O
incubation	O
,	O
the	O
number	O
of	O
colony	O
forming	O
units	O
(	O
CFU	O
)	O
was	O
obtained	O
and	O
the	O
isolates	O
were	O
identified	O
at	O
species	O
level	O
.	O

Microbial	O
counts	O
were	O
compared	O
between	O
SLE	O
and	O
control	O
by	O
analysis	O
of	O
variance	O
(	O
ANOVA	O
)	O
and	O
Mann	O
-	O
Whitney	O
(	O
p	O
<	O
0	O
.	O
05	O
significant	O
)	O
.	O

Microorganism	O
counts	O
in	O
patients	O
with	O
and	O
without	O
immunosuppressive	O
drugs	O
,	O
as	O
well	O
with	O
active	O
and	O
inactive	O
disease	O
(	O
according	O
to	O
SLEDAI	O
score	O
)	O
were	O
also	O
compared	O
.	O

No	O
significant	O
differences	O
in	O
CFU	O
/	O
mL	O
between	O
SLE	O
and	O
control	O
patients	O
were	O
observed	O
(	O
yeasts	O
,	O
p	O
=	O
0	O
.	O
55	O
;	O
Staphylococci	B-bacteria
,	O
p	O
=	O
0	O
.	O
24	O
;	O
Enterobacteria	B-bacteria
/	I-bacteria
Pseudomonas	I-bacteria
spp	I-bacteria
.	I-bacteria
,	O
p	O
=	O
0	O
.	O
26	O
)	O
.	O

No	O
differences	O
in	O
microbial	O
counts	O
were	O
observed	O
regarding	O
clinical	O
parameters	O
tested	O
.	O

The	O
most	O
frequent	O
species	O
isolated	O
in	O
the	O
SLE	O
group	O
were	O
Candida	O
albicans	O
,	O
Staphylococcus	B-bacteria
epidermidis	I-bacteria
and	O
Klebsiella	B-bacteria
oxytoca	I-bacteria
.	O

In	O
conclusion	O
,	O
no	O
differences	O
in	O
frequency	O
and	O
microorganism	O
levels	O
were	O
found	O
between	O
SLE	O
patients	O
and	O
healthy	O
individuals	O
.	O

SGP1	B-bacteria
(	O
T	O
)	O
,	O
a	O
strain	O
belonging	O
to	O
a	O
lineage	O
of	O
the	O
phylum	O
Synergistetes	B-bacteria
with	O
no	O
previously	O
cultivated	O
representatives	O
was	O
subjected	O
to	O
a	O
comprehensive	O
range	O
of	O
phenotypic	O
and	O
genotypic	O
tests	O
.	O

For	O
good	O
growth	O
the	O
strain	O
was	O
dependent	O
on	O
co	O
-	O
culture	O
with	O
,	O
or	O
extracts	O
from	O
,	O
selected	O
other	O
oral	O
bacteria	O
.	O

Cells	O
of	O
strain	O
SGP1	B-bacteria
(	O
T	O
)	O
were	O
asaccharolytic	O
and	O
major	O
amounts	O
of	O
acetic	O
acid	O
and	O
moderate	O
amounts	O
of	O
propionic	O
acid	O
were	O
produced	O
as	O
end	O
products	O
of	O
metabolism	O
in	O
peptone	O
-	O
yeast	O
extract	O
-	O
glucose	O
broth	O
supplemented	O
with	O
a	O
filtered	O
cell	O
sonicate	O
of	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
subsp	I-bacteria
.	I-bacteria
nucleatum	I-bacteria
ATCC	I-bacteria
25586	I-bacteria
(	O
T	O
)	O
(	O
25	O
%	O
,	O
v	O
/	O
v	O
)	O
.	O

Hydrogen	O
sulphide	O
was	O
produced	O
and	O
gelatin	O
was	O
weakly	O
hydrolysed	O
.	O

The	O
major	O
cellular	O
fatty	O
acids	O
were	O
C	O
(	O
14	O
:	O
0	O
)	O
,	O
C	O
(	O
18	O
:	O
0	O
)	O
and	O
C	O
(	O
16	O
:	O
0	O
)	O
.	O

The	O
DNA	O
G	O
+	O
C	O
content	O
of	O
strain	O
SGP1	B-bacteria
(	O
T	O
)	O
was	O
63	O
mol	O
%	O
.	O

Phylogenetic	O
analysis	O
of	O
the	O
full	O
-	O
length	O
16S	O
rRNA	O
gene	O
showed	O
that	O
strain	O
SGP1	B-bacteria
(	O
T	O
)	O
represented	O
a	O
novel	O
group	O
within	O
the	O
phylum	O
Synergistetes	B-bacteria
.	O

A	O
novel	O
species	O
in	O
a	O
new	O
genus	O
,	O
Fretibacterium	B-bacteria
fastidiosum	I-bacteria
gen	I-bacteria
.	I-bacteria
nov	I-bacteria
.	I-bacteria
,	I-bacteria
sp	I-bacteria
.	I-bacteria
nov	I-bacteria
.	I-bacteria
,	O
is	O
proposed	O
.	O

The	O
type	O
strain	O
of	O
Fretibacterium	B-bacteria
fastidiosum	I-bacteria
is	O
SGP1	B-bacteria
(	O
T	O
)	O
(	O
=	O
DSM	B-bacteria
25557	I-bacteria
(	O
T	O
)	O
=	O
JCM	B-bacteria
16858	I-bacteria
(	O
T	O
)	O
)	O
.	O

Critical	O
care	O
nursing	O
interventions	O
to	O
oral	O
care	O
can	O
reduce	O
microorganisms	O
in	O
the	O
oropharynx	O
available	O
for	O
translocation	O
.	O

To	O
analyse	O
the	O
effect	O
of	O
0	O
.	O
12	O
%	O
chlorhexidine	O
digluconate	O
on	O
the	O
colonization	O
of	O
oropharyngeal	O
and	O
tracheal	O
secretions	O
by	O
Gram	O
-	O
negative	O
pathogens	O
in	O
mechanically	O
ventilated	O
children	O
.	O

A	O
randomized	O
,	O
controlled	O
and	O
double	O
-	O
blinded	O
study	O
was	O
performed	O
in	O
the	O
paediatric	O
intensive	O
care	O
unit	O
(	O
PICU	O
)	O
of	O
a	O
Brazilian	O
university	O
hospital	O
.	O

Exclusion	O
criteria	O
included	O
child	O
age	O
under	O
28	O
days	O
,	O
pneumonia	O
diagnosis	O
at	O
admission	O
,	O
use	O
of	O
tracheostomy	O
,	O
PICU	O
length	O
of	O
stay	O
(	O
LOS	O
)	O
less	O
than	O
48	O
h	O
and	O
refusal	O
to	O
participate	O
.	O

Children	O
were	O
randomly	O
allocated	O
to	O
the	O
interventional	O
group	O
(	O
IG	O
)	O
,	O
in	O
which	O
oral	O
care	O
with	O
chlorhexidine	O
was	O
administered	O
,	O
or	O
to	O
the	O
placebo	O
group	O
(	O
PG	O
)	O
,	O
which	O
received	O
oral	O
care	O
without	O
antiseptic	O
use	O
.	O

The	O
data	O
were	O
analysed	O
through	O
Pearson	O
'	O
s	O
chi	O
(	O
2	O
)	O
test	O
,	O
Fisher	O
'	O
s	O
exact	O
and	O
ANOVA	O
tests	O
with	O
significance	O
levels	O
set	O
at	O
0	O
.	O
05	O
.	O

The	O
demographic	O
characteristics	O
of	O
the	O
74	O
children	O
were	O
not	O
statistically	O
different	O
between	O
groups	O
.	O

No	O
between	O
-	O
group	O
differences	O
in	O
oropharyx	O
colonization	O
by	O
Gram	O
-	O
negative	O
pathogens	O
were	O
identified	O
(	O
p	O
=	O
0	O
.	O
316	O
)	O
.	O

Pathogens	O
were	O
isolated	O
in	O
the	O
tracheal	O
secretions	O
of	O
two	O
(	O
10	O
.	O
0	O
%	O
)	O
children	O
in	O
the	O
PG	O
and	O
four	O
(	O
19	O
.	O
0	O
%	O
)	O
children	O
in	O
the	O
IG	O
(	O
p	O
=	O
0	O
.	O
355	O
)	O
.	O

The	O
use	O
of	O
chlorhexidine	O
did	O
not	O
significantly	O
influence	O
the	O
colonization	O
of	O
oropharyngeal	O
and	O
tracheal	O
secretions	O
by	O
Gram	O
-	O
negative	O
pathogens	O
of	O
the	O
studied	O
sample	O
.	O

This	O
study	O
demonstrated	O
no	O
influence	O
of	O
a	O
specific	O
antiseptic	O
agent	O
on	O
colonization	O
profile	O
of	O
mechanically	O
ventilated	O
children	O
in	O
PICU	O
.	O

Further	O
research	O
in	O
this	O
field	O
is	O
necessary	O
to	O
promote	O
evidence	O
-	O
based	O
nursing	O
practice	O
on	O
oral	O
care	O
of	O
critically	O
ill	O
children	O
.	O

Helicobacter	B-bacteria
pylori	I-bacteria
colonizes	O
the	O
stomachs	O
of	O
at	O
least	O
half	O
of	O
the	O
world	O
'	O
s	O
human	O
population	O
.	O

The	O
role	O
of	O
the	O
oral	O
cavity	O
in	O
this	O
colonization	O
is	O
not	O
clear	O
and	O
there	O
are	O
,	O
to	O
date	O
,	O
no	O
comprehensive	O
data	O
that	O
clearly	O
demonstrate	O
the	O
isolation	O
of	O
this	O
bacterium	O
from	O
the	O
oral	O
cavity	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
prevalence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
the	O
oral	O
cavity	O
of	O
15	O
patients	O
who	O
tested	O
positive	O
for	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
.	O

A	O
comprehensive	O
dental	O
examination	O
of	O
all	O
patients	O
was	O
conducted	O
.	O

Samples	O
were	O
taken	O
from	O
supragingival	O
and	O
subgingival	O
plaque	O
,	O
saliva	O
,	O
periapical	O
exudates	O
and	O
tongue	O
swabs	O
.	O

All	O
samples	O
were	O
taken	O
before	O
the	O
application	O
of	O
antibiotics	O
.	O

A	O
total	O
of	O
163	O
oral	O
samples	O
were	O
investigated	O
by	O
PCR	O
using	O
two	O
different	O
H	O
.	O
pylori	O
-	O
specific	O
primer	O
pairs	O
.	O

A	O
PCR	O
inhibition	O
control	O
using	O
a	O
modified	O
plasmid	O
was	O
always	O
included	O
for	O
the	O
most	O
specific	O
primer	O
pair	O
.	O

In	O
addition	O
,	O
a	O
culture	O
technique	O
was	O
used	O
to	O
confirm	O
PCR	O
results	O
.	O

Despite	O
a	O
PCR	O
detection	O
limit	O
of	O
10	O
(	O
2	O
)	O
bacteria	O
ml	O
(	O
-	O
1	O
)	O
,	O
out	O
of	O
14	O
patients	O
,	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
could	O
not	O
be	O
detected	O
in	O
any	O
of	O
the	O
samples	O
taken	O
.	O

In	O
one	O
patient	O
,	O
H	O
.	O
pylori	O
-	O
positive	O
PCR	O
signals	O
were	O
obtained	O
in	O
two	O
samples	O
using	O
only	O
one	O
primer	O
pair	O
.	O

H	B-bacteria
.	I-bacteria
pylori	I-bacteria
could	O
not	O
be	O
cultivated	O
from	O
these	O
two	O
PCR	O
-	O
positive	O
samples	O
;	O
therefore	O
,	O
no	O
correlation	O
to	O
oral	O
colonization	O
status	O
could	O
be	O
established	O
.	O

This	O
study	O
challenges	O
the	O
misleading	O
preconception	O
that	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
resides	O
in	O
the	O
human	O
oral	O
cavity	O
and	O
suggests	O
that	O
this	O
bacterium	O
should	O
be	O
considered	O
transient	O
and	O
independent	O
of	O
the	O
oral	O
status	O
.	O

To	O
date	O
,	O
positive	O
PCR	O
results	O
for	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
the	O
oral	O
cavity	O
have	O
been	O
overestimated	O
and	O
not	O
critically	O
interpreted	O
in	O
literature	O
.	O

Microbial	O
flora	O
can	O
provide	O
insight	O
into	O
the	O
ecology	O
and	O
natural	O
history	O
of	O
wildlife	O
in	O
addition	O
to	O
improving	O
understanding	O
of	O
health	O
risks	O
.	O

This	O
study	O
examines	O
the	O
anaerobic	O
oral	O
flora	O
of	O
hunter	O
killed	O
black	O
bears	O
(	O
Ursus	O
americanus	O
)	O
in	O
eastern	O
North	O
Carolina	O
.	O

Oral	O
swabs	O
from	O
the	O
buccal	O
and	O
lingual	O
supragingival	O
tooth	O
surfaces	O
of	O
the	O
first	O
and	O
second	O
mandibular	O
and	O
maxillary	O
molars	O
of	O
22	O
black	O
bears	O
were	O
inoculated	O
onto	O
Brucella	B-bacteria
Blood	O
Agar	O
plates	O
supplemented	O
with	O
hemin	O
and	O
vitamin	O
K	O
after	O
transport	O
from	O
the	O
field	O
using	O
reduced	O
oxoid	O
nutrient	O
broth	O
.	O

Sixteen	O
anaerobic	O
bacterial	O
species	O
,	O
representing	O
nine	O
genera	O
were	O
identified	O
using	O
the	O
RapID	O
ANA	O
II	O
Micromethod	O
Kit	O
system	O
and	O
a	O
number	O
of	O
organisms	O
grown	O
that	O
could	O
not	O
be	O
identified	O
with	O
the	O
system	O
.	O

The	O
most	O
frequently	O
identified	O
anaerobes	O
were	O
Peptostreptococcus	B-bacteria
prevotii	I-bacteria
,	O
Streptococcus	B-bacteria
constellatus	I-bacteria
,	O
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
.	O

The	O
diversity	O
in	O
the	O
anaerobic	O
oral	O
flora	O
of	O
black	O
bear	O
in	O
eastern	O
North	O
Carolina	O
suggests	O
the	O
importance	O
of	O
including	O
these	O
organisms	O
in	O
basic	O
health	O
risk	O
assessment	O
protocols	O
and	O
suggests	O
a	O
potential	O
tool	O
for	O
assessment	O
of	O
bear	O
/	O
habitat	O
interactions	O
.	O

Tobacco	O
chewing	O
habit	O
,	O
presence	O
of	O
squamous	O
cell	O
carcinoma	O
in	O
oral	O
cavity	O
and	O
radiotherapy	O
causes	O
alterations	O
in	O
healthy	O
oral	O
microflora	O
.	O

Abnormal	O
flora	O
developed	O
due	O
to	O
radiotherapy	O
in	O
oral	O
squamous	O
cell	O
carcinoma	O
(	O
OSCC	O
)	O
patients	O
can	O
exacerbate	O
mucositis	O
and	O
can	O
cause	O
systemic	O
infections	O
.	O

The	O
role	O
of	O
oral	O
microorganisms	O
in	O
carcinogenesis	O
is	O
gaining	O
interest	O
recently	O
.	O

Abnormal	O
flora	O
in	O
development	O
of	O
second	O
tumor	O
in	O
the	O
field	O
of	O
first	O
tumor	O
is	O
to	O
be	O
established	O
.	O

The	O
study	O
fundamentally	O
tries	O
to	O
evaluate	O
the	O
shift	O
that	O
occurs	O
during	O
the	O
radiotherapy	O
in	O
OSCC	O
patients	O
.	O

Microbial	O
analysis	O
of	O
saliva	O
samples	O
from	O
OSCC	O
patients	O
undergoing	O
radiotherapy	O
,	O
tobacco	O
chewers	O
and	O
controls	O
was	O
undertaken	O
.	O

The	O
microorganisms	O
were	O
grouped	O
into	O
categories	O
as	O
total	O
aerobes	O
,	O
total	O
anaerobes	O
,	O
candida	O
,	O
coliforms	B-bacteria
and	O
gram	O
negative	O
anaerobic	O
bacteria	O
.	O

The	O
frequency	O
of	O
isolation	O
of	O
total	O
aerobes	O
,	O
total	O
anaerobes	O
,	O
coliforms	B-bacteria
and	O
gram	O
negative	O
anaerobic	O
bacteria	O
was	O
significantly	O
high	O
in	O
OSCC	O
patients	O
compared	O
to	O
healthy	O
controls	O
whereas	O
candida	O
was	O
isolated	O
most	O
frequently	O
during	O
radiation	O
period	O
.	O

The	O
tobacco	O
chewers	O
showed	O
significant	O
increase	O
in	O
colony	O
forming	O
units	O
of	O
total	O
aerobes	O
and	O
coliforms	B-bacteria
.	O

All	O
the	O
microbial	O
groups	O
were	O
high	O
in	O
OSCC	O
and	O
radiotherapy	O
patients	O
.	O

While	O
OSCC	O
patients	O
showed	O
significant	O
increase	O
in	O
total	O
anaerobes	O
and	O
gram	O
negative	O
anaerobes	O
,	O
candida	O
was	O
increased	O
in	O
radiotherapy	O
patients	O
only	O
.	O

Habits	O
promote	O
coliforms	B-bacteria
.	O

Tumor	O
supports	O
efficiently	O
anaerobes	O
and	O
candida	O
.	O

The	O
latter	O
is	O
supported	O
more	O
by	O
radiation	O
.	O

The	O
study	O
stresses	O
the	O
importance	O
on	O
administration	O
of	O
appropriate	O
antimicrobial	O
therapy	O
right	O
at	O
the	O
time	O
of	O
diagnosis	O
of	O
the	O
lesion	O
.	O

High	O
throughput	O
sequencing	O
of	O
16S	O
ribosomal	O
RNA	O
gene	O
amplicons	O
is	O
a	O
cost	O
-	O
effective	O
method	O
for	O
characterization	O
of	O
oral	O
bacterial	O
communities	O
.	O

However	O
,	O
before	O
undertaking	O
large	O
-	O
scale	O
studies	O
,	O
it	O
is	O
necessary	O
to	O
understand	O
the	O
technique	O
-	O
associated	O
limitations	O
and	O
intrinsic	O
variability	O
of	O
the	O
oral	O
ecosystem	O
.	O

In	O
this	O
work	O
we	O
evaluated	O
bias	O
in	O
species	O
representation	O
using	O
an	O
in	O
vitro	O
-	O
assembled	O
mock	O
community	O
of	O
oral	O
bacteria	O
.	O

We	O
then	O
characterized	O
the	O
bacterial	O
communities	O
in	O
saliva	O
and	O
buccal	O
mucosa	O
of	O
five	O
healthy	O
subjects	O
to	O
investigate	O
the	O
power	O
of	O
high	O
throughput	O
sequencing	O
in	O
revealing	O
their	O
diversity	O
and	O
biogeography	O
patterns	O
.	O

Mock	O
community	O
analysis	O
showed	O
primer	O
and	O
DNA	O
isolation	O
biases	O
and	O
an	O
overestimation	O
of	O
diversity	O
that	O
was	O
reduced	O
after	O
eliminating	O
singleton	O
operational	O
taxonomic	O
units	O
(	O
OTUs	O
)	O
.	O

Sequencing	O
of	O
salivary	O
and	O
mucosal	O
communities	O
found	O
a	O
total	O
of	O
455	O
OTUs	O
(	O
0	O
.	O
3	O
%	O
dissimilarity	O
)	O
with	O
only	O
78	O
of	O
these	O
present	O
in	O
all	O
subjects	O
.	O

We	O
demonstrate	O
that	O
this	O
variability	O
was	O
partly	O
the	O
result	O
of	O
incomplete	O
richness	O
coverage	O
even	O
at	O
great	O
sequencing	O
depths	O
,	O
and	O
so	O
comparing	O
communities	O
by	O
their	O
structure	O
was	O
more	O
effective	O
than	O
comparisons	O
based	O
solely	O
on	O
membership	O
.	O

With	O
respect	O
to	O
oral	O
biogeography	O
,	O
we	O
found	O
inter	O
-	O
subject	O
variability	O
in	O
community	O
structure	O
was	O
lower	O
than	O
site	O
differences	O
between	O
salivary	O
and	O
mucosal	O
communities	O
within	O
subjects	O
.	O

These	O
differences	O
were	O
evident	O
at	O
very	O
low	O
sequencing	O
depths	O
and	O
were	O
mostly	O
caused	O
by	O
the	O
abundance	O
of	O
Streptococcus	B-bacteria
mitis	I-bacteria
and	O
Gemella	B-bacteria
haemolysans	I-bacteria
in	O
mucosa	O
.	O

In	O
summary	O
,	O
we	O
present	O
an	O
experimental	O
and	O
data	O
analysis	O
framework	O
that	O
will	O
facilitate	O
design	O
and	O
interpretation	O
of	O
pyrosequencing	O
-	O
based	O
studies	O
.	O

Despite	O
challenges	O
associated	O
with	O
this	O
technique	O
,	O
we	O
demonstrate	O
its	O
power	O
for	O
evaluation	O
of	O
oral	O
diversity	O
and	O
biogeography	O
patterns	O
.	O

to	O
test	O
the	O
association	O
between	O
Candida	O
and	O
mutans	B-bacteria
streptococci	I-bacteria
(	O
ms	B-bacteria
)	O
,	O
oral	O
hygiene	O
and	O
caries	O
levels	O
and	O
in	O
children	O
.	O

22	O
boys	O
and	O
12	O
girls	O
(	O
age	O
6	O
to	O
14	O
.	O
5	O
years	O
)	O
participated	O
in	O
the	O
study	O
.	O

Each	O
participant	O
received	O
a	O
toothbrush	O
,	O
and	O
was	O
asked	O
to	O
brush	O
his	O
/	O
her	O
teeth	O
after	O
proper	O
instructions	O
.	O

Dental	O
caries	O
and	O
oral	O
hygiene	O
were	O
recorded	O
.	O

Candida	O
and	O
ms	B-bacteria
levels	O
were	O
determined	O
in	O
saliva	O
samples	O
.	O

Candida	O
colonies	O
were	O
observed	O
in	O
70	O
.	O
5	O
%	O
of	O
the	O
children	O
.	O

No	O
association	O
was	O
found	O
between	O
Candida	O
and	O
caries	O
or	O
plaque	O
and	O
gingival	O
indices	O
.	O

C	O
.	O
albicans	O
-	O
positive	O
children	O
demonstrated	O
significantly	O
higher	O
brushing	O
scores	O
.	O

Our	O
findings	O
may	O
suggest	O
that	O
there	O
is	O
no	O
clear	O
association	O
between	O
Candida	O
in	O
saliva	O
,	O
and	O
levels	O
of	O
cariogenic	O
bacteria	O
and	O
caries	O
risk	O
in	O
children	O
.	O

Oral	O
mucositis	O
is	O
a	O
serious	O
and	O
debilitating	O
side	O
effect	O
of	O
conditioning	O
regimens	O
for	O
hematopoietic	O
stem	O
cell	O
transplant	O
(	O
HSCT	O
)	O
.	O

Through	O
HSCT	O
,	O
the	O
homeostasis	O
in	O
the	O
oral	O
cavity	O
is	O
disrupted	O
.	O

The	O
contribution	O
of	O
the	O
oral	O
microflora	O
to	O
mucositis	O
remains	O
to	O
be	O
clarified	O
.	O

The	O
aim	O
of	O
our	O
study	O
was	O
to	O
investigate	O
the	O
relationship	O
between	O
yeasts	O
,	O
bacteria	O
associated	O
with	O
periodontitis	O
,	O
and	O
oral	O
ulcerations	O
in	O
HSCT	O
recipients	O
.	O

This	O
prospective	O
observational	O
study	O
included	O
49	O
adult	O
HSCT	O
recipients	O
.	O

Twice	O
weekly	O
,	O
oral	O
ulcerations	O
were	O
scored	O
,	O
and	O
oral	O
rinsing	O
samples	O
were	O
obtained	O
.	O

Samples	O
were	O
evaluated	O
for	O
the	O
total	O
bacterial	O
load	O
;	O
the	O
Gram	O
-	O
negative	O
bacteria	O
:	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Parvimonas	B-bacteria
micra	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
,	O
and	O
Treponema	B-bacteria
denticola	I-bacteria
;	O
and	O
the	O
yeasts	O
:	O
Candida	O
albicans	O
,	O
Candida	O
glabrata	O
,	O
Candida	O
kefyr	O
,	O
Candida	O
krusei	O
,	O
Candida	O
parapsilosis	O
,	O
and	O
Candida	O
tropicalis	O
using	O
real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
with	O
specific	O
primers	O
and	O
probes	O
.	O

Explanatory	O
variables	O
for	O
oral	O
ulcerations	O
were	O
calculated	O
using	O
the	O
multilevel	O
generalized	O
estimated	O
equations	O
(	O
GEE	O
)	O
technique	O
.	O

None	O
of	O
the	O
samples	O
was	O
positive	O
for	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
,	O
while	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
was	O
found	O
most	O
often	O
(	O
66	O
%	O
of	O
samples	O
)	O
.	O

C	O
.	O
albicans	O
was	O
the	O
most	O
isolated	O
yeast	O
(	O
88	O
%	O
of	O
samples	O
)	O
,	O
whereas	O
C	O
.	O
parapsilosis	O
was	O
found	O
in	O
only	O
8	O
%	O
of	O
the	O
samples	O
.	O

Multivariate	O
GEE	O
analyses	O
identified	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
micra	I-bacteria
,	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
,	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
,	O
C	O
.	O
glabrata	O
,	O
and	O
C	O
.	O
kefyr	O
as	O
significant	O
explanatory	O
variables	O
of	O
oral	O
ulcerations	O
.	O

Our	O
data	O
indicate	O
that	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
in	O
particular	O
,	O
but	O
also	O
P	B-bacteria
.	I-bacteria
micra	I-bacteria
,	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
,	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
,	O
C	O
.	O
glabrata	O
,	O
and	O
C	O
.	O
kefyr	O
may	O
play	O
a	O
role	O
in	O
ulcerative	O
oral	O
mucositis	O
in	O
patients	O
undergoing	O
HSCT	O
.	O

This	O
study	O
aims	O
to	O
assess	O
the	O
effects	O
of	O
rinsing	O
with	O
zinc	O
-	O
and	O
chlorhexidine	O
-	O
containing	O
mouth	O
rinse	O
with	O
or	O
without	O
adjunct	O
tongue	O
scraping	O
on	O
volatile	O
sulfur	O
compounds	O
(	O
VSCs	O
)	O
in	O
breath	O
air	O
,	O
and	O
the	O
microbiota	O
at	O
the	O
dorsum	O
of	O
the	O
tongue	O
.	O

A	O
randomized	O
single	O
-	O
masked	O
controlled	O
clinical	O
trial	O
with	O
a	O
cross	O
-	O
over	O
study	O
design	O
over	O
14	O
days	O
including	O
21	O
subjects	O
was	O
performed	O
.	O

Bacterial	O
samples	O
from	O
the	O
dorsum	O
of	O
the	O
tongue	O
were	O
assayed	O
by	O
checkerboard	O
DNA	O
-	O
DNA	O
hybridization	O
.	O

No	O
halitosis	O
(	O
identified	O
by	O
VSC	O
assessments	O
)	O
at	O
day	O
14	O
was	O
identified	O
in	O
12	O
/	O
21	O
subjects	O
with	O
active	O
rinse	O
alone	O
,	O
in	O
10	O
/	O
21	O
with	O
adjunct	O
use	O
of	O
tongue	O
scraper	O
,	O
in	O
1	O
/	O
21	O
for	O
negative	O
control	O
rinse	O
alone	O
,	O
and	O
in	O
3	O
/	O
21	O
in	O
the	O
control	O
and	O
tongue	O
scraping	O
sequence	O
.	O

At	O
day	O
14	O
,	O
significantly	O
lower	O
counts	O
were	O
identified	O
only	O
in	O
the	O
active	O
rinse	O
sequence	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
for	O
15	O
/	O
78	O
species	O
including	O
,	O
Fusobacterium	B-bacteria
sp	I-bacteria
.	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
,	O
Staphylococcus	B-bacteria
aureus	I-bacteria
,	O
and	O
Tannerella	B-bacteria
forsythia	I-bacteria
.	O

A	O
decrease	O
in	O
bacteria	O
from	O
baseline	O
to	O
day	O
14	O
was	O
found	O
in	O
successfully	O
treated	O
subjects	O
for	O
9	O
/	O
74	O
species	O
including	O
:	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
Prevotella	B-bacteria
melaninogenica	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
,	O
and	O
Treponema	B-bacteria
denticola	I-bacteria
.	O

Baseline	O
VSC	O
scores	O
were	O
correlated	O
with	O
several	O
bacterial	O
species	O
.	O

The	O
use	O
of	O
a	O
tongue	O
scraper	O
combined	O
with	O
active	O
rinse	O
did	O
not	O
change	O
the	O
levels	O
of	O
VSC	O
compared	O
to	O
rinsing	O
alone	O
.	O

VSC	O
scores	O
were	O
not	O
associated	O
with	O
bacterial	O
counts	O
in	O
samples	O
taken	O
from	O
the	O
dorsum	O
of	O
the	O
tongue	O
.	O

The	O
active	O
rinse	O
alone	O
containing	O
zinc	O
and	O
chlorhexidine	O
had	O
effects	O
on	O
intra	O
-	O
oral	O
halitosis	O
and	O
reduced	O
bacterial	O
counts	O
of	O
species	O
associated	O
with	O
malodor	O
.	O

Tongue	O
scraping	O
provided	O
no	O
beneficial	O
effects	O
on	O
the	O
microbiota	O
studied	O
.	O

Periodontally	O
healthy	O
subjects	O
with	O
intra	O
-	O
oral	O
halitosis	O
benefit	O
from	O
daily	O
rinsing	O
with	O
zinc	O
-	O
and	O
chlorhexidine	O
-	O
containing	O
mouth	O
rinse	O
.	O

To	O
profile	O
the	O
abundance	O
and	O
diversity	O
of	O
subgingival	O
oral	O
microbiota	O
in	O
patients	O
with	O
never	O
-	O
treated	O
,	O
new	O
-	O
onset	O
rheumatoid	O
arthritis	O
(	O
RA	O
)	O
.	O

Periodontal	O
disease	O
(	O
PD	O
)	O
status	O
,	O
clinical	O
activity	O
,	O
and	O
sociodemographic	O
factors	O
were	O
determined	O
in	O
patients	O
with	O
new	O
-	O
onset	O
RA	O
,	O
patients	O
with	O
chronic	O
RA	O
,	O
and	O
healthy	O
subjects	O
.	O

Multiplexed	O
-	O
454	O
pyrosequencing	O
was	O
used	O
to	O
compare	O
the	O
composition	O
of	O
subgingival	O
microbiota	O
and	O
establish	O
correlations	O
between	O
the	O
presence	O
/	O
abundance	O
of	O
bacteria	O
and	O
disease	O
phenotypes	O
.	O

Anti	O
-	O
Porphyromonas	O
gingivalis	O
antibody	O
testing	O
was	O
performed	O
to	O
assess	O
prior	O
exposure	O
to	O
the	O
bacterial	O
pathogen	O
P	B-bacteria
gingivalis	I-bacteria
.	O

The	O
more	O
advanced	O
forms	O
of	O
periodontitis	O
were	O
already	O
present	O
at	O
disease	O
onset	O
in	O
patients	O
with	O
new	O
-	O
onset	O
RA	O
.	O

The	O
subgingival	O
microbiota	O
observed	O
in	O
patients	O
with	O
new	O
-	O
onset	O
RA	O
was	O
distinct	O
from	O
that	O
found	O
in	O
healthy	O
controls	O
.	O

In	O
most	O
cases	O
,	O
however	O
,	O
these	O
microbial	O
differences	O
could	O
be	O
attributed	O
to	O
the	O
severity	O
of	O
PD	O
and	O
were	O
not	O
inherent	O
to	O
RA	O
.	O

The	O
presence	O
and	O
abundance	O
of	O
P	B-bacteria
gingivalis	I-bacteria
were	O
also	O
directly	O
associated	O
with	O
the	O
severity	O
of	O
PD	O
and	O
were	O
not	O
unique	O
to	O
RA	O
.	O

The	O
presence	O
of	O
P	B-bacteria
gingivalis	I-bacteria
was	O
not	O
correlated	O
with	O
anti	O
-	O
citrullinated	O
protein	O
antibody	O
(	O
ACPA	O
)	O
titers	O
.	O

Overall	O
exposure	O
to	O
P	B-bacteria
gingivalis	I-bacteria
was	O
similar	O
between	O
patients	O
with	O
new	O
-	O
onset	O
RA	O
and	O
controls	O
,	O
observed	O
in	O
78	O
%	O
of	O
patients	O
and	O
83	O
%	O
of	O
controls	O
.	O

The	O
presence	O
and	O
abundance	O
of	O
Anaeroglobus	B-bacteria
geminatus	I-bacteria
correlated	O
with	O
the	O
presence	O
of	O
ACPAs	O
/	O
rheumatoid	O
factor	O
.	O

Prevotella	B-bacteria
and	O
Leptotrichia	B-bacteria
species	I-bacteria
were	O
the	O
only	O
characteristic	O
taxa	O
observed	O
in	O
patients	O
with	O
new	O
-	O
onset	O
RA	O
irrespective	O
of	O
PD	O
status	O
.	O

Patients	O
with	O
new	O
-	O
onset	O
RA	O
exhibited	O
a	O
high	O
prevalence	O
of	O
PD	O
at	O
disease	O
onset	O
,	O
despite	O
their	O
young	O
age	O
and	O
paucity	O
of	O
smoking	O
history	O
.	O

The	O
subgingival	O
microbiota	O
profile	O
in	O
patients	O
with	O
new	O
-	O
onset	O
RA	O
was	O
similar	O
to	O
that	O
in	O
patients	O
with	O
chronic	O
RA	O
and	O
healthy	O
subjects	O
whose	O
PD	O
was	O
of	O
comparable	O
severity	O
.	O

Although	O
colonization	O
with	O
P	B-bacteria
gingivalis	I-bacteria
correlated	O
with	O
the	O
severity	O
of	O
PD	O
,	O
overall	O
exposure	O
to	O
P	B-bacteria
gingivalis	I-bacteria
was	O
similar	O
among	O
the	O
groups	O
.	O

The	O
role	O
of	O
A	B-bacteria
geminatus	I-bacteria
and	O
Prevotella	B-bacteria
/	O
Leptotrichia	B-bacteria
species	I-bacteria
in	O
this	O
process	O
merits	O
further	O
study	O
.	O

Antimicrobial	O
peptides	O
,	O
molecules	O
produced	O
in	O
many	O
different	O
organisms	O
,	O
have	O
high	O
biocidal	O
activity	O
against	O
several	O
microorganisms	O
.	O

However	O
,	O
several	O
questions	O
about	O
these	O
molecules	O
remain	O
unclear	O
.	O

Therefore	O
,	O
this	O
report	O
details	O
a	O
systematic	O
survey	O
of	O
the	O
literature	O
on	O
the	O
use	O
of	O
antimicrobial	O
peptides	O
against	O
oral	O
pathogens	O
and	O
indicates	O
which	O
peptides	O
and	O
microorganisms	O
are	O
most	O
extensively	O
studied	O
.	O

Articles	O
were	O
located	O
using	O
the	O
PubMed	O
and	O
Science	O
Direct	O
databases	O
with	O
the	O
following	O
inclusion	O
criteria	O
:	O
publication	O
date	O
between	O
2002	O
and	O
2011	O
;	O
keywords	O
`	O
`	O
biofilm	O
OR	O
biological	O
film	O
OR	O
biological	O
layer	O
OR	O
bacterial	O
growth	O
'	O
'	O
AND	O
`	O
`	O
peptide	O
'	O
'	O
AND	O
`	O
`	O
oral	O
cavity	O
OR	O
mouth	O
OR	O
buccal	O
mucosa	O
OR	O
oral	O
mucosa	O
OR	O
mouth	O
mucosa	O
'	O
'	O
;	O
and	O
abstract	O
in	O
English	O
.	O

A	O
total	O
of	O
73	O
articles	O
were	O
selected	O
after	O
refinement	O
of	O
the	O
data	O
.	O

An	O
increase	O
in	O
publications	O
focusing	O
on	O
the	O
use	O
of	O
antimicrobial	O
peptides	O
against	O
oral	O
microorganisms	O
was	O
observed	O
.	O

In	O
addition	O
,	O
the	O
peptides	O
produced	O
by	O
cells	O
of	O
the	O
oral	O
mucosa	O
(	O
defensins	O
,	O
LL	O
-	O
37	O
and	O
histatins	O
)	O
as	O
well	O
as	O
Streptococcus	B-bacteria
mutans	I-bacteria
(	O
among	O
cariogenic	O
bacteria	O
)	O
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
(	O
among	O
periodontal	O
bacteria	O
)	O
were	O
the	O
most	O
studied	O
subjects	O
.	O

It	O
was	O
concluded	O
that	O
the	O
use	O
of	O
antimicrobial	O
peptides	O
as	O
a	O
tool	O
for	O
microbial	O
control	O
is	O
of	O
increasing	O
importance	O
,	O
likely	O
due	O
to	O
its	O
widespread	O
use	O
,	O
mechanism	O
of	O
action	O
,	O
and	O
low	O
rates	O
of	O
bacterial	O
resistance	O
.	O

Oral	O
health	O
is	O
affected	O
by	O
its	O
resident	O
microorganisms	O
.	O

Three	O
prominent	O
oral	O
disorders	O
are	O
dental	O
caries	O
,	O
gingivitis	O
and	O
periodontitis	O
,	O
with	O
the	O
oral	O
microbiota	O
playing	O
a	O
key	O
role	O
in	O
the	O
initiation	O
/	O
progression	O
of	O
all	O
three	O
.	O

Understanding	O
the	O
microbiota	O
and	O
the	O
diseases	O
they	O
may	O
cause	O
is	O
critical	O
to	O
the	O
development	O
of	O
new	O
therapeutics	O
.	O

This	O
review	O
is	O
focused	O
on	O
probiotics	O
for	O
the	O
prevention	O
and	O
/	O
or	O
treatment	O
of	O
oral	O
diseases	O
.	O

This	O
review	O
describes	O
the	O
oral	O
ecosystem	O
and	O
its	O
correlation	O
with	O
oral	O
health	O
/	O
disease	O
.	O

The	O
pathogenesis	O
and	O
current	O
prevention	O
/	O
treatment	O
strategies	O
of	O
periodontal	O
diseases	O
(	O
PD	O
)	O
and	O
dental	O
caries	O
(	O
DC	O
)	O
are	O
depicted	O
.	O

An	O
introduction	O
of	O
probiotics	O
is	O
followed	O
by	O
an	O
analysis	O
of	O
their	O
role	O
in	O
PD	O
and	O
DC	O
,	O
and	O
their	O
potential	O
role	O
(	O
s	O
)	O
in	O
oral	O
health	O
.	O

Finally	O
,	O
a	O
discussion	O
ensues	O
on	O
the	O
future	O
research	O
directions	O
and	O
limitations	O
of	O
probiotics	O
for	O
oral	O
health	O
.	O

An	O
effective	O
oral	O
probiotic	O
formulation	O
should	O
contribute	O
to	O
the	O
prevention	O
/	O
treatment	O
of	O
microbial	O
diseases	O
of	O
the	O
oral	O
cavity	O
.	O

Understanding	O
the	O
oral	O
microbiota	O
'	O
s	O
role	O
in	O
oral	O
disease	O
is	O
important	O
for	O
the	O
development	O
of	O
a	O
therapeutic	O
to	O
prevent	O
/	O
treat	O
dental	O
diseases	O
.	O

However	O
,	O
investigations	O
into	O
clinical	O
efficacy	O
,	O
delivery	O
/	O
dose	O
optimization	O
,	O
mechanism	O
(	O
s	O
)	O
of	O
action	O
and	O
other	O
related	O
parameters	O
are	O
yet	O
to	O
be	O
fully	O
explored	O
.	O

Keeping	O
this	O
in	O
mind	O
,	O
investigations	O
into	O
oral	O
probiotic	O
therapies	O
are	O
proving	O
promising	O
.	O

To	O
understand	O
the	O
relationship	O
between	O
our	O
bacterial	O
microbiome	O
and	O
health	O
,	O
it	O
is	O
essential	O
to	O
define	O
the	O
microbiome	O
in	O
the	O
absence	O
of	O
disease	O
.	O

The	O
digestive	O
tract	O
includes	O
diverse	O
habitats	O
and	O
hosts	O
the	O
human	O
body	O
'	O
s	O
greatest	O
bacterial	O
density	O
.	O

We	O
describe	O
the	O
bacterial	O
community	O
composition	O
of	O
ten	O
digestive	O
tract	O
sites	O
from	O
more	O
than	O
200	O
normal	O
adults	O
enrolled	O
in	O
the	O
Human	O
Microbiome	O
Project	O
,	O
and	O
metagenomically	O
determined	O
metabolic	O
potentials	O
of	O
four	O
representative	O
sites	O
.	O

The	O
microbiota	O
of	O
these	O
diverse	O
habitats	O
formed	O
four	O
groups	O
based	O
on	O
similar	O
community	O
compositions	O
:	O
buccal	O
mucosa	O
,	O
keratinized	O
gingiva	O
,	O
hard	O
palate	O
;	O
saliva	O
,	O
tongue	O
,	O
tonsils	O
,	O
throat	O
;	O
sub	O
-	O
and	O
supra	O
-	O
gingival	O
plaques	O
;	O
and	O
stool	O
.	O

Phyla	O
initially	O
identified	O
from	O
environmental	O
samples	O
were	O
detected	O
throughout	O
this	O
population	O
,	O
primarily	O
TM7	B-bacteria
,	O
SR1	B-bacteria
,	O
and	O
Synergistetes	B-bacteria
.	O

Genera	O
with	O
pathogenic	O
members	O
were	O
well	O
-	O
represented	O
among	O
this	O
disease	O
-	O
free	O
cohort	O
.	O

Tooth	O
-	O
associated	O
communities	O
were	O
distinct	O
,	O
but	O
not	O
entirely	O
dissimilar	O
,	O
from	O
other	O
oral	O
surfaces	O
.	O

The	O
Porphyromonadaceae	B-bacteria
,	O
Veillonellaceae	B-bacteria
and	O
Lachnospiraceae	B-bacteria
families	O
were	O
common	O
to	O
all	O
sites	O
,	O
but	O
the	O
distributions	O
of	O
their	O
genera	O
varied	O
significantly	O
.	O

Most	O
metabolic	O
processes	O
were	O
distributed	O
widely	O
throughout	O
the	O
digestive	O
tract	O
microbiota	O
,	O
with	O
variations	O
in	O
metagenomic	O
abundance	O
between	O
body	O
habitats	O
.	O

These	O
included	O
shifts	O
in	O
sugar	O
transporter	O
types	O
between	O
the	O
supragingival	O
plaque	O
,	O
other	O
oral	O
surfaces	O
,	O
and	O
stool	O
;	O
hydrogen	O
and	O
hydrogen	O
sulfide	O
production	O
were	O
also	O
differentially	O
distributed	O
.	O

The	O
microbiomes	O
of	O
ten	O
digestive	O
tract	O
sites	O
separated	O
into	O
four	O
types	O
based	O
on	O
composition	O
.	O

A	O
core	O
set	O
of	O
metabolic	O
pathways	O
was	O
present	O
across	O
these	O
diverse	O
digestive	O
tract	O
habitats	O
.	O

These	O
data	O
provide	O
a	O
critical	O
baseline	O
for	O
future	O
studies	O
investigating	O
local	O
and	O
systemic	O
diseases	O
affecting	O
human	O
health	O
.	O

The	O
compounds	O
2	O
'	O
,	O
6	O
'	O
-	O
dihydroxy	O
-	O
4	O
'	O
-	O
geranyloxyacetophenone	O
(	O
1	O
)	O
and	O
2	O
'	O
,	O
6	O
'	O
-	O
dihydroxy	O
-	O
4	O
'	O
-	O
farnesyloxy	O
-	O
acetophenone	O
(	O
2	O
)	O
are	O
oxyprenylated	O
secondary	O
metabolites	O
extracted	O
from	O
plants	O
belonging	O
to	O
the	O
Rutaceae	O
family	O
.	O

In	O
this	O
study	O
,	O
1	O
and	O
2	O
were	O
synthesized	O
and	O
tested	O
for	O
their	O
antimicrobial	O
activity	O
toward	O
major	O
oral	O
pathogens	O
.	O

Compounds	O
1	O
and	O
2	O
were	O
synthesized	O
by	O
selective	O
prenylation	O
of	O
2	O
,	O
4	O
,	O
6	O
-	O
trihydroxyacetophenone	O
at	O
the	O
4	O
'	O
position	O
with	O
geranyl	O
and	O
farnesyl	O
bromide	O
,	O
respectively	O
.	O

Compound	O
1	O
showed	O
stronger	O
antimicrobial	O
activity	O
than	O
2	O
against	O
major	O
oral	O
pathogens	O
,	O
including	O
Gram	O
positive	O
bacteria	O
(	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Streptococcus	B-bacteria
sobrinus	I-bacteria
)	O
,	O
Gram	O
negative	O
bacteria	O
(	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
)	O
and	O
Candida	O
albicans	O
.	O

Evidences	O
were	O
obtained	O
that	O
the	O
mode	O
of	O
action	O
of	O
1	O
and	O
2	O
may	O
be	O
related	O
to	O
their	O
iron	O
-	O
chelating	O
property	O
.	O

This	O
study	O
suggests	O
that	O
1	O
and	O
2	O
may	O
represent	O
potential	O
natural	O
molecules	O
for	O
the	O
prevention	O
/	O
treatment	O
of	O
common	O
oral	O
infections	O
,	O
including	O
dental	O
caries	O
,	O
periodontal	O
disease	O
,	O
and	O
candidiasis	O
.	O

Attenuated	O
Salmonella	B-bacteria
has	O
been	O
used	O
as	O
a	O
carrier	O
for	O
DNA	O
vaccine	O
.	O

However	O
,	O
in	O
vitro	O
and	O
in	O
vivo	O
studies	O
on	O
the	O
bacteria	O
following	O
transfection	O
of	O
plasmid	O
DNA	O
were	O
poorly	O
studied	O
.	O

In	O
this	O
paper	O
,	O
eukaryotic	O
expression	O
plasmids	O
encoding	O
avian	O
influenza	O
virus	O
(	O
AIV	O
)	O
subtype	O
H5N1	O
genes	O
,	O
pcDNA3	O
.	O
1	O
/	O
HA	O
,	O
NA	O
,	O
and	O
NP	O
,	O
were	O
transfected	O
into	O
an	O
attenuated	O
Salmonella	B-bacteria
enteric	I-bacteria
typhimurium	I-bacteria
SV4089	I-bacteria
.	O

In	O
vitro	O
stability	O
of	O
the	O
transfected	O
plasmids	O
into	O
Salmonella	B-bacteria
were	O
over	O
90	O
%	O
after	O
100	O
generations	O
.	O

The	O
attenuated	O
Salmonella	B-bacteria
were	O
able	O
to	O
invade	O
MCF	O
-	O
7	O
(	O
1	O
.	O
2	O
%	O
)	O
and	O
MCF	O
-	O
10A	O
(	O
0	O
.	O
5	O
%	O
)	O
human	O
breast	O
cancer	O
cells	O
.	O

Newly	O
hatched	O
specific	O
-	O
pathogen	O
-	O
free	O
(	O
SPF	O
)	O
chicks	O
were	O
inoculated	O
once	O
by	O
oral	O
gavage	O
with	O
10	O
(	O
9	O
)	O
colony	O
-	O
forming	O
unit	O
(	O
CFU	O
)	O
of	O
the	O
attenuated	O
Salmonella	B-bacteria
.	O

No	O
abnormal	O
clinical	O
signs	O
or	O
deaths	O
were	O
recorded	O
after	O
inoculation	O
.	O

Viable	O
bacteria	O
were	O
detected	O
3	O
days	O
after	O
inoculation	O
by	O
plating	O
from	O
spleen	O
,	O
liver	O
,	O
and	O
cecum	O
.	O

Fluorescent	O
in	O
situ	O
hybridization	O
(	O
FISH	O
)	O
and	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
were	O
carried	O
out	O
for	O
confirmation	O
.	O

Salmonella	B-bacteria
was	O
not	O
detected	O
in	O
blood	O
cultures	O
although	O
serum	O
antibody	O
immune	O
responses	O
to	O
Salmonella	B-bacteria
O	O
antiserum	O
group	O
D1	O
factor	O
1	O
,	O
9	O
,	O
and	O
12	O
antigens	O
were	O
observed	O
in	O
all	O
the	O
inoculated	O
chickens	O
after	O
7	O
days	O
up	O
to	O
35	O
days	O
.	O

Our	O
results	O
showed	O
that	O
live	O
attenuated	O
S	B-bacteria
.	I-bacteria
typhimurium	I-bacteria
SV4089	I-bacteria
harboring	O
pcDNA3	O
.	O
1	O
/	O
HA	O
,	O
NA	O
,	O
and	O
NP	O
may	O
provide	O
a	O
unique	O
alternative	O
as	O
a	O
carrier	O
for	O
DNA	O
oral	O
vaccine	O
in	O
chickens	O
.	O

The	O
presence	O
of	O
microorganisms	O
in	O
pharmaceuticals	O
is	O
undesirable	O
because	O
they	O
may	O
cause	O
spoilage	O
of	O
the	O
product	O
and	O
may	O
present	O
an	O
infection	O
hazard	O
to	O
the	O
consumers	O
or	O
patients	O
.	O

A	O
total	O
of	O
102	O
samples	O
of	O
oral	O
and	O
topical	O
non	O
-	O
sterile	O
pharmaceutical	O
products	O
were	O
collected	O
at	O
random	O
from	O
different	O
drug	O
houses	O
and	O
pharmacies	O
in	O
Iraq	O
,	O
to	O
investigate	O
the	O
microbial	O
contamination	O
of	O
these	O
products	O
.	O

Bacterial	O
isolates	O
recovered	O
from	O
these	O
medicaments	O
were	O
subjected	O
to	O
susceptibility	O
testing	O
against	O
various	O
antibiotics	O
by	O
disk	O
diffusion	O
method	O
according	O
to	O
Clinical	O
and	O
Laboratory	O
Standards	O
(	O
CLSI	O
)	O
guidelines	O
.	O

The	O
results	O
revealed	O
that	O
the	O
occurrence	O
of	O
gram	O
-	O
positive	O
bacteria	O
was	O
in	O
oral	O
and	O
topical	O
medicaments	O
while	O
gram	O
-	O
negative	O
bacteria	O
were	O
only	O
detected	O
in	O
topical	O
medicaments	O
.	O

More	O
than	O
58	O
%	O
of	O
Bacillus	B-bacteria
isolates	I-bacteria
were	O
resistant	O
to	O
lincomycin	O
and	O
Bacillus	B-bacteria
mycoides	I-bacteria
isolates	I-bacteria
were	O
resistant	O
to	O
beta	O
-	O
lactam	O
antibiotics	O
and	O
trimethoprim	O
-	O
sulfamethoxazole	O
.	O

Staphylococcus	B-bacteria
spp	I-bacteria
.	I-bacteria
showed	O
a	O
relatively	O
high	O
resistance	O
to	O
ampicillin	O
,	O
amoxicillin	O
,	O
penicillin	O
,	O
tetracycline	O
,	O
and	O
trimethoprim	O
-	O
sulfamethoxazole	O
.	O

S	B-bacteria
.	I-bacteria
epidermidis	I-bacteria
had	O
the	O
highest	O
number	O
of	O
multi	O
-	O
resistant	O
isolates	O
.	O

Furthermore	O
,	O
87	O
.	O
5	O
%	O
of	O
isolated	O
gram	O
-	O
negative	O
rods	O
showed	O
high	O
resistance	O
to	O
beta	O
-	O
lactam	O
antibiotics	O
and	O
75	O
%	O
of	O
them	O
were	O
highly	O
resistant	O
to	O
erythromycin	O
.	O

One	O
isolate	O
of	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
was	O
the	O
most	O
resistant	O
among	O
all	O
gram	O
-	O
negative	O
rod	O
isolates	O
.	O

The	O
high	O
rate	O
of	O
resistance	O
to	O
antimicrobial	O
agents	O
of	O
bacterial	O
isolates	O
recovered	O
from	O
oral	O
and	O
topical	O
medicaments	O
in	O
this	O
study	O
may	O
indicate	O
a	O
widespread	O
antibiotic	O
resistance	O
among	O
bacteria	O
isolated	O
from	O
different	O
sources	O
,	O
including	O
those	O
of	O
anthropological	O
and	O
environmental	O
origin	O
.	O

The	O
inherent	O
instabilities	O
associated	O
with	O
the	O
development	O
of	O
multispecies	O
biofilm	O
communities	O
within	O
the	O
constant	O
-	O
depth	O
film	O
fermenter	O
(	O
CDFF	O
)	O
and	O
other	O
microcosm	O
systems	O
can	O
yield	O
unacceptable	O
variability	O
between	O
experiments	O
,	O
which	O
could	O
limit	O
their	O
potential	O
applications	O
in	O
oral	O
microbiology	O
.	O

The	O
extent	O
of	O
this	O
variability	O
needs	O
to	O
be	O
determined	O
and	O
a	O
protocol	O
developed	O
which	O
minimizes	O
it	O
.	O

Two	O
custom	O
-	O
made	O
CDFFs	O
were	O
supplied	O
concurrently	O
with	O
the	O
same	O
inoculation	O
culture	O
,	O
begat	O
from	O
an	O
aliquot	O
of	O
a	O
saliva	O
pool	O
and	O
artificial	O
saliva	O
growth	O
medium	O
via	O
a	O
dual	O
-	O
channel	O
pump	O
.	O

Transformed	O
log	O
(	O
10	O
)	O
data	O
of	O
the	O
viable	O
counts	O
at	O
fixed	O
time	O
points	O
were	O
analysed	O
using	O
the	O
Bland	O
-	O
Altman	O
approach	O
to	O
test	O
for	O
the	O
levels	O
of	O
agreement	O
between	O
two	O
CDFFs	O
running	O
concurrently	O
and	O
those	O
CDFFs	O
run	O
in	O
series	O
.	O

The	O
coefficients	O
(	O
95	O
%	O
)	O
of	O
agreement	O
were	O
lower	O
(	O
i	O
.	O
e	O
.	O
less	O
variable	O
)	O
in	O
the	O
concurrent	O
model	O
than	O
when	O
run	O
in	O
series	O
for	O
total	O
counts	O
of	O
bacteria	O
(	O
1	O
.	O
238	O
vs	O
2	O
.	O
124	O
)	O
,	O
Lactobacillus	B-bacteria
spp	I-bacteria
.	I-bacteria
(	O
0	O
.	O
517	O
vs	O
1	O
.	O
431	O
)	O
and	O
Mutans	B-bacteria
streptococci	I-bacteria
(	O
2	O
.	O
817	O
vs	O
3	O
.	O
864	O
)	O
.	O

Other	O
measures	O
of	O
variability	O
showed	O
a	O
similar	O
trend	O
.	O

Operating	O
CDFFs	O
concurrently	O
minimizes	O
the	O
degree	O
of	O
difference	O
and	O
variability	O
between	O
them	O
.	O

Operating	O
CDFFs	O
concurrently	O
will	O
improve	O
the	O
sensitivity	O
for	O
experiments	O
that	O
seek	O
to	O
determine	O
the	O
effects	O
of	O
a	O
variable	O
,	O
such	O
as	O
a	O
nutritional	O
supplement	O
or	O
antimicrobial	O
agent	O
,	O
and	O
a	O
control	O
.	O

Five	O
strains	O
of	O
anaerobic	O
,	O
gram	O
-	O
negative	O
bacilli	O
isolated	O
from	O
the	O
human	O
oral	O
cavity	O
were	O
subjected	O
to	O
a	O
comprehensive	O
range	O
of	O
phenotypic	O
and	O
genotypic	O
tests	O
and	O
were	O
found	O
to	O
comprise	O
a	O
homogeneous	O
group	O
.	O

Phylogenetic	O
analysis	O
of	O
full	O
-	O
length	O
16S	O
rRNA	O
gene	O
sequences	O
showed	O
that	O
these	O
strains	O
represented	O
a	O
novel	O
group	O
within	O
the	O
family	O
Prevotellaceae	B-bacteria
,	O
and	O
the	O
most	O
closely	O
related	O
species	O
was	O
Prevotella	B-bacteria
tannerae	I-bacteria
.	O

P	B-bacteria
.	I-bacteria
tannerae	I-bacteria
and	O
the	O
novel	O
taxon	O
are	O
deeply	O
branched	O
from	O
the	O
genus	O
Prevotella	B-bacteria
,	O
with	O
sequence	O
identities	O
to	O
the	O
type	O
strain	O
of	O
the	O
type	O
species	O
of	O
Prevotella	B-bacteria
,	O
Prevotella	B-bacteria
melaninogenica	I-bacteria
,	O
of	O
82	O
.	O
2	O
and	O
85	O
.	O
6	O
%	O
,	O
respectively	O
.	O

The	O
novel	O
genus	O
Alloprevotella	B-bacteria
gen	I-bacteria
.	I-bacteria
nov	I-bacteria
.	I-bacteria
is	O
proposed	O
to	O
accommodate	O
the	O
novel	O
species	O
Alloprevotella	B-bacteria
rava	I-bacteria
gen	I-bacteria
.	I-bacteria
nov	I-bacteria
.	I-bacteria
,	I-bacteria
sp	I-bacteria
.	I-bacteria
nov	I-bacteria
.	O
and	O
the	O
previously	O
named	O
Prevotella	B-bacteria
tannerae	I-bacteria
Moore	I-bacteria
et	I-bacteria
al	I-bacteria
.	I-bacteria
1994	I-bacteria
as	O
Alloprevotella	B-bacteria
tannerae	I-bacteria
gen	I-bacteria
.	I-bacteria
nov	I-bacteria
.	I-bacteria
,	I-bacteria
comb	B-bacteria
.	I-bacteria
nov	I-bacteria
.	O

The	O
type	O
species	O
is	O
Alloprevotella	B-bacteria
tannerae	I-bacteria
.	O

The	O
type	O
strain	O
of	O
Alloprevotella	B-bacteria
rava	I-bacteria
is	O
81	B-bacteria
/	I-bacteria
4	I-bacteria
-	I-bacteria
12	I-bacteria
(	O
T	O
)	O
(	O
=	O
DSM	B-bacteria
22548	I-bacteria
(	O
T	O
)	O
=	O
CCUG	B-bacteria
58091	I-bacteria
(	O
T	O
)	O
)	O
and	O
the	O
type	O
strain	O
of	O
Alloprevotella	B-bacteria
tannerae	I-bacteria
is	O
ATCC	B-bacteria
51259	I-bacteria
(	O
T	O
)	O
=	O
CCUG	B-bacteria
34292	I-bacteria
(	O
T	O
)	O
=	O
CIP	B-bacteria
104476	I-bacteria
(	O
T	O
)	O
=	O
NCTC	B-bacteria
13073	I-bacteria
(	O
T	O
)	O
.	O

Alloprevotella	B-bacteria
rava	I-bacteria
is	O
weakly	O
to	O
moderately	O
saccharolytic	O
and	O
produces	O
moderate	O
amounts	O
of	O
acetic	O
acid	O
and	O
major	O
amounts	O
of	O
succinic	O
acid	O
as	O
end	O
products	O
of	O
fermentation	O
.	O

Strains	O
are	O
sensitive	O
to	O
20	O
%	O
bile	O
and	O
hydrolyse	O
gelatin	O
.	O

The	O
principal	O
cellular	O
long	O
-	O
chain	O
fatty	O
acids	O
are	O
anteiso	O
-	O
C15	O
:	O
0	O
,	O
iso	O
-	O
C15	O
:	O
0	O
,	O
C16	O
:	O
0	O
,	O
iso	O
-	O
C17	O
:	O
0	O
and	O
iso	O
-	O
C17	O
:	O
0	O
3	O
-	O
OH	O
.	O

The	O
G	O
+	O
C	O
content	O
of	O
the	O
DNA	O
of	O
the	O
type	O
strain	O
is	O
47	O
mol	O
%	O
.	O

Despite	O
the	O
increased	O
frequency	O
of	O
recurrent	O
pneumonia	O
in	O
HIV	O
-	O
infected	O
patients	O
and	O
recent	O
studies	O
linking	O
the	O
airway	O
bacterial	O
community	O
(	O
microbiota	O
)	O
to	O
acute	O
and	O
chronic	O
respiratory	O
infection	O
,	O
little	O
is	O
known	O
of	O
the	O
oral	O
and	O
airway	O
microbiota	O
that	O
exist	O
in	O
these	O
individuals	O
and	O
their	O
propensity	O
to	O
harbor	O
pathogens	O
despite	O
antimicrobial	O
treatment	O
for	O
acute	O
pneumonia	O
.	O

This	O
pilot	O
study	O
compared	O
paired	O
samples	O
of	O
the	O
oral	O
and	O
airway	O
microbiota	O
from	O
15	O
hospitalized	O
HIV	O
-	O
infected	O
patients	O
receiving	O
antimicrobial	O
treatment	O
for	O
acute	O
pneumonia	O
.	O

Total	O
DNA	O
was	O
extracted	O
,	O
bacterial	O
burden	O
was	O
assessed	O
by	O
quantitative	O
PCR	O
,	O
and	O
amplified	O
16S	O
rRNA	O
was	O
profiled	O
for	O
microbiome	O
composition	O
using	O
a	O
phylogenetic	O
microarray	O
(	O
16S	O
rRNA	O
PhyloChip	O
)	O
.	O

Though	O
the	O
bacterial	O
burden	O
of	O
the	O
airway	O
was	O
significantly	O
lower	O
than	O
that	O
of	O
the	O
oral	O
cavity	O
,	O
microbiota	O
in	O
both	O
niches	O
were	O
comparably	O
diverse	O
.	O

However	O
,	O
oral	O
and	O
airway	O
microbiota	O
exhibited	O
niche	O
specificity	O
.	O

Oral	O
microbiota	O
were	O
characterized	O
by	O
significantly	O
increased	O
relative	O
abundance	O
of	O
multiple	O
species	O
associated	O
with	O
the	O
mouth	O
,	O
including	O
members	O
of	O
the	O
Bacteroides	B-bacteria
,	O
Firmicutes	B-bacteria
,	O
and	O
TM7	B-bacteria
phyla	I-bacteria
,	O
while	O
airway	O
microbiota	O
were	O
primarily	O
characterized	O
by	O
a	O
relative	O
expansion	O
of	O
the	O
Proteobacteria	B-bacteria
.	O

Twenty	O
-	O
two	O
taxa	O
were	O
detected	O
in	O
both	O
niches	O
,	O
including	O
Streptococcus	B-bacteria
bovis	I-bacteria
and	O
Chryseobacterium	B-bacteria
species	I-bacteria
,	O
pathogens	O
associated	O
with	O
HIV	O
-	O
infected	O
populations	O
.	O

In	O
addition	O
,	O
we	O
compared	O
the	O
airway	O
microbiota	O
of	O
five	O
of	O
these	O
patients	O
to	O
those	O
of	O
five	O
non	O
-	O
HIV	O
-	O
infected	O
pneumonia	O
patients	O
from	O
a	O
previous	O
study	O
.	O

Compared	O
to	O
the	O
control	O
population	O
,	O
HIV	O
-	O
infected	O
patients	O
exhibited	O
relative	O
increased	O
abundance	O
of	O
a	O
large	O
number	O
of	O
phylogenetically	O
distinct	O
taxa	O
,	O
which	O
included	O
several	O
known	O
or	O
suspected	O
pathogenic	O
organisms	O
,	O
suggesting	O
that	O
recurrent	O
pneumonia	O
in	O
HIV	O
-	O
infected	O
populations	O
may	O
be	O
related	O
to	O
the	O
presence	O
of	O
these	O
species	O
.	O

Rothia	B-bacteria
dentocariosa	I-bacteria
is	O
an	O
indigenous	O
microbial	O
flora	O
of	O
dental	O
plaque	O
.	O

To	O
examine	O
the	O
bacterium	O
population	O
in	O
oral	O
cavities	O
,	O
a	O
novel	O
selective	O
medium	O
,	O
designated	O
RDSM	O
,	O
was	O
developed	O
for	O
the	O
isolation	O
of	O
R	B-bacteria
.	I-bacteria
dentocariosa	I-bacteria
.	O

RDSM	O
was	O
prepared	O
by	O
adding	O
0	O
.	O
5	O
mug	O
/	O
ml	O
of	O
lincomycin	O
,	O
10	O
mug	O
/	O
ml	O
of	O
colistin	O
,	O
and	O
40	O
%	O
sucrose	O
to	O
Heart	O
Infusion	O
(	O
HI	O
)	O
.	O

Average	O
growth	O
recovery	O
of	O
R	B-bacteria
.	I-bacteria
dentocariosa	I-bacteria
on	O
RDSM	O
was	O
93	O
.	O
8	O
%	O
that	O
of	O
HI	O
medium	O
.	O

Growth	O
of	O
other	O
bacteria	O
including	O
Rothia	B-bacteria
mucilaginosa	I-bacteria
,	O
Neisseria	B-bacteria
,	O
Actinomyces	B-bacteria
,	O
or	O
streptococci	B-bacteria
was	O
remarkably	O
inhibited	O
on	O
the	O
selective	O
medium	O
.	O

Clinical	O
efficacy	O
was	O
evaluated	O
by	O
the	O
recovery	O
of	O
R	B-bacteria
.	I-bacteria
dentocariosa	I-bacteria
on	O
RDSM	O
from	O
the	O
stimulated	O
saliva	O
samples	O
of	O
8	O
volunteers	O
.	O

R	B-bacteria
.	I-bacteria
dentocariosa	I-bacteria
was	O
detected	O
at	O
2	O
.	O
6	O
(	O
range	O
:	O
1	O
.	O
0	O
-	O
4	O
.	O
6	O
)	O
%	O
to	O
total	O
bacteria	O
of	O
8	O
.	O
0x10	O
(	O
7	O
)	O
CFU	O
/	O
ml	O
on	O
BHI	O
in	O
their	O
oral	O
cavities	O
.	O

The	O
new	O
selective	O
medium	O
,	O
RDSM	O
,	O
was	O
highly	O
selective	O
for	O
R	B-bacteria
.	I-bacteria
dentocariosa	I-bacteria
and	O
was	O
useful	O
for	O
the	O
isolation	O
of	O
R	B-bacteria
.	I-bacteria
dentocariosa	I-bacteria
from	O
clinical	O
samples	O
.	O

Although	O
it	O
is	O
well	O
-	O
known	O
that	O
variations	O
of	O
the	O
microbial	O
community	O
in	O
a	O
specific	O
location	O
of	O
human	O
body	O
may	O
be	O
associated	O
with	O
some	O
diseases	O
,	O
the	O
developing	O
change	O
of	O
the	O
oral	O
microbiota	O
related	O
to	O
oral	O
diseases	O
before	O
and	O
after	O
wearing	O
the	O
removable	O
partial	O
dentures	O
(	O
RPD	O
)	O
is	O
not	O
completely	O
understood	O
.	O

In	O
this	O
study	O
,	O
three	O
kinds	O
of	O
samples	O
(	O
saliva	O
,	O
supra	O
-	O
and	O
subgingival	O
plaque	O
,	O
and	O
oral	O
mucosal	O
surfaces	O
)	O
were	O
collected	O
from	O
the	O
10	O
-	O
patients	O
group	O
at	O
three	O
different	O
times	O
:	O
before	O
,	O
1	O
-	O
month	O
and	O
6	O
-	O
months	O
after	O
the	O
treatment	O
.	O

Ten	O
healthy	O
adults	O
were	O
also	O
selected	O
as	O
the	O
control	O
group	O
.	O

Denaturing	O
gradient	O
gel	O
electrophoresis	O
was	O
applied	O
to	O
identify	O
the	O
bacterial	O
profiles	O
and	O
to	O
analyze	O
the	O
dynamics	O
of	O
the	O
oral	O
microbial	O
population	O
in	O
the	O
pre	O
-	O
and	O
post	O
-	O
therapy	O
.	O

The	O
ANOVA	O
of	O
Repeated	O
Measurement	O
Data	O
indicated	O
that	O
,	O
in	O
the	O
saliva	O
and	O
mucosal	O
surfaces	O
,	O
wearing	O
RPDs	O
caused	O
significant	O
change	O
of	O
numbers	O
of	O
amplicons	O
.	O

As	O
many	O
as	O
607	O
amplicons	O
were	O
chosen	O
to	O
cut	O
out	O
and	O
re	O
-	O
amplify	O
by	O
PCR	O
.	O

After	O
cloning	O
and	O
sequencing	O
,	O
a	O
total	O
of	O
16	O
bacterial	O
genera	O
were	O
identified	O
.	O

The	O
health	O
-	O
associated	O
genera	O
such	O
as	O
Streptococcus	B-bacteria
,	O
Neisseria	B-bacteria
,	O
Rothia	B-bacteria
,	O
Corynebacterium	B-bacteria
,	O
Leptotrichia	B-bacteria
,	O
Gemella	B-bacteria
,	O
Veillonella	B-bacteria
,	O
Selenomona	B-bacteria
and	O
Actinomyces	B-bacteria
tended	O
to	O
decrease	O
,	O
whereas	O
the	O
disease	O
-	O
associated	O
species	O
including	O
Streptococcus	B-bacteria
mutans	I-bacteria
tended	O
to	O
increase	O
.	O

In	O
general	O
,	O
wearing	O
RPDs	O
influenced	O
the	O
diversity	O
of	O
the	O
bacterial	O
species	O
in	O
the	O
oral	O
microbial	O
ecosystem	O
.	O

It	O
is	O
noteworthy	O
that	O
the	O
oral	O
environment	O
will	O
be	O
changed	O
from	O
the	O
healthy	O
status	O
towards	O
the	O
disease	O
status	O
after	O
the	O
treatment	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
analyze	O
the	O
association	O
of	O
maternal	O
antenatal	O
therapy	O
on	O
initial	O
preterm	O
infant	O
oral	O
microbial	O
acquisition	O
of	O
gut	O
metabolically	O
important	O
bacteria	O
:	O
Firmicutes	B-bacteria
,	O
Bacteroidetes	B-bacteria
,	O
Lactobacillus	B-bacteria
,	O
Bifidobacterium	B-bacteria
,	O
and	O
Bacteroides	B-bacteria
species	I-bacteria
.	O

Infant	O
oral	O
samples	O
were	O
collected	O
prefeeding	O
at	O
24	O
hours	O
and	O
analyzed	O
using	O
group	O
-	O
specific	O
primers	O
by	O
real	O
-	O
time	O
16S	O
rRNA	O
quantitative	O
polymerase	O
chain	O
reaction	O
with	O
analysis	O
of	O
variance	O
and	O
logistic	O
regression	O
to	O
evaluate	O
effect	O
of	O
antenatal	O
exposure	O
.	O

Sixty	O
-	O
five	O
infants	O
<	O
34	O
weeks	O
'	O
gestational	O
age	O
(	O
GA	O
)	O
were	O
evaluated	O
;	O
mean	O
GA	O
was	O
28	O
.	O
6	O
+	O
/	O
-	O
2	O
.	O
6	O
(	O
standard	O
deviation	O
)	O
weeks	O
.	O

Infants	O
unexposed	O
to	O
antenatal	O
treatment	O
(	O
n	O
=	O
5	O
)	O
acquired	O
<	O
1	O
%	O
Firmicutes	B-bacteria
,	O
which	O
was	O
composed	O
of	O
100	O
%	O
Lactobacillus	B-bacteria
species	I-bacteria
with	O
no	O
detectable	O
Bifidobacterium	B-bacteria
,	O
Bacteroidetes	B-bacteria
,	O
or	O
Bacteroides	B-bacteria
species	I-bacteria
.	O

Infants	O
exposed	O
to	O
antibiotics	O
(	O
n	O
=	O
7	O
)	O
,	O
acquired	O
fivefold	O
less	O
total	O
bacterial	O
density	O
(	O
TBD	O
)	O
with	O
45	O
%	O
Firmicutes	B-bacteria
1	O
.	O
3	O
%	O
Lactobacillus	B-bacteria
species	I-bacteria
,	O
23	O
.	O
5	O
%	O
Bacteroidetes	B-bacteria
and	O
rare	O
Bacteroides	B-bacteria
.	O

Compared	O
with	O
unexposed	O
infants	O
,	O
steroids	O
(	O
n	O
=	O
26	O
)	O
or	O
steroid	O
and	O
antibiotics	O
(	O
n	O
=	O
27	O
)	O
exposure	O
led	O
to	O
an	O
eightfold	O
increase	O
in	O
TBD	O
with	O
<	O
1	O
%	O
Lactobacillus	B-bacteria
species	I-bacteria
and	O
Bacteroides	B-bacteria
species	I-bacteria
100	O
%	O
and	O
30	O
%	O
,	O
respectively	O
(	O
p	O
<	O
0	O
.	O
04	O
)	O
.	O

Bifidobacterium	B-bacteria
was	O
undetectable	O
in	O
all	O
groups	O
.	O

Preterm	O
infant	O
exposure	O
to	O
routine	O
maternal	O
antenatal	O
treatments	O
influence	O
early	O
oral	O
microbial	O
acquisition	O
during	O
the	O
primary	O
hours	O
related	O
to	O
establishment	O
of	O
gut	O
commensal	O
bacteria	O
.	O

Bacterial	O
infections	O
have	O
been	O
linked	O
to	O
malignancies	O
due	O
to	O
their	O
ability	O
to	O
induce	O
chronic	O
inflammation	O
.	O

We	O
investigated	O
the	O
association	O
of	O
oral	O
bacteria	O
in	O
oral	O
squamous	O
cell	O
carcinoma	O
(	O
OSCC	O
/	O
tumor	O
)	O
tissues	O
and	O
compared	O
with	O
adjacent	O
non	O
-	O
tumor	O
mucosa	O
sampled	O
5	O
cm	O
distant	O
from	O
the	O
same	O
patient	O
(	O
n	O
=	O
10	O
)	O
.	O

By	O
using	O
culture	O
-	O
independent	O
16S	O
rRNA	O
approaches	O
,	O
denaturing	O
gradient	O
gel	O
electrophoresis	O
(	O
DGGE	O
)	O
and	O
cloning	O
and	O
sequencing	O
,	O
we	O
assessed	O
the	O
total	O
bacterial	O
diversity	O
in	O
these	O
clinical	O
samples	O
.	O

DGGE	O
fingerprints	O
showed	O
variations	O
in	O
the	O
band	O
intensity	O
profiles	O
within	O
non	O
-	O
tumor	O
and	O
tumor	O
tissues	O
of	O
the	O
same	O
patient	O
and	O
among	O
the	O
two	O
groups	O
.	O

The	O
clonal	O
analysis	O
indicated	O
that	O
from	O
a	O
total	O
of	O
1200	O
sequences	O
characterized	O
,	O
80	O
bacterial	O
species	O
/	O
phylotypes	O
were	O
detected	O
representing	O
six	O
phyla	O
,	O
Firmicutes	B-bacteria
,	O
Bacteroidetes	B-bacteria
,	O
Proteobacteria	B-bacteria
,	O
Fusobacteria	B-bacteria
,	O
Actinobacteria	B-bacteria
and	O
uncultivated	O
TM7	B-bacteria
in	O
non	O
-	O
tumor	O
and	O
tumor	O
libraries	O
.	O

In	O
combined	O
library	O
,	O
12	O
classes	O
,	O
16	O
order	O
,	O
26	O
families	O
and	O
40	O
genera	O
were	O
observed	O
.	O

Bacterial	O
species	O
,	O
Streptococcus	B-bacteria
sp	I-bacteria
.	I-bacteria
oral	I-bacteria
taxon	I-bacteria
058	I-bacteria
,	O
Peptostreptococcus	B-bacteria
stomatis	I-bacteria
,	O
Streptococcus	B-bacteria
salivarius	I-bacteria
,	O
Streptococcus	B-bacteria
gordonii	I-bacteria
,	O
Gemella	B-bacteria
haemolysans	I-bacteria
,	O
Gemella	B-bacteria
morbillorum	I-bacteria
,	O
Johnsonella	B-bacteria
ignava	I-bacteria
and	O
Streptococcus	B-bacteria
parasanguinis	I-bacteria
I	I-bacteria
were	O
highly	O
associated	O
with	O
tumor	O
site	O
where	O
as	O
Granulicatella	B-bacteria
adiacens	I-bacteria
was	O
prevalent	O
at	O
non	O
-	O
tumor	O
site	O
.	O

Streptococcus	B-bacteria
intermedius	I-bacteria
was	O
present	O
in	O
70	O
%	O
of	O
both	O
non	O
-	O
tumor	O
and	O
tumor	O
sites	O
.	O

The	O
underlying	O
changes	O
in	O
the	O
bacterial	O
diversity	O
in	O
the	O
oral	O
mucosal	O
tissues	O
from	O
non	O
-	O
tumor	O
and	O
tumor	O
sites	O
of	O
OSCC	O
subjects	O
indicated	O
a	O
shift	O
in	O
bacterial	O
colonization	O
.	O

These	O
most	O
prevalent	O
or	O
unique	O
bacterial	O
species	O
/	O
phylotypes	O
present	O
in	O
tumor	O
tissues	O
may	O
be	O
associated	O
with	O
OSCC	O
and	O
needs	O
to	O
be	O
further	O
investigated	O
with	O
a	O
larger	O
sample	O
size	O
.	O

Over	O
the	O
past	O
decade	O
,	O
advances	O
in	O
cancer	O
treatments	O
have	O
been	O
counterbalanced	O
by	O
a	O
rising	O
number	O
of	O
immunosuppressed	O
patients	O
with	O
a	O
multitude	O
of	O
new	O
risk	O
factors	O
for	O
infection	O
.	O

Hence	O
,	O
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
determine	O
risk	O
factors	O
,	O
infectious	O
pathogens	O
in	O
blood	O
and	O
oral	O
cavity	O
of	O
oral	O
cancer	O
patients	O
undergoing	O
different	O
treatment	O
procedures	O
.	O

The	O
present	O
prospective	O
cohort	O
analysis	O
was	O
conducted	O
on	O
the	O
patients	O
undergoing	O
treatment	O
in	O
the	O
radiotherapy	O
unit	O
of	O
Regional	O
Cancer	O
Institute	O
,	O
Pt	O
.	O
B	O
.	O
D	O
.	O

Sharma	O
University	O
of	O
Health	O
Sciences	O
,	O
Rohtak	O
,	O
Haryana	O
,	O
during	O
the	O
period	O
of	O
January	O
2007	O
to	O
October	O
2009	O
.	O

Total	O
186	O
patients	O
with	O
squamous	O
cell	O
carcinoma	O
of	O
oral	O
cavity	O
were	O
analyzed	O
in	O
the	O
study	O
.	O

Based	O
on	O
treatment	O
procedures	O
patients	O
were	O
divided	O
into	O
three	O
groups	O
,	O
group	O
I	O
were	O
under	O
radiotherapy	O
,	O
group	O
II	O
under	O
chemotherapy	O
and	O
group	O
III	O
were	O
of	O
radio	O
chemotherapy	O
together	O
.	O

Clinical	O
isolates	O
from	O
blood	O
and	O
oral	O
cavity	O
were	O
identified	O
by	O
following	O
general	O
microbiological	O
,	O
staining	O
and	O
biochemical	O
methods	O
.	O

The	O
absolute	O
neutrophile	O
counts	O
were	O
done	O
by	O
following	O
the	O
standard	O
methods	O
.	O

Prevalent	O
bacterial	O
pathogens	O
isolated	O
were	O
Staphylococcus	B-bacteria
aureus	I-bacteria
,	O
Escherichia	B-bacteria
coli	I-bacteria
,	O
Staphylococcus	B-bacteria
epidermidis	I-bacteria
,	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
,	O
Klebsiella	B-bacteria
pneumonia	I-bacteria
,	O
Proteus	B-bacteria
mirabilis	I-bacteria
,	O
Proteus	B-bacteria
vulgaris	I-bacteria
and	O
the	O
fungal	O
pathogens	O
were	O
Candida	O
albicans	O
,	O
Aspergillus	O
fumigatus	O
.	O

The	O
predominant	O
gram	O
negative	O
bacteria	O
,	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
and	O
Klebsiella	B-bacteria
pneumonia	I-bacteria
were	O
isolated	O
from	O
blood	O
of	O
radiotherapy	O
and	O
oral	O
cavity	O
of	O
chemotherapy	O
treated	O
cases	O
respectively	O
.	O

The	O
predominance	O
of	O
gram	O
positive	O
bacteria	O
(	O
Staphylococcus	B-bacteria
aureus	I-bacteria
and	O
Staphylococcus	B-bacteria
epidermidis	I-bacteria
)	O
were	O
observed	O
in	O
blood	O
of	O
chemotherapy	O
,	O
radio	O
chemotherapy	O
cases	O
and	O
oral	O
cavity	O
of	O
radiotherapy	O
,	O
radio	O
chemotherapy	O
treated	O
cases	O
.	O

Our	O
study	O
also	O
revealed	O
the	O
presence	O
of	O
C	O
.	O
albicans	O
fungi	O
as	O
most	O
significant	O
oral	O
cavity	O
pathogens	O
in	O
radiotherapy	O
and	O
radio	O
chemotherapy	O
cases	O
.	O

Gram	O
positive	O
bacteria	O
and	O
Gram	O
negative	O
were	O
reported	O
from	O
the	O
blood	O
of	O
all	O
the	O
three	O
groups	O
of	O
patients	O
.	O

Oral	O
mucositis	O
played	O
a	O
significant	O
role	O
in	O
oral	O
cavity	O
infection	O
and	O
make	O
patients	O
more	O
prone	O
to	O
C	O
.	O
albicans	O
infection	O
.	O

Despite	O
the	O
role	O
of	O
the	O
oral	O
cavity	O
as	O
a	O
reservoir	O
of	O
opportunistic	O
pathogens	O
for	O
infection	O
in	O
patients	O
following	O
stroke	O
,	O
the	O
evaluation	O
of	O
the	O
effects	O
of	O
oral	O
hygiene	O
interventions	O
has	O
been	O
largely	O
neglected	O
.	O

This	O
randomized	O
clinical	O
trial	O
included	O
102	O
patients	O
undergoing	O
hospital	O
-	O
based	O
rehabilitation	O
for	O
stroke	O
.	O

Patients	O
were	O
randomized	O
to	O
one	O
of	O
3	O
groups	O
:	O
oral	O
hygiene	O
instruction	O
(	O
OHI	O
)	O
only	O
;	O
OHI	O
and	O
0	O
.	O
2	O
%	O
chlorhexidine	O
mouth	O
rinse	O
twice	O
daily	O
;	O
or	O
OHI	O
,	O
0	O
.	O
2	O
%	O
chlorhexidine	O
mouth	O
rinse	O
twice	O
daily	O
,	O
and	O
assisted	O
brushing	O
twice	O
weekly	O
.	O

Oral	O
samples	O
were	O
obtained	O
at	O
baseline	O
and	O
after	O
3	O
weeks	O
for	O
detection	O
of	O
Staphylococcus	B-bacteria
aureus	I-bacteria
,	O
aerobic	O
and	O
facultatively	O
anaerobic	O
gram	O
-	O
negative	O
bacilli	O
,	O
and	O
yeasts	O
.	O

Almost	O
three	O
-	O
quarters	O
(	O
72	O
.	O
8	O
%	O
)	O
of	O
the	O
patients	O
harbored	O
oral	O
anaerobic	O
gram	O
-	O
negative	O
bacilli	O
at	O
baseline	O
,	O
and	O
more	O
than	O
half	O
had	O
detectable	O
S	B-bacteria
aureus	I-bacteria
(	O
56	O
.	O
8	O
%	O
)	O
and	O
yeasts	O
(	O
59	O
.	O
3	O
%	O
)	O
.	O

Percentage	O
frequencies	O
and	O
viable	O
counts	O
of	O
pathogens	O
remained	O
relatively	O
stable	O
during	O
the	O
course	O
of	O
the	O
clinical	O
trial	O
,	O
and	O
no	O
significant	O
differences	O
were	O
observed	O
among	O
the	O
3	O
patient	O
groups	O
.	O

In	O
our	O
study	O
cohort	O
,	O
there	O
was	O
no	O
significant	O
difference	O
in	O
the	O
effectiveness	O
of	O
the	O
3	O
different	O
oral	O
hygiene	O
interventions	O
on	O
the	O
prevalence	O
or	O
viable	O
counts	O
of	O
oral	O
opportunistic	O
pathogens	O
.	O

Endodontic	O
infections	O
are	O
a	O
leading	O
cause	O
of	O
oro	O
-	O
facial	O
pain	O
and	O
tooth	O
loss	O
in	O
western	O
countries	O
,	O
and	O
may	O
lead	O
to	O
severe	O
life	O
-	O
threatening	O
infections	O
.	O

These	O
infections	O
are	O
polymicrobial	O
with	O
high	O
bacterial	O
diversity	O
.	O

Understanding	O
the	O
spatial	O
transition	O
of	O
microbiota	O
from	O
normal	O
oral	O
cavities	O
through	O
the	O
infected	O
root	O
canal	O
to	O
the	O
acute	O
periapical	O
abscess	O
can	O
improve	O
our	O
knowledge	O
of	O
the	O
pathogenesis	O
of	O
endodontic	O
infections	O
and	O
lead	O
to	O
more	O
effective	O
treatment	O
.	O

We	O
obtained	O
samples	O
from	O
the	O
oral	O
cavity	O
,	O
infected	O
root	O
canal	O
and	O
periapical	O
abscess	O
of	O
8	O
patients	O
(	O
5	O
with	O
localized	O
and	O
3	O
with	O
systemic	O
infections	O
)	O
.	O

Microbial	O
populations	O
in	O
these	O
samples	O
were	O
analyzed	O
using	O
next	O
-	O
generation	O
sequencing	O
of	O
16S	O
rRNA	O
amplicons	O
.	O

Bioinformatics	O
tools	O
and	O
statistical	O
tests	O
with	O
rigorous	O
criteria	O
were	O
used	O
to	O
elucidate	O
the	O
spatial	O
transition	O
of	O
the	O
microbiota	O
from	O
normal	O
to	O
diseased	O
sites	O
.	O

On	O
average	O
,	O
10	O
,	O
000	O
partial	O
16S	O
rRNA	O
gene	O
sequences	O
were	O
obtained	O
from	O
each	O
sample	O
.	O

All	O
sequences	O
fell	O
into	O
11	O
different	O
bacterial	O
phyla	O
.	O

The	O
microbial	O
diversity	O
in	O
root	O
canal	O
and	O
abscess	O
samples	O
was	O
significantly	O
lower	O
than	O
in	O
the	O
oral	O
samples	O
.	O

Streptococcus	B-bacteria
was	O
the	O
most	O
abundant	O
genus	O
in	O
oral	O
cavities	O
while	O
Prevotella	B-bacteria
and	O
Fusobacterium	B-bacteria
were	O
most	O
abundant	O
in	O
diseased	O
samples	O
.	O

The	O
microbiota	O
community	O
structures	O
of	O
root	O
canal	O
and	O
abscess	O
samples	O
were	O
,	O
however	O
,	O
more	O
similar	O
to	O
each	O
other	O
than	O
to	O
the	O
oral	O
cavity	O
microbiota	O
.	O

Using	O
rigorous	O
criteria	O
and	O
novel	O
bioinformatics	O
tools	O
,	O
we	O
found	O
that	O
Granulicatella	B-bacteria
adiacens	I-bacteria
,	O
Eubacterium	B-bacteria
yurii	I-bacteria
,	O
Prevotella	B-bacteria
melaninogenica	I-bacteria
,	O
Prevotella	B-bacteria
salivae	I-bacteria
,	O
Streptococcus	B-bacteria
mitis	I-bacteria
,	O
and	O
Atopobium	B-bacteria
rimae	I-bacteria
were	O
over	O
-	O
represented	O
in	O
diseased	O
samples	O
.	O

We	O
used	O
a	O
novel	O
approach	O
and	O
high	O
-	O
throughput	O
methodologies	O
to	O
characterize	O
the	O
microbiota	O
associated	O
normal	O
and	O
diseased	O
oral	O
sites	O
in	O
the	O
same	O
individuals	O
.	O

The	O
salivary	O
glands	O
of	O
adults	O
concentrate	O
nitrate	O
from	O
plasma	O
into	O
saliva	O
where	O
it	O
is	O
converted	O
to	O
nitrite	O
by	O
bacterial	O
nitrate	O
reductases	O
.	O

Nitrite	O
can	O
play	O
a	O
beneficial	O
role	O
in	O
adult	O
gastrointestinal	O
and	O
cardiovascular	O
physiology	O
.	O

When	O
nitrite	O
is	O
swallowed	O
,	O
some	O
of	O
it	O
is	O
converted	O
to	O
nitric	O
oxide	O
(	O
NO	O
)	O
in	O
the	O
stomach	O
and	O
may	O
then	O
exert	O
protective	O
effects	O
in	O
the	O
gastrointestinal	O
tract	O
and	O
throughout	O
the	O
body	O
.	O

It	O
has	O
yet	O
to	O
be	O
determined	O
either	O
when	O
newborn	O
infants	O
acquire	O
oral	O
nitrate	O
reducing	O
bacteria	O
or	O
what	O
the	O
effects	O
of	O
antimicrobial	O
therapy	O
or	O
premature	O
birth	O
may	O
be	O
on	O
the	O
bacterial	O
processing	O
of	O
nitrate	O
to	O
nitrite	O
.	O

We	O
measured	O
nitrate	O
and	O
nitrite	O
levels	O
in	O
the	O
saliva	O
of	O
adults	O
and	O
both	O
preterm	O
and	O
term	O
human	O
infants	O
in	O
the	O
early	O
weeks	O
of	O
life	O
.	O

We	O
also	O
measured	O
oral	O
bacterial	O
reductase	O
activity	O
in	O
the	O
saliva	O
of	O
both	O
infants	O
and	O
adults	O
,	O
and	O
characterized	O
the	O
species	O
of	O
nitrate	O
reducing	O
bacteria	O
present	O
.	O

Oral	O
bacterial	O
conversion	O
of	O
nitrate	O
to	O
nitrite	O
in	O
infants	O
was	O
either	O
undetectable	O
or	O
markedly	O
lower	O
than	O
the	O
conversion	O
rates	O
of	O
adults	O
.	O

No	O
measurable	O
reductase	O
activity	O
was	O
found	O
in	O
infants	O
within	O
the	O
first	O
two	O
weeks	O
of	O
life	O
,	O
despite	O
the	O
presence	O
of	O
oral	O
nitrate	O
reducing	O
bacteria	O
such	O
as	O
Actinomyces	B-bacteria
odontolyticus	I-bacteria
,	O
Veillonella	B-bacteria
atypica	I-bacteria
,	O
and	O
Rothia	B-bacteria
mucilaginosa	I-bacteria
.	O

We	O
conclude	O
that	O
relatively	O
little	O
nitrite	O
reaches	O
the	O
infant	O
gastrointestinal	O
tract	O
due	O
to	O
the	O
lack	O
of	O
oral	O
bacterial	O
nitrate	O
reductase	O
activity	O
.	O

Given	O
the	O
importance	O
of	O
the	O
nitrate	O
-	O
nitrite	O
-	O
NO	O
axis	O
in	O
adults	O
,	O
the	O
lack	O
of	O
oral	O
nitrate	O
-	O
reducing	O
bacteria	O
in	O
infants	O
may	O
be	O
relevant	O
to	O
the	O
vulnerability	O
of	O
newborns	O
to	O
hypoxic	O
stress	O
and	O
gastrointestinal	O
tract	O
pathologies	O
.	O

A	O
strictly	O
anaerobic	O
Gram	O
-	O
stain	O
-	O
variable	O
but	O
positive	O
by	O
structure	O
,	O
non	O
-	O
spore	O
-	O
forming	O
bacterium	O
designated	O
Lachnospiraceae	B-bacteria
bacterium	I-bacteria
ACC2	I-bacteria
strain	I-bacteria
DSM	I-bacteria
24645	I-bacteria
(	O
T	O
)	O
was	O
isolated	O
from	O
human	O
subgingival	O
dental	O
plaque	O
.	O

Bacterial	O
cells	O
were	O
4	O
-	O
40	O
microm	O
long	O
non	O
-	O
motile	O
rods	O
,	O
often	O
swollen	O
and	O
forming	O
curved	O
filaments	O
up	O
to	O
200	O
microm	O
.	O

Cells	O
contained	O
intracellular	O
,	O
poorly	O
crystalline	O
,	O
nanometre	O
-	O
sized	O
iron	O
-	O
and	O
sulfur	O
-	O
rich	O
particles	O
.	O

The	O
micro	O
-	O
organism	O
was	O
able	O
to	O
grow	O
on	O
yeast	O
extract	O
,	O
trypticase	O
peptone	O
,	O
milk	O
,	O
some	O
sugars	O
and	O
organic	O
acids	O
.	O

The	O
major	O
metabolic	O
end	O
-	O
products	O
of	O
glucose	O
fermentation	O
were	O
butyrate	O
,	O
lactate	O
,	O
isovalerate	O
and	O
acetate	O
.	O

The	O
growth	O
temperature	O
and	O
pH	O
ranges	O
were	O
30	O
-	O
42	O
degrees	O
C	O
and	O
4	O
.	O
9	O
-	O
7	O
.	O
5	O
,	O
respectively	O
.	O

Major	O
fatty	O
acids	O
were	O
C14	O
:	O
0	O
,	O
C14	O
:	O
0	O
DMA	O
(	O
dimethyl	O
aldehyde	O
)	O
,	O
C16	O
:	O
0	O
,	O
C16	O
:	O
1omega7c	O
DMA	O
.	O

The	O
whole	O
-	O
cell	O
hydrolysate	O
contained	O
meso	O
-	O
diaminopimelic	O
acid	O
,	O
indicating	O
peptidoglycan	O
type	O
A1gamma	O
.	O

The	O
DNA	O
G	O
+	O
C	O
content	O
was	O
calculated	O
to	O
be	O
55	O
.	O
05	O
mol	O
%	O
from	O
the	O
whole	O
-	O
genome	O
sequence	O
and	O
55	O
.	O
3	O
mol	O
%	O
as	O
determined	O
by	O
HPLC	O
.	O

There	O
were	O
no	O
predicted	O
genes	O
responsible	O
for	O
biosynthesis	O
of	O
respiratory	O
lipoquinones	O
,	O
mycolic	O
acids	O
and	O
lipopolysaccharides	O
.	O

Genes	O
associated	O
with	O
synthesis	O
of	O
teichoic	O
and	O
lipoteichoic	O
acids	O
,	O
diaminopimelic	O
acid	O
,	O
polar	O
lipids	O
and	O
polyamines	O
were	O
present	O
.	O

According	O
to	O
the	O
16S	O
rRNA	O
gene	O
sequence	O
phylogeny	O
,	O
strain	O
DSM	B-bacteria
24645	I-bacteria
(	O
T	O
)	O
formed	O
,	O
together	O
with	O
several	O
uncultured	O
oral	O
clones	O
,	O
a	O
separate	O
branch	O
within	O
the	O
family	O
Lachnospiraceae	B-bacteria
,	O
with	O
the	O
highest	O
sequence	O
similarity	O
to	O
the	O
type	O
strain	O
of	O
Moryella	B-bacteria
indoligenes	I-bacteria
at	O
94	O
.	O
2	O
%	O
.	O

Based	O
on	O
distinct	O
phenotypic	O
and	O
genotypic	O
characteristics	O
,	O
we	O
suggest	O
that	O
strain	O
DSM	B-bacteria
24645	I-bacteria
(	O
T	O
)	O
represents	O
a	O
novel	O
species	O
in	O
a	O
new	O
genus	O
,	O
for	O
which	O
the	O
name	O
Stomatobaculum	B-bacteria
longum	I-bacteria
gen	I-bacteria
.	I-bacteria
nov	I-bacteria
.	I-bacteria
,	I-bacteria
sp	I-bacteria
.	I-bacteria
nov	I-bacteria
.	I-bacteria
is	O
proposed	O
.	O

The	O
type	O
strain	O
of	O
Stomatobaculum	B-bacteria
longum	I-bacteria
is	O
DSM	B-bacteria
24645	I-bacteria
(	O
T	O
)	O
(	O
=	O
HM	B-bacteria
-	I-bacteria
480	I-bacteria
(	O
T	O
)	O
;	O
deposited	O
in	O
BEI	O
Resources	O
,	O
an	O
NIH	O
collection	O
managed	O
by	O
the	O
ATCC	O
)	O
.	O

Tobacco	O
use	O
has	O
been	O
identified	O
as	O
the	O
most	O
important	O
environmental	O
risk	O
factor	O
for	O
periodontitis	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
effect	O
of	O
green	O
tea	O
epigallocatechin	O
-	O
3	O
-	O
gallate	O
on	O
the	O
nicotine	O
-	O
induced	O
toxic	O
and	O
inflammatory	O
responses	O
in	O
oral	O
epithelial	O
cells	O
and	O
gingival	O
fibroblasts	O
.	O

The	O
effect	O
of	O
nicotine	O
,	O
alone	O
and	O
in	O
combination	O
with	O
the	O
lipopolysaccharide	O
of	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
on	O
the	O
viability	O
of	O
oral	O
epithelial	O
cells	O
and	O
fibroblasts	O
was	O
evaluated	O
using	O
a	O
3	O
-	O
(	O
4	O
,	O
5	O
-	O
dimethylthiazol	O
-	O
2	O
-	O
yl	O
)	O
-	O
2	O
,	O
5	O
-	O
diphenyltetrazolium	O
bromide	O
colorimetric	O
assay	O
.	O

The	O
ability	O
of	O
epigallocatechin	O
-	O
3	O
-	O
gallate	O
to	O
neutralize	O
the	O
nicotine	O
-	O
induced	O
cytotoxicity	O
was	O
then	O
investigated	O
.	O

The	O
nicotine	O
-	O
induced	O
cytokine	O
secretion	O
in	O
epithelial	O
cells	O
and	O
the	O
inhibitory	O
effect	O
of	O
epigallocatechin	O
-	O
3	O
-	O
gallate	O
were	O
determined	O
by	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
.	O

Our	O
results	O
indicated	O
that	O
nicotine	O
caused	O
a	O
dose	O
-	O
dependent	O
loss	O
of	O
viability	O
in	O
both	O
epithelial	O
cells	O
and	O
fibroblasts	O
.	O

A	O
mixture	O
of	O
nicotine	O
and	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
lipopolysaccharide	O
demonstrated	O
additive	O
instead	O
of	O
synergistic	O
effects	O
on	O
loss	O
of	O
cell	O
viability	O
.	O

Pretreatment	O
of	O
cells	O
with	O
epigallocatechin	O
-	O
3	O
-	O
gallate	O
efficiently	O
neutralized	O
the	O
nicotine	O
-	O
induced	O
toxic	O
effects	O
in	O
epithelial	O
cells	O
and	O
fibroblasts	O
.	O

It	O
also	O
dose	O
dependently	O
inhibited	O
the	O
nicotine	O
-	O
induced	O
secretion	O
of	O
chemokine	O
(	O
C	O
-	O
C	O
motif	O
)	O
ligand	O
5	O
by	O
epithelial	O
cells	O
.	O

The	O
present	O
study	O
suggests	O
that	O
epigallocatechin	O
-	O
3	O
-	O
gallate	O
,	O
the	O
major	O
polyphenol	O
in	O
green	O
tea	O
,	O
may	O
represent	O
a	O
novel	O
preventive	O
/	O
therapeutic	O
agent	O
for	O
smoking	O
-	O
related	O
periodontitis	O
.	O

Chronic	O
periodontal	O
diseases	O
are	O
characterised	O
by	O
a	O
dysregulated	O
and	O
exaggerated	O
inflammatory	O
/	O
immune	O
response	O
to	O
plaque	O
bacteria	O
.	O

We	O
have	O
demonstrated	O
previously	O
that	O
oral	O
keratinocytes	O
up	O
-	O
regulate	O
key	O
molecular	O
markers	O
of	O
inflammation	O
,	O
including	O
NF	O
-	O
kappaB	O
and	O
cytokine	O
signalling	O
,	O
when	O
exposed	O
to	O
the	O
periodontal	O
bacteria	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
and	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
in	O
vitro	O
.	O

The	O
purpose	O
of	O
the	O
current	O
study	O
was	O
to	O
investigate	O
whether	O
alpha	O
-	O
lipoic	O
acid	O
was	O
able	O
to	O
abrogate	O
bacterially	O
-	O
induced	O
pro	O
-	O
inflammatory	O
changes	O
in	O
the	O
H400	O
oral	O
epithelial	O
cell	O
line	O
.	O

Initial	O
studies	O
indicated	O
that	O
alpha	O
-	O
lipoic	O
acid	O
supplementation	O
(	O
1	O
-	O
4	O
mM	O
)	O
significantly	O
reduced	O
cell	O
attachment	O
;	O
lower	O
concentrations	O
(	O
<	O
0	O
.	O
5	O
mM	O
)	O
enabled	O
>	O
85	O
%	O
cell	O
adhesion	O
at	O
24	O
h	O
.	O
While	O
a	O
pro	O
-	O
inflammatory	O
response	O
,	O
demonstrable	O
by	O
NF	O
-	O
kappaB	O
translocation	O
,	O
gene	O
expression	O
and	O
protein	O
production	O
was	O
evident	O
in	O
H400	O
cells	O
following	O
exposure	O
to	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
and	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
,	O
pre	O
-	O
incubation	O
of	O
cells	O
with	O
0	O
.	O
5	O
mM	O
alpha	O
-	O
lipoic	O
acid	O
modulated	O
this	O
response	O
.	O

alpha	O
-	O
Lipoic	O
acid	O
pre	O
-	O
treatment	O
significantly	O
decreased	O
levels	O
of	O
bacterially	O
-	O
induced	O
NF	O
-	O
kappaB	O
activation	O
and	O
IL	O
-	O
8	O
protein	O
production	O
,	O
and	O
differentially	O
modulated	O
transcript	O
levels	O
for	O
IL	O
-	O
8	O
,	O
IL	O
-	O
1beta	O
,	O
TNF	O
-	O
alpha	O
and	O
GM	O
-	O
CSF	O
,	O
TLR2	O
,	O
4	O
,	O
9	O
,	O
S100A8	O
,	O
S100A9	O
,	O
lysyl	O
oxidase	O
,	O
NF	O
-	O
kappaB1	O
,	O
HMOX	O
,	O
and	O
SOD2	O
.	O

Overall	O
,	O
the	O
data	O
indicate	O
that	O
alpha	O
-	O
lipoic	O
acid	O
exerts	O
an	O
anti	O
-	O
inflammatory	O
effect	O
on	O
oral	O
epithelial	O
cells	O
exposed	O
to	O
periodontal	O
bacteria	O
and	O
thus	O
may	O
provide	O
a	O
novel	O
adjunctive	O
treatment	O
for	O
periodontal	O
diseases	O
.	O

To	O
determine	O
if	O
a	O
novel	O
formulation	O
is	O
effective	O
in	O
killing	O
oral	O
biofilm	O
streptococci	B-bacteria
in	O
vitro	O
and	O
in	O
vivo	O
.	O

Efficacy	O
of	O
0	O
.	O
5	O
%	O
levulinic	O
acid	O
and	O
0	O
.	O
05	O
%	O
sodium	O
dodecyl	O
sulfate	O
(	O
SDS	O
)	O
in	O
killing	O
Streptococcus	B-bacteria
gordonii	I-bacteria
CH1	I-bacteria
,	O
Streptococcus	B-bacteria
gordonii	I-bacteria
DL1	I-bacteria
,	O
Streptococcus	B-bacteria
mitis	I-bacteria
NCTC10712	I-bacteria
,	O
Streptococcus	B-bacteria
oralis	I-bacteria
KS32AR	I-bacteria
,	O
Streptococcus	B-bacteria
mutans	I-bacteria
BM71	I-bacteria
,	O
and	O
Streptococcus	B-bacteria
mutans	I-bacteria
GS5	I-bacteria
in	O
their	O
biofilm	O
form	O
was	O
measured	O
in	O
vitro	O
,	O
using	O
microtiter	O
plates	O
and	O
subsequent	O
counts	O
on	O
Mitis	O
-	O
Salivarius	O
agar	O
plates	O
.	O

The	O
safety	O
and	O
efficacy	O
in	O
vivo	O
were	O
evaluated	O
using	O
a	O
mouse	O
model	O
.	O

Our	O
anti	O
-	O
microbial	O
formulation	O
completely	O
eliminated	O
all	O
the	O
biofilm	O
streptococcal	B-bacteria
species	I-bacteria
tested	O
within	O
30	O
seconds	O
(	O
a	O
reduction	O
of	O
10	O
(	O
7	O
)	O
CFU	O
/	O
ml	O
)	O
,	O
whereas	O
the	O
positive	O
control	O
Listerine	O
only	O
demonstrated	O
moderate	O
reduction	O
in	O
vitro	O
.	O

Application	O
of	O
the	O
formulation	O
twice	O
a	O
day	O
for	O
7	O
days	O
in	O
the	O
murine	O
oral	O
cavity	O
resulted	O
in	O
significantly	O
more	O
reduction	O
of	O
established	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
DL1	I-bacteria
oral	O
biofilm	O
bacteria	O
than	O
Listerine	O
.	O

The	O
formulation	O
did	O
not	O
cause	O
any	O
adverse	O
effect	O
in	O
murine	O
oral	O
cavity	O
within	O
a	O
2	O
-	O
week	O
period	O
.	O

We	O
have	O
demonstrated	O
that	O
the	O
novel	O
mouth	O
rinse	O
exhibits	O
high	O
efficacy	O
in	O
killing	O
oral	O
bacteria	O
in	O
their	O
biofilm	O
forms	O
,	O
results	O
in	O
no	O
adverse	O
effect	O
in	O
vivo	O
,	O
and	O
contains	O
alcohol	O
-	O
free	O
components	O
.	O

This	O
study	O
compared	O
the	O
antimicrobial	O
effects	O
of	O
three	O
commercial	O
dentifrice	O
formulations	O
:	O
sodium	O
fluoride	O
/	O
triclosan	O
/	O
copolymer	O
(	O
TCN	O
/	O
C	O
)	O
,	O
stannous	O
fluoride	O
/	O
sodium	O
hexametaphosphate	O
/	O
zinc	O
lactate	O
(	O
SnF	O
(	O
2	O
)	O
/	O
SHMP	O
)	O
and	O
sodium	O
fluoride	O
(	O
NaF	O
)	O
.	O

adults	O
(	O
15	O
men	O
and	O
20	O
women	O
;	O
average	O
age	O
33	O
years	O
and	O
pockets	O
<	O
5	O
mm	O
)	O
completed	O
this	O
double	O
-	O
blind	O
,	O
triple	O
-	O
crossover	O
study	O
.	O

After	O
washout	O
,	O
baseline	O
samples	O
from	O
four	O
sites	O
,	O
plaque	O
,	O
saliva	O
,	O
tongue	O
and	O
buccal	O
mucosa	O
,	O
were	O
collected	O
and	O
evaluated	O
for	O
six	O
microbial	O
types	O
,	O
anaerobes	O
,	O
Streptococci	B-bacteria
,	O
Actinomyces	B-bacteria
,	O
hydrogen	O
-	O
sulphide	O
(	O
H	O
(	O
2	O
)	O
S	O
)	O
-	O
producing	O
bacteria	O
,	O
Fusobacteria	B-bacteria
and	O
Veillonella	B-bacteria
.	O

A	O
specific	O
dentifrice	O
was	O
randomly	O
assigned	O
for	O
twice	O
-	O
daily	O
use	O
for	O
13	O
days	O
.	O

On	O
day	O
14	O
,	O
12	O
h	O
after	O
brushing	O
,	O
samples	O
were	O
collected	O
for	O
microbiological	O
evaluations	O
.	O

Alternate	O
dentifrices	O
followed	O
this	O
identical	O
protocol	O
.	O

For	O
all	O
four	O
oral	O
sites	O
and	O
six	O
organisms	O
evaluated	O
in	O
each	O
site	O
,	O
the	O
TCN	O
/	O
C	O
demonstrated	O
significant	O
reductions	O
(	O
49	O
-	O
83	O
%	O
)	O
as	O
compared	O
with	O
the	O
other	O
treatments	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O

The	O
SnF	O
(	O
2	O
)	O
/	O
SHMP	O
group	O
showed	O
significant	O
reductions	O
of	O
14	O
-	O
43	O
%	O
for	O
14	O
of	O
24	O
outcomes	O
as	O
compared	O
with	O
the	O
NaF	O
group	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
,	O
with	O
no	O
differences	O
in	O
10	O
outcomes	O
.	O

The	O
TCN	O
/	O
C	O
dentifrice	O
formulation	O
consistently	O
demonstrated	O
significant	O
reductions	O
for	O
a	O
range	O
of	O
microorganisms	O
in	O
diverse	O
oral	O
sites	O
in	O
comparison	O
with	O
the	O
NaF	O
,	O
or	O
the	O
SnF	O
(	O
2	O
)	O
/	O
SHMP	O
dentifrice	O
formulations	O
as	O
seen	O
12	O
h	O
after	O
brushing	O
.	O

The	O
University	O
of	O
Nevada	O
,	O
Las	O
Vegas	O
School	O
of	O
Dental	O
Medicine	O
recently	O
opened	O
an	O
orthodontic	O
treatment	O
clinic	O
to	O
address	O
the	O
needs	O
of	O
the	O
racially	O
and	O
ethnically	O
diverse	O
population	O
of	O
Southern	O
Nevada	O
,	O
primarily	O
focusing	O
on	O
the	O
treatment	O
and	O
care	O
of	O
low	O
-	O
income	O
and	O
minority	O
patients	O
.	O

Although	O
orthodontic	O
treatment	O
and	O
therapy	O
has	O
been	O
shown	O
to	O
induce	O
changes	O
in	O
the	O
oral	O
cavity	O
,	O
much	O
of	O
this	O
evidence	O
was	O
collected	O
from	O
traditional	O
White	O
,	O
teenage	O
orthodontic	O
clinic	O
populations	O
.	O

The	O
primary	O
goal	O
of	O
this	O
study	O
was	O
to	O
describe	O
the	O
microbial	O
burden	O
of	O
the	O
cariogenic	O
and	O
periodontal	O
pathogens	O
,	O
Streptococcus	B-bacteria
mutans	I-bacteria
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
within	O
the	O
UNLV	O
-	O
SDM	O
patient	O
population	O
.	O

Representative	O
saliva	O
samples	O
were	O
collected	O
from	O
healthy	O
adult	O
patients	O
for	O
DNA	O
isolation	O
.	O

Relative	O
endpoint	O
polymerase	O
chain	O
reaction	O
(	O
RE	O
-	O
PCR	O
)	O
was	O
performed	O
to	O
ascertain	O
the	O
presence	O
and	O
relative	O
microbial	O
burden	O
of	O
these	O
oral	O
pathogens	O
.	O

Nearly	O
one	O
quarter	O
(	O
13	O
/	O
56	O
)	O
or	O
23	O
.	O
3	O
%	O
of	O
these	O
patients	O
had	O
elevated	O
levels	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
while	O
(	O
10	O
/	O
56	O
)	O
and	O
17	O
.	O
8	O
%	O
of	O
these	O
samples	O
were	O
found	O
to	O
have	O
elevated	O
levels	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
-	O
with	O
(	O
90	O
%	O
)	O
of	O
P	O
.	O
gingivalis	O
-	O
positive	O
samples	O
from	O
minority	O
patients	O
(	O
X2	O
=	O
17	O
.	O
921	O
,	O
d	O
.	O
f	O
.	O
=	O
1	O
;	O
p	O
<	O
0	O
.	O
0001	O
)	O
.	O

These	O
findings	O
of	O
elevated	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
levels	O
,	O
primarily	O
among	O
minority	O
patients	O
,	O
may	O
suggest	O
underlying	O
oral	O
health	O
practices	O
contributing	O
to	O
adverse	O
oral	O
health	O
conditions	O
within	O
this	O
population	O
.	O

Oral	O
health	O
knowledge	O
and	O
practices	O
among	O
minority	O
patients	O
may	O
be	O
strongly	O
influenced	O
by	O
other	O
factors	O
,	O
including	O
education	O
and	O
socioeconomic	O
status	O
,	O
suggesting	O
additional	O
research	O
may	O
be	O
needed	O
to	O
accurately	O
determine	O
the	O
most	O
appropriate	O
standards	O
for	O
care	O
and	O
oral	O
health	O
education	O
within	O
this	O
patient	O
population	O
.	O

To	O
compare	O
the	O
oral	O
prevalence	O
and	O
antimicrobial	O
susceptibility	O
of	O
candida	O
spp	O
.	O
,	O
staphylococci	B-bacteria
,	O
enterobacteriaceae	B-bacteria
,	O
and	O
pseudomonas	B-bacteria
spp	I-bacteria
.	I-bacteria
from	O
ankylosing	O
spondylitis	O
(	O
AS	O
)	O
patients	O
receiving	O
conventional	O
and	O
anti	O
-	O
TNF	O
-	O
alpha	O
therapy	O
.	O

The	O
study	O
included	O
70	O
AS	O
patients	O
,	O
diagnosed	O
according	O
to	O
the	O
modified	O
New	O
York	O
criteria	O
(	O
1984	O
)	O
.	O

The	O
volunteers	O
were	O
divided	O
into	O
2	O
groups	O
:	O
a	O
biological	O
group	O
(	O
AS	O
BioG	O
)	O
(	O
n	O
=	O
35	O
)	O
(	O
on	O
anti	O
-	O
TNF	O
-	O
alpha	O
therapy	O
)	O
and	O
a	O
conventional	O
group	O
(	O
AS	O
ConvG	O
)	O
(	O
n	O
=	O
35	O
)	O
.	O

The	O
control	O
group	O
(	O
ContG	O
)	O
(	O
n	O
=	O
70	O
)	O
was	O
made	O
up	O
of	O
healthy	O
individuals	O
matched	O
for	O
age	O
,	O
gender	O
,	O
and	O
oral	O
conditions	O
.	O

After	O
clinical	O
examination	O
,	O
oral	O
rinse	O
samples	O
were	O
collected	O
and	O
plated	O
in	O
specific	O
culture	O
media	O
.	O

The	O
number	O
of	O
colony	O
-	O
forming	O
units	O
per	O
milliliter	O
(	O
cfu	O
/	O
ml	O
)	O
was	O
obtained	O
,	O
and	O
isolates	O
were	O
identified	O
using	O
the	O
API	O
system	O
.	O

Antimicrobial	O
susceptibility	O
tests	O
were	O
performed	O
according	O
to	O
the	O
NCCLS	O
guidelines	O
.	O

Prevalence	O
and	O
counts	O
of	O
microorganisms	O
were	O
statistically	O
compared	O
between	O
the	O
3	O
groups	O
,	O
using	O
the	O
Mann	O
-	O
Whitney	O
and	O
Chi	O
-	O
square	O
tests	O
.	O

Significance	O
level	O
was	O
set	O
at	O
5	O
%	O
.	O

In	O
both	O
the	O
AS	O
BioG	O
and	O
the	O
AS	O
ConvG	O
,	O
staphylococci	B-bacteria
counts	O
were	O
higher	O
than	O
that	O
in	O
the	O
ContG	O
(	O
p	O
<	O
0	O
.	O
0001	O
)	O
.	O

Candida	O
albicans	O
and	O
staphylococcus	B-bacteria
epidermidis	I-bacteria
were	O
the	O
most	O
commonly	O
found	O
species	O
in	O
all	O
the	O
groups	O
.	O

Serratia	B-bacteria
marcescens	I-bacteria
and	O
klebsiella	B-bacteria
oxytoca	I-bacteria
were	O
more	O
prevalent	O
in	O
the	O
AS	O
BioG	O
and	O
the	O
AS	O
ConvG	O
,	O
respectively	O
.	O

Two	O
candida	O
isolates	O
(	O
2	O
.	O
8	O
%	O
)	O
from	O
the	O
AS	O
BioG	O
and	O
5	O
(	O
10	O
.	O
8	O
%	O
)	O
from	O
the	O
AS	O
ConvG	O
were	O
resistant	O
to	O
amphotericin	O
B	O
and	O
5	O
-	O
fluorocytosine	O
.	O

A	O
low	O
percentage	O
of	O
staphylococci	B-bacteria
isolates	I-bacteria
was	O
resistant	O
to	O
amoxicillin	O
,	O
ciprofloxacin	O
,	O
and	O
doxycycline	O
.	O

Higher	O
counts	O
of	O
staphylococci	B-bacteria
were	O
observed	O
in	O
both	O
AS	O
groups	O
,	O
regardless	O
of	O
the	O
current	O
therapy	O
,	O
age	O
,	O
sex	O
,	O
and	O
oral	O
conditions	O
.	O

Anti	O
-	O
TNF	O
-	O
alpha	O
therapy	O
could	O
not	O
be	O
correlated	O
with	O
increased	O
counts	O
of	O
microorganisms	O
.	O

This	O
study	O
aimed	O
to	O
evaluate	O
the	O
capacity	O
of	O
whole	O
-	O
genome	O
DNA	O
probes	O
prepared	O
from	O
human	O
oral	O
bacteria	O
to	O
cross	O
-	O
react	O
with	O
bacteria	O
from	O
the	O
oral	O
cavity	O
of	O
rats	O
,	O
and	O
to	O
assess	O
the	O
influence	O
of	O
alcohol	O
ingestion	O
on	O
the	O
animals	O
'	O
oral	O
biofilm	O
.	O

Twenty	O
four	O
mature	O
Wistar	O
rats	O
were	O
equally	O
divided	O
in	O
two	O
groups	O
.	O

One	O
group	O
(	O
control	O
)	O
was	O
fed	O
balanced	O
diet	O
of	O
rat	O
pellets	O
and	O
water	O
.	O

The	O
alcohol	O
-	O
treated	O
group	O
(	O
AT	O
)	O
received	O
the	O
same	O
diet	O
and	O
20	O
%	O
ethanol	O
solution	O
.	O

Upon	O
euthanasia	O
after	O
30	O
days	O
,	O
bacterial	O
samples	O
from	O
the	O
oral	O
biofilm	O
covering	O
the	O
animals	O
'	O
teeth	O
were	O
collected	O
using	O
microbrushes	O
.	O

Bacteria	O
identification	O
and	O
quantification	O
were	O
performed	O
using	O
the	O
DNA	O
checkerboard	O
hybridization	O
method	O
with	O
33	O
probes	O
prepared	O
from	O
human	O
oral	O
bacteria	O
.	O

Signals	O
corresponding	O
to	O
bacterial	O
genome	O
counts	O
and	O
percentages	O
were	O
compared	O
using	O
a	O
Mann	O
-	O
Whitney	O
U	O
test	O
with	O
a	O
significance	O
level	O
<	O
0	O
.	O
05	O
.	O

Cross	O
-	O
reaction	O
for	O
all	O
targeted	O
species	O
,	O
except	O
Streptococcus	B-bacteria
mutans	I-bacteria
and	O
Streptococcus	O
mitis	O
-	O
like	O
species	O
,	O
occurred	O
in	O
the	O
control	O
group	O
.	O

Escherichia	B-bacteria
coli	I-bacteria
,	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
,	O
Porphyromonas	B-bacteria
endodontalis	I-bacteria
,	O
and	O
Veillonella	O
parvula	O
-	O
like	O
species	O
only	O
produced	O
detectable	O
signals	O
in	O
the	O
AT	O
group	O
.	O

Significantly	O
more	O
signals	O
were	O
detected	O
in	O
the	O
control	O
group	O
compared	O
to	O
the	O
AT	O
group	O
(	O
p	O
=	O
0	O
.	O
001	O
)	O
.	O

The	O
percentage	O
of	O
E	O
.	O
coli	O
-	O
like	O
species	O
was	O
highest	O
in	O
both	O
groups	O
.	O

Whole	O
-	O
genome	O
DNA	O
probes	O
prepared	O
from	O
human	O
oral	O
bacteria	O
can	O
cross	O
-	O
react	O
with	O
rats	O
'	O
oral	O
bacterial	O
species	O
.	O

Alcohol	O
consumption	O
is	O
associated	O
with	O
lower	O
levels	O
and	O
diversity	O
of	O
bacterial	O
species	O
in	O
the	O
oral	O
cavity	O
of	O
rats	O
.	O

Little	O
is	O
known	O
about	O
the	O
effect	O
of	O
diet	O
on	O
the	O
oral	O
microbiota	O
of	O
infants	O
,	O
although	O
diet	O
is	O
known	O
to	O
affect	O
the	O
gut	O
microbiota	O
.	O

The	O
aims	O
of	O
the	O
present	O
study	O
were	O
to	O
compare	O
the	O
oral	O
microbiota	O
in	O
breast	O
-	O
fed	O
and	O
formula	O
-	O
fed	O
infants	O
,	O
and	O
investigate	O
growth	O
inhibition	O
of	O
streptococci	B-bacteria
by	O
infant	O
-	O
isolated	O
lactobacilli	B-bacteria
.	O

A	O
total	O
of	O
207	O
mothers	O
consented	O
to	O
participation	O
of	O
their	O
3	O
-	O
month	O
-	O
old	O
infants	O
.	O

A	O
total	O
of	O
146	O
(	O
70	O
.	O
5	O
%	O
)	O
infants	O
were	O
exclusively	O
and	O
38	O
(	O
18	O
.	O
4	O
%	O
)	O
partially	O
breast	O
-	O
fed	O
,	O
and	O
23	O
(	O
11	O
.	O
1	O
%	O
)	O
were	O
exclusively	O
formula	O
-	O
fed	O
.	O

Saliva	O
from	O
all	O
of	O
their	O
infants	O
was	O
cultured	O
for	O
Lactobacillus	B-bacteria
species	I-bacteria
,	O
with	O
isolate	O
identifications	O
from	O
21	O
infants	O
.	O

Lactobacillus	B-bacteria
isolates	I-bacteria
were	O
tested	O
for	O
their	O
ability	O
to	O
suppress	O
Streptococcus	B-bacteria
mutans	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
.	O

Oral	O
swabs	O
from	O
73	O
infants	O
were	O
analysed	O
by	O
the	O
Human	O
Oral	O
Microbe	O
Identification	O
Microarray	O
(	O
HOMIM	O
)	O
and	O
by	O
quantitative	O
polymerase	O
chain	O
reaction	O
for	O
Lactobacillus	B-bacteria
gasseri	I-bacteria
.	O

Lactobacilli	B-bacteria
were	O
cultured	O
from	O
27	O
.	O
8	O
%	O
of	O
exclusively	O
and	O
partially	O
breast	O
-	O
fed	O
infants	O
,	O
but	O
not	O
from	O
formula	O
-	O
fed	O
infants	O
.	O

The	O
prevalence	O
of	O
14	O
HOMIM	O
-	O
detected	O
taxa	O
,	O
and	O
total	O
salivary	O
lactobacilli	B-bacteria
counts	O
differed	O
by	O
feeding	O
method	O
.	O

Multivariate	O
modelling	O
of	O
HOMIM	O
-	O
detected	O
bacteria	O
and	O
possible	O
confounders	O
clustered	O
samples	O
from	O
breast	O
-	O
fed	O
infants	O
separately	O
from	O
formula	O
-	O
fed	O
infants	O
.	O

The	O
microbiota	O
of	O
breast	O
-	O
fed	O
infants	O
differed	O
based	O
on	O
vaginal	O
or	O
C	O
-	O
section	O
delivery	O
.	O

Isolates	O
of	O
L	B-bacteria
plantarum	I-bacteria
,	O
L	B-bacteria
gasseri	I-bacteria
,	O
and	O
L	B-bacteria
vaginalis	I-bacteria
inhibited	O
growth	O
of	O
the	O
cariogenic	O
S	B-bacteria
mutans	I-bacteria
and	O
the	O
commensal	O
S	B-bacteria
sanguinis	I-bacteria
:	O
L	B-bacteria
plantarum	I-bacteria
>	O
L	B-bacteria
gasseri	I-bacteria
>	O
L	B-bacteria
vaginalis	I-bacteria
.	O

The	O
microbiota	O
of	O
the	O
mouth	O
differs	O
between	O
3	O
-	O
month	O
-	O
old	O
breast	O
-	O
fed	O
and	O
formula	O
-	O
fed	O
infants	O
.	O

Possible	O
mechanisms	O
for	O
microbial	O
differences	O
observed	O
include	O
species	O
suppression	O
by	O
lactobacilli	B-bacteria
indigenous	O
to	O
breast	O
milk	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
analyze	O
the	O
improvement	O
in	O
oral	O
function	O
and	O
environment	O
in	O
high	O
-	O
risk	O
elderly	O
persons	O
participating	O
in	O
a	O
program	O
to	O
improve	O
oral	O
function	O
organized	O
by	O
their	O
local	O
government	O
.	O

Participants	O
comprised	O
36	O
high	O
-	O
risk	O
elderly	O
and	O
the	O
mean	O
age	O
was	O
77	O
.	O
11	O
+	O
/	O
-	O
7	O
.	O
24	O
years	O
.	O

The	O
program	O
involved	O
training	O
sessions	O
carried	O
out	O
five	O
or	O
six	O
times	O
every	O
2	O
-	O
3	O
weeks	O
for	O
3	O
months	O
.	O

Oral	O
function	O
and	O
environment	O
was	O
evaluated	O
before	O
and	O
after	O
the	O
program	O
.	O

The	O
research	O
period	O
extended	O
from	O
2008	O
to	O
2010	O
.	O

The	O
effects	O
of	O
intervention	O
were	O
clearly	O
observed	O
in	O
oral	O
diadochokinesis	O
score	O
in	O
the	O
high	O
-	O
risk	O
elderly	O
.	O

Persons	O
with	O
a	O
lower	O
repetitive	O
saliva	O
swallowing	O
test	O
(	O
RSST	O
)	O
and	O
oral	O
diadochokinesis	O
score	O
before	O
intervention	O
showed	O
a	O
tendency	O
toward	O
even	O
greater	O
improvement	O
.	O

No	O
significant	O
changes	O
were	O
observed	O
in	O
saliva	O
secretion	O
or	O
total	O
amounts	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Lactobacilli	B-bacteria
,	O
Candida	O
or	O
total	O
microorganisms	O
.	O

The	O
effects	O
of	O
intervention	O
were	O
clearly	O
recognized	O
in	O
regards	O
to	O
oral	O
diadochokinesis	O
.	O

Improvement	O
in	O
RSST	O
and	O
oral	O
diadochokinesis	O
scores	O
was	O
marked	O
in	O
those	O
persons	O
showing	O
a	O
lower	O
number	O
of	O
articulations	O
before	O
intervention	O
.	O

Salvadora	O
persica	O
L	O
.	O
(	O
miswak	O
)	O
is	O
traditionally	O
used	O
to	O
ensure	O
oral	O
hygiene	O
Muslim	O
people	O
in	O
developing	O
countries	O
where	O
it	O
is	O
growing	O
.	O

The	O
antibacterial	O
properties	O
of	O
Salvadora	O
persica	O
L	O
.	O
originating	O
from	O
various	O
geographic	O
areas	O
have	O
already	O
been	O
reported	O
.	O

However	O
,	O
they	O
have	O
never	O
been	O
tested	O
for	O
samples	O
originating	O
from	O
Hoggar	O
,	O
where	O
extreme	O
weather	O
conditions	O
could	O
lead	O
to	O
different	O
properties	O
for	O
this	O
Salvadora	O
persica	O
L	O
.	O
ecotype	O
.	O

To	O
assess	O
the	O
in	O
vitro	O
and	O
in	O
vivo	O
antimicrobial	O
activities	O
of	O
methanolic	O
extract	O
of	O
Algerian	O
Hoggar	O
Salvadora	O
persica	O
L	O
.	O
(	O
miswak	O
)	O
on	O
some	O
isolated	O
and	O
identified	O
strains	O
from	O
the	O
oral	O
cavity	O
of	O
school	O
children	O
aged	O
from	O
6	O
to	O
12	O
with	O
(	O
n	O
=	O
20	O
)	O
and	O
without	O
(	O
n	O
=	O
20	O
)	O
caries	O
.	O

After	O
a	O
qualitative	O
and	O
quantitative	O
analysis	O
of	O
dental	O
plaque	O
samples	O
from	O
the	O
selected	O
children	O
,	O
the	O
effect	O
of	O
methanolic	O
extract	O
of	O
Hoggar	O
miswak	O
against	O
oral	O
bacterial	O
and	O
fungal	O
strains	O
isolated	O
from	O
the	O
oral	O
cavity	O
of	O
children	O
with	O
caries	O
was	O
tested	O
by	O
both	O
agar	O
disc	O
diffusion	O
and	O
microdilution	O
methods	O
.	O

The	O
stability	O
and	O
physicochemical	O
parameters	O
of	O
Hoggar	O
Salvadora	O
persica	O
L	O
.	O
mouthwash	O
were	O
also	O
assessed	O
compared	O
.	O

The	O
in	O
vivo	O
antimicrobial	O
effect	O
of	O
Hoggar	O
miswak	O
rinse	O
on	O
dental	O
plaque	O
samples	O
was	O
also	O
tested	O
over	O
a	O
week	O
.	O

Four	O
bacterial	O
genera	O
(	O
Staphylococcus	B-bacteria
,	O
Streptococcus	B-bacteria
,	O
Escherichia	B-bacteria
and	O
Lactobacillus	B-bacteria
)	O
were	O
commonly	O
identified	O
in	O
all	O
subjects	O
at	O
different	O
colonization	O
levels	O
.	O

A	O
statistically	O
significant	O
difference	O
in	O
colonization	O
levels	O
between	O
the	O
two	O
groups	O
of	O
children	O
was	O
recorded	O
.	O

Hoggar	O
miswak	O
extract	O
more	O
significantly	O
inhibited	O
the	O
growth	O
of	O
Gram	O
negative	O
bacteria	O
from	O
the	O
dental	O
plaque	O
than	O
Gram	O
positive	O
ones	O
.	O

Hoggar	O
Salvadora	O
persica	O
L	O
.	O
mouthwash	O
was	O
stable	O
at	O
4	O
degrees	O
C	O
and	O
25	O
degrees	O
C	O
over	O
the	O
period	O
of	O
conservation	O
(	O
one	O
week	O
)	O
while	O
a	O
temperature	O
of	O
40	O
degrees	O
C	O
induced	O
variations	O
in	O
the	O
physicochemical	O
parameters	O
and	O
considered	O
not	O
suitable	O
for	O
preservation	O
.	O

The	O
in	O
vivo	O
study	O
revealed	O
a	O
significant	O
reduction	O
in	O
bacteria	O
of	O
the	O
oral	O
cavity	O
using	O
miswak	O
mouthwash	O
as	O
compared	O
to	O
placebo	O
.	O

Hoggar	O
miswak	O
extract	O
displayed	O
a	O
strong	O
antimicrobial	O
effect	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

Its	O
use	O
as	O
a	O
mouthrinse	O
could	O
therefore	O
be	O
recommended	O
as	O
a	O
preventive	O
measure	O
to	O
preserve	O
from	O
tooth	O
decay	O
.	O

Examine	O
the	O
relationship	O
between	O
antibodies	O
to	O
25	O
oral	O
bacteria	O
and	O
pancreatic	O
cancer	O
risk	O
in	O
a	O
prospective	O
cohort	O
study	O
.	O

We	O
measured	O
antibodies	O
to	O
oral	O
bacteria	O
in	O
prediagnosis	O
blood	O
samples	O
from	O
405	O
pancreatic	O
cancer	O
cases	O
and	O
416	O
matched	O
controls	O
,	O
nested	O
within	O
the	O
European	O
Prospective	O
Investigation	O
into	O
Cancer	O
and	O
Nutrition	O
study	O
.	O

Analyses	O
were	O
conducted	O
using	O
conditional	O
logistic	O
regression	O
and	O
additionally	O
adjusted	O
for	O
smoking	O
status	O
and	O
body	O
mass	O
index	O
.	O

Individuals	O
with	O
high	O
levels	O
of	O
antibodies	O
against	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
ATTC	I-bacteria
53978	I-bacteria
,	O
a	O
pathogenic	O
periodontal	O
bacteria	O
,	O
had	O
a	O
twofold	O
higher	O
risk	O
of	O
pancreatic	O
cancer	O
than	O
individuals	O
with	O
lower	O
levels	O
of	O
these	O
antibodies	O
(	O
OR	O
2	O
.	O
14	O
;	O
95	O
%	O
CI	O
1	O
.	O
05	O
to	O
4	O
.	O
36	O
;	O
>	O
200	O
ng	O
/	O
ml	O
vs	O
<	O
/	O
=	O
200	O
ng	O
/	O
ml	O
)	O
.	O

To	O
explore	O
the	O
association	O
with	O
commensal	O
(	O
non	O
-	O
pathogenic	O
)	O
oral	O
bacteria	O
,	O
we	O
performed	O
a	O
cluster	O
analysis	O
and	O
identified	O
two	O
groups	O
of	O
individuals	O
,	O
based	O
on	O
their	O
antibody	O
profiles	O
.	O

A	O
cluster	O
with	O
overall	O
higher	O
levels	O
of	O
antibodies	O
had	O
a	O
45	O
%	O
lower	O
risk	O
of	O
pancreatic	O
cancer	O
than	O
a	O
cluster	O
with	O
overall	O
lower	O
levels	O
of	O
antibodies	O
(	O
OR	O
0	O
.	O
55	O
;	O
95	O
%	O
CI	O
0	O
.	O
36	O
to	O
0	O
.	O
83	O
)	O
.	O

Periodontal	O
disease	O
might	O
increase	O
the	O
risk	O
for	O
pancreatic	O
cancer	O
.	O

Moreover	O
,	O
increased	O
levels	O
of	O
antibodies	O
against	O
specific	O
commensal	O
oral	O
bacteria	O
,	O
which	O
can	O
inhibit	O
growth	O
of	O
pathogenic	O
bacteria	O
,	O
might	O
reduce	O
the	O
risk	O
of	O
pancreatic	O
cancer	O
.	O

Studies	O
are	O
needed	O
to	O
determine	O
whether	O
oral	O
bacteria	O
have	O
direct	O
effects	O
on	O
pancreatic	O
cancer	O
pathogenesis	O
or	O
serve	O
as	O
markers	O
of	O
the	O
immune	O
response	O
.	O

Oral	O
microbial	O
flora	O
and	O
a	O
damaged	O
oral	O
mucosa	O
may	O
increase	O
the	O
risk	O
of	O
bacteriemia	O
,	O
fungemia	O
and	O
complications	O
in	O
immunocompromised	O
patients	O
.	O

Assessment	O
of	O
presence	O
:	O
bacteria	O
and	O
Candida	O
spp	O
.	O
in	O
different	O
oral	O
lesions	O
,	O
and	O
the	O
incidence	O
of	O
bacteremia	O
in	O
the	O
case	O
of	O
a	O
damaged	O
mucosa	O
in	O
transplant	O
recipients	O
and	O
patients	O
receiving	O
anti	O
-	O
tumour	O
chemotherapy	O
.	O

Forty	O
-	O
five	O
patients	O
-	O
18	O
months	O
to	O
18	O
years	O
of	O
life	O
,	O
were	O
included	O
(	O
20	O
-	O
organ	O
recipients	O
,	O
14	O
-	O
anti	O
-	O
tumour	O
chemotherapy	O
,	O
11	O
-	O
control	O
group	O
)	O
.	O

Clinical	O
,	O
oral	O
mucosa	O
examination	O
focused	O
on	O
the	O
type	O
,	O
severity	O
and	O
site	O
of	O
lesions	O
,	O
and	O
microbiology	O
assessed	O
the	O
presence	O
of	O
bacteria	O
and	O
fungi	O
in	O
the	O
material	O
from	O
lesions	O
.	O

Blood	O
cultures	O
were	O
performed	O
in	O
ten	O
immunocompromised	O
patients	O
with	O
manifestations	O
of	O
systemic	O
infection	O
.	O

The	O
control	O
material	O
consisted	O
of	O
blood	O
cultures	O
made	O
prior	O
to	O
the	O
onset	O
of	O
oral	O
lesions	O
and	O
after	O
4	O
-	O
6	O
weeks	O
following	O
their	O
remission	O
in	O
a	O
diagnosed	O
bacteremia	O
.	O

The	O
statistical	O
analysis	O
was	O
performed	O
.	O

In	O
the	O
subjects	O
with	O
secondary	O
immunodeficiency	O
,	O
among	O
other	O
coagulase	B-bacteria
-	I-bacteria
negative	I-bacteria
Staphylococcus	I-bacteria
(	O
CoNS	B-bacteria
)	O
,	O
Candidia	O
spp	O
.	O
were	O
more	O
frequent	O
.	O

In	O
cancer	O
patients	O
,	O
mucositis	O
was	O
associated	O
with	O
Candida	O
spp	O
.	O
,	O
Streptococcus	B-bacteria
spp	I-bacteria
.	O

Organ	O
recipients	O
with	O
stomatitis	O
exhibited	O
the	O
presence	O
of	O
CoNS	B-bacteria
,	O
Streptococcus	B-bacteria
viridians	I-bacteria
and	O
other	O
.	O

Oral	O
lesions	O
in	O
the	O
control	O
group	O
contained	O
Haemophilus	B-bacteria
parainfluenzae	I-bacteria
,	O
Neisseria	B-bacteria
spp	I-bacteria
.	I-bacteria
and	O
Staphylococcus	B-bacteria
aureus	I-bacteria
.	O

In	O
30	O
%	O
of	O
immunocompromised	O
patients	O
,	O
oral	O
lesions	O
were	O
accompanied	O
by	O
bacteremia	O
.	O

A	O
correlation	O
has	O
been	O
found	O
between	O
oral	O
lesions	O
and	O
the	O
presence	O
of	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
in	O
patients	O
without	O
secondary	O
immunodeficiency	O
,	O
and	O
of	O
CoNS	B-bacteria
,	O
Enterococcus	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
Candida	O
spp	O
.	O
in	O
immunocompromised	O
patients	O
.	O

Infants	O
with	O
moderate	O
to	O
severe	O
congenital	O
heart	O
disease	O
(	O
CHD	O
)	O
are	O
at	O
a	O
higher	O
risk	O
for	O
growth	O
failure	O
and	O
malnutrition	O
due	O
to	O
increased	O
metabolic	O
demands	O
and	O
inadequate	O
energy	O
intake	O
.	O

This	O
state	O
requires	O
meals	O
that	O
are	O
more	O
frequent	O
and	O
a	O
special	O
enriched	O
diet	O
,	O
which	O
may	O
have	O
negative	O
implications	O
on	O
oral	O
health	O
.	O

To	O
examine	O
the	O
oral	O
colonisation	O
of	O
some	O
bacteria	O
associated	O
with	O
caries	O
development	O
during	O
infancy	O
;	O
mutans	B-bacteria
streptococci	I-bacteria
(	O
MS	B-bacteria
)	O
and	O
lactobacilli	B-bacteria
(	O
LCB	B-bacteria
)	O
in	O
infants	O
with	O
CHD	O
and	O
whether	O
their	O
dietary	O
intake	O
had	O
an	O
impact	O
on	O
the	O
bacterial	O
levels	O
.	O

This	O
was	O
a	O
prospective	O
case	O
-	O
control	O
study	O
.	O

11	O
infants	O
with	O
CHD	O
and	O
22	O
healthy	O
,	O
age	O
-	O
matched	O
infants	O
were	O
enrolled	O
.	O

Saliva	O
samples	O
and	O
food	O
diaries	O
were	O
collected	O
at	O
6	O
,	O
9	O
,	O
and	O
12	O
months	O
of	O
age	O
.	O

The	O
total	O
viable	O
counts	O
of	O
MS	B-bacteria
and	O
LCB	B-bacteria
in	O
saliva	O
were	O
determined	O
,	O
and	O
energy	O
intake	O
,	O
meal	O
frequency	O
,	O
intake	O
of	O
proteins	O
,	O
fat	O
,	O
carbohydrates	O
and	O
sucrose	O
were	O
calculated	O
.	O

At	O
12	O
months	O
of	O
age	O
,	O
the	O
MS	B-bacteria
count	O
was	O
higher	O
in	O
the	O
CHD	O
group	O
than	O
in	O
the	O
controls	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
,	O
and	O
MS	B-bacteria
constituted	O
a	O
higher	O
ratio	O
of	O
the	O
total	O
viable	O
count	O
of	O
oral	O
bacteria	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O

Meal	O
frequency	O
was	O
higher	O
in	O
the	O
CHD	O
group	O
at	O
6	O
and	O
9	O
months	O
of	O
age	O
than	O
in	O
the	O
controls	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

The	O
intake	O
of	O
sucrose	O
did	O
not	O
differ	O
between	O
the	O
groups	O
,	O
while	O
the	O
total	O
carbohydrate	O
intake	O
was	O
higher	O
in	O
the	O
control	O
group	O
at	O
6	O
and	O
12	O
months	O
of	O
age	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

Compared	O
with	O
the	O
control	O
group	O
,	O
which	O
had	O
six	O
courses	O
of	O
antibiotic	O
administration	O
,	O
the	O
CHD	O
infants	O
had	O
21	O
courses	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

Infants	O
with	O
severe	O
CHD	O
have	O
higher	O
levels	O
of	O
MS	B-bacteria
at	O
12	O
months	O
of	O
age	O
than	O
the	O
healthy	O
controls	O
.	O

A	O
higher	O
meal	O
frequency	O
and	O
use	O
of	O
diuretic	O
medication	O
and	O
antibiotics	O
may	O
have	O
influenced	O
MS	B-bacteria
colonisation	O
.	O

A	O
total	O
of	O
550	O
oral	O
streptococci	B-bacteria
:	O
270	O
Streptococcus	B-bacteria
mitis	I-bacteria
,	O
110	O
Streptococcus	B-bacteria
sanguis	I-bacteria
,	O
90	O
Streptococcus	B-bacteria
anginosus	I-bacteria
,	O
50	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
30	O
Streptococcus	B-bacteria
salivarius	I-bacteria
,	O
were	O
isolated	O
from	O
dental	O
plaque	O
and	O
gengival	O
crevices	O
of	O
patients	O
and	O
tested	O
for	O
their	O
susceptibility	O
to	O
12	O
beta	O
-	O
lactam	O
antibiotics	O
and	O
to	O
5	O
non	O
-	O
beta	O
-	O
lactam	O
antibiotics	O
,	O
using	O
the	O
microdiluition	O
method	O
.	O

Overall	O
,	O
a	O
reduced	O
susceptibility	O
to	O
penicillin	O
was	O
recorded	O
in	O
13	O
.	O
4	O
%	O
of	O
cases	O
.	O

The	O
percentage	O
of	O
strains	O
resistant	O
to	O
penicillin	O
appeared	O
significantly	O
higher	O
in	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
(	O
24	O
%	O
)	O
than	O
in	O
S	B-bacteria
.	I-bacteria
sanguis	I-bacteria
(	O
19	O
%	O
)	O
,	O
in	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
(	O
14	O
%	O
)	O
and	O
in	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
(	O
10	O
%	O
)	O
.	O

No	O
levels	O
of	O
penicillin	O
resistance	O
were	O
shown	O
by	O
90	O
strains	O
of	O
S	B-bacteria
.	I-bacteria
anginosus	I-bacteria
.	O

In	O
susceptibility	O
test	O
to	O
antibiotics	O
,	O
imipenem	O
was	O
the	O
most	O
active	O
molecule	O
tested	O
,	O
confirming	O
its	O
general	O
good	O
activity	O
against	O
oral	O
streptococci	B-bacteria
.	O

Also	O
third	O
generation	O
cephalosporins	O
such	O
as	O
ceftriaxone	O
and	O
fourth	O
generation	O
cephalosporins	O
such	O
as	O
cefepime	O
,	O
showed	O
good	O
activity	O
.	O

Chinolones	O
,	O
glycopeptides	O
and	O
rifampicin	O
confirmed	O
a	O
good	O
activity	O
against	O
oral	O
streptococci	B-bacteria
.	O

To	O
compare	O
the	O
virulence	O
genotype	O
(	O
cagA	O
and	O
vacA	O
ml	O
genes	O
)	O
of	O
Helicobacter	B-bacteria
pylori	I-bacteria
obtained	O
simultaneously	O
from	O
gastric	O
mucosa	O
and	O
oral	O
cavity	O
.	O

Gastric	O
samples	O
of	O
18	O
patients	O
were	O
obtained	O
by	O
endoscopic	O
biopsies	O
.	O

Oral	O
samples	O
of	O
these	O
patients	O
were	O
obtained	O
from	O
dental	O
plaque	O
and	O
saliva	O
swabs	O
from	O
the	O
floor	O
of	O
the	O
mouth	O
and	O
the	O
base	O
of	O
the	O
tongue	O
.	O

All	O
samples	O
were	O
studied	O
by	O
conventional	O
PCR	O
and	O
real	O
-	O
time	O
PCR	O
(	O
RT	O
-	O
PCR	O
)	O
.	O

Virulence	O
genes	O
cagA	O
and	O
vacA	O
ml	O
were	O
studied	O
by	O
RT	O
-	O
PCR	O
.	O

According	O
to	O
presence	O
and	O
/	O
or	O
absence	O
of	O
cagA	O
and	O
vacAm1	O
genes	O
,	O
seven	O
different	O
combinations	O
were	O
observed	O
.	O

These	O
results	O
suggest	O
that	O
there	O
is	O
a	O
variety	O
of	O
genetic	O
profiles	O
of	O
Helicobacter	B-bacteria
pylori	I-bacteria
in	O
the	O
stomach	O
and	O
oral	O
cavity	O
,	O
with	O
a	O
predominance	O
of	O
less	O
virulent	O
genotypes	O
in	O
the	O
patients	O
included	O
in	O
this	O
study	O
(	O
cagA	O
-	O
,	O
vacA	O
m1	O
-	O
)	O
.	O

In	O
the	O
oral	O
cavity	O
,	O
we	O
can	O
find	O
a	O
complex	O
mixture	O
of	O
microorganisms	O
,	O
commensals	O
,	O
and	O
pathogens	O
.	O

The	O
studies	O
of	O
normal	O
oral	O
microbiota	O
,	O
as	O
well	O
as	O
the	O
studies	O
of	O
much	O
oral	O
pathology	O
(	O
e	O
.	O
g	O
.	O
,	O
caries	O
,	O
periodontitis	O
)	O
,	O
involve	O
the	O
isolation	O
and	O
cultivation	O
of	O
these	O
microorganisms	O
and	O
their	O
molecular	O
analysis	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
validate	O
a	O
quick	O
,	O
easy	O
,	O
efficient	O
,	O
and	O
inexpensive	O
DNA	O
extraction	O
method	O
for	O
the	O
recovery	O
of	O
genomic	O
DNA	O
from	O
gram	O
-	O
positive	O
and	O
gram	O
-	O
negative	O
oral	O
bacteria	O
to	O
be	O
used	O
in	O
polymerase	O
chain	O
reaction	O
amplification	O
.	O

This	O
method	O
worked	O
great	O
with	O
all	O
samples	O
analyzed	O
,	O
providing	O
an	O
approach	O
to	O
extract	O
DNA	O
for	O
different	O
microorganisms	O
.	O

Streptococcus	B-bacteria
mutans	I-bacteria
(	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
)	O
is	O
the	O
prime	O
pathogen	O
of	O
dental	O
caries	O
.	O

There	O
are	O
few	O
reports	O
that	O
studied	O
the	O
relationship	O
between	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
bacteria	O
and	O
dental	O
caries	O
in	O
permanent	O
teeth	O
when	O
compared	O
to	O
those	O
in	O
primary	O
teeth	O
.	O

This	O
study	O
aimed	O
to	O
detect	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
bacteria	O
of	O
dental	O
caries	O
and	O
non	O
-	O
caries	O
groups	O
in	O
permanent	O
teeth	O
from	O
a	O
north	O
China	O
population	O
by	O
real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
and	O
compare	O
the	O
relationship	O
between	O
the	O
number	O
of	O
these	O
bacteria	O
and	O
the	O
prevalence	O
of	O
dental	O
caries	O
in	O
permanent	O
teeth	O
.	O

Human	O
saliva	O
samples	O
were	O
collected	O
from	O
142	O
subjects	O
with	O
permanent	O
teeth	O
.	O

According	O
to	O
their	O
dental	O
tooth	O
(	O
DT	O
)	O
,	O
142	O
subjects	O
were	O
divided	O
into	O
a	O
dental	O
caries	O
group	O
(	O
DT	O
>	O
/	O
=	O
1	O
)	O
and	O
a	O
non	O
-	O
caries	O
group	O
(	O
DT	O
=	O
0	O
)	O
.	O

With	O
specific	O
primers	O
for	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
16S	O
rRNA	O
,	O
the	O
total	O
number	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
total	O
bacteria	O
of	O
142	O
saliva	O
samples	O
were	O
detected	O
by	O
real	O
-	O
time	O
PCR	O
and	O
statistically	O
analyzed	O
.	O

There	O
was	O
no	O
significant	O
difference	O
between	O
the	O
detection	O
rates	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
(	O
P	O
=	O
0	O
.	O
118	O
)	O
and	O
medians	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
(	O
P	O
=	O
0	O
.	O
115	O
)	O
.	O

The	O
ratio	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
to	O
total	O
bacteria	O
in	O
people	O
with	O
dental	O
caries	O
was	O
significantly	O
higher	O
than	O
in	O
those	O
without	O
caries	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
,	O
but	O
the	O
total	O
number	O
of	O
bacteria	O
in	O
people	O
with	O
dental	O
caries	O
was	O
significantly	O
lower	O
than	O
in	O
those	O
without	O
caries	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
.	O

S	B-bacteria
.	I-bacteria
mutans	I-bacteria
had	O
different	O
effects	O
on	O
caries	O
in	O
the	O
permanent	O
teeth	O
of	O
several	O
individuals	O
from	O
a	O
north	O
China	O
population	O
.	O

The	O
ratios	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
to	O
total	O
bacteria	O
in	O
saliva	O
detected	O
by	O
real	O
-	O
time	O
PCR	O
with	O
Sm479F	O
/	O
R	O
and	O
16S	O
RNA	O
primers	O
were	O
closely	O
associated	O
with	O
the	O
prevalence	O
of	O
dental	O
caries	O
in	O
the	O
same	O
population	O
.	O

These	O
assays	O
may	O
be	O
useful	O
for	O
the	O
assessment	O
of	O
an	O
individual	O
'	O
s	O
risk	O
of	O
dental	O
caries	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
determine	O
whether	O
measurements	O
of	O
volatile	O
sulfur	O
compounds	O
(	O
VSCs	O
)	O
are	O
useful	O
to	O
predict	O
colonization	O
of	O
periodontopathic	O
bacteria	O
.	O

For	O
this	O
purpose	O
,	O
we	O
assessed	O
the	O
relationships	O
among	O
distributions	O
of	O
4	O
species	O
of	O
periodontopathic	O
bacteria	O
in	O
tongue	O
coating	O
and	O
dental	O
plaque	O
,	O
oral	O
conditions	O
including	O
VSC	O
concentration	O
in	O
mouth	O
air	O
,	O
and	O
smoking	O
habit	O
of	O
periodontal	O
healthy	O
young	O
subjects	O
.	O

The	O
subjects	O
were	O
108	O
young	O
adults	O
(	O
mean	O
age	O
,	O
23	O
.	O
5	O
+	O
/	O
-	O
2	O
.	O
56	O
years	O
)	O
without	O
clinical	O
periodontal	O
pockets	O
.	O

Information	O
regarding	O
smoking	O
habit	O
was	O
obtained	O
by	O
interview	O
.	O

After	O
VSC	O
concentration	O
in	O
mouth	O
,	O
air	O
was	O
measured	O
with	O
a	O
portable	O
sulfide	O
monitor	O
(	O
Halimeter	O
(	O
(	O
R	O
)	O
)	O
)	O
,	O
non	O
-	O
stimulated	O
saliva	O
flow	O
and	O
dental	O
caries	O
status	O
were	O
assessed	O
,	O
and	O
tongue	O
coating	O
and	O
dental	O
plaque	O
samples	O
were	O
collected	O
from	O
the	O
subjects	O
.	O

The	O
tongue	O
coating	O
samples	O
were	O
weighed	O
to	O
determine	O
the	O
amount	O
.	O

The	O
colonization	O
of	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
and	O
Treponema	B-bacteria
denticola	I-bacteria
in	O
both	O
tongue	O
coating	O
and	O
plaque	O
samples	O
was	O
investigated	O
using	O
species	O
-	O
specific	O
polymerase	O
chain	O
reaction	O
assays	O
.	O

Significant	O
relationships	O
were	O
observed	O
between	O
the	O
colonization	O
of	O
periodontopathic	O
bacteria	O
in	O
tongue	O
coating	O
and	O
plaque	O
samples	O
,	O
especially	O
that	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
.	O

VSC	O
concentration	O
showed	O
the	O
most	O
significant	O
association	O
with	O
colonization	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
in	O
both	O
tongue	O
coating	O
and	O
dental	O
plaque	O
.	O

Logistic	O
regression	O
analysis	O
demonstrated	O
that	O
the	O
adjusted	O
partial	O
correlation	O
coefficient	O
[	O
Exp	O
(	O
B	O
)	O
]	O
values	O
for	O
VSC	O
concentration	O
with	O
the	O
colonization	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
,	O
and	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
in	O
dental	O
plaque	O
were	O
135	O
,	O
35	O
.	O
4	O
and	O
10	O
.	O
4	O
,	O
respectively	O
.	O

In	O
addition	O
,	O
smoking	O
habit	O
was	O
also	O
shown	O
to	O
be	O
a	O
significant	O
variable	O
in	O
regression	O
models	O
[	O
Exp	O
(	O
B	O
)	O
=	O
6	O
.	O
19	O
,	O
8	O
.	O
92	O
and	O
2	O
.	O
53	O
,	O
respectively	O
]	O
.	O

Therefore	O
,	O
receiver	O
operating	O
characteristic	O
analysis	O
was	O
performed	O
to	O
predict	O
the	O
colonization	O
of	O
periodontal	O
bacteria	O
in	O
dental	O
plaque	O
in	O
the	O
subjects	O
divided	O
by	O
smoking	O
habit	O
.	O

Based	O
on	O
our	O
results	O
,	O
we	O
found	O
cut	O
-	O
off	O
values	O
that	O
indicated	O
likelihood	O
ratios	O
(	O
LR	O
)	O
within	O
the	O
efficient	O
range	O
for	O
positive	O
findings	O
in	O
both	O
groups	O
.	O

The	O
present	O
results	O
demonstrated	O
that	O
measurement	O
of	O
VSC	O
concentration	O
in	O
mouth	O
air	O
is	O
a	O
useful	O
method	O
to	O
predict	O
the	O
presence	O
of	O
colonization	O
of	O
some	O
periodontopathic	O
bacteria	O
in	O
dental	O
plaque	O
.	O

Numerous	O
publications	O
have	O
reported	O
the	O
presence	O
of	O
periodontopathogenic	O
bacteria	O
in	O
peripheral	O
and	O
central	O
vascular	O
lesions	O
.	O

However	O
,	O
it	O
is	O
unclear	O
how	O
this	O
bacterial	O
translocation	O
occurs	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
investigate	O
whether	O
periodontopathic	O
bacteria	O
are	O
translocated	O
to	O
lymph	O
nodes	O
proximal	O
to	O
the	O
oral	O
cavity	O
.	O

Obtaining	O
lymph	O
node	O
samples	O
is	O
not	O
ethically	O
feasible	O
unless	O
they	O
are	O
excised	O
as	O
part	O
of	O
the	O
surgical	O
management	O
of	O
patients	O
with	O
cancer	O
.	O

This	O
study	O
analyzed	O
formalin	O
-	O
fixed	O
and	O
paraffin	O
-	O
embedded	O
lymph	O
nodes	O
,	O
histologically	O
negative	O
for	O
cancer	O
cell	O
invasion	O
,	O
that	O
were	O
excised	O
from	O
66	O
patients	O
with	O
histories	O
of	O
head	O
and	O
neck	O
cancer	O
.	O

Real	O
-	O
time	O
PCR	O
was	O
performed	O
to	O
amplify	O
the	O
16S	O
ribosomal	O
DNA	O
fragments	O
from	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Treponema	B-bacteria
denticola	I-bacteria
,	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
,	O
and	O
Prevotella	B-bacteria
intermedia	I-bacteria
.	O

The	O
relationship	O
between	O
bacterial	O
detection	O
and	O
cancer	O
severity	O
,	O
gender	O
,	O
and	O
the	O
use	O
of	O
anti	O
-	O
cancer	O
therapy	O
was	O
examined	O
by	O
Fisher	O
'	O
s	O
exact	O
test	O
.	O

P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
T	B-bacteria
.	I-bacteria
forsythia	I-bacteria
,	O
and	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
were	O
present	O
in	O
17	O
%	O
,	O
8	O
%	O
,	O
and	O
8	O
%	O
of	O
the	O
samples	O
of	O
submandibular	O
and	O
submental	O
lymph	O
nodes	O
,	O
respectively	O
.	O

There	O
were	O
no	O
significant	O
relationships	O
between	O
bacterial	O
detection	O
and	O
the	O
cancer	O
disease	O
status	O
,	O
patient	O
gender	O
or	O
use	O
of	O
anticancer	O
therapy	O
.	O

According	O
to	O
these	O
data	O
,	O
it	O
appears	O
that	O
the	O
translocation	O
of	O
periodontopathic	O
bacteria	O
may	O
occur	O
via	O
lymphatic	O
drainage	O
,	O
irrespective	O
of	O
the	O
cancer	O
disease	O
status	O
,	O
gender	O
or	O
anticancer	O
therapy	O
.	O

We	O
aim	O
to	O
develop	O
antibacterial	O
peptide	O
mimics	O
resistant	O
to	O
protease	O
degradation	O
,	O
with	O
broad	O
-	O
spectrum	O
activity	O
at	O
sites	O
of	O
infection	O
.	O

The	O
bactericidal	O
activities	O
of	O
LL	O
-	O
37	O
,	O
ceragenins	O
CSA	O
-	O
13	O
,	O
CSA	O
-	O
90	O
and	O
CSA	O
-	O
92	O
and	O
the	O
spermine	O
-	O
conjugated	O
dexamethasone	O
derivative	O
D2S	O
were	O
evaluated	O
using	O
MIC	O
and	O
MBC	O
measurements	O
.	O

Gingival	O
fibroblast	O
counting	O
,	O
interleukin	O
-	O
8	O
(	O
IL	O
-	O
8	O
)	O
and	O
lactate	O
dehydrogenase	O
(	O
LDH	O
)	O
release	O
from	O
keratinocytes	O
(	O
HaCat	O
)	O
were	O
used	O
to	O
determine	O
effects	O
on	O
cell	O
growth	O
,	O
pro	O
-	O
inflammatory	O
response	O
and	O
toxicity	O
.	O

All	O
tested	O
cationic	O
lipids	O
showed	O
stronger	O
bactericidal	O
activity	O
than	O
LL	O
-	O
37	O
.	O

Incubation	O
of	O
Staphylococcus	B-bacteria
aureus	I-bacteria
with	O
half	O
the	O
MIC	O
of	O
LL	O
-	O
37	O
led	O
to	O
the	O
appearance	O
of	O
bacteria	O
resistant	O
to	O
its	O
bactericidal	O
effects	O
,	O
but	O
identical	O
incubations	O
with	O
CSA	O
-	O
13	O
or	O
D2S	O
did	O
not	O
produce	O
resistant	O
bacteria	O
.	O

Cathelicidin	O
LL	O
-	O
37	O
significantly	O
increased	O
the	O
total	O
number	O
of	O
gingival	O
fibroblasts	O
,	O
but	O
ceragenins	O
and	O
D2S	O
did	O
not	O
alter	O
gingival	O
fibroblast	O
growth	O
.	O

Cationic	O
lipids	O
showed	O
no	O
toxicity	O
to	O
HaCat	O
cells	O
at	O
concentrations	O
resulting	O
in	O
bacterial	O
killing	O
.	O

These	O
data	O
suggest	O
that	O
cationic	O
lipids	O
such	O
as	O
ceragenins	O
warrant	O
further	O
testing	O
as	O
potential	O
novel	O
antibacterial	O
agents	O
.	O

Beta	O
-	O
lactam	O
antibiotics	O
prescribed	O
in	O
periodontal	O
therapy	O
are	O
vulnerable	O
to	O
degradation	O
by	O
bacterial	O
beta	O
-	O
lactamases	O
.	O

This	O
study	O
evaluated	O
the	O
occurrence	O
of	O
beta	O
-	O
lactamase	O
-	O
positive	O
subgingival	O
bacteria	O
in	O
chronic	O
periodontitis	O
subjects	O
of	O
USA	O
origin	O
,	O
and	O
assessed	O
their	O
in	O
vitro	O
resistance	O
to	O
metronidazole	O
at	O
a	O
breakpoint	O
concentration	O
of	O
4	O
mug	O
/	O
mL	O
.	O

Subgingival	O
plaque	O
specimens	O
from	O
deep	O
periodontal	O
pockets	O
with	O
bleeding	O
on	O
probing	O
were	O
removed	O
from	O
564	O
adults	O
with	O
severe	O
chronic	O
periodontitis	O
before	O
treatment	O
.	O

The	O
samples	O
were	O
transported	O
in	O
VMGA	O
III	O
and	O
then	O
plated	O
onto	O
:	O
(	O
i	O
)	O
nonselective	O
enriched	O
Brucella	B-bacteria
blood	O
agar	O
(	O
EBBA	O
)	O
and	O
incubated	O
anaerobically	O
for	O
7	O
d	O
;	O
and	O
(	O
ii	O
)	O
selective	O
trypticase	O
soy	O
-	O
bacitracin	O
-	O
vancomycin	O
(	O
TSBV	O
)	O
and	O
incubated	O
for	O
3	O
d	O
in	O
air	O
+	O
5	O
%	O
CO2	O
.	O

At	O
the	O
end	O
of	O
the	O
incubation	O
periods	O
,	O
the	O
bacterial	O
test	O
species	O
were	O
identified	O
and	O
quantified	O
.	O

Specimen	O
dilutions	O
were	O
also	O
plated	O
onto	O
EBBA	O
plates	O
supplemented	O
with	O
2	O
mug	O
/	O
mL	O
of	O
amoxicillin	O
,	O
a	O
combination	O
of	O
2	O
mug	O
/	O
mL	O
of	O
amoxicillin	O
plus	O
2	O
mug	O
/	O
mL	O
of	O
the	O
beta	O
-	O
lactamase	O
inhibitor	O
clavulanic	O
acid	O
,	O
or	O
4	O
mug	O
/	O
mL	O
of	O
metronidazole	O
,	O
followed	O
by	O
anaerobic	O
incubation	O
for	O
7	O
d	O
.	O
Bacterial	O
test	O
species	O
presumptively	O
positive	O
for	O
beta	O
-	O
lactamase	O
production	O
were	O
identified	O
by	O
growth	O
on	O
EBBA	O
primary	O
isolation	O
plates	O
supplemented	O
with	O
amoxicillin	O
alone	O
and	O
no	O
growth	O
on	O
EBBA	O
primary	O
isolation	O
plates	O
containing	O
both	O
amoxicillin	O
plus	O
clavulanic	O
acid	O
.	O

A	O
subset	O
of	O
such	O
isolates	O
was	O
subjected	O
to	O
nitrocefin	O
-	O
based	O
chromogenic	O
disk	O
testing	O
to	O
confirm	O
the	O
presence	O
of	O
beta	O
-	O
lactamase	O
activity	O
.	O

In	O
vitro	O
resistance	O
to	O
4	O
mug	O
/	O
mL	O
of	O
metronidazole	O
was	O
noted	O
when	O
growth	O
of	O
test	O
species	O
occurred	O
on	O
metronidazole	O
-	O
supplemented	O
EBBA	O
culture	O
plates	O
.	O

Two	O
-	O
hundred	O
and	O
ninety	O
-	O
four	O
(	O
52	O
.	O
1	O
%	O
)	O
of	O
the	O
study	O
subjects	O
yielded	O
beta	O
-	O
lactamase	O
-	O
producing	O
subgingival	O
bacterial	O
test	O
species	O
,	O
with	O
Prevotella	B-bacteria
intermedia	I-bacteria
/	I-bacteria
nigrescens	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
and	O
other	O
Prevotella	B-bacteria
species	I-bacteria
most	O
frequently	O
identified	O
as	O
beta	O
-	O
lactamase	O
-	O
producing	O
organisms	O
.	O

Of	O
the	O
beta	O
-	O
lactamase	O
-	O
producing	O
bacterial	O
test	O
species	O
strains	O
recovered	O
,	O
98	O
.	O
9	O
%	O
were	O
susceptible	O
in	O
vitro	O
to	O
metronidazole	O
at	O
4	O
mug	O
/	O
mL	O
.	O

The	O
occurrence	O
of	O
beta	O
-	O
lactamase	O
-	O
positive	O
subgingival	O
bacterial	O
species	O
in	O
more	O
than	O
half	O
of	O
the	O
subjects	O
with	O
severe	O
chronic	O
periodontitis	O
raises	O
questions	O
about	O
the	O
therapeutic	O
potential	O
of	O
single	O
-	O
drug	O
regimens	O
with	O
beta	O
-	O
lactam	O
antibiotics	O
in	O
periodontal	O
therapy	O
.	O

The	O
in	O
vitro	O
effectiveness	O
of	O
metronidazole	O
against	O
nearly	O
all	O
recovered	O
beta	O
-	O
lactamase	O
-	O
producing	O
subgingival	O
bacterial	O
species	O
further	O
supports	O
clinical	O
periodontitis	O
treatment	O
strategies	O
involving	O
the	O
combination	O
of	O
systemic	O
amoxicillin	O
plus	O
metronidazole	O
.	O

Circulating	O
nitrate	O
(	O
NO	O
(	O
3	O
)	O
(	O
-	O
)	O
)	O
,	O
derived	O
from	O
dietary	O
sources	O
or	O
endogenous	O
nitric	O
oxide	O
production	O
,	O
is	O
extracted	O
from	O
blood	O
by	O
the	O
salivary	O
glands	O
,	O
accumulates	O
in	O
saliva	O
,	O
and	O
is	O
then	O
reduced	O
to	O
nitrite	O
(	O
NO	O
(	O
2	O
)	O
(	O
-	O
)	O
)	O
by	O
the	O
oral	O
microflora	O
.	O

This	O
process	O
has	O
historically	O
been	O
viewed	O
as	O
harmful	O
,	O
because	O
nitrite	O
can	O
promote	O
formation	O
of	O
potentially	O
carcinogenic	O
N	O
-	O
nitrosamines	O
.	O

More	O
recent	O
research	O
,	O
however	O
,	O
suggests	O
that	O
nitrite	O
can	O
also	O
serve	O
as	O
a	O
precursor	O
for	O
systemic	O
generation	O
of	O
vasodilatory	O
nitric	O
oxide	O
,	O
and	O
exogenous	O
administration	O
of	O
nitrate	O
reduces	O
blood	O
pressure	O
in	O
humans	O
.	O

However	O
,	O
whether	O
oral	O
nitrate	O
-	O
reducing	O
bacteria	O
participate	O
in	O
`	O
`	O
setting	O
'	O
'	O
blood	O
pressure	O
is	O
unknown	O
.	O

We	O
investigated	O
whether	O
suppression	O
of	O
the	O
oral	O
microflora	O
affects	O
systemic	O
nitrite	O
levels	O
and	O
hence	O
blood	O
pressure	O
in	O
healthy	O
individuals	O
.	O

We	O
measured	O
blood	O
pressure	O
(	O
clinic	O
,	O
home	O
,	O
and	O
24	O
-	O
h	O
ambulatory	O
)	O
in	O
19	O
healthy	O
volunteers	O
during	O
an	O
initial	O
7	O
-	O
day	O
control	O
period	O
followed	O
by	O
a	O
7	O
-	O
day	O
treatment	O
period	O
with	O
a	O
chlorhexidine	O
-	O
based	O
antiseptic	O
mouthwash	O
.	O

Oral	O
nitrate	O
-	O
reducing	O
capacity	O
and	O
nitrite	O
levels	O
were	O
measured	O
after	O
each	O
study	O
period	O
.	O

Antiseptic	O
mouthwash	O
treatment	O
reduced	O
oral	O
nitrite	O
production	O
by	O
90	O
%	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
plasma	O
nitrite	O
levels	O
by	O
25	O
%	O
(	O
p	O
=	O
0	O
.	O
001	O
)	O
compared	O
to	O
the	O
control	O
period	O
.	O

Systolic	O
and	O
diastolic	O
blood	O
pressure	O
increased	O
by	O
2	O
-	O
3	O
.	O
5mmHg	O
,	O
increases	O
correlated	O
to	O
a	O
decrease	O
in	O
circulating	O
nitrite	O
concentrations	O
(	O
r	O
(	O
2	O
)	O
=	O
0	O
.	O
56	O
,	O
p	O
=	O
0	O
.	O
002	O
)	O
.	O

The	O
blood	O
pressure	O
effect	O
appeared	O
within	O
1	O
day	O
of	O
disruption	O
of	O
the	O
oral	O
microflora	O
and	O
was	O
sustained	O
during	O
the	O
7	O
-	O
day	O
mouthwash	O
intervention	O
.	O

These	O
results	O
suggest	O
that	O
the	O
recycling	O
of	O
endogenous	O
nitrate	O
by	O
oral	O
bacteria	O
plays	O
an	O
important	O
role	O
in	O
determination	O
of	O
plasma	O
nitrite	O
levels	O
and	O
thereby	O
in	O
the	O
physiological	O
control	O
of	O
blood	O
pressure	O
.	O

The	O
human	O
mouth	O
harbours	O
one	O
of	O
the	O
most	O
diverse	O
microbiomes	O
in	O
the	O
human	O
body	O
,	O
including	O
viruses	O
,	O
fungi	O
,	O
protozoa	O
,	O
archaea	O
and	O
bacteria	O
.	O

The	O
bacteria	O
are	O
responsible	O
for	O
the	O
two	O
commonest	O
bacterial	O
diseases	O
of	O
man	O
:	O
dental	O
caries	O
(	O
tooth	O
decay	O
)	O
and	O
the	O
periodontal	O
(	O
gum	O
)	O
diseases	O
.	O

Archaea	O
are	O
restricted	O
to	O
a	O
small	O
number	O
of	O
species	O
of	O
methanogens	O
while	O
around	O
1000	O
bacterial	O
species	O
have	O
been	O
found	O
,	O
with	O
representatives	O
from	O
the	O
phyla	O
Actinobacteria	B-bacteria
,	O
Bacteroidetes	B-bacteria
,	O
Firmicutes	B-bacteria
,	O
Proteobacteria	B-bacteria
,	O
Spirochaetes	B-bacteria
,	O
Synergistetes	B-bacteria
and	O
Tenericutes	B-bacteria
and	O
the	O
uncultured	O
divisions	O
GN02	B-bacteria
,	O
SR1	B-bacteria
and	O
TM7	B-bacteria
.	O

Around	O
half	O
of	O
oral	O
bacteria	O
are	O
as	O
yet	O
uncultured	O
and	O
culture	O
-	O
independent	O
methods	O
have	O
been	O
successfully	O
used	O
to	O
comprehensively	O
describe	O
the	O
oral	O
bacterial	O
community	O
.	O

The	O
human	O
oral	O
microbiome	O
database	O
(	O
HOMD	O
,	O
www	O
.	O
homd	O
.	O
org	O
)	O
provides	O
a	O
comprehensive	O
resource	O
consisting	O
of	O
descriptions	O
of	O
oral	O
bacterial	O
taxa	O
,	O
a	O
16S	O
rRNA	O
identification	O
tool	O
and	O
a	O
repository	O
of	O
oral	O
bacterial	O
genome	O
sequences	O
.	O

Individuals	O
'	O
oral	O
microbiomes	O
are	O
highly	O
specific	O
at	O
the	O
species	O
level	O
,	O
although	O
overall	O
the	O
human	O
oral	O
microbiome	O
shows	O
few	O
geographical	O
differences	O
.	O

Although	O
caries	O
and	O
periodontitis	O
are	O
clearly	O
bacterial	O
diseases	O
,	O
they	O
are	O
not	O
infectious	O
diseases	O
in	O
the	O
classical	O
sense	O
because	O
they	O
result	O
from	O
a	O
complex	O
interaction	O
between	O
the	O
commensal	O
microbiota	O
,	O
host	O
susceptibility	O
and	O
environmental	O
factors	O
such	O
as	O
diet	O
and	O
smoking	O
.	O

Periodontitis	O
,	O
in	O
particular	O
,	O
appears	O
to	O
result	O
from	O
an	O
inappropriate	O
inflammatory	O
reaction	O
to	O
the	O
normal	O
microbiota	O
,	O
exacerbated	O
by	O
the	O
presence	O
of	O
some	O
disease	O
-	O
associated	O
bacterial	O
species	O
.	O

In	O
functional	O
terms	O
,	O
there	O
appears	O
to	O
considerable	O
redundancy	O
among	O
the	O
oral	O
microbiota	O
and	O
a	O
focus	O
on	O
functional	O
rather	O
than	O
phylogenetic	O
diversity	O
may	O
be	O
required	O
in	O
order	O
to	O
fully	O
understand	O
host	O
-	O
microbiome	O
interactions	O
.	O

Lactic	B-bacteria
acid	I-bacteria
bacteria	I-bacteria
(	O
LAB	B-bacteria
)	O
have	O
become	O
increasingly	O
studied	O
over	O
the	O
last	O
two	O
decades	O
as	O
potential	O
delivery	O
systems	O
for	O
various	O
biological	O
molecules	O
to	O
the	O
gastrointestinal	O
tract	O
.	O

This	O
article	O
presents	O
an	O
overview	O
of	O
characteristics	O
of	O
LAB	B-bacteria
as	O
delivery	O
systems	O
and	O
of	O
the	O
applications	O
which	O
have	O
already	O
been	O
developed	O
.	O

The	O
majority	O
of	O
LAB	B-bacteria
strains	I-bacteria
are	O
able	O
to	O
survive	O
the	O
intestinal	O
passage	O
and	O
some	O
are	O
also	O
able	O
to	O
persist	O
and	O
colonize	O
the	O
intestine	O
.	O

Several	O
strains	O
were	O
in	O
fact	O
described	O
as	O
members	O
of	O
the	O
human	O
commensal	O
flora	O
.	O

They	O
can	O
interact	O
with	O
their	O
host	O
and	O
are	O
able	O
to	O
deliver	O
large	O
molecular	O
weight	O
biomolecules	O
across	O
the	O
epithelium	O
via	O
M	O
-	O
cells	O
or	O
dendritic	O
cells	O
.	O

The	O
most	O
widely	O
applied	O
LAB	B-bacteria
species	I-bacteria
has	O
been	O
Lactococcus	B-bacteria
lactis	I-bacteria
;	O
however	O
species	O
from	O
genus	O
Lactobacillus	B-bacteria
are	O
gaining	O
popularity	O
and	O
the	O
first	O
examples	O
from	O
genus	O
Bifidobacterium	B-bacteria
are	O
starting	O
to	O
emerge	O
.	O

Bacteria	O
are	O
mostly	O
applied	O
live	O
and	O
enable	O
continuous	O
delivery	O
of	O
the	O
biomolecules	O
.	O

However	O
,	O
killed	O
bacteria	O
(	O
e	O
.	O
g	O
.	O
gram	O
-	O
positive	O
enhancer	O
matrix	O
)	O
,	O
with	O
bound	O
biomolecules	O
or	O
as	O
adjuvants	O
,	O
are	O
also	O
being	O
developed	O
.	O

The	O
techniques	O
for	O
genetic	O
modification	O
of	O
LAB	B-bacteria
are	O
well	O
known	O
.	O

This	O
review	O
focuses	O
on	O
the	O
delivery	O
of	O
recombinant	O
proteins	O
and	O
DNA	O
,	O
which	O
can	O
cause	O
either	O
local	O
or	O
systemic	O
effects	O
.	O

We	O
divide	O
recombinant	O
proteins	O
into	O
antigens	O
and	O
therapeutic	O
proteins	O
.	O

Delivery	O
of	O
antigens	O
for	O
the	O
purpose	O
of	O
vaccination	O
represents	O
the	O
most	O
abundant	O
application	O
with	O
numerous	O
successful	O
demonstrations	O
of	O
the	O
efficacy	O
on	O
the	O
animal	O
model	O
.	O

Therapeutic	O
proteins	O
have	O
mostly	O
been	O
developed	O
for	O
the	O
treatment	O
of	O
the	O
inflammatory	O
bowel	O
disease	O
,	O
by	O
the	O
delivery	O
of	O
anti	O
-	O
inflammatory	O
cytokines	O
,	O
or	O
downregulation	O
of	O
proinflammatory	O
cytokines	O
.	O

Delivery	O
of	O
allergens	O
for	O
the	O
modulation	O
of	O
allergic	O
disorders	O
represents	O
the	O
second	O
most	O
popular	O
application	O
of	O
therapeutic	O
proteins	O
.	O

The	O
delivery	O
of	O
DNA	O
by	O
LAB	B-bacteria
was	O
demonstrated	O
and	O
offers	O
exciting	O
opportunities	O
,	O
especially	O
as	O
a	O
vaccine	O
.	O

New	O
discoveries	O
may	O
eventually	O
lead	O
to	O
the	O
transition	O
of	O
LAB	B-bacteria
as	O
delivery	O
systems	O
in	O
clinical	O
practice	O
.	O

Efficient	O
characterization	O
of	O
the	O
canine	O
oral	O
microbiome	O
is	O
critical	O
for	O
understanding	O
the	O
role	O
of	O
oral	O
bacteria	O
in	O
health	O
and	O
for	O
providing	O
insight	O
into	O
early	O
diagnosis	O
and	O
treatment	O
strategies	O
against	O
periodontal	O
disease	O
.	O

To	O
date	O
,	O
characterization	O
has	O
been	O
limited	O
to	O
cloning	O
-	O
based	O
sequencing	O
and	O
conventional	O
culture	O
-	O
based	O
studies	O
,	O
which	O
generally	O
underestimate	O
community	O
diversity	O
as	O
a	O
result	O
of	O
inherent	O
biases	O
in	O
their	O
methodologies	O
.	O

Pyrosequencing	O
,	O
a	O
cloning	O
-	O
and	O
culture	O
-	O
independent	O
sequencing	O
approach	O
,	O
eliminates	O
these	O
elements	O
of	O
bias	O
from	O
the	O
analysis	O
and	O
enables	O
extensive	O
sequencing	O
of	O
microbial	O
populations	O
.	O

In	O
this	O
report	O
,	O
pyrosequencing	O
of	O
the	O
16S	O
rRNA	O
gene	O
was	O
used	O
to	O
examine	O
oral	O
samples	O
from	O
six	O
healthy	O
dogs	O
in	O
an	O
effort	O
to	O
determine	O
community	O
membership	O
,	O
diversity	O
,	O
and	O
zoonotic	O
implications	O
.	O

Pyrosequencing	O
revealed	O
a	O
mean	O
(	O
SD	O
)	O
of	O
226	O
(	O
59	O
)	O
operational	O
taxonomic	O
units	O
(	O
OTUs	O
,	O
97	O
%	O
similarity	O
)	O
,	O
representing	O
181	O
genera	O
from	O
13	O
bacterial	O
phyla	O
.	O

The	O
phyla	O
Bacteroidetes	B-bacteria
(	O
60	O
.	O
2	O
%	O
)	O
,	O
Proteobacteria	B-bacteria
(	O
20	O
.	O
8	O
%	O
)	O
,	O
Firmicutes	B-bacteria
(	O
11	O
.	O
4	O
%	O
)	O
,	O
Fusobacteria	B-bacteria
(	O
4	O
.	O
7	O
%	O
)	O
,	O
and	O
Spirochaetes	B-bacteria
(	O
1	O
.	O
7	O
%	O
)	O
predominated	O
.	O

The	O
most	O
commonly	O
identified	O
genera	O
were	O
Porphyromonas	B-bacteria
(	O
39	O
.	O
2	O
%	O
of	O
sequences	O
)	O
,	O
Fusobacterium	B-bacteria
(	O
4	O
.	O
5	O
%	O
)	O
,	O
Capnocytophaga	B-bacteria
(	O
3	O
.	O
8	O
%	O
)	O
,	O
Derxia	B-bacteria
(	O
3	O
.	O
7	O
%	O
)	O
,	O
Moraxella	B-bacteria
(	O
3	O
.	O
3	O
%	O
)	O
,	O
and	O
Bergeyella	B-bacteria
(	O
2	O
.	O
7	O
%	O
)	O
.	O

Fifty	O
-	O
six	O
OTUs	O
,	O
corresponding	O
to	O
38	O
unique	O
genus	O
-	O
level	O
identifications	O
,	O
were	O
present	O
in	O
all	O
samples	O
,	O
which	O
supports	O
the	O
concept	O
of	O
a	O
stable	O
core	O
microbiome	O
existing	O
between	O
healthy	O
dogs	O
.	O

Potentially	O
zoonotic	O
and	O
periodontal	O
bacteria	O
were	O
detected	O
in	O
all	O
dogs	O
,	O
and	O
highlights	O
the	O
zoonotic	O
and	O
disease	O
potential	O
of	O
the	O
oral	O
microflora	O
.	O

Results	O
suggest	O
that	O
the	O
canine	O
oral	O
cavity	O
harbors	O
a	O
rich	O
and	O
diverse	O
bacterial	O
community	O
,	O
and	O
exceeds	O
estimates	O
by	O
previous	O
culture	O
-	O
and	O
cloning	O
-	O
based	O
studies	O
.	O

Children	O
born	O
extremely	O
preterm	O
often	O
suffer	O
from	O
medical	O
complications	O
that	O
have	O
been	O
shown	O
to	O
affect	O
their	O
oral	O
health	O
as	O
toddlers	O
and	O
school	O
children	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
oral	O
health	O
and	O
possible	O
risk	O
indicators	O
for	O
poor	O
oral	O
health	O
in	O
adolescents	O
born	O
extremely	O
preterm	O
compared	O
with	O
a	O
control	O
group	O
and	O
relate	O
the	O
findings	O
to	O
medical	O
diagnoses	O
at	O
the	O
clinical	O
examination	O
.	O

Also	O
in	O
the	O
same	O
groups	O
,	O
compare	O
the	O
frequency	O
of	O
mineralization	O
disturbances	O
and	O
its	O
relation	O
to	O
postnatal	O
morbidity	O
and	O
treatments	O
.	O

The	O
medical	O
records	O
postnatally	O
,	O
was	O
noted	O
in	O
45	O
extremely	O
preterm	O
infants	O
with	O
a	O
gestational	O
age	O
(	O
GA	O
)	O
of	O
<	O
29	O
weeks	O
,	O
at	O
12	O
-	O
16	O
years	O
of	O
age	O
and	O
in	O
age	O
and	O
gender	O
matched	O
fullterm	O
controls	O
with	O
37	O
-	O
43	O
weeks	O
GA	O
.	O

A	O
dental	O
clinical	O
examination	O
was	O
performed	O
including	O
a	O
salivary	O
examination	O
.	O

Medical	O
diagnoses	O
were	O
noted	O
at	O
the	O
time	O
of	O
the	O
survey	O
.	O

Data	O
from	O
the	O
patient	O
dental	O
records	O
at	O
3	O
,	O
6	O
,	O
and	O
9	O
years	O
of	O
age	O
was	O
compiled	O
.	O

The	O
findings	O
were	O
related	O
to	O
gestational	O
age	O
,	O
birth	O
weight	O
,	O
neonatal	O
and	O
postnatal	O
medical	O
diagnoses	O
treatments	O
and	O
medical	O
diagnoses	O
at	O
the	O
clinical	O
examination	O
.	O

The	O
result	O
showed	O
that	O
the	O
prevalence	O
of	O
plaque	O
,	O
gingivitis	O
and	O
the	O
occurrence	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
were	O
higher	O
among	O
adolescents	O
born	O
extremely	O
preterm	O
compared	O
to	O
matched	O
controls	O
,	O
and	O
the	O
saliva	O
secretion	O
was	O
lower	O
in	O
the	O
extremely	O
preterm	O
infants	O
.	O

The	O
frequency	O
of	O
caries	O
did	O
not	O
differ	O
between	O
the	O
groups	O
.	O

Mineralization	O
disturbances	O
were	O
more	O
frequent	O
in	O
the	O
primary	O
dentition	O
and	O
more	O
severe	O
in	O
the	O
permanent	O
dentition	O
among	O
the	O
children	O
born	O
extremely	O
preterm	O
.	O

No	O
association	O
between	O
dental	O
pathology	O
,	O
neonatal	O
and	O
postnatal	O
morbidity	O
and	O
treatments	O
was	O
found	O
.	O

In	O
conclusion	O
,	O
adolescents	O
born	O
extremely	O
preterm	O
have	O
an	O
increased	O
number	O
of	O
risk	O
indicators	O
for	O
a	O
poorer	O
oral	O
outcome	O
compared	O
with	O
the	O
controls	O
and	O
more	O
severe	O
mineralization	O
disturbances	O
.	O

These	O
findings	O
may	O
imply	O
an	O
increased	O
vulnerability	O
for	O
poorer	O
oral	O
health	O
later	O
in	O
life	O
.	O

The	O
occurrence	O
of	O
bacteria	O
belonging	O
to	O
Pasteurellaceae	B-bacteria
in	O
the	O
oral	O
cavity	O
of	O
captive	O
marine	O
mammals	O
was	O
investigated	O
using	O
culture	O
and	O
subsequent	O
geno	O
-	O
and	O
phenotypic	O
characterization	O
and	O
phylogenetic	O
analyses	O
.	O

A	O
total	O
of	O
89	O
bacterial	O
isolates	O
from	O
pinnipeds	O
tentatively	O
classified	O
with	O
the	O
family	O
Pasteurellaceae	B-bacteria
were	O
further	O
characterized	O
by	O
phylogenetic	O
analysis	O
of	O
rpoB	O
gene	O
sequences	O
,	O
which	O
showed	O
that	O
the	O
isolates	O
investigated	O
formed	O
five	O
distinct	O
groups	O
.	O

Four	O
strains	O
from	O
California	O
sea	O
lions	O
(	O
Zalophus	O
californianus	O
)	O
made	O
up	O
group	O
I	O
,	O
which	O
was	O
classified	O
with	O
Pasteurella	B-bacteria
canis	I-bacteria
.	O

Group	O
II	O
comprised	O
four	O
strains	O
from	O
harbor	O
seals	O
(	O
Phoca	O
vitulina	O
)	O
and	O
grey	O
seals	O
(	O
Halichoerus	O
grypus	O
)	O
classified	O
with	O
Pasteurella	B-bacteria
stomatis	I-bacteria
.	O

Group	O
III	O
consisted	O
of	O
28	O
strains	O
,	O
isolated	O
from	O
harbor	O
and	O
gray	O
seals	O
and	O
represented	O
Bisgaardia	B-bacteria
genomospecies	I-bacteria
1	I-bacteria
.	O

Two	O
strains	O
from	O
a	O
harbor	O
and	O
a	O
grey	O
seal	O
,	O
group	O
IV	O
,	O
were	O
classified	O
with	O
Bisgaardia	B-bacteria
hudsonensis	I-bacteria
.	O

Fifty	O
-	O
two	O
strains	O
from	O
northern	O
fur	O
seals	O
(	O
Callorhinus	O
ursinus	O
)	O
,	O
walruses	O
(	O
Odobenus	O
rosmarus	O
)	O
,	O
and	O
California	O
and	O
Steller	O
sea	O
lions	O
(	O
Eumetopias	O
jubatus	O
)	O
formed	O
group	O
V	O
and	O
represented	O
Otariodibacter	B-bacteria
oris	I-bacteria
.	O

No	O
Pasteurellaceae	B-bacteria
isolates	I-bacteria
were	O
obtained	O
from	O
cetaceans	O
,	O
but	O
Pasteurellaceae	B-bacteria
were	O
isolated	O
from	O
all	O
sampled	O
pinnipeds	O
.	O

On	O
the	O
basis	O
of	O
these	O
results	O
,	O
it	O
is	O
very	O
likely	O
that	O
Pasteurellaceae	B-bacteria
bacteria	I-bacteria
represent	O
a	O
part	O
of	O
the	O
normal	O
oral	O
flora	O
in	O
pinnipeds	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
:	O
(	O
i	O
)	O
to	O
evaluate	O
whether	O
an	O
endodontic	O
pathology	O
on	O
the	O
extracted	O
tooth	O
or	O
adjacent	O
teeth	O
of	O
an	O
implant	O
site	O
has	O
an	O
influence	O
on	O
the	O
emergence	O
of	O
a	O
periapical	O
lesion	O
,	O
(	O
ii	O
)	O
to	O
retrospectively	O
analyse	O
the	O
outcome	O
of	O
different	O
treatment	O
strategies	O
,	O
(	O
iii	O
)	O
to	O
determine	O
which	O
bacteria	O
were	O
present	O
in	O
periapical	O
lesions	O
.	O

The	O
endodontic	O
status	O
of	O
the	O
tooth	O
at	O
the	O
implant	O
site	O
and	O
the	O
adjacent	O
teeth	O
was	O
explored	O
and	O
linked	O
to	O
the	O
periapical	O
status	O
of	O
the	O
implant	O
.	O

For	O
all	O
the	O
lesions	O
treated	O
since	O
2000	O
,	O
their	O
survival	O
was	O
assessed	O
.	O

Finally	O
,	O
microbial	O
samples	O
(	O
culturing	O
)	O
from	O
the	O
periapical	O
lesions	O
,	O
were	O
analysed	O
.	O

If	O
an	O
endodontic	O
treatment	O
or	O
a	O
periapical	O
lesion	O
at	O
the	O
apex	O
of	O
a	O
tooth	O
is	O
present	O
,	O
a	O
periapical	O
lesion	O
around	O
the	O
implant	O
can	O
be	O
detected	O
in	O
8	O
.	O
2	O
%	O
up	O
to	O
13	O
.	O
6	O
%	O
(	O
OR	O
7	O
.	O
2	O
)	O
.	O

For	O
periapical	O
pathology	O
at	O
the	O
adjacent	O
teeth	O
,	O
the	O
percentage	O
rises	O
to	O
25	O
%	O
(	O
OR	O
8	O
.	O
0	O
)	O
.	O

The	O
best	O
treatment	O
option	O
could	O
not	O
be	O
found	O
.	O

Bacteria	O
were	O
found	O
in	O
9	O
/	O
21	O
lesions	O
.	O

The	O
most	O
prominent	O
species	O
was	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
.	O

When	O
an	O
endodontic	O
pathology	O
is	O
present	O
on	O
the	O
extracted	O
or	O
neighbouring	O
teeth	O
,	O
it	O
is	O
significantly	O
more	O
likely	O
that	O
a	O
periapical	O
lesion	O
will	O
develop	O
around	O
a	O
future	O
implant	O
.	O

Feline	O
chronic	O
gingivostomatitis	O
(	O
FCGS	O
)	O
is	O
an	O
inflammatory	O
disease	O
of	O
the	O
oral	O
cavity	O
that	O
causes	O
severe	O
pain	O
and	O
distress	O
in	O
affected	O
cats	O
.	O

Treatment	O
methods	O
are	O
currently	O
very	O
limited	O
.	O

The	O
aims	O
of	O
this	O
study	O
were	O
to	O
assess	O
the	O
feline	O
innate	O
immune	O
response	O
by	O
investigating	O
the	O
levels	O
of	O
cytokine	O
and	O
Toll	O
-	O
like	O
receptor	O
(	O
TLR	O
)	O
mRNAs	O
in	O
tissue	O
biopsies	O
of	O
cats	O
with	O
and	O
without	O
FCGS	O
,	O
and	O
to	O
relate	O
this	O
to	O
the	O
presence	O
or	O
absence	O
of	O
putative	O
oral	O
pathogens	O
identified	O
previously	O
within	O
these	O
cats	O
.	O

Mucosal	O
biopsies	O
were	O
collected	O
from	O
28	O
cats	O
with	O
FCGS	O
and	O
eight	O
healthy	O
cats	O
.	O

The	O
levels	O
of	O
TLR	O
(	O
TLR2	O
,	O
TLR3	O
,	O
TLR4	O
,	O
TLR7	O
,	O
TLR9	O
)	O
and	O
cytokine	O
(	O
IL	O
-	O
1beta	O
,	O
IL	O
-	O
4	O
,	O
IL	O
-	O
6	O
,	O
IL	O
-	O
10	O
,	O
IL	O
-	O
12	O
,	O
TNF	O
-	O
alpha	O
,	O
IFN	O
-	O
gamma	O
)	O
mRNA	O
was	O
determined	O
using	O
quantitative	O
PCR	O
.	O

In	O
the	O
FCGS	O
group	O
a	O
statistically	O
significant	O
increase	O
was	O
seen	O
in	O
TLR2	O
,	O
TLR7	O
,	O
TNF	O
-	O
alpha	O
,	O
IFN	O
-	O
gamma	O
,	O
IL	O
-	O
1beta	O
and	O
IL	O
-	O
6	O
mRNA	O
levels	O
compared	O
to	O
the	O
healthy	O
group	O
.	O

In	O
cats	O
where	O
Tannerella	B-bacteria
forsythia	I-bacteria
was	O
present	O
,	O
statistically	O
significant	O
increases	O
were	O
seen	O
in	O
TLR2	O
,	O
TLR4	O
,	O
TLR7	O
,	O
TLR9	O
,	O
TNF	O
-	O
alpha	O
and	O
IL	O
-	O
1beta	O
mRNA	O
levels	O
compared	O
to	O
cats	O
where	O
this	O
putative	O
pathogen	O
was	O
absent	O
.	O

Statistically	O
significant	O
increases	O
in	O
mRNA	O
expression	O
were	O
also	O
seen	O
in	O
cats	O
harbouring	O
feline	O
calicivirus	O
(	O
FCV	O
)	O
(	O
TLR2	O
,	O
IL	O
-	O
1beta	O
,	O
IL	O
-	O
6	O
,	O
IFN	O
-	O
gamma	O
)	O
and	O
Porphyromonas	B-bacteria
circumdentaria	I-bacteria
(	O
TLR2	O
,	O
TLR3	O
)	O
compared	O
to	O
cats	O
where	O
these	O
putative	O
pathogens	O
were	O
absent	O
.	O

Pasteurella	B-bacteria
multocida	I-bacteria
subsp	I-bacteria
.	I-bacteria
multocida	I-bacteria
and	O
Pseudomonas	B-bacteria
sp	I-bacteria
.	I-bacteria
did	O
not	O
significantly	O
alter	O
the	O
expression	O
of	O
any	O
TLR	O
or	O
cytokine	O
mRNAs	O
when	O
compared	O
to	O
animals	O
who	O
tested	O
negative	O
for	O
these	O
species	O
,	O
while	O
cats	O
colonised	O
with	O
P	B-bacteria
.	I-bacteria
multocida	I-bacteria
subsp	I-bacteria
.	I-bacteria
septica	I-bacteria
demonstrated	O
a	O
statistically	O
significant	O
reduction	O
in	O
the	O
expression	O
of	O
TLR7	O
,	O
TNF	O
-	O
alpha	O
and	O
IFN	O
-	O
gamma	O
mRNAs	O
compared	O
to	O
cats	O
free	O
of	O
this	O
species	O
.	O

The	O
expression	O
of	O
mRNA	O
for	O
several	O
TLRs	O
and	O
cytokines	O
is	O
elevated	O
in	O
FCGS	O
.	O

A	O
positive	O
correlation	O
was	O
observed	O
between	O
clinical	O
disease	O
severity	O
and	O
the	O
presence	O
of	O
FCV	O
(	O
p	O
=	O
0	O
.	O
001	O
;	O
Rho	O
=	O
0	O
.	O
58	O
)	O
.	O

Although	O
the	O
number	O
of	O
cats	O
harbouring	O
T	B-bacteria
.	I-bacteria
forsythia	I-bacteria
was	O
low	O
by	O
comparison	O
,	O
80	O
%	O
of	O
samples	O
in	O
which	O
it	O
was	O
present	O
were	O
from	O
cases	O
with	O
the	O
highest	O
clinical	O
disease	O
severity	O
.	O

Positive	O
correlations	O
with	O
clinical	O
disease	O
severity	O
were	O
seen	O
for	O
TLR2	O
(	O
p	O
=	O
0	O
.	O
00086	O
)	O
,	O
TLR7	O
(	O
p	O
=	O
0	O
.	O
049	O
)	O
,	O
TNF	O
-	O
alpha	O
(	O
p	O
=	O
0	O
.	O
027	O
)	O
,	O
IFN	O
-	O
gamma	O
(	O
p	O
=	O
0	O
.	O
0015	O
)	O
,	O
IL	O
-	O
1beta	O
(	O
p	O
=	O
0	O
.	O
004	O
)	O
and	O
IL	O
-	O
6	O
(	O
p	O
=	O
0	O
.	O
00001	O
)	O
mRNAs	O
.	O

The	O
putative	O
pathogens	O
FCV	O
and	O
T	B-bacteria
.	I-bacteria
forsythia	I-bacteria
may	O
be	O
important	O
in	O
stimulating	O
a	O
host	O
immune	O
response	O
to	O
FCGS	O
and	O
may	O
play	O
a	O
role	O
in	O
the	O
pathogenesis	O
of	O
this	O
disease	O
.	O

The	O
aim	O
of	O
the	O
study	O
was	O
to	O
compare	O
the	O
antimicrobial	O
activity	O
of	O
a	O
mouth	O
rinse	O
containing	O
chlorhexidine	O
and	O
cetylpyridinium	O
chloride	O
(	O
MR1	O
)	O
with	O
a	O
stannous	O
fluoride	O
-	O
based	O
mouth	O
rinse	O
(	O
MR2	O
)	O
in	O
vitro	O
.	O

Samples	O
of	O
the	O
tongues	O
from	O
10	O
subjects	O
with	O
and	O
10	O
subjects	O
without	O
halitosis	O
were	O
inoculated	O
on	O
blood	O
agar	O
plates	O
.	O

The	O
agar	O
was	O
perforated	O
,	O
and	O
the	O
cylindrical	O
holes	O
were	O
filled	O
either	O
with	O
mouth	O
rinse	O
MR1	O
or	O
with	O
mouth	O
rinse	O
MR2	O
.	O

After	O
incubation	O
,	O
inhibition	O
zones	O
of	O
the	O
whole	O
tongue	O
microbiota	O
and	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
were	O
measured	O
.	O

In	O
addition	O
,	O
MR1	O
and	O
MR2	O
were	O
applied	O
in	O
a	O
short	O
interval	O
killing	O
test	O
(	O
SIKT	O
)	O
on	O
four	O
oral	O
pathogens	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
and	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
.	O

Total	O
viable	O
cell	O
counts	O
were	O
made	O
after	O
two	O
minutes	O
of	O
incubation	O
with	O
increasing	O
concentrations	O
of	O
MR1	O
and	O
MR2	O
.	O

MR1	O
showed	O
a	O
significantly	O
higher	O
in	O
vitro	O
antimicrobial	O
activity	O
against	O
the	O
whole	O
tongue	O
microbiota	O
and	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
than	O
MR2	O
in	O
both	O
groups	O
of	O
subjects	O
.	O

In	O
the	O
SIK	O
test	O
,	O
MR1	O
showed	O
a	O
significantly	O
greater	O
killing	O
capacity	O
than	O
MR2	O
.	O

The	O
results	O
show	O
that	O
a	O
mouth	O
rinse	O
with	O
low	O
concentrations	O
of	O
chlorhexidine	O
and	O
0	O
.	O
05	O
%	O
cetylpyridinium	O
chloride	O
appears	O
to	O
be	O
more	O
effective	O
in	O
inhibiting	O
growth	O
of	O
the	O
human	O
tongue	O
microbiota	O
in	O
vitro	O
than	O
a	O
fluoride	O
/	O
stannous	O
fluoride	O
-	O
containing	O
mouth	O
rinse	O
.	O

This	O
in	O
vitro	O
observation	O
supports	O
the	O
use	O
of	O
chlorhexidine	O
and	O
cetylpyridinium	O
chloride	O
in	O
the	O
treatment	O
of	O
oral	O
halitosis	O
.	O

Dental	O
caries	O
and	O
periodontal	O
disease	O
are	O
widespread	O
diseases	O
for	O
which	O
microorganism	O
infections	O
have	O
been	O
identified	O
as	O
the	O
main	O
etiology	O
.	O

Silver	O
nanoparticles	O
(	O
Ag	O
Nps	O
)	O
were	O
considered	O
as	O
potential	O
control	O
oral	O
bacteria	O
infection	O
agent	O
due	O
to	O
its	O
excellent	O
antimicrobial	O
activity	O
and	O
non	O
acute	O
toxic	O
effects	O
on	O
human	O
cells	O
.	O

In	O
this	O
work	O
,	O
stable	O
Ag	O
Nps	O
with	O
different	O
sizes	O
(	O
~	O
5	O
,	O
15	O
and	O
55	O
nm	O
mean	O
values	O
)	O
were	O
synthesized	O
by	O
using	O
a	O
simple	O
reduction	O
method	O
or	O
hydrothermal	O
method	O
.	O

The	O
Nps	O
were	O
characterized	O
by	O
powder	O
X	O
-	O
ray	O
diffraction	O
,	O
transmission	O
electron	O
microscopy	O
and	O
UV	O
-	O
vis	O
absorption	O
spectroscopy	O
.	O

The	O
antibacterial	O
activities	O
were	O
evaluated	O
by	O
colony	O
counting	O
assay	O
and	O
growth	O
inhibition	O
curve	O
method	O
,	O
and	O
corresponding	O
minimum	O
inhibitory	O
concentration	O
(	O
MIC	O
)	O
against	O
five	O
anaerobic	O
oral	O
pathogenic	O
bacteria	O
and	O
aerobic	O
bacteria	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
were	O
determined	O
.	O

The	O
results	O
showed	O
that	O
Ag	O
Nps	O
had	O
apparent	O
antibacterial	O
effects	O
against	O
the	O
anaerobic	O
oral	O
pathogenic	O
bacteria	O
and	O
aerobic	O
bacteria	O
.	O

The	O
MIC	O
values	O
of	O
5	O
-	O
nm	O
Ag	O
against	O
anaerobic	O
oral	O
pathogenic	O
bacteria	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
,	O
F	B-bacteria
.	I-bacteria
nuceatum	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
sanguis	I-bacteria
were	O
25	O
,	O
25	O
,	O
25	O
,	O
50	O
and	O
50	O
mug	O
/	O
mL	O
,	O
respectively	O
.	O

The	O
aerobic	O
bacteria	O
were	O
more	O
susceptible	O
to	O
Ag	O
NPs	O
than	O
the	O
anaerobic	O
oral	O
pathogenic	O
bacteria	O
.	O

In	O
the	O
mean	O
time	O
,	O
Ag	O
NPs	O
displayed	O
an	O
obvious	O
size	O
-	O
dependent	O
antibacterial	O
activity	O
against	O
the	O
anaerobic	O
bacteria	O
.	O

The	O
5	O
-	O
nm	O
Ag	O
presents	O
the	O
highest	O
antibacterial	O
activity	O
.	O

The	O
results	O
of	O
this	O
work	O
indicated	O
a	O
potential	O
application	O
of	O
Ag	O
Nps	O
in	O
the	O
inhibition	O
of	O
oral	O
microorganism	O
infections	O
.	O

Autologous	O
platelet	O
concentrates	O
(	O
PCs	O
)	O
have	O
been	O
extensively	O
used	O
in	O
a	O
variety	O
of	O
medical	O
fields	O
to	O
promote	O
soft	O
and	O
hard	O
tissue	O
regeneration	O
.	O

The	O
significance	O
behind	O
their	O
use	O
lies	O
in	O
the	O
abundance	O
of	O
growth	O
factors	O
in	O
platelets	O
alpha	O
-	O
granules	O
that	O
promotes	O
wound	O
healing	O
.	O

In	O
addition	O
,	O
antibacterial	O
properties	O
of	O
PCs	O
against	O
various	O
bacteria	O
have	O
been	O
recently	O
pointed	O
out	O
.	O

In	O
this	O
study	O
,	O
the	O
antimicrobial	O
effect	O
of	O
pure	O
platelet	O
-	O
rich	O
plasma	O
(	O
P	O
-	O
PRP	O
)	O
was	O
evaluated	O
against	O
oral	O
cavity	O
microorganisms	O
such	O
as	O
Enterococcus	B-bacteria
faecalis	I-bacteria
,	O
Candida	O
albicans	O
,	O
Streptococcus	B-bacteria
agalactiae	I-bacteria
,	O
Streptococcus	B-bacteria
oralis	I-bacteria
and	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
.	O

Blood	O
samples	O
were	O
obtained	O
from	O
17	O
patients	O
who	O
underwent	O
oral	O
surgery	O
procedures	O
involving	O
the	O
use	O
of	O
P	O
-	O
PRP	O
.	O

The	O
antibacterial	O
activity	O
of	O
P	O
-	O
PRP	O
,	O
evaluated	O
as	O
the	O
minimum	O
inhibitory	O
concentration	O
(	O
MIC	O
)	O
,	O
was	O
determined	O
through	O
the	O
microdilution	O
twofold	O
serial	O
method	O
.	O

P	O
-	O
PRP	O
inhibited	O
the	O
growth	O
of	O
Enterococcus	B-bacteria
faecalis	I-bacteria
,	O
Candida	O
albicans	O
,	O
Streptococcus	B-bacteria
agalactiae	I-bacteria
and	O
Streptococcus	B-bacteria
oralis	I-bacteria
,	O
but	O
not	O
of	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
strains	I-bacteria
.	O

P	O
-	O
PRP	O
is	O
a	O
potentially	O
useful	O
substance	O
in	O
the	O
fight	O
against	O
postoperative	O
infections	O
.	O

This	O
might	O
represent	O
a	O
valuable	O
property	O
in	O
adjunct	O
to	O
the	O
enhancement	O
of	O
tissue	O
regeneration	O
.	O

To	O
compare	O
via	O
a	O
split	O
-	O
mouth	O
randomized	O
clinical	O
trial	O
the	O
efficacy	O
of	O
1	O
%	O
chlorhexidine	O
gel	O
,	O
calcium	O
hydroxide	O
/	O
camphorated	O
paramonochlorophenol	O
(	O
Callen	O
PMCC	O
)	O
,	O
and	O
a	O
one	O
-	O
visit	O
endodontic	O
treatment	O
against	O
mutans	B-bacteria
streptococci	I-bacteria
and	O
anaerobic	O
bacteria	O
found	O
in	O
primary	O
molars	O
with	O
necrotic	O
pulps	O
and	O
to	O
assess	O
clinical	O
success	O
rates	O
after	O
12	O
months	O
.	O

Pre	O
-	O
and	O
posttreatment	O
intracanal	O
samples	O
were	O
collected	O
from	O
37	O
teeth	O
(	O
from	O
21	O
children	O
)	O
for	O
analysis	O
of	O
the	O
number	O
of	O
mutans	B-bacteria
streptococci	I-bacteria
and	O
anaerobic	O
bacteria	O
.	O

Clinical	O
and	O
radiographic	O
criteria	O
were	O
analyzed	O
to	O
determine	O
treatment	O
outcome	O
.	O

Chlorhexidine	O
gel	O
significantly	O
reduced	O
mutans	B-bacteria
streptococci	I-bacteria
levels	O
(	O
P	O
=	O
.	O
010	O
)	O
,	O
whereas	O
Callen	O
PMCC	O
significantly	O
reduced	O
the	O
levels	O
of	O
anaerobic	O
bacteria	O
(	O
P	O
=	O
.	O
002	O
)	O
.	O

No	O
differences	O
in	O
the	O
reduction	O
of	O
mutans	B-bacteria
streptococci	I-bacteria
(	O
P	O
=	O
.	O
187	O
)	O
and	O
anaerobes	O
(	O
P	O
=	O
.	O
564	O
)	O
were	O
observed	O
between	O
groups	O
.	O

The	O
clinical	O
success	O
rates	O
were	O
85	O
.	O
71	O
%	O
(	O
Callen	O
PMCC	O
)	O
,	O
78	O
.	O
57	O
%	O
(	O
chlorexidine	O
gel	O
)	O
,	O
and	O
77	O
.	O
77	O
%	O
(	O
one	O
-	O
visit	O
treatment	O
)	O
.	O

Teeth	O
treated	O
with	O
Callen	O
PMCC	O
presented	O
the	O
highest	O
clinical	O
success	O
rate	O
.	O

The	O
1	O
%	O
chlorhexidine	O
gel	O
,	O
as	O
well	O
as	O
calcium	O
hydroxide	O
/	O
camphorated	O
paramonochlorophenol	O
,	O
presented	O
limited	O
efficacy	O
in	O
reducing	O
bacteria	O
from	O
necrotic	O
primary	O
root	O
canals	O
.	O

The	O
levels	O
of	O
compounds	O
in	O
exhaled	O
mouth	O
air	O
do	O
not	O
necessarily	O
reflect	O
levels	O
in	O
the	O
systemic	O
circulation	O
as	O
bacteria	O
can	O
bio	O
-	O
transform	O
substrates	O
to	O
produce	O
compounds	O
within	O
the	O
mouth	O
.	O

This	O
should	O
be	O
of	O
concern	O
to	O
researchers	O
measuring	O
breath	O
volatiles	O
with	O
the	O
aim	O
of	O
diagnosing	O
systemic	O
or	O
metabolic	O
conditions	O
as	O
very	O
little	O
is	O
known	O
about	O
the	O
origin	O
of	O
many	O
compounds	O
detected	O
on	O
the	O
breath	O
.	O

This	O
pilot	O
study	O
investigated	O
the	O
production	O
of	O
volatile	O
compounds	O
by	O
bacterial	O
communities	O
present	O
within	O
the	O
mouth	O
.	O

Solid	O
-	O
phase	O
micro	O
-	O
extraction	O
was	O
used	O
to	O
extract	O
volatiles	O
from	O
the	O
headspace	O
gas	O
of	O
two	O
Gram	O
-	O
positive	O
and	O
two	O
Gram	O
-	O
negative	O
bacterial	O
cultures	O
known	O
to	O
be	O
present	O
within	O
the	O
mouth	O
and	O
from	O
tongue	O
biofilm	O
microflora	O
.	O

Analyses	O
were	O
undertaken	O
using	O
gas	O
chromatography	O
mass	O
spectrometry	O
.	O

Between	O
64	O
and	O
82	O
volatile	O
compounds	O
were	O
detected	O
from	O
sampling	O
the	O
headspace	O
gas	O
above	O
each	O
of	O
the	O
cultures	O
.	O

Gram	O
-	O
negative	O
anaerobes	O
were	O
found	O
to	O
produce	O
more	O
volatile	O
sulfur	O
compounds	O
(	O
VSCs	O
)	O
and	O
amines	O
.	O

Solobacterium	B-bacteria
moorei	I-bacteria
,	O
a	O
Gram	O
-	O
positive	O
species	O
was	O
however	O
found	O
to	O
produce	O
higher	O
levels	O
of	O
acids	O
,	O
hydrocarbons	O
,	O
alcohols	O
and	O
aldehydes	O
than	O
the	O
other	O
species	O
studied	O
.	O

Tongue	O
-	O
scrape	O
biofilm	O
systems	O
at	O
lower	O
pH	O
gave	O
more	O
hydrocarbons	O
,	O
ketones	O
and	O
fatty	O
acids	O
whilst	O
at	O
higher	O
pH	O
more	O
alcohols	O
,	O
aldehydes	O
,	O
VSCs	O
and	O
amines	O
were	O
detected	O
in	O
the	O
headspace	O
.	O

The	O
results	O
show	O
that	O
a	O
number	O
of	O
compounds	O
detected	O
in	O
mouth	O
breath	O
are	O
produced	O
by	O
anaerobic	O
bacteria	O
in	O
tongue	O
biofilms	O
.	O

Thus	O
,	O
the	O
contribution	O
of	O
volatiles	O
from	O
oral	O
anaerobes	O
can	O
not	O
be	O
ignored	O
and	O
more	O
research	O
is	O
required	O
to	O
identify	O
the	O
major	O
source	O
of	O
breath	O
compounds	O
as	O
this	O
will	O
help	O
determine	O
their	O
clinical	O
significance	O
as	O
indicators	O
of	O
systemic	O
disease	O
or	O
metabolic	O
disorders	O
in	O
the	O
body	O
.	O

Traditional	O
Chinese	O
medicine	O
(	O
TCM	O
)	O
,	O
used	O
in	O
clinical	O
practice	O
for	O
thousands	O
of	O
years	O
,	O
has	O
been	O
taken	O
as	O
a	O
new	O
way	O
to	O
tackle	O
chronic	O
diseases	O
.	O

In	O
Chinese	O
medicine	O
,	O
many	O
ingredients	O
which	O
are	O
known	O
to	O
have	O
biological	O
effects	O
just	O
pass	O
through	O
the	O
gut	O
,	O
they	O
do	O
not	O
get	O
into	O
the	O
bloodstream	O
.	O

Study	O
on	O
interactions	O
of	O
these	O
active	O
ingredients	O
with	O
the	O
intestinal	O
bacteria	O
is	O
very	O
helpful	O
to	O
unravel	O
how	O
TCM	O
works	O
.	O

AIM	O
OF	O
THE	O
STUDY	O
:	O
Hyperoside	O
is	O
a	O
major	O
active	O
constituent	O
in	O
many	O
medicinal	O
plants	O
which	O
are	O
traditionally	O
used	O
in	O
Chinese	O
medicines	O
for	O
their	O
neuroprotective	O
,	O
anti	O
-	O
inflammatory	O
and	O
anti	O
-	O
oxidative	O
effects	O
.	O

It	O
would	O
be	O
metabolized	O
by	O
intestinal	O
bacteria	O
after	O
oral	O
administration	O
which	O
leads	O
to	O
the	O
variation	O
of	O
ethnopharmacological	O
profile	O
of	O
these	O
traditional	O
medicines	O
.	O

Thus	O
,	O
it	O
is	O
necessary	O
to	O
investigate	O
the	O
metabolic	O
routes	O
and	O
metabolites	O
of	O
hyperoside	O
produced	O
by	O
human	O
intestinal	O
bacteria	O
.	O

MATERIALS	O
AND	O
Ultra	O
performance	O
liquid	O
chromatography	O
/	O
quadrupole	O
-	O
time	O
-	O
of	O
-	O
flight	O
mass	O
spectrometry	O
(	O
UPLC	O
/	O
QTOF	O
-	O
MS	O
)	O
technique	O
combined	O
with	O
Metabolynx	O
(	O
)	O
software	O
was	O
used	O
for	O
analysis	O
of	O
the	O
metabolic	O
profile	O
of	O
hyperoside	O
by	O
the	O
isolated	O
human	O
intestinal	O
bacteria	O
from	O
the	O
human	O
feces	O
.	O

Parent	O
compound	O
and	O
6	O
metabolites	O
(	O
M1	O
-	O
M7	O
)	O
were	O
detected	O
in	O
the	O
isolated	O
bacterial	O
samples	O
compared	O
with	O
blank	O
samples	O
.	O

Quercetin	O
,	O
3	O
,	O
4	O
-	O
dihydroxyphenylacetic	O
acid	O
and	O
3	O
,	O
4	O
-	O
dihydroxyphenylbenzoic	O
acid	O
(	O
M2	O
-	O
M4	O
)	O
were	O
only	O
found	O
in	O
the	O
sample	O
of	O
Bacteroides	B-bacteria
sp	I-bacteria
.	I-bacteria
45	I-bacteria
.	O

Dehydroxylation	O
of	O
hyperoside	O
and	O
the	O
conjugates	O
:	O
acetylation	O
and	O
hydroxylation	O
of	O
hyperoside	O
(	O
M5	O
-	O
M7	O
)	O
were	O
identified	O
in	O
the	O
majority	O
of	O
isolated	O
intestinal	O
bacterial	O
samples	O
.	O

Only	O
Bacteroides	B-bacteria
sp	I-bacteria
.	I-bacteria
45	I-bacteria
could	O
metabolize	O
hyperoside	O
to	O
form	O
its	O
aglycone	O
quercetin	O
,	O
thereafter	O
,	O
quercetin	O
was	O
further	O
metabolized	O
to	O
3	O
,	O
4	O
-	O
dihydroxyphenylacetic	O
acid	O
and	O
3	O
,	O
4	O
-	O
dihydroxyphenylacetic	O
acid	O
.	O

Furthermore	O
,	O
the	O
majority	O
of	O
bacteria	O
could	O
metabolize	O
hyperoside	O
to	O
dehydroxylation	O
of	O
hyperoside	O
and	O
the	O
conjugates	O
:	O
hydroxylation	O
and	O
acetylation	O
of	O
hyperoside	O
.	O

In	O
this	O
study	O
,	O
the	O
metabolic	O
routes	O
and	O
metabolites	O
of	O
hyperoside	O
produced	O
by	O
the	O
different	O
intestinal	O
bacteria	O
were	O
investigated	O
for	O
the	O
first	O
time	O
.	O

Furthermore	O
,	O
the	O
production	O
of	O
metabolites	O
of	O
hyperoside	O
might	O
influence	O
the	O
effects	O
of	O
traditional	O
medicines	O
.	O

Thus	O
,	O
the	O
study	O
on	O
the	O
metabolism	O
of	O
hyperoside	O
by	O
human	O
intestinal	O
bacteria	O
is	O
of	O
great	O
importance	O
to	O
an	O
understanding	O
of	O
the	O
effects	O
of	O
traditional	O
medicines	O
.	O

In	O
leprosy	O
,	O
the	O
nasal	O
mucosa	O
is	O
considered	O
as	O
the	O
principal	O
route	O
of	O
transmission	O
for	O
the	O
bacillus	B-bacteria
Mycobacterium	B-bacteria
leprae	I-bacteria
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
identify	O
M	B-bacteria
.	I-bacteria
leprae	I-bacteria
in	O
the	O
oral	O
mucosa	O
of	O
50	O
untreated	O
leprosy	O
patients	O
,	O
including	O
21	O
paucibacillary	O
(	O
PB	O
)	O
and	O
29	O
multibacillary	O
(	O
MB	O
)	O
patients	O
,	O
using	O
immunohistochemistry	O
(	O
IHC	O
)	O
,	O
with	O
antibodies	O
against	O
bacillus	O
Calmette	O
-	O
Guerin	O
(	O
BCG	O
)	O
and	O
phenolic	O
glycolipid	O
antigen	O
-	O
1	O
(	O
PGL	O
-	O
1	O
)	O
,	O
and	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
,	O
with	O
MntH	O
-	O
specific	O
primers	O
for	O
M	B-bacteria
.	I-bacteria
leprae	I-bacteria
,	O
and	O
to	O
compare	O
the	O
results	O
.	O

The	O
material	O
was	O
represented	O
by	O
163	O
paraffin	O
blocks	O
containing	O
biopsy	O
samples	O
obtained	O
from	O
clinically	O
normal	O
sites	O
(	O
including	O
the	O
tongue	O
,	O
buccal	O
mucosa	O
and	O
soft	O
palate	O
)	O
and	O
visible	O
lesions	O
anywhere	O
in	O
the	O
oral	O
mucosa	O
.	O

All	O
patients	O
and	O
158	O
available	O
samples	O
were	O
included	O
for	O
IHC	O
study	O
.	O

Among	O
the	O
161	O
available	O
samples	O
for	O
PCR	O
,	O
110	O
had	O
viable	O
DNA	O
.	O

There	O
was	O
viable	O
DNA	O
in	O
at	O
least	O
one	O
area	O
of	O
the	O
oral	O
mucosa	O
for	O
47	O
patients	O
.	O

M	B-bacteria
.	I-bacteria
leprae	I-bacteria
was	O
detected	O
in	O
70	O
%	O
and	O
78	O
%	O
of	O
patients	O
using	O
IHC	O
and	O
PCR	O
,	O
respectively	O
,	O
and	O
in	O
94	O
%	O
of	O
the	O
patients	O
by	O
at	O
least	O
one	O
of	O
the	O
two	O
diagnostic	O
methods	O
.	O

There	O
were	O
no	O
differences	O
in	O
detection	O
of	O
M	B-bacteria
.	I-bacteria
leprae	I-bacteria
between	O
MB	O
and	O
PB	O
patients	O
.	O

Similar	O
results	O
were	O
obtained	O
using	O
anti	O
-	O
BCG	O
and	O
anti	O
-	O
PGL	O
-	O
1	O
antibodies	O
,	O
and	O
immunoreactivity	O
occurred	O
predominantly	O
on	O
free	O
-	O
living	O
bacteria	O
on	O
the	O
epithelial	O
surface	O
,	O
with	O
a	O
predilection	O
for	O
the	O
tongue	O
.	O

Conversely	O
,	O
there	O
was	O
no	O
area	O
of	O
predilection	O
according	O
to	O
the	O
PCR	O
results	O
.	O

M	B-bacteria
.	I-bacteria
leprae	I-bacteria
is	O
present	O
in	O
the	O
oral	O
mucosa	O
at	O
a	O
high	O
frequency	O
,	O
implicating	O
this	O
site	O
as	O
a	O
potential	O
means	O
of	O
leprosy	O
transmission	O
.	O

Results	O
from	O
16S	O
rDNA	O
-	O
encoding	O
gene	O
sequence	O
-	O
based	O
,	O
culture	O
-	O
independent	O
techniques	O
have	O
led	O
to	O
conflicting	O
conclusions	O
about	O
the	O
composition	O
of	O
the	O
lower	O
respiratory	O
tract	O
microbiome	O
.	O

To	O
compare	O
the	O
microbiome	O
of	O
the	O
upper	O
and	O
lower	O
respiratory	O
tract	O
in	O
healthy	O
HIV	O
-	O
uninfected	O
nonsmokers	O
and	O
smokers	O
in	O
a	O
multicenter	O
cohort	O
.	O

Participants	O
were	O
nonsmokers	O
and	O
smokers	O
without	O
significant	O
comorbidities	O
.	O

Oral	O
washes	O
and	O
bronchoscopic	O
alveolar	O
lavages	O
were	O
collected	O
in	O
a	O
standardized	O
manner	O
.	O

Sequence	O
analysis	O
of	O
bacterial	O
16S	O
rRNA	O
-	O
encoding	O
genes	O
was	O
performed	O
,	O
and	O
the	O
neutral	O
model	O
in	O
community	O
ecology	O
was	O
used	O
to	O
identify	O
bacteria	O
that	O
were	O
the	O
most	O
plausible	O
members	O
of	O
a	O
lung	O
microbiome	O
.	O

Sixty	O
-	O
four	O
participants	O
were	O
enrolled	O
.	O

Most	O
bacteria	O
identified	O
in	O
the	O
lung	O
were	O
also	O
in	O
the	O
mouth	O
,	O
but	O
specific	O
bacteria	O
such	O
as	O
Enterobacteriaceae	B-bacteria
,	O
Haemophilus	B-bacteria
,	O
Methylobacterium	B-bacteria
,	O
and	O
Ralstonia	B-bacteria
species	I-bacteria
were	O
disproportionally	O
represented	O
in	O
the	O
lungs	O
compared	O
with	O
values	O
predicted	O
by	O
the	O
neutral	O
model	O
.	O

Tropheryma	B-bacteria
was	O
also	O
in	O
the	O
lung	O
,	O
but	O
not	O
the	O
mouth	O
.	O

Mouth	O
communities	O
differed	O
between	O
nonsmokers	O
and	O
smokers	O
in	O
species	O
such	O
as	O
Porphyromonas	B-bacteria
,	O
Neisseria	B-bacteria
,	O
and	O
Gemella	B-bacteria
,	O
but	O
lung	O
bacterial	O
populations	O
did	O
not	O
.	O

This	O
study	O
is	O
the	O
largest	O
to	O
examine	O
composition	O
of	O
the	O
lower	O
respiratory	O
tract	O
microbiome	O
in	O
healthy	O
individuals	O
and	O
the	O
first	O
to	O
use	O
the	O
neutral	O
model	O
to	O
compare	O
the	O
lung	O
to	O
the	O
mouth	O
.	O

Specific	O
bacteria	O
appear	O
in	O
significantly	O
higher	O
abundance	O
in	O
the	O
lungs	O
than	O
would	O
be	O
expected	O
if	O
they	O
originated	O
from	O
the	O
mouth	O
,	O
demonstrating	O
that	O
the	O
lung	O
microbiome	O
does	O
not	O
derive	O
entirely	O
from	O
the	O
mouth	O
.	O

The	O
mouth	O
microbiome	O
differs	O
in	O
nonsmokers	O
and	O
smokers	O
,	O
but	O
lung	O
communities	O
were	O
not	O
significantly	O
altered	O
by	O
smoking	O
.	O

The	O
composition	O
of	O
the	O
human	O
microbiota	O
is	O
recognized	O
as	O
an	O
important	O
factor	O
in	O
human	O
health	O
and	O
disease	O
.	O

Many	O
of	O
our	O
cohabitating	O
microbes	O
belong	O
to	O
phylum	O
-	O
level	O
divisions	O
for	O
which	O
there	O
are	O
no	O
cultivated	O
representatives	O
and	O
are	O
only	O
represented	O
by	O
small	O
subunit	O
rRNA	O
sequences	O
.	O

For	O
one	O
such	O
taxon	O
(	O
SR1	B-bacteria
)	O
,	O
which	O
includes	O
bacteria	O
with	O
elevated	O
abundance	O
in	O
periodontitis	O
,	O
we	O
provide	O
a	O
single	O
-	O
cell	O
genome	O
sequence	O
from	O
a	O
healthy	O
oral	O
sample	O
.	O

SR1	B-bacteria
bacteria	I-bacteria
use	O
a	O
unique	O
genetic	O
code	O
.	O

In	O
-	O
frame	O
TGA	O
(	O
opal	O
)	O
codons	O
are	O
found	O
in	O
most	O
genes	O
(	O
85	O
%	O
)	O
,	O
often	O
at	O
loci	O
normally	O
encoding	O
conserved	O
glycine	O
residues	O
.	O

UGA	O
appears	O
not	O
to	O
function	O
as	O
a	O
stop	O
codon	O
and	O
is	O
in	O
equilibrium	O
with	O
the	O
canonical	O
GGN	O
glycine	O
codons	O
,	O
displaying	O
strain	O
-	O
specific	O
variation	O
across	O
the	O
human	O
population	O
.	O

SR1	B-bacteria
encodes	O
a	O
divergent	O
tRNA	O
(	O
Gly	O
)	O
UCA	O
with	O
an	O
opal	O
-	O
decoding	O
anticodon	O
.	O

SR1	B-bacteria
glycyl	O
-	O
tRNA	O
synthetase	O
acylates	O
tRNA	O
(	O
Gly	O
)	O
UCA	O
with	O
glycine	O
in	O
vitro	O
with	O
similar	O
activity	O
compared	O
with	O
normal	O
tRNA	O
(	O
Gly	O
)	O
UCC	O
.	O

Coexpression	O
of	O
SR1	B-bacteria
glycyl	O
-	O
tRNA	O
synthetase	O
and	O
tRNA	O
(	O
Gly	O
)	O
UCA	O
in	O
Escherichia	B-bacteria
coli	I-bacteria
yields	O
significant	O
beta	O
-	O
galactosidase	O
activity	O
in	O
vivo	O
from	O
a	O
lacZ	O
gene	O
containing	O
an	O
in	O
-	O
frame	O
TGA	O
codon	O
.	O

Comparative	O
genomic	O
analysis	O
with	O
Human	O
Microbiome	O
Project	O
data	O
revealed	O
that	O
the	O
human	O
body	O
harbors	O
a	O
striking	O
diversity	O
of	O
SR1	B-bacteria
bacteria	I-bacteria
.	O

This	O
is	O
a	O
surprising	O
finding	O
because	O
SR1	B-bacteria
is	O
most	O
closely	O
related	O
to	O
bacteria	O
that	O
live	O
in	O
anoxic	O
and	O
thermal	O
environments	O
.	O

Some	O
of	O
these	O
bacteria	O
share	O
common	O
genetic	O
and	O
metabolic	O
features	O
with	O
SR1	B-bacteria
,	O
including	O
UGA	O
to	O
glycine	O
reassignment	O
and	O
an	O
archaeal	O
-	O
type	O
ribulose	O
-	O
1	O
,	O
5	O
-	O
bisphosphate	O
carboxylase	O
(	O
RubisCO	O
)	O
involved	O
in	O
AMP	O
recycling	O
.	O

UGA	O
codon	O
reassignment	O
renders	O
SR1	B-bacteria
genes	O
untranslatable	O
by	O
other	O
bacteria	O
,	O
which	O
impacts	O
horizontal	O
gene	O
transfer	O
within	O
the	O
human	O
microbiota	O
.	O

To	O
study	O
the	O
preventive	O
effects	O
of	O
chlorhexidine	O
against	O
root	O
caries	O
under	O
oral	O
biofilm	O
in	O
an	O
artificial	O
mouth	O
.	O

Sixteen	O
human	O
tooth	O
-	O
root	O
disks	O
were	O
inoculated	O
with	O
a	O
salivary	O
sample	O
that	O
was	O
produced	O
by	O
mixing	O
the	O
unstimulated	O
saliva	O
of	O
three	O
adults	O
who	O
had	O
no	O
untreated	O
caries	O
.	O

The	O
disks	O
were	O
incubated	O
in	O
an	O
artificial	O
mouth	O
fed	O
with	O
a	O
5	O
%	O
sucrose	O
solution	O
three	O
times	O
daily	O
for	O
one	O
week	O
.	O

Eight	O
disks	O
received	O
a	O
twice	O
daily	O
rinse	O
of	O
0	O
.	O
12	O
%	O
chlorhexidine	O
(	O
test	O
group	O
)	O
.	O

The	O
other	O
eight	O
disks	O
were	O
rinsed	O
in	O
distilled	O
water	O
(	O
control	O
)	O
.	O

The	O
biofilm	O
was	O
then	O
studied	O
with	O
three	O
techniques	O
:	O
colony	O
forming	O
unit	O
(	O
CFU	O
)	O
counting	O
,	O
scanning	O
electron	O
microscopy	O
(	O
SEM	O
)	O
and	O
confocal	O
laser	O
scanning	O
microscopy	O
(	O
CLSM	O
)	O
.	O

The	O
changes	O
in	O
the	O
chemical	O
structure	O
of	O
the	O
root	O
surface	O
were	O
studied	O
using	O
Fourier	O
transform	O
infra	O
-	O
Red	O
spectroscopy	O
.	O

Type	O
-	O
I	O
collagen	O
and	O
proteoglycans	O
on	O
the	O
root	O
surface	O
were	O
quantified	O
using	O
immunocytochemical	O
staining	O
.	O

The	O
log	O
CFU	O
for	O
the	O
test	O
and	O
control	O
groups	O
were	O
4	O
.	O
21	O
and	O
8	O
.	O
27	O
,	O
respectively	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

The	O
CFU	O
count	O
of	O
Streptococci	B-bacteria
and	O
Lactobacilli	B-bacteria
were	O
negligible	O
.	O

Both	O
the	O
SEM	O
and	O
the	O
CLSM	O
showed	O
suppressed	O
bacteria	O
growth	O
in	O
the	O
test	O
group	O
.	O

The	O
log	O
[	O
amide	O
-	O
I	O
:	O
HPO	O
(	O
4	O
)	O
(	O
2	O
-	O
)	O
]	O
of	O
the	O
test	O
and	O
control	O
groups	O
were	O
1	O
.	O
11	O
and	O
1	O
.	O
93	O
,	O
respectively	O
(	O
p	O
=	O
0	O
.	O
02	O
)	O
.	O

The	O
mean	O
counts	O
of	O
sound	O
type	O
-	O
I	O
collagen	O
in	O
the	O
test	O
and	O
control	O
groups	O
were	O
16	O
.	O
8	O
/	O
mum	O
(	O
2	O
)	O
and	O
13	O
.	O
0	O
/	O
mum	O
(	O
2	O
)	O
,	O
respectively	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
whereas	O
the	O
mean	O
counts	O
of	O
intact	O
proteoglycans	O
were	O
5	O
.	O
6	O
/	O
mum	O
(	O
2	O
)	O
and	O
3	O
.	O
5	O
/	O
mum	O
(	O
2	O
)	O
,	O
respectively	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
.	O

Chlorhexidine	O
suppressed	O
the	O
growth	O
of	O
selected	O
cariogenic	O
bacteria	O
in	O
oral	O
biofilm	O
on	O
the	O
root	O
surface	O
and	O
thus	O
protected	O
tooth	O
-	O
root	O
from	O
cariogenic	O
challenge	O
.	O

Despite	O
a	O
long	O
history	O
of	O
investigation	O
,	O
many	O
bacteria	O
associated	O
with	O
the	O
human	O
oral	O
cavity	O
have	O
yet	O
to	O
be	O
cultured	O
.	O

Studies	O
that	O
correlate	O
the	O
presence	O
or	O
abundance	O
of	O
uncultured	O
species	O
with	O
oral	O
health	O
or	O
disease	O
highlight	O
the	O
importance	O
of	O
these	O
community	O
members	O
.	O

Thus	O
,	O
we	O
sequenced	O
several	O
single	O
-	O
cell	O
genomic	O
amplicons	O
from	O
Desulfobulbus	B-bacteria
and	O
Desulfovibrio	B-bacteria
(	O
class	O
Deltaproteobacteria	B-bacteria
)	O
to	O
better	O
understand	O
their	O
function	O
within	O
the	O
human	O
oral	O
community	O
and	O
their	O
association	O
with	O
periodontitis	O
,	O
as	O
well	O
as	O
other	O
systemic	O
diseases	O
.	O

Genomic	O
data	O
from	O
oral	O
Desulfobulbus	B-bacteria
and	O
Desulfovibrio	B-bacteria
species	I-bacteria
were	O
compared	O
to	O
other	O
available	O
deltaproteobacterial	O
genomes	O
,	O
including	O
from	O
a	O
subset	O
of	O
host	O
-	O
associated	O
species	O
.	O

While	O
both	O
groups	O
share	O
a	O
large	O
number	O
of	O
genes	O
with	O
other	O
environmental	O
Deltaproteobacteria	B-bacteria
genomes	O
,	O
they	O
encode	O
a	O
wide	O
array	O
of	O
unique	O
genes	O
that	O
appear	O
to	O
function	O
in	O
survival	O
in	O
a	O
host	O
environment	O
.	O

Many	O
of	O
these	O
genes	O
are	O
similar	O
to	O
virulence	O
and	O
host	O
adaptation	O
factors	O
of	O
known	O
human	O
pathogens	O
,	O
suggesting	O
that	O
the	O
oral	O
Deltaproteobacteria	B-bacteria
have	O
the	O
potential	O
to	O
play	O
a	O
role	O
in	O
the	O
etiology	O
of	O
periodontal	O
disease	O
.	O

To	O
test	O
the	O
hypothesis	O
that	O
the	O
oral	O
cavity	O
is	O
a	O
potential	O
source	O
for	O
implantable	O
pacemaker	O
and	O
cardioverter	O
defibrillators	O
infections	O
,	O
the	O
bacterial	O
diversity	O
on	O
explanted	O
rhythm	O
heart	O
management	O
devices	O
was	O
investigated	O
and	O
compared	O
to	O
the	O
oral	O
microbiome	O
.	O

A	O
metagenomic	O
approach	O
was	O
used	O
to	O
analyze	O
the	O
bacterial	O
diversity	O
on	O
the	O
surfaces	O
of	O
non	O
-	O
infected	O
and	O
infected	O
pacemakers	O
.	O

The	O
DNA	O
from	O
surfaces	O
swaps	O
of	O
24	O
non	O
-	O
infected	O
and	O
23	O
infected	O
pacemaker	O
were	O
isolated	O
and	O
subjected	O
to	O
bacterial	O
-	O
specific	O
DNA	O
amplification	O
,	O
single	O
strand	O
conformation	O
polymorphism	O
-	O
(	O
SSCP	O
)	O
and	O
sequencing	O
analysis	O
.	O

Species	O
-	O
specific	O
primer	O
sets	O
were	O
used	O
to	O
analyze	O
for	O
any	O
correlation	O
between	O
bacterial	O
diversity	O
on	O
pacemakers	O
and	O
in	O
the	O
oral	O
cavity	O
.	O

DNA	O
of	O
bacterial	O
origin	O
was	O
detected	O
in	O
21	O
cases	O
on	O
infected	O
pacemakers	O
and	O
assigned	O
to	O
the	O
bacterial	O
phylotypes	O
Staphylococcus	B-bacteria
epidermidis	I-bacteria
,	O
Propionibacterium	B-bacteria
acnes	I-bacteria
,	O
Staphylococcus	B-bacteria
aureus	I-bacteria
,	O
Staphylococcus	B-bacteria
schleiferi	I-bacteria
and	O
Stapyhlococcus	B-bacteria
.	O

In	O
17	O
cases	O
bacterial	O
DNA	O
was	O
found	O
on	O
pacemakers	O
with	O
no	O
clinical	O
signs	O
of	O
infections	O
.	O

On	O
the	O
basis	O
of	O
the	O
obtained	O
sequence	O
data	O
,	O
the	O
phylotypes	O
Propionibacterium	B-bacteria
acnes	I-bacteria
,	O
Staphylococcus	B-bacteria
and	O
an	O
uncultured	O
bacterium	O
were	O
identified	O
.	O

Propionibacterium	B-bacteria
acnes	I-bacteria
and	O
Staphylococcus	B-bacteria
epidermidis	I-bacteria
were	O
the	O
only	O
bacteria	O
detected	O
in	O
pacemeaker	O
(	O
n	O
=	O
25	O
)	O
and	O
oral	O
samples	O
(	O
n	O
=	O
11	O
)	O
.	O

The	O
frequency	O
of	O
the	O
coincidental	O
detection	O
of	O
bacteria	O
on	O
infected	O
devices	O
and	O
in	O
the	O
oral	O
cavity	O
is	O
low	O
and	O
the	O
detected	O
bacteria	O
are	O
highly	O
abundant	O
colonizers	O
of	O
non	O
-	O
oral	O
human	O
niches	O
.	O

The	O
transmission	O
of	O
oral	O
bacteria	O
to	O
the	O
lead	O
or	O
device	O
of	O
implantable	O
pacemaker	O
or	O
cardioverter	O
defibrillators	O
is	O
unlikely	O
relevant	O
for	O
the	O
pathogenesis	O
of	O
pacemaker	O
or	O
cardioverter	O
defibrillators	O
infections	O
.	O

Tea	O
has	O
been	O
suggested	O
to	O
promote	O
oral	O
health	O
by	O
inhibiting	O
bacterial	O
attachment	O
to	O
the	O
oral	O
cavity	O
.	O

Most	O
studies	O
have	O
focused	O
on	O
prevention	O
of	O
bacterial	O
attachment	O
to	O
hard	O
surfaces	O
such	O
as	O
enamel	O
.	O

This	O
study	O
investigated	O
the	O
effect	O
of	O
five	O
commercial	O
tea	O
(	O
green	O
,	O
oolong	O
,	O
black	O
,	O
pu	O
-	O
erh	O
and	O
chrysanthemum	O
)	O
extracts	O
and	O
tea	O
components	O
(	O
epigallocatechin	O
gallate	O
and	O
gallic	O
acid	O
)	O
on	O
the	O
attachment	O
of	O
five	O
oral	O
pathogens	O
(	O
Streptococcus	B-bacteria
mutans	I-bacteria
ATCC	I-bacteria
25175	I-bacteria
,	O
Streptococcus	B-bacteria
mutans	I-bacteria
ATCC	I-bacteria
35668	I-bacteria
,	O
Streptococcus	B-bacteria
mitis	I-bacteria
ATCC	I-bacteria
49456	I-bacteria
,	O
Streptococcus	B-bacteria
salivarius	I-bacteria
ATCC	I-bacteria
13419	I-bacteria
and	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
ATCC	I-bacteria
51655	I-bacteria
)	O
to	O
the	O
HGF	O
-	O
1	O
gingival	O
cell	O
line	O
.	O

Extracts	O
of	O
two	O
of	O
the	O
teas	O
(	O
pu	O
-	O
erh	O
and	O
chrysanthemum	O
)	O
significantly	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
reduced	O
attachment	O
of	O
all	O
the	O
Streptococcus	B-bacteria
strains	I-bacteria
by	O
up	O
to	O
4	O
log	O
CFU	O
/	O
well	O
but	O
effects	O
of	O
other	O
teas	O
and	O
components	O
were	O
small	O
.	O

Pu	O
-	O
erh	O
and	O
chrysanthemum	O
tea	O
may	O
have	O
the	O
potential	O
to	O
reduce	O
attachment	O
of	O
oral	O
pathogens	O
to	O
gingival	O
tissue	O
and	O
improve	O
the	O
health	O
of	O
oral	O
soft	O
tissues	O
.	O

Laminaria	O
japonica	O
is	O
a	O
brown	O
alga	O
,	O
which	O
is	O
consumed	O
widely	O
in	O
Korea	O
,	O
Japan	O
,	O
and	O
China	O
.	O

This	O
study	O
investigated	O
the	O
antimicrobial	O
activity	O
of	O
ethanol	O
extracts	O
of	O
L	O
.	O
japonica	O
against	O
oral	O
microbial	O
species	O
to	O
assess	O
the	O
possible	O
application	O
of	O
L	O
.	O
japonica	O
extracts	O
in	O
dental	O
care	O
products	O
.	O

The	O
minimal	O
inhibitory	O
concentration	O
(	O
MIC	O
)	O
and	O
minimal	O
bactericidal	O
concentration	O
(	O
MBC	O
)	O
were	O
determined	O
in	O
culture	O
medium	O
using	O
a	O
microdilution	O
method	O
.	O

The	O
MICs	O
of	O
ethanol	O
extracts	O
of	O
L	O
.	O
japonica	O
with	O
oral	O
streptococci	B-bacteria
were	O
62	O
.	O
5	O
-	O
500	O
mug	O
/	O
ml	O
and	O
the	O
MBCs	O
were	O
125	O
-	O
1000	O
mug	O
/	O
ml	O
.	O

The	O
MICs	O
of	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
and	O
Actinomyces	B-bacteria
odontolyticus	I-bacteria
were	O
250	O
and	O
62	O
.	O
5	O
mug	O
/	O
ml	O
,	O
respectively	O
.	O

The	O
MBCs	O
of	O
A	B-bacteria
.	I-bacteria
naeslundii	I-bacteria
and	O
A	B-bacteria
.	I-bacteria
odontolyticus	I-bacteria
were	O
500	O
and	O
250	O
mug	O
/	O
ml	O
,	O
respectively	O
.	O

The	O
MICs	O
were	O
250	O
and	O
62	O
.	O
5	O
mug	O
/	O
ml	O
for	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
respectively	O
.	O

The	O
killing	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
was	O
dependent	O
on	O
the	O
incubation	O
time	O
.	O

The	O
killing	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
A	B-bacteria
.	I-bacteria
odontolyticus	I-bacteria
,	O
and	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
was	O
significantly	O
dependent	O
on	O
the	O
extract	O
concentration	O
.	O

Bacterial	O
treatment	O
with	O
L	O
.	O
japonica	O
extracts	O
changed	O
the	O
cell	O
surface	O
texture	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
A	B-bacteria
.	I-bacteria
odontolyticus	I-bacteria
,	O
and	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
.	O

The	O
results	O
of	O
this	O
study	O
suggest	O
that	O
L	O
.	O
japonica	O
extracts	O
may	O
be	O
useful	O
for	O
the	O
development	O
of	O
antimicrobial	O
agents	O
to	O
combat	O
oral	O
pathogens	O
.	O

The	O
human	O
oral	O
cavity	O
has	O
an	O
indigenous	O
microbiota	O
known	O
to	O
include	O
a	O
robust	O
community	O
of	O
viruses	O
.	O

Very	O
little	O
is	O
known	O
about	O
how	O
oral	O
viruses	O
are	O
spread	O
throughout	O
the	O
environment	O
or	O
to	O
which	O
viruses	O
individuals	O
are	O
exposed	O
.	O

We	O
sought	O
to	O
determine	O
whether	O
shared	O
living	O
environment	O
is	O
associated	O
with	O
the	O
composition	O
of	O
human	O
oral	O
viral	O
communities	O
by	O
examining	O
the	O
saliva	O
of	O
21	O
human	O
subjects	O
;	O
11	O
subjects	O
from	O
different	O
households	O
and	O
10	O
unrelated	O
subjects	O
comprising	O
4	O
separate	O
households	O
.	O

Although	O
there	O
were	O
many	O
viral	O
homologues	O
shared	O
among	O
all	O
subjects	O
studied	O
,	O
there	O
were	O
significant	O
patterns	O
of	O
shared	O
homologues	O
in	O
three	O
of	O
the	O
four	O
households	O
that	O
suggest	O
shared	O
living	O
environment	O
affects	O
viral	O
community	O
composition	O
.	O

We	O
also	O
examined	O
CRISPR	O
(	O
clustered	O
regularly	O
interspaced	O
short	O
palindromic	O
repeat	O
)	O
loci	O
,	O
which	O
are	O
involved	O
in	O
acquired	O
bacterial	O
and	O
archaeal	O
resistance	O
against	O
invading	O
viruses	O
by	O
acquiring	O
short	O
viral	O
sequences	O
.	O

We	O
analyzed	O
2	O
065	O
246	O
CRISPR	O
spacers	O
from	O
5	O
separate	O
repeat	O
motifs	O
found	O
in	O
oral	O
bacterial	O
species	O
of	O
Gemella	B-bacteria
,	O
Veillonella	B-bacteria
,	O
Leptotrichia	B-bacteria
and	O
Streptococcus	B-bacteria
to	O
determine	O
whether	O
individuals	O
from	O
shared	O
living	O
environments	O
may	O
have	O
been	O
exposed	O
to	O
similar	O
viruses	O
.	O

A	O
significant	O
proportion	O
of	O
CRISPR	O
spacers	O
were	O
shared	O
within	O
subjects	O
from	O
the	O
same	O
households	O
,	O
suggesting	O
either	O
shared	O
ancestry	O
of	O
their	O
oral	O
microbiota	O
or	O
similar	O
viral	O
exposures	O
.	O

Many	O
CRISPR	O
spacers	O
matched	O
virome	O
sequences	O
from	O
different	O
subjects	O
,	O
but	O
no	O
pattern	O
specific	O
to	O
any	O
household	O
was	O
found	O
.	O

Our	O
data	O
on	O
viromes	O
and	O
CRISPR	O
content	O
indicate	O
that	O
shared	O
living	O
environment	O
may	O
have	O
a	O
significant	O
role	O
in	O
determining	O
the	O
ecology	O
of	O
human	O
oral	O
viruses	O
.	O

Helicobacter	B-bacteria
pylori	I-bacteria
since	O
Marshall	O
and	O
Warren	O
'	O
s	O
discovery	O
has	O
been	O
an	O
object	O
of	O
interest	O
of	O
gastroenterologists	O
and	O
many	O
researchers	O
of	O
other	O
specialties	O
.	O

What	O
needs	O
to	O
be	O
highlighted	O
is	O
also	O
the	O
growing	O
interest	O
of	O
dentists	O
in	O
the	O
role	O
of	O
oral	O
residue	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
oral	O
pathologies	O
such	O
as	O
burning	O
mouth	O
syndrome	O
,	O
periodontitis	O
and	O
gingivitis	O
.	O

With	O
the	O
development	O
of	O
medical	O
techniques	O
more	O
studies	O
using	O
highly	O
specific	O
diagnostic	O
methods	O
are	O
performed	O
in	O
order	O
to	O
determine	O
the	O
transmission	O
pattern	O
of	O
bacterial	O
infection	O
.	O

Suggested	O
faecal	O
-	O
oral	O
and	O
oral	O
-	O
oral	O
routes	O
of	O
bacterial	O
transmission	O
raised	O
interest	O
in	O
molecular	O
biology	O
methods	O
as	O
tools	O
for	O
the	O
study	O
of	O
these	O
environments	O
.	O

Additionally	O
,	O
co	O
-	O
existence	O
of	O
helical	O
and	O
coccoidal	O
forms	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
the	O
mentioned	O
niches	O
raised	O
the	O
question	O
whether	O
the	O
latter	O
is	O
potentially	O
pathogenic	O
.	O

This	O
is	O
why	O
molecular	O
biology	O
is	O
now	O
giving	O
a	O
great	O
opportunity	O
to	O
explore	O
parts	O
of	O
the	O
human	O
body	O
that	O
could	O
not	O
have	O
been	O
diagnosed	O
before	O
using	O
only	O
gold	O
standard	O
diagnostic	O
methods	O
.	O

Molecular	O
techniques	O
have	O
shown	O
their	O
usefulness	O
in	O
examining	O
the	O
potential	O
virulence	O
of	O
coccoid	O
forms	O
of	O
bacterium	O
.	O

This	O
review	O
was	O
created	O
also	O
to	O
summarize	O
the	O
knowledge	O
about	O
molecular	O
methods	O
,	O
especially	O
different	O
PCR	O
techniques	O
,	O
as	O
diagnostic	O
tools	O
that	O
can	O
help	O
medical	O
teams	O
during	O
regular	O
diagnosis	O
of	O
gastritis	O
.	O

The	O
link	O
between	O
oral	O
infections	O
and	O
adverse	O
systemic	O
conditions	O
has	O
attracted	O
much	O
attention	O
in	O
the	O
research	O
community	O
.	O

Several	O
mechanisms	O
have	O
been	O
proposed	O
,	O
including	O
spread	O
of	O
the	O
oral	O
infection	O
due	O
to	O
transient	O
bacteremia	O
resulting	O
in	O
bacterial	O
colonization	O
in	O
extra	O
-	O
oral	O
sites	O
,	O
systemic	O
injury	O
by	O
free	O
toxins	O
of	O
oral	O
pathogens	O
,	O
and	O
systemic	O
inflammation	O
caused	O
by	O
soluble	O
antigens	O
of	O
oral	O
pathogens	O
.	O

Mounting	O
evidence	O
supports	O
a	O
major	O
role	O
of	O
the	O
systemic	O
spread	O
of	O
oral	O
commensals	O
and	O
pathogens	O
to	O
distant	O
body	O
sites	O
causing	O
extra	O
-	O
oral	O
infections	O
and	O
inflammation	O
.	O

We	O
review	O
here	O
the	O
most	O
recent	O
findings	O
on	O
systemic	O
infections	O
and	O
inflammation	O
complicated	O
by	O
oral	O
bacteria	O
,	O
including	O
cardiovascular	O
disease	O
,	O
adverse	O
pregnancy	O
outcomes	O
,	O
rheumatoid	O
arthritis	O
,	O
inflammatory	O
bowel	O
disease	O
and	O
colorectal	O
cancer	O
,	O
respiratory	O
tract	O
infections	O
,	O
and	O
organ	O
inflammations	O
and	O
abscesses	O
.	O

The	O
recently	O
identified	O
virulence	O
mechanisms	O
of	O
oral	O
species	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
and	O
Campylobacter	B-bacteria
rectus	I-bacteria
are	O
also	O
reviewed	O
.	O

A	O
pattern	O
emerges	O
indicating	O
that	O
only	O
select	O
subtype	O
(	O
s	O
)	O
of	O
a	O
given	O
species	O
,	O
e	O
.	O
g	O
.	O
,	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
subspecies	I-bacteria
animalis	I-bacteria
and	I-bacteria
polymorphum	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
non	O
-	O
c	O
serotypes	O
,	O
are	O
prone	O
to	O
extra	O
-	O
oral	O
translocation	O
.	O

These	O
findings	O
advocate	O
the	O
importance	O
of	O
identification	O
and	O
quantification	O
of	O
potential	O
pathogens	O
at	O
the	O
subtype	O
levels	O
for	O
accurate	O
prediction	O
of	O
disease	O
potential	O
.	O

Ethanol	O
consumption	O
and	O
poor	O
oral	O
hygiene	O
are	O
risk	O
factors	O
for	O
oral	O
and	O
oesophageal	O
cancers	O
.	O

Although	O
oral	O
streptococci	B-bacteria
have	O
been	O
found	O
to	O
produce	O
excessive	O
acetaldehyde	O
from	O
ethanol	O
,	O
little	O
is	O
known	O
about	O
the	O
mechanism	O
by	O
which	O
this	O
carcinogen	O
is	O
produced	O
.	O

By	O
screening	O
52	O
strains	O
of	O
diverse	O
oral	O
streptococcal	B-bacteria
species	I-bacteria
,	O
we	O
identified	O
Streptococcus	B-bacteria
gordonii	I-bacteria
V2016	I-bacteria
that	O
produced	O
the	O
most	O
acetaldehyde	O
from	O
ethanol	O
.	O

We	O
then	O
constructed	O
gene	O
deletion	O
mutants	O
in	O
this	O
strain	O
and	O
analysed	O
them	O
for	O
alcohol	O
and	O
acetaldehyde	O
dehydrogenases	O
by	O
zymograms	O
.	O

The	O
results	O
showed	O
that	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
V2016	I-bacteria
expressed	O
three	O
primary	O
alcohol	O
dehydrogenases	O
,	O
AdhA	O
,	O
AdhB	O
and	O
AdhE	O
,	O
which	O
all	O
oxidize	O
ethanol	O
to	O
acetaldehyde	O
,	O
but	O
their	O
preferred	O
substrates	O
were	O
1	O
-	O
propanol	O
,	O
1	O
-	O
butanol	O
and	O
ethanol	O
,	O
respectively	O
.	O

Two	O
additional	O
dehydrogenases	O
,	O
S	O
-	O
AdhA	O
and	O
TdhA	O
,	O
were	O
identified	O
with	O
specificities	O
to	O
the	O
secondary	O
alcohol	O
2	O
-	O
propanol	O
and	O
threonine	O
,	O
respectively	O
,	O
but	O
not	O
to	O
ethanol	O
.	O

S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
V2016	I-bacteria
did	O
not	O
show	O
a	O
detectable	O
acetaldehyde	O
dehydrogenase	O
even	O
though	O
its	O
adhE	O
gene	O
encodes	O
a	O
putative	O
bifunctional	O
acetaldehyde	O
/	O
alcohol	O
dehydrogenase	O
.	O

Mutants	O
with	O
adhE	O
deletion	O
showed	O
greater	O
tolerance	O
to	O
ethanol	O
in	O
comparison	O
with	O
the	O
wild	O
-	O
type	O
and	O
mutant	O
with	O
adhA	O
or	O
adhB	O
deletion	O
,	O
indicating	O
that	O
AdhE	O
is	O
the	O
major	O
alcohol	O
dehydrogenase	O
in	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
.	O

Analysis	O
of	O
19	O
additional	O
strains	O
of	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
oralis	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
showed	O
expressions	O
of	O
up	O
to	O
three	O
alcohol	O
dehydrogenases	O
,	O
but	O
none	O
showed	O
detectable	O
acetaldehyde	O
dehydrogenase	O
,	O
except	O
one	O
strain	O
that	O
showed	O
a	O
novel	O
ALDH	O
.	O

Therefore	O
,	O
expression	O
of	O
multiple	O
alcohol	O
dehydrogenases	O
but	O
no	O
functional	O
acetaldehyde	O
dehydrogenase	O
may	O
contribute	O
to	O
excessive	O
production	O
of	O
acetaldehyde	O
from	O
ethanol	O
by	O
certain	O
oral	O
streptococci	B-bacteria
.	O

The	O
aim	O
of	O
the	O
current	O
study	O
was	O
to	O
investigate	O
the	O
presence	O
of	O
sulphate	B-bacteria
-	I-bacteria
reducing	I-bacteria
bacteria	I-bacteria
(	O
SRB	B-bacteria
)	O
in	O
human	O
saliva	O
and	O
correlate	O
with	O
oral	O
and	O
systemic	O
conditions	O
.	O

Saliva	O
samples	O
were	O
collected	O
from	O
118	O
patients	O
and	O
inoculated	O
in	O
2	O
ml	O
of	O
modified	O
Postgate	O
'	O
s	O
E	O
medium	O
culture	O
.	O

After	O
28	O
days	O
of	O
incubation	O
at	O
30	O
degrees	O
C	O
the	O
presence	O
of	O
SRB	B-bacteria
was	O
identified	O
by	O
the	O
production	O
of	O
sulphide	O
.	O

Of	O
118	O
saliva	O
samples	O
collected	O
,	O
35	O
were	O
positive	O
for	O
the	O
presence	O
of	O
SRB	B-bacteria
.	O

Three	O
positive	O
samples	O
were	O
randomly	O
chosen	O
to	O
identify	O
the	O
species	O
of	O
SRB	B-bacteria
by	O
PCR	O
and	O
sequenced	O
.	O

The	O
three	O
selected	O
samples	O
were	O
identified	O
as	O
Desulfovibrio	B-bacteria
fairfieldensis	I-bacteria
,	O
Desulfovibrio	B-bacteria
desulfuricans	I-bacteria
and	O
Raoultella	B-bacteria
ornithinolytic	I-bacteria
.	O

Gastritis	O
(	O
14	O
.	O
4	O
%	O
)	O
was	O
the	O
most	O
prevalent	O
systemic	O
disease	O
,	O
followed	O
by	O
diabetes	O
(	O
3	O
.	O
4	O
%	O
)	O
,	O
while	O
periodontitis	O
(	O
11	O
%	O
)	O
and	O
traumatic	O
fibroma	O
(	O
4	O
.	O
2	O
%	O
)	O
were	O
the	O
oral	O
manifestations	O
most	O
frequently	O
found	O
.	O

A	O
bivariate	O
analysis	O
was	O
performed	O
to	O
examine	O
for	O
the	O
presence	O
of	O
SRB	B-bacteria
and	O
the	O
most	O
prevalent	O
systemic	O
and	O
oral	O
manifestations	O
.	O

Only	O
periodontitis	O
showed	O
a	O
statistically	O
significant	O
association	O
(	O
p	O
=	O
0	O
.	O
0003	O
)	O
.	O

The	O
results	O
showed	O
SRB	B-bacteria
can	O
be	O
found	O
in	O
oral	O
microbiota	O
of	O
healthy	O
patients	O
.	O

Regarding	O
the	O
several	O
conditions	O
studied	O
,	O
there	O
was	O
a	O
higher	O
prevalence	O
of	O
SRB	B-bacteria
in	O
patients	O
with	O
gastritis	O
and	O
patients	O
with	O
periodontal	O
disease	O
,	O
with	O
a	O
possible	O
correlation	O
between	O
the	O
presence	O
of	O
SRB	B-bacteria
in	O
the	O
oral	O
microbiota	O
and	O
periodontal	O
disease	O
.	O

Oral	O
cavity	O
has	O
been	O
proposed	O
as	O
an	O
important	O
reservoir	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
,	O
being	O
implicated	O
in	O
bacterial	O
transmission	O
through	O
oral	O
-	O
oral	O
route	O
.	O

However	O
,	O
some	O
investigators	O
believe	O
that	O
the	O
newborn	O
acquires	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
from	O
mother	O
through	O
vaginal	O
delivery	O
.	O

In	O
this	O
study	O
,	O
oral	O
and	O
vaginal	O
yeasts	O
were	O
examined	O
for	O
the	O
intracellular	O
occurrence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
and	O
their	O
possible	O
role	O
in	O
bacterial	O
transmission	O
.	O

Sixty	O
nine	O
oral	O
and	O
vaginal	O
yeasts	O
from	O
expecting	O
mothers	O
(	O
39	O
oral	O
and	O
30	O
vaginal	O
)	O
and	O
seven	O
oral	O
yeasts	O
from	O
neonates	O
(	O
6	O
/	O
46	O
vaginal	O
delivery	O
,	O
1	O
/	O
43	O
cesarean	O
)	O
were	O
identified	O
and	O
studied	O
by	O
light	O
and	O
fluorescent	O
microscopy	O
for	O
observing	O
the	O
intracellular	O
bacterium	O
-	O
like	O
bodies	O
(	O
BLBs	O
)	O
.	O

Whole	O
DNAs	O
of	O
yeasts	O
were	O
recruited	O
for	O
detection	O
of	O
H	O
.	O
pylori	O
-	O
specific	O
genes	O
.	O

Urea	O
breath	O
test	O
(	O
UBT	O
)	O
was	O
performed	O
for	O
detection	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
infection	O
in	O
mothers	O
.	O

Stool	O
antigen	O
test	O
(	O
SAT	O
)	O
was	O
used	O
for	O
detection	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
antigens	O
in	O
infants	O
'	O
stool	O
at	O
birth	O
and	O
six	O
months	O
of	O
age	O
.	O

Oral	O
yeasts	O
were	O
isolated	O
more	O
frequently	O
from	O
normally	O
-	O
delivered	O
neonates	O
.	O

The	O
frequency	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
genes	O
in	O
mothers	O
'	O
vaginal	O
yeasts	O
was	O
significantly	O
higher	O
than	O
in	O
mothers	O
'	O
oral	O
yeasts	O
.	O

A	O
significant	O
correlation	O
was	O
found	O
between	O
the	O
occurrence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
genes	O
in	O
vaginal	O
yeasts	O
and	O
that	O
in	O
neonates	O
'	O
oral	O
yeasts	O
,	O
occurrence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
genes	O
in	O
mothers	O
'	O
vaginal	O
yeasts	O
or	O
neonates	O
'	O
oral	O
yeasts	O
,	O
and	O
UBT	O
+	O
results	O
in	O
mothers	O
.	O

C	O
.	O
albicans	O
which	O
colonizes	O
the	O
oral	O
cavity	O
of	O
neonates	O
through	O
vaginal	O
delivery	O
or	O
contact	O
with	O
environment	O
or	O
healthcare	O
workers	O
could	O
be	O
an	O
important	O
reservoir	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
.	O

Vaginal	O
yeasts	O
are	O
more	O
potent	O
in	O
accommodating	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
than	O
oral	O
yeasts	O
.	O

Accordingly	O
,	O
vaginal	O
yeast	O
is	O
proposed	O
as	O
the	O
primary	O
reservoir	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
which	O
facilitates	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
transmission	O
to	O
neonates	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
assess	O
the	O
red	O
autofluorescence	O
from	O
bacterial	O
species	O
related	O
to	O
dental	O
caries	O
and	O
periodontitis	O
in	O
the	O
presence	O
of	O
different	O
nutrients	O
in	O
the	O
growth	O
medium	O
.	O

Bacteria	O
were	O
grown	O
anaerobically	O
on	O
tryptic	O
soy	O
agar	O
(	O
TSA	O
)	O
supplemented	O
with	O
nutrients	O
,	O
including	O
magnesium	O
-	O
porphyrins	O
from	O
spinach	O
and	O
iron	O
-	O
porphyrins	O
from	O
heme	O
.	O

The	O
autofluorescence	O
was	O
then	O
assessed	O
at	O
405	O
nm	O
excitation	O
.	O

On	O
the	O
TSA	O
without	O
additives	O
,	O
no	O
autofluorescence	O
was	O
observed	O
from	O
any	O
of	O
the	O
species	O
tested	O
.	O

On	O
the	O
TSA	O
containing	O
sheep	O
blood	O
,	O
red	O
autofluorescence	O
was	O
observed	O
only	O
from	O
Parvimonas	B-bacteria
micra	I-bacteria
.	O

When	O
the	O
TSA	O
was	O
supplemented	O
with	O
blood	O
,	O
hemin	O
,	O
and	O
vitamin	O
K	O
,	O
red	O
autofluorescence	O
was	O
observed	O
from	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
,	O
Bifidobacterium	B-bacteria
dentium	I-bacteria
,	O
and	O
Streptococcus	B-bacteria
mutans	I-bacteria
.	O

Finally	O
,	O
on	O
the	O
TSA	O
supplemented	O
with	O
spinach	O
extract	O
,	O
red	O
autofluorescence	O
was	O
observed	O
from	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
A	B-bacteria
.	I-bacteria
naeslundii	I-bacteria
,	O
Enterococcus	B-bacteria
faecalis	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
Lactobacillus	B-bacteria
salivarius	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
and	O
Veillonella	B-bacteria
parvula	I-bacteria
.	O

We	O
conclude	O
that	O
the	O
bacteria	O
related	O
to	O
dental	O
caries	O
and	O
periodontal	O
disease	O
exhibit	O
red	O
autofluorescence	O
.	O

The	O
autofluorescence	O
characteristics	O
of	O
the	O
tested	O
strains	O
depended	O
on	O
the	O
nutrients	O
present	O
,	O
such	O
as	O
metalloporphyrins	O
,	O
suggesting	O
that	O
the	O
metabolic	O
products	O
of	O
the	O
oral	O
biofilm	O
could	O
be	O
responsible	O
for	O
red	O
autofluorescence	O
.	O

Approximately	O
15	O
%	O
of	O
human	O
deaths	O
from	O
cancer	O
are	O
associated	O
with	O
chronic	O
viral	O
or	O
bacterial	O
infections	O
.	O

Helicobacter	B-bacteria
pylori	I-bacteria
(	O
HP	B-bacteria
)	O
,	O
a	O
flagellated	O
,	O
Gram	O
-	O
negative	O
,	O
spiral	O
,	O
microaerophilic	O
bacteria	O
is	O
considered	O
to	O
be	O
the	O
most	O
common	O
chronic	O
bacterial	O
infection	O
in	O
humans	O
.	O

Toll	O
-	O
like	O
receptor	O
5	O
(	O
TLR5	O
)	O
is	O
involved	O
in	O
recognition	O
of	O
bacterial	O
flagella	O
and	O
is	O
thought	O
to	O
promote	O
tumour	O
growth	O
through	O
inflammation	O
-	O
dependent	O
mechanisms	O
in	O
epithelial	O
cells	O
.	O

Expression	O
of	O
HP	B-bacteria
and	O
TLR5	O
was	O
analysed	O
in	O
OSCC	O
specimen	O
(	O
n	O
=	O
191	O
)	O
by	O
immunohistochemistry	O
.	O

TLR5	O
expression	O
specificity	O
was	O
conducted	O
by	O
Western	O
blotting	O
in	O
cancer	O
cell	O
lines	O
(	O
BICR3	O
,	O
BICR56	O
)	O
.	O

TLR5	O
-	O
stained	O
sections	O
were	O
scanned	O
and	O
digitally	O
analysed	O
using	O
ImageJ	O
and	O
the	O
immunomembrane	O
plug	O
-	O
in	O
.	O

HP	B-bacteria
expression	O
and	O
TLR5	O
expression	O
were	O
associated	O
with	O
clinicopathological	O
characteristics	O
and	O
impact	O
on	O
survival	O
.	O

Helicobacter	B-bacteria
pylori	I-bacteria
detection	O
was	O
significantly	O
associated	O
with	O
recurrence	O
of	O
the	O
tumour	O
,	O
whereas	O
TLR5	O
expression	O
was	O
not	O
.	O

Multivariate	O
analysis	O
demonstrated	O
HP	B-bacteria
expression	O
as	O
an	O
independent	O
prognostic	O
factor	O
(	O
P	O
=	O
0	O
.	O
0260	O
)	O
.	O

TLR5	O
specificity	O
was	O
confirmed	O
by	O
Western	O
blot	O
analysis	O
.	O

For	O
the	O
first	O
time	O
,	O
this	O
study	O
provides	O
evidence	O
that	O
immunohistochemically	O
detected	O
HP	B-bacteria
expression	O
in	O
OSCC	O
is	O
associated	O
with	O
reduced	O
disease	O
-	O
free	O
survival	O
in	O
a	O
large	O
patient	O
cohort	O
.	O

Although	O
TLR5	O
was	O
not	O
associated	O
with	O
any	O
clinicopathological	O
characteristics	O
or	O
impact	O
on	O
survival	O
,	O
investigation	O
of	O
the	O
TLR	O
family	O
seems	O
to	O
be	O
reasonable	O
due	O
to	O
the	O
possible	O
existence	O
of	O
other	O
pathogenic	O
bacterial	O
or	O
viral	O
compounds	O
in	O
oral	O
cavity	O
cancer	O
.	O

There	O
is	O
a	O
paucity	O
of	O
data	O
in	O
relation	O
to	O
the	O
possible	O
emergence	O
of	O
triclosan	O
(	O
TCS	O
)	O
-	O
resistant	O
bacteria	O
following	O
long	O
-	O
term	O
exposure	O
to	O
TCS	O
toothpaste	O
.	O

Therefore	O
,	O
this	O
study	O
investigated	O
whether	O
long	O
-	O
term	O
continuous	O
exposure	O
to	O
TCS	O
in	O
toothpaste	O
selects	O
for	O
TCS	O
-	O
resistant	O
bacteria	O
within	O
the	O
oral	O
biofilm	O
.	O

Dental	O
plaque	O
samples	O
were	O
collected	O
from	O
40	O
individuals	O
during	O
year	O
5	O
of	O
a	O
randomised	O
controlled	O
trial	O
.	O

Participants	O
had	O
been	O
randomly	O
assigned	O
to	O
use	O
TCS	O
(	O
3000	O
mug	O
/	O
mL	O
TCS	O
)	O
(	O
n	O
=	O
18	O
)	O
or	O
placebo	O
toothpaste	O
(	O
n	O
=	O
22	O
)	O
.	O

Diluted	O
plaque	O
samples	O
were	O
plated	O
on	O
to	O
Wilkins	O
-	O
Chalgren	O
agar	O
plates	O
containing	O
5	O
%	O
(	O
v	O
/	O
v	O
)	O
laked	O
sheep	O
red	O
blood	O
cells	O
and	O
TCS	O
(	O
concentrations	O
ranging	O
from	O
25	O
to	O
150	O
mug	O
/	O
mL	O
)	O
and	O
incubated	O
at	O
37	O
degrees	O
C	O
under	O
microaerophilic	O
and	O
anaerobic	O
conditions	O
for	O
2	O
-	O
10	O
d	O
.	O
Selected	O
bacterial	O
isolates	O
were	O
identified	O
by	O
partial	O
16S	O
rDNA	O
sequencing	O
and	O
TCS	O
minimum	O
inhibitory	O
concentration	O
(	O
MIC	O
)	O
determined	O
for	O
each	O
isolate	O
.	O

At	O
3000	O
mug	O
/	O
mL	O
TCS	O
no	O
growth	O
was	O
observed	O
under	O
microaerophilic	O
or	O
anaerobic	O
conditions	O
in	O
either	O
group	O
.	O

The	O
MICs	O
of	O
TCS	O
for	O
all	O
isolates	O
ranged	O
from	O
125	O
to	O
1000	O
mug	O
/	O
mL	O
in	O
both	O
groups	O
.	O

Species	O
common	O
to	O
both	O
groups	O
had	O
similar	O
MICs	O
.	O

Veillonella	B-bacteria
parvula	I-bacteria
and	O
Campylobacter	B-bacteria
gracilis	I-bacteria
were	O
the	O
most	O
frequent	O
isolates	O
from	O
both	O
groups	O
,	O
with	O
similar	O
MICs	O
in	O
both	O
groups	O
.	O

The	O
use	O
of	O
TCS	O
-	O
containing	O
toothpaste	O
did	O
not	O
appear	O
to	O
lead	O
to	O
an	O
increase	O
in	O
MIC	O
of	O
TCS	O
of	O
oral	O
bacterial	O
isolates	O
.	O

Molecular	O
biological	O
modalities	O
with	O
better	O
detection	O
rates	O
have	O
been	O
applied	O
to	O
identify	O
the	O
bacteria	O
causing	O
infectious	O
diseases	O
.	O

Approximately	O
10	O
-	O
48	O
%	O
of	O
bacterial	O
pathogens	O
causing	O
community	O
-	O
acquired	O
pneumonia	O
are	O
not	O
identified	O
using	O
conventional	O
cultivation	O
methods	O
.	O

This	O
study	O
evaluated	O
the	O
bacteriological	O
causes	O
of	O
community	O
-	O
acquired	O
pneumonia	O
using	O
a	O
cultivation	O
-	O
independent	O
clone	O
library	O
analysis	O
of	O
the	O
16S	O
ribosomal	O
RNA	O
gene	O
of	O
bronchoalveolar	O
lavage	O
specimens	O
,	O
and	O
compared	O
the	O
results	O
with	O
those	O
of	O
conventional	O
cultivation	O
methods	O
.	O

Patients	O
with	O
community	O
-	O
acquired	O
pneumonia	O
were	O
enrolled	O
based	O
on	O
their	O
clinical	O
and	O
radiological	O
findings	O
.	O

Bronchoalveolar	O
lavage	O
specimens	O
were	O
collected	O
from	O
pulmonary	O
pathological	O
lesions	O
using	O
bronchoscopy	O
and	O
evaluated	O
by	O
both	O
a	O
culture	O
-	O
independent	O
molecular	O
method	O
and	O
conventional	O
cultivation	O
methods	O
.	O

For	O
the	O
culture	O
-	O
independent	O
molecular	O
method	O
,	O
approximately	O
600	O
base	O
pairs	O
of	O
16S	O
ribosomal	O
RNA	O
genes	O
were	O
amplified	O
using	O
polymerase	O
chain	O
reaction	O
with	O
universal	O
primers	O
,	O
followed	O
by	O
the	O
construction	O
of	O
clone	O
libraries	O
.	O

The	O
nucleotide	O
sequences	O
of	O
96	O
clones	O
randomly	O
chosen	O
for	O
each	O
specimen	O
were	O
determined	O
,	O
and	O
bacterial	O
homology	O
was	O
searched	O
.	O

Conventional	O
cultivation	O
methods	O
,	O
including	O
anaerobic	O
cultures	O
,	O
were	O
also	O
performed	O
using	O
the	O
same	O
specimens	O
.	O

In	O
addition	O
to	O
known	O
common	O
pathogens	O
of	O
community	O
-	O
acquired	O
pneumonia	O
[	O
Streptococcus	B-bacteria
pneumoniae	I-bacteria
(	O
18	O
.	O
8	O
%	O
)	O
,	O
Haemophilus	B-bacteria
influenzae	I-bacteria
(	O
18	O
.	O
8	O
%	O
)	O
,	O
Mycoplasma	B-bacteria
pneumoniae	I-bacteria
(	O
17	O
.	O
2	O
%	O
)	O
]	O
,	O
molecular	O
analysis	O
of	O
specimens	O
from	O
64	O
patients	O
with	O
community	O
-	O
acquired	O
pneumonia	O
showed	O
relatively	O
higher	O
rates	O
of	O
anaerobes	O
(	O
15	O
.	O
6	O
%	O
)	O
and	O
oral	O
bacteria	O
(	O
15	O
.	O
6	O
%	O
)	O
than	O
previous	O
reports	O
.	O

Our	O
findings	O
suggest	O
that	O
anaerobes	O
and	O
oral	O
bacteria	O
are	O
more	O
frequently	O
detected	O
in	O
patients	O
with	O
community	O
-	O
acquired	O
pneumonia	O
than	O
previously	O
believed	O
.	O

It	O
is	O
possible	O
that	O
these	O
bacteria	O
may	O
play	O
more	O
important	O
roles	O
in	O
community	O
-	O
acquired	O
pneumonia	O
.	O

We	O
aimed	O
to	O
determine	O
the	O
bacterial	O
diversity	O
of	O
different	O
oral	O
micro	O
-	O
niches	O
and	O
to	O
assess	O
whether	O
saliva	O
and	O
plaque	O
samples	O
are	O
representative	O
of	O
oral	O
microbial	O
composition	O
.	O

We	O
took	O
minute	O
samples	O
from	O
each	O
surface	O
of	O
the	O
individual	O
teeth	O
and	O
gingival	O
crevices	O
of	O
two	O
healthy	O
volunteers	O
(	O
112	O
samples	O
per	O
donor	O
)	O
,	O
as	O
well	O
as	O
samples	O
from	O
the	O
tongue	O
dorsum	O
and	O
non	O
-	O
stimulated	O
and	O
stimulated	O
saliva	O
.	O

DNA	O
was	O
extracted	O
from	O
67	O
selected	O
samples	O
of	O
each	O
donor	O
,	O
and	O
the	O
16S	O
rRNA	O
gene	O
was	O
amplified	O
by	O
PCR	O
and	O
pyrosequenced	O
to	O
obtain	O
,	O
on	O
average	O
,	O
over	O
2	O
,	O
700	O
reads	O
per	O
sample	O
,	O
which	O
were	O
taxonomically	O
assigned	O
to	O
obtain	O
a	O
geographic	O
map	O
of	O
bacterial	O
diversity	O
at	O
each	O
tooth	O
and	O
sulcus	O
location	O
.	O

Analysis	O
of	O
the	O
data	O
shows	O
considerable	O
differences	O
in	O
bacterial	O
composition	O
between	O
teeth	O
at	O
different	O
intra	O
-	O
oral	O
locations	O
and	O
between	O
surfaces	O
of	O
the	O
same	O
tooth	O
.	O

The	O
most	O
pronounced	O
differences	O
were	O
observed	O
in	O
incisors	O
and	O
canines	O
,	O
where	O
genera	O
like	O
Streptococcus	B-bacteria
were	O
found	O
at	O
40	O
%	O
to	O
70	O
%	O
on	O
the	O
vestibular	O
surfaces	O
but	O
were	O
almost	O
absent	O
on	O
the	O
lingual	O
sides	O
.	O

Saliva	O
samples	O
,	O
especially	O
non	O
-	O
stimulated	O
saliva	O
,	O
were	O
not	O
representative	O
of	O
supra	O
-	O
and	O
subgingival	O
plaque	O
in	O
the	O
two	O
individuals	O
tested	O
.	O

We	O
suggest	O
that	O
more	O
precise	O
sampling	O
is	O
required	O
for	O
the	O
proper	O
determination	O
of	O
oral	O
microbial	O
composition	O
and	O
to	O
relate	O
that	O
diversity	O
to	O
epidemiological	O
,	O
clinical	O
,	O
and	O
etiological	O
parameters	O
.	O

Streptococcus	B-bacteria
mutans	I-bacteria
can	O
aggravate	O
colitis	O
in	O
mice	O
.	O

We	O
evaluated	O
the	O
virulence	O
of	O
colitis	O
using	O
type	O
strains	O
as	O
well	O
as	O
blood	O
isolates	O
of	O
several	O
oral	O
streptococcal	B-bacteria
species	I-bacteria
.	O

We	O
investigated	O
the	O
susceptibility	O
of	O
blood	O
isolates	O
of	O
several	O
oral	O
streptococci	B-bacteria
to	O
phagocytosis	O
,	O
adhesion	O
to	O
and	O
invasion	O
of	O
hepatic	O
cells	O
and	O
interferon	O
-	O
gamma	O
secretion	O
.	O

A	O
mouse	O
model	O
of	O
dextran	O
sodium	O
sulphate	O
-	O
induced	O
colitis	O
was	O
used	O
to	O
evaluate	O
bacterial	O
aggravation	O
of	O
colitis	O
.	O

In	O
addition	O
,	O
interferon	O
-	O
gamma	O
antibody	O
was	O
administered	O
to	O
mice	O
with	O
prominent	O
aggravation	O
of	O
colitis	O
.	O

In	O
vitro	O
analyses	O
showed	O
that	O
Streptococcus	B-bacteria
sanguinis	I-bacteria
ATCC	I-bacteria
10556	I-bacteria
was	O
a	O
possible	O
virulent	O
strain	O
among	O
type	O
strains	O
of	O
several	O
oral	O
streptococci	B-bacteria
,	O
and	O
that	O
analysis	O
of	O
blood	O
isolates	O
of	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
TW289	I-bacteria
revealed	O
a	O
potential	O
virulent	O
strain	O
.	O

Intravenous	O
administration	O
of	O
ATCC	B-bacteria
10556	I-bacteria
and	O
TW289	B-bacteria
caused	O
prominent	O
aggravation	O
of	O
dextran	O
sodium	O
sulphate	O
-	O
induced	O
colitis	O
,	O
and	O
histopathological	O
examinations	O
showed	O
that	O
interferon	O
-	O
gamma	O
secretion	O
due	O
to	O
infection	O
of	O
hepatic	O
cells	O
caused	O
colitis	O
aggravation	O
.	O

Administration	O
of	O
interferon	O
-	O
gamma	O
antibody	O
suppressed	O
TW289	O
-	O
induced	O
colitis	O
.	O

These	O
results	O
suggest	O
that	O
some	O
virulent	O
oral	O
streptococcal	B-bacteria
strains	I-bacteria
are	O
associated	O
with	O
the	O
aggravation	O
of	O
colitis	O
induced	O
by	O
enhanced	O
secretion	O
of	O
interferon	O
-	O
gamma	O
when	O
they	O
invade	O
the	O
bloodstream	O
.	O

In	O
this	O
study	O
,	O
we	O
introduced	O
species	O
-	O
specific	O
quantitative	O
real	O
-	O
time	O
PCR	O
(	O
qPCR	O
)	O
primers	O
designed	O
based	O
on	O
a	O
DNA	O
-	O
dependent	O
RNA	O
polymerase	O
beta	O
-	O
subunit	O
gene	O
(	O
rpoB	O
)	O
for	O
detecting	O
42	O
oral	O
bacterial	O
species	O
.	O

The	O
specificity	O
of	O
the	O
qPCR	O
primers	O
was	O
confirmed	O
by	O
conventional	O
PCR	O
with	O
the	O
genomic	O
DNAs	O
of	O
73	O
-	O
79	O
strains	O
regarding	O
73	O
-	O
75	O
bacterial	O
species	O
including	O
the	O
type	O
strain	O
for	O
the	O
target	O
species	O
.	O

The	O
standard	O
curves	O
revealed	O
the	O
lower	O
detection	O
limits	O
of	O
42	O
bacterial	O
species	O
-	O
specific	O
qPCR	O
primers	O
ranged	O
from	O
4	O
to	O
40	O
fg	O
below	O
a	O
cycle	O
threshold	O
(	O
C	O
T	O
)	O
value	O
of	O
35	O
,	O
except	O
Atopobium	B-bacteria
rimae	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
Neisseria	B-bacteria
meningitidis	I-bacteria
,	O
and	O
Porphyromonas	B-bacteria
asaccharolytica	I-bacteria
which	O
were	O
400	O
fg	O
.	O

These	O
results	O
suggest	O
that	O
42	O
bacterial	O
species	O
-	O
specific	O
qPCR	O
primers	O
are	O
suitable	O
for	O
applications	O
in	O
epidemiological	O
studies	O
related	O
to	O
oral	O
infectious	O
diseases	O
such	O
as	O
periodontal	O
diseases	O
,	O
endodontic	O
infection	O
,	O
and	O
dental	O
caries	O
.	O

Oral	O
health	O
is	O
influenced	O
by	O
the	O
mouth	O
'	O
s	O
resident	O
microorganisms	O
.	O

Dental	O
caries	O
and	O
periodontitis	O
are	O
oral	O
disorders	O
caused	O
by	O
imbalances	O
in	O
the	O
oral	O
microbiota	O
.	O

Probiotics	O
have	O
potential	O
for	O
the	O
prevention	O
and	O
treatment	O
of	O
oral	O
disorders	O
.	O

Current	O
formulations	O
,	O
including	O
supplements	O
and	O
foods	O
,	O
have	O
limitations	O
for	O
oral	O
delivery	O
including	O
short	O
storage	O
time	O
,	O
low	O
residence	O
time	O
in	O
the	O
mouth	O
,	O
effects	O
on	O
food	O
consistency	O
,	O
and	O
low	O
patient	O
compliance	O
.	O

Oral	O
thin	O
films	O
(	O
OTFs	O
)	O
may	O
be	O
efficient	O
in	O
delivering	O
probiotics	O
to	O
the	O
mouth	O
.	O

This	O
research	O
aims	O
to	O
develop	O
a	O
novel	O
carboxymethyl	O
cellulose	O
(	O
CMC	O
)	O
-	O
probiotic	O
-	O
OTF	O
to	O
deliver	O
probiotics	O
for	O
the	O
treatment	O
/	O
prevention	O
of	O
oral	O
disorders	O
.	O

CMC	O
-	O
OTFs	O
were	O
developed	O
with	O
varying	O
CMC	O
concentration	O
(	O
1	O
.	O
25	O
-	O
10	O
mg	O
/	O
mL	O
)	O
,	O
weight	O
(	O
5	O
-	O
40	O
g	O
)	O
,	O
thickness	O
(	O
16	O
-	O
262	O
mum	O
)	O
,	O
hygroscopicity	O
(	O
30	O
.	O
8	O
-	O
78	O
.	O
9	O
mg	O
/	O
cm	O
(	O
2	O
)	O
film	O
)	O
,	O
and	O
dissolving	O
time	O
(	O
135	O
-	O
600	O
s	O
)	O
.	O

The	O
10	O
g	O
5	O
mg	O
/	O
mL	O
CMC	O
-	O
OTF	O
was	O
selected	O
and	O
used	O
to	O
incorporate	O
Lactobacillus	B-bacteria
fermentum	I-bacteria
NCIMB	I-bacteria
5221	I-bacteria
(	O
6	O
.	O
75	O
x	O
10	O
(	O
8	O
)	O
cells	O
/	O
film	O
)	O
,	O
a	O
probiotic	O
with	O
anti	O
-	O
inflammatory	O
potential	O
for	O
periodontitis	O
treatment	O
and	O
capable	O
of	O
inhibiting	O
microorganisms	O
responsible	O
for	O
dental	O
caries	O
and	O
oral	O
candidiasis	O
.	O

The	O
CMC	O
-	O
OTF	O
maintained	O
probiotic	O
viability	O
and	O
antioxidant	O
activity	O
following	O
150	O
days	O
of	O
storage	O
with	O
a	O
production	O
of	O
549	O
.	O
52	O
+	O
/	O
-	O
26	O
.	O
08	O
muM	O
Trolox	O
equivalents	O
.	O

This	O
research	O
shows	O
the	O
successful	O
development	O
and	O
characterization	O
of	O
a	O
novel	O
probiotic	O
-	O
CMC	O
-	O
OTF	O
with	O
potential	O
as	O
an	O
oral	O
health	O
biotherapeutic	O
.	O

Coeliac	O
disease	O
is	O
characterized	O
by	O
intestinal	O
inflammation	O
caused	O
by	O
gluten	O
,	O
proteins	O
which	O
are	O
widely	O
contained	O
in	O
the	O
Western	O
diet	O
.	O

Mammalian	O
digestive	O
enzymes	O
are	O
only	O
partly	O
capable	O
of	O
cleaving	O
gluten	O
,	O
and	O
fragments	O
remain	O
that	O
induce	O
toxic	O
responses	O
in	O
patients	O
with	O
coeliac	O
disease	O
.	O

We	O
found	O
that	O
the	O
oral	O
microbiome	O
is	O
a	O
novel	O
and	O
rich	O
source	O
of	O
gluten	O
-	O
degrading	O
organisms	O
.	O

Here	O
we	O
report	O
on	O
the	O
isolation	O
and	O
characterization	O
of	O
the	O
cultivable	O
resident	O
oral	O
microbes	O
that	O
are	O
capable	O
of	O
cleaving	O
gluten	O
,	O
with	O
special	O
emphasis	O
on	O
the	O
immunogenic	O
domains	O
.	O

Bacteria	O
were	O
obtained	O
by	O
a	O
selective	O
culturing	O
approach	O
and	O
enzyme	O
activities	O
were	O
characterized	O
by	O
:	O
(	O
i	O
)	O
hydrolysis	O
of	O
paranitroanilide	O
-	O
derivatized	O
gliadin	O
-	O
derived	O
tripeptide	O
substrates	O
;	O
(	O
ii	O
)	O
gliadin	O
degradation	O
in	O
-	O
gel	O
(	O
gliadin	O
zymography	O
)	O
;	O
(	O
iii	O
)	O
gliadin	O
degradation	O
in	O
solution	O
;	O
(	O
iv	O
)	O
proteolysis	O
of	O
the	O
highly	O
immunogenic	O
alpha	O
-	O
gliadin	O
-	O
derived	O
33	O
-	O
mer	O
peptide	O
.	O

For	O
selected	O
strains	O
pH	O
activity	O
profiles	O
were	O
determined	O
.	O

The	O
culturing	O
strategy	O
yielded	O
87	O
aerobic	O
and	O
63	O
anaerobic	O
strains	O
.	O

Species	O
with	O
activity	O
in	O
at	O
least	O
two	O
of	O
the	O
four	O
assays	O
were	O
typed	O
as	O
:	O
Rothia	B-bacteria
mucilaginosa	I-bacteria
HOT	I-bacteria
-	I-bacteria
681	I-bacteria
,	O
Rothia	B-bacteria
aeria	I-bacteria
HOT	I-bacteria
-	I-bacteria
188	I-bacteria
,	O
Actinomyces	B-bacteria
odontolyticus	I-bacteria
HOT	I-bacteria
-	I-bacteria
701	I-bacteria
,	O
Streptococcus	B-bacteria
mitis	I-bacteria
HOT	I-bacteria
-	I-bacteria
677	I-bacteria
,	O
Streptococcus	B-bacteria
sp	I-bacteria
.	I-bacteria
HOT	I-bacteria
-	I-bacteria
071	I-bacteria
,	O
Neisseria	B-bacteria
mucosa	I-bacteria
HOT	I-bacteria
-	I-bacteria
682	I-bacteria
and	O
Capnocytophaga	B-bacteria
sputigena	I-bacteria
HOT	I-bacteria
-	I-bacteria
775	I-bacteria
,	O
with	O
Rothia	B-bacteria
species	I-bacteria
being	O
active	O
in	O
all	O
four	O
assays	O
.	O

Cleavage	O
specificities	O
and	O
substrate	O
preferences	O
differed	O
among	O
the	O
strains	O
identified	O
.	O

The	O
approximate	O
molecular	O
weights	O
of	O
the	O
enzymes	O
were	O
~	O
75	O
kD	O
(	O
Rothia	B-bacteria
spp	I-bacteria
.	I-bacteria
)	O
,	O
~	O
60	O
kD	O
(	O
A	B-bacteria
.	I-bacteria
odontolyticus	I-bacteria
)	O
and	O
~	O
150	O
kD	O
(	O
Streptococcus	B-bacteria
spp	I-bacteria
.	I-bacteria
)	O
.	O

In	O
conclusion	O
,	O
this	O
study	O
identified	O
new	O
gluten	O
-	O
degrading	O
microorganisms	O
in	O
the	O
upper	O
gastrointestinal	O
tract	O
.	O

A	O
cocktail	O
of	O
the	O
most	O
active	O
oral	O
bacteria	O
,	O
or	O
their	O
isolated	O
enzymes	O
,	O
may	O
offer	O
promising	O
new	O
treatment	O
modalities	O
for	O
coeliac	O
disease	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
prevalence	O
of	O
oral	O
microflora	O
and	O
association	O
of	O
oral	O
candidiasis	O
and	O
multiple	O
risk	O
factors	O
in	O
HIV	O
(	O
+	O
)	O
patients	O
.	O

The	O
present	O
study	O
included	O
100	O
HIV	O
-	O
infected	O
patients	O
participated	O
in	O
Imam	O
Khomeini	O
Hospital	O
,	O
Tehran	O
,	O
Iran	O
for	O
Oropharyngeal	O
candidiasis	O
(	O
OPC	O
)	O
and	O
HIV	O
.	O

We	O
assessed	O
the	O
presence	O
or	O
absence	O
of	O
OPC	O
,	O
and	O
samples	O
were	O
obtained	O
from	O
the	O
oral	O
cavity	O
and	O
direct	O
microscopic	O
examination	O
,	O
gram	O
staining	O
and	O
culture	O
on	O
standard	O
microbiological	O
media	O
were	O
performed	O
in	O
all	O
patients	O
.	O

CD4	O
(	O
+	O
)	O
cell	O
count	O
/	O
CD4	O
(	O
+	O
)	O
percentage	O
were	O
also	O
calculated	O
.	O

The	O
demographic	O
characteristics	O
showed	O
that	O
the	O
patients	O
had	O
a	O
mean	O
age	O
of	O
32	O
.	O
3	O
years	O
old	O
,	O
78	O
%	O
male	O
and	O
22	O
%	O
female	O
.	O

Patients	O
belonging	O
to	O
'	O
O	O
(	O
+	O
)	O
'	O
blood	O
group	O
(	O
27	O
%	O
)	O
were	O
more	O
prone	O
to	O
develop	O
OPC	O
.	O

A	O
total	O
of	O
460	O
bacterial	O
colonies	O
were	O
obtained	O
and	O
Streptococcus	B-bacteria
mutans	I-bacteria
(	O
15	O
.	O
4	O
%	O
)	O
was	O
the	O
most	O
frequently	O
isolated	O
species	O
in	O
the	O
HIV	O
(	O
+	O
)	O
patients	O
,	O
followed	O
by	O
Staphylococcus	B-bacteria
epidermidis	I-bacteria
(	O
12	O
.	O
8	O
%	O
)	O
and	O
Corynebacterium	B-bacteria
(	O
8	O
.	O
7	O
%	O
)	O
.	O

In	O
addition	O
,	O
254	O
yeasts	O
(	O
from	O
four	O
different	O
genera	O
)	O
were	O
isolated	O
from	O
the	O
patient	O
under	O
study	O
.	O

Candida	O
species	O
(	O
94	O
.	O
4	O
%	O
)	O
were	O
the	O
most	O
frequently	O
obtained	O
genera	O
,	O
followed	O
by	O
Saccharomyces	O
(	O
2	O
.	O
4	O
%	O
)	O
,	O
Kluyveromyces	O
and	O
Cryptococcus	O
(	O
1	O
.	O
6	O
%	O
for	O
both	O
)	O
species	O
.	O

Candida	O
albicans	O
(	O
37	O
.	O
2	O
%	O
)	O
was	O
the	O
most	O
common	O
species	O
isolated	O
from	O
HIV	O
(	O
+	O
)	O
patients	O
with	O
OPC	O
and	O
its	O
frequency	O
was	O
significantly	O
higher	O
than	O
that	O
of	O
other	O
Candida	O
species	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

Candida	O
glabrata	O
,	O
C	O
.	O
dubliniensis	O
,	O
C	O
.	O
tropicalis	O
,	O
C	O
.	O
parapsilosis	O
,	O
C	O
.	O
krusei	O
,	O
C	O
.	O
lusitaniae	O
,	O
C	O
.	O
guilliermondii	O
and	O
C	O
.	O
norvegensis	O
were	O
also	O
identified	O
.	O

Forty	O
percent	O
of	O
the	O
patients	O
had	O
angular	O
cheilitis	O
as	O
the	O
most	O
frequent	O
clinical	O
variant	O
.	O

The	O
mean	O
CD4	O
(	O
+	O
)	O
cell	O
counts	O
were	O
154	O
.	O
5	O
cells	O
/	O
muL	O
,	O
with	O
a	O
range	O
of	O
8	O
to	O
611	O
cells	O
/	O
muL	O
.	O

Thirty	O
percent	O
patients	O
had	O
a	O
CD4	O
(	O
+	O
)	O
cell	O
count	O
between	O
101	O
and	O
200	O
cells	O
/	O
muL	O
(	O
28	O
.	O
7	O
%	O
of	O
total	O
yeasts	O
isolated	O
)	O
.	O

Yeast	O
and	O
bacteria	O
counts	O
did	O
not	O
differ	O
statistically	O
among	O
HIV	O
(	O
+	O
)	O
patients	O
'	O
subgroups	O
with	O
different	O
levels	O
of	O
CD4	O
(	O
+	O
)	O
cells	O
counts	O
.	O

Our	O
results	O
showed	O
that	O
yeasts	O
of	O
the	O
genus	O
Candida	O
were	O
isolated	O
at	O
a	O
comparable	O
rate	O
from	O
the	O
oral	O
cavity	O
of	O
HIV	O
(	O
+	O
)	O
patients	O
and	O
there	O
was	O
no	O
significant	O
difference	O
of	O
the	O
variables	O
CD4	O
(	O
+	O
)	O
cell	O
count	O
and	O
yeast	O
counts	O
.	O

The	O
findings	O
of	O
this	O
study	O
would	O
be	O
helpful	O
in	O
any	O
further	O
study	O
,	O
which	O
,	O
if	O
done	O
prospectively	O
on	O
a	O
large	O
cohort	O
,	O
can	O
be	O
confirmatory	O
.	O

Experimental	O
infection	O
systems	O
are	O
important	O
for	O
studying	O
antagonistic	O
interactions	O
and	O
coevolution	O
between	O
hosts	O
and	O
their	O
pathogens	O
.	O

The	O
red	O
flour	O
beetle	O
Tribolium	O
castaneum	O
and	O
the	O
spore	O
-	O
forming	O
bacterial	O
insect	O
pathogen	O
Bacillus	B-bacteria
thuringiensis	I-bacteria
(	O
Bt	B-bacteria
)	O
are	O
widely	O
used	O
and	O
tractable	O
model	O
organisms	O
.	O

However	O
,	O
they	O
have	O
not	O
been	O
employed	O
yet	O
as	O
an	O
efficient	O
experimental	O
system	O
to	O
study	O
host	O
-	O
pathogen	O
interactions	O
.	O

We	O
used	O
a	O
high	O
throughput	O
oral	O
infection	O
protocol	O
to	O
infect	O
T	O
.	O
castaneum	O
insects	O
with	O
coleopteran	O
specific	O
B	B-bacteria
.	I-bacteria
thuringiensis	I-bacteria
bv	I-bacteria
.	I-bacteria
tenebrionis	I-bacteria
(	O
Btt	B-bacteria
)	O
bacteria	O
.	O

We	O
found	O
that	O
larval	O
mortality	O
depends	O
on	O
the	O
dietary	O
spore	O
concentration	O
and	O
on	O
the	O
duration	O
of	O
exposure	O
to	O
the	O
spores	O
.	O

Furthermore	O
,	O
differential	O
susceptibility	O
of	O
larvae	O
from	O
different	O
T	O
.	O
castaneum	O
populations	O
indicates	O
that	O
the	O
host	O
genetic	O
background	O
influences	O
infection	O
success	O
.	O

The	O
recovery	O
of	O
high	O
numbers	O
of	O
infectious	O
spores	O
from	O
the	O
cadavers	O
indicates	O
successful	O
replication	O
of	O
bacteria	O
in	O
the	O
host	O
and	O
suggests	O
that	O
Btt	B-bacteria
could	O
establish	O
infectious	O
cycles	O
in	O
T	O
.	O
castaneum	O
in	O
nature	O
.	O

We	O
were	O
able	O
to	O
transfer	O
plasmids	O
from	O
Btt	B-bacteria
to	O
a	O
non	O
-	O
pathogenic	O
but	O
genetically	O
well	O
-	O
characterised	O
Bt	B-bacteria
strain	I-bacteria
,	O
which	O
was	O
thereafter	O
able	O
to	O
successfully	O
infect	O
T	O
.	O
castaneum	O
,	O
suggesting	O
that	O
factors	O
residing	O
on	O
the	O
plasmids	O
are	O
important	O
for	O
the	O
virulence	O
of	O
Btt	B-bacteria
.	O

The	O
availability	O
of	O
a	O
genetically	O
accessible	O
strain	O
will	O
provide	O
an	O
ideal	O
model	O
for	O
more	O
in	O
-	O
depth	O
analyses	O
of	O
pathogenicity	O
factors	O
during	O
oral	O
infections	O
.	O

Combined	O
with	O
the	O
availability	O
of	O
the	O
full	O
genome	O
sequence	O
of	O
T	O
.	O
castaneum	O
,	O
this	O
system	O
will	O
enable	O
analyses	O
of	O
host	O
responses	O
during	O
infection	O
,	O
as	O
well	O
as	O
addressing	O
basic	O
questions	O
concerning	O
host	O
-	O
parasite	O
coevolution	O
.	O

Drug	O
-	O
resistant	O
opportunistic	O
infections	O
may	O
cause	O
health	O
problems	O
in	O
immunocompromised	O
hosts	O
.	O

Representative	O
microorganisms	O
in	O
opportunistic	O
infections	O
of	O
the	O
oral	O
cavity	O
are	O
Staphylococcus	B-bacteria
aureus	I-bacteria
,	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
,	O
and	O
Candida	O
albicans	O
.	O

We	O
investigated	O
the	O
prevalence	O
of	O
drug	O
-	O
resistant	O
opportunistic	O
microorganisms	O
in	O
elderly	O
adults	O
receiving	O
follow	O
-	O
up	O
examinations	O
after	O
primary	O
treatment	O
of	O
oral	O
cancer	O
.	O

Oral	O
microorganisms	O
were	O
collected	O
from	O
patients	O
satisfactorily	O
treated	O
for	O
oral	O
cancer	O
(	O
defined	O
as	O
good	O
outcomes	O
to	O
date	O
)	O
and	O
a	O
group	O
of	O
healthy	O
adults	O
(	O
controls	O
)	O
.	O

After	O
identification	O
of	O
microorganisms	O
,	O
the	O
prevalence	O
of	O
drug	O
-	O
resistant	O
microorganisms	O
was	O
studied	O
.	O

Pulsed	O
-	O
field	O
gel	O
electrophoresis	O
(	O
PFGE	O
)	O
and	O
staphylococcal	O
cassette	O
chromosome	O
mec	O
(	O
SCCmec	O
)	O
typing	O
were	O
also	O
performed	O
for	O
methicillin	B-bacteria
-	I-bacteria
resistant	I-bacteria
S	I-bacteria
aureus	I-bacteria
(	O
MRSA	B-bacteria
)	O
.	O

Statistical	O
analysis	O
revealed	O
no	O
significant	O
differences	O
in	O
the	O
prevalences	O
of	O
the	O
three	O
microorganisms	O
between	O
the	O
groups	O
.	O

Surprisingly	O
,	O
69	O
.	O
2	O
%	O
of	O
S	B-bacteria
aureus	I-bacteria
isolates	I-bacteria
showed	O
oxacillin	O
resistance	O
,	O
suggesting	O
that	O
MRSA	B-bacteria
colonization	O
is	O
increasing	O
among	O
older	O
Japanese	O
.	O

These	O
MRSA	B-bacteria
isolates	I-bacteria
possessed	O
SCCmec	O
types	O
II	O
and	O
IV	O
but	O
no	O
representative	O
toxin	O
genes	O
.	O

Our	O
results	O
indicate	O
that	O
a	O
basic	O
infection	O
control	O
strategy	O
,	O
including	O
standard	O
precautions	O
against	O
MRSA	B-bacteria
,	O
is	O
important	O
for	O
elderly	O
adults	O
,	O
particularly	O
after	O
treatment	O
for	O
oral	O
cancer	O
.	O

To	O
compare	O
early	O
bacterial	O
adhesion	O
and	O
biofilm	O
formation	O
in	O
vitro	O
by	O
different	O
oral	O
streptococci	B-bacteria
on	O
a	O
variety	O
of	O
commercial	O
brackets	O
.	O

Adhesion	O
and	O
biofilm	O
formation	O
in	O
vitro	O
of	O
6	O
Streptococcus	B-bacteria
spp	I-bacteria
.	I-bacteria
on	O
15	O
different	O
commercial	O
brackets	O
,	O
in	O
standard	O
culture	O
medium	O
and	O
in	O
human	O
saliva	O
were	O
evaluated	O
by	O
the	O
MTT	O
reduction	O
assay	O
.	O

Significant	O
differences	O
were	O
evidenced	O
in	O
both	O
early	O
adhesion	O
and	O
biofilm	O
formation	O
among	O
the	O
studied	O
brackets	O
and	O
between	O
the	O
two	O
conditions	O
of	O
growth	O
.	O

Gold	O
brackets	O
resulted	O
less	O
prone	O
to	O
colonisation	O
compared	O
to	O
composite	O
brackets	O
.	O

The	O
growth	O
rates	O
of	O
the	O
tested	O
species	O
on	O
the	O
different	O
tested	O
materials	O
were	O
significantly	O
different	O
.	O

The	O
adopted	O
experimental	O
plan	O
,	O
dissecting	O
the	O
two	O
phases	O
of	O
plaque	O
formation	O
on	O
different	O
brackets	O
in	O
different	O
conditions	O
,	O
showed	O
that	O
composite	O
brackets	O
are	O
more	O
susceptible	O
to	O
adhesion	O
and	O
colonisation	O
by	O
streptococci	B-bacteria
,	O
while	O
the	O
remaining	O
tested	O
brackets	O
did	O
not	O
show	O
differences	O
that	O
could	O
be	O
clinically	O
relevant	O
.	O

Data	O
suggest	O
that	O
different	O
personal	O
behaviours	O
affecting	O
the	O
oral	O
environment	O
could	O
significantly	O
affect	O
colonisation	O
of	O
brackets	O
by	O
oral	O
streptococci	B-bacteria
.	O

Patients	O
with	O
ruptured	O
saccular	O
intracranial	O
aneurysms	O
have	O
excess	O
long	O
-	O
term	O
mortality	O
due	O
to	O
cerebrovascular	O
and	O
cardiovascular	O
diseases	O
compared	O
with	O
general	O
population	O
.	O

Chronic	O
inflammation	O
is	O
detected	O
in	O
ruptured	O
intracranial	O
aneurysms	O
,	O
abdominal	O
aortic	O
aneurysms	O
and	O
coronary	O
artery	O
plaques	O
.	O

Bacterial	O
infections	O
have	O
been	O
suggested	O
to	O
have	O
a	O
role	O
in	O
the	O
aetiology	O
of	O
atherosclerosis	O
.	O

Bacteria	O
have	O
been	O
detected	O
both	O
in	O
abdominal	O
and	O
coronary	O
arteries	O
but	O
their	O
presence	O
in	O
intracranial	O
aneurysms	O
has	O
not	O
yet	O
been	O
properly	O
studied	O
.	O

The	O
aim	O
of	O
this	O
preliminary	O
study	O
was	O
to	O
assess	O
the	O
presence	O
of	O
oral	O
and	O
pharyngeal	O
bacterial	O
genome	O
in	O
ruptured	O
intracranial	O
aneurysms	O
and	O
to	O
ascertain	O
if	O
dental	O
infection	O
is	O
a	O
previously	O
unknown	O
risk	O
factor	O
for	O
subarachnoid	O
haemorrhage	O
.	O

A	O
total	O
of	O
36	O
ruptured	O
aneurysm	O
specimens	O
were	O
obtained	O
perioperatively	O
in	O
aneurysm	O
clipping	O
operations	O
(	O
n	O
=	O
29	O
)	O
and	O
by	O
autopsy	O
(	O
n	O
=	O
7	O
)	O
.	O

Aneurysmal	O
sac	O
tissue	O
was	O
analysed	O
by	O
real	O
time	O
quantitative	O
PCR	O
with	O
specific	O
primers	O
and	O
probes	O
to	O
detect	O
bacterial	O
DNA	O
from	O
several	O
oral	O
species	O
.	O

Immunohistochemical	O
staining	O
for	O
bacterial	O
receptors	O
(	O
CD14	O
and	O
toll	O
-	O
like	O
receptor	O
-	O
2	O
(	O
TLR	O
-	O
2	O
)	O
)	O
was	O
performed	O
from	O
four	O
autopsy	O
cases	O
.	O

Bacterial	O
DNA	O
was	O
detected	O
in	O
21	O
/	O
36	O
(	O
58	O
%	O
)	O
of	O
specimens	O
.	O

A	O
third	O
of	O
the	O
positive	O
samples	O
contained	O
DNA	O
from	O
both	O
endodontic	O
and	O
periodontal	O
bacteria	O
.	O

DNA	O
from	O
endodontic	O
bacteria	O
were	O
detected	O
in	O
20	O
/	O
36	O
(	O
56	O
%	O
)	O
and	O
from	O
periodontal	O
bacteria	O
in	O
17	O
/	O
36	O
(	O
47	O
%	O
)	O
of	O
samples	O
.	O

Bacterial	O
DNA	O
of	O
the	O
Streptococcus	B-bacteria
mitis	I-bacteria
group	O
was	O
found	O
to	O
be	O
most	O
common	O
.	O

Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatu	I-bacteria
and	O
Treponema	B-bacteria
denticola	I-bacteria
were	O
the	O
three	O
most	O
common	O
periodontal	O
pathogens	O
.	O

The	O
highly	O
intensive	O
staining	O
of	O
CD14	O
and	O
TLR	O
-	O
2	O
in	O
ruptured	O
aneurysms	O
was	O
observed	O
.	O

This	O
is	O
the	O
first	O
report	O
showing	O
evidence	O
that	O
dental	O
infection	O
could	O
be	O
a	O
part	O
of	O
pathophysiology	O
in	O
intracranial	O
aneurysm	O
disease	O
.	O

Bacteriocin	O
-	O
producing	O
probiotic	O
Streptococcus	B-bacteria
salivarius	I-bacteria
M18	I-bacteria
offers	O
beneficial	O
modulatory	O
capabilities	O
within	O
the	O
oral	O
microbiome	O
,	O
apparently	O
through	O
potent	O
inhibitory	O
activity	O
against	O
potentially	O
deleterious	O
bacteria	O
,	O
such	O
as	O
Streptococcus	B-bacteria
pyogenes	I-bacteria
.	O

The	O
oral	O
cavity	O
persistence	O
of	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
M18	I-bacteria
was	O
investigated	O
in	O
75	O
subjects	O
receiving	O
four	O
different	O
doses	O
for	O
28	O
days	O
.	O

Sixty	O
per	O
cent	O
of	O
the	O
subjects	O
already	O
had	O
some	O
inhibitor	O
-	O
producing	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
in	O
their	O
saliva	O
prior	O
to	O
probiotic	O
intervention	O
.	O

Strain	O
M18	B-bacteria
'	O
s	O
persistence	O
was	O
dependent	O
upon	O
the	O
dose	O
,	O
but	O
not	O
the	O
period	O
of	O
administration	O
.	O

Culture	O
analysis	O
indicated	O
that	O
in	O
some	O
individuals	O
the	O
introduced	O
strain	O
had	O
almost	O
entirely	O
replaced	O
the	O
indigenous	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
,	O
though	O
the	O
total	O
numbers	O
of	O
the	O
species	O
did	O
not	O
increase	O
.	O

Selected	O
subjects	O
showing	O
either	O
high	O
or	O
low	O
probiotic	O
persistence	O
had	O
their	O
salivary	O
populations	O
profiled	O
using	O
Illumina	O
sequencing	O
of	O
the	O
V6	O
region	O
of	O
the	O
16S	O
rRNA	O
gene	O
.	O

Analysis	O
indicated	O
that	O
while	O
certain	O
bacterial	O
phenotypes	O
were	O
markedly	O
modulated	O
,	O
the	O
overall	O
composition	O
of	O
the	O
oral	O
microbiome	O
was	O
not	O
modified	O
by	O
the	O
probiotic	O
treatment	O
.	O

Megaplasmids	O
encoding	O
bacteriocins	O
and	O
adhesion	O
factors	O
were	O
transferred	O
in	O
vitro	O
to	O
generate	O
a	O
transconjugant	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
exhibiting	O
enhanced	O
antimicrobial	O
production	O
and	O
binding	O
capabilities	O
to	O
HEp	O
-	O
2	O
cells	O
.	O

Since	O
no	O
widespread	O
perturbation	O
of	O
the	O
existing	O
indigenous	O
microbiota	O
was	O
associated	O
with	O
oral	O
instillation	O
and	O
given	O
its	O
antimicrobial	O
activity	O
against	O
potentially	O
pathogenic	O
streptococci	B-bacteria
,	O
it	O
appears	O
that	O
application	O
of	O
probiotic	O
strain	O
M18	B-bacteria
offers	O
potential	O
low	O
impact	O
alternative	O
to	O
classical	O
antibiotic	O
prophylaxis	O
.	O

For	O
candidate	O
probiotic	O
strains	O
having	O
relatively	O
poor	O
antimicrobial	O
or	O
adhesive	O
properties	O
,	O
unique	O
derivatives	O
displaying	O
improved	O
probiotic	O
performance	O
may	O
be	O
engineered	O
in	O
vitro	O
by	O
megaplasmid	O
transfer	O
.	O

The	O
purpose	O
of	O
this	O
prospective	O
clinical	O
study	O
was	O
to	O
identify	O
the	O
bacterial	O
spectra	O
on	O
the	O
surface	O
of	O
oral	O
squamous	O
cell	O
carcinomas	O
(	O
OSCC	O
)	O
in	O
comparison	O
to	O
oral	O
mucosa	O
of	O
patients	O
with	O
a	O
higher	O
risk	O
to	O
emerge	O
an	O
OSCC	O
and	O
a	O
control	O
group	O
to	O
determine	O
their	O
susceptibility	O
to	O
various	O
common	O
antibiotics	O
.	O

Swabs	O
from	O
90	O
patients	O
,	O
30	O
patients	O
of	O
each	O
group	O
,	O
were	O
cultured	O
on	O
media	O
for	O
aerobes	O
and	O
anaerobes	O
and	O
tested	O
with	O
agar	O
diffusion	O
and	O
Etest	O
.	O

The	O
predominant	O
pathogens	O
of	O
the	O
normal	O
healthy	O
oral	O
mucosa	O
were	O
aerobes	O
.	O

The	O
ratio	O
between	O
aerobes	O
and	O
anaerobes	O
was	O
2	O
:	O
1	O
,	O
balanced	O
in	O
risk	O
patients	O
and	O
inverted	O
in	O
the	O
OSCC	O
group	O
.	O

Altogether	O
,	O
1	O
,	O
006	O
isolates	O
were	O
cultured	O
.	O

The	O
most	O
frequent	O
strains	O
were	O
47	O
viridans	B-bacteria
streptococci	I-bacteria
,	O
30	O
Staphylococcus	B-bacteria
species	I-bacteria
,	O
14	O
Enterococcus	B-bacteria
faecalis	I-bacteria
,	O
36	O
Neisseria	B-bacteria
species	I-bacteria
,	O
14	O
Escherichia	B-bacteria
coli	I-bacteria
,	O
and	O
23	O
other	O
aerobes	O
,	O
66	O
Peptostreptococcus	B-bacteria
species	I-bacteria
,	O
39	O
Fusobacterium	B-bacteria
species	I-bacteria
,	O
and	O
34	O
Prevotella	B-bacteria
species	I-bacteria
.	O

The	O
resistance	O
rates	O
in	O
the	O
OSCC	O
group	O
were	O
penicillin	O
40	O
%	O
,	O
ampicillin	O
57	O
%	O
,	O
doxycycline	O
23	O
%	O
,	O
clindamycin	O
47	O
%	O
,	O
and	O
amoxicillin	O
/	O
clavulanic	O
acid	O
20	O
%	O
,	O
but	O
up	O
to	O
100	O
%	O
of	O
pathogens	O
were	O
susceptible	O
to	O
azithromycin	O
,	O
telithromycin	O
,	O
levofloxacin	O
,	O
and	O
moxifloxacin	O
.	O

Gram	O
-	O
negative	O
anaerobes	O
play	O
a	O
decisive	O
role	O
in	O
the	O
development	O
of	O
postoperative	O
infections	O
in	O
patients	O
with	O
OSCC	O
.	O

This	O
tumor	O
special	O
type	O
of	O
colonization	O
does	O
not	O
agree	O
with	O
the	O
normal	O
flora	O
of	O
the	O
oral	O
cavity	O
.	O

Biofilms	O
on	O
OSCC	O
surfaces	O
provide	O
an	O
important	O
reservoir	O
for	O
anaerobic	O
bacteria	O
.	O

As	O
a	O
consequence	O
,	O
a	O
proposal	O
for	O
an	O
antibiotic	O
prophylactic	O
regime	O
should	O
be	O
given	O
.	O

Epithelial	O
cells	O
in	O
oral	O
cavities	O
can	O
be	O
considered	O
reservoirs	O
for	O
a	O
variety	O
of	O
bacterial	O
species	O
.	O

A	O
polymicrobial	O
intracellular	O
flora	O
associated	O
with	O
periodontal	O
disease	O
has	O
been	O
demonstrated	O
in	O
buccal	O
cells	O
.	O

Important	O
aetiological	O
agents	O
of	O
systemic	O
and	O
nosocomial	O
infections	O
have	O
been	O
detected	O
in	O
the	O
microbiota	O
of	O
subgingival	O
biofilm	O
,	O
especially	O
in	O
individuals	O
with	O
periodontal	O
disease	O
.	O

However	O
,	O
non	O
-	O
oral	O
pathogens	O
internalized	O
in	O
oral	O
epithelial	O
cells	O
and	O
their	O
relationship	O
with	O
periodontal	O
status	O
are	O
poorly	O
understood	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
detect	O
opportunistic	O
species	O
within	O
buccal	O
and	O
gingival	O
crevice	O
epithelial	O
cells	O
collected	O
from	O
subjects	O
with	O
periodontitis	O
or	O
individuals	O
with	O
good	O
periodontal	O
health	O
,	O
and	O
to	O
associate	O
their	O
prevalence	O
with	O
periodontal	O
clinical	O
status	O
.	O

Quantitative	O
detection	O
of	O
total	O
bacteria	O
and	O
Staphylococcus	B-bacteria
aureus	I-bacteria
,	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
and	O
Enterococcus	B-bacteria
faecalis	I-bacteria
in	O
oral	O
epithelial	O
cells	O
was	O
determined	O
by	O
quantitative	O
real	O
-	O
time	O
PCR	O
using	O
universal	O
and	O
species	O
-	O
specific	O
primer	O
sets	O
.	O

Intracellular	O
bacteria	O
were	O
visualized	O
by	O
confocal	O
microscopy	O
and	O
fluorescence	O
in	O
situ	O
hybridization	O
.	O

Overall	O
,	O
33	O
%	O
of	O
cell	O
samples	O
from	O
patients	O
with	O
periodontitis	O
contained	O
at	O
least	O
one	O
opportunistic	O
species	O
,	O
compared	O
with	O
15	O
%	O
of	O
samples	O
from	O
healthy	O
individuals	O
.	O

E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
was	O
the	O
most	O
prevalent	O
species	O
found	O
in	O
oral	O
epithelial	O
cells	O
(	O
detected	O
in	O
20	O
.	O
6	O
%	O
of	O
patients	O
with	O
periodontitis	O
,	O
P	O
=	O
0	O
.	O
03	O
versus	O
healthy	O
individuals	O
)	O
and	O
was	O
detected	O
only	O
in	O
cells	O
from	O
patients	O
with	O
periodontitis	O
.	O

Quantitative	O
real	O
-	O
time	O
PCR	O
showed	O
that	O
high	O
levels	O
of	O
P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
were	O
present	O
in	O
both	O
the	O
periodontitis	O
and	O
healthy	O
groups	O
.	O

However	O
,	O
the	O
proportion	O
of	O
these	O
species	O
was	O
significantly	O
higher	O
in	O
epithelial	O
cells	O
of	O
subjects	O
with	O
periodontitis	O
compared	O
with	O
healthy	O
individuals	O
(	O
P	O
=	O
0	O
.	O
016	O
for	O
P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
and	O
P	O
=	O
0	O
.	O
047	O
for	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
)	O
.	O

Although	O
E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
were	O
detected	O
in	O
57	O
%	O
and	O
50	O
%	O
of	O
patients	O
,	O
respectively	O
,	O
with	O
probing	O
depth	O
and	O
clinical	O
attachment	O
level	O
>	O
/	O
=	O
6	O
mm	O
,	O
no	O
correlation	O
was	O
found	O
with	O
age	O
,	O
sex	O
,	O
bleeding	O
on	O
probing	O
or	O
the	O
presence	O
of	O
supragingival	O
biofilm	O
.	O

The	O
prevalence	O
of	O
these	O
pathogens	O
in	O
epithelial	O
cells	O
is	O
correlated	O
with	O
the	O
state	O
of	O
periodontal	O
disease	O
.	O

It	O
has	O
been	O
speculated	O
that	O
the	O
oral	O
flora	O
of	O
the	O
Komodo	O
dragon	O
(	O
Varanus	O
komodoensis	O
)	O
exerts	O
a	O
lethal	O
effect	O
on	O
its	O
prey	O
;	O
yet	O
,	O
scant	O
information	O
about	O
their	O
specific	O
oral	O
flora	O
bacteriology	O
,	O
especially	O
anaerobes	O
,	O
exists	O
.	O

Consequently	O
,	O
the	O
aerobic	O
and	O
anaerobic	O
oral	O
bacteriology	O
of	O
16	O
captive	O
Komodo	O
dragons	O
(	O
10	O
adults	O
and	O
six	O
neonates	O
)	O
,	O
aged	O
2	O
-	O
17	O
yr	O
for	O
adults	O
and	O
7	O
-	O
10	O
days	O
for	O
neonates	O
,	O
from	O
three	O
U	O
.	O
S	O
.	O
zoos	O
were	O
studied	O
.	O

Saliva	O
and	O
gingival	O
samples	O
were	O
collected	O
by	O
zoo	O
personnel	O
,	O
inoculated	O
into	O
anaerobic	O
transport	O
media	O
,	O
and	O
delivered	O
by	O
courier	O
to	O
a	O
reference	O
laboratory	O
.	O

Samples	O
were	O
cultured	O
for	O
aerobes	O
and	O
anaerobes	O
.	O

Strains	O
were	O
identified	O
by	O
standard	O
methods	O
and	O
16S	O
rRNA	O
gene	O
sequencing	O
when	O
required	O
.	O

The	O
oral	O
flora	O
consisted	O
of	O
39	O
aerobic	O
and	O
21	O
anaerobic	O
species	O
,	O
with	O
some	O
variation	O
by	O
zoo	O
.	O

Adult	O
dragons	O
grew	O
128	O
isolates	O
,	O
including	O
37	O
aerobic	O
gram	O
-	O
negative	O
rods	O
(	O
one	O
to	O
eight	O
per	O
specimen	O
)	O
,	O
especially	O
Enterobacteriaceae	B-bacteria
;	O
50	O
aerobic	O
gram	O
-	O
positive	O
bacteria	O
(	O
two	O
to	O
nine	O
per	O
specimen	O
)	O
,	O
especially	O
Staphylococcus	B-bacteria
sciuri	I-bacteria
and	O
Enterococcusfaecalis	B-bacteria
,	O
present	O
in	O
eight	O
of	O
10	O
and	O
nine	O
of	O
10	O
dragons	O
,	O
respectively	O
;	O
and	O
41	O
anaerobes	O
(	O
one	O
to	O
six	O
per	O
specimen	O
)	O
,	O
especially	O
clostridia	B-bacteria
.	O

All	O
hatchlings	O
grew	O
aerobes	O
but	O
none	O
grew	O
anaerobes	O
.	O

No	O
virulent	O
species	O
were	O
isolated	O
.	O

As	O
with	O
other	O
carnivores	O
,	O
captive	O
Komodo	O
oral	O
flora	O
is	O
simply	O
reflective	O
of	O
the	O
gut	O
and	O
skin	O
flora	O
of	O
their	O
recent	O
meals	O
and	O
environment	O
and	O
is	O
unlikely	O
to	O
cause	O
rapid	O
fatal	O
infection	O
.	O

Bacteria	O
in	O
the	O
oral	O
cavity	O
grow	O
in	O
the	O
form	O
of	O
biofilms	O
;	O
these	O
structures	O
are	O
subject	O
to	O
constant	O
saliva	O
or	O
gingival	O
crevicular	O
fluid	O
flow	O
conditions	O
.	O

The	O
aims	O
of	O
this	O
study	O
were	O
:	O
(	O
i	O
)	O
to	O
develop	O
and	O
to	O
characterize	O
an	O
in	O
-	O
vitro	O
biofilm	O
model	O
with	O
oral	O
bacteria	O
growing	O
under	O
flow	O
and	O
shear	O
conditions	O
;	O
and	O
(	O
ii	O
)	O
to	O
demonstrate	O
the	O
usefulness	O
of	O
the	O
model	O
for	O
evaluating	O
the	O
activity	O
of	O
three	O
antiplaque	O
agents	O
.	O

We	O
used	O
a	O
bioreactor	O
to	O
grow	O
the	O
oral	O
bacteria	O
Streptococcus	B-bacteria
oralis	I-bacteria
,	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
,	O
Veillonella	B-bacteria
parvula	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
under	O
planktonic	O
conditions	O
.	O

Biofilms	O
were	O
established	O
using	O
a	O
modified	O
Robbins	O
device	O
on	O
hydroxyapatite	O
(	O
HAP	O
)	O
discs	O
.	O

Three	O
-	O
to	O
7	O
-	O
d	O
-	O
old	O
biofilms	O
were	O
analysed	O
using	O
culture	O
methods	O
,	O
scanning	O
electron	O
microscopy	O
,	O
Live	O
/	O
Dead	O
staining	O
and	O
fluorescence	O
in	O
-	O
situ	O
hybridization	O
(	O
confocal	O
laser	O
scanning	O
microscopy	O
)	O
.	O

Finally	O
,	O
we	O
assessed	O
the	O
antimicrobial	O
activity	O
of	O
three	O
mouthrinses	O
[	O
0	O
.	O
12	O
%	O
chlorhexidine	O
(	O
CHX	O
)	O
,	O
0	O
.	O
12	O
%	O
chlorhexidine	O
and	O
sodium	O
fluoride	O
(	O
CHX	O
+	O
NaF	O
)	O
and	O
0	O
.	O
12	O
%	O
chlorhexidine	O
and	O
0	O
.	O
05	O
%	O
cetylpyridinium	O
chloride	O
(	O
CHX	O
+	O
CPC	O
)	O
]	O
using	O
a	O
planktonic	O
test	O
(	O
short	O
interval	O
-	O
killing	O
test	O
)	O
and	O
in	O
our	O
4	O
-	O
d	O
biofilm	O
model	O
.	O

The	O
viable	O
cell	O
counts	O
showed	O
that	O
each	O
species	O
was	O
consistently	O
found	O
in	O
the	O
biofilms	O
throughout	O
the	O
study	O
.	O

The	O
architecture	O
and	O
cell	O
distribution	O
were	O
similar	O
to	O
those	O
described	O
for	O
biofilms	O
in	O
situ	O
,	O
with	O
the	O
exception	O
of	O
a	O
thin	O
layer	O
of	O
living	O
cells	O
that	O
was	O
found	O
close	O
to	O
the	O
HAP	O
.	O

The	O
effectiveness	O
test	O
of	O
the	O
mouthwashes	O
demonstrated	O
that	O
cells	O
in	O
biofilms	O
showed	O
more	O
tolerance	O
compared	O
with	O
planktonic	O
cells	O
.	O

Moreover	O
,	O
it	O
was	O
observed	O
that	O
in	O
4	O
-	O
d	O
biofilm	O
formed	O
in	O
vitro	O
,	O
CHX	O
+	O
CPC	O
caused	O
significantly	O
higher	O
mortality	O
compared	O
with	O
CHX	O
(	O
p	O
=	O
0	O
.	O
003	O
)	O
and	O
CHX	O
+	O
NaF	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

Our	O
results	O
suggest	O
that	O
we	O
have	O
a	O
highly	O
reproducible	O
system	O
for	O
multispecies	O
oral	O
biofilm	O
formation	O
and	O
that	O
it	O
is	O
a	O
useful	O
tool	O
for	O
assessing	O
antibacterial	O
molecules	O
before	O
their	O
clinical	O
evaluation	O
.	O

It	O
also	O
has	O
great	O
potential	O
to	O
be	O
used	O
in	O
basic	O
research	O
on	O
supragingival	O
and	O
subgingival	O
biofilms	O
.	O

Mucosal	O
surfaces	O
such	O
as	O
the	O
gut	O
,	O
vagina	O
and	O
oral	O
cavity	O
are	O
colonized	O
by	O
microbiota	O
that	O
are	O
an	O
integral	O
component	O
of	O
the	O
healthy	O
ecosystem	O
.	O

Recent	O
molecular	O
techniques	O
make	O
it	O
feasible	O
to	O
correlate	O
antimicrobial	O
dosing	O
levels	O
with	O
changes	O
in	O
microbiome	O
composition	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
characterize	O
the	O
rat	O
oral	O
plaque	O
microbiome	O
composition	O
at	O
doses	O
of	O
ciprofloxacin	O
that	O
were	O
considerably	O
above	O
and	O
below	O
nominal	O
in	O
vitro	O
minimal	O
inhibitory	O
concentrations	O
of	O
a	O
variety	O
of	O
gram	O
-	O
positive	O
oral	O
commensal	O
bacteria	O
.	O

We	O
exposed	O
the	O
oral	O
cavities	O
of	O
rats	O
to	O
relatively	O
low	O
(	O
0	O
.	O
1	O
mug	O
ml	O
(	O
-	O
1	O
)	O
)	O
and	O
high	O
(	O
20	O
mug	O
ml	O
(	O
-	O
1	O
)	O
)	O
doses	O
of	O
ciprofloxacin	O
in	O
the	O
drinking	O
water	O
over	O
a	O
3	O
-	O
day	O
period	O
.	O

Plaque	O
microbiota	O
were	O
characterized	O
using	O
454	O
pyrosequencing	O
.	O

The	O
rat	O
indigenous	O
community	O
was	O
dominated	O
by	O
the	O
genera	O
Rothia	B-bacteria
(	O
74	O
.	O
4	O
%	O
)	O
and	O
Streptococcus	B-bacteria
(	O
4	O
.	O
7	O
%	O
)	O
.	O

Dosing	O
at	O
0	O
.	O
1	O
mug	O
ml	O
(	O
-	O
1	O
)	O
was	O
associated	O
with	O
changes	O
in	O
Rothia	B-bacteria
and	O
Streptococcus	B-bacteria
species	I-bacteria
that	O
were	O
not	O
significant	O
,	O
whereas	O
dosing	O
at	O
20	O
mug	O
ml	O
(	O
-	O
1	O
)	O
caused	O
a	O
pronounced	O
(	O
significant	O
)	O
reduction	O
in	O
the	O
relative	O
abundance	O
of	O
the	O
Streptococcus	B-bacteria
genus	I-bacteria
.	O

Taxonomic	O
independent	O
analysis	O
indicated	O
that	O
the	O
perturbation	O
in	O
the	O
overall	O
community	O
structure	O
attributed	O
to	O
dosing	O
with	O
ciprofloxacin	O
at	O
either	O
the	O
low	O
or	O
high	O
dose	O
was	O
relatively	O
low	O
.	O

The	O
results	O
suggest	O
that	O
it	O
is	O
feasible	O
to	O
use	O
an	O
antimicrobial	O
dosing	O
regimen	O
to	O
selectively	O
target	O
a	O
specific	O
subset	O
of	O
a	O
mucosal	O
microbiome	O
for	O
elimination	O
with	O
minimal	O
perturbation	O
of	O
the	O
entire	O
community	O
.	O

Streptococcus	B-bacteria
mutans	I-bacteria
and	O
Streptococcus	B-bacteria
sobrinus	I-bacteria
are	O
associated	O
with	O
the	O
development	O
of	O
dental	O
caries	O
in	O
humans	O
.	O

However	O
,	O
previous	O
diagnostic	O
systems	O
are	O
unsuitable	O
for	O
monitoring	O
viable	O
cell	O
numbers	O
in	O
oral	O
specimens	O
.	O

Assessing	O
the	O
relationship	O
between	O
the	O
numbers	O
of	O
viable	O
and	O
dead	O
bacterial	O
cells	O
and	O
oral	O
status	O
is	O
important	O
for	O
understanding	O
oral	O
infectious	O
diseases	O
.	O

Propidium	O
monoazide	O
(	O
PMA	O
)	O
has	O
been	O
reported	O
to	O
penetrate	O
dead	O
cells	O
following	O
membrane	O
damage	O
and	O
to	O
cross	O
-	O
link	O
DNA	O
,	O
thereby	O
inhibiting	O
DNA	O
amplification	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
established	O
an	O
assay	O
for	O
selective	O
analysis	O
of	O
two	O
viable	O
human	O
cariogenic	O
pathogens	O
,	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
sobrinus	I-bacteria
,	O
using	O
PMA	O
combined	O
with	O
real	O
-	O
time	O
PCR	O
(	O
PMA	O
-	O
qPCR	O
)	O
.	O

We	O
designed	O
species	O
-	O
specific	O
primer	O
sets	O
for	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
sobrinus	I-bacteria
,	O
generated	O
standard	O
curves	O
for	O
measuring	O
cell	O
numbers	O
,	O
and	O
evaluated	O
the	O
dynamic	O
range	O
of	O
the	O
assay	O
.	O

To	O
determine	O
the	O
effectiveness	O
of	O
the	O
assay	O
,	O
PMA	O
was	O
added	O
to	O
viable	O
and	O
autoclave	O
-	O
killed	O
cell	O
mixtures	O
.	O

PMA	O
treatment	O
effectively	O
prevented	O
DNA	O
amplification	O
from	O
dead	O
cells	O
.	O

No	O
amplification	O
of	O
DNA	O
from	O
dead	O
cells	O
was	O
observed	O
in	O
these	O
organisms	O
.	O

In	O
addition	O
,	O
we	O
applied	O
this	O
assay	O
to	O
analyze	O
viable	O
cell	O
numbers	O
in	O
oral	O
specimens	O
.	O

A	O
significant	O
correlation	O
was	O
found	O
between	O
the	O
number	O
of	O
viable	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
cells	O
in	O
saliva	O
and	O
that	O
in	O
plaque	O
among	O
caries	O
-	O
free	O
patients	O
,	O
whereas	O
no	O
correlation	O
was	O
observed	O
between	O
saliva	O
and	O
carious	O
dentin	O
.	O

The	O
total	O
and	O
viable	O
cell	O
numbers	O
in	O
caries	O
-	O
positive	O
saliva	O
were	O
significantly	O
higher	O
than	O
those	O
in	O
caries	O
-	O
free	O
saliva	O
.	O

Finally	O
,	O
we	O
analyzed	O
the	O
usefulness	O
of	O
this	O
assay	O
for	O
in	O
vitro	O
oral	O
biofilm	O
analysis	O
.	O

We	O
applied	O
PMA	O
-	O
qPCR	O
for	O
monitoring	O
viable	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
cell	O
numbers	O
in	O
vitro	O
in	O
planktonic	O
cells	O
and	O
oral	O
biofilm	O
treated	O
with	O
hydrogen	O
peroxide	O
(	O
H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
)	O
.	O

In	O
planktonic	O
cells	O
,	O
the	O
number	O
of	O
viable	O
cells	O
decreased	O
significantly	O
with	O
increasing	O
H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
concentration	O
,	O
whereas	O
only	O
a	O
small	O
decrease	O
was	O
observed	O
in	O
biofilm	O
cell	O
numbers	O
.	O

PMA	O
-	O
qPCR	O
is	O
potentially	O
useful	O
for	O
quantifying	O
viable	O
cariogenic	O
pathogens	O
in	O
oral	O
specimens	O
and	O
is	O
applicable	O
to	O
oral	O
biofilm	O
experiments	O
.	O

This	O
assay	O
will	O
help	O
to	O
elucidate	O
the	O
relationship	O
between	O
the	O
number	O
of	O
viable	O
cells	O
in	O
oral	O
specimens	O
and	O
the	O
oral	O
status	O
.	O

From	O
oral	O
cavity	O
we	O
isolated	O
and	O
characterized	O
probiotic	O
lactobacilli	B-bacteria
that	O
could	O
probability	O
be	O
applied	O
to	O
therapy	O
and	O
prevention	O
of	O
oral	O
diseases	O
.	O

Lactobacillus	B-bacteria
strains	I-bacteria
were	O
isolated	O
by	O
plating	O
the	O
saliva	O
and	O
dental	O
plaque	O
of	O
healthy	O
donors	O
on	O
selective	O
medium	O
.	O

Then	O
the	O
target	O
strains	O
were	O
tested	O
for	O
inhibiting	O
the	O
growth	O
of	O
a	O
Streptococcus	B-bacteria
mutans	I-bacteria
strain	I-bacteria
belonging	O
to	O
cariogenic	O
pathogen	O
species	O
.	O

Other	O
properties	O
such	O
as	O
production	O
of	O
extracellular	O
polysaccharide	O
and	O
resistance	O
to	O
the	O
antibacterial	O
substances	O
were	O
also	O
investigated	O
.	O

Lactobacillus	B-bacteria
fermentum	I-bacteria
Y29	I-bacteria
,	O
a	O
strain	O
with	O
antimicrobial	O
activity	O
against	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
was	O
obtained	O
from	O
dental	O
plaque	O
.	O

This	O
strain	O
was	O
an	O
extracellular	O
polysaccharide	O
producer	O
,	O
which	O
corresponds	O
to	O
its	O
aggregation	O
ability	O
.	O

Moreover	O
,	O
L	B-bacteria
.	I-bacteria
fermentum	I-bacteria
Y29	I-bacteria
showed	O
resistance	O
to	O
1	O
.	O
0	O
mg	O
/	O
mL	O
lysozyme	O
and	O
140	O
microg	O
/	O
g	O
hydrogen	O
peroxide	O
that	O
may	O
guarantee	O
its	O
persistence	O
in	O
the	O
complex	O
oral	O
niche	O
.	O

Probiotic	O
properties	O
were	O
characterized	O
of	O
an	O
oral	O
isolate	O
L	B-bacteria
.	I-bacteria
fermentum	I-bacteria
Y29	I-bacteria
,	O
which	O
provided	O
a	O
possibility	O
for	O
its	O
application	O
in	O
prevention	O
and	O
treatment	O
of	O
oral	O
diseases	O
.	O

Oral	O
mucosal	O
and	O
salivary	O
lipids	O
exhibit	O
potent	O
antimicrobial	O
activity	O
for	O
a	O
variety	O
of	O
Gram	O
-	O
positive	O
and	O
Gram	O
-	O
negative	O
bacteria	O
;	O
however	O
,	O
little	O
is	O
known	O
about	O
their	O
spectrum	O
of	O
antimicrobial	O
activity	O
or	O
mechanisms	O
of	O
action	O
against	O
oral	O
bacteria	O
.	O

In	O
this	O
study	O
,	O
we	O
examine	O
the	O
activity	O
of	O
two	O
fatty	O
acids	O
and	O
three	O
sphingoid	O
bases	O
against	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
an	O
important	O
colonizer	O
of	O
the	O
oral	O
cavity	O
implicated	O
in	O
periodontitis	O
.	O

Minimal	O
inhibitory	O
concentrations	O
,	O
minimal	O
bactericidal	O
concentrations	O
,	O
and	O
kill	O
kinetics	O
revealed	O
variable	O
,	O
but	O
potent	O
,	O
activity	O
of	O
oral	O
mucosal	O
and	O
salivary	O
lipids	O
against	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
indicating	O
that	O
lipid	O
structure	O
may	O
be	O
an	O
important	O
determinant	O
in	O
lipid	O
mechanisms	O
of	O
activity	O
against	O
bacteria	O
,	O
although	O
specific	O
components	O
of	O
bacterial	O
membranes	O
are	O
also	O
likely	O
important	O
.	O

Electron	O
micrographs	O
showed	O
ultrastructural	O
damage	O
induced	O
by	O
sapienic	O
acid	O
and	O
phytosphingosine	O
and	O
confirmed	O
disruption	O
of	O
the	O
bacterial	O
plasma	O
membrane	O
.	O

This	O
information	O
,	O
coupled	O
with	O
the	O
association	O
of	O
treatment	O
lipids	O
with	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
lipids	O
revealed	O
via	O
thin	O
layer	O
chromatography	O
,	O
suggests	O
that	O
the	O
plasma	O
membrane	O
is	O
a	O
likely	O
target	O
of	O
lipid	O
antibacterial	O
activity	O
.	O

Utilizing	O
a	O
combination	O
of	O
two	O
-	O
dimensional	O
in	O
-	O
gel	O
electrophoresis	O
and	O
Western	O
blot	O
followed	O
by	O
mass	O
spectroscopy	O
and	O
N	O
-	O
terminus	O
degradation	O
sequencing	O
we	O
also	O
show	O
that	O
treatment	O
with	O
sapienic	O
acid	O
induces	O
upregulation	O
of	O
a	O
set	O
of	O
proteins	O
comprising	O
a	O
unique	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
stress	O
response	O
,	O
including	O
proteins	O
important	O
in	O
fatty	O
acid	O
biosynthesis	O
,	O
metabolism	O
and	O
energy	O
production	O
,	O
protein	O
processing	O
,	O
cell	O
adhesion	O
and	O
virulence	O
.	O

Prophylactic	O
or	O
therapeutic	O
lipid	O
treatments	O
may	O
be	O
beneficial	O
for	O
intervention	O
of	O
infection	O
by	O
supplementing	O
the	O
natural	O
immune	O
function	O
of	O
endogenous	O
lipids	O
on	O
mucosal	O
surfaces	O
.	O

Adhesion	O
to	O
oral	O
soft	O
and	O
hard	O
tissue	O
is	O
crucial	O
for	O
bacterial	O
colonisation	O
in	O
the	O
mouth	O
.	O

The	O
aim	O
of	O
this	O
work	O
was	O
to	O
select	O
strains	O
of	O
oral	O
lactic	B-bacteria
acid	I-bacteria
bacteria	I-bacteria
that	O
could	O
be	O
used	O
as	O
probiotics	O
for	O
oral	O
health	O
.	O

To	O
this	O
end	O
,	O
the	O
adhesive	O
properties	O
of	O
some	O
lactic	B-bacteria
acid	I-bacteria
bacteria	I-bacteria
were	O
investigated	O
.	O

Seventeen	O
lactic	B-bacteria
acid	I-bacteria
bacteria	I-bacteria
including	O
two	O
Streptococcus	B-bacteria
mutans	I-bacteria
strains	I-bacteria
were	O
isolated	O
from	O
the	O
oral	O
cavity	O
of	O
healthy	O
children	O
,	O
while	O
other	O
strains	O
were	O
isolated	O
from	O
fermented	O
meat	O
products	O
.	O

The	O
bacterial	O
strains	O
were	O
applied	O
to	O
teeth	O
surfaces	O
covered	O
with	O
saliva	O
or	O
without	O
saliva	O
.	O

A	O
significant	O
diversity	O
in	O
adhesion	O
capacity	O
to	O
teeth	O
surfaces	O
among	O
the	O
lactic	B-bacteria
acid	I-bacteria
bacteria	I-bacteria
was	O
observed	O
.	O

Lactic	B-bacteria
acid	I-bacteria
bacteria	I-bacteria
isolated	O
from	O
the	O
oral	O
cavity	O
adhered	O
the	O
best	O
to	O
teeth	O
surfaces	O
covered	O
with	O
saliva	O
,	O
whereas	O
lactic	B-bacteria
acid	I-bacteria
bacteria	I-bacteria
isolated	O
from	O
fermented	O
meat	O
samples	O
adhered	O
the	O
best	O
to	O
tooth	O
surface	O
without	O
saliva	O
.	O

All	O
strains	O
of	O
lactic	B-bacteria
acid	I-bacteria
bacteria	I-bacteria
were	O
able	O
to	O
reduce	O
the	O
number	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
cells	O
,	O
in	O
particular	O
on	O
saliva	O
-	O
coated	O
tooth	O
surface	O
.	O

Therefore	O
,	O
they	O
might	O
have	O
potential	O
as	O
probiotics	O
for	O
the	O
oral	O
cavity	O
.	O

The	O
objective	O
of	O
our	O
study	O
was	O
to	O
investigate	O
the	O
relationship	O
between	O
halitosis	O
and	O
oral	O
bacteria	O
in	O
tongue	O
coating	O
(	O
TC	O
)	O
and	O
saliva	O
samples	O
from	O
patients	O
with	O
halitosis	O
,	O
and	O
to	O
evaluate	O
the	O
effect	O
of	O
tongue	O
cleaning	O
on	O
halitosis	O
.	O

Ninety	O
-	O
four	O
participants	O
complaining	O
of	O
oral	O
malodour	O
were	O
included	O
in	O
the	O
study	O
.	O

Organoleptic	O
(	O
OR	O
)	O
values	O
,	O
volatile	O
sulphur	O
compound	O
(	O
VSC	O
)	O
concentrations	O
determined	O
by	O
gas	O
chromatography	O
and	O
TC	O
scores	O
were	O
used	O
as	O
clinical	O
parameters	O
of	O
halitosis	O
.	O

Quantitative	O
real	O
-	O
time	O
polymerase	O
chain	O
reactions	O
were	O
used	O
to	O
determine	O
the	O
numbers	O
of	O
periodontal	O
disease	O
-	O
associated	O
oral	O
bacteria	O
.	O

There	O
was	O
a	O
significant	O
correlation	O
between	O
TC	O
scores	O
and	O
OR	O
values	O
,	O
methylmercaptan	O
(	O
CH3	O
SH	O
)	O
concentrations	O
and	O
VSC	O
concentrations	O
(	O
Spearman	O
'	O
s	O
rank	O
-	O
correlation	O
coefficient	O
test	O
,	O
P	O
<	O
0	O
.	O
01	O
)	O
.	O

There	O
was	O
also	O
a	O
positive	O
correlation	O
between	O
the	O
clinical	O
parameters	O
of	O
halitosis	O
and	O
total	O
bacterial	O
numbers	O
and	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
and	O
Campylobacter	B-bacteria
rectus	I-bacteria
concentrations	O
in	O
the	O
TC	O
samples	O
.	O

However	O
,	O
there	O
was	O
no	O
similar	O
correlation	O
with	O
respect	O
to	O
the	O
saliva	O
samples	O
.	O

The	O
participants	O
were	O
sub	O
-	O
divided	O
into	O
two	O
groups	O
based	O
on	O
whether	O
they	O
had	O
the	O
habit	O
of	O
tongue	O
cleaning	O
or	O
not	O
.	O

The	O
participants	O
with	O
the	O
habit	O
of	O
tongue	O
cleaning	O
had	O
significantly	O
lower	O
OR	O
scores	O
,	O
VSC	O
concentrations	O
and	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
,	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
and	O
C	B-bacteria
.	I-bacteria
rectus	I-bacteria
levels	O
than	O
the	O
other	O
participants	O
(	O
Mann	O
-	O
Whitney	O
U	O
-	O
test	O
,	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

These	O
results	O
suggested	O
that	O
periodontal	O
disease	O
-	O
associated	O
oral	O
bacteria	O
in	O
TCs	O
are	O
closely	O
related	O
to	O
halitosis	O
and	O
that	O
tongue	O
cleaning	O
may	O
be	O
an	O
effective	O
method	O
for	O
improving	O
halitosis	O
.	O

The	O
in	O
vitro	O
effect	O
of	O
a	O
novel	O
,	O
oligosaccharide	O
nanomedicine	O
OligoG	O
against	O
oral	O
pathogen	O
-	O
related	O
biofilms	O
,	O
both	O
alone	O
and	O
in	O
the	O
presence	O
of	O
the	O
conventional	O
anti	O
-	O
bacterial	O
agent	O
triclosan	O
,	O
was	O
evaluated	O
.	O

The	O
effect	O
of	O
OligoG	O
+	O
/	O
-	O
triclosan	O
was	O
assessed	O
against	O
established	O
Streptococcus	B-bacteria
mutans	I-bacteria
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
biofilms	O
by	O
bacterial	O
counts	O
and	O
image	O
analysis	O
using	O
LIVE	O
/	O
DEAD	O
(	O
(	O
R	O
)	O
)	O
staining	O
and	O
atomic	O
force	O
microscopy	O
(	O
AFM	O
)	O
.	O

The	O
effect	O
of	O
triclosan	O
and	O
OligoG	O
surface	O
pre	O
-	O
treatments	O
on	O
bacterial	O
attachment	O
to	O
titanium	O
and	O
polymethylmethacrylate	O
was	O
also	O
studied	O
.	O

OligoG	O
potentiated	O
the	O
antimicrobial	O
effect	O
of	O
triclosan	O
,	O
particularly	O
when	O
used	O
in	O
combination	O
at	O
0	O
.	O
3	O
%	O
against	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
grown	O
in	O
artificial	O
saliva	O
.	O

OligoG	O
was	O
less	O
effective	O
against	O
established	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
biofilms	O
.	O

However	O
,	O
attachment	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
to	O
titanium	O
in	O
particular	O
,	O
was	O
significantly	O
reduced	O
after	O
surface	O
pre	O
-	O
treatment	O
with	O
OligoG	O
and	O
triclosan	O
at	O
0	O
.	O
01	O
%	O
when	O
compared	O
to	O
controls	O
.	O

Light	O
microscopy	O
and	O
AFM	O
showed	O
that	O
OligoG	O
was	O
biocidal	O
to	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
but	O
not	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

OligoG	O
and	O
triclosan	O
when	O
used	O
in	O
combination	O
produced	O
an	O
enhanced	O
antimicrobial	O
effect	O
against	O
two	O
important	O
oral	O
pathogens	O
and	O
reduced	O
bacterial	O
attachment	O
to	O
dental	O
materials	O
such	O
as	O
titanium	O
,	O
even	O
at	O
reduced	O
triclosan	O
concentrations	O
.	O

Whilst	O
the	O
use	O
of	O
triclosan	O
against	O
oral	O
bacteria	O
has	O
been	O
widely	O
documented	O
,	O
its	O
synergistic	O
use	O
with	O
OligoG	O
described	O
here	O
,	O
has	O
not	O
previously	O
been	O
reported	O
.	O

The	O
use	O
of	O
lower	O
concentrations	O
of	O
triclosan	O
,	O
if	O
used	O
in	O
combination	O
therapy	O
with	O
OligoG	O
,	O
could	O
have	O
environmental	O
benefits	O
.	O

The	O
potentiation	O
of	O
antimicrobial	O
agents	O
by	O
naturally	O
occurring	O
oligomers	O
such	O
as	O
OligoG	O
may	O
represent	O
a	O
novel	O
,	O
safe	O
adjunct	O
to	O
conventional	O
oral	O
hygiene	O
and	O
periodontal	O
therapy	O
.	O

The	O
ability	O
of	O
OligoG	O
to	O
inhibit	O
the	O
growth	O
and	O
impair	O
bacterial	O
adherence	O
highlights	O
its	O
potential	O
in	O
the	O
management	O
of	O
peri	O
-	O
implantitis	O
.	O

'	O
Broken	O
mouth	O
'	O
periodontitis	O
(	O
BMP	O
)	O
is	O
a	O
painful	O
condition	O
of	O
sheep	O
grazed	O
on	O
rough	O
pasture	O
and	O
involves	O
periodontal	O
infection	O
of	O
the	O
incisor	O
teeth	O
and	O
progressive	O
tooth	O
loss	O
.	O

This	O
can	O
reduce	O
the	O
efficiency	O
of	O
grazing	O
of	O
sheep	O
,	O
which	O
contributes	O
to	O
malnutrition	O
,	O
weight	O
loss	O
,	O
systemic	O
health	O
problems	O
,	O
poor	O
quality	O
of	O
life	O
and	O
early	O
culling	O
from	O
flocks	O
.	O

Consequently	O
,	O
this	O
condition	O
is	O
a	O
major	O
economic	O
problem	O
to	O
sheep	O
farmers	O
.	O

However	O
,	O
there	O
are	O
no	O
treatment	O
or	O
control	O
methods	O
available	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
identify	O
the	O
bacteria	O
associated	O
with	O
BMP	O
and	O
oral	O
health	O
in	O
sheep	O
.	O

Swabs	O
were	O
collected	O
from	O
the	O
gingival	O
pockets	O
of	O
three	O
sheep	O
with	O
BMP	O
and	O
from	O
the	O
gingival	O
margin	O
of	O
three	O
orally	O
healthy	O
(	O
normal	O
)	O
sheep	O
.	O

Bacteria	O
were	O
identified	O
using	O
culture	O
-	O
independent	O
(	O
16S	O
rRNA	O
gene	O
sequencing	O
)	O
methods	O
.	O

In	O
the	O
normal	O
samples	O
,	O
26	O
phylotypes	O
were	O
identified	O
.	O

The	O
most	O
prevalent	O
species	O
were	O
Enterobacter	B-bacteria
hormaechei	I-bacteria
(	O
21	O
.	O
3	O
%	O
of	O
analysed	O
clones	O
)	O
and	O
Hafnia	B-bacteria
alvei	I-bacteria
(	O
21	O
.	O
3	O
%	O
)	O
,	O
with	O
uncultured	O
(	O
4	O
.	O
4	O
%	O
)	O
and	O
novel	O
(	O
5	O
.	O
0	O
%	O
)	O
phylotypes	O
also	O
being	O
identified	O
.	O

For	O
the	O
BMP	O
samples	O
,	O
24	O
phylotypes	O
were	O
identified	O
.	O

The	O
most	O
prevalent	O
species	O
were	O
Mannheimia	B-bacteria
ruminalis	I-bacteria
(	O
28	O
.	O
4	O
%	O
)	O
and	O
Moraxella	B-bacteria
caprae	I-bacteria
(	O
13	O
.	O
5	O
%	O
)	O
,	O
with	O
uncultured	O
(	O
2	O
.	O
6	O
%	O
)	O
and	O
novel	O
(	O
24	O
.	O
5	O
%	O
)	O
phylotypes	O
also	O
being	O
identified	O
.	O

In	O
conclusion	O
,	O
a	O
distinct	O
microflora	O
is	O
associated	O
with	O
BMP	O
and	O
oral	O
health	O
in	O
sheep	O
and	O
M	B-bacteria
.	I-bacteria
ruminalis	I-bacteria
may	O
be	O
involved	O
in	O
the	O
aetiology	O
of	O
BMP	O
.	O

Lactobacillus	B-bacteria
species	I-bacteria
can	O
contribute	O
positively	O
to	O
general	O
and	O
oral	O
health	O
and	O
are	O
frequently	O
acquired	O
by	O
breastfeeding	O
in	O
infancy	O
.	O

The	O
present	O
study	O
aimed	O
to	O
identify	O
oral	O
lactobacilli	B-bacteria
in	O
breast	O
and	O
formula	O
-	O
fed	O
4	O
month	O
-	O
old	O
infants	O
and	O
to	O
evaluate	O
potential	O
probiotic	O
properties	O
of	O
the	O
dominant	O
Lactobacillus	B-bacteria
species	I-bacteria
detected	O
.	O

Saliva	O
and	O
oral	O
swab	O
samples	O
were	O
collected	O
from	O
133	O
infants	O
who	O
were	O
enrolled	O
in	O
a	O
longitudinal	O
study	O
(	O
n	O
=	O
240	O
)	O
examining	O
the	O
effect	O
of	O
a	O
new	O
infant	O
formula	O
on	O
child	O
growth	O
and	O
development	O
.	O

Saliva	O
was	O
cultured	O
and	O
Lactobacillus	B-bacteria
isolates	I-bacteria
were	O
identified	O
from	O
16S	O
rRNA	O
gene	O
sequences	O
.	O

Five	O
L	B-bacteria
.	I-bacteria
gasseri	I-bacteria
isolates	I-bacteria
that	O
differed	O
in	O
16S	O
rRNA	O
sequence	O
were	O
tested	O
for	O
their	O
ability	O
to	O
inhibit	O
growth	O
of	O
selected	O
oral	O
bacteria	O
and	O
for	O
adhesion	O
to	O
oral	O
tissues	O
.	O

Oral	O
swab	O
samples	O
were	O
analyzed	O
by	O
qPCR	O
for	O
Lactobacillus	B-bacteria
gasseri	I-bacteria
.	O

43	O
(	O
32	O
.	O
3	O
%	O
)	O
infants	O
were	O
breastfed	O
and	O
90	O
(	O
67	O
.	O
7	O
%	O
)	O
were	O
formula	O
-	O
fed	O
with	O
either	O
a	O
standard	O
formula	O
(	O
43	O
out	O
of	O
90	O
)	O
or	O
formula	O
supplemented	O
with	O
a	O
milk	O
fat	O
globule	O
membrane	O
(	O
MFGM	O
)	O
fraction	O
(	O
47	O
out	O
of	O
90	O
)	O
.	O

lactobacilli	B-bacteria
were	O
cultured	O
from	O
saliva	O
of	O
34	O
.	O
1	O
%	O
breastfed	O
infants	O
,	O
but	O
only	O
in	O
4	O
.	O
7	O
%	O
of	O
the	O
standard	O
and	O
9	O
.	O
3	O
%	O
of	O
the	O
MFGM	O
supplemented	O
formula	O
-	O
fed	O
infants	O
.	O

L	B-bacteria
.	I-bacteria
gasseri	I-bacteria
was	O
the	O
most	O
prevalent	O
(	O
88	O
%	O
of	O
Lactobacillus	B-bacteria
positive	O
infants	O
)	O
of	O
six	O
Lactobacillus	B-bacteria
species	I-bacteria
detected	O
.	O

L	B-bacteria
.	I-bacteria
gasseri	I-bacteria
isolates	I-bacteria
inhibited	O
Streptococcus	B-bacteria
mutans	I-bacteria
binding	O
to	O
saliva	O
-	O
coated	O
hydroxyapatite	O
,	O
and	O
inhibited	O
growth	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
Streptococcus	B-bacteria
sobrinus	I-bacteria
,	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
,	O
Actinomyces	B-bacteria
oris	I-bacteria
,	O
Candida	O
albicans	O
and	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
in	O
a	O
concentration	O
dependent	O
fashion	O
.	O

L	B-bacteria
.	I-bacteria
gasseri	I-bacteria
isolates	I-bacteria
bound	O
to	O
parotid	O
and	O
submandibular	O
saliva	O
,	O
salivary	O
gp340	O
and	O
MUC7	O
,	O
and	O
purified	O
MFGM	O
,	O
and	O
adhered	O
to	O
epithelial	O
cells	O
.	O

L	B-bacteria
.	I-bacteria
gasseri	I-bacteria
was	O
detected	O
by	O
qPCR	O
in	O
29	O
.	O
7	O
%	O
of	O
the	O
oral	O
swabs	O
.	O

Breastfed	O
infants	O
had	O
significantly	O
higher	O
mean	O
DNA	O
levels	O
of	O
L	B-bacteria
.	I-bacteria
gasseri	I-bacteria
(	O
2	O
.	O
14	O
pg	O
/	O
uL	O
)	O
than	O
infants	O
fed	O
the	O
standard	O
(	O
0	O
.	O
363	O
pg	O
/	O
uL	O
)	O
or	O
MFGM	O
(	O
0	O
.	O
697	O
pg	O
/	O
uL	O
)	O
formula	O
.	O

lactobacilli	B-bacteria
colonized	O
the	O
oral	O
cavity	O
of	O
breastfed	O
infants	O
significantly	O
more	O
frequently	O
than	O
formula	O
-	O
fed	O
infants	O
.	O

The	O
dominant	O
Lactobacillus	B-bacteria
was	O
L	B-bacteria
.	I-bacteria
gasseri	I-bacteria
,	O
which	O
was	O
detected	O
at	O
higher	O
levels	O
in	O
breastfed	O
than	O
formula	O
-	O
fed	O
infants	O
and	O
displayed	O
probiotic	O
traits	O
in	O
vitro	O
.	O

Oral	O
infection	O
may	O
be	O
a	O
source	O
of	O
bacteremia	O
in	O
patients	O
undergoing	O
hematopoietic	O
stem	O
cell	O
transplant	O
(	O
HSCT	O
)	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
relationship	O
between	O
patients	O
with	O
poor	O
periodontal	O
status	O
and	O
complications	O
after	O
HSCT	O
.	O

A	O
cohort	O
of	O
patients	O
with	O
hematological	O
malignancies	O
candidates	O
for	O
autologous	O
HSCT	O
was	O
observed	O
before	O
and	O
during	O
the	O
neutropenic	O
phase	O
of	O
HSCT	O
.	O

A	O
primary	O
evaluation	O
was	O
performed	O
before	O
the	O
HSCT	O
procedure	O
,	O
including	O
medical	O
and	O
socio	O
-	O
demographic	O
data	O
and	O
physical	O
examination	O
(	O
number	O
of	O
teeth	O
and	O
decayed	O
,	O
missing	O
and	O
filled	O
teeth	O
index	O
(	O
DMFT	O
)	O
,	O
oral	O
mucosa	O
,	O
and	O
full	O
mouth	O
periodontal	O
assessment	O
)	O
.	O

During	O
the	O
neutropenic	O
phase	O
,	O
data	O
regarding	O
the	O
development	O
of	O
febrile	O
neutropenia	O
,	O
bacteremia	O
,	O
and	O
mucositis	O
were	O
also	O
prospectively	O
obtained	O
.	O

Forty	O
-	O
eight	O
patients	O
were	O
included	O
.	O

The	O
most	O
common	O
baseline	O
disease	O
was	O
multiple	O
myeloma	O
(	O
70	O
%	O
)	O
.	O

In	O
the	O
primary	O
evaluations	O
,	O
the	O
median	O
DMFT	O
was	O
13	O
(	O
ranging	O
0	O
-	O
27	O
)	O
,	O
and	O
periodontitis	O
and	O
gingivitis	O
were	O
present	O
in	O
29	O
and	O
60	O
%	O
of	O
the	O
patients	O
,	O
respectively	O
.	O

During	O
the	O
neutropenic	O
phase	O
of	O
HSCT	O
,	O
fever	O
occurred	O
in	O
96	O
%	O
of	O
patients	O
,	O
and	O
bacteremia	O
was	O
documented	O
in	O
29	O
%	O
.	O

Coagulase	B-bacteria
-	I-bacteria
negative	I-bacteria
Staphylococcus	B-bacteria
was	O
the	O
most	O
common	O
isolated	O
bacteria	O
.	O

Patients	O
who	O
developed	O
bacteremia	O
had	O
a	O
higher	O
frequency	O
of	O
oral	O
disorders	O
compared	O
with	O
those	O
without	O
bacteremia	O
,	O
but	O
it	O
was	O
not	O
statistically	O
significant	O
.	O

Oral	O
mucositis	O
affected	O
89	O
.	O
6	O
%	O
of	O
the	O
patients	O
,	O
and	O
patients	O
with	O
gingivitis	O
or	O
periodontal	O
disorders	O
had	O
a	O
high	O
frequency	O
of	O
mucositis	O
.	O

The	O
prevalence	O
of	O
oral	O
pathologic	O
conditions	O
previous	O
to	O
HSCT	O
procedures	O
was	O
very	O
high	O
in	O
the	O
studied	O
population	O
.	O

A	O
possible	O
association	O
was	O
noted	O
between	O
previous	O
gingivitis	O
and	O
the	O
development	O
of	O
mucositis	O
during	O
the	O
neutropenia	O
of	O
HSCT	O
.	O

To	O
investigate	O
the	O
DNA	O
sequence	O
variations	O
of	O
Helicobacter	B-bacteria
pylori	I-bacteria
in	O
the	O
oral	O
cavities	O
and	O
stomachs	O
of	O
children	O
with	O
chronic	O
gastritis	O
.	O

Dental	O
plaques	O
and	O
gargle	O
on	O
235	O
patients	O
were	O
obtained	O
before	O
gastroscopy	O
.	O

Gastric	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
infection	O
was	O
diagnosed	O
using	O
rapid	O
urease	O
test	O
or	O
Giemsa	O
staining	O
.	O

H	B-bacteria
.	I-bacteria
pylori	I-bacteria
16S	O
rDNA	O
and	O
CagA	O
gene	O
were	O
analyzed	O
using	O
PCR	O
methods	O
.	O

Thymine	O
adenine	O
cloning	O
-	O
based	O
sequencing	O
was	O
performed	O
in	O
patients	O
with	O
CagA	O
gene	O
positive	O
from	O
oral	O
cavities	O
.	O

The	O
sequence	O
alignments	O
and	O
V1	O
variable	O
region	O
were	O
evaluated	O
by	O
comparison	O
with	O
the	O
sequence	O
of	O
the	O
standard	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
26695	I-bacteria
strain	I-bacteria
.	O

Totally	O
,	O
46	O
out	O
of	O
the	O
235	O
patients	O
were	O
positive	O
for	O
gastric	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
infection	O
.	O

Of	O
the	O
46	O
patients	O
,	O
26	O
cases	O
had	O
amplified	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
16S	O
rDNA	O
in	O
both	O
oral	O
(	O
plaque	O
and	O
gargle	O
)	O
and	O
gastric	O
samples	O
.	O

Of	O
the	O
26	O
cases	O
,	O
12	O
patients	O
(	O
46	O
.	O
1	O
%	O
)	O
were	O
positive	O
for	O
the	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
CagA	O
gene	O
in	O
the	O
oral	O
samples	O
,	O
which	O
was	O
significantly	O
lower	O
than	O
that	O
in	O
the	O
gastric	O
mucosa	O
(	O
80	O
.	O
8	O
%	O
;	O
P	O
=	O
0	O
.	O
010	O
)	O
.	O

The	O
homology	O
of	O
the	O
complete	O
sequence	O
alignment	O
ranged	O
from	O
74	O
.	O
0	O
%	O
to	O
92	O
.	O
1	O
%	O
in	O
the	O
oral	O
and	O
gastric	O
samples	O
.	O

The	O
V1	O
region	O
alleles	O
(	O
positions	O
75	O
-	O
99	O
)	O
had	O
7	O
-	O
22	O
polymorphisms	O
(	O
homology	O
from	O
12	O
.	O
0	O
%	O
to	O
72	O
.	O
0	O
%	O
)	O
in	O
11	O
patients	O
between	O
the	O
oral	O
and	O
gastric	O
samples	O
,	O
but	O
had	O
100	O
%	O
homology	O
in	O
1	O
patient	O
.	O

Our	O
study	O
found	O
that	O
distinct	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
strains	I-bacteria
exist	O
in	O
the	O
oral	O
cavities	O
of	O
children	O
,	O
but	O
we	O
would	O
not	O
support	O
the	O
hypothesis	O
that	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
the	O
oral	O
cavities	O
is	O
an	O
important	O
reservoir	O
of	O
gastric	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
infections	O
in	O
children	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
association	O
of	O
dry	O
mouth	O
with	O
denture	O
plaque	O
microflora	O
in	O
patients	O
with	O
palatal	O
obturator	O
prostheses	O
from	O
the	O
viewpoint	O
of	O
infection	O
control	O
.	O

Thirty	O
palatal	O
obturator	O
prosthesis	O
wearers	O
were	O
compared	O
with	O
30	O
healthy	O
maxillary	O
complete	O
denture	O
wearers	O
.	O

Dry	O
mouth	O
was	O
examined	O
using	O
a	O
moisture	O
-	O
checking	O
device	O
and	O
was	O
diagnosed	O
by	O
the	O
measured	O
moisture	O
levels	O
.	O

Denture	O
plaque	O
was	O
collected	O
by	O
rubbing	O
the	O
mucosal	O
surface	O
of	O
the	O
denture	O
with	O
a	O
swab	O
;	O
collected	O
microorganisms	O
were	O
cultured	O
and	O
identified	O
using	O
culture	O
-	O
dependent	O
methods	O
.	O

The	O
number	O
of	O
colonising	O
microorganisms	O
and	O
prevalence	O
of	O
microorganisms	O
were	O
examined	O
according	O
to	O
the	O
type	O
of	O
prostheses	O
and	O
presence	O
of	O
dry	O
mouth	O
using	O
nonparametric	O
tests	O
and	O
frequency	O
analysis	O
(	O
alpha	O
=	O
0	O
.	O
05	O
)	O
.	O

The	O
prevalence	O
of	O
Candida	O
spp	O
.	O
and	O
Staphylococcus	B-bacteria
spp	I-bacteria
.	I-bacteria
in	O
palatal	O
obturator	O
prostheses	O
was	O
significantly	O
higher	O
than	O
that	O
in	O
complete	O
dentures	O
.	O

In	O
palatal	O
obturator	O
prostheses	O
,	O
the	O
total	O
number	O
of	O
colonising	O
microorganisms	O
showed	O
no	O
significant	O
differences	O
between	O
the	O
groups	O
with	O
and	O
without	O
dry	O
mouth	O
on	O
each	O
side	O
of	O
the	O
prostheses	O
.	O

However	O
,	O
the	O
prevalence	O
of	O
Candida	O
spp	O
.	O
and	O
Staphylococcus	B-bacteria
spp	I-bacteria
.	I-bacteria
in	O
the	O
group	O
with	O
dry	O
mouth	O
was	O
significantly	O
higher	O
than	O
that	O
in	O
the	O
group	O
without	O
dry	O
mouth	O
.	O

The	O
number	O
of	O
microorganisms	O
and	O
moisture	O
levels	O
of	O
palatal	O
obturator	O
prosthesis	O
wearers	O
showed	O
a	O
significantly	O
negative	O
correlation	O
with	O
Candida	O
spp	O
.	O
and	O
Staphylococcus	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
but	O
a	O
positive	O
correlation	O
with	O
Neisseria	B-bacteria
spp	I-bacteria
.	O

It	O
was	O
concluded	O
that	O
palatal	O
obturator	O
prosthesis	O
wearers	O
with	O
a	O
dry	O
mouth	O
have	O
greater	O
colonisation	O
by	O
Candida	O
spp	O
.	O
and	O
Staphylococcus	B-bacteria
spp	I-bacteria
.	I-bacteria
than	O
do	O
complete	O
denture	O
wearers	O
.	O

To	O
detect	O
predominant	O
bacteria	O
associated	O
with	O
radicular	O
cysts	O
and	O
discuss	O
in	O
light	O
of	O
the	O
literature	O
.	O

Clinical	O
materials	O
were	O
obtained	O
from	O
35	O
radicular	O
cysts	O
by	O
aspiration	O
.	O

Cultures	O
were	O
made	O
from	O
clinical	O
materials	O
by	O
modern	O
laboratory	O
techniques	O
,	O
they	O
underwent	O
microbiologic	O
analysis	O
.	O

The	O
following	O
are	O
microorganisms	O
isolated	O
from	O
cultures	O
:	O
Streptococcus	B-bacteria
milleri	I-bacteria
Group	I-bacteria
(	O
SMG	B-bacteria
)	O
(	O
23	O
.	O
8	O
%	O
)	O
[	O
Streptococcus	B-bacteria
constellatus	I-bacteria
(	O
19	O
.	O
1	O
%	O
)	O
and	O
Streptococcus	B-bacteria
anginosus	I-bacteria
(	O
4	O
.	O
7	O
%	O
)	O
]	O
,	O
Streptococcus	B-bacteria
sanguis	I-bacteria
(	O
14	O
.	O
3	O
%	O
)	O
,	O
Streptococcus	B-bacteria
mitis	I-bacteria
(	O
4	O
.	O
7	O
%	O
)	O
,	O
Streptococcus	B-bacteria
cremoris	I-bacteria
(	O
4	O
.	O
7	O
%	O
)	O
,	O
Peptostreptococcus	B-bacteria
pevotii	I-bacteria
(	O
4	O
.	O
7	O
%	O
)	O
,	O
Prevotella	B-bacteria
buccae	I-bacteria
(	O
4	O
.	O
7	O
%	O
)	O
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
(	O
4	O
.	O
7	O
%	O
)	O
,	O
Actinomyces	B-bacteria
meyeri	I-bacteria
(	O
4	O
.	O
7	O
%	O
)	O
,	O
Actinomyces	B-bacteria
viscosus	I-bacteria
(	O
4	O
.	O
7	O
%	O
)	O
,	O
Propionibacterium	B-bacteria
propionicum	I-bacteria
(	O
4	O
.	O
7	O
%	O
)	O
,	O
Bacteroides	B-bacteria
capillosus	I-bacteria
(	O
4	O
.	O
7	O
%	O
)	O
,	O
Staphylococcus	B-bacteria
hominis	I-bacteria
(	O
4	O
.	O
7	O
%	O
)	O
,	O
Rothia	B-bacteria
denticariosa	I-bacteria
(	O
4	O
.	O
7	O
%	O
)	O
,	O
Gemella	B-bacteria
haemolysans	I-bacteria
(	O
4	O
.	O
7	O
%	O
)	O
,	O
and	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
(	O
4	O
.	O
7	O
%	O
)	O
.	O

Results	O
of	O
this	O
study	O
demonstrated	O
that	O
radicular	O
cysts	O
show	O
a	O
great	O
variety	O
of	O
anaerobic	O
and	O
facultative	O
anaerobic	O
bacterial	O
flora	O
.	O

It	O
was	O
observed	O
that	O
all	O
isolated	O
microorganisms	O
were	O
the	O
types	O
commonly	O
found	O
in	O
oral	O
flora	O
.	O

Although	O
no	O
specific	O
microorganism	O
was	O
found	O
,	O
Streptococcus	B-bacteria
spp	I-bacteria
.	I-bacteria
bacteria	I-bacteria
(	O
47	O
.	O
5	O
%	O
)	O
-	O
especially	O
SMG	B-bacteria
(	O
23	O
.	O
8	O
%	O
)	O
-	O
were	O
predominantly	O
found	O
in	O
the	O
microorganisms	O
isolated	O
.	O

Furthermore	O
,	O
radicular	O
cysts	O
might	O
be	O
polymicrobial	O
originated	O
.	O

Although	O
radicular	O
cyst	O
is	O
an	O
inflammatory	O
cyst	O
,	O
some	O
radicular	O
cyst	O
fluids	O
might	O
be	O
sterile	O
.	O

Gingivitis	O
and	O
lumpy	O
jaw	O
are	O
diseases	O
of	O
polymicrobial	O
aetiology	O
.	O

Although	O
Fusobacterium	B-bacteria
necrophorum	I-bacteria
has	O
been	O
associated	O
with	O
these	O
diseases	O
in	O
macropods	O
,	O
little	O
is	O
known	O
about	O
other	O
organisms	O
associated	O
with	O
these	O
diseases	O
in	O
this	O
animal	O
species	O
.	O

PCR	O
-	O
DGGE	O
analysis	O
revealed	O
the	O
potential	O
pathogens	O
associated	O
with	O
gingivitis	O
and	O
lumpy	O
jaw	O
in	O
macropods	O
.	O

PCR	O
-	O
DGGE	O
profile	O
comparison	O
between	O
the	O
healthy	O
and	O
disease	O
groups	O
indicated	O
a	O
shift	O
in	O
the	O
oral	O
bacterial	O
community	O
structures	O
with	O
similarity	O
coefficients	O
of	O
48	O
%	O
and	O
35	O
%	O
for	O
gingivitis	O
and	O
lumpy	O
jaw	O
respectively	O
.	O

Moreover	O
,	O
gingivitis	O
was	O
associated	O
with	O
increase	O
in	O
bacterial	O
diversity	O
(	O
Shannon	O
index	O
=	O
2	O
.	O
87	O
;	O
PL	O
curve	O
=	O
45	O
%	O
)	O
while	O
lumpy	O
jaw	O
resulted	O
in	O
a	O
decline	O
in	O
bacterial	O
diversity	O
(	O
Shannon	O
index	O
=	O
2	O
.	O
47	O
;	O
PL	O
curve	O
=	O
74	O
%	O
)	O
.	O

This	O
study	O
suggest	O
that	O
the	O
establishment	O
of	O
gingivitis	O
and	O
lumpy	O
jaw	O
diseases	O
follows	O
the	O
ecological	O
plaque	O
hypothesis	O
.	O

This	O
forms	O
the	O
basis	O
for	O
an	O
expanded	O
investigation	O
in	O
an	O
epidemiological	O
scale	O
and	O
suggests	O
the	O
need	O
for	O
the	O
appropriate	O
choice	O
of	O
antimicrobial	O
agent	O
(	O
s	O
)	O
and	O
for	O
the	O
effective	O
management	O
and	O
control	O
of	O
polymicrobial	O
diseases	O
.	O

Induced	O
plant	O
defenses	O
in	O
response	O
to	O
herbivore	O
attack	O
are	O
modulated	O
by	O
cross	O
-	O
talk	O
between	O
jasmonic	O
acid	O
(	O
JA	O
)	O
-	O
and	O
salicylic	O
acid	O
(	O
SA	O
)	O
-	O
signaling	O
pathways	O
.	O

Oral	O
secretions	O
from	O
some	O
insect	O
herbivores	O
contain	O
effectors	O
that	O
overcome	O
these	O
antiherbivore	O
defenses	O
.	O

Herbivores	O
possess	O
diverse	O
microbes	O
in	O
their	O
digestive	O
systems	O
and	O
these	O
microbial	O
symbionts	O
can	O
modify	O
plant	O
-	O
insect	O
interactions	O
;	O
however	O
,	O
the	O
specific	O
role	O
of	O
herbivore	O
-	O
associated	O
microbes	O
in	O
manipulating	O
plant	O
defenses	O
remains	O
unclear	O
.	O

Here	O
,	O
we	O
demonstrate	O
that	O
Colorado	O
potato	O
beetle	O
(	O
Leptinotarsa	O
decemlineata	O
)	O
larvae	O
exploit	O
bacteria	O
in	O
their	O
oral	O
secretions	O
to	O
suppress	O
antiherbivore	O
defenses	O
in	O
tomato	O
(	O
Solanum	O
lycopersicum	O
)	O
.	O

We	O
found	O
that	O
antibiotic	O
-	O
untreated	O
larvae	O
decreased	O
production	O
of	O
JA	O
and	O
JA	O
-	O
responsive	O
antiherbivore	O
defenses	O
,	O
but	O
increased	O
SA	O
accumulation	O
and	O
SA	O
-	O
responsive	O
gene	O
expression	O
.	O

Beetles	O
benefit	O
from	O
down	O
-	O
regulating	O
plant	O
defenses	O
by	O
exhibiting	O
enhanced	O
larval	O
growth	O
.	O

In	O
SA	O
-	O
deficient	O
plants	O
,	O
suppression	O
was	O
not	O
observed	O
,	O
indicating	O
that	O
suppression	O
of	O
JA	O
-	O
regulated	O
defenses	O
depends	O
on	O
the	O
SA	O
-	O
signaling	O
pathway	O
.	O

Applying	O
bacteria	O
isolated	O
from	O
larval	O
oral	O
secretions	O
to	O
wounded	O
plants	O
confirmed	O
that	O
three	O
microbial	O
symbionts	O
belonging	O
to	O
the	O
genera	O
Stenotrophomonas	B-bacteria
,	O
Pseudomonas	B-bacteria
,	O
and	O
Enterobacter	B-bacteria
are	O
responsible	O
for	O
defense	O
suppression	O
.	O

Additionally	O
,	O
reinoculation	O
of	O
these	O
bacteria	O
to	O
antibiotic	O
-	O
treated	O
larvae	O
restored	O
their	O
ability	O
to	O
suppress	O
defenses	O
.	O

Flagellin	O
isolated	O
from	O
Pseudomonas	B-bacteria
sp	I-bacteria
.	I-bacteria
was	O
associated	O
with	O
defense	O
suppression	O
.	O

Our	O
findings	O
show	O
that	O
the	O
herbivore	O
exploits	O
symbiotic	O
bacteria	O
as	O
a	O
decoy	O
to	O
deceive	O
plants	O
into	O
incorrectly	O
perceiving	O
the	O
threat	O
as	O
microbial	O
.	O

By	O
interfering	O
with	O
the	O
normal	O
perception	O
of	O
herbivory	O
,	O
beetles	O
can	O
evade	O
antiherbivore	O
defenses	O
of	O
its	O
host	O
.	O

To	O
examine	O
the	O
histopathological	O
characteristics	O
of	O
inflammatory	O
lesions	O
containing	O
Actinomyces	B-bacteria
based	O
on	O
DNA	O
sequencing	O
.	O

Furthermore	O
,	O
case	O
reports	O
of	O
actinomycosis	O
in	O
the	O
maxillofacial	O
region	O
are	O
summarized	O
by	O
a	O
review	O
of	O
the	O
literature	O
.	O

The	O
study	O
comprised	O
12	O
cases	O
of	O
inflammatory	O
lesions	O
containing	O
Actinomyces	B-bacteria
as	O
diagnosed	O
by	O
DNA	O
analysis	O
.	O

The	O
average	O
age	O
of	O
the	O
subjects	O
was	O
59	O
+	O
/	O
-	O
15	O
years	O
(	O
6	O
males	O
;	O
6	O
females	O
)	O
.	O

The	O
distribution	O
of	O
causative	O
bacteria	O
was	O
:	O
Actinomyces	B-bacteria
israelii	I-bacteria
in	O
9	O
cases	O
,	O
Actinomyces	B-bacteria
gerencseriae	I-bacteria
in	O
2	O
cases	O
,	O
and	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
in	O
1	O
case	O
.	O

Four	O
cases	O
diagnosed	O
by	O
DNA	O
sequencing	O
were	O
positive	O
for	O
`	O
`	O
Druse	O
,	O
'	O
'	O
a	O
known	O
morphological	O
diagnostic	O
characteristic	O
of	O
actinomycosis	O
,	O
and	O
8	O
cases	O
lacked	O
typical	O
colony	O
formation	O
.	O

DNA	O
analysis	O
using	O
paraffin	O
-	O
embedded	O
samples	O
is	O
effective	O
for	O
both	O
early	O
and	O
accurate	O
diagnosis	O
of	O
oral	O
lesions	O
containing	O
Actinomyces	B-bacteria
.	O

The	O
antimicrobial	O
activity	O
of	O
isothiocyanates	O
(	O
ITCs	O
)	O
extracted	O
from	O
horseradish	O
root	O
was	O
investigated	O
against	O
oral	O
microorganisms	O
:	O
6	O
strains	O
of	O
facultative	O
anaerobic	O
bacteria	O
,	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Streptococcus	B-bacteria
sobrinus	I-bacteria
,	O
Lactobacillus	B-bacteria
casei	I-bacteria
,	O
Staphylococcus	B-bacteria
aureus	I-bacteria
,	O
Enterococcus	B-bacteria
faecalis	I-bacteria
and	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
;	O
one	O
strain	O
of	O
yeast	O
,	O
Candida	O
albicans	O
,	O
and	O
3	O
strains	O
of	O
anaerobic	O
bacteria	O
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
Prevotella	B-bacteria
nigrescens	I-bacteria
,	O
and	O
Clostridium	B-bacteria
perfringens	I-bacteria
.	O

The	O
ITCs	O
extracted	O
from	O
horseradish	O
root	O
showed	O
antimicrobial	O
activity	O
against	O
all	O
oral	O
microorganisms	O
by	O
the	O
paper	O
disk	O
method	O
.	O

The	O
minimum	O
bactericidal	O
concentration	O
(	O
MBC	O
)	O
of	O
the	O
ITCs	O
extracted	O
from	O
horseradish	O
root	O
ranged	O
from	O
1	O
.	O
25	O
to	O
5	O
.	O
00	O
mg	O
/	O
ml	O
against	O
6	O
strains	O
of	O
facultative	O
anaerobic	O
bacteria	O
and	O
one	O
strain	O
of	O
yeast	O
,	O
and	O
4	O
.	O
17	O
to	O
16	O
.	O
67	O
mg	O
/	O
ml	O
against	O
3	O
strains	O
of	O
anaerobic	O
bacteria	O
.	O

The	O
ITCs	O
extracted	O
from	O
horseradish	O
root	O
showed	O
the	O
strongest	O
antimicrobial	O
activity	O
,	O
with	O
a	O
MBC	O
of	O
1	O
.	O
25	O
mg	O
/	O
ml	O
,	O
against	O
C	O
.	O
albicans	O
among	O
facultative	O
microorganisms	O
,	O
and	O
4	O
.	O
17	O
mg	O
/	O
ml	O
against	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
among	O
anaerobic	O
bacteria	O
.	O

These	O
results	O
suggest	O
that	O
the	O
ITCs	O
extracted	O
from	O
horseradish	O
root	O
may	O
be	O
a	O
candidate	O
for	O
use	O
as	O
an	O
antimicrobial	O
agent	O
against	O
oral	O
microorganisms	O
.	O

Filamentous	O
multicellular	O
bacteria	O
are	O
among	O
the	O
most	O
ancient	O
multicellular	O
organisms	O
.	O

They	O
inhabit	O
a	O
great	O
variety	O
of	O
environments	O
and	O
are	O
present	O
in	O
the	O
human	O
body	O
,	O
including	O
the	O
oral	O
cavity	O
.	O

Beside	O
the	O
selective	O
advantages	O
related	O
to	O
the	O
larger	O
size	O
achieved	O
through	O
filamentation	O
,	O
the	O
development	O
of	O
multicellular	O
bacteria	O
can	O
be	O
also	O
driven	O
by	O
simple	O
ecological	O
factors	O
such	O
as	O
birth	O
and	O
death	O
rates	O
at	O
the	O
cellular	O
level	O
.	O

In	O
order	O
to	O
extend	O
earlier	O
results	O
obtained	O
in	O
aquatic	O
species	O
,	O
we	O
investigate	O
the	O
filamentation	O
process	O
of	O
four	O
different	O
strains	O
of	O
oral	O
streptococci	B-bacteria
,	O
namely	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
oralis	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
anginosus	I-bacteria
.	O

The	O
results	O
indicate	O
differences	O
in	O
the	O
capacities	O
of	O
different	O
streptococcus	B-bacteria
species	I-bacteria
to	O
form	O
filaments	O
,	O
manifested	O
in	O
terms	O
of	O
length	O
and	O
the	O
time	O
-	O
scale	O
of	O
filament	O
elongation	O
.	O

The	O
filamentation	O
pattern	O
of	O
these	O
oral	O
streptococci	B-bacteria
resembles	O
that	O
of	O
aquatic	O
bacteria	O
,	O
whereby	O
filaments	O
reach	O
a	O
peak	O
length	O
during	O
exponential	O
growth	O
and	O
become	O
short	O
when	O
the	O
population	O
reaches	O
a	O
steady	O
state	O
.	O

Hence	O
,	O
this	O
study	O
validates	O
that	O
multicellularity	O
can	O
be	O
an	O
emergent	O
property	O
of	O
filamentous	O
bacteria	O
of	O
different	O
ecological	O
niches	O
,	O
and	O
that	O
phenotypic	O
differences	O
in	O
filamentation	O
can	O
occur	O
within	O
species	O
of	O
the	O
same	O
genus	O
,	O
in	O
this	O
case	O
oral	O
streptococci	B-bacteria
.	O

Moreover	O
,	O
given	O
the	O
role	O
that	O
specific	O
oral	O
streptococci	B-bacteria
can	O
play	O
in	O
the	O
etiology	O
of	O
oral	O
diseases	O
,	O
these	O
results	O
can	O
possibly	O
open	O
new	O
perspectives	O
in	O
the	O
study	O
of	O
the	O
virulence	O
properties	O
of	O
these	O
species	O
.	O

Filifactor	B-bacteria
alocis	I-bacteria
is	O
a	O
gram	O
positive	O
anaerobe	O
that	O
is	O
emerging	O
as	O
an	O
important	O
periodontal	O
pathogen	O
.	O

In	O
the	O
oral	O
cavity	O
F	B-bacteria
.	I-bacteria
alocis	I-bacteria
colonizes	O
polymicrobial	O
biofilm	O
communities	O
;	O
however	O
,	O
little	O
is	O
known	O
regarding	O
the	O
nature	O
of	O
the	O
interactions	O
between	O
F	B-bacteria
.	I-bacteria
alocis	I-bacteria
and	O
other	O
oral	O
biofilm	O
bacteria	O
.	O

Here	O
we	O
investigate	O
the	O
community	O
interactions	O
of	O
two	O
strains	O
of	O
F	B-bacteria
.	I-bacteria
alocis	I-bacteria
with	O
Streptococcus	B-bacteria
gordonii	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
and	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
organisms	O
with	O
differing	O
pathogenic	O
potential	O
in	O
the	O
oral	O
cavity	O
.	O

In	O
an	O
in	O
vitro	O
community	O
development	O
model	O
,	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
was	O
antagonistic	O
to	O
the	O
accumulation	O
of	O
F	B-bacteria
.	I-bacteria
alocis	I-bacteria
into	O
a	O
dual	O
species	O
community	O
.	O

In	O
contrast	O
,	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
and	O
the	O
type	O
strain	O
of	O
F	B-bacteria
.	I-bacteria
alocis	I-bacteria
formed	O
a	O
synergistic	O
partnership	O
.	O

Accumulation	O
of	O
a	O
low	O
passage	O
isolate	O
of	O
F	B-bacteria
.	I-bacteria
alocis	I-bacteria
was	O
also	O
enhanced	O
by	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
.	O

In	O
three	O
species	O
communities	O
of	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
,	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
and	O
F	B-bacteria
.	I-bacteria
alocis	I-bacteria
,	O
the	O
antagonistic	O
effects	O
of	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
superseded	O
the	O
synergistic	O
effects	O
of	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
toward	O
F	B-bacteria
.	I-bacteria
alocis	I-bacteria
.	O

The	O
interaction	O
between	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
and	O
F	B-bacteria
.	I-bacteria
alocis	I-bacteria
was	O
strain	O
specific	O
and	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
could	O
either	O
stimulate	O
F	B-bacteria
.	I-bacteria
alocis	I-bacteria
accumulation	O
or	O
have	O
no	O
effect	O
depending	O
on	O
the	O
strain	O
.	O

P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
and	O
F	B-bacteria
.	I-bacteria
alocis	I-bacteria
formed	O
heterotypic	O
communities	O
with	O
the	O
amount	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
greater	O
than	O
in	O
the	O
absence	O
of	O
F	B-bacteria
.	I-bacteria
alocis	I-bacteria
.	O

However	O
,	O
while	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
benefited	O
from	O
the	O
relationship	O
,	O
levels	O
of	O
F	B-bacteria
.	I-bacteria
alocis	I-bacteria
in	O
the	O
dual	O
species	O
community	O
were	O
lower	O
compared	O
to	O
F	B-bacteria
.	I-bacteria
alocis	I-bacteria
alone	O
.	O

The	O
inhibitory	O
effect	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
toward	O
F	B-bacteria
.	I-bacteria
alocis	I-bacteria
was	O
dependent	O
,	O
at	O
least	O
partially	O
,	O
on	O
the	O
presence	O
of	O
the	O
Mfa1	O
fimbrial	O
subunit	O
.	O

In	O
addition	O
,	O
AI	O
-	O
2	O
production	O
by	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
helped	O
maintain	O
levels	O
of	O
F	B-bacteria
.	I-bacteria
alocis	I-bacteria
.	O

Collectively	O
,	O
these	O
results	O
show	O
that	O
the	O
pattern	O
of	O
F	B-bacteria
.	I-bacteria
alocis	I-bacteria
colonization	O
will	O
be	O
dictated	O
by	O
the	O
spatial	O
composition	O
of	O
microbial	O
microenvironments	O
,	O
and	O
that	O
the	O
organism	O
may	O
preferentially	O
accumulate	O
at	O
sites	O
rich	O
in	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
.	O

To	O
better	O
understand	O
the	O
microbial	O
basis	O
of	O
oral	O
malodor	O
development	O
in	O
humans	O
,	O
we	O
used	O
a	O
cross	O
-	O
sectional	O
and	O
longitudinal	O
study	O
design	O
and	O
the	O
pyrosequencing	O
approach	O
to	O
track	O
and	O
compare	O
the	O
tongue	O
microbiota	O
associated	O
with	O
oral	O
malodor	O
in	O
29	O
Chinese	O
adults	O
who	O
underwent	O
a	O
consecutive	O
three	O
-	O
day	O
evaluation	O
for	O
the	O
amount	O
of	O
H2S	O
excreted	O
orally	O
.	O

Three	O
levels	O
of	O
the	O
oral	O
malodor	O
state	O
(	O
healthy	O
,	O
oral	O
malodor	O
,	O
and	O
severe	O
oral	O
malodor	O
)	O
were	O
defined	O
based	O
on	O
the	O
H2S	O
level	O
.	O

Community	O
structure	O
of	O
the	O
tongue	O
plaques	O
was	O
more	O
sensitive	O
to	O
changes	O
of	O
malodor	O
state	O
than	O
to	O
interpersonal	O
variations	O
or	O
differences	O
in	O
sampling	O
times	O
.	O

Within	O
each	O
individual	O
,	O
the	O
structure	O
of	O
microbiota	O
was	O
relatively	O
stable	O
,	O
while	O
their	O
variations	O
were	O
correlated	O
with	O
the	O
change	O
in	O
the	O
H2S	O
level	O
.	O

Severe	O
oral	O
malodor	O
microbiota	O
were	O
the	O
most	O
conserved	O
in	O
community	O
structure	O
,	O
whereas	O
the	O
healthy	O
ones	O
were	O
relatively	O
varied	O
.	O

Oral	O
-	O
malodor	O
-	O
associated	O
bacteria	O
were	O
identified	O
.	O

The	O
relative	O
abundance	O
of	O
Leptotrichia	B-bacteria
and	O
Prevotella	B-bacteria
was	O
positively	O
correlated	O
with	O
oral	O
malodor	O
severity	O
,	O
whereas	O
Hemophilus	B-bacteria
and	O
Gemella	B-bacteria
exhibited	O
a	O
negative	O
relationship	O
with	O
oral	O
malodor	O
severity	O
.	O

Our	O
study	O
provides	O
one	O
of	O
the	O
first	O
landscapes	O
of	O
oral	O
microbiota	O
changes	O
associated	O
with	O
oral	O
malodor	O
development	O
and	O
reveals	O
microbes	O
potentially	O
useful	O
to	O
the	O
evaluation	O
and	O
control	O
of	O
oral	O
malodor	O
.	O

Actinomyces	B-bacteria
are	O
predominant	O
oral	O
bacteria	O
;	O
however	O
,	O
their	O
cariogenic	O
potential	O
in	O
terms	O
of	O
acid	O
production	O
and	O
fluoride	O
sensitivity	O
has	O
not	O
been	O
elucidated	O
in	O
detail	O
and	O
compared	O
with	O
that	O
of	O
other	O
caries	O
-	O
associated	O
oral	O
bacteria	O
,	O
such	O
as	O
Streptococcus	B-bacteria
.	O

Therefore	O
,	O
this	O
study	O
aimed	O
to	O
elucidate	O
and	O
compare	O
the	O
acid	O
production	O
and	O
growth	O
of	O
Actinomyces	B-bacteria
and	O
Streptococcus	B-bacteria
in	O
the	O
presence	O
of	O
bicarbonate	O
and	O
fluoride	O
to	O
mimic	O
conditions	O
in	O
the	O
oral	O
cavity	O
.	O

Acid	O
production	O
from	O
glucose	O
was	O
measured	O
by	O
pH	O
-	O
stat	O
at	O
pH	O
5	O
.	O
5	O
and	O
7	O
.	O
0	O
under	O
anaerobic	O
conditions	O
.	O

Growth	O
rate	O
was	O
assessed	O
by	O
optical	O
density	O
in	O
anaerobic	O
culture	O
.	O

Although	O
Actinomyces	B-bacteria
produced	O
acid	O
at	O
a	O
lower	O
rate	O
than	O
did	O
Streptococcus	B-bacteria
,	O
their	O
acid	O
production	O
was	O
more	O
tolerant	O
of	O
fluoride	O
(	O
IDacid	O
production	O
50	O
=	O
110	O
-	O
170	O
ppm	O
at	O
pH	O
7	O
.	O
0	O
and	O
10	O
-	O
13	O
ppm	O
at	O
pH	O
5	O
.	O
5	O
)	O
than	O
that	O
of	O
Streptococcus	B-bacteria
(	O
IDacid	O
production	O
50	O
=	O
36	O
-	O
53	O
ppm	O
at	O
pH	O
7	O
.	O
0	O
and	O
6	O
.	O
3	O
-	O
6	O
.	O
5	O
ppm	O
at	O
pH	O
5	O
.	O
5	O
)	O
.	O

Bicarbonate	O
increased	O
acid	O
production	O
by	O
Actinomyces	B-bacteria
with	O
prominent	O
succinate	O
production	O
and	O
enhanced	O
their	O
fluoride	O
tolerance	O
(	O
IDacid	O
production	O
50	O
=	O
220	O
-	O
320	O
ppm	O
at	O
pH	O
7	O
.	O
0	O
and	O
33	O
-	O
52	O
ppm	O
at	O
pH	O
5	O
.	O
5	O
)	O
.	O

Bicarbonate	O
had	O
no	O
effect	O
on	O
these	O
variables	O
in	O
Streptococcus	B-bacteria
.	O

In	O
addition	O
,	O
although	O
the	O
growth	O
rate	O
of	O
Actinomyces	B-bacteria
was	O
lower	O
than	O
that	O
of	O
Streptococcus	B-bacteria
,	O
Actinomyces	B-bacteria
growth	O
was	O
more	O
tolerant	O
of	O
fluoride	O
(	O
IDgrowth	O
50	O
=	O
130	O
-	O
160	O
ppm	O
)	O
than	O
was	O
that	O
of	O
Streptococcus	B-bacteria
(	O
IDgrowth	O
50	O
=	O
27	O
-	O
36	O
ppm	O
)	O
.	O

These	O
results	O
indicate	O
that	O
oral	O
Actinomyces	B-bacteria
are	O
more	O
tolerant	O
of	O
fluoride	O
than	O
oral	O
Streptococcus	B-bacteria
,	O
and	O
bicarbonate	O
enhances	O
the	O
fluoride	O
tolerance	O
of	O
oral	O
Actinomyces	B-bacteria
.	O

Because	O
of	O
the	O
limited	O
number	O
of	O
species	O
tested	O
here	O
,	O
further	O
study	O
is	O
needed	O
to	O
generalize	O
these	O
findings	O
to	O
the	O
genus	O
level	O
.	O

To	O
investigate	O
the	O
distribution	O
of	O
bacteria	O
within	O
the	O
dentine	O
tubular	O
network	O
in	O
a	O
two	O
-	O
chamber	O
model	O
in	O
order	O
to	O
determine	O
a	O
possible	O
route	O
of	O
penetration	O
.	O

Root	O
canals	O
of	O
teeth	O
in	O
the	O
experimental	O
group	O
(	O
n	O
=	O
16	O
)	O
were	O
instrumented	O
and	O
root	O
filled	O
using	O
AH26	O
and	O
gutta	O
-	O
percha	O
.	O

Canals	O
in	O
the	O
teeth	O
serving	O
as	O
positive	O
(	O
n	O
=	O
1	O
)	O
and	O
negative	O
(	O
n	O
=	O
1	O
)	O
controls	O
were	O
instrumented	O
,	O
but	O
not	O
root	O
filled	O
.	O

A	O
two	O
-	O
chamber	O
model	O
was	O
fabricated	O
for	O
each	O
root	O
-	O
upper	O
chambers	O
were	O
inoculated	O
weekly	O
with	O
Streptococcus	B-bacteria
gordonii	I-bacteria
in	O
brain	O
-	O
heart	O
infusion	O
broth	O
over	O
90	O
days	O
.	O

Turbidity	O
of	O
the	O
lower	O
chamber	O
was	O
checked	O
daily	O
.	O

Samples	O
that	O
showed	O
turbidity	O
during	O
the	O
experimental	O
period	O
and	O
samples	O
that	O
showed	O
no	O
signs	O
of	O
turbidity	O
at	O
90	O
days	O
were	O
fractured	O
and	O
prepared	O
for	O
SEM	O
examination	O
.	O

SEM	O
examination	O
for	O
the	O
presence	O
of	O
bacteria	O
within	O
the	O
dentinal	O
tubules	O
was	O
performed	O
in	O
the	O
cervical	O
,	O
middle	O
and	O
apical	O
root	O
thirds	O
.	O

In	O
each	O
root	O
third	O
,	O
the	O
depth	O
of	O
bacterial	O
penetration	O
was	O
recorded	O
as	O
inner	O
,	O
middle	O
or	O
outer	O
dentine	O
.	O

Bacteria	O
were	O
most	O
commonly	O
detected	O
in	O
the	O
cervical	O
third	O
(	O
14	O
of	O
30	O
areas	O
)	O
.	O

Irrespective	O
of	O
the	O
root	O
third	O
examined	O
,	O
bacteria	O
were	O
most	O
commonly	O
detected	O
in	O
the	O
inner	O
dentine	O
(	O
i	O
.	O
e	O
.	O
adjacent	O
to	O
the	O
root	O
canal	O
)	O
.	O

Only	O
two	O
samples	O
demonstrated	O
bacterial	O
penetration	O
in	O
the	O
outer	O
dentine	O
.	O

The	O
dentine	O
tubular	O
network	O
provides	O
a	O
potential	O
pathway	O
for	O
bacteria	O
to	O
penetrate	O
tooth	O
roots	O
in	O
a	O
two	O
-	O
chamber	O
model	O
.	O

For	O
selective	O
detection	O
of	O
viable	O
bacteria	O
with	O
molecular	O
methods	O
,	O
propidium	O
monoazide	O
(	O
PMA	O
)	O
treatment	O
has	O
been	O
successfully	O
applied	O
to	O
a	O
wide	O
range	O
of	O
bacteria	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
compare	O
the	O
quantity	O
of	O
live	O
cells	O
with	O
the	O
total	O
amounts	O
of	O
both	O
live	O
and	O
dead	O
cells	O
before	O
and	O
after	O
chemomechanical	O
preparation	O
by	O
using	O
PMA	O
in	O
combination	O
with	O
real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
(	O
qPCR	O
)	O
.	O

Twenty	O
-	O
one	O
teeth	O
with	O
pulp	O
necrosis	O
and	O
a	O
periapical	O
lesion	O
were	O
included	O
.	O

Bacterial	O
sampling	O
of	O
the	O
root	O
canals	O
was	O
performed	O
before	O
(	O
S1	O
)	O
and	O
after	O
(	O
S2	O
)	O
chemomechanical	O
root	O
canal	O
treatment	O
.	O

Each	O
sample	O
was	O
separated	O
into	O
2	O
different	O
tubes	O
.	O

PMA	O
was	O
added	O
to	O
one	O
of	O
the	O
tubes	O
,	O
and	O
the	O
other	O
was	O
left	O
untreated	O
.	O

Then	O
,	O
DNA	O
extraction	O
and	O
qPCR	O
were	O
performed	O
.	O

To	O
evaluate	O
the	O
validity	O
of	O
the	O
PMA	O
treatment	O
,	O
the	O
defined	O
mixtures	O
containing	O
different	O
ratios	O
of	O
live	O
and	O
dead	O
cell	O
suspensions	O
of	O
Enterococcus	B-bacteria
faecalis	I-bacteria
were	O
either	O
subjected	O
to	O
PMA	O
treatment	O
or	O
not	O
subjected	O
to	O
PMA	O
treatment	O
,	O
followed	O
by	O
qPCR	O
quantification	O
.	O

A	O
paired	O
t	O
test	O
showed	O
a	O
highly	O
significant	O
difference	O
in	O
the	O
mean	O
threshold	O
cycle	O
values	O
between	O
S1	O
with	O
and	O
without	O
PMA	O
(	O
P	O
=	O
.	O
0002	O
)	O
,	O
and	O
this	O
difference	O
(	O
0	O
.	O
89	O
)	O
was	O
similar	O
to	O
that	O
(	O
0	O
.	O
96	O
)	O
obtained	O
from	O
the	O
samples	O
consisting	O
of	O
80	O
%	O
live	O
cell	O
suspension	O
and	O
20	O
%	O
dead	O
cell	O
suspension	O
of	O
E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
.	O

The	O
threshold	O
cycle	O
values	O
between	O
the	O
S2	O
samples	O
with	O
and	O
without	O
PMA	O
were	O
also	O
significantly	O
different	O
(	O
P	O
=	O
.	O
0134	O
)	O
,	O
and	O
this	O
difference	O
(	O
0	O
.	O
37	O
)	O
was	O
similar	O
to	O
that	O
obtained	O
from	O
the	O
100	O
%	O
live	O
cell	O
suspension	O
of	O
E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
(	O
0	O
.	O
42	O
)	O
.	O

PMA	O
in	O
conjunction	O
with	O
qPCR	O
appeared	O
to	O
be	O
useful	O
in	O
analyzing	O
the	O
primary	O
infections	O
of	O
root	O
canals	O
because	O
there	O
were	O
significant	O
amounts	O
of	O
dead	O
bacteria	O
in	O
the	O
root	O
canals	O
.	O

Although	O
the	O
use	O
of	O
PMA	O
treatment	O
in	O
post	O
-	O
preparation	O
samples	O
significantly	O
reduced	O
the	O
detection	O
of	O
dead	O
bacteria	O
,	O
this	O
difference	O
was	O
still	O
small	O
,	O
so	O
further	O
studies	O
should	O
be	O
carried	O
out	O
to	O
confirm	O
the	O
necessity	O
of	O
PMA	O
treatment	O
.	O

The	O
acquisition	O
and	O
development	O
of	O
the	O
complex	O
oral	O
microbiome	O
remain	O
ill	O
defined	O
.	O

While	O
selected	O
species	O
of	O
oral	O
bacteria	O
have	O
been	O
examined	O
in	O
relation	O
to	O
their	O
initial	O
colonization	O
in	O
neonates	O
,	O
a	O
more	O
detailed	O
understanding	O
of	O
the	O
dynamics	O
of	O
the	O
microbiome	O
has	O
been	O
developed	O
only	O
in	O
adults	O
.	O

The	O
current	O
investigation	O
used	O
a	O
nonhuman	O
primate	O
model	O
to	O
document	O
the	O
kinetics	O
of	O
colonization	O
of	O
the	O
oral	O
cavities	O
of	O
newborns	O
and	O
infants	O
by	O
a	O
range	O
of	O
oral	O
commensals	O
and	O
pathogens	O
.	O

Differences	O
in	O
colonization	O
were	O
evaluated	O
in	O
newborns	O
from	O
mothers	O
who	O
were	O
maintained	O
on	O
an	O
oral	O
hygiene	O
regimen	O
pre	O
-	O
and	O
postparturition	O
with	O
those	O
displaying	O
naturally	O
acquired	O
gingivitis	O
/	O
periodontitis	O
.	O

The	O
results	O
demonstrate	O
distinct	O
profiles	O
of	O
acquisition	O
of	O
selected	O
oral	O
bacteria	O
,	O
with	O
the	O
transmission	O
of	O
targeted	O
pathogens	O
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
and	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
being	O
passed	O
on	O
primarily	O
from	O
mothers	O
with	O
gingivitis	O
/	O
periodontitis	O
.	O

This	O
colonization	O
resulted	O
in	O
defined	O
patterns	O
of	O
systemic	O
antibody	O
responses	O
in	O
the	O
infants	O
.	O

The	O
significant	O
relative	O
risk	O
measures	O
for	O
infection	O
with	O
the	O
pathogens	O
,	O
as	O
well	O
as	O
the	O
relationship	O
of	O
oral	O
infection	O
and	O
blood	O
serum	O
antibody	O
levels	O
,	O
were	O
consistent	O
with	O
those	O
of	O
the	O
newborns	O
from	O
mothers	O
with	O
gingivitis	O
/	O
periodontitis	O
.	O

These	O
findings	O
indicate	O
that	O
the	O
early	O
acquisition	O
of	O
potentially	O
pathogenic	O
oral	O
bacterial	O
species	O
might	O
impact	O
the	O
development	O
of	O
mucosal	O
responses	O
in	O
the	O
gingiva	O
and	O
may	O
provide	O
an	O
enhanced	O
risk	O
for	O
the	O
development	O
of	O
periodontitis	O
later	O
in	O
life	O
.	O

Oropharyngeal	O
candidiasis	O
(	O
OPC	O
)	O
is	O
caused	O
by	O
the	O
opportunistic	O
fungi	O
Candida	O
albicans	O
and	O
is	O
prevalent	O
in	O
immunocompromised	O
patients	O
,	O
individuals	O
with	O
dry	O
mouth	O
,	O
or	O
patients	O
with	O
prolonged	O
antibiotic	O
therapies	O
that	O
reduce	O
oral	O
commensal	O
bacteria	O
.	O

Human	O
salivary	O
histatins	O
,	O
including	O
histatin	O
5	O
(	O
Hst	O
5	O
)	O
,	O
are	O
small	O
cationic	O
proteins	O
that	O
are	O
the	O
major	O
source	O
of	O
fungicidal	O
activity	O
of	O
saliva	O
.	O

However	O
,	O
Hsts	O
are	O
rapidly	O
degraded	O
in	O
vivo	O
,	O
limiting	O
their	O
usefulness	O
as	O
therapeutic	O
agents	O
despite	O
their	O
lack	O
of	O
toxicity	O
.	O

We	O
constructed	O
a	O
conjugate	O
peptide	O
using	O
spermidine	O
(	O
Spd	O
)	O
linked	O
to	O
the	O
active	O
fragment	O
of	O
Hst	O
5	O
(	O
Hst	O
54	O
-	O
15	O
)	O
,	O
based	O
upon	O
our	O
findings	O
that	O
C	O
.	O
albicans	O
spermidine	O
transporters	O
are	O
required	O
for	O
Hst	O
5	O
uptake	O
and	O
fungicidal	O
activity	O
.	O

We	O
found	O
that	O
Hst	O
54	O
-	O
15	O
-	O
Spd	O
was	O
significantly	O
more	O
effective	O
in	O
killing	O
C	O
.	O
albicans	O
and	O
Candida	O
glabrata	O
than	O
Hst	O
5	O
alone	O
in	O
both	O
planktonic	O
and	O
biofilm	O
growth	O
and	O
that	O
Hst	O
54	O
-	O
15	O
-	O
Spd	O
retained	O
high	O
activity	O
in	O
both	O
serum	O
and	O
saliva	O
.	O

Hst	O
54	O
-	O
15	O
-	O
Spd	O
was	O
not	O
bactericidal	O
against	O
streptococcal	B-bacteria
oral	O
commensal	O
bacteria	O
and	O
had	O
no	O
hemolytic	O
activity	O
.	O

We	O
tested	O
the	O
effectiveness	O
of	O
Hst	O
54	O
-	O
15	O
-	O
Spd	O
in	O
vivo	O
by	O
topical	O
application	O
to	O
tongue	O
surfaces	O
of	O
immunocompromised	O
mice	O
with	O
OPC	O
.	O

Mice	O
treated	O
with	O
Hst	O
54	O
-	O
15	O
-	O
Spd	O
had	O
significant	O
clearance	O
of	O
candidal	O
tongue	O
lesions	O
macroscopically	O
,	O
which	O
was	O
confirmed	O
by	O
a	O
3	O
-	O
to	O
5	O
-	O
log	O
fold	O
reduction	O
of	O
C	O
.	O
albicans	O
colonies	O
recovered	O
from	O
tongue	O
tissues	O
.	O

Hst	O
54	O
-	O
15	O
-	O
Spd	O
conjugates	O
are	O
a	O
new	O
class	O
of	O
peptide	O
-	O
based	O
drugs	O
with	O
high	O
selectivity	O
for	O
fungi	O
and	O
potential	O
as	O
topical	O
therapeutic	O
agents	O
for	O
oral	O
candidiasis	O
.	O

Previous	O
findings	O
of	O
an	O
association	O
between	O
25	O
-	O
hydroxyvitamin	O
D	O
[	O
25	O
(	O
OH	O
)	O
D	O
]	O
concentrations	O
and	O
periodontal	O
disease	O
may	O
be	O
partially	O
explained	O
by	O
the	O
antimicrobial	O
properties	O
of	O
vitamin	O
D	O
.	O
To	O
the	O
best	O
of	O
the	O
authors	O
'	O
knowledge	O
,	O
no	O
study	O
has	O
investigated	O
the	O
association	O
between	O
25	O
(	O
OH	O
)	O
D	O
and	O
pathogenic	O
oral	O
bacteria	O
,	O
a	O
putative	O
cause	O
of	O
periodontal	O
disease	O
.	O

The	O
association	O
between	O
plasma	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
and	O
pathogenic	O
oral	O
bacteria	O
was	O
examined	O
among	O
postmenopausal	O
females	O
in	O
the	O
Buffalo	O
Osteoporosis	O
and	O
Periodontal	O
Disease	O
Study	O
(	O
1997	O
to	O
2000	O
)	O
,	O
an	O
ancillary	O
study	O
of	O
the	O
Women	O
'	O
s	O
Health	O
Initiative	O
Observational	O
Study	O
.	O

Subgingival	O
plaque	O
samples	O
were	O
assessed	O
using	O
immunofluorescence	O
for	O
the	O
presence	O
of	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
and	O
Campylobacter	B-bacteria
rectus	I-bacteria
.	O

Logistic	O
regression	O
was	O
used	O
to	O
calculate	O
odds	O
ratios	O
(	O
ORs	O
)	O
and	O
95	O
%	O
confidence	O
intervals	O
(	O
CIs	O
)	O
for	O
prevalent	O
bacteria	O
by	O
quintile	O
(	O
Q	O
)	O
of	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
,	O
adjusting	O
for	O
age	O
and	O
body	O
mass	O
index	O
.	O

Of	O
the	O
855	O
participants	O
,	O
288	O
(	O
34	O
%	O
)	O
had	O
deficient	O
/	O
inadequate	O
(	O
<	O
50	O
nmol	O
/	O
L	O
)	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
,	O
and	O
496	O
(	O
58	O
%	O
)	O
had	O
at	O
least	O
one	O
species	O
of	O
pathogenic	O
bacteria	O
.	O

No	O
significant	O
association	O
was	O
found	O
between	O
25	O
(	O
OH	O
)	O
D	O
and	O
presence	O
of	O
any	O
of	O
these	O
bacteria	O
(	O
adjusted	O
OR	O
for	O
high	O
[	O
Q5	O
]	O
compared	O
to	O
low	O
[	O
Q1	O
]	O
25	O
(	O
OH	O
)	O
D	O
=	O
0	O
.	O
96	O
;	O
95	O
%	O
CI	O
:	O
0	O
.	O
61	O
to	O
1	O
.	O
50	O
;	O
P	O
for	O
trend	O
=	O
0	O
.	O
50	O
)	O
.	O

Inverse	O
,	O
although	O
not	O
statistically	O
significant	O
,	O
associations	O
were	O
found	O
between	O
25	O
(	O
OH	O
)	O
D	O
and	O
more	O
than	O
one	O
species	O
of	O
pathogenic	O
bacteria	O
(	O
adjusted	O
OR	O
for	O
adequate	O
compared	O
to	O
deficient	O
/	O
inadequate	O
25	O
(	O
OH	O
)	O
D	O
=	O
0	O
.	O
85	O
;	O
95	O
%	O
CI	O
:	O
0	O
.	O
60	O
to	O
1	O
.	O
19	O
)	O
.	O

No	O
association	O
was	O
observed	O
between	O
pathogenic	O
oral	O
bacteria	O
and	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
in	O
postmenopausal	O
females	O
.	O

This	O
may	O
be	O
attributable	O
to	O
the	O
species	O
of	O
bacteria	O
assessed	O
,	O
small	O
effect	O
size	O
,	O
or	O
a	O
true	O
absence	O
of	O
an	O
association	O
.	O

Streptococcus	B-bacteria
salivarius	I-bacteria
is	O
one	O
of	O
the	O
first	O
colonizers	O
of	O
the	O
human	O
oral	O
cavity	O
and	O
gut	O
after	O
birth	O
and	O
therefore	O
may	O
contribute	O
to	O
the	O
establishment	O
of	O
immune	O
homeostasis	O
and	O
regulation	O
of	O
host	O
inflammatory	O
responses	O
.	O

The	O
anti	O
-	O
inflammatory	O
potential	O
of	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
was	O
first	O
evaluated	O
in	O
vitro	O
on	O
human	O
intestinal	O
epithelial	O
cells	O
and	O
human	O
peripheral	O
blood	O
mononuclear	O
cells	O
.	O

We	O
show	O
that	O
live	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
strains	I-bacteria
inhibited	O
in	O
vitro	O
the	O
activation	O
of	O
the	O
NF	O
-	O
kappaB	O
pathway	O
on	O
intestinal	O
epithelial	O
cells	O
.	O

We	O
also	O
demonstrate	O
that	O
the	O
live	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
JIM8772	I-bacteria
strain	I-bacteria
significantly	O
inhibited	O
inflammation	O
in	O
severe	O
and	O
moderate	O
colitis	O
mouse	O
models	O
.	O

These	O
in	O
vitro	O
and	O
in	O
vivo	O
anti	O
-	O
inflammatory	O
properties	O
were	O
not	O
found	O
with	O
heat	O
-	O
killed	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
,	O
suggesting	O
a	O
protective	O
response	O
exclusively	O
with	O
metabolically	O
active	O
bacteria	O
.	O

Salivary	O
contamination	O
of	O
surgical	O
wounds	O
in	O
clean	O
-	O
contaminated	O
head	O
and	O
neck	O
surgery	O
with	O
free	O
flap	O
reconstruction	O
remains	O
a	O
major	O
cause	O
of	O
infection	O
and	O
leads	O
to	O
significant	O
morbidity	O
.	O

This	O
study	O
investigates	O
the	O
correlation	O
between	O
intraoral	O
flora	O
and	O
surgical	O
site	O
infections	O
(	O
SSIs	O
)	O
among	O
high	O
-	O
risk	O
head	O
and	O
neck	O
cancer	O
patients	O
undergoing	O
resection	O
and	O
free	O
flap	O
reconstruction	O
.	O

One	O
hundred	O
twenty	O
-	O
nine	O
patients	O
were	O
identified	O
as	O
being	O
at	O
high	O
risk	O
for	O
infective	O
complications	O
based	O
on	O
cancer	O
stage	O
,	O
tumor	O
size	O
,	O
comorbid	O
factors	O
,	O
and	O
extent	O
of	O
reconstruction	O
.	O

All	O
patients	O
had	O
intraoral	O
swab	O
cultures	O
before	O
surgery	O
.	O

Patients	O
with	O
culture	O
-	O
confirmed	O
SSI	O
after	O
surgery	O
were	O
chosen	O
for	O
analysis	O
,	O
using	O
the	O
kappa	O
index	O
and	O
its	O
95	O
%	O
confidence	O
interval	O
for	O
concordance	O
analysis	O
.	O

All	O
patients	O
received	O
clindamycin	O
and	O
gentamicin	O
for	O
antibiotic	O
prophylaxis	O
for	O
5	O
days	O
.	O

Antibiotic	O
susceptibility	O
testing	O
of	O
all	O
isolates	O
was	O
obtained	O
and	O
analyzed	O
.	O

Thirty	O
-	O
seven	O
patients	O
experienced	O
SSI	O
,	O
or	O
an	O
infection	O
rate	O
of	O
28	O
.	O
3	O
%	O
,	O
occurring	O
at	O
a	O
mean	O
of	O
9	O
.	O
3	O
postoperative	O
days	O
.	O

The	O
overall	O
concordance	O
between	O
oral	O
flora	O
and	O
SSI	O
was	O
fair	O
to	O
moderate	O
(	O
kappa	O
index	O
of	O
0	O
.	O
25	O
)	O
,	O
but	O
detailed	O
analysis	O
shows	O
a	O
higher	O
concordance	O
for	O
known	O
and	O
opportunistic	O
pathogens	O
,	O
such	O
as	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
and	O
Enterococcus	B-bacteria
faecalis	I-bacteria
,	O
compared	O
to	O
typical	O
oral	O
commensals	O
.	O

Antibiotic	O
susceptibility	O
tests	O
show	O
rapid	O
and	O
significant	O
increases	O
in	O
resistance	O
to	O
clindamycin	O
,	O
indicating	O
a	O
need	O
for	O
a	O
more	O
effective	O
alternative	O
.	O

Predicting	O
pathogens	O
in	O
SSI	O
using	O
preoperative	O
oral	O
swabs	O
did	O
not	O
demonstrate	O
a	O
good	O
concordance	O
in	O
general	O
for	O
patients	O
undergoing	O
clean	O
-	O
contaminated	O
head	O
and	O
neck	O
surgery	O
,	O
although	O
concordance	O
for	O
certain	O
pathogenic	O
species	O
seem	O
to	O
be	O
higher	O
than	O
for	O
typical	O
intraoral	O
commensals	O
.	O

The	O
rapid	O
development	O
of	O
resistance	O
to	O
clindamycin	O
precludes	O
its	O
use	O
as	O
a	O
prophylactic	O
agent	O
.	O

Oral	O
ulcerations	O
often	O
arise	O
as	O
a	O
side	O
effect	O
from	O
chemo	O
-	O
and	O
radiation	O
therapy	O
.	O

In	O
a	O
previous	O
clinical	O
study	O
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
was	O
identified	O
as	O
a	O
positive	O
predictor	O
for	O
oral	O
ulcerations	O
after	O
hematopoetic	O
stem	O
cell	O
transplantation	O
,	O
possibly	O
incriminating	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
in	O
delayed	O
healing	O
of	O
the	O
ulcerations	O
.	O

Therefore	O
,	O
it	O
was	O
tested	O
whether	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
and	O
its	O
secreted	O
products	O
could	O
inhibit	O
the	O
migration	O
of	O
oral	O
epithelial	O
cells	O
in	O
an	O
in	O
vitro	O
scratch	O
assay	O
.	O

To	O
compare	O
,	O
the	O
oral	O
bacteria	O
Prevotella	B-bacteria
nigrescens	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
,	O
and	O
Streptococcus	B-bacteria
mitis	I-bacteria
were	O
included	O
.	O

A	O
standardized	O
scratch	O
was	O
made	O
in	O
a	O
confluent	O
layer	O
of	O
human	O
oral	O
epithelial	O
cells	O
.	O

The	O
epithelial	O
cells	O
were	O
challenged	O
with	O
bacterial	O
cells	O
and	O
with	O
medium	O
containing	O
secretions	O
of	O
these	O
bacteria	O
.	O

Closure	O
of	O
the	O
scratch	O
was	O
measured	O
after	O
17	O
h	O
using	O
a	O
phase	O
contrast	O
microscope	O
.	O

P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
nigrescens	I-bacteria
,	O
and	O
secretions	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
strongly	O
inhibited	O
cell	O
migration	O
.	O

A	O
challenge	O
with	O
1000	O
heat	O
-	O
killed	O
bacteria	O
versus	O
1	O
epithelial	O
cell	O
resulted	O
in	O
a	O
relative	O
closure	O
of	O
the	O
scratch	O
of	O
25	O
%	O
for	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
and	O
20	O
%	O
for	O
P	B-bacteria
.	I-bacteria
nigrescens	I-bacteria
.	O

Weaker	O
inhibitory	O
effects	O
were	O
found	O
for	O
the	O
other	O
bacteria	O
.	O

The	O
results	O
confirmed	O
our	O
hypothesis	O
that	O
the	O
oral	O
bacteria	O
may	O
be	O
involved	O
in	O
delayed	O
wound	O
healing	O
.	O

Modern	O
dentistry	O
emphasizes	O
the	O
importance	O
of	O
dental	O
plaque	O
control	O
to	O
improve	O
oral	O
health	O
.	O

To	O
that	O
end	O
the	O
development	O
of	O
oral	O
care	O
formulations	O
has	O
been	O
geared	O
toward	O
the	O
incorporation	O
of	O
antiplaque	O
agents	O
that	O
may	O
play	O
a	O
crucial	O
role	O
in	O
oral	O
health	O
maintenance	O
.	O

In	O
later	O
years	O
the	O
research	O
into	O
antiplaque	O
agents	O
has	O
led	O
to	O
the	O
discovery	O
of	O
compounds	O
with	O
significant	O
capability	O
to	O
affect	O
biofilm	O
formation	O
.	O

Among	O
these	O
compounds	O
was	O
chitosan	O
,	O
a	O
polysaccharide	O
which	O
showed	O
great	O
ability	O
to	O
interfere	O
with	O
Streptococcus	B-bacteria
mutans	I-bacteria
biofilm	O
formation	O
.	O

As	O
such	O
the	O
aim	O
of	O
this	O
work	O
was	O
to	O
incorporate	O
chitosan	O
into	O
a	O
mouthwash	O
matrix	O
and	O
assess	O
its	O
effect	O
upon	O
biofilm	O
formation	O
of	O
oral	O
microorganisms	O
.	O

This	O
assessment	O
was	O
performed	O
via	O
study	O
of	O
the	O
impact	O
the	O
mouthwash	O
upon	O
microbial	O
adherence	O
,	O
biofilm	O
formation	O
and	O
mature	O
biofilms	O
.	O

Additionally	O
,	O
the	O
action	O
of	O
the	O
chitosan	O
mouthwash	O
was	O
compared	O
with	O
two	O
commercially	O
available	O
mouthwashes	O
.	O

The	O
results	O
here	O
obtained	O
show	O
that	O
only	O
the	O
chitosan	O
containing	O
mouthwash	O
was	O
capable	O
of	O
interfering	O
with	O
all	O
microorganisms	O
'	O
adherence	O
,	O
biofilm	O
formation	O
and	O
mature	O
biofilms	O
while	O
at	O
the	O
same	O
time	O
showing	O
vastly	O
superior	O
activity	O
than	O
both	O
commercial	O
mouthwashes	O
assayed	O
.	O

As	O
such	O
a	O
chitosan	O
mouthwash	O
shows	O
great	O
potential	O
as	O
a	O
natural	O
and	O
efficient	O
alternative	O
to	O
traditional	O
mouthwashes	O
.	O

The	O
study	O
was	O
carried	O
out	O
to	O
see	O
the	O
diversity	O
of	O
oral	O
microflora	O
and	O
its	O
antibiotic	O
sensitivity	O
test	O
in	O
children	O
of	O
age	O
group	O
6	O
to	O
12	O
years	O
was	O
carried	O
.	O

Total	O
50	O
patients	O
of	O
age	O
group	O
6	O
to	O
12	O
years	O
were	O
analyzed	O
for	O
their	O
oral	O
microflora	O
and	O
then	O
checked	O
for	O
the	O
antibiotic	O
susceptibility	O
test	O
.	O

The	O
samples	O
that	O
were	O
collected	O
were	O
incubated	O
at	O
37	O
degrees	O
C	O
for	O
48	O
hours	O
.	O

Once	O
dispersed	O
samples	O
were	O
taken	O
and	O
Gram	O
staining	O
was	O
done	O
,	O
also	O
they	O
were	O
spread	O
on	O
to	O
a	O
number	O
of	O
freshly	O
prepared	O
agar	O
plates	O
and	O
incubated	O
to	O
allow	O
cells	O
to	O
form	O
microbial	O
colony	O
.	O

The	O
result	O
showed	O
microflora	O
common	O
in	O
all	O
types	O
,	O
Gram	O
-	O
positive	O
facultative	O
anaerobic	O
rods	O
and	O
cocci	O
.	O

In	O
normal	O
children	O
Gram	O
-	O
positive	O
facultative	O
anaerobi	O
and	O
fermenting	O
cocci	O
were	O
predominant	O
where	O
as	O
in	O
children	O
with	O
caries	O
growth	O
of	O
microbiota	O
that	O
were	O
Gram	O
-	O
negative	O
and	O
positive	O
,	O
capnophilic	O
,	O
motile	O
and	O
anaerobic	O
rods	O
and	O
cocci	O
belonging	O
to	O
members	O
of	O
genera	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
was	O
seen	O
.	O

By	O
the	O
present	O
study	O
it	O
has	O
been	O
concluded	O
that	O
the	O
number	O
of	O
bacteria	O
determined	O
by	O
microscopic	O
counts	O
was	O
twice	O
as	O
high	O
in	O
caries	O
patients	O
as	O
in	O
healthy	O
sites	O
,	O
and	O
also	O
recommended	O
that	O
amoxicillin	O
,	O
ampicillin	O
and	O
amikacin	O
are	O
the	O
most	O
effective	O
antibacterial	O
drugs	O
for	O
the	O
treatment	O
of	O
dental	O
caries	O
.	O

To	O
study	O
and	O
compare	O
the	O
number	O
of	O
colony	O
forming	O
units	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Streptococcus	B-bacteria
sanguis	I-bacteria
,	O
Streptococcus	B-bacteria
salivarius	I-bacteria
,	O
Streptococcus	B-bacteria
mitis	I-bacteria
and	O
Streptococcus	B-bacteria
milleri	I-bacteria
in	O
dentulous	O
,	O
edentulous	O
and	O
in	O
those	O
wearing	O
partial	O
and	O
complete	O
dentures	O
by	O
using	O
semi	O
-	O
quantitative	O
culture	O
method	O
of	O
saliva	O
samples	O
with	O
calibrated	O
standard	O
loop	O
.	O

Sterile	O
specimen	O
collection	O
bottles	O
,	O
Mitis	O
salivarius	O
agar	O
plates	O
,	O
Standard	O
loop	O
,	O
Candle	O
jar	O
,	O
Incubator	O
,	O
Colony	O
counter	O
.	O

Study	O
population	O
consisted	O
of	O
100	O
subjects	O
with	O
25	O
in	O
each	O
group	O
,	O
with	O
an	O
age	O
range	O
of	O
40	O
to	O
80	O
years	O
,	O
who	O
were	O
attending	O
the	O
Department	O
of	O
Community	O
Dentistry	O
and	O
Prosthodontics	O
at	O
MNR	O
Dental	O
College	O
,	O
Sangareddy	O
,	O
Hyderabad	O
.	O

Unstimulated	O
saliva	O
samples	O
were	O
collected	O
from	O
patients	O
and	O
inoculated	O
on	O
to	O
Mitis	O
salivarius	O
agar	O
plates	O
using	O
calibrated	O
standard	O
loop	O
.	O

The	O
plates	O
were	O
then	O
incubated	O
anaerobically	O
at	O
37	O
degrees	O
C	O
for	O
24	O
hours	O
and	O
left	O
at	O
room	O
temperature	O
for	O
further	O
24	O
hours	O
.	O

Using	O
a	O
colony	O
counter	O
,	O
the	O
number	O
of	O
colonies	O
of	O
each	O
species	O
was	O
counted	O
.	O

Streptococcus	B-bacteria
mutans	I-bacteria
and	O
Streptococcus	B-bacteria
mitis	I-bacteria
predominates	O
in	O
the	O
dentulous	O
group	O
,	O
Streptococcus	B-bacteria
sanguis	I-bacteria
in	O
complete	O
denture	O
group	O
,	O
Streptococcus	B-bacteria
salivarius	I-bacteria
in	O
edentulous	O
group	O
and	O
Streptococcus	B-bacteria
milleri	I-bacteria
in	O
removable	O
partial	O
denture	O
group	O
.	O

The	O
results	O
of	O
our	O
study	O
are	O
in	O
accordance	O
with	O
the	O
previous	O
studies	O
,	O
which	O
have	O
sought	O
to	O
differentiate	O
different	O
groups	O
of	O
mutans	B-bacteria
streptococci	I-bacteria
using	O
a	O
simple	O
calibrated	O
standard	O
loop	O
.	O

A	O
majority	O
of	O
individuals	O
infected	O
with	O
human	O
immunodeficiency	O
virus	O
(	O
HIV	O
)	O
have	O
inadequate	O
access	O
to	O
antiretroviral	O
therapy	O
and	O
ultimately	O
develop	O
debilitating	O
oral	O
infections	O
that	O
often	O
correlate	O
with	O
disease	O
progression	O
.	O

Due	O
to	O
the	O
impracticalities	O
of	O
conducting	O
host	O
-	O
microbe	O
systems	O
-	O
based	O
studies	O
in	O
HIV	O
infected	O
patients	O
,	O
we	O
have	O
evaluated	O
the	O
potential	O
of	O
simian	O
immunodeficiency	O
virus	O
(	O
SIV	O
)	O
infected	O
rhesus	O
macaques	O
to	O
serve	O
as	O
a	O
non	O
-	O
human	O
primate	O
model	O
for	O
oral	O
manifestations	O
of	O
HIV	O
disease	O
.	O

We	O
present	O
the	O
first	O
description	O
of	O
the	O
rhesus	O
macaque	O
oral	O
microbiota	O
and	O
show	O
that	O
a	O
mixture	O
of	O
human	O
commensal	O
bacteria	O
and	O
`	O
`	O
macaque	O
versions	O
'	O
'	O
of	O
human	O
commensals	O
colonize	O
the	O
tongue	O
dorsum	O
and	O
dental	O
plaque	O
.	O

Our	O
findings	O
indicate	O
that	O
SIV	O
infection	O
results	O
in	O
chronic	O
activation	O
of	O
antiviral	O
and	O
inflammatory	O
responses	O
in	O
the	O
tongue	O
mucosa	O
that	O
may	O
collectively	O
lead	O
to	O
repression	O
of	O
epithelial	O
development	O
and	O
impact	O
the	O
microbiome	O
.	O

In	O
addition	O
,	O
we	O
show	O
that	O
dysbiosis	O
of	O
the	O
lingual	O
microbiome	O
in	O
SIV	O
infection	O
is	O
characterized	O
by	O
outgrowth	O
of	O
Gemella	B-bacteria
morbillorum	I-bacteria
that	O
may	O
result	O
from	O
impaired	O
macrophage	O
function	O
.	O

Finally	O
,	O
we	O
provide	O
evidence	O
that	O
the	O
increased	O
capacity	O
of	O
opportunistic	O
pathogens	O
(	O
e	O
.	O
g	O
.	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
)	O
to	O
colonize	O
the	O
microbiome	O
is	O
associated	O
with	O
reduced	O
production	O
of	O
antimicrobial	O
peptides	O
.	O

This	O
study	O
compared	O
the	O
oral	O
hygiene	O
and	O
caries	O
risk	O
of	O
patients	O
treated	O
with	O
labial	O
and	O
lingual	O
orthodontic	O
appliances	O
throughout	O
a	O
prospective	O
evaluation	O
of	O
the	O
status	O
of	O
the	O
oral	O
environment	O
before	O
and	O
after	O
bracket	O
placement	O
.	O

A	O
total	O
of	O
20	O
orthodontic	O
patients	O
aged	O
19	O
to	O
23	O
years	O
were	O
included	O
in	O
the	O
study	O
and	O
were	O
divided	O
into	O
two	O
groups	O
:	O
10	O
patients	O
wore	O
Roth	O
labial	O
appliance	O
(	O
American	O
Orthodontics	O
,	O
Sheboygan	O
,	O
WI	O
,	O
USA	O
)	O
and	O
10	O
patients	O
wore	O
STb	O
lingual	O
appliance	O
(	O
Ormco	O
Corporation	O
,	O
Glendora	O
,	O
CA	O
,	O
USA	O
)	O
.	O

Plaque	O
index	O
(	O
PI	O
)	O
,	O
gingival	O
bleeding	O
index	O
(	O
GBI	O
)	O
,	O
salivary	O
flow	O
rate	O
,	O
saliva	O
buffer	O
capacity	O
,	O
salivary	O
pH	O
,	O
and	O
Streptococcus	B-bacteria
mutans	I-bacteria
and	O
Lactobacillus	B-bacteria
counts	O
in	O
saliva	O
were	O
determined	O
at	O
three	O
time	O
points	O
:	O
before	O
orthodontic	O
appliance	O
placement	O
(	O
T0	O
)	O
,	O
4	O
weeks	O
after	O
bonding	O
(	O
T1	O
)	O
,	O
and	O
8	O
weeks	O
after	O
bonding	O
(	O
T2	O
)	O
.	O

After	O
appliance	O
placement	O
,	O
all	O
patients	O
were	O
periodically	O
educated	O
to	O
the	O
oral	O
hygiene	O
procedures	O
.	O

Wilcoxon	O
rank	O
and	O
Mann	O
-	O
Whitney	O
U	O
tests	O
were	O
used	O
to	O
determine	O
intragroup	O
and	O
intergroup	O
differences	O
as	O
regards	O
qualitative	O
data	O
.	O

To	O
compare	O
quantitative	O
data	O
between	O
the	O
groups	O
,	O
chi	O
-	O
square	O
and	O
Fisher	O
'	O
s	O
exact	O
tests	O
were	O
undertaken	O
,	O
while	O
intragroup	O
differences	O
were	O
tested	O
with	O
McNemar	O
test	O
.	O

The	O
level	O
of	O
statistical	O
significance	O
was	O
set	O
at	O
p	O
<	O
0	O
.	O
05	O
.	O

Statistical	O
analysis	O
of	O
the	O
data	O
obtained	O
revealed	O
a	O
statistically	O
significant	O
difference	O
between	O
the	O
data	O
of	O
T0	O
and	O
T1	O
and	O
the	O
data	O
of	O
T0	O
and	O
T2	O
of	O
the	O
PI	O
scores	O
and	O
between	O
T0	O
and	O
T2	O
of	O
the	O
GBI	O
scores	O
in	O
the	O
group	O
treated	O
with	O
the	O
lingual	O
appliance	O
.	O

The	O
GBI	O
value	O
increased	O
significantly	O
between	O
T0	O
and	O
T1	O
but	O
decreased	O
significantly	O
between	O
T1	O
and	O
T2	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
in	O
the	O
group	O
treated	O
with	O
labial	O
appliance	O
.	O

S	B-bacteria
.	I-bacteria
mutans	I-bacteria
counts	O
increased	O
significantly	O
between	O
T0	O
and	O
T2	O
in	O
the	O
saliva	O
samples	O
of	O
patients	O
treated	O
with	O
lingual	O
appliance	O
.	O

No	O
statistically	O
significant	O
differences	O
were	O
found	O
between	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
Lactobacillus	B-bacteria
counts	O
at	O
the	O
three	O
terms	O
of	O
saliva	O
collection	O
in	O
patients	O
treated	O
with	O
labial	O
appliance	O
.	O

No	O
statistically	O
significant	O
differences	O
were	O
found	O
between	O
the	O
two	O
groups	O
at	O
the	O
three	O
time	O
points	O
as	O
regards	O
the	O
salivary	O
flow	O
rate	O
and	O
saliva	O
buffer	O
capacity	O
.	O

Lingual	O
and	O
labial	O
orthodontic	O
appliances	O
showed	O
a	O
different	O
potential	O
in	O
modifying	O
the	O
investigated	O
clinical	O
parameters	O
:	O
patients	O
wearing	O
STb	O
lingual	O
orthodontic	O
appliance	O
had	O
more	O
plaque	O
retention	O
4	O
and	O
8	O
weeks	O
after	O
bonding	O
,	O
while	O
there	O
were	O
more	O
gingival	O
inflammation	O
and	O
more	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
counts	O
8	O
weeks	O
after	O
bonding	O
.	O

No	O
differences	O
were	O
found	O
between	O
the	O
two	O
groups	O
as	O
regards	O
the	O
Lactobacillus	B-bacteria
counts	O
,	O
the	O
salivary	O
flow	O
rate	O
,	O
and	O
saliva	O
buffer	O
capacity	O
.	O

A	O
significant	O
portion	O
of	O
the	O
bacteria	O
taking	O
part	O
of	O
the	O
microbiome	O
associated	O
with	O
apical	O
periodontitis	O
still	O
remain	O
to	O
be	O
cultivated	O
and	O
phenotypically	O
characterized	O
.	O

This	O
molecular	O
study	O
evaluated	O
the	O
prevalence	O
of	O
selected	O
as	O
-	O
yet	O
-	O
uncultivated	O
and	O
difficult	O
-	O
to	O
-	O
culture	O
bacterial	O
taxa	O
in	O
infected	O
root	O
canals	O
and	O
their	O
susceptibility	O
to	O
chemomechanical	O
procedures	O
.	O

Root	O
canals	O
of	O
single	O
-	O
rooted	O
teeth	O
with	O
apical	O
periodontitis	O
were	O
prepared	O
using	O
rotary	O
nickel	O
-	O
titanium	O
instruments	O
and	O
2	O
.	O
5	O
%	O
sodium	O
hypochlorite	O
as	O
the	O
irrigant	O
.	O

DNA	O
extracts	O
from	O
samples	O
taken	O
before	O
(	O
S1	O
)	O
and	O
after	O
(	O
S2	O
)	O
chemomechanical	O
preparation	O
were	O
surveyed	O
for	O
the	O
presence	O
of	O
7	O
as	O
-	O
yet	O
-	O
uncultivated	O
phylotypes	O
and	O
1	O
difficult	O
-	O
to	O
-	O
culture	O
species	O
using	O
end	O
-	O
point	O
polymerase	O
chain	O
reaction	O
.	O

Samples	O
were	O
also	O
subjected	O
to	O
quantitative	O
analysis	O
of	O
total	O
bacteria	O
and	O
levels	O
of	O
the	O
2	O
most	O
prevalent	O
taxa	O
.	O

Bacteroidaceae	B-bacteria
sp	I-bacteria
.	I-bacteria
HOT	I-bacteria
-	I-bacteria
272	I-bacteria
(	O
24	O
%	O
)	O
and	O
Fretibacterium	B-bacteria
fastidiosum	I-bacteria
(	O
20	O
%	O
)	O
were	O
the	O
most	O
prevalent	O
taxa	O
in	O
S1	O
.	O

Their	O
mean	O
counts	O
in	O
S1	O
were	O
8	O
.	O
25	O
x	O
10	O
(	O
3	O
)	O
and	O
2	O
.	O
13	O
x	O
10	O
(	O
3	O
)	O
rRNA	O
gene	O
copies	O
,	O
corresponding	O
to	O
0	O
.	O
18	O
%	O
and	O
0	O
.	O
55	O
%	O
of	O
the	O
total	O
bacteria	O
.	O

Chemomechanical	O
debridement	O
promoted	O
a	O
highly	O
statistically	O
significant	O
reduction	O
in	O
total	O
bacterial	O
counts	O
(	O
P	O
<	O
.	O
001	O
)	O
,	O
but	O
64	O
%	O
of	O
the	O
canals	O
were	O
still	O
positive	O
for	O
bacterial	O
presence	O
.	O

Of	O
the	O
target	O
taxa	O
,	O
only	O
Bacteroidaceae	B-bacteria
sp	I-bacteria
.	I-bacteria
HOT	I-bacteria
-	I-bacteria
272	I-bacteria
and	O
F	B-bacteria
.	I-bacteria
fastidiosum	I-bacteria
were	O
detected	O
in	O
S2	O
(	O
each	O
one	O
in	O
1	O
sample	O
)	O
.	O

The	O
reduction	O
in	O
counts	O
of	O
both	O
taxa	O
was	O
also	O
highly	O
significant	O
(	O
P	O
<	O
.	O
001	O
)	O
.	O

Findings	O
confirmed	O
that	O
several	O
as	O
-	O
yet	O
-	O
uncultivated	O
and	O
difficult	O
-	O
to	O
-	O
grow	O
bacterial	O
taxa	O
can	O
participate	O
in	O
the	O
microbiome	O
associated	O
with	O
apical	O
periodontitis	O
.	O

Two	O
of	O
them	O
were	O
found	O
in	O
relatively	O
high	O
prevalence	O
but	O
rarely	O
as	O
a	O
dominant	O
species	O
.	O

Chemomechanical	O
procedures	O
were	O
highly	O
effective	O
in	O
completely	O
eliminating	O
these	O
taxa	O
or	O
at	O
least	O
substantially	O
reducing	O
their	O
numbers	O
.	O

One	O
of	O
the	O
most	O
important	O
factors	O
implicated	O
in	O
preterm	O
birth	O
(	O
PTB	O
)	O
is	O
acute	O
genitourinary	O
tract	O
infection	O
.	O

The	O
bacteria	O
causing	O
chronic	O
periodontal	O
inflammation	O
include	O
Gram	O
-	O
negative	O
rods	O
and	O
anaerobes	O
similar	O
to	O
those	O
found	O
in	O
women	O
with	O
bacterial	O
vaginosis	O
.	O

The	O
aim	O
of	O
this	O
prospective	O
study	O
is	O
to	O
investigate	O
the	O
relationship	O
between	O
oral	O
and	O
vaginal	O
microflora	O
and	O
preterm	O
low	O
birth	O
weight	O
.	O

Real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
was	O
used	O
to	O
detect	O
both	O
the	O
presence	O
and	O
level	O
of	O
six	O
periodontitis	O
-	O
related	O
species	O
:	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
(	O
Aa	B-bacteria
)	O
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
(	O
Pg	B-bacteria
)	O
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
(	O
Tf	B-bacteria
)	O
,	O
Treponema	B-bacteria
denticola	I-bacteria
(	O
Td	B-bacteria
)	O
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
ssp	I-bacteria
(	O
Fn	B-bacteria
)	O
,	O
and	O
Prevotella	B-bacteria
intermedia	I-bacteria
(	O
Pi	B-bacteria
)	O
for	O
both	O
oral	O
samples	O
of	O
subgingival	O
plaque	O
and	O
cervical	O
samples	O
,	O
obtained	O
from	O
80	O
patients	O
,	O
during	O
gynaecological	O
examinations	O
.	O

The	O
more	O
representative	O
oral	O
pathogen	O
(	O
less	O
than	O
60	O
percent	O
)	O
species	O
in	O
oral	O
samples	O
of	O
preterm	O
and	O
term	O
group	O
were	O
Tf	B-bacteria
,	O
Td	B-bacteria
,	O
and	O
Fn	B-bacteria
.	O

24	O
.	O
4	O
percent	O
of	O
pregnant	O
women	O
presented	O
periodontal	O
pathogens	O
in	O
vaginal	O
swab	O
;	O
the	O
most	O
representative	O
species	O
with	O
a	O
percentage	O
over	O
0	O
.	O
1	O
percent	O
of	O
total	O
bacteria	O
in	O
genital	O
tract	O
of	O
preterm	O
group	O
were	O
Tf	B-bacteria
,	O
Td	B-bacteria
,	O
and	O
Pi	B-bacteria
with	O
a	O
positive	O
correlation	O
(	O
less	O
than	O
0	O
.	O
5	O
)	O
.	O

The	O
presence	O
of	O
the	O
bacterium	O
T	B-bacteria
.	I-bacteria
denticolain	I-bacteria
the	O
vagina	O
,	O
regardless	O
of	O
the	O
amount	O
,	O
adversely	O
affects	O
preterm	O
delivery	O
.	O

Astilbin	O
,	O
mainly	O
isolated	O
from	O
a	O
commonly	O
used	O
herbal	O
medicine	O
,	O
Smilax	O
glabra	O
Roxb	O
(	O
SGR	O
)	O
,	O
exhibits	O
a	O
variety	O
of	O
pharmacological	O
activities	O
and	O
biological	O
effects	O
.	O

It	O
is	O
metabolized	O
by	O
intestinal	O
bacteria	O
after	O
oral	O
administration	O
which	O
leads	O
to	O
the	O
variation	O
of	O
ethnopharmacological	O
profile	O
of	O
this	O
traditional	O
medicine	O
.	O

However	O
,	O
little	O
is	O
known	O
on	O
the	O
interactions	O
of	O
this	O
active	O
compound	O
with	O
intestinal	O
bacteria	O
,	O
which	O
would	O
be	O
very	O
helpful	O
in	O
unravelling	O
how	O
SGR	O
works	O
.	O

In	O
this	O
study	O
,	O
different	O
pure	O
bacteria	O
from	O
human	O
feces	O
were	O
isolated	O
and	O
were	O
used	O
to	O
investigate	O
their	O
conversion	O
capability	O
of	O
astilbin	O
.	O

Ultra	O
-	O
performance	O
liquid	O
chromatography	O
/	O
quadrupole	O
-	O
time	O
-	O
of	O
-	O
flight	O
mass	O
spectrometry	O
(	O
UPLC	O
-	O
Q	O
-	O
TOF	O
/	O
MS	O
)	O
technique	O
combined	O
with	O
Metabolynx	O
(	O
TM	O
)	O
software	O
was	O
used	O
to	O
analyze	O
astilbin	O
and	O
its	O
metabolites	O
.	O

The	O
parent	O
compound	O
and	O
two	O
metabolites	O
(	O
quercetin	O
and	O
eriodictyol	O
)	O
were	O
detected	O
in	O
the	O
isolated	O
bacterial	O
samples	O
compared	O
with	O
blank	O
samples	O
.	O

Quercetin	O
was	O
present	O
in	O
Enterococcus	B-bacteria
sp	I-bacteria
.	I-bacteria
8B	O
,	O
8	O
-	O
2	O
and	O
9	O
-	O
2	O
samples	O
.	O

Eriodictyol	O
was	O
only	O
identified	O
in	O
Enterococcus	B-bacteria
sp	I-bacteria
.	I-bacteria
8B	O
sample	O
.	O

The	O
metabolic	O
routes	O
and	O
metabolites	O
of	O
astilbin	O
produced	O
by	O
the	O
different	O
intestinal	O
bacteria	O
are	O
reported	O
for	O
the	O
first	O
time	O
.	O

This	O
will	O
be	O
useful	O
for	O
the	O
investigation	O
of	O
the	O
pharmacokinetic	O
study	O
of	O
astilbin	O
in	O
vivo	O
and	O
the	O
role	O
of	O
different	O
intestinal	O
bacteria	O
in	O
the	O
metabolism	O
of	O
natural	O
compounds	O
.	O

Periodontitis	O
is	O
a	O
common	O
dental	O
disease	O
which	O
results	O
in	O
irreversible	O
alveolar	O
bone	O
loss	O
around	O
teeth	O
,	O
and	O
subsequent	O
tooth	O
loss	O
.	O

Previous	O
studies	O
have	O
focused	O
on	O
bacteria	O
that	O
damage	O
the	O
host	O
and	O
the	O
roles	O
of	O
commensals	O
to	O
facilitate	O
their	O
colonization	O
.	O

Although	O
some	O
immune	O
responses	O
targeting	O
oral	O
bacteria	O
protect	O
the	O
host	O
from	O
alveolar	O
bone	O
loss	O
,	O
recent	O
studies	O
show	O
that	O
particular	O
host	O
defense	O
responses	O
to	O
oral	O
bacteria	O
can	O
induce	O
alveolar	O
bone	O
loss	O
.	O

Host	O
-	O
damaging	O
and	O
immunostimulatory	O
oral	O
bacteria	O
cooperatively	O
induce	O
bone	O
loss	O
by	O
inducing	O
gingival	O
damage	O
followed	O
by	O
immunostimulation	O
.	O

In	O
mouse	O
models	O
of	O
experimental	O
periodontitis	O
induced	O
by	O
either	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
or	O
ligature	O
,	O
gamma	B-bacteria
-	I-bacteria
proteobacteria	I-bacteria
accumulate	O
and	O
stimulate	O
host	O
immune	O
responses	O
to	O
induce	O
host	O
damage	O
.	O

Here	O
we	O
review	O
the	O
differential	O
roles	O
of	O
individual	O
bacterial	O
groups	O
in	O
promoting	O
bone	O
loss	O
through	O
the	O
induction	O
of	O
host	O
damage	O
and	O
immunostimulation	O
.	O

Oral	O
biofilms	O
harbor	O
several	O
hundreds	O
of	O
species	O
of	O
bacteria	O
as	O
well	O
as	O
spirochetes	B-bacteria
,	O
protozoa	O
,	O
fungi	O
and	O
viruses	O
.	O

The	O
composition	O
of	O
the	O
oral	O
biofilm	O
varies	O
from	O
health	O
to	O
disease	O
.	O

It	O
is	O
the	O
source	O
of	O
microorganisms	O
that	O
cause	O
dental	O
and	O
periodontal	O
infections	O
.	O

Oral	O
infections	O
and	O
periodontal	O
disease	O
have	O
been	O
implicated	O
in	O
the	O
etiopathogenesis	O
of	O
several	O
important	O
chronic	O
systemic	O
diseases	O
.	O

It	O
is	O
now	O
clear	O
that	O
the	O
most	O
common	O
oral	O
diseases	O
,	O
dental	O
caries	O
and	O
periodontitis	O
,	O
are	O
caused	O
by	O
mixed	O
-	O
species	O
communities	O
rather	O
than	O
by	O
individual	O
pathogens	O
working	O
in	O
isolation	O
.	O

Oral	O
streptococci	B-bacteria
are	O
central	O
to	O
these	O
disease	O
processes	O
since	O
they	O
are	O
frequently	O
the	O
first	O
microorganisms	O
to	O
colonize	O
oral	O
surfaces	O
and	O
they	O
are	O
numerically	O
the	O
dominant	O
microorganisms	O
in	O
the	O
human	O
mouth	O
.	O

Numerous	O
interactions	O
between	O
oral	O
streptococci	B-bacteria
and	O
other	O
bacteria	O
have	O
been	O
documented	O
.	O

These	O
are	O
thought	O
to	O
be	O
critical	O
for	O
the	O
development	O
of	O
mixed	O
-	O
species	O
oral	O
microbial	O
communities	O
and	O
for	O
the	O
transition	O
from	O
oral	O
health	O
to	O
disease	O
.	O

Recent	O
metagenomic	O
studies	O
are	O
beginning	O
to	O
shed	O
light	O
on	O
the	O
co	O
-	O
occurrence	O
patterns	O
of	O
streptococci	B-bacteria
with	O
other	O
oral	O
bacteria	O
.	O

Refinements	O
in	O
microscopy	O
techniques	O
and	O
biofilm	O
models	O
are	O
providing	O
detailed	O
insights	O
into	O
the	O
spatial	O
distribution	O
of	O
streptococci	B-bacteria
in	O
oral	O
biofilms	O
.	O

Targeted	O
genetic	O
manipulation	O
is	O
increasingly	O
being	O
applied	O
for	O
the	O
analysis	O
of	O
specific	O
genes	O
and	O
networks	O
that	O
modulate	O
interspecies	O
interactions	O
.	O

From	O
this	O
work	O
,	O
it	O
is	O
clear	O
that	O
streptococci	B-bacteria
produce	O
a	O
range	O
of	O
extracellular	O
factors	O
that	O
promote	O
their	O
integration	O
into	O
mixed	O
-	O
species	O
communities	O
and	O
enable	O
them	O
to	O
form	O
social	O
networks	O
with	O
neighboring	O
taxa	O
.	O

These	O
`	O
`	O
community	O
integration	O
factors	O
'	O
'	O
include	O
coaggregation	O
-	O
mediating	O
adhesins	O
and	O
receptors	O
,	O
small	O
signaling	O
molecules	O
such	O
as	O
peptides	O
or	O
autoinducer	O
-	O
2	O
,	O
bacteriocins	O
,	O
by	O
-	O
products	O
of	O
metabolism	O
including	O
hydrogen	O
peroxide	O
and	O
lactic	O
acid	O
,	O
and	O
a	O
range	O
of	O
extracellular	O
enzymes	O
.	O

Here	O
,	O
we	O
provide	O
an	O
overview	O
of	O
various	O
types	O
of	O
community	O
interactions	O
between	O
oral	O
streptococci	B-bacteria
and	O
other	O
microorganisms	O
,	O
and	O
we	O
consider	O
the	O
possibilities	O
for	O
the	O
development	O
of	O
new	O
technologies	O
to	O
interfere	O
with	O
these	O
interactions	O
to	O
help	O
control	O
oral	O
biofilms	O
.	O

Wounded	O
tissue	O
offers	O
opportunity	O
to	O
microflora	O
to	O
adhere	O
,	O
colonize	O
,	O
invade	O
and	O
infect	O
surrounding	O
healthy	O
tissue	O
.	O

The	O
bacteria	O
of	O
the	O
oral	O
cavity	O
have	O
the	O
potential	O
to	O
alter	O
the	O
wound	O
healing	O
process	O
by	O
interacting	O
with	O
keratinocytes	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
mechanisms	O
through	O
which	O
oral	O
bacteria	O
may	O
influence	O
re	O
-	O
epithelialization	O
by	O
interacting	O
with	O
gingival	O
keratinocytes	O
.	O

By	O
an	O
in	O
vitro	O
scratch	O
assay	O
we	O
demonstrate	O
that	O
primary	O
gingival	O
keratinocytes	O
have	O
impaired	O
closure	O
when	O
exposed	O
to	O
two	O
well	O
characterized	O
oral	O
bacteria	O
,	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
and	O
to	O
a	O
lesser	O
extent	O
,	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
.	O

P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
reduced	O
wound	O
closure	O
by	O
approximately	O
40	O
%	O
,	O
which	O
was	O
partially	O
dependent	O
on	O
proteolytic	O
activity	O
,	O
and	O
bacteria	O
was	O
still	O
present	O
within	O
infected	O
cells	O
9	O
days	O
later	O
despite	O
exposure	O
to	O
bacteria	O
for	O
only	O
24	O
h	O
.	O
Both	O
oral	O
bacteria	O
caused	O
keratinocyte	O
apoptosis	O
at	O
the	O
wound	O
site	O
with	O
cell	O
death	O
being	O
greatest	O
at	O
the	O
wound	O
edge	O
.	O

P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
and	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
adversely	O
affected	O
cell	O
proliferation	O
and	O
the	O
effect	O
also	O
had	O
a	O
spatial	O
component	O
being	O
most	O
striking	O
at	O
the	O
edge	O
.	O

The	O
impact	O
of	O
the	O
bacteria	O
was	O
long	O
lasting	O
even	O
when	O
exposure	O
was	O
brief	O
.	O

Cell	O
migration	O
was	O
compromised	O
in	O
bacteria	O
challenged	O
keratinocytes	O
with	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
having	O
more	O
severe	O
effect	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
than	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
.	O

Quantitative	O
real	O
time	O
PCR	O
of	O
bacteria	O
challenged	O
cells	O
showed	O
that	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
and	O
to	O
a	O
lesser	O
extent	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
significantly	O
downregulated	O
cell	O
cycle	O
genes	O
cyclin1	O
,	O
CDK1	O
,	O
and	O
CDK4	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
that	O
are	O
critical	O
for	O
GI	O
/	O
S	O
transition	O
.	O

Further	O
,	O
genes	O
associated	O
with	O
cell	O
migration	O
such	O
as	O
integrin	O
beta	O
-	O
3	O
and	O
-	O
6	O
were	O
significantly	O
downregulated	O
by	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

We	O
investigated	O
the	O
response	O
of	O
oral	O
cancer	O
cells	O
to	O
intracellular	O
invasion	O
of	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
to	O
define	O
changes	O
in	O
the	O
biological	O
characteristics	O
of	O
oral	O
cancer	O
cells	O
evoked	O
by	O
the	O
presence	O
of	O
oral	O
pathogenic	O
bacteria	O
within	O
a	O
tumour	O
microenvironment	O
.	O

The	O
proliferative	O
activity	O
,	O
cell	O
cycle	O
,	O
and	O
autophagic	O
response	O
were	O
evaluated	O
in	O
oral	O
cancer	O
cells	O
infected	O
with	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
381	I-bacteria
.	O

ROS	O
generation	O
was	O
detected	O
in	O
these	O
cells	O
by	O
DCFDA	O
assay	O
,	O
and	O
its	O
role	O
in	O
the	O
responses	O
of	O
oral	O
cancer	O
cells	O
to	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
infection	O
was	O
further	O
investigated	O
.	O

P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
inhibited	O
proliferation	O
of	O
oral	O
cancer	O
cells	O
by	O
inducing	O
G1	O
cell	O
cycle	O
arrest	O
,	O
but	O
had	O
no	O
effect	O
on	O
apoptosis	O
.	O

Following	O
infection	O
with	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
the	O
expression	O
of	O
cyclin	O
D1	O
and	O
cdk4	O
was	O
decreased	O
in	O
oral	O
cancer	O
cells	O
,	O
whereas	O
p21	O
,	O
a	O
Cdk	O
inhibitor	O
,	O
was	O
upregulated	O
,	O
in	O
comparison	O
with	O
non	O
-	O
infected	O
controls	O
.	O

Autophagy	O
was	O
prominently	O
enhanced	O
in	O
these	O
infected	O
cells	O
,	O
presumably	O
contributing	O
to	O
the	O
suppressed	O
proliferation	O
.	O

Further	O
experiments	O
revealed	O
that	O
such	O
autophagic	O
response	O
was	O
activated	O
by	O
the	O
formation	O
of	O
reactive	O
oxygen	O
species	O
,	O
as	O
evidenced	O
by	O
the	O
lack	O
of	O
autophagic	O
response	O
and	O
cell	O
proliferation	O
upon	O
removal	O
of	O
reactive	O
oxygen	O
species	O
.	O

These	O
findings	O
provide	O
a	O
novel	O
insight	O
into	O
the	O
mechanism	O
by	O
which	O
cancer	O
cells	O
are	O
influenced	O
by	O
tumour	O
microenvironment	O
including	O
oral	O
bacteria	O
.	O

Titanium	O
and	O
stainless	O
steel	O
wires	O
used	O
for	O
retainers	O
in	O
orthodontic	O
procedures	O
were	O
coated	O
with	O
Ag	O
ions	O
and	O
the	O
effects	O
of	O
the	O
coating	O
on	O
common	O
oral	O
pathogens	O
and	O
their	O
pathogenicity	O
were	O
investigated	O
.	O

Two	O
species	O
of	O
cariogenic	O
and	O
three	O
species	O
of	O
periodontopathic	O
bacteria	O
were	O
assessed	O
.	O

Biofilms	O
of	O
Streptococcus	B-bacteria
sobrinus	I-bacteria
and	O
two	O
VSC	O
gases	O
produced	O
by	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
were	O
also	O
examined	O
.	O

Ag	O
ion	O
-	O
coated	O
wires	O
showed	O
marked	O
antibacterial	O
activities	O
compared	O
with	O
uncoated	O
wires	O
;	O
in	O
most	O
cases	O
,	O
the	O
differences	O
were	O
statistically	O
significant	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

All	O
Ag	O
ion	O
-	O
coated	O
wires	O
(	O
Ti	O
+	O
and	O
SS	O
+	O
wires	O
)	O
displayed	O
more	O
than	O
2	O
-	O
mm	O
diameter	O
bacteria	O
growth	O
-	O
resistant	O
zones	O
around	O
them	O
in	O
radial	O
diffusion	O
tests	O
.	O

Ag	O
ion	O
release	O
was	O
0	O
.	O
043	O
+	O
/	O
-	O
0	O
.	O
005	O
ppm	O
in	O
24	O
h	O
that	O
did	O
n	O
'	O
t	O
show	O
cytotoxicity	O
.	O

Thus	O
,	O
these	O
results	O
suggest	O
that	O
a	O
simple	O
Ag	O
ion	O
coating	O
on	O
pure	O
titanium	O
and	O
stainless	O
steel	O
wires	O
can	O
restrict	O
growth	O
and	O
pathogenic	O
activities	O
of	O
oral	O
pathogenic	O
bacteria	O
,	O
even	O
in	O
the	O
early	O
stages	O
of	O
culture	O
.	O

Mycoplasma	B-bacteria
salivarium	I-bacteria
belongs	O
to	O
the	O
class	O
of	O
the	O
smallest	O
self	O
-	O
replicating	O
Tenericutes	B-bacteria
and	O
is	O
predominantly	O
found	O
in	O
the	O
oral	O
cavity	O
of	O
humans	O
.	O

In	O
general	O
it	O
is	O
considered	O
as	O
a	O
non	O
-	O
pathogenic	O
commensal	O
.	O

However	O
,	O
some	O
reports	O
point	O
to	O
an	O
association	O
with	O
human	O
diseases	O
.	O

M	B-bacteria
.	I-bacteria
salivarium	I-bacteria
was	O
found	O
e	O
.	O
g	O
.	O
as	O
causative	O
agent	O
of	O
a	O
submasseteric	O
abscess	O
,	O
in	O
necrotic	O
dental	O
pulp	O
,	O
in	O
brain	O
abscess	O
and	O
clogged	O
biliary	O
stent	O
.	O

Here	O
we	O
describe	O
the	O
detection	O
of	O
M	B-bacteria
.	I-bacteria
salivarium	I-bacteria
on	O
the	O
surface	O
of	O
a	O
squamous	O
cell	O
carcinoma	O
of	O
the	O
tongue	O
of	O
a	O
patient	O
with	O
Fanconi	O
anaemia	O
(	O
FA	O
)	O
.	O

FA	O
is	O
an	O
inherited	O
bone	O
marrow	O
failure	O
syndrome	O
based	O
on	O
defective	O
DNA	O
-	O
repair	O
that	O
increases	O
the	O
risk	O
of	O
carcinomas	O
especially	O
oral	O
squamous	O
cell	O
carcinoma	O
.	O

Employing	O
high	O
coverage	O
,	O
massive	O
parallel	O
Roche	O
/	O
454	O
-	O
next	O
-	O
generation	O
-	O
sequencing	O
of	O
16S	O
rRNA	O
gene	O
amplicons	O
we	O
analysed	O
the	O
oral	O
microbiome	O
of	O
this	O
FA	O
patient	O
in	O
comparison	O
to	O
that	O
of	O
an	O
FA	O
patient	O
with	O
a	O
benign	O
leukoplakia	O
and	O
five	O
healthy	O
individuals	O
.	O

The	O
microbiota	O
of	O
the	O
FA	O
patient	O
with	O
leukoplakia	O
correlated	O
well	O
with	O
that	O
of	O
the	O
healthy	O
controls	O
.	O

A	O
dominance	O
of	O
Streptococcus	B-bacteria
,	O
Veillonella	B-bacteria
and	O
Neisseria	B-bacteria
species	I-bacteria
was	O
typically	O
observed	O
.	O

In	O
contrast	O
,	O
the	O
microbiome	O
of	O
the	O
cancer	O
bearing	O
FA	O
patient	O
was	O
dominated	O
by	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
at	O
the	O
healthy	O
sites	O
,	O
which	O
changed	O
to	O
a	O
predominance	O
of	O
98	O
%	O
M	B-bacteria
.	I-bacteria
salivarium	I-bacteria
on	O
the	O
tumour	O
surface	O
.	O

Quantification	O
of	O
the	O
mycoplasma	O
load	O
in	O
five	O
healthy	O
,	O
two	O
tumour	O
-	O
and	O
two	O
leukoplakia	O
-	O
FA	O
patients	O
by	O
TaqMan	O
-	O
PCR	O
confirmed	O
the	O
prevalence	O
of	O
M	B-bacteria
.	I-bacteria
salivarium	I-bacteria
at	O
the	O
tumour	O
sites	O
.	O

These	O
new	O
findings	O
suggest	O
that	O
this	O
mycoplasma	B-bacteria
species	I-bacteria
with	O
its	O
reduced	O
coding	O
capacity	O
found	O
ideal	O
breeding	O
grounds	O
at	O
the	O
tumour	O
sites	O
.	O

Interestingly	O
,	O
the	O
oral	O
cavity	O
of	O
all	O
FA	O
patients	O
and	O
especially	O
samples	O
at	O
the	O
tumour	O
sites	O
were	O
in	O
addition	O
positive	O
for	O
Candida	O
albicans	O
.	O

It	O
remains	O
to	O
be	O
elucidated	O
in	O
further	O
studies	O
whether	O
M	B-bacteria
.	I-bacteria
salivarium	I-bacteria
can	O
be	O
used	O
as	O
a	O
predictive	O
biomarker	O
for	O
tumour	O
development	O
in	O
these	O
patients	O
.	O

The	O
microbiota	O
of	O
the	O
human	O
lower	O
intestinal	O
tract	O
helps	O
maintain	O
healthy	O
host	O
physiology	O
,	O
for	O
example	O
through	O
nutrient	O
acquisition	O
and	O
bile	O
acid	O
recycling	O
,	O
but	O
specific	O
positive	O
contributions	O
of	O
the	O
oral	O
microbiota	O
to	O
host	O
health	O
are	O
not	O
well	O
established	O
.	O

Nitric	O
oxide	O
(	O
NO	O
)	O
homeostasis	O
is	O
crucial	O
to	O
mammalian	O
physiology	O
.	O

The	O
recently	O
described	O
entero	O
-	O
salivary	O
nitrate	O
-	O
nitrite	O
-	O
nitric	O
oxide	O
pathway	O
has	O
been	O
shown	O
to	O
provide	O
bioactive	O
NO	O
from	O
dietary	O
nitrate	O
sources	O
.	O

Interestingly	O
,	O
this	O
pathway	O
is	O
dependent	O
upon	O
oral	O
nitrate	O
-	O
reducing	O
bacteria	O
,	O
since	O
humans	O
lack	O
this	O
enzyme	O
activity	O
.	O

This	O
pathway	O
appears	O
to	O
represent	O
a	O
newly	O
recognized	O
symbiosis	O
between	O
oral	O
nitrate	O
-	O
reducing	O
bacteria	O
and	O
their	O
human	O
hosts	O
in	O
which	O
the	O
bacteria	O
provide	O
nitrite	O
and	O
nitric	O
oxide	O
from	O
nitrate	O
reduction	O
.	O

Here	O
we	O
measure	O
the	O
nitrate	O
-	O
reducing	O
capacity	O
of	O
tongue	O
-	O
scraping	O
samples	O
from	O
six	O
healthy	O
human	O
volunteers	O
,	O
and	O
analyze	O
metagenomes	O
of	O
the	O
bacterial	O
communities	O
to	O
identify	O
bacteria	O
contributing	O
to	O
nitrate	O
reduction	O
.	O

We	O
identified	O
14	O
candidate	O
species	O
,	O
seven	O
of	O
which	O
were	O
not	O
previously	O
believed	O
to	O
contribute	O
to	O
nitrate	O
reduction	O
.	O

We	O
cultivated	O
isolates	O
of	O
four	O
candidate	O
species	O
in	O
single	O
-	O
and	O
mixed	O
-	O
species	O
biofilms	O
,	O
revealing	O
that	O
they	O
have	O
substantial	O
nitrate	O
-	O
and	O
nitrite	O
-	O
reduction	O
capabilities	O
.	O

Colonization	O
by	O
specific	O
oral	O
bacteria	O
may	O
thus	O
contribute	O
to	O
host	O
NO	O
homeostasis	O
by	O
providing	O
nitrite	O
and	O
nitric	O
oxide	O
.	O

Conversely	O
,	O
the	O
lack	O
of	O
specific	O
nitrate	O
-	O
reducing	O
communities	O
may	O
disrupt	O
the	O
nitrate	O
-	O
nitrite	O
-	O
nitric	O
oxide	O
pathway	O
and	O
lead	O
to	O
a	O
state	O
of	O
NO	O
insufficiency	O
.	O

These	O
findings	O
may	O
also	O
provide	O
mechanistic	O
evidence	O
for	O
the	O
oral	O
systemic	O
link	O
.	O

Our	O
results	O
provide	O
a	O
possible	O
new	O
therapeutic	O
target	O
and	O
paradigm	O
for	O
NO	O
restoration	O
in	O
humans	O
by	O
specific	O
oral	O
bacteria	O
.	O

Knowledge	O
of	O
the	O
microbial	O
composition	O
of	O
deciduous	O
endodontic	O
infections	O
is	O
limited	O
.	O

This	O
study	O
aimed	O
to	O
evaluate	O
the	O
presence	O
of	O
the	O
10	O
oral	O
bacterial	O
species	O
in	O
samples	O
from	O
primary	O
tooth	O
root	O
canals	O
by	O
using	O
microarray	O
technology	O
and	O
to	O
determine	O
the	O
association	O
of	O
these	O
organisms	O
with	O
clinical	O
conditions	O
.	O

The	O
samples	O
were	O
collected	O
from	O
30	O
root	O
canals	O
of	O
primary	O
teeth	O
with	O
primer	O
infection	O
.	O

The	O
bacterial	O
composition	O
of	O
the	O
samples	O
was	O
semi	O
-	O
quantitatively	O
defined	O
using	O
a	O
microarray	O
system	O
(	O
Parocheck	O
)	O
.	O

All	O
the	O
tested	O
species	O
were	O
detected	O
in	O
the	O
samples	O
.	O

Fusobacterium	B-bacteria
nucleatum	I-bacteria
was	O
the	O
most	O
frequently	O
isolated	O
bacterium	O
(	O
96	O
.	O
7	O
%	O
)	O
,	O
followed	O
by	O
Prevotella	B-bacteria
intermedia	I-bacteria
(	O
86	O
.	O
7	O
%	O
)	O
,	O
Parvimonas	B-bacteria
micra	I-bacteria
(	O
83	O
.	O
3	O
%	O
)	O
,	O
Treponema	B-bacteria
denticola	I-bacteria
(	O
76	O
.	O
7	O
%	O
)	O
and	O
Tannerella	B-bacteria
forsythia	I-bacteria
(	O
66	O
.	O
7	O
%	O
)	O
.	O

These	O
bacteria	O
were	O
also	O
present	O
in	O
high	O
levels	O
.	O

All	O
pairs	O
of	O
bacterial	O
species	O
were	O
positively	O
associated	O
(	O
RR	O
>	O
1	O
)	O
,	O
except	O
Pintermedia	O
and	O
P	O
>	O
micra	O
.	O

On	O
average	O
,	O
five	O
species	O
(	O
range	O
:	O
3	O
-	O
8	O
)	O
were	O
detected	O
per	O
amplified	O
sample	O
.	O

Root	O
canals	O
of	O
teeth	O
with	O
>	O
5	O
different	O
species	O
were	O
statistically	O
associated	O
with	O
periapical	O
radiolucency	O
(	O
P	O
=	O
0	O
.	O
049	O
)	O
.	O

Primary	O
teeth	O
with	O
endodontic	O
infections	O
show	O
a	O
highly	O
diverse	O
variety	O
of	O
bacteria	O
,	O
in	O
which	O
the	O
most	O
prevalent	O
specie	O
are	O
present	O
in	O
high	O
proportions	O
.	O

The	O
well	O
-	O
directed	O
use	O
of	O
the	O
improved	O
microarray	O
technology	O
will	O
provide	O
additional	O
valuable	O
information	O
for	O
causative	O
factors	O
associated	O
with	O
endodontic	O
diseases	O
,	O
helping	O
to	O
develop	O
more	O
successful	O
antibacterial	O
or	O
anti	O
-	O
inflammatory	O
treatment	O
strategies	O
.	O

Peanut	O
allergy	O
(	O
PNA	O
)	O
has	O
becoming	O
a	O
non	O
-	O
negligible	O
health	O
concern	O
worldwide	O
.	O

Thus	O
far	O
,	O
allergen	O
-	O
specific	O
immunotherapy	O
aimed	O
at	O
inducing	O
mucosal	O
tolerance	O
has	O
widely	O
been	O
regarded	O
as	O
a	O
major	O
management	O
strategy	O
for	O
PNA	O
.	O

The	O
safety	O
profiles	O
and	O
the	O
intrinsic	O
probiotic	O
properties	O
of	O
lactic	B-bacteria
acid	I-bacteria
bacteria	I-bacteria
(	O
LAB	B-bacteria
)	O
render	O
them	O
attractive	O
delivery	O
vehicles	O
for	O
mucosal	O
vaccines	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
exploited	O
genetically	O
modified	O
Lactococcus	B-bacteria
lactis	I-bacteria
to	O
produce	O
peanut	O
allergen	O
Ara	O
h	O
2	O
via	O
different	O
protein	O
-	O
targeting	O
systems	O
and	O
their	O
immunomodulatory	O
potency	O
for	O
allergic	O
immune	O
responses	O
in	O
mice	O
were	O
investigated	O
.	O

By	O
comparison	O
with	O
the	O
strain	O
expressing	O
the	O
cytoplasmic	O
form	O
of	O
Ara	O
h	O
2	O
(	O
LL1	O
)	O
,	O
the	O
strains	O
expressing	O
the	O
secreted	O
and	O
anchored	O
forms	O
of	O
Ara	O
h	O
2	O
(	O
LL2	O
and	O
LL3	O
)	O
were	O
more	O
potent	O
in	O
redirecting	O
a	O
Th2	O
-	O
polarized	O
to	O
a	O
non	O
-	O
allergic	O
Th1	O
immune	O
responses	O
.	O

Induction	O
of	O
SIgA	O
and	O
regulatory	O
T	O
cells	O
were	O
also	O
observed	O
at	O
the	O
local	O
levels	O
by	O
orally	O
administration	O
of	O
recombinant	O
L	B-bacteria
.	I-bacteria
lactis	I-bacteria
.	O

Our	O
results	O
indicate	O
that	O
allergen	O
-	O
producing	O
L	B-bacteria
.	I-bacteria
lactis	I-bacteria
strains	I-bacteria
modulated	O
allergic	O
immune	O
responses	O
and	O
may	O
be	O
developed	O
as	O
promising	O
mucosal	O
vaccines	O
for	O
managing	O
allergic	O
diseases	O
.	O

Atherosclerotic	O
vascular	O
disease	O
is	O
a	O
leading	O
cause	O
of	O
myocardial	O
infarction	O
and	O
cerebrovascular	O
accident	O
,	O
and	O
independent	O
associations	O
with	O
periodontal	O
disease	O
(	O
PD	O
)	O
are	O
reported	O
.	O

PD	O
is	O
caused	O
by	O
polymicrobial	O
infections	O
and	O
aggressive	O
immune	O
responses	O
.	O

Genomic	O
DNA	O
of	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
the	O
best	O
-	O
studied	O
bacterial	O
pathogen	O
associated	O
with	O
severe	O
PD	O
,	O
is	O
detected	O
within	O
atherosclerotic	O
plaque	O
.	O

We	O
examined	O
causal	O
relationships	O
between	O
chronic	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
oral	O
infection	O
,	O
PD	O
,	O
and	O
atherosclerosis	O
in	O
hyperlipidemic	O
ApoEnull	O
mice	O
.	O

ApoEnull	O
mice	O
(	O
n	O
=	O
24	O
)	O
were	O
orally	O
infected	O
with	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
for	O
12	O
and	O
24	O
weeks	O
.	O

PD	O
was	O
assessed	O
by	O
standard	O
clinical	O
measurements	O
while	O
the	O
aorta	O
was	O
examined	O
for	O
atherosclerotic	O
lesions	O
and	O
inflammatory	O
markers	O
by	O
array	O
.	O

Systemic	O
inflammatory	O
markers	O
serum	O
amyloid	O
A	O
,	O
nitric	O
oxide	O
,	O
and	O
oxidized	O
low	O
-	O
density	O
lipoprotein	O
were	O
analyzed	O
.	O

P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
infection	O
elicited	O
specific	O
antibodies	O
and	O
alveolar	O
bone	O
loss	O
.	O

Fluorescent	O
in	O
situ	O
hybridization	O
detected	O
viable	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
within	O
oral	O
epithelium	O
and	O
aorta	O
,	O
and	O
genomic	O
DNA	O
was	O
detected	O
within	O
systemic	O
organs	O
.	O

Aortic	O
plaque	O
area	O
was	O
significantly	O
increased	O
in	O
P	O
.	O
gingivalis	O
-	O
infected	O
mice	O
at	O
24	O
weeks	O
(	O
P	O
<	O
0	O
.	O
01	O
)	O
.	O

Aortic	O
RNA	O
and	O
protein	O
arrays	O
indicated	O
a	O
strong	O
Th2	O
response	O
.	O

Chronic	O
oral	O
infection	O
with	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
results	O
in	O
a	O
specific	O
immune	O
response	O
,	O
significant	O
increases	O
in	O
oral	O
bone	O
resorption	O
,	O
aortic	O
inflammation	O
,	O
viable	O
bacteria	O
in	O
oral	O
epithelium	O
and	O
aorta	O
,	O
and	O
plaque	O
development	O
.	O

Individual	O
bacteria	O
and	O
shifts	O
in	O
the	O
composition	O
of	O
the	O
microbiome	O
have	O
been	O
associated	O
with	O
human	O
diseases	O
including	O
cancer	O
.	O

To	O
investigate	O
changes	O
in	O
the	O
microbiome	O
associated	O
with	O
oral	O
cancers	O
,	O
we	O
profiled	O
cancers	O
and	O
anatomically	O
matched	O
contralateral	O
normal	O
tissue	O
from	O
the	O
same	O
patient	O
by	O
sequencing	O
16S	O
rDNA	O
hypervariable	O
region	O
amplicons	O
.	O

In	O
cancer	O
samples	O
from	O
both	O
a	O
discovery	O
and	O
a	O
subsequent	O
confirmation	O
cohort	O
,	O
abundance	O
of	O
Firmicutes	B-bacteria
(	O
especially	O
Streptococcus	B-bacteria
)	O
and	O
Actinobacteria	B-bacteria
(	O
especially	O
Rothia	B-bacteria
)	O
was	O
significantly	O
decreased	O
relative	O
to	O
contralateral	O
normal	O
samples	O
from	O
the	O
same	O
patient	O
.	O

Significant	O
decreases	O
in	O
abundance	O
of	O
these	O
phyla	O
were	O
observed	O
for	O
pre	O
-	O
cancers	O
,	O
but	O
not	O
when	O
comparing	O
samples	O
from	O
contralateral	O
sites	O
(	O
tongue	O
and	O
floor	O
of	O
mouth	O
)	O
from	O
healthy	O
individuals	O
.	O

Weighted	O
UniFrac	O
principal	O
coordinates	O
analysis	O
based	O
on	O
12	O
taxa	O
separated	O
most	O
cancers	O
from	O
other	O
samples	O
with	O
greatest	O
separation	O
of	O
node	O
positive	O
cases	O
.	O

These	O
studies	O
begin	O
to	O
develop	O
a	O
framework	O
for	O
exploiting	O
the	O
oral	O
microbiome	O
for	O
monitoring	O
oral	O
cancer	O
development	O
,	O
progression	O
and	O
recurrence	O
.	O

Fusobacterium	B-bacteria
nucleatum	I-bacteria
is	O
a	O
ubiquitous	O
member	O
of	O
the	O
human	O
oral	O
flora	O
and	O
is	O
associated	O
with	O
the	O
development	O
of	O
periodontitis	O
and	O
a	O
variety	O
of	O
other	O
types	O
of	O
polymicrobial	O
infections	O
of	O
the	O
mucosa	O
.	O

In	O
the	O
oral	O
cavity	O
,	O
this	O
species	O
is	O
one	O
of	O
the	O
few	O
that	O
is	O
prevalent	O
in	O
both	O
healthy	O
and	O
diseased	O
subgingival	O
plaque	O
.	O

Using	O
microarray	O
analysis	O
,	O
we	O
examined	O
the	O
transcriptional	O
response	O
of	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
subspecies	I-bacteria
nucleatum	I-bacteria
to	O
whole	O
blood	O
in	O
order	O
to	O
identify	O
some	O
of	O
the	O
genetic	O
responses	O
that	O
might	O
occur	O
during	O
the	O
transition	O
from	O
health	O
to	O
disease	O
.	O

From	O
these	O
studies	O
,	O
we	O
identified	O
a	O
sialic	O
acid	O
catabolism	O
operon	O
that	O
was	O
induced	O
by	O
the	O
presence	O
of	O
blood	O
.	O

We	O
subsequently	O
confirmed	O
that	O
this	O
operon	O
was	O
inducible	O
by	O
the	O
presence	O
of	O
synthetic	O
sialic	O
acid	O
,	O
but	O
we	O
found	O
no	O
evidence	O
suggesting	O
sialic	O
acid	O
was	O
used	O
as	O
a	O
major	O
carbon	O
source	O
.	O

However	O
,	O
this	O
organism	O
was	O
found	O
to	O
possess	O
a	O
de	O
novo	O
synthesized	O
surface	O
sialylation	O
ability	O
that	O
is	O
widely	O
conserved	O
among	O
the	O
various	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
subspecies	I-bacteria
as	O
well	O
as	O
in	O
F	B-bacteria
.	I-bacteria
periodonticum	I-bacteria
.	O

We	O
provide	O
evidence	O
that	O
fusobacterial	O
sialylation	O
does	O
occur	O
in	O
the	O
oral	O
cavity	O
irrespective	O
of	O
health	O
status	O
.	O

Interestingly	O
,	O
only	O
a	O
minority	O
of	O
fusobacterial	O
cells	O
exhibit	O
surface	O
sialylation	O
within	O
dental	O
plaque	O
,	O
whereas	O
most	O
cells	O
are	O
uniformly	O
sialylated	O
when	O
grown	O
in	O
pure	O
culture	O
.	O

The	O
implications	O
of	O
these	O
results	O
are	O
discussed	O
.	O

Many	O
viruses	O
,	O
fungi	O
and	O
bacteria	O
inhabit	O
the	O
mouth	O
.	O

Most	O
of	O
these	O
microorganisms	O
can	O
be	O
easily	O
cultured	O
and	O
identified	O
by	O
classical	O
microbiological	O
tests	O
,	O
but	O
some	O
of	O
them	O
,	O
such	O
as	O
human	O
papilloma	O
virus	O
,	O
can	O
only	O
be	O
identified	O
by	O
the	O
methods	O
of	O
molecular	O
biology	O
.	O

Some	O
microorganisms	O
are	O
present	O
in	O
a	O
very	O
small	O
amount	O
and	O
can	O
not	O
be	O
detected	O
by	O
classical	O
tests	O
;	O
therefore	O
,	O
in	O
this	O
case	O
,	O
molecular	O
diagnosis	O
is	O
also	O
a	O
logical	O
alternative	O
.	O

Molecular	O
biology	O
assays	O
are	O
sensitive	O
,	O
objective	O
,	O
easy	O
to	O
perform	O
and	O
less	O
demanding	O
than	O
conventional	O
microbiological	O
methods	O
in	O
terms	O
of	O
training	O
and	O
quality	O
assurance	O
.	O

This	O
paper	O
describes	O
the	O
molecular	O
methods	O
that	O
are	O
commonly	O
used	O
for	O
the	O
detection	O
of	O
microorganisms	O
that	O
colonize	O
the	O
oral	O
cavity	O
.	O

In	O
leukemia	O
,	O
oral	O
manifestations	O
indicate	O
aberrations	O
in	O
oral	O
microbiota	O
.	O

Microbiota	O
structure	O
is	O
determined	O
by	O
both	O
host	O
and	O
environmental	O
factors	O
.	O

In	O
human	O
hosts	O
,	O
how	O
health	O
status	O
shapes	O
the	O
composition	O
of	O
oral	O
microbiota	O
is	O
largely	O
unknown	O
.	O

Taking	O
advantage	O
of	O
advances	O
in	O
high	O
-	O
throughput	O
sequencing	O
,	O
we	O
compared	O
the	O
composition	O
of	O
supragingival	O
plaque	O
microbiota	O
of	O
acute	O
lymphoblastic	O
leukemia	O
(	O
ALL	O
)	O
pediatric	O
patients	O
with	O
healthy	O
controls	O
.	O

The	O
oral	O
microbiota	O
of	O
leukemia	O
patients	O
had	O
lower	O
richness	O
and	O
less	O
diversity	O
compared	O
to	O
healthy	O
controls	O
.	O

Microbial	O
samples	O
clustered	O
into	O
two	O
major	O
groups	O
,	O
one	O
of	O
ALL	O
patients	O
and	O
another	O
of	O
healthy	O
children	O
,	O
with	O
different	O
structure	O
and	O
composition	O
.	O

Abundance	O
changes	O
of	O
certain	O
taxa	O
including	O
the	O
Phylum	O
Firmicutes	B-bacteria
,	O
the	O
Class	O
Bacilli	B-bacteria
,	O
the	O
Order	O
Lactobacillales	B-bacteria
,	O
the	O
Family	O
Aerococcaceae	B-bacteria
and	O
Carnobacteriaceae	B-bacteria
,	O
as	O
well	O
as	O
the	O
Genus	O
Abiotrophia	B-bacteria
and	O
Granulicatella	B-bacteria
were	O
associated	O
with	O
leukemia	O
status	O
.	O

ALL	O
patients	O
demonstrated	O
a	O
structural	O
imbalance	O
of	O
the	O
oral	O
microbiota	O
,	O
characterized	O
by	O
reduced	O
diversity	O
and	O
abundance	O
alterations	O
,	O
possibly	O
involved	O
in	O
systemic	O
infections	O
,	O
indicating	O
the	O
importance	O
of	O
immune	O
status	O
in	O
shaping	O
the	O
structure	O
of	O
oral	O
microbiota	O
.	O

Nature	O
is	O
an	O
unexplored	O
reservoir	O
of	O
novel	O
phytopharmaceuticals	O
.	O

Since	O
biofilm	O
-	O
related	O
oral	O
diseases	O
often	O
correlate	O
with	O
antibiotic	O
resistance	O
,	O
plant	O
-	O
derived	O
antimicrobial	O
agents	O
could	O
enhance	O
existing	O
treatment	O
options	O
.	O

Therefore	O
,	O
the	O
rationale	O
of	O
the	O
present	O
report	O
was	O
to	O
examine	O
the	O
antimicrobial	O
impact	O
of	O
Mediterranean	O
natural	O
extracts	O
on	O
oral	O
microorganisms	O
.	O

Five	O
different	O
extracts	O
from	O
Olea	O
europaea	O
,	O
mastic	O
gum	O
,	O
and	O
Inula	O
viscosa	O
were	O
tested	O
against	O
ten	O
bacteria	O
and	O
one	O
Candida	O
albicans	O
strain	O
.	O

The	O
extraction	O
protocols	O
were	O
conducted	O
according	O
to	O
established	O
experimental	O
procedures	O
.	O

Two	O
antimicrobial	O
assays	O
-	O
-	O
the	O
minimum	O
inhibitory	O
concentration	O
(	O
MIC	O
)	O
assay	O
and	O
the	O
minimum	O
bactericidal	O
concentration	O
(	O
MBC	O
)	O
assay	O
-	O
-	O
were	O
applied	O
.	O

The	O
screened	O
extracts	O
were	O
found	O
to	O
be	O
active	O
against	O
each	O
of	O
the	O
tested	O
microorganisms	O
.	O

O	O
.	O
europaea	O
presented	O
MIC	O
and	O
MBC	O
ranges	O
of	O
0	O
.	O
07	O
-	O
10	O
.	O
00	O
mg	O
mL	O
(	O
-	O
1	O
)	O
and	O
0	O
.	O
60	O
-	O
10	O
.	O
00	O
mg	O
mL	O
(	O
-	O
1	O
)	O
,	O
respectively	O
.	O

The	O
mean	O
MBC	O
values	O
for	O
mastic	O
gum	O
and	O
I	O
.	O
viscosa	O
were	O
0	O
.	O
07	O
-	O
10	O
.	O
00	O
mg	O
mL	O
(	O
-	O
1	O
)	O
and	O
0	O
.	O
15	O
-	O
10	O
.	O
00	O
mg	O
mL	O
(	O
-	O
1	O
)	O
,	O
respectively	O
.	O

Extracts	O
were	O
less	O
effective	O
against	O
C	O
.	O
albicans	O
and	O
exerted	O
bactericidal	O
effects	O
at	O
a	O
concentration	O
range	O
of	O
0	O
.	O
07	O
-	O
5	O
.	O
00	O
mg	O
mL	O
(	O
-	O
1	O
)	O
on	O
strict	O
anaerobic	O
bacteria	O
(	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
and	O
Parvimonas	B-bacteria
micra	I-bacteria
)	O
.	O

Ethyl	O
acetate	O
I	O
.	O
viscosa	O
extract	O
and	O
total	O
mastic	O
extract	O
showed	O
considerable	O
antimicrobial	O
activity	O
against	O
oral	O
microorganisms	O
and	O
could	O
therefore	O
be	O
considered	O
as	O
alternative	O
natural	O
anti	O
-	O
infectious	O
agents	O
.	O

Oral	O
bacteria	O
live	O
in	O
symbiosis	O
with	O
the	O
host	O
.	O

Therefore	O
,	O
when	O
mouthwashes	O
are	O
indicated	O
,	O
selective	O
inhibition	O
of	O
taxa	O
contributing	O
to	O
disease	O
is	O
preferred	O
instead	O
of	O
broad	O
-	O
spectrum	O
antimicrobials	O
.	O

The	O
potential	O
selectivity	O
of	O
an	O
oxygenating	O
mouthwash	O
,	O
Ardox	O
-	O
X	O
(	O
R	O
)	O
(	O
AX	O
)	O
,	O
has	O
not	O
been	O
assessed	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
antimicrobial	O
potential	O
of	O
AX	O
and	O
the	O
effects	O
of	O
a	O
twice	O
-	O
daily	O
oral	O
rinse	O
on	O
dental	O
plaque	O
composition	O
.	O

In	O
vitro	O
,	O
16	O
oral	O
bacterial	O
strains	O
were	O
tested	O
using	O
agar	O
diffusion	O
susceptibility	O
,	O
minimum	O
inhibitory	O
and	O
minimum	O
bactericidal	O
concentration	O
tests	O
.	O

A	O
pilot	O
clinical	O
study	O
was	O
performed	O
with	O
25	O
healthy	O
volunteers	O
.	O

Clinical	O
assessments	O
and	O
microbiological	O
sampling	O
of	O
supragingival	O
plaque	O
were	O
performed	O
at	O
1	O
month	O
before	O
the	O
experiment	O
(	O
Pre	O
-	O
exp	O
)	O
,	O
at	O
the	O
start	O
of	O
the	O
experiment	O
(	O
Baseline	O
)	O
and	O
after	O
the	O
one	O
-	O
week	O
experimental	O
period	O
(	O
Post	O
-	O
exp	O
)	O
.	O

During	O
the	O
experiment	O
individuals	O
used	O
AX	O
mouthwash	O
twice	O
daily	O
in	O
absence	O
of	O
other	O
oral	O
hygiene	O
measures	O
.	O

The	O
microbiological	O
composition	O
of	O
plaque	O
was	O
assessed	O
by	O
16S	O
rRNA	O
gene	O
amplicon	O
sequencing	O
.	O

AX	O
showed	O
high	O
inter	O
-	O
species	O
variation	O
in	O
microbial	O
growth	O
inhibition	O
.	O

The	O
tested	O
Prevotella	B-bacteria
strains	I-bacteria
and	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
showed	O
the	O
highest	O
sensitivity	O
,	O
while	O
streptococci	B-bacteria
and	O
Lactobacillus	B-bacteria
acidophilus	I-bacteria
were	O
most	O
resistant	O
to	O
AX	O
.	O

Plaque	O
scores	O
at	O
Pre	O
-	O
exp	O
and	O
Baseline	O
visits	O
did	O
not	O
differ	O
significantly	O
(	O
p	O
=	O
0	O
.	O
193	O
)	O
,	O
nor	O
did	O
the	O
microbial	O
composition	O
of	O
plaque	O
.	O

During	O
a	O
period	O
of	O
7	O
-	O
days	O
non	O
-	O
brushing	O
but	O
twice	O
daily	O
rinsing	O
plaque	O
scores	O
increased	O
from	O
2	O
.	O
21	O
(	O
0	O
.	O
31	O
)	O
at	O
Baseline	O
to	O
2	O
.	O
43	O
(	O
0	O
.	O
39	O
)	O
Post	O
-	O
exp	O
.	O

A	O
significant	O
microbial	O
shift	O
in	O
composition	O
was	O
observed	O
:	O
genus	O
Streptococcus	B-bacteria
and	O
Veillonella	B-bacteria
increased	O
while	O
Corynebacterium	B-bacteria
,	O
Haemophilus	B-bacteria
,	O
Leptotrichia	B-bacteria
,	O
Cardiobacterium	B-bacteria
and	O
Capnocytophaga	B-bacteria
decreased	O
(	O
p	O
<	O
/	O
=	O
0	O
.	O
001	O
)	O
.	O

AX	O
has	O
the	O
potential	O
for	O
selective	O
inhibition	O
of	O
oral	O
bacteria	O
.	O

The	O
shift	O
in	O
oral	O
microbiome	O
after	O
1	O
week	O
of	O
rinsing	O
deserves	O
further	O
research	O
.	O

Sharks	O
possess	O
a	O
variety	O
of	O
pathogenic	O
bacteria	O
in	O
their	O
oral	O
cavity	O
that	O
may	O
potentially	O
be	O
transferred	O
into	O
humans	O
during	O
a	O
bite	O
.	O

The	O
aim	O
of	O
the	O
presented	O
study	O
focused	O
on	O
the	O
identification	O
of	O
the	O
bacteria	O
present	O
in	O
the	O
mouths	O
of	O
live	O
blacktip	O
sharks	O
,	O
Carcharhinus	O
limbatus	O
,	O
and	O
the	O
extent	O
that	O
these	O
bacteria	O
possess	O
multi	O
-	O
drug	O
resistance	O
.	O

Swabs	O
were	O
taken	O
from	O
the	O
oral	O
cavity	O
of	O
nineteen	O
live	O
blacktip	O
sharks	O
,	O
which	O
were	O
subsequently	O
released	O
.	O

The	O
average	O
fork	O
length	O
was	O
146	O
cm	O
(	O
+	O
/	O
-	O
11	O
)	O
,	O
suggesting	O
the	O
blacktip	O
sharks	O
were	O
mature	O
adults	O
at	O
least	O
8	O
years	O
old	O
.	O

All	O
swabs	O
underwent	O
standard	O
microbiological	O
work	O
-	O
up	O
with	O
identification	O
of	O
organisms	O
and	O
reporting	O
of	O
antibiotic	O
susceptibilities	O
using	O
an	O
automated	O
microbiology	O
system	O
.	O

The	O
oral	O
samples	O
revealed	O
an	O
average	O
of	O
2	O
.	O
72	O
(	O
+	O
/	O
-	O
1	O
.	O
4	O
)	O
bacterial	O
isolates	O
per	O
shark	O
.	O

Gram	O
-	O
negative	O
bacteria	O
,	O
making	O
up	O
61	O
%	O
of	O
all	O
bacterial	O
isolates	O
,	O
were	O
significantly	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
more	O
common	O
than	O
gram	O
-	O
positive	O
bacteria	O
(	O
39	O
%	O
)	O
.	O

The	O
most	O
common	O
organisms	O
were	O
Vibrio	B-bacteria
spp	I-bacteria
.	I-bacteria
(	O
28	O
%	O
)	O
,	O
various	O
coagulase	B-bacteria
-	I-bacteria
negative	I-bacteria
Staphylococcus	I-bacteria
spp	I-bacteria
.	I-bacteria
(	O
16	O
%	O
)	O
,	O
and	O
Pasteurella	B-bacteria
spp	I-bacteria
.	I-bacteria
(	O
12	O
%	O
)	O
.	O

The	O
overall	O
resistance	O
rate	O
was	O
12	O
%	O
for	O
all	O
antibiotics	O
tested	O
with	O
nearly	O
43	O
%	O
of	O
bacteria	O
resistant	O
to	O
at	O
least	O
one	O
antibiotic	O
.	O

Multi	O
-	O
drug	O
resistance	O
was	O
seen	O
in	O
4	O
%	O
of	O
bacteria	O
.	O

No	O
association	O
between	O
shark	O
gender	O
or	O
fork	O
length	O
with	O
bacterial	O
density	O
or	O
antibiotic	O
resistance	O
was	O
observed	O
.	O

Antibiotics	O
with	O
the	O
highest	O
overall	O
susceptibility	O
rates	O
included	O
fluoroquinolones	O
,	O
3rd	O
generation	O
cephalosporins	O
and	O
sulfamethoxazole	O
/	O
trimethoprim	O
.	O

Recommended	O
empiric	O
antimicrobial	O
therapy	O
for	O
adult	O
blacktip	O
shark	O
bites	O
should	O
encompass	O
either	O
a	O
fluoroquinolone	O
or	O
combination	O
of	O
a	O
3rd	O
generation	O
cephalosporin	O
plus	O
doxycycline	O
.	O

Dental	O
caries	O
is	O
one	O
of	O
the	O
most	O
common	O
chronic	O
and	O
multifactorial	O
diseases	O
affecting	O
the	O
human	O
population	O
.	O

The	O
appearance	O
of	O
a	O
caries	O
lesion	O
is	O
determined	O
by	O
the	O
coexistence	O
of	O
three	O
main	O
factors	O
:	O
acidogenic	O
and	O
acidophilic	O
microorganisms	O
,	O
carbohydrates	O
derived	O
from	O
the	O
diet	O
,	O
and	O
host	O
factors	O
.	O

Socio	O
-	O
economic	O
and	O
behavioral	O
factors	O
also	O
play	O
an	O
important	O
role	O
in	O
the	O
etiology	O
of	O
the	O
disease	O
.	O

Caries	O
develops	O
as	O
a	O
result	O
of	O
an	O
ecological	O
imbalance	O
in	O
the	O
stable	O
oral	O
microbiom	O
.	O

Oral	O
microorganisms	O
form	O
dental	O
plaque	O
on	O
the	O
surfaces	O
of	O
teeth	O
,	O
which	O
is	O
the	O
cause	O
of	O
the	O
caries	O
process	O
,	O
and	O
shows	O
features	O
of	O
the	O
classic	O
biofilm	O
.	O

Biofilm	O
formation	O
appears	O
to	O
be	O
influenced	O
by	O
large	O
scale	O
changes	O
in	O
protein	O
expression	O
over	O
time	O
and	O
under	O
genetic	O
control	O
Cariogenic	O
microorganisms	O
produce	O
lactic	O
,	O
formic	O
,	O
acetic	O
and	O
propionic	O
acids	O
,	O
which	O
are	O
a	O
product	O
of	O
carbohydrate	O
metabolism	O
.	O

Their	O
presence	O
causes	O
a	O
decrease	O
in	O
pH	O
level	O
below	O
5	O
.	O
5	O
,	O
resulting	O
in	O
demineralization	O
of	O
enamel	O
hydroxyapatite	O
crystals	O
and	O
proteolytic	O
breakdown	O
of	O
the	O
structure	O
of	O
tooth	O
hard	O
tissues	O
.	O

Streptococcus	B-bacteria
mutans	I-bacteria
,	O
other	O
streptococci	B-bacteria
of	O
the	O
so	O
-	O
called	O
non	B-bacteria
-	I-bacteria
mutans	I-bacteria
streptococci	I-bacteria
group	O
,	O
Actinomyces	B-bacteria
and	O
Lactobacillus	B-bacteria
play	O
a	O
key	O
role	O
in	O
this	O
process	O
.	O

Dental	O
biofilm	O
is	O
a	O
dynamic	O
,	O
constantly	O
active	O
metabolically	O
structure	O
.	O

The	O
alternating	O
processes	O
of	O
decrease	O
and	O
increase	O
of	O
biofilm	O
pH	O
occur	O
,	O
which	O
are	O
followed	O
by	O
the	O
respective	O
processes	O
of	O
de	O
-	O
and	O
remineralisation	O
of	O
the	O
tooth	O
surface	O
.	O

In	O
healthy	O
conditions	O
,	O
these	O
processes	O
are	O
in	O
balance	O
and	O
no	O
permanent	O
damage	O
to	O
the	O
tooth	O
enamel	O
surface	O
occurs	O
.	O

High	O
throughput	O
sequencing	O
has	O
accelerated	O
knowledge	O
on	O
the	O
oral	O
microbiome	O
.	O

While	O
the	O
bacterial	O
component	O
of	O
oral	O
communities	O
has	O
been	O
extensively	O
characterized	O
,	O
the	O
role	O
of	O
the	O
fungal	O
microbiota	O
in	O
the	O
oral	O
cavity	O
is	O
largely	O
unknown	O
.	O

Interactions	O
among	O
fungi	O
and	O
bacteria	O
are	O
likely	O
to	O
influence	O
oral	O
health	O
as	O
exemplified	O
by	O
the	O
synergistic	O
relationship	O
between	O
Candida	O
albicans	O
and	O
oral	O
streptococci	B-bacteria
.	O

In	O
this	O
perspective	O
,	O
we	O
discuss	O
the	O
current	O
state	O
of	O
the	O
field	O
of	O
fungal	O
-	O
bacterial	O
interactions	O
in	O
the	O
context	O
of	O
the	O
oral	O
cavity	O
.	O

We	O
highlight	O
the	O
need	O
to	O
conduct	O
longitudinal	O
clinical	O
studies	O
to	O
simultaneously	O
characterize	O
the	O
bacterial	O
and	O
fungal	O
components	O
of	O
the	O
human	O
oral	O
microbiome	O
in	O
health	O
and	O
during	O
disease	O
progression	O
.	O

Such	O
studies	O
need	O
to	O
be	O
coupled	O
with	O
investigations	O
using	O
disease	O
-	O
relevant	O
models	O
to	O
mechanistically	O
test	O
the	O
associations	O
observed	O
in	O
humans	O
and	O
eventually	O
identify	O
fungal	O
-	O
bacterial	O
interactions	O
that	O
could	O
serve	O
as	O
preventive	O
or	O
therapeutic	O
targets	O
for	O
oral	O
diseases	O
.	O

Antrodia	O
camphorata	O
(	O
A	O
.	O
camphorata	O
)	O
is	O
a	O
unique	O
,	O
endemic	O
and	O
extremely	O
rare	O
mushroom	O
species	O
native	O
to	O
Taiwan	O
,	O
and	O
both	O
crude	O
extracts	O
of	O
and	O
purified	O
chemical	O
compounds	O
from	O
A	O
.	O
camphorata	O
have	O
been	O
reported	O
to	O
have	O
a	O
variety	O
of	O
significant	O
beneficial	O
effects	O
,	O
such	O
as	O
anti	O
-	O
tumor	O
and	O
anti	O
-	O
inflammatory	O
activity	O
.	O

However	O
,	O
reports	O
on	O
the	O
effects	O
of	O
A	O
.	O
camphorata	O
against	O
dental	O
pathogens	O
have	O
been	O
limited	O
.	O

Oral	O
health	O
is	O
now	O
recognized	O
as	O
important	O
for	O
overall	O
general	O
health	O
,	O
including	O
conditions	O
such	O
as	O
dental	O
caries	O
,	O
periodontal	O
disease	O
and	O
rheumatoid	O
arthritis	O
.	O

Streptococcus	B-bacteria
mutans	I-bacteria
(	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
)	O
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
(	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
)	O
are	O
the	O
most	O
common	O
bacteria	O
associated	O
with	O
dental	O
plaque	O
and	O
periodontopathic	O
diseases	O
,	O
respectively	O
.	O

Thus	O
,	O
our	O
study	O
examined	O
the	O
ability	O
of	O
five	O
various	O
crude	O
extracts	O
of	O
A	O
.	O
camphorata	O
to	O
inhibit	O
the	O
growth	O
of	O
dental	O
bacteria	O
and	O
anti	O
-	O
adherence	O
in	O
vitro	O
.	O

Among	O
the	O
extracts	O
,	O
the	O
ethanol	O
,	O
ethyl	O
acetate	O
and	O
chloroform	O
extracts	O
exhibited	O
the	O
lowest	O
MICs	O
against	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
(	O
MIC	O
=	O
4	O
approximately	O
16	O
microg	O
/	O
mL	O
)	O
.	O

The	O
MIC	O
of	O
the	O
aqueous	O
extract	O
was	O
greater	O
than	O
2048	O
microg	O
/	O
mL	O
against	O
both	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

In	O
vitro	O
adherence	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
was	O
significantly	O
inhibited	O
by	O
the	O
addition	O
of	O
either	O
the	O
ethyl	O
acetate	O
extract	O
or	O
chloroform	O
extract	O
(	O
MIC	O
=	O
16	O
approximately	O
24	O
microg	O
/	O
mL	O
)	O
,	O
while	O
the	O
ethanol	O
extract	O
(	O
MIC	O
=	O
32	O
approximately	O
64	O
microg	O
/	O
mL	O
)	O
exhibited	O
moderate	O
inhibitory	O
activity	O
.	O

Based	O
on	O
the	O
result	O
of	O
this	O
study	O
,	O
the	O
ethyl	O
acetate	O
and	O
chloroform	O
extracts	O
of	O
A	O
.	O
camphorata	O
may	O
be	O
good	O
candidates	O
for	O
oral	O
hygiene	O
agents	O
to	O
control	O
dental	O
caries	O
and	O
periodontopathic	O
conditions	O
.	O

Chlorhexidine	O
(	O
CHX	O
)	O
is	O
a	O
widely	O
used	O
antimicrobial	O
agent	O
in	O
dentistry	O
.	O

Herein	O
,	O
we	O
report	O
the	O
synthesis	O
of	O
a	O
novel	O
mesoporous	O
silica	O
nanoparticle	O
-	O
encapsulated	O
pure	O
CHX	O
(	O
Nano	O
-	O
CHX	O
)	O
,	O
and	O
its	O
mechanical	O
profile	O
and	O
antimicrobial	O
properties	O
against	O
oral	O
biofilms	O
.	O

The	O
release	O
of	O
CHX	O
from	O
the	O
Nano	O
-	O
CHX	O
was	O
characterized	O
by	O
UV	O
/	O
visible	O
absorption	O
spectroscopy	O
.	O

The	O
antimicrobial	O
properties	O
of	O
Nano	O
-	O
CHX	O
were	O
evaluated	O
in	O
both	O
planktonic	O
and	O
biofilm	O
modes	O
of	O
representative	O
oral	O
pathogenic	O
bacteria	O
.	O

The	O
Nano	O
-	O
CHX	O
demonstrated	O
potent	O
antibacterial	O
effects	O
on	O
planktonic	O
bacteria	O
and	O
mono	O
-	O
species	O
biofilms	O
at	O
the	O
concentrations	O
of	O
50	O
-	O
200	O
microg	O
/	O
mL	O
against	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Streptococcus	B-bacteria
sobrinus	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
and	O
Enterococccus	B-bacteria
faecalis	I-bacteria
.	O

Moreover	O
,	O
Nano	O
-	O
CHX	O
effectively	O
suppressed	O
multi	O
-	O
species	O
biofilms	O
such	O
as	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
,	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
up	O
to	O
72	O
h	O
.	O
This	O
pioneering	O
study	O
demonstrates	O
the	O
potent	O
antibacterial	O
effects	O
of	O
the	O
Nano	O
-	O
CHX	O
on	O
oral	O
biofilms	O
,	O
and	O
it	O
may	O
be	O
developed	O
as	O
a	O
novel	O
and	O
promising	O
anti	O
-	O
biofilm	O
agent	O
for	O
clinical	O
use	O
.	O

The	O
prevalence	O
of	O
infections	O
caused	O
by	O
Cefotaximase	O
-	O
Munich	O
(	O
CTX	O
-	O
M	O
)	O
-	O
type	O
extended	B-bacteria
-	I-bacteria
spectrum	I-bacteria
beta	I-bacteria
-	I-bacteria
lactamase	I-bacteria
-	I-bacteria
producing	I-bacteria
Enterobacteriaceae	I-bacteria
(	O
ESBL	B-bacteria
-	I-bacteria
E	I-bacteria
)	O
has	O
rapidly	O
increased	O
during	O
the	O
past	O
15	O
years	O
.	O

Enterobacteriaceae	B-bacteria
are	O
commonly	O
found	O
in	O
the	O
gastrointestinal	O
tract	O
and	O
long	O
-	O
term	O
intestinal	O
carriage	O
is	O
considered	O
important	O
for	O
the	O
spread	O
of	O
ESBL	B-bacteria
and	O
as	O
a	O
source	O
of	O
clinical	O
infections	O
.	O

Oral	O
biofilm	O
such	O
as	O
supragingival	O
plaque	O
is	O
known	O
to	O
contain	O
numerous	O
antibiotic	O
resistance	O
determinants	O
and	O
may	O
also	O
represent	O
a	O
poorly	O
investigated	O
site	O
for	O
ESBL	B-bacteria
carriage	O
and	O
further	O
spread	O
.	O

To	O
investigate	O
possible	O
carriage	O
of	O
ESBL	O
-	O
producing	O
bacteria	O
in	O
supragingival	O
plaque	O
of	O
known	O
fecal	O
carriers	O
of	O
these	O
bacteria	O
.	O

We	O
screened	O
for	O
the	O
presence	O
of	O
aerobic	O
and	O
anaerobic	O
ESBL	O
-	O
producing	O
bacteria	O
and	O
bla	O
CTX	O
-	O
M	O
in	O
supragingival	O
plaque	O
samples	O
from	O
healthy	O
human	O
adults	O
with	O
culture	O
-	O
verified	O
fecal	O
carriage	O
of	O
CTX	O
-	O
M	O
-	O
producing	O
Escherichia	B-bacteria
coli	I-bacteria
.	O

The	O
presence	O
or	O
absence	O
of	O
Enterobacteriaceae	B-bacteria
and	O
ESBL	O
-	O
producing	O
bacteria	O
in	O
plaque	O
samples	O
was	O
evaluated	O
using	O
culture	O
-	O
based	O
methods	O
and	O
consensus	O
CTX	O
-	O
M	O
PCR	O
.	O

Oral	O
samples	O
were	O
obtained	O
from	O
17	O
participants	O
with	O
known	O
previous	O
carriage	O
of	O
ESBL	B-bacteria
-	I-bacteria
producing	I-bacteria
E	I-bacteria
.	I-bacteria
coli	I-bacteria
.	O

No	O
ESBL	O
-	O
producing	O
bacteria	O
or	O
ESBL	O
genes	O
were	O
detected	O
using	O
culture	O
-	O
based	O
and	O
molecular	O
methods	O
.	O

One	O
colony	O
of	O
Rahnella	B-bacteria
aquatilis	I-bacteria
harboring	O
the	O
class	O
A	O
ESBL	O
gene	O
bla	O
RAHN	O
-	O
1	O
/	O
2	O
was	O
identified	O
in	O
an	O
oral	O
sample	O
from	O
one	O
of	O
the	O
participants	O
.	O

This	O
pilot	O
study	O
supports	O
the	O
notion	O
that	O
the	O
presence	O
of	O
CTX	O
-	O
M	O
-	O
producing	O
bacteria	O
is	O
uncommon	O
in	O
oral	O
plaque	O
of	O
healthy	O
human	O
adult	O
fecal	O
carriers	O
.	O

Due	O
to	O
the	O
limited	O
number	O
of	O
persons	O
tested	O
,	O
a	O
low	O
prevalence	O
of	O
oral	O
ESBL	O
-	O
carriage	O
in	O
healthy	O
adults	O
or	O
carriage	O
in	O
selected	O
groups	O
of	O
patients	O
can	O
not	O
be	O
excluded	O
.	O

To	O
our	O
knowledge	O
,	O
this	O
is	O
the	O
first	O
description	O
of	O
an	O
R	B-bacteria
.	I-bacteria
aquatilis	I-bacteria
with	O
the	O
RAHN	O
-	O
1	O
/	O
2	O
gene	O
in	O
the	O
oral	O
cavity	O
.	O

Microorganisms	O
interact	O
with	O
each	O
other	O
within	O
a	O
community	O
.	O

Within	O
the	O
same	O
community	O
,	O
some	O
microorganisms	O
tend	O
to	O
co	O
-	O
exist	O
,	O
whereas	O
some	O
others	O
tend	O
to	O
avoid	O
each	O
other	O
.	O

The	O
association	O
among	O
microorganisms	O
can	O
be	O
revealed	O
by	O
computing	O
the	O
correlation	O
between	O
their	O
abundance	O
patterns	O
that	O
are	O
measured	O
through	O
metagenomic	O
sequencing	O
across	O
multiple	O
communities	O
.	O

In	O
this	O
paper	O
,	O
we	O
built	O
an	O
association	O
network	O
among	O
microorganisms	O
from	O
the	O
human	O
oral	O
microbiome	O
.	O

To	O
improve	O
its	O
accuracy	O
,	O
we	O
adopted	O
a	O
network	O
deconvolution	O
algorithm	O
to	O
filter	O
out	O
indirect	O
associations	O
,	O
and	O
we	O
used	O
an	O
ensemble	O
of	O
three	O
correlation	O
measures	O
to	O
filter	O
out	O
the	O
false	O
-	O
positive	O
associations	O
.	O

When	O
applying	O
on	O
the	O
metagenomic	O
data	O
from	O
human	O
oral	O
samples	O
,	O
experimental	O
results	O
showed	O
that	O
phylogenetically	O
close	O
microorganisms	O
formed	O
highly	O
correlated	O
network	O
clusters	O
.	O

Additionally	O
,	O
most	O
of	O
the	O
identified	O
mutually	O
exclusive	O
associations	O
were	O
related	O
to	O
the	O
order	O
Lactobacillales	B-bacteria
.	O

Polycystic	O
ovary	O
syndrome	O
(	O
PCOS	O
)	O
is	O
a	O
hormonal	O
disorder	O
of	O
women	O
that	O
not	O
only	O
is	O
the	O
leading	O
cause	O
of	O
infertility	O
but	O
also	O
shows	O
a	O
reciprocal	O
link	O
with	O
oral	O
health	O
.	O

This	O
study	O
aimed	O
to	O
investigate	O
the	O
hypothesis	O
that	O
the	O
levels	O
of	O
putative	O
periodontal	O
pathogens	O
in	O
saliva	O
and	O
their	O
antibody	O
response	O
in	O
serum	O
are	O
elevated	O
in	O
PCOS	O
,	O
compared	O
to	O
systemic	O
health	O
.	O

A	O
total	O
of	O
125	O
women	O
were	O
included	O
in	O
four	O
groups	O
;	O
45	O
women	O
with	O
PCOS	O
and	O
healthy	O
periodontium	O
,	O
35	O
women	O
with	O
PCOS	O
and	O
gingivitis	O
,	O
25	O
systemically	O
and	O
periodontally	O
healthy	O
women	O
,	O
20	O
systemically	O
healthy	O
women	O
with	O
gingivitis	O
.	O

Salivary	O
levels	O
of	O
seven	O
putative	O
periodontal	O
pathogens	O
were	O
analyzed	O
by	O
quantitative	O
real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
and	O
serum	O
antibody	O
levels	O
were	O
analyzed	O
by	O
ELISA	O
.	O

In	O
women	O
with	O
PCOS	O
,	O
salivary	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
Streptococcus	B-bacteria
oralis	I-bacteria
and	O
Tannerella	B-bacteria
forsythia	I-bacteria
levels	O
were	O
higher	O
than	O
matched	O
systemically	O
healthy	O
women	O
,	O
particularly	O
in	O
the	O
case	O
of	O
gingivitis	O
.	O

Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
and	O
Treponema	B-bacteria
denticola	I-bacteria
levels	O
were	O
similar	O
among	O
study	O
groups	O
.	O

The	O
presence	O
of	O
PCOS	O
also	O
enhanced	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
oralis	I-bacteria
serum	O
antibody	O
levels	O
,	O
when	O
gingivitis	O
was	O
also	O
present	O
.	O

Gingival	O
inflammation	O
correlated	O
positively	O
with	O
levels	O
of	O
the	O
studied	O
taxa	O
in	O
saliva	O
,	O
particularly	O
in	O
PCOS	O
.	O

The	O
presence	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
and	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
in	O
saliva	O
also	O
exhibited	O
a	O
strong	O
positive	O
correlation	O
with	O
the	O
corresponding	O
serum	O
antibody	O
levels	O
.	O

In	O
conclusion	O
,	O
as	O
an	O
underlying	O
systemic	O
endocrine	O
condition	O
,	O
PCOS	O
may	O
quantitatively	O
affect	O
the	O
composition	O
of	O
oral	O
microbiota	O
and	O
the	O
raised	O
systemic	O
response	O
to	O
selective	O
members	O
of	O
this	O
microbial	O
community	O
,	O
exerting	O
a	O
confounding	O
role	O
in	O
resultant	O
gingival	O
inflammation	O
and	O
periodontal	O
health	O
.	O

The	O
most	O
consistent	O
effect	O
appeared	O
to	O
be	O
exerted	O
on	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
.	O

Honey	O
is	O
an	O
ancient	O
natural	O
remedy	O
for	O
the	O
treatment	O
of	O
infected	O
wounds	O
.	O

It	O
has	O
regained	O
attention	O
in	O
the	O
medical	O
profession	O
,	O
as	O
it	O
has	O
recently	O
been	O
reported	O
to	O
have	O
a	O
broad	O
-	O
spectrum	O
inhibitory	O
effect	O
against	O
bacteria	O
.	O

Data	O
concerning	O
Manuka	O
honey	O
of	O
New	O
Zealand	O
origin	O
,	O
which	O
is	O
claimed	O
to	O
provide	O
additional	O
non	O
-	O
peroxide	O
antimicrobial	O
activity	O
(	O
so	O
-	O
called	O
standard	O
NPA	O
)	O
against	O
oral	O
pathogens	O
,	O
is	O
still	O
scarce	O
.	O

Therefore	O
,	O
this	O
study	O
aimed	O
to	O
screen	O
for	O
the	O
antibacterial	O
efficacy	O
of	O
different	O
Manuka	O
honey	O
products	O
against	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
(	O
OMZ	B-bacteria
918	I-bacteria
)	O
,	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
(	O
OMZ	B-bacteria
925	I-bacteria
)	O
and	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
(	O
OMZ	B-bacteria
299	I-bacteria
)	O
.	O

Chlorhexidine	O
and	O
saline	O
served	O
as	O
positive	O
and	O
negative	O
controls	O
,	O
respectively	O
,	O
whereas	O
a	O
Swiss	O
multifloral	O
honey	O
served	O
as	O
control	O
honey	O
without	O
intrinsic	O
non	O
-	O
peroxide	O
activity	O
.	O

Chlorhexidine	O
showed	O
the	O
highest	O
inhibiting	O
potential	O
against	O
all	O
specimens	O
tested	O
.	O

Manuka	O
honey	O
below	O
an	O
NPA	O
value	O
of	O
15	O
showed	O
the	O
least	O
bacterial	O
growth	O
-	O
inhibiting	O
potential	O
,	O
even	O
less	O
although	O
not	O
significantly	O
so	O
than	O
multifloral	O
Swiss	O
honey	O
.	O

Manuka	O
honey	O
above	O
an	O
NPA	O
value	O
of	O
15	O
showed	O
a	O
significantly	O
higher	O
antibacterial	O
effect	O
compared	O
to	O
the	O
other	O
honeys	O
tested	O
.	O

All	O
Manuka	O
honey	O
preparations	O
were	O
more	O
effective	O
in	O
inhibiting	O
the	O
growth	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
and	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
,	O
rather	O
than	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

In	O
conclusion	O
,	O
the	O
study	O
showed	O
an	O
NPA	O
dose	O
-	O
dependent	O
antibacterial	O
efficacy	O
of	O
Manuka	O
honey	O
.	O

Further	O
investigations	O
of	O
this	O
natural	O
product	O
are	O
now	O
open	O
for	O
scrutiny	O
.	O

A	O
complex	O
of	O
species	O
has	O
been	O
associated	O
with	O
dental	O
caries	O
under	O
the	O
ecological	O
hypothesis	O
.	O

This	O
study	O
aimed	O
to	O
develop	O
a	O
rapid	O
,	O
sensitive	O
PCR	O
-	O
dipstick	O
DNA	O
chromatography	O
assay	O
that	O
could	O
be	O
read	O
by	O
eye	O
for	O
multiplex	O
and	O
semiquantitative	O
analysis	O
of	O
plaque	O
bacteria	O
.	O

Parallel	O
oligonucleotides	O
were	O
immobilized	O
on	O
a	O
dipstick	O
strip	O
for	O
multiplex	O
analysis	O
of	O
target	O
DNA	O
sequences	O
of	O
the	O
caries	O
-	O
associated	O
bacteria	O
,	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Streptococcus	B-bacteria
sobrinus	I-bacteria
,	O
Scardovia	B-bacteria
wiggsiae	I-bacteria
,	O
Actinomyces	B-bacteria
species	I-bacteria
,	O
and	O
Veillonella	B-bacteria
parvula	I-bacteria
.	O

Streptavidin	O
-	O
coated	O
blue	O
-	O
colored	O
latex	O
microspheres	O
were	O
to	O
generate	O
signal	O
.	O

Target	O
DNA	O
amplicons	O
with	O
an	O
oligonucleotide	O
-	O
tagged	O
terminus	O
and	O
a	O
biotinylated	O
terminus	O
were	O
coupled	O
with	O
latex	O
beads	O
through	O
a	O
streptavidin	O
-	O
biotin	O
interaction	O
and	O
then	O
hybridized	O
with	O
complementary	O
oligonucleotides	O
on	O
the	O
strip	O
.	O

The	O
accumulation	O
of	O
captured	O
latex	O
beads	O
on	O
the	O
test	O
and	O
control	O
lines	O
produced	O
blue	O
bands	O
,	O
enabling	O
visual	O
detection	O
with	O
the	O
naked	O
eye	O
.	O

The	O
PCR	O
-	O
dipstick	O
DNA	O
chromatography	O
detected	O
quantities	O
as	O
low	O
as	O
100	O
pg	O
of	O
DNA	O
amplicons	O
and	O
demonstrated	O
10	O
-	O
to	O
1000	O
-	O
fold	O
higher	O
sensitivity	O
than	O
PCR	O
-	O
agarose	O
gel	O
electrophoresis	O
,	O
depending	O
on	O
the	O
target	O
bacterial	O
species	O
.	O

Semiquantification	O
of	O
bacteria	O
was	O
performed	O
by	O
obtaining	O
a	O
series	O
of	O
chromatograms	O
using	O
serial	O
10	O
-	O
fold	O
dilution	O
of	O
PCR	O
-	O
amplified	O
DNA	O
extracted	O
from	O
dental	O
plaque	O
samples	O
.	O

The	O
assay	O
time	O
was	O
less	O
than	O
3	O
h	O
.	O
The	O
semiquantification	O
procedure	O
revealed	O
the	O
relative	O
amounts	O
of	O
each	O
test	O
species	O
in	O
dental	O
plaque	O
samples	O
,	O
indicating	O
that	O
this	O
disposable	O
device	O
has	O
great	O
potential	O
in	O
analysis	O
of	O
microbial	O
composition	O
in	O
the	O
oral	O
cavity	O
and	O
intestinal	O
tract	O
,	O
as	O
well	O
as	O
in	O
point	O
-	O
of	O
-	O
care	O
diagnosis	O
of	O
microbiota	O
-	O
associated	O
diseases	O
.	O

Black	O
lion	O
tamarins	O
(	O
Leontopithecus	O
chrysopygus	O
)	O
are	O
endangered	O
callithrichids	O
.	O

Their	O
conservation	O
may	O
require	O
future	O
translocations	O
or	O
reintroductions	O
;	O
however	O
these	O
approaches	O
involve	O
risks	O
of	O
pathogen	O
introduction	O
in	O
the	O
environment	O
and	O
stress	O
-	O
related	O
opportunistic	O
infections	O
in	O
these	O
animals	O
.	O

In	O
order	O
to	O
screen	O
for	O
opportunistic	O
and	O
potential	O
pathogenic	O
bacterial	O
and	O
fungal	O
microbiota	O
,	O
ten	O
free	O
-	O
ranging	O
and	O
ten	O
captive	O
Black	O
lion	O
tamarins	O
were	O
studied	O
and	O
the	O
results	O
compared	O
.	O

Nasal	O
,	O
oral	O
and	O
rectal	O
swabs	O
were	O
collected	O
and	O
cultured	O
for	O
aerobic	O
and	O
facultative	O
anaerobic	O
bacteria	O
and	O
fungi	O
,	O
and	O
a	O
total	O
203	O
bacterial	O
and	O
84	O
fungal	O
isolates	O
were	O
obtained	O
.	O

Overall	O
,	O
the	O
most	O
frequent	O
organisms	O
were	O
Staphylococcus	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
Bacillus	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
Candida	O
spp	O
.	O
and	O
Aspergillus	O
spp	O
.	O

Microbiota	O
of	O
free	O
-	O
ranging	O
and	O
captive	O
animals	O
were	O
similar	O
in	O
composition	O
.	O

A	O
number	O
of	O
potentially	O
pathogenic	O
organisms	O
were	O
identified	O
,	O
emphasizing	O
the	O
importance	O
of	O
microbiological	O
screening	O
in	O
future	O
translocation	O
or	O
reintroduction	O
conservation	O
management	O
programs	O
.	O

Nonimmune	O
binding	O
of	O
immunoglobulins	O
via	O
the	O
Fc	O
fragment	O
may	O
reduce	O
opsonization	O
and	O
phagocytosis	O
of	O
bacteria	O
and	O
is	O
thus	O
considered	O
a	O
virulence	O
factor	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
a	O
wide	O
range	O
of	O
oral	O
bacterial	O
strains	O
for	O
the	O
presence	O
of	O
human	O
immunoglobulin	O
G	O
(	O
IgG	O
)	O
Fc	O
-	O
binding	O
activity	O
.	O

A	O
total	O
of	O
132	O
strains	O
representing	O
40	O
different	O
gram	O
-	O
positive	O
and	O
gram	O
negative	O
bacterial	O
species	O
were	O
tested	O
for	O
IgG	O
Fc	O
-	O
binding	O
activity	O
by	O
using	O
a	O
fast	O
and	O
simple	O
dot	O
blot	O
procedure	O
with	O
horseradish	O
peroxidase	O
-	O
conjugated	O
Fc	O
fragments	O
from	O
human	O
IgG	O
.	O

Neither	O
the	O
human	O
nor	O
animal	O
biotype	O
of	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
possessed	O
IgG	O
Fc	O
-	O
binding	O
activity	O
.	O

The	O
strongest	O
positive	O
reaction	O
of	O
gram	O
-	O
negative	O
species	O
with	O
the	O
IgG	O
Fc	O
fragments	O
were	O
obtained	O
with	O
strains	O
of	O
Prevotella	B-bacteria
intermedia	I-bacteria
and	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
.	O

Among	O
the	O
gram	O
-	O
positive	O
bacteria	O
tested	O
,	O
Peptostreptococcus	B-bacteria
micros	I-bacteria
,	O
Lactobacillus	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
and	O
several	O
species	O
of	O
streptococci	B-bacteria
possessed	O
IgG	O
Fc	O
-	O
binding	O
activity	O
.	O

In	O
the	O
present	O
investigation	O
,	O
the	O
ability	O
of	O
several	O
oral	O
bacterial	O
species	O
to	O
bind	O
IgG	O
Fc	O
fragments	O
was	O
demonstrated	O
.	O

This	O
factor	O
represents	O
a	O
potential	O
virulence	O
determinant	O
as	O
it	O
may	O
help	O
pathogenic	O
oral	O
bacteria	O
escape	O
host	O
defense	O
mechanisms	O
.	O

Viable	O
counts	O
and	O
activities	O
of	O
sulfate	B-bacteria
-	I-bacteria
reducing	I-bacteria
bacteria	I-bacteria
were	O
determined	O
in	O
the	O
oral	O
cavities	O
of	O
12	O
healthy	O
volunteers	O
.	O

Of	O
these	O
,	O
10	O
harboured	O
viable	O
sulfate	B-bacteria
-	I-bacteria
reducing	I-bacteria
bacteria	I-bacteria
populations	O
.	O

Six	O
separate	O
sites	O
were	O
sampled	O
:	O
the	O
posterior	O
tongue	O
,	O
anterior	O
tongue	O
,	O
mid	O
buccal	O
mucosa	O
,	O
vestibular	O
mucosa	O
,	O
supragingival	O
plaque	O
and	O
subgingival	O
plaque	O
.	O

Sulfate	B-bacteria
-	I-bacteria
reducing	I-bacteria
bacteria	I-bacteria
occurred	O
in	O
all	O
areas	O
,	O
with	O
the	O
highest	O
incidence	O
in	O
supragingival	O
plaque	O
.	O

Viable	O
counts	O
and	O
sulfate	O
-	O
reducing	O
activities	O
in	O
each	O
of	O
the	O
regions	O
varied	O
from	O
0	O
to	O
10	O
(	O
8	O
)	O
cfu	O
(	O
g	O
wet	O
weight	O
)	O
-	O
1	O
and	O
from	O
0	O
to	O
50	O
nmol	O
(	O
g	O
wet	O
weight	O
)	O
-	O
1	O
h	O
-	O
1	O
,	O
respectively	O
.	O

As	O
sulfate		B-bacteria
-	I-bacteria
reducing	I-bacteria
bacteria	I-bacteria
can	O
be	O
detected	O
in	O
the	O
oral	O
cavity	O
,	O
they	O
may	O
potentially	O
be	O
involved	O
in	O
terminal	O
oxidative	O
processes	O
carried	O
out	O
by	O
the	O
microflora	O
of	O
the	O
mouth	O
.	O

The	O
expression	O
of	O
sialy	O
-	O
Lewis	O
(	O
x	O
)	O
(	O
sLe	O
(	O
x	O
)	O
;	O
Neu5Ac	O
alpha	O
2	O
-	O
3	O
Gal	O
beta	O
1	O
-	O
4	O
)	O
(	O
Fuc	O
alpha	O
1	O
-	O
3	O
)	O
GlcNAc	O
-	O
R	O
)	O
on	O
oral	O
bacteria	O
producing	O
infective	O
endocarditis	O
was	O
determined	O
by	O
a	O
whole	O
-	O
cell	O
enzyme	O
linked	O
immunosorbent	O
assay	O
and	O
an	O
immunoelectron	O
microscopy	O
using	O
the	O
well	O
-	O
characterized	O
anti	O
-	O
sLe	O
(	O
x	O
)	O
monoclonal	O
antibody	O
SNH	O
-	O
3	O
(	O
mAb	O
SNH	O
-	O
3	O
;	O
IgM	O
class	O
)	O
.	O

mAb	O
SNH	O
-	O
3	O
reacted	O
strongly	O
with	O
whole	O
cells	O
of	O
oral	O
bacteria	O
:	O
Streptococcus	B-bacteria
sanguis	I-bacteria
,	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Streptococcus	B-bacteria
mitis	I-bacteria
,	O
Streptococcus	B-bacteria
salivarius	I-bacteria
,	O
Streptococcus	B-bacteria
intermedius	I-bacteria
,	O
Streptococcus	B-bacteria
constellatus	I-bacteria
,	O
Streptococcus	B-bacteria
anginosus	I-bacteria
,	O
Streptococcus	B-bacteria
pyogenes	I-bacteria
,	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Eikenella	B-bacteria
corrodens	I-bacteria
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
.	O

The	O
negatively	O
stained	O
immuno	O
-	O
electron	O
micrograph	O
of	O
Streptococcus	B-bacteria
pyogenes	I-bacteria
showed	O
many	O
reactive	O
gold	O
particles	O
on	O
the	O
cell	O
surface	O
.	O

Our	O
findings	O
demonstrated	O
the	O
existence	O
of	O
immunologic	O
mimicry	O
between	O
the	O
sLe	O
(	O
x	O
)	O
oligosaccharide	O
and	O
cell	O
surface	O
antigens	O
of	O
many	O
species	O
associated	O
with	O
infective	O
endocarditis	O
.	O

We	O
propose	O
the	O
hypothesis	O
that	O
if	O
these	O
bacteria	O
escape	O
their	O
normal	O
habitats	O
,	O
the	O
surface	O
components	O
that	O
mimic	O
the	O
sLe	O
(	O
x	O
)	O
oligosaccharide	O
might	O
bind	O
to	O
host	O
antigens	O
of	O
the	O
selectin	O
family	O
which	O
could	O
promote	O
binding	O
to	O
endothelial	O
cells	O
and	O
,	O
consequently	O
,	O
initiation	O
of	O
the	O
events	O
leading	O
to	O
infective	O
endocarditis	O
.	O

In	O
order	O
to	O
examine	O
the	O
possible	O
implication	O
of	O
human	O
epithelial	O
and	O
endothelial	O
cells	O
in	O
the	O
pathogenesis	O
of	O
various	O
diseases	O
associated	O
with	O
oral	O
viridans	B-bacteria
streptococci	I-bacteria
,	O
we	O
tested	O
the	O
immunomodulatory	O
effects	O
of	O
11	O
representative	O
strains	O
of	O
oral	O
viridans	B-bacteria
streptococci	I-bacteria
on	O
human	O
epithelial	O
cells	O
and	O
endothelial	O
cells	O
.	O

We	O
then	O
examined	O
the	O
possible	O
role	O
of	O
two	O
major	O
adhesins	O
from	O
oral	O
viridans	B-bacteria
streptococci	I-bacteria
,	O
protein	O
I	O
/	O
II	O
and	O
rhamnose	O
-	O
glucose	O
polymers	O
(	O
RGPs	O
)	O
,	O
in	O
this	O
process	O
.	O

In	O
this	O
study	O
we	O
demonstrate	O
that	O
oral	O
viridans	B-bacteria
streptococci	I-bacteria
are	O
potent	O
stimulators	O
of	O
interleukin	O
-	O
8	O
(	O
IL	O
-	O
8	O
)	O
production	O
from	O
KB	O
cells	O
and	O
of	O
IL	O
-	O
6	O
and	O
IL	O
-	O
8	O
production	O
from	O
endothelial	O
cells	O
.	O

The	O
ability	O
of	O
protein	O
I	O
/	O
II	O
and	O
RGPs	O
to	O
contribute	O
to	O
these	O
effects	O
was	O
then	O
examined	O
.	O

Using	O
biotinylated	O
protein	O
I	O
/	O
IIf	O
and	O
RGPs	O
from	O
Streptococcus	B-bacteria
mutans	I-bacteria
OMZ	I-bacteria
175	I-bacteria
,	O
we	O
showed	O
that	O
these	O
adhesins	O
bind	O
to	O
KB	O
and	O
endothelial	O
cells	O
through	O
specific	O
interactions	O
and	O
that	O
the	O
binding	O
of	O
these	O
molecules	O
initiates	O
the	O
release	O
of	O
IL	O
-	O
8	O
from	O
KB	O
cells	O
and	O
of	O
IL	O
-	O
6	O
and	O
IL	O
-	O
8	O
from	O
endothelial	O
cells	O
.	O

These	O
results	O
suggest	O
that	O
protein	O
I	O
/	O
IIf	O
and	O
RGPs	O
play	O
an	O
important	O
role	O
in	O
the	O
interactions	O
between	O
bacteria	O
and	O
KB	O
and	O
endothelial	O
cells	O
in	O
that	O
similar	O
cytokine	O
profiles	O
are	O
obtained	O
when	O
cells	O
are	O
stimulated	O
with	O
bacteria	O
or	O
surface	O
components	O
.	O

We	O
also	O
provide	O
evidence	O
that	O
protein	O
I	O
/	O
IIf	O
binds	O
to	O
and	O
stimulates	O
KB	O
and	O
endothelial	O
cells	O
through	O
lectin	O
interactions	O
that	O
N	O
-	O
acetyl	O
neuraminic	O
acid	O
(	O
NANA	O
)	O
and	O
fucose	O
present	O
on	O
cell	O
surface	O
glycoproteins	O
may	O
form	O
the	O
recognition	O
site	O
since	O
binding	O
and	O
cytokine	O
release	O
can	O
be	O
inhibited	O
by	O
dispase	O
and	O
periodate	O
treatment	O
of	O
cells	O
and	O
by	O
NANA	O
and	O
fucose	O
.	O

These	O
results	O
demonstrate	O
that	O
ora	O
viridans	B-bacteria
streptococci	I-bacteria
,	O
probably	O
by	O
engaging	O
two	O
cell	O
surface	O
adhesins	O
,	O
exert	O
immunomodulatory	O
effects	O
on	O
human	O
KB	O
and	O
endothelial	O
cells	O
.	O

This	O
study	O
compared	O
the	O
antimicrobial	O
effectiveness	O
of	O
nine	O
dental	O
materials	O
and	O
a	O
negative	O
control	O
agent	O
against	O
21	O
strains	O
or	O
species	O
of	O
bacteria	O
using	O
an	O
agar	O
diffusion	O
assay	O
.	O

The	O
materials	O
were	O
:	O
1	O
.	O
Camphorated	O
parachlorophenol	O
mixed	O
with	O
calcium	O
hydroxide	O
(	O
CPC	O
+	O
Ca	O
(	O
OH	O
)	O
2	O
)	O
.	O

2	O
.	O
CPC	O
mixed	O
with	O
zinc	O
oxide	O
(	O
CPC	O
+	O
ZnO	O
)	O
.	O

3	O
.	O
Formocresol	O
mixed	O
with	O
zinc	O
oxide	O
and	O
eugenol	O
(	O
FC	O
+	O
ZOE	O
)	O
.	O

4	O
.	O
Chlorhexidine	O
mixed	O
with	O
ZOE	O
(	O
CHX	O
+	O
ZOE	O
)	O
.	O

5	O
.	O
Kri	O
paste	O
.	O

6	O
.	O
ZOE	O
.	O

7	O
.	O
Zinc	O
oxide	O
mixed	O
with	O
sterile	O
water	O
(	O
ZnO	O
+	O
H2O	O
)	O
.	O

8	O
.	O
Calcium	O
hydroxide	O
mixed	O
with	O
sterile	O
water	O
(	O
Ca	O
(	O
OH	O
)	O
2	O
+	O
H2O	O
)	O
.	O

9	O
.	O
Vitapex	O
.	O

10	O
.	O
Vaseline	O
(	O
control	O
)	O
.	O

The	O
test	O
bacteria	O
represented	O
species	O
commonly	O
isolated	O
from	O
nonvital	O
primary	O
and	O
permanent	O
tooth	O
root	O
canals	O
.	O

The	O
antimicrobial	O
effectiveness	O
of	O
the	O
materials	O
was	O
divided	O
into	O
five	O
groups	O
based	O
on	O
the	O
diameters	O
of	O
the	O
zones	O
of	O
inhibition	O
against	O
all	O
test	O
bacteria	O
and	O
distribution	O
of	O
the	O
data	O
.	O

All	O
materials	O
except	O
Vaseline	O
showed	O
antimicrobial	O
activity	O
against	O
some	O
of	O
the	O
21	O
organisms	O
.	O

Generally	O
,	O
all	O
materials	O
inhibited	O
gram	O
-	O
negative	O
anaerobic	O
bacteria	O
more	O
effectively	O
than	O
aerotolerant	O
gram	O
-	O
negative	O
or	O
gram	O
-	O
positive	O
bacteria	O
.	O

Materials	O
containing	O
CPC	O
or	O
FC	O
(	O
except	O
Kri	O
paste	O
)	O
produced	O
strong	O
or	O
medium	O
strong	O
inhibition	O
against	O
most	O
bacteria	O
.	O

CHX	O
+	O
ZOE	O
,	O
Kri	O
paste	O
,	O
ZnO	O
+	O
H2O	O
,	O
and	O
ZOE	O
inhibited	O
all	O
or	O
most	O
bacteria	O
,	O
but	O
to	O
lesser	O
extent	O
than	O
CPC	O
+	O
Ca	O
(	O
OH	O
)	O
2	O
,	O
CPC	O
+	O
ZnO	O
,	O
or	O
FC	O
+	O
ZOE	O
.	O

Ca	O
(	O
OH	O
)	O
2	O
+	O
H2O	O
,	O
Vitapex	O
,	O
and	O
Vaseline	O
generally	O
were	O
nonihibitory	O
.	O

The	O
findings	O
should	O
allow	O
a	O
comparative	O
evaluation	O
of	O
antimicrobial	O
effectiveness	O
to	O
be	O
made	O
of	O
materials	O
commonly	O
used	O
in	O
pulpectomy	O
procedures	O
with	O
primary	O
teeth	O
.	O

Extra	O
Parotid	O
Glycoprotein	O
(	O
EP	O
-	O
GP	O
)	O
is	O
a	O
glycoprotein	O
isolated	O
from	O
human	O
saliva	O
,	O
having	O
homologues	O
in	O
several	O
other	O
body	O
fluids	O
.	O

The	O
biological	O
role	O
of	O
EP	O
-	O
GP	O
and	O
its	O
homologues	O
is	O
unknown	O
.	O

Recently	O
,	O
EP	O
-	O
GP	O
was	O
shown	O
to	O
bind	O
in	O
vitro	O
to	O
the	O
bacterium	O
Streptococcus	B-bacteria
salivarius	I-bacteria
HB	I-bacteria
.	O

In	O
contrast	O
,	O
no	O
binding	O
to	O
a	O
number	O
of	O
other	O
oral	O
microorganisms	O
could	O
be	O
demonstrated	O
.	O

In	O
the	O
present	O
study	O
we	O
have	O
determined	O
whether	O
binding	O
of	O
EP	O
-	O
GP	O
to	O
bacteria	O
occurs	O
in	O
vivo	O
in	O
saliva	O
and	O
in	O
other	O
EP	O
-	O
GP	O
containing	O
body	O
fluids	O
.	O

Therefore	O
the	O
presence	O
of	O
EP	O
-	O
GP	O
on	O
bacteria	O
in	O
vivo	O
was	O
determined	O
by	O
analyzing	O
oral	O
,	O
skin	O
and	O
ear	O
floras	O
by	O
confocal	O
fluoresence	O
microscopy	O
using	O
specific	O
antibodies	O
.	O

About	O
12	O
%	O
of	O
the	O
in	O
vivo	O
oral	O
flora	O
had	O
EP	O
-	O
GP	O
present	O
on	O
their	O
surface	O
,	O
while	O
approximately	O
5	O
%	O
of	O
the	O
bacteria	O
from	O
ear	O
canal	O
or	O
skin	O
was	O
positive	O
for	O
EP	O
-	O
GP	O
.	O

IgA	O
was	O
detected	O
on	O
approximately	O
65	O
%	O
of	O
the	O
salivary	O
bacteria	O
,	O
whereas	O
the	O
high	O
-	O
molecular	O
weight	O
mucin	O
(	O
MG1	O
)	O
and	O
cystatin	O
C	O
were	O
not	O
detectable	O
on	O
any	O
oral	O
bacterium	O
.	O

Using	O
a	O
replica	O
-	O
plate	O
assay	O
,	O
a	O
number	O
of	O
EP	O
-	O
GP	O
binding	O
strains	O
in	O
saliva	O
were	O
isolated	O
and	O
identified	O
as	O
Gemella	B-bacteria
haemolysans	I-bacteria
,	O
Gemella	B-bacteria
morbillorium	I-bacteria
,	O
Streptococcus	B-bacteria
acidominimus	I-bacteria
,	O
Streptococcus	B-bacteria
oralis	I-bacteria
,	O
Streptococcus	B-bacteria
salivarius	I-bacteria
and	O
Streptococcus	B-bacteria
parasanguis	I-bacteria
.	O

Bacteria	O
from	O
the	O
ear	O
canal	O
and	O
skin	O
bacteria	O
were	O
identified	O
as	O
Staphylococcus	B-bacteria
hominis	I-bacteria
.	O

It	O
is	O
concluded	O
that	O
EP	O
-	O
GP	O
is	O
selectively	O
bound	O
in	O
vivo	O
to	O
several	O
oral	O
and	O
non	O
-	O
oral	O
bacterial	O
species	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
prevalence	O
of	O
the	O
microbiota	O
on	O
the	O
oral	O
mucosal	O
surfaces	O
and	O
in	O
the	O
peri	O
-	O
implant	O
pocket	O
in	O
edentulous	O
subjects	O
with	O
a	O
past	O
history	O
of	O
periodontitis	O
.	O

Twenty	O
edentulous	O
subjects	O
wearing	O
dental	O
implants	O
for	O
at	O
least	O
one	O
year	O
and	O
with	O
a	O
history	O
of	O
periodontitis	O
participated	O
in	O
this	O
study	O
.	O

Clinical	O
parameters	O
were	O
assessed	O
(	O
plaque	O
,	O
redness	O
,	O
swelling	O
,	O
peri	O
-	O
implant	O
probing	O
depth	O
[	O
PIPD	O
]	O
,	O
and	O
bleeding	O
on	O
probing	O
)	O
and	O
microbiological	O
samples	O
were	O
taken	O
(	O
oral	O
mucosal	O
surfaces	O
,	O
saliva	O
,	O
plaque	O
,	O
and	O
peri	O
-	O
implant	O
pocket	O
)	O
.	O

Based	O
on	O
the	O
clinical	O
results	O
,	O
the	O
group	O
as	O
a	O
whole	O
showed	O
healthy	O
peri	O
-	O
implant	O
tissues	O
.	O

A	O
mean	O
PIPD	O
of	O
3	O
.	O
6	O
mm	O
was	O
found	O
.	O

A	O
statistically	O
significant	O
correlation	O
was	O
found	O
between	O
the	O
PIPD	O
and	O
bleeding	O
upon	O
probing	O
,	O
plaque	O
scores	O
,	O
redness	O
,	O
and	O
swelling	O
.	O

Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
were	O
not	O
detected	O
.	O

The	O
subjects	O
harboring	O
Prevotella	B-bacteria
intermedia	I-bacteria
showed	O
presence	O
of	O
PIPD	O
of	O
>	O
or	O
=	O
5	O
mm	O
.	O

All	O
subjects	O
harbored	O
Peptostreptococcus	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
Fusobacterium	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
and	O
other	O
Prevotella	B-bacteria
species	I-bacteria
.	O

Actinomyces	B-bacteria
odontolyticus	I-bacteria
,	O
Bacteroides	B-bacteria
forsythus	I-bacteria
,	O
Campylobacter	B-bacteria
rectus	I-bacteria
,	O
Pseudomonas	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
and	O
enterobacteria	B-bacteria
were	O
detected	O
less	O
frequently	O
.	O

Three	O
subjects	O
showed	O
signs	O
of	O
overt	O
soft	O
tissue	O
inflammation	O
.	O

They	O
harbored	O
higher	O
proportions	O
of	O
Peptostreptococcus	B-bacteria
spp	I-bacteria
.	I-bacteria
than	O
the	O
other	O
subjects	O
.	O

The	O
results	O
corroborate	O
the	O
suggestion	O
that	O
the	O
primary	O
source	O
of	O
colonization	O
for	O
dental	O
implants	O
in	O
edentulous	O
patients	O
are	O
the	O
oral	O
mucous	O
membranes	O
.	O

The	O
results	O
indicate	O
that	O
the	O
microbiota	O
of	O
subjects	O
wearing	O
dental	O
implants	O
with	O
a	O
past	O
history	O
of	O
periodontitis	O
are	O
composed	O
of	O
bacteria	O
associated	O
with	O
a	O
healthy	O
periodontium	O
or	O
gingivitis	O
.	O

It	O
is	O
suggested	O
that	O
elimination	O
of	O
the	O
subgingival	O
environment	O
by	O
extraction	O
of	O
all	O
natural	O
teeth	O
probably	O
initiates	O
the	O
disappearance	O
of	O
the	O
two	O
periodonta	O
bacteria	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
.	O

Various	O
oral	O
bacterial	O
species	O
were	O
found	O
to	O
inhibit	O
the	O
growth	O
of	O
Helicobacter	B-bacteria
pylori	I-bacteria
strains	I-bacteria
.	O

The	O
growth	O
inhibitory	O
activities	O
of	O
most	O
of	O
these	O
oral	O
bacteria	O
were	O
adversely	O
affected	O
by	O
heating	O
at	O
80	O
degrees	O
C	O
for	O
60	O
min	O
or	O
by	O
protease	O
treatment	O
,	O
indicating	O
that	O
these	O
bacteria	O
produce	O
bacteriocin	O
-	O
like	O
inhibitory	O
proteins	O
against	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
strains	I-bacteria
.	O

The	O
antagonistic	O
effects	O
of	O
oral	O
bacteria	O
against	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
may	O
restrain	O
colonization	O
by	O
this	O
organism	O
in	O
the	O
oral	O
cavity	O
.	O

Halitosis	O
is	O
most	O
often	O
caused	O
by	O
oral	O
conditions	O
.	O

Volatile	O
sulfur	O
compounds	O
(	O
VSC	O
)	O
,	O
constituting	O
the	O
major	O
components	O
of	O
oral	O
malodor	O
,	O
are	O
produced	O
by	O
anaerobic	O
,	O
gram	O
-	O
negative	O
bacteria	O
retained	O
mainly	O
in	O
periodontal	O
pockets	O
or	O
on	O
the	O
tongue	O
dorsum	O
.	O

Sulfur	O
-	O
containing	O
amino	O
acids	O
serve	O
as	O
substrate	O
for	O
these	O
bacteria	O
.	O

VSC	O
have	O
also	O
been	O
found	O
to	O
have	O
unfavorable	O
effect	O
on	O
the	O
tissue	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
examine	O
whether	O
normal	O
,	O
healthy	O
individuals	O
with	O
no	O
history	O
of	O
halitosis	O
were	O
able	O
to	O
produce	O
VSC	O
from	O
cysteine	O
,	O
when	O
applied	O
as	O
a	O
mouthrinse	O
.	O

A	O
further	O
aim	O
of	O
the	O
study	O
was	O
to	O
investigate	O
and	O
compare	O
the	O
potential	O
of	O
other	O
Sulfur	O
-	O
containing	O
amino	O
acids	O
and	O
peptides	O
as	O
substrates	O
for	O
oral	O
VSC	O
production	O
and	O
to	O
localize	O
the	O
odor	O
-	O
production	O
sites	O
.	O

A	O
portable	O
sulfide	O
monitor	O
was	O
used	O
for	O
VSC	O
registration	O
.	O

Results	O
showed	O
that	O
all	O
test	O
subjects	O
produced	O
high	O
oral	O
concentrations	O
of	O
VSC	O
upon	O
rinses	O
with	O
cysteine	O
,	O
which	O
thus	O
seems	O
to	O
be	O
a	O
major	O
substrate	O
for	O
VSC	O
production	O
.	O

The	O
other	O
sulfur	O
-	O
containing	O
substrates	O
had	O
much	O
less	O
effect	O
.	O

It	O
was	O
found	O
that	O
the	O
tongue	O
was	O
the	O
major	O
site	O
for	O
VSC	O
production	O
,	O
and	O
that	O
saliva	O
per	O
se	O
caused	O
low	O
VSC	O
production	O
.	O

In	O
the	O
antimicrobial	O
therapy	O
of	O
denture	O
stomatitis	O
,	O
it	O
is	O
desirable	O
to	O
inhibit	O
the	O
growth	O
of	O
not	O
only	O
the	O
primary	O
causative	O
organism	O
,	O
Candida	O
albicans	O
,	O
but	O
also	O
other	O
oral	O
bacteria	O
closely	O
associated	O
with	O
the	O
condition	O
.	O

Three	O
synthetic	O
anti	O
-	O
candidal	O
chalcones	O
were	O
characterized	O
and	O
compared	O
for	O
their	O
additional	O
activity	O
in	O
inhibiting	O
these	O
causative	O
bacteria	O
.	O

Among	O
the	O
tested	O
chalcones	O
,	O
2	O
,	O
4	O
,	O
2	O
'	O
-	O
trihydroxy	O
-	O
5	O
'	O
-	O
methylchalcone	O
showed	O
the	O
highest	O
activity	O
for	O
different	O
Gram	O
-	O
positive	O
bacteria	O
.	O

It	O
inhibited	O
the	O
growth	O
of	O
streptococci	B-bacteria
,	O
staphylococci	B-bacteria
and	O
lactobacilli	B-bacteria
at	O
25	O
.	O
0	O
-	O
50	O
.	O
0	O
micrograms	O
/	O
mL	O
which	O
was	O
lower	O
than	O
or	O
comparable	O
to	O
its	O
minimum	O
inhibitory	O
concentration	O
for	O
candida	O
.	O

It	O
functioned	O
with	O
a	O
bactericidal	O
action	O
and	O
leaked	O
260	O
nm	O
-	O
absorbing	O
substances	O
from	O
the	O
streptococcal	O
cells	O
.	O

The	O
antimicrobial	O
activity	O
of	O
2	O
,	O
4	O
,	O
2	O
'	O
-	O
trihydroxy	O
-	O
5	O
'	O
-	O
methylchalcone	O
against	O
both	O
primary	O
and	O
secondary	O
causative	O
agents	O
suggests	O
it	O
could	O
be	O
useful	O
as	O
a	O
potent	O
therapeutic	O
agent	O
in	O
denture	O
stomatitis	O
.	O

The	O
objective	O
of	O
this	O
60	O
-	O
day	O
single	O
-	O
blind	O
,	O
parallel	O
trial	O
,	O
using	O
150	O
subjects	O
,	O
was	O
to	O
evaluate	O
the	O
effect	O
of	O
a	O
20	O
%	O
sodium	O
bicarbonate	O
dentifrice	O
,	O
a	O
1	O
.	O
5	O
%	O
hydrogen	O
peroxide	O
solution	O
and	O
a	O
mouth	O
moisturizer	O
on	O
oral	O
tissues	O
and	O
microflora	O
.	O

Subjects	O
were	O
randomly	O
assigned	O
to	O
one	O
of	O
five	O
groups	O
.	O

The	O
treatments	O
were	O
:	O
1	O
)	O
Sage	O
dentifrice	O
(	O
sodium	O
bicarbonate	O
)	O
.	O

Toothette	O
Plus	O
containing	O
baking	O
soda	O
saturated	O
with	O
the	O
hydrogen	O
peroxide	O
solution	O
and	O
use	O
of	O
a	O
mouth	O
moisturizer	O
,	O
2	O
)	O
Crest	O
dentifrice	O
,	O
Toothette	O
Plus	O
containing	O
baking	O
soda	O
saturated	O
with	O
the	O
hydrogen	O
peroxide	O
solution	O
and	O
use	O
of	O
a	O
mouth	O
moisturizer	O
,	O
3	O
)	O
Crest	O
dentifrice	O
,	O
Toothette	O
Plus	O
containing	O
baking	O
soda	O
with	O
a	O
control	O
solution	O
and	O
no	O
mouth	O
moisturizer	O
,	O
4	O
)	O
Crest	O
dentifrice	O
,	O
Toothette	O
(	O
without	O
baking	O
soda	O
)	O
,	O
saturated	O
with	O
a	O
control	O
solution	O
and	O
no	O
mouth	O
moisturizer	O
,	O
and	O
5	O
)	O
Crest	O
dentifrice	O
,	O
Toothette	O
saturated	O
with	O
1	O
.	O
5	O
%	O
flavored	O
H2O2	O
and	O
no	O
mouth	O
moisturizer	O
.	O

From	O
a	O
subgroup	O
of	O
35	O
patients	O
(	O
seven	O
from	O
each	O
group	O
)	O
buccal	O
smears	O
for	O
exfoliative	O
cytology	O
were	O
taken	O
as	O
were	O
supragingival	O
microbiological	O
samples	O
from	O
the	O
mesial	O
aspect	O
of	O
first	O
molars	O
(	O
pooled	O
)	O
.	O

Buccal	O
smears	O
were	O
evaluated	O
for	O
signs	O
of	O
histopathological	O
changes	O
.	O

Microbiological	O
samples	O
from	O
supra	O
-	O
and	O
subgingival	O
plaque	O
for	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
,	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
.	O

A	B-bacteria
viscosus	I-bacteria
,	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
,	O
F	B-bacteria
.	I-bacteria
sanguis	I-bacteria
and	O
C	O
.	O
albicans	O
were	O
evaluated	O
.	O

Clinical	O
parameters	O
measured	O
were	O
a	O
stain	O
index	O
(	O
SI	O
)	O
,	O
the	O
modified	O
gingival	O
index	O
(	O
MGI	O
)	O
,	O
and	O
a	O
plaque	O
index	O
(	O
PI	O
)	O
.	O

There	O
were	O
no	O
adverse	O
changes	O
in	O
the	O
oral	O
microflora	O
and	O
no	O
anaplastic	O
or	O
other	O
pathological	O
changes	O
in	O
any	O
subjects	O
.	O

Clinical	O
parameters	O
showed	O
a	O
statistically	O
significant	O
reduction	O
in	O
the	O
MGI	O
ranging	O
from	O
26	O
.	O
7	O
-	O
29	O
.	O
9	O
%	O
with	O
no	O
significant	O
differences	O
among	O
the	O
groups	O
(	O
p	O
>	O
0	O
.	O
05	O
)	O
.	O

The	O
PI	O
showed	O
small	O
reductions	O
in	O
all	O
groups	O
except	O
group	O
2	O
,	O
but	O
the	O
differences	O
were	O
not	O
statistically	O
significant	O
from	O
each	O
other	O
or	O
baseline	O
(	O
p	O
>	O
0	O
.	O
05	O
)	O
.	O

The	O
SI	O
revealed	O
slight	O
increases	O
in	O
all	O
groups	O
and	O
no	O
differences	O
among	O
the	O
groups	O
.	O

It	O
can	O
be	O
concluded	O
that	O
use	O
of	O
Sage	O
dentifrice	O
,	O
Toothette	O
Plus	O
saturated	O
with	O
Perox	O
-	O
A	O
-	O
Mint	O
and	O
Sage	O
Mouth	O
Moisturizer	O
are	O
safe	O
to	O
oral	O
tissues	O
.	O

Using	O
these	O
components	O
did	O
not	O
result	O
in	O
clinically	O
noticeable	O
stain	O
formation	O
,	O
promote	O
plaque	O
formation	O
,	O
or	O
produce	O
any	O
significant	O
adverse	O
changes	O
in	O
the	O
oral	O
microflora	O
.	O

The	O
bactericidal	O
efficacy	O
of	O
two	O
types	O
of	O
Listerine	O
;	O
Listerine	O
and	O
Cool	O
Mint	O
Listerine	O
,	O
and	O
povidone	O
iodine	O
on	O
oral	O
microorganisms	O
,	O
methicillin	B-bacteria
-	I-bacteria
resistant	I-bacteria
Staphylococcus	I-bacteria
aureus	I-bacteria
(	O
MRSA	B-bacteria
)	O
,	O
Streptococcus	B-bacteria
pyogenes	I-bacteria
,	O
Helicobacter	B-bacteria
pylori	I-bacteria
and	O
Candida	O
albicans	O
were	O
examined	O
.	O

Most	O
of	O
the	O
oral	O
bacteria	O
were	O
killed	O
completely	O
by	O
a	O
10	O
-	O
sec	O
exposure	O
to	O
Listerine	O
or	O
Cool	O
Mint	O
Listerine	O
.	O

H	B-bacteria
.	I-bacteria
pylori	I-bacteria
,	O
MRSA	B-bacteria
and	O
C	O
.	O
albicans	O
were	O
also	O
reduced	O
by	O
a	O
30	O
-	O
sec	O
exposure	O
to	O
the	O
Listerine	O
mouth	O
rinse	O
.	O

Bacteria	O
in	O
dental	O
plaque	O
were	O
decreased	O
by	O
exposure	O
to	O
Listerine	O
,	O
Cool	O
Mint	O
Listerine	O
,	O
and	O
povidone	O
iodine	O
for	O
30	O
seconds	O
.	O

Mouthwashing	O
with	O
Listerine	O
for	O
30	O
seconds	O
resulted	O
in	O
a	O
decrease	O
to	O
approximately	O
1	O
/	O
100	O
of	O
the	O
viable	O
bacterial	O
counts	O
in	O
saliva	O
.	O

These	O
bactericidal	O
effects	O
against	O
bacteria	O
in	O
saliva	O
and	O
dental	O
plaque	O
indicated	O
that	O
Listerine	O
and	O
Cool	O
Mint	O
Listerine	O
antiseptic	O
are	O
useful	O
in	O
oral	O
cavity	O
as	O
antiseptic	O
mouth	O
rinses	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
determine	O
if	O
endodontic	O
bacterial	O
act	O
in	O
vitro	O
on	O
human	O
gingival	O
fibroblast	O
functions	O
via	O
extracellular	O
products	O
.	O

The	O
bacteria	O
used	O
were	O
Prevotella	B-bacteria
nigrescens	I-bacteria
,	O
Capnocytophaga	B-bacteria
ochracea	I-bacteria
,	O
Peptostreptoccocus	B-bacteria
micros	I-bacteria
and	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
.	O

Supernatants	O
were	O
collected	O
from	O
bacterial	O
cultures	O
at	O
the	O
beginning	O
of	O
the	O
stationary	O
phase	O
when	O
their	O
density	O
was	O
similar	O
.	O

Toxins	O
that	O
inhibited	O
fibroblast	O
proliferation	O
were	O
found	O
in	O
all	O
culture	O
supernatants	O
of	O
Gram	O
-	O
positive	O
or	O
Gram	O
-	O
negative	O
bacterial	O
strains	O
,	O
except	O
for	O
Prev	B-bacteria
.	I-bacteria
nigrescens	I-bacteria
.	O

The	O
cytotoxicity	O
of	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
supernatant	O
was	O
about	O
1000	O
fold	O
higher	O
than	O
the	O
others	O
.	O

This	O
supernatant	O
diluted	O
to	O
1	O
/	O
1000	O
led	O
to	O
total	O
fibroblast	O
growth	O
inhibition	O
whereas	O
only	O
25	O
%	O
growth	O
inhibition	O
was	O
obtained	O
with	O
Capn	B-bacteria
.	I-bacteria
ochracea	I-bacteria
and	O
Pept	I-bacteria
.	B-bacteria
micros	I-bacteria
diluted	O
to	O
1	O
/	O
10	O
.	O

Bacterial	O
supernatant	O
proteolytic	O
activity	O
was	O
investigated	O
in	O
confluent	O
fibroblast	O
cultures	O
that	O
were	O
incubated	O
for	O
48	O
hr	O
with	O
each	O
of	O
the	O
supernatants	O
diluted	O
to	O
1	O
/	O
2	O
except	O
for	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
supernatant	O
diluted	O
to	O
1	O
/	O
20	O
.	O

Indirect	O
immunofluorescence	O
studies	O
of	O
extracellular	O
-	O
matrix	O
molecules	O
,	O
followed	O
by	O
immunoelectrophoretic	O
analysis	O
of	O
extracts	O
of	O
whole	O
-	O
cell	O
layers	O
,	O
demonstrated	O
that	O
only	O
conditioned	O
medium	O
of	O
Prev	B-bacteria
.	I-bacteria
nigrescens	I-bacteria
had	O
a	O
proteolytic	O
activity	O
capable	O
of	O
degrading	O
the	O
greater	O
part	O
of	O
type	O
I	O
collagen	O
and	O
fibronectin	O
fibres	O
in	O
the	O
extracellular	O
matrix	O
.	O

There	O
is	O
growing	O
public	O
recognition	O
of	O
the	O
importance	O
of	O
oral	O
health	O
,	O
as	O
symbolized	O
by	O
the	O
theme	O
.	O

`	O
`	O
Oral	O
Health	O
for	O
a	O
Healthy	O
Life	O
'	O
'	O
proposed	O
for	O
the	O
1994	O
World	O
Health	O
Day	O
.	O

In	O
this	O
report	O
,	O
the	O
efficacy	O
of	O
antimicrobial	O
mouth	O
rinses	O
,	O
mainly	O
Listerine	O
,	O
was	O
reviewed	O
by	O
three	O
investigators	O
who	O
are	O
working	O
as	O
a	O
microbiologist	O
,	O
a	O
microbiologist	O
,	O
a	O
dentist	O
,	O
and	O
a	O
dental	O
hygienist	O
participating	O
in	O
oral	O
health	O
care	O
.	O

Listerine	O
,	O
an	O
antimicrobial	O
mouth	O
rinse	O
,	O
completely	O
killed	O
microorganisms	O
in	O
10	O
to	O
30	O
seconds	O
;	O
the	O
microbes	O
includes	O
methicillin	B-bacteria
-	I-bacteria
resistant	I-bacteria
Staphylococcus	I-bacteria
aureus	I-bacteria
,	O
Streptococcus	B-bacteria
pyogenes	I-bacteria
,	O
Helicobacter	B-bacteria
pylori	I-bacteria
,	O
Candida	O
albicans	O
,	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Actinomyces	B-bacteria
viscosus	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
and	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
.	O

Listerine	O
was	O
also	O
weakly	O
effective	O
in	O
inactivating	O
human	O
immunodeficiency	O
viruses	O
.	O

Bacteria	O
in	O
samples	O
collected	O
from	O
human	O
dental	O
plaque	O
and	O
saliva	O
were	O
completely	O
killed	O
within	O
30	O
seconds	O
when	O
exposed	O
to	O
Listerine	O
.	O

When	O
saliva	O
samples	O
were	O
collected	O
from	O
subjects	O
who	O
had	O
rinsed	O
their	O
mouths	O
with	O
20	O
ml	O
of	O
Listerine	O
or	O
1	O
:	O
50	O
diluted	O
povidone	O
-	O
iodine	O
,	O
levels	O
of	O
viable	O
anaerobic	O
bacteria	O
in	O
the	O
samples	O
were	O
reduced	O
to	O
1	O
%	O
.	O

When	O
Listerine	O
was	O
used	O
for	O
oral	O
surgery	O
such	O
as	O
tooth	O
extraction	O
and	O
periodontal	O
surgery	O
,	O
the	O
agent	O
was	O
effective	O
in	O
relieving	O
toothache	O
.	O

This	O
was	O
probably	O
due	O
to	O
a	O
decrease	O
in	O
oral	O
bacteria	O
by	O
the	O
antimicrobial	O
action	O
of	O
Listerine	O
,	O
leading	O
to	O
lowering	O
the	O
inflammatory	O
response	O
of	O
the	O
host	O
.	O

The	O
use	O
of	O
antimicrobial	O
mouth	O
rinse	O
during	O
dental	O
treatments	O
such	O
as	O
endodontic	O
treatment	O
proved	O
effective	O
for	O
more	O
reliable	O
infection	O
control	O
.	O

In	O
Japan	O
,	O
there	O
are	O
an	O
increasing	O
number	O
of	O
elderly	O
and	O
medically	O
compromised	O
hosts	O
who	O
are	O
potentially	O
at	O
risk	O
for	O
developing	O
pneumonia	O
due	O
to	O
silent	O
aspiration	O
of	O
microbes	O
in	O
the	O
oral	O
cavity	O
and	O
throat	O
.	O

For	O
the	O
aged	O
with	O
such	O
potential	O
risk	O
,	O
using	O
of	O
antimicrobial	O
mouth	O
rinse	O
may	O
be	O
effective	O
in	O
preventing	O
dental	O
plaque	O
accumulation	O
when	O
used	O
in	O
addition	O
to	O
the	O
mechanical	O
control	O
of	O
plaque	O
,	O
since	O
they	O
tend	O
to	O
have	O
difficulty	O
in	O
brushing	O
teeth	O
by	O
themselves	O
.	O

Indeed	O
,	O
the	O
use	O
of	O
antimicrobial	O
mouth	O
rinse	O
in	O
these	O
elderly	O
people	O
proved	O
useful	O
not	O
only	O
in	O
preventing	O
bacterial	O
pneumonia	O
,	O
but	O
also	O
in	O
improving	O
their	O
quality	O
of	O
life	O
by	O
preserving	O
their	O
oral	O
health	O
.	O

The	O
correlation	O
between	O
the	O
number	O
of	O
blood	O
polymorphonuclear	O
granulocytes	O
(	O
PMNs	O
)	O
and	O
the	O
counts	O
of	O
oral	O
bacteria	O
in	O
92	O
children	O
(	O
33	O
girls	O
and	O
59	O
boys	O
)	O
,	O
aged	O
4	O
-	O
15	O
was	O
investigated	O
.	O

The	O
groups	O
of	O
children	O
comprised	O
44	O
healthy	O
individuals	O
and	O
48	O
children	O
suffering	O
from	O
acute	O
lymphoblastic	O
leukaemia	O
who	O
were	O
given	O
intensive	O
antileukaemic	O
chemotherapy	O
.	O

It	O
was	O
found	O
that	O
while	O
the	O
number	O
of	O
PMNs	O
in	O
blood	O
decreased	O
,	O
the	O
counts	O
of	O
Streptococcus	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
Staphylococcus	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
mutans	B-bacteria
streptococci	I-bacteria
,	O
Lactobacillus	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
and	O
Actinomyces	B-bacteria
spp	I-bacteria
.	I-bacteria
in	O
the	O
saliva	O
tended	O
to	O
increase	O
.	O

The	O
similar	O
reciprocal	O
correlation	O
between	O
the	O
number	O
of	O
blood	O
PMNs	O
and	O
the	O
counts	O
of	O
these	O
bacteria	O
in	O
the	O
saliva	O
was	O
found	O
in	O
the	O
group	O
of	O
healthy	O
children	O
.	O

We	O
concluded	O
that	O
the	O
blood	O
PMNs	O
,	O
by	O
influencing	O
the	O
number	O
of	O
oral	O
PMNs	O
which	O
control	O
bacteria	O
in	O
this	O
habitat	O
,	O
influence	O
also	O
the	O
number	O
of	O
some	O
groups	O
of	O
bacteria	O
there	O
.	O

Bacteriocin	O
production	O
has	O
been	O
studied	O
in	O
very	O
few	O
anaerobic	O
bacteria	O
,	O
and	O
no	O
report	O
is	O
available	O
for	O
Fusobacterium	B-bacteria
species	I-bacteria
.	O

In	O
the	O
present	O
study	O
a	O
total	O
of	O
167	O
Fusobacterium	B-bacteria
isolates	I-bacteria
were	O
tested	O
for	O
bacteriocin	O
production	O
:	O
70	O
isolates	O
were	O
obtained	O
from	O
the	O
oral	O
cavity	O
of	O
patients	O
with	O
periodontal	O
disease	O
,	O
47	O
were	O
recovered	O
from	O
healthy	O
oral	O
sites	O
of	O
human	O
subjects	O
and	O
50	O
from	O
the	O
oral	O
cavity	O
of	O
Callithrix	O
penicillata	O
.	O

Autoantagonism	O
and	O
isoantagonism	O
were	O
observed	O
when	O
the	O
bacteriocin	O
-	O
producing	O
isolates	O
were	O
tested	O
against	O
themselves	O
.	O

Heteroantagonism	O
was	O
detected	O
by	O
testing	O
the	O
Fusobacterium	B-bacteria
isolates	I-bacteria
against	O
14	O
reference	O
strains	O
and	O
2	O
strains	O
of	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
from	O
our	O
laboratory	O
collection	O
.	O

The	O
auto	O
-	O
,	O
iso	O
-	O
and	O
heteroantagonism	O
phenomena	O
observed	O
in	O
this	O
comparative	O
study	O
suggest	O
a	O
possible	O
ecological	O
role	O
for	O
this	O
(	O
these	O
)	O
antagonistic	O
substance	O
(	O
s	O
)	O
in	O
the	O
oral	O
environment	O
.	O

Competitive	O
PCR	O
was	O
used	O
to	O
monitor	O
the	O
survival	O
of	O
a	O
520	O
-	O
bp	O
DNA	O
target	O
sequence	O
from	O
a	O
recombinant	O
plasmid	O
,	O
pVACMC1	O
,	O
after	O
admixture	O
of	O
the	O
plasmid	O
with	O
freshly	O
sampled	O
human	O
saliva	O
.	O

The	O
fraction	O
of	O
the	O
target	O
remaining	O
amplifiable	O
ranged	O
from	O
40	O
to	O
65	O
%	O
after	O
10	O
min	O
of	O
exposure	O
to	O
saliva	O
samples	O
from	O
five	O
subjects	O
and	O
from	O
6	O
to	O
25	O
%	O
after	O
60	O
min	O
of	O
exposure	O
.	O

pVACMC1	O
plasmid	O
DNA	O
that	O
had	O
been	O
exposed	O
to	O
degradation	O
by	O
fresh	O
saliva	O
was	O
capable	O
of	O
transforming	O
naturally	O
competent	O
Streptococcus	B-bacteria
gordonii	I-bacteria
DL1	I-bacteria
to	O
erythromycin	O
resistance	O
,	O
although	O
transforming	O
activity	O
decreased	O
rapidly	O
,	O
with	O
a	O
half	O
-	O
life	O
of	O
approximately	O
50	O
s	O
.	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
DL1	I-bacteria
transformants	O
were	O
obtained	O
in	O
the	O
presence	O
of	O
filter	O
-	O
sterilized	O
saliva	O
and	O
a	O
1	O
-	O
microg	O
/	O
ml	O
final	O
concentration	O
of	O
pVACMC1	O
DNA	O
.	O

Addition	O
of	O
filter	O
-	O
sterilized	O
saliva	O
instead	O
of	O
heat	O
-	O
inactivated	O
horse	O
serum	O
to	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
DL1	I-bacteria
cells	O
induced	O
competence	O
,	O
although	O
with	O
slightly	O
lower	O
efficiency	O
.	O

These	O
findings	O
indicate	O
that	O
DNA	O
released	O
from	O
bacteria	O
or	O
food	O
sources	O
within	O
the	O
mouth	O
has	O
the	O
potential	O
to	O
transform	O
naturally	O
competent	O
oral	O
bacteria	O
.	O

However	O
,	O
further	O
investigations	O
are	O
needed	O
to	O
establish	O
whether	O
transformation	O
of	O
oral	O
bacteria	O
can	O
occur	O
at	O
significant	O
frequencies	O
in	O
vivo	O
.	O

There	O
are	O
over	O
300	O
species	O
of	O
bacteria	O
forming	O
populations	O
of	O
several	O
hundred	O
billion	O
in	O
the	O
human	O
oral	O
cavity	O
.	O

The	O
number	O
of	O
bacteria	O
reaches	O
a	O
thousand	O
billion	O
when	O
the	O
mouth	O
is	O
not	O
sufficiently	O
cleaned	O
.	O

Using	O
saliva	O
and	O
gingival	O
crevicular	O
fluid	O
as	O
their	O
main	O
nutrients	O
,	O
these	O
bacteria	O
create	O
their	O
ecological	O
niches	O
on	O
tooth	O
surfaces	O
,	O
gingival	O
crevices	O
,	O
saliva	O
,	O
dorsum	O
linguae	O
,	O
and	O
buccal	O
and	O
pharyngeal	O
mucosa	O
,	O
threatening	O
oral	O
and	O
systemic	O
health	O
.	O

It	O
is	O
known	O
that	O
primary	O
lesions	O
of	O
these	O
chronic	O
bacterial	O
infections	O
secondarily	O
cause	O
nephritis	O
,	O
rheumatoid	O
arthritis	O
,	O
and	O
dermatitis	O
.	O

Further	O
,	O
it	O
has	O
been	O
demonstrated	O
in	O
recent	O
years	O
that	O
bacteria	O
inhabiting	O
the	O
oral	O
cavity	O
can	O
cause	O
bacterial	O
pneumonia	O
and	O
endocarditis	O
and	O
that	O
the	O
periodontal	O
-	O
disease	O
-	O
associated	O
bacteria	O
become	O
causative	O
agents	O
for	O
pregnancy	O
troubles	O
and	O
are	O
involved	O
in	O
blood	O
circulation	O
problem	O
and	O
coronary	O
heart	O
disease	O
.	O

Dentistry	O
reviewed	O
the	O
theme	O
of	O
World	O
Health	O
Day	O
,	O
Oral	O
Health	O
for	O
a	O
Healthy	O
Life	O
,	O
in	O
1994	O
.	O

The	O
8020	O
campaign	O
to	O
promote	O
tooth	O
care	O
is	O
also	O
becoming	O
established	O
in	O
Japan	O
;	O
however	O
,	O
the	O
authors	O
emphasized	O
that	O
this	O
achievement	O
is	O
not	O
the	O
goal	O
of	O
dental	O
health	O
care	O
.	O

In	O
this	O
article	O
,	O
we	O
explain	O
the	O
bases	O
supporting	O
the	O
concept	O
that	O
oral	O
health	O
care	O
,	O
primarily	O
mouth	O
cleaning	O
,	O
is	O
important	O
for	O
not	O
only	O
oral	O
disease	O
but	O
also	O
a	O
healthy	O
life	O
.	O

